Citrus Sinensis ID: 012832

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-----
Protein Sequence
MTVKITWRSIVPNCFSIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGRRRHMRSPRSRTFQSENDHSRNESKSPLHPSSKGA
Secondary Structure (PSIPRED)
ccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHcccccccccccccccEEEcccccccccccccHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHcccccccccEEEEEEccccccccccEEEEEEEEccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEEcccccccHcHccccccccccccccEEEEEccccccccHHHHHcccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHHHHHcccccccccccccccccccccccccccccHHccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccc
Coil and Loop (DISEMBL)
mtvkitwrsivpncfsiqeeekackpkkavkkqssiqrisfvdlsnpssttlsedLSISLAGSNLHVFTLAELKVttqsfsssnflgeggfgavhkgfiddklrpglqaqpvavknldleglqgHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVyeymprgslenqlfrrysvslpwsTRMKIALGAAKGLaflhdaekpviyrdfkasnilldsdytaklsdfglakdgpegddthvstrvmgtqgyaapeyvmtghltsmsDVYSFGVVLLELLSgrksvdksrpqREQSLVEWARPMLNDarklgrimdprlegqyseTGARKAAALAYQClshrpkqrptmsTVVKTleplkdfdddiaiGTFVFtvptessnndknnnedLKECEAKKETKkekgnhrqnhklhndivngrrrhmrsprsrtfqsendhsrnesksplhpsskga
Flexible Loop (DISEMBL)
mtvkitwrsivpncfsiqeeekackpkkavkkqssiqrisfvdlsnpssTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFglakdgpegddTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSgrksvdksrpqreqslvewarpmlndarklgrimdpRLEGQYSETGARKAAALAYQCLshrpkqrptmstVVKTLEPLKDFDDDIAIGTFVftvptessnndknnnedLKECEAKKEtkkekgnhrqnhklhndivngrrrhmrsprsrtfqsendhsrnesksplhpsskga
Low Complexity Region (SEG)
MTVKITWRSIVPNCFSIQeeekackpkkavkkQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTEssnndknnnedlkeceakketkkekGNHRQNHKLHNDIVNGrrrhmrsprsrTFQSENDHSRNESKSPLHPSSKGA
Disordered region (IsUnstruct)
***KITWRSIVPNCFSI**************************************LSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA***********STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS*************************************************AAALAYQCL***********TVVKTLEPLKDFDDDIAIGTFVFTV*******************************************************************************
Disordered Region (DISOPRED)
*TVKITWRSIVPN*****************************************************VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK**********************************************************************************************
Disordered Region (DISEMBL)
MTVKITWRSIVPNCFSIQEE***************IQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR***********QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKE****************NHKLHNDIVNGR**********************************
Disordered Region (DISPRO)
MTVKITWRSIVPNCFSIQ********************************************SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDI****************************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTVKITWRSIVPNCFSIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGRRRHMRSPRSRTFQSENDHSRNESKSPLHPSSKGA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	455	2.2.26 [Sep-21-2011]
Q8GXZ3	410	Serine/threonine-protein	no	no	0.778	0.863	0.659	1e-133
Q9CAH1	450	Putative receptor-like pr	no	no	0.808	0.817	0.618	1e-129
Q9LFP7	493	Probable receptor-like pr	no	no	0.780	0.720	0.594	1e-116
Q9FM85	408	Probable receptor-like pr	no	no	0.778	0.867	0.576	1e-114
P43293	389	Probable serine/threonine	no	no	0.659	0.771	0.641	1e-111
Q9SRH7	490	Receptor-like serine/thre	no	no	0.712	0.661	0.611	1e-111
P46573	412	Protein kinase APK1B, chl	no	no	0.670	0.740	0.628	1e-109
O49840	426	Protein kinase 2B, chloro	no	no	0.681	0.727	0.625	1e-108
Q06548	410	Protein kinase APK1A, chl	no	no	0.676	0.751	0.625	1e-107
O49839	426	Protein kinase 2A, chloro	no	no	0.661	0.706	0.633	1e-106

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  474 bits (1220), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 234/355 (65%), Positives = 277/355 (78%), Gaps = 1/355 (0%)

Query: 13  NCFSIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAE 72
           NC   ++E     P+   ++       S  DLS+PS+    +D    ++ + +  FTL E
Sbjct: 3   NC-GTRDEAAVFTPQAQAQQLQKKHSRSVSDLSDPSTPRFRDDSRTPISYAQVIPFTLFE 61

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV 132
           L+  T+SF     LGEGGFG V+KG+IDD LR GL++ PVAVK L+ EGLQGHREWLTEV
Sbjct: 62  LETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEV 121

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
            FLGQLRHP+LVKLIGYCCE++HRLLVYE+M RGSLEN LFR+ +  L WS RM IALGA
Sbjct: 122 NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGA 181

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           AKGLAFLH+AE+PVIYRDFK SNILLDSDYTAKLSDFGLAK GP+GD+THVSTRVMGT G
Sbjct: 182 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 241

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           YAAPEYVMTGHLT+ SDVYSFGVVLLE+L+GRKSVDK+RP +EQ+LV+WARP LND RKL
Sbjct: 242 YAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKL 301

Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDI 367
            +I+DPRLE QYS   A+KA +LAY CLS  PK RP MS VV+TLEPL+   D +
Sbjct: 302 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDAL 356

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  463 bits (1191), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 233/377 (61%), Positives = 284/377 (75%), Gaps = 9/377 (2%)

Query: 30  VKKQSSI-QRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGE 88
           + +Q+S+  R+   D SN  ST    D S S    N+H+FT  ELK  TQ FS  NFLGE
Sbjct: 36  LSRQTSVPSRVYMSDFSN--STISLNDFSNSFF-INIHIFTYEELKTITQGFSKYNFLGE 92

Query: 89  GGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIG 148
           GGFG V+KGF+DD L+ GL+ QPVAVK L  EG QGHREWL EVI LGQL+HPHLV L+G
Sbjct: 93  GGFGEVYKGFVDDSLKTGLKDQPVAVKALKREGGQGHREWLAEVIILGQLKHPHLVNLVG 152

Query: 149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIY 208
           YCCE++ RLLVYEYM RG+LE+ LF++Y  +LPW TR+KI LGAAKGL FLH  EKPVIY
Sbjct: 153 YCCEDDERLLVYEYMERGNLEDHLFQKYGGALPWLTRVKILLGAAKGLEFLHKQEKPVIY 212

Query: 209 RDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS 268
           RDFK SNILL SD+++KLSDFGLA DG E +D++ +  VMGT+GYAAPEY+  G+LT+MS
Sbjct: 213 RDFKPSNILLSSDFSSKLSDFGLATDGSEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMS 272

Query: 269 DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG 328
           DV+SFGVVLLE+L+ RK+V+K R QR ++LVEWARPML D  KL RI+DP LEG+YS  G
Sbjct: 273 DVFSFGVVLLEMLTARKAVEKYRAQRGRNLVEWARPMLKDPNKLERIIDPSLEGKYSVEG 332

Query: 329 ARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTE--SSNNDKN 386
            RKAAALAYQCLSH PK RPTM+TVVKTLEP+ D   DI  G FV+ VP    S  ++  
Sbjct: 333 IRKAAALAYQCLSHNPKSRPTMTTVVKTLEPILDL-KDIQNGPFVYIVPVAGVSEVHEIK 391

Query: 387 NNEDLKECEAKKETKKE 403
             +D+K    K+ET+K+
Sbjct: 392 CKDDVK--VVKEETEKD 406

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  418 bits (1074), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 220/370 (59%), Positives = 271/370 (73%), Gaps = 15/370 (4%)

Query: 13  NCFSIQEEEKACKPK---KAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFT 69
           NC     E K+   K   + V + SS    S  + S+ S+  +SE+L+IS   S+L  FT
Sbjct: 76  NCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAE-SSSSTPVISEELNIS---SHLRKFT 131

Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDK----LRPGLQAQPVAVKNLDLEGLQGH 125
             +LK++T++F   + LGEGGFG V KG+I++     ++PG     VAVK L+ +GLQGH
Sbjct: 132 FNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG-TGLTVAVKTLNPDGLQGH 190

Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR 185
           +EWL E+ FLG L HP+LVKL+GYC E++ RLLVYE+MPRGSLEN LFRR S+ LPWS R
Sbjct: 191 KEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIR 249

Query: 186 MKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
           MKIALGAAKGL+FLH+ A KPVIYRDFK SNILLD+DY AKLSDFGLAKD P+   THVS
Sbjct: 250 MKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVS 309

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP 304
           TRVMGT GYAAPEYVMTGHLTS SDVYSFGVVLLE+L+GR+S+DK+RP  E +LVEWARP
Sbjct: 310 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 369

Query: 305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
            L D R+  R++DPRLEG +S  GA+K   LA QCLS  PK RP MS VV+ L+PL    
Sbjct: 370 HLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHL- 428

Query: 365 DDIAIGTFVF 374
            D+A  ++ F
Sbjct: 429 KDMASSSYYF 438

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  412 bits (1059), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 208/361 (57%), Positives = 255/361 (70%), Gaps = 7/361 (1%)

Query: 47  PSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL--R 104
           PS+    EDL    A + L  FT  ELK  T +F     LG GGFG+V+KGFI + L  +
Sbjct: 43  PSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQ 102

Query: 105 PGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM 163
              +  PVAVK  D +   QGHREWL EVIFLGQL HP+LVKLIGYCCE+ HR+L+YEYM
Sbjct: 103 EVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYM 162

Query: 164 PRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT 223
            RGS+EN LF R  + L W+ RMKIA GAAKGLAFLH+A+KPVIYRDFK SNILLD DY 
Sbjct: 163 ARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYN 222

Query: 224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           AKLSDFGLAKDGP GD +HVSTR+MGT GYAAPEY+MTGHLT  SDVYSFGVVLLELL+G
Sbjct: 223 AKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTG 282

Query: 284 RKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHR 343
           RKS+DKSRP REQ+L++WA P+L + +K+  I+DP++  +Y     +KAA LAY CL+  
Sbjct: 283 RKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRN 342

Query: 344 PKQRPTMSTVVKTLEPLKDFDDDI----AIGTFVFTVPTESSNNDKNNNEDLKECEAKKE 399
           PK RP M  +V +LEPL+  +++      +   V T+  E   N     E+LK+ E  K+
Sbjct: 343 PKARPLMRDIVDSLEPLQATEEEALLVPPVQKAVITIIDEMPKNGLKKVEELKKVEEVKK 402

Query: 400 T 400
            
Sbjct: 403 V 403

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  403 bits (1036), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 197/307 (64%), Positives = 242/307 (78%), Gaps = 7/307 (2%)

Query: 60  LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL----RPGLQAQPVAVK 115
           L  +NL  F+L+ELK  T++F   + +GEGGFG V KG+ID+      +PG     +AVK
Sbjct: 48  LQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPG-TGIVIAVK 106

Query: 116 NLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR 175
            L+ EG QGHREWL E+ +LGQL HP+LVKLIGYC EEEHRLLVYE+M RGSLEN LFRR
Sbjct: 107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166

Query: 176 --YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             +   L W+TR+++ALGAA+GLAFLH+A+  VIYRDFKASNILLDS+Y AKLSDFGLA+
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLAR 226

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           DGP GD++HVSTRVMGTQGYAAPEY+ TGHL+  SDVYSFGVVLLELLSGR+++DK++P 
Sbjct: 227 DGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPV 286

Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            E +LV+WARP L + R+L R+MDPRL+GQYS T A K A LA  C+S   K RPTM+ +
Sbjct: 287 GEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEI 346

Query: 354 VKTLEPL 360
           VKT+E L
Sbjct: 347 VKTMEEL 353

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  403 bits (1036), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 205/335 (61%), Positives = 254/335 (75%), Gaps = 11/335 (3%)

Query: 45  SNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDK-- 102
           S+ S+  +SE+L+I    S+L  F+  +LK+ T++F   + LGEGGFG V KG++++   
Sbjct: 104 SSLSTPIISEELNIY---SHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 160

Query: 103 --LRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY 160
             ++PG     VAVK L+ +GLQGH+EWL E+ +LG L HP+LVKL+GYC E++ RLLVY
Sbjct: 161 APVKPG-TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVY 219

Query: 161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLD 219
           E+MPRGSLEN LFRR S+ LPWS RMKIALGAAKGL+FLH+ A KPVIYRDFK SNILLD
Sbjct: 220 EFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 278

Query: 220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLE 279
            +Y AKLSDFGLAKD P+   THVSTRVMGT GYAAPEYVMTGHLTS SDVYSFGVVLLE
Sbjct: 279 GEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 338

Query: 280 LLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQC 339
           +L+GR+S+DK+RP  E +LVEWARP L D R+  R++DPRLEG +S  GA+K   LA QC
Sbjct: 339 MLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQC 398

Query: 340 LSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVF 374
           LS   K RP MS VV+ L+PL     D+A  ++ F
Sbjct: 399 LSRDSKIRPKMSEVVEVLKPLPHL-KDMASASYYF 432

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  397 bits (1019), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 196/312 (62%), Positives = 238/312 (76%), Gaps = 7/312 (2%)

Query: 60  LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL----RPGLQAQPVAVK 115
           L   NL  FT AELK  T++F   + LGEGGFG+V KG+ID++     +PG     +AVK
Sbjct: 49  LQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG-TGVVIAVK 107

Query: 116 NLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR 175
            L+ +G QGH+EWL EV +LGQ  HP+LVKLIGYC E+EHRLLVYE+MPRGSLEN LFRR
Sbjct: 108 KLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 167

Query: 176 --YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             Y   L W+ R+K+ALGAAKGLAFLH+AE  VIYRDFK SNILLDS+Y AKLSDFGLAK
Sbjct: 168 GSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAK 227

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           DGP GD +HVSTR+MGT GYAAPEY+ TGHLT+ SDVYS+GVVLLE+LSGR++VDK+RP 
Sbjct: 228 DGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP 287

Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            EQ LVEWARP+L + RKL R++D RL+ QYS   A K A LA +CL+   K RP M+ V
Sbjct: 288 GEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEV 347

Query: 354 VKTLEPLKDFDD 365
           V  LE ++  ++
Sbjct: 348 VSHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  392 bits (1007), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 197/315 (62%), Positives = 233/315 (73%), Gaps = 5/315 (1%)

Query: 60  LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL----RPGLQAQPVAVK 115
           L+  NL  FT  ELK  T++F   + LGEGGFG V KG+ID       +PG     VAVK
Sbjct: 63  LSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPG-SGIVVAVK 121

Query: 116 NLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR 175
            L  EG QGH+EWLTEV +LGQL HP+LVKL+GYC E E+RLLVYE+MP+GSLEN LFRR
Sbjct: 122 KLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRR 181

Query: 176 YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 235
            +  L W+ RMK+A+GAAKGL FLHDA+  VIYRDFKA+NILLD+++ +KLSDFGLAK G
Sbjct: 182 GAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241

Query: 236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE 295
           P GD THVST+VMGT GYAAPEYV TG LT+ SDVYSFGVVLLELLSGR++VDKS+   E
Sbjct: 242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301

Query: 296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           QSLV+WA P L D RKL RIMD RL GQY + GA  AA+LA QCL+   K RP MS V+ 
Sbjct: 302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361

Query: 356 TLEPLKDFDDDIAIG 370
            L+ L+       +G
Sbjct: 362 KLDQLESTKPGTGVG 376

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  390 bits (1002), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 197/315 (62%), Positives = 234/315 (74%), Gaps = 7/315 (2%)

Query: 60  LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL----RPGLQAQPVAVK 115
           L   NL  F+ AELK  T++F   + LGEGGFG V KG+ID+K     RPG     +AVK
Sbjct: 48  LQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPG-TGLVIAVK 106

Query: 116 NLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR 175
            L+ +G QGH+EWL EV +LGQ  H HLVKLIGYC E+EHRLLVYE+MPRGSLEN LFRR
Sbjct: 107 KLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 166

Query: 176 --YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             Y   L W  R+K+ALGAAKGLAFLH +E  VIYRDFK SNILLDS+Y AKLSDFGLAK
Sbjct: 167 GLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAK 226

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           DGP GD +HVSTRVMGT GYAAPEY+ TGHLT+ SDVYSFGVVLLELLSGR++VDK+RP 
Sbjct: 227 DGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPS 286

Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            E++LVEWA+P L + RK+ R++D RL+ QYS   A K A L+ +CL+   K RP MS V
Sbjct: 287 GERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEV 346

Query: 354 VKTLEPLKDFDDDIA 368
           V  LE ++  +  I 
Sbjct: 347 VSHLEHIQSLNAAIG 361

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  385 bits (989), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/306 (63%), Positives = 228/306 (74%), Gaps = 5/306 (1%)

Query: 60  LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDD----KLRPGLQAQPVAVK 115
           L+  NL  FT  ELK  T++F   N LGEGGFG V KG+ID       RPG     VAVK
Sbjct: 66  LSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPG-SGIVVAVK 124

Query: 116 NLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR 175
            L  EG QGH+EWLTEV +LGQL HP+LV L+GYC E E+RLLVYE+MP+GSLEN LFRR
Sbjct: 125 QLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRR 184

Query: 176 YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 235
            +  L W+ RMK+A+GAAKGL FLH+A+  VIYRDFKA+NILLD+D+ AKLSDFGLAK G
Sbjct: 185 GAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAG 244

Query: 236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE 295
           P GD+THVST+V+GT GYAAPEYV TG LT+ SDVYSFGVVLLEL+SGR+++D S    E
Sbjct: 245 PTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNE 304

Query: 296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            SLV+WA P L D RKL RIMD +L GQY + GA  AA LA QCL+   K RP MS V+ 
Sbjct: 305 YSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLV 364

Query: 356 TLEPLK 361
           TLE L+
Sbjct: 365 TLEQLE 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
255550441	451	Protein kinase APK1B, chloroplast precur	0.975	0.984	0.781	0.0
224068458	454	predicted protein [Populus trichocarpa]	0.971	0.973	0.777	0.0
225444724	442	PREDICTED: serine/threonine-protein kina	0.951	0.979	0.757	0.0
356558419	458	PREDICTED: serine/threonine-protein kina	0.940	0.934	0.737	0.0
356530433	460	PREDICTED: serine/threonine-protein kina	0.907	0.897	0.753	0.0
356547940	451	PREDICTED: putative receptor-like protei	0.936	0.944	0.747	0.0
351734456	456	kinase-like protein [Glycine max] gi|223	0.940	0.938	0.739	0.0
53857147	442	Avr9/Cf-9 induced kinase 1 [Nicotiana ta	0.953	0.981	0.724	0.0
297835852	472	hypothetical protein ARALYDRAFT_899389 [	0.896	0.864	0.754	0.0
15225019	462	kinase-like protein [Arabidopsis thalian	0.837	0.824	0.790	1e-180

>gi|255550441|ref|XP_002516271.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223544757|gb|EEF46273.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  702 bits (1811), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/462 (78%), Positives = 389/462 (84%), Gaps = 18/462 (3%)

Query: 1   MTV-KITWRSIVPNCFSIQEEEKACK-PKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSI 58
           MTV K  W S+V +CF   E+++A K PKK V KQ+S  R+S  DLSNPSS  LSEDLSI
Sbjct: 1   MTVHKAKWISMVSSCFKPLEQKRALKAPKKEVTKQTSFTRLSLSDLSNPSS--LSEDLSI 58

Query: 59  SLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD 118
           SLAGSNLHVFTLAELKV TQ+FSSSNFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LD
Sbjct: 59  SLAGSNLHVFTLAELKVITQNFSSSNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLD 118

Query: 119 LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178
           L+GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV
Sbjct: 119 LDGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178

Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
           SLPWSTRMKIALGAAKGLAFLH++EK VIYRDFKASNILLDSDY AKLSDFGLAKDGP+G
Sbjct: 179 SLPWSTRMKIALGAAKGLAFLHESEKSVIYRDFKASNILLDSDYNAKLSDFGLAKDGPQG 238

Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL 298
            DTHVSTRVMGTQGYAAPEY+MTGHLT+MSDVYSFGVVLLELL+GR+SVDKSRPQREQ L
Sbjct: 239 SDTHVSTRVMGTQGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKSRPQREQKL 298

Query: 299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            EWARPMLND RKLGRIMDPRLEGQYSETGARKAAALAY CLSHRPKQRP MS VVKTLE
Sbjct: 299 AEWARPMLNDPRKLGRIMDPRLEGQYSETGARKAAALAYLCLSHRPKQRPIMSIVVKTLE 358

Query: 359 PLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKEC-EAKKETKKE-KGNHRQNHKLHND 416
             KDF +DI +G FV+TVPTES     N+ ED+KEC E KKE KKE  G H Q H L   
Sbjct: 359 SFKDF-EDIPVGPFVYTVPTESD----NHKEDVKECIEPKKELKKESNGQHHQKHPL--- 410

Query: 417 IVNGRRRHMRSPRSRTFQSENDHSRNES---KSPLHPSSKGA 455
             +G R    SPRS T  SE    +N+    +S LHP++K A
Sbjct: 411 -HHGHRHRHGSPRSPTIHSETALRQNQRSGLQSSLHPNAKAA 451

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068458|ref|XP_002326125.1| predicted protein [Populus trichocarpa] gi|222833318|gb|EEE71795.1| predicted protein [Populus trichocarpa]

 Score =  701 bits (1809), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/462 (77%), Positives = 388/462 (83%), Gaps = 20/462 (4%)

Query: 1   MTV-KITWRSIVPNCFSIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSIS 59
           MTV K TWRS+V +CF   E   + KPKK V KQ+S QRIS  DLSNPS  TLSEDLSIS
Sbjct: 1   MTVEKTTWRSMVSSCFKPNEISPS-KPKKIVTKQTSFQRISMSDLSNPS--TLSEDLSIS 57

Query: 60  LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL 119
           LAGSNLHVFTL ELKV TQ+F++SNFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LDL
Sbjct: 58  LAGSNLHVFTLPELKVITQNFAASNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDL 117

Query: 120 EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS 179
           +G QGHREWL EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS
Sbjct: 118 DGSQGHREWLAEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS 177

Query: 180 LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
           LPWS R KIA+GAAKGLAFLH++EKPVIYRDFKASNILLDSDYT KLSDFGLAKDGPEG 
Sbjct: 178 LPWSARTKIAVGAAKGLAFLHESEKPVIYRDFKASNILLDSDYTPKLSDFGLAKDGPEGS 237

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           DTHVSTRVMGTQGYAAPEY+MTGHLTS SDVYSFGVVLLELL+GR+SVDKSRPQREQ+LV
Sbjct: 238 DTHVSTRVMGTQGYAAPEYIMTGHLTSRSDVYSFGVVLLELLTGRRSVDKSRPQREQNLV 297

Query: 300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP 359
           EWARPMLND RKLGRIMDPRLEGQYSETGARKAA LAYQCLSHRPK RPTMS VV TL+P
Sbjct: 298 EWARPMLNDPRKLGRIMDPRLEGQYSETGARKAAELAYQCLSHRPKHRPTMSIVVNTLDP 357

Query: 360 LKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKK-ETKKEK-GNHRQNHKLHNDI 417
           LKDF +D+ IG FV+TVPTE+   D N     KECE K+ ETKKEK G   Q H+LH   
Sbjct: 358 LKDF-EDVPIGPFVYTVPTENLKEDDN-----KECETKRDETKKEKNGQQHQRHQLH--- 408

Query: 418 VNGRRRHMRS-PRSRTFQSENDHSRNESK---SPLHPSSKGA 455
             G++R  RS PRS T  SE   S+N      SPLH  ++G+
Sbjct: 409 -RGQKRQGRSRPRSPTIHSETALSQNHGNGLHSPLHHKARGS 449

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225444724|ref|XP_002277991.1| PREDICTED: serine/threonine-protein kinase At5g01020 [Vitis vinifera] gi|297738561|emb|CBI27806.3| unnamed protein product [Vitis vinifera]

 Score =  673 bits (1737), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/457 (75%), Positives = 380/457 (83%), Gaps = 24/457 (5%)

Query: 4   KITWRSIVPNCFSIQEEEKACKPKKA--VKKQSSIQRISFVDLSNPSSTTLSEDLSISLA 61
           KITWRS+ P C+    E+ A K +KA  V KQ+S QRIS  DLSNP ST LSEDLS SL 
Sbjct: 5   KITWRSVFPACYG--SEKMASKRRKAAVVAKQTSFQRISISDLSNPGST-LSEDLSTSLM 61

Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           GSNLHVFTL ELKV  Q+FSS+NF+GEGGFG VHKGFIDDKLRPGL+AQPVAVK LDLEG
Sbjct: 62  GSNLHVFTLTELKVICQNFSSNNFIGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLEG 121

Query: 122 LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
           LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE+EHRLLVYEYMPRGSLENQLFRRYSVSLP
Sbjct: 122 LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEDEHRLLVYEYMPRGSLENQLFRRYSVSLP 181

Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
           WSTRMKIALGAAKGLAFLH+AEKPVIYRDFKASNILLDSD+T KLSDFGLAKDGPEGDDT
Sbjct: 182 WSTRMKIALGAAKGLAFLHEAEKPVIYRDFKASNILLDSDHTPKLSDFGLAKDGPEGDDT 241

Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW 301
           HVSTRVMGTQGYAAPEY+MTGHLT+MSDVYSFGVVLLELL+GR+SVDK+RP REQ+L EW
Sbjct: 242 HVSTRVMGTQGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKTRPNREQNLAEW 301

Query: 302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
           ARP LND+RKL RIMDPRLEGQYSE GA+ AAALAYQCLSHRPK RPTMSTVVKTLEPL+
Sbjct: 302 ARPQLNDSRKLARIMDPRLEGQYSEAGAQSAAALAYQCLSHRPKHRPTMSTVVKTLEPLQ 361

Query: 362 DFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGR 421
           D+ ++I +GTFV+TVP+E   ND    E  +  EA+KE KKE  +             G 
Sbjct: 362 DY-NEIPVGTFVYTVPSE---NDLPKEETKEGGEAQKEPKKESSH------------QGH 405

Query: 422 RRHMRSPRSRTFQSEN---DHSRNESKSPLHPSSKGA 455
           R  MRSP+S T  SE     + RN   SPLHP S+G+
Sbjct: 406 RHRMRSPKSPTIYSETALRQNLRNSPNSPLHPRSRGS 442

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558419|ref|XP_003547504.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/445 (73%), Positives = 373/445 (83%), Gaps = 17/445 (3%)

Query: 3   VKITWRSIVPNCFSIQEEEKACKPKKAVK-KQSSIQRISFVDLSNPSSTTLSEDLSISLA 61
           +K  W+SI P C+  + E  + KPKK V  K +S  RIS  DLS PS TTLSEDLSISLA
Sbjct: 4   MKTLWKSIFPGCY--KGEYPSPKPKKVVATKPNSSHRISVTDLSYPS-TTLSEDLSISLA 60

Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           G+NLHVF+LAELK+ TQ FSSSNFLGEGGFG VHKGFIDDKLR GL+AQPVAVK LDL+G
Sbjct: 61  GTNLHVFSLAELKIITQQFSSSNFLGEGGFGPVHKGFIDDKLRHGLKAQPVAVKLLDLDG 120

Query: 122 LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
            QGH+EWLTEV+FLGQLRHPHLVKLIGYCCEEEHR+LVYEY+PRGSLENQLFRR+S SL 
Sbjct: 121 SQGHKEWLTEVVFLGQLRHPHLVKLIGYCCEEEHRVLVYEYLPRGSLENQLFRRFSASLS 180

Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
           WSTRMKIA+GAAKGLAFLH+AEKPVIYRDFKASNILL SDY AKLSDFGLAKDGPEGDDT
Sbjct: 181 WSTRMKIAVGAAKGLAFLHEAEKPVIYRDFKASNILLGSDYNAKLSDFGLAKDGPEGDDT 240

Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW 301
           HVSTRVMGT GYAAPEY+MTGHLT+MSDVYSFGVVLLELL+GR+SVDK+RP REQ+LVEW
Sbjct: 241 HVSTRVMGTHGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKNRPPREQNLVEW 300

Query: 302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
           ARPMLND+RKL RIMDPRLEGQYSE G +KAAALAYQCLSHRP+ RP+MSTVVKTLEPL+
Sbjct: 301 ARPMLNDSRKLSRIMDPRLEGQYSEMGTKKAAALAYQCLSHRPRSRPSMSTVVKTLEPLQ 360

Query: 362 DFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGR 421
           DF DDI IGTFV+T P +  NN+ ++ +D  +C    ET K + N+  N  LH    NG 
Sbjct: 361 DF-DDIPIGTFVYTAPPD--NNEMHSAKD--QC----ETPKRRENNNNNGHLHR---NGH 408

Query: 422 RRH-MRSPRSRTFQSENDHSRNESK 445
           R H ++SP++   QS++    N+ K
Sbjct: 409 RHHPLKSPKTPRPQSQSQSRSNDHK 433

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356530433|ref|XP_003533786.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/430 (75%), Positives = 369/430 (85%), Gaps = 17/430 (3%)

Query: 3   VKITWRSIVPNCFSIQEEEKACKPKKAVK-KQSSIQRISFVDLSNPSSTTLSEDLSISLA 61
           +KI W+S+ P C+  + E  + KPKK V  K +S  RIS  DLS PS TTLSEDLSISLA
Sbjct: 1   MKILWKSLFPGCY--KGEYPSPKPKKVVATKPNSSHRISVTDLSYPS-TTLSEDLSISLA 57

Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           G+NLHVF++AELK+ TQ FSSSNFLGEGGFG VHKGFIDDKLR GL+AQPVAVK L+L+G
Sbjct: 58  GTNLHVFSIAELKIITQQFSSSNFLGEGGFGPVHKGFIDDKLRHGLKAQPVAVKLLNLDG 117

Query: 122 LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
            QGH+EWLTEV+FLGQLRHPHLVKLIGYCCEEEHR+LVYEY+PRGSLENQLFRR+S SLP
Sbjct: 118 SQGHKEWLTEVVFLGQLRHPHLVKLIGYCCEEEHRVLVYEYLPRGSLENQLFRRFSASLP 177

Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
           WSTRMKIA+GAAKGLAFLH+AEKPVIYRDFKASNILLDSDY AKLSDFGLAKDGPEGDDT
Sbjct: 178 WSTRMKIAVGAAKGLAFLHEAEKPVIYRDFKASNILLDSDYNAKLSDFGLAKDGPEGDDT 237

Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW 301
           HVSTRVMGT GYAAPEYVMTGHLT+MSDVYSFGVVLLELL+GR+SVDK+RP REQ+LVEW
Sbjct: 238 HVSTRVMGTHGYAAPEYVMTGHLTAMSDVYSFGVVLLELLTGRRSVDKNRPPREQNLVEW 297

Query: 302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
           ARPMLND+RKL RIMDPRLEGQYSE G +KAAALAYQCLSHRP+ RP+MSTVVKTLEPL+
Sbjct: 298 ARPMLNDSRKLSRIMDPRLEGQYSEMGTKKAAALAYQCLSHRPRSRPSMSTVVKTLEPLQ 357

Query: 362 DFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGR 421
           DF DDI IGTFV+T P +  NN++  ++D  +C    ET K + N+   H +H    NG 
Sbjct: 358 DF-DDIPIGTFVYTAPPD--NNNEVQHKD--QC----ETPKRRENNNNGHNIHR---NGH 405

Query: 422 RRH-MRSPRS 430
           R H ++SP++
Sbjct: 406 RHHPLKSPKA 415

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547940|ref|XP_003542362.1| PREDICTED: putative receptor-like protein kinase At1g72540-like isoform 1 [Glycine max]

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/439 (74%), Positives = 366/439 (83%), Gaps = 13/439 (2%)

Query: 13  NCFSIQEEEKACKPKKAV--KKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTL 70
           +C+  +    + KP K V  K  SS  R+S  DLS P ST LSEDLS+SL GSNLHVF+L
Sbjct: 7   SCYEGESVSPSPKPTKVVATKGGSSSNRVSITDLSFPGST-LSEDLSVSLVGSNLHVFSL 65

Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT 130
           +ELK+ TQSFSSSNFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LDL+G QGH+EWLT
Sbjct: 66  SELKIITQSFSSSNFLGEGGFGPVHKGFIDDKLRPGLEAQPVAVKLLDLDGSQGHKEWLT 125

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV+FLGQLRHPHLVKLIGYCCEEEHRLLVYEY+PRGSLENQLFRRY+ SLPWSTRMKIA 
Sbjct: 126 EVVFLGQLRHPHLVKLIGYCCEEEHRLLVYEYLPRGSLENQLFRRYTASLPWSTRMKIAA 185

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
           GAAKGLAFLH+A+KPVIYRDFKASNILLDSDY AKLSDFGLAKDGPEGDDTHVSTRVMGT
Sbjct: 186 GAAKGLAFLHEAKKPVIYRDFKASNILLDSDYNAKLSDFGLAKDGPEGDDTHVSTRVMGT 245

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
           QGYAAPEY+MTGHLT+MSDVYSFGVVLLELL+GR+SVDK RPQREQ+LVEWARP LND+R
Sbjct: 246 QGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKGRPQREQNLVEWARPALNDSR 305

Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIG 370
           KLGRIMDPRLEGQYSE GARKAAALAYQCLSHRP+ RP MSTVV  LEPL+DF DD+ IG
Sbjct: 306 KLGRIMDPRLEGQYSEVGARKAAALAYQCLSHRPRSRPLMSTVVNVLEPLQDF-DDVPIG 364

Query: 371 TFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGRRRH-MRSPR 429
            FV+TVP E       +NE  KE E  KE K+E  +H  N   H+   NG R H ++SP+
Sbjct: 365 PFVYTVPAE------QHNEVAKESETPKERKRENDHHHHNRHHHHHRHNGHRHHPLKSPK 418

Query: 430 S--RTFQSENDHSRNESKS 446
           +   + QS+ND  RN  +S
Sbjct: 419 TPMSSDQSQNDEHRNGRRS 437

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351734456|ref|NP_001238581.1| kinase-like protein [Glycine max] gi|223452333|gb|ACM89494.1| kinase-like protein [Glycine max]

 Score =  642 bits (1657), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/438 (73%), Positives = 360/438 (82%), Gaps = 10/438 (2%)

Query: 13  NCFSIQEEEKACKPKKAV--KKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTL 70
           +C+  +    + KP K V  K  SS  R+S  DLS P ST LSEDLS+SL GSNLHVF+L
Sbjct: 7   SCYEGESVSPSPKPTKVVATKGGSSSNRVSITDLSFPGST-LSEDLSVSLVGSNLHVFSL 65

Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT 130
           AELK+ TQ FSSSNFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LDL+G QGH+EWLT
Sbjct: 66  AELKIITQGFSSSNFLGEGGFGPVHKGFIDDKLRPGLEAQPVAVKLLDLDGSQGHKEWLT 125

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV+FLGQLRHPHLVKLIGYCCEEEHRLLVYEY+PRGSLENQLFRRY+ SLPWSTRMKIA 
Sbjct: 126 EVVFLGQLRHPHLVKLIGYCCEEEHRLLVYEYLPRGSLENQLFRRYTASLPWSTRMKIAA 185

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
           GAAKGLAFLH+A+KPVIYRDFKASNILLDSDY AKLSDFGLAKDGPEGDDTHVSTRVMGT
Sbjct: 186 GAAKGLAFLHEAKKPVIYRDFKASNILLDSDYNAKLSDFGLAKDGPEGDDTHVSTRVMGT 245

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
           QGYAAPEY+MTGHLT+MSDVYSFGVVLLELL+GR+SVDK RPQREQ+LVEWAR  LND+R
Sbjct: 246 QGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKGRPQREQNLVEWARSALNDSR 305

Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIG 370
           KL RIMDPRLEGQYSE GARKAAALAYQCLSHRP+ RP MSTVV  LEPL+DF DD+ IG
Sbjct: 306 KLSRIMDPRLEGQYSEVGARKAAALAYQCLSHRPRSRPLMSTVVNVLEPLQDF-DDVPIG 364

Query: 371 TFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGRRRHMRSPRS 430
            FV+TVP E     +  NE  KE E  KE K+E G+H      H+     R   ++SP++
Sbjct: 365 PFVYTVPAE----QQQYNEVAKESETPKERKRENGHHHNRRHHHHRHNGHRHHPLKSPKT 420

Query: 431 --RTFQSENDHSRNESKS 446
              + QS+ND  RN  KS
Sbjct: 421 PMPSDQSQNDEHRNGRKS 438

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|53857147|gb|AAP03880.2| Avr9/Cf-9 induced kinase 1 [Nicotiana tabacum]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/447 (72%), Positives = 365/447 (81%), Gaps = 13/447 (2%)

Query: 3   VKITWRSIVPNCFSIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAG 62
           +KITW S+VP+CF  +  +   K  K V KQSS  RIS  D S   ++T+SEDLSISLAG
Sbjct: 1   MKITWESLVPSCFKGENPKPKAKEIKVVTKQSSFHRISISDFS---ASTISEDLSISLAG 57

Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           SNL++FTL ELKV TQ+FSSSNFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LDL+G 
Sbjct: 58  SNLYIFTLQELKVITQNFSSSNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDGT 117

Query: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182
           QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL YEYMPRGSLENQLFRRYSVSLPW
Sbjct: 118 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLAYEYMPRGSLENQLFRRYSVSLPW 177

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
           STRMKIA+GAAKGLAFLH+AEKPVIYRDFKASNILLDSDY+AKLSDFGLAKDGPEGDDTH
Sbjct: 178 STRMKIAVGAAKGLAFLHEAEKPVIYRDFKASNILLDSDYSAKLSDFGLAKDGPEGDDTH 237

Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
           VSTRVMGTQGYAAPEY+MTGHLT+ SDVYSFGVVLLELL+GR+SVDK+RP REQ+LV+WA
Sbjct: 238 VSTRVMGTQGYAAPEYLMTGHLTAASDVYSFGVVLLELLTGRRSVDKTRPNREQNLVDWA 297

Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
           RP L D RKL RIMDPRLEG YSE GA+KAA +AYQCLSHRPK RP MS+VVKTLEPLKD
Sbjct: 298 RPQLKDPRKLRRIMDPRLEGLYSEEGAQKAALVAYQCLSHRPKARPEMSSVVKTLEPLKD 357

Query: 363 FDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNGRR 422
           +  DI+   FV+  P E     K + ++    + KK  KKE   + Q  K H+  ++  R
Sbjct: 358 Y-KDISNMIFVYIAPAEVKEMCKESEKE----DQKKTIKKENSPYHQ--KHHHHHLD--R 408

Query: 423 RHMRSPRSRTFQSEND-HSRNESKSPL 448
           +H RSP++ T  SE   H +    SPL
Sbjct: 409 KHRRSPQNSTIYSEKALHKKLGPNSPL 435

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297835852|ref|XP_002885808.1| hypothetical protein ARALYDRAFT_899389 [Arabidopsis lyrata subsp. lyrata] gi|297331648|gb|EFH62067.1| hypothetical protein ARALYDRAFT_899389 [Arabidopsis lyrata subsp. lyrata]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/416 (75%), Positives = 346/416 (83%), Gaps = 8/416 (1%)

Query: 4   KITWRSIVPNCFSIQEEEKAC--KPKK---AVKKQSSIQRISFVDLSNPSSTTLSEDLSI 58
           K++WRS++  C    E   A   KPK+    +KKQSS QR+S +D+SNPSS TLSEDLSI
Sbjct: 6   KVSWRSLIVGCLGDPETLMASSKKPKRKDDVIKKQSSFQRLSILDMSNPSSNTLSEDLSI 65

Query: 59  SLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD 118
           SLAGS+LHVFTLAELKV TQSFSS+NFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LD
Sbjct: 66  SLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLD 125

Query: 119 LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178
           LEGLQGHREWLTEV+FLGQL+H +LVKLIGYCCEEEHR LVYE+MPRGSLENQLFRRYS 
Sbjct: 126 LEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSA 185

Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
           SLPWSTRMKIA GAA GL FLH+AE PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG
Sbjct: 186 SLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 245

Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL 298
           DDTHVSTRVMGTQGYAAPEY+MTGHLT+ SDVYSFGVVLLELL+GR+SVDK R  REQ+L
Sbjct: 246 DDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNL 305

Query: 299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           V+WARPMLND RKL RIMDPRLEGQYSETGARKAA LAYQCLSHRPK RP MS VV  L 
Sbjct: 306 VDWARPMLNDPRKLCRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILN 365

Query: 359 PLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLH 414
            LKD+ +DI +GTF +TVP     +  +N ED  E     + +K   +H Q    H
Sbjct: 366 DLKDY-NDIPMGTFTYTVPNTPDKSVSDNKED--EGRVGNKPRKSSNHHHQQQSNH 418

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15225019|ref|NP_178651.1| kinase-like protein [Arabidopsis thaliana] gi|4006829|gb|AAC95171.1| putative protein kinase [Arabidopsis thaliana] gi|15810413|gb|AAL07094.1| putative protein kinase [Arabidopsis thaliana] gi|21280977|gb|AAM45011.1| putative protein kinase [Arabidopsis thaliana] gi|330250892|gb|AEC05986.1| kinase-like protein [Arabidopsis thaliana]

 Score =  636 bits (1641), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 310/392 (79%), Positives = 338/392 (86%), Gaps = 11/392 (2%)

Query: 4   KITWRSIVPNCFSIQEEEKAC--KPKK---AVKKQSSIQRISFVDLSNPSSTTLSEDLSI 58
           K++WRS++  C    E   A   KPK+    +KKQSS QR+S +D+SNPSS TLSEDLSI
Sbjct: 6   KVSWRSLIVGCLGDPETLMASSKKPKRKNDVIKKQSSFQRLSILDMSNPSSNTLSEDLSI 65

Query: 59  SLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD 118
           SLAGS+LHVFTLAELKV TQSFSS+NFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LD
Sbjct: 66  SLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLD 125

Query: 119 LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178
           LEGLQGHREWLTEV+FLGQL+H +LVKLIGYCCEEEHR LVYE+MPRGSLENQLFRRYS 
Sbjct: 126 LEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSA 185

Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
           SLPWSTRMKIA GAA GL FLH+AE PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG
Sbjct: 186 SLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 245

Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL 298
           DDTHVSTRVMGTQGYAAPEY+MTGHLT+ SDVYSFGVVLLELL+GR+SVDK R  REQ+L
Sbjct: 246 DDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNL 305

Query: 299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           V+WARPMLND RKL RIMDPRLEGQYSETGARKAA LAYQCLSHRPK RP MS VV  L 
Sbjct: 306 VDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILN 365

Query: 359 PLKDFDDDIAIGTFVFTVPTESSNNDKNNNED 390
            LKD+ +DI +GTF +TVP     N  +N ED
Sbjct: 366 DLKDY-NDIPMGTFTYTVP-----NTPDNKED 391

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.819	0.807	0.788	6.1e-158
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.760	0.700	0.806	8.8e-150
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.725	0.778	0.703	9.9e-126
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.707	0.785	0.711	6.7e-120
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.725	0.778	0.664	2.6e-118
TAIR|locus:2030185	450	AT1G72540 [Arabidopsis thalian	0.749	0.757	0.653	1.6e-116
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.685	0.705	0.637	4.6e-105
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.712	0.657	0.629	4.6e-105
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.694	0.697	0.628	9.8e-103
TAIR|locus:2161093	408	AT5G56460 [Arabidopsis thalian	0.703	0.784	0.616	4.2e-102

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1539 (546.8 bits), Expect = 6.1e-158, P = 6.1e-158
 Identities = 299/379 (78%), Positives = 325/379 (85%)

Query:     4 KITWRSIVPNCFS-----IQXXXXXXXXXXXXXXQSSIQRISFVDLSNPSSTTLSEDLSI 58
             K++WRS++  C       +               QSS QR+S +D+SNPSS TLSEDLSI
Sbjct:     6 KVSWRSLIVGCLGDPETLMASSKKPKRKNDVIKKQSSFQRLSILDMSNPSSNTLSEDLSI 65

Query:    59 SLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD 118
             SLAGS+LHVFTLAELKV TQSFSS+NFLGEGGFG VHKGFIDDKLRPGL+AQPVAVK LD
Sbjct:    66 SLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLD 125

Query:   119 LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178
             LEGLQGHREWLTEV+FLGQL+H +LVKLIGYCCEEEHR LVYE+MPRGSLENQLFRRYS 
Sbjct:   126 LEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSA 185

Query:   179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
             SLPWSTRMKIA GAA GL FLH+AE PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG
Sbjct:   186 SLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 245

Query:   239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL 298
             DDTHVSTRVMGTQGYAAPEY+MTGHLT+ SDVYSFGVVLLELL+GR+SVDK R  REQ+L
Sbjct:   246 DDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNL 305

Query:   299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             V+WARPMLND RKL RIMDPRLEGQYSETGARKAA LAYQCLSHRPK RP MS VV  L 
Sbjct:   306 VDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILN 365

Query:   359 PLKDFDDDIAIGTFVFTVP 377
              LKD++D I +GTF +TVP
Sbjct:   366 DLKDYND-IPMGTFTYTVP 383

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1462 (519.7 bits), Expect = 8.8e-150, P = 8.8e-150
 Identities = 279/346 (80%), Positives = 313/346 (90%)

Query:    33 QSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFG 92
             Q S   +S +D+SNPSSTTLSEDLSISLAGS+LHVFT AEL+V TQSFSSSNFLGEGGFG
Sbjct:    29 QKSFLGLSILDISNPSSTTLSEDLSISLAGSDLHVFTQAELRVITQSFSSSNFLGEGGFG 88

Query:    93 AVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE 152
              VHKGFIDDKLRPGL+AQPVAVK LDL+GLQGHRE++TEV+ LG+L+HP+LVKLIGYCCE
Sbjct:    89 PVHKGFIDDKLRPGLKAQPVAVKLLDLDGLQGHREFMTEVMCLGKLKHPNLVKLIGYCCE 148

Query:   153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK 212
             E HRLLVYE+MPRGSLE+QLFRR S+ LPW+TR+ IA  AAKGL FLH+AEKP+IYRDFK
Sbjct:   149 EAHRLLVYEFMPRGSLESQLFRRCSLPLPWTTRLNIAYEAAKGLQFLHEAEKPIIYRDFK 208

Query:   213 ASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYS 272
             ASNILLDSDYTAKLSDFGLAKDGP+GDDTHVSTRVMGTQGYAAPEY+MTGHLT+ SDVYS
Sbjct:   209 ASNILLDSDYTAKLSDFGLAKDGPQGDDTHVSTRVMGTQGYAAPEYIMTGHLTAKSDVYS 268

Query:   273 FGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKA 332
             FGVVLLELL+GRKSVD +R  R+++LVEWARPMLNDARKLGRIMDPRLE QYSETGARKA
Sbjct:   269 FGVVLLELLTGRKSVDIARSSRKETLVEWARPMLNDARKLGRIMDPRLEDQYSETGARKA 328

Query:   333 AALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPT 378
             A LAYQCL +RPK RP +STVV  L+ +KD+ DDI IG F +TVPT
Sbjct:   329 ATLAYQCLRYRPKTRPDISTVVSVLQDIKDYKDDIPIGIFTYTVPT 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1235 (439.8 bits), Expect = 9.9e-126, P = 9.9e-126
 Identities = 233/331 (70%), Positives = 279/331 (84%)

Query:    35 SIQRISFVDLSNPSST-TLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGA 93
             + +R+S  D+S+PSS  ++ +DLS S     L +FTL+EL+V T +FS SN LGEGGFG 
Sbjct:    42 AFKRLSLSDISDPSSPMSVMDDLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGP 101

Query:    94 VHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE 153
             V+KGFIDDK++PG++AQPVAVK LDL G QGHREWL E++FLGQL + HLVKLIG+CCEE
Sbjct:   102 VYKGFIDDKVKPGIEAQPVAVKALDLHGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEE 161

Query:   154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKA 213
             E R+LVYEYMPRGSLENQLFRR S+++ W  RMKIALGAAKGLAFLH+AEKPVIYRDFK 
Sbjct:   162 EQRVLVYEYMPRGSLENQLFRRNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKT 221

Query:   214 SNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSF 273
             SNILLDSDY AKLSDFGLAKDGPEG+ THV+TRVMGTQGYAAPEY+MTGHLT+M+DVYSF
Sbjct:   222 SNILLDSDYNAKLSDFGLAKDGPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSF 281

Query:   274 GVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAA 333
             GVVLLEL++G++S+D +R +REQSLVEWARPML D RKL RI+DPRL  Q+    A+ AA
Sbjct:   282 GVVLLELITGKRSMDNTRTRREQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAA 341

Query:   334 ALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
             +LAY+CLS  PK RPTM  VVK LE +++ D
Sbjct:   342 SLAYKCLSQHPKYRPTMCEVVKVLESIQEVD 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1180 (420.4 bits), Expect = 6.7e-120, P = 6.7e-120
 Identities = 229/322 (71%), Positives = 266/322 (82%)

Query:    40 SFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFI 99
             S  DLS+PS+    +D    ++ + +  FTL EL+  T+SF     LGEGGFG V+KG+I
Sbjct:    29 SVSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYI 88

Query:   100 DDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV 159
             DD LR GL++ PVAVK L+ EGLQGHREWLTEV FLGQLRHP+LVKLIGYCCE++HRLLV
Sbjct:    89 DDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV 148

Query:   160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
             YE+M RGSLEN LFR+ +  L WS RM IALGAAKGLAFLH+AE+PVIYRDFK SNILLD
Sbjct:   149 YEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLD 208

Query:   220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLE 279
             SDYTAKLSDFGLAK GP+GD+THVSTRVMGT GYAAPEYVMTGHLT+ SDVYSFGVVLLE
Sbjct:   209 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 268

Query:   280 LLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQC 339
             +L+GRKSVDK+RP +EQ+LV+WARP LND RKL +I+DPRLE QYS   A+KA +LAY C
Sbjct:   269 MLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYC 328

Query:   340 LSHRPKQRPTMSTVVKTLEPLK 361
             LS  PK RP MS VV+TLEPL+
Sbjct:   329 LSQNPKARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
 Identities = 220/331 (66%), Positives = 271/331 (81%)

Query:    35 SIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAV 94
             S +R+SF DLS  SS  ++EDL+ +L G++L  F + ELK+ TQSFS +  LGEGGFG V
Sbjct:    55 SFRRLSFADLSRSSSARINEDLAQTL-GADLVDFQMCELKMITQSFSGNYLLGEGGFGKV 113

Query:    95 HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE 154
             +KG++DD LR  L+AQPVAVK LD+EGLQGHREWL+EVIFLGQL+HP+LVKLIGYCCEEE
Sbjct:   114 YKGYVDDYLRQSLKAQPVAVKLLDIEGLQGHREWLSEVIFLGQLKHPNLVKLIGYCCEEE 173

Query:   155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS 214
              R+L+YE+MPRGSLEN LFRR S+SLPW+TR+KIA+ AAKGLAFLHD E P+IYRDFK S
Sbjct:   174 ERVLIYEFMPRGSLENHLFRRISLSLPWATRLKIAVAAAKGLAFLHDLESPIIYRDFKTS 233

Query:   215 NILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFG 274
             NILLDSD+TAKLSDFGLAK GPEG  +HV+TRVMGT GYAAPEYV TGHLT+ SDVYS+G
Sbjct:   234 NILLDSDFTAKLSDFGLAKMGPEGSKSHVTTRVMGTYGYAAPEYVSTGHLTTKSDVYSYG 293

Query:   275 VVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAA 334
             VVLLELL+GR++ +KSRP+ +Q++++W++P L  +R+L  +MDPRL GQYS   A+  A 
Sbjct:   294 VVLLELLTGRRATEKSRPKNQQNIIDWSKPYLTSSRRLRCVMDPRLAGQYSVKAAKDTAL 353

Query:   335 LAYQCLSHRPKQRPTMSTVVKTLEPLKDFDD 365
             LA QC+S  PK RP M  VV+ LE L  + D
Sbjct:   354 LALQCVSPNPKDRPKMLAVVEALESLIHYKD 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2030185 AT1G72540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
 Identities = 226/346 (65%), Positives = 268/346 (77%)

Query:    33 QSSI-QRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGF 91
             Q+S+  R+   D SN  ST    D S S    N+H+FT  ELK  TQ FS  NFLGEGGF
Sbjct:    39 QTSVPSRVYMSDFSN--STISLNDFSNSFF-INIHIFTYEELKTITQGFSKYNFLGEGGF 95

Query:    92 GAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC 151
             G V+KGF+DD L+ GL+ QPVAVK L  EG QGHREWL EVI LGQL+HPHLV L+GYCC
Sbjct:    96 GEVYKGFVDDSLKTGLKDQPVAVKALKREGGQGHREWLAEVIILGQLKHPHLVNLVGYCC 155

Query:   152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF 211
             E++ RLLVYEYM RG+LE+ LF++Y  +LPW TR+KI LGAAKGL FLH  EKPVIYRDF
Sbjct:   156 EDDERLLVYEYMERGNLEDHLFQKYGGALPWLTRVKILLGAAKGLEFLHKQEKPVIYRDF 215

Query:   212 KASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVY 271
             K SNILL SD+++KLSDFGLA DG E +D++ +  VMGT+GYAAPEY+  G+LT+MSDV+
Sbjct:   216 KPSNILLSSDFSSKLSDFGLATDGSEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMSDVF 275

Query:   272 SFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARK 331
             SFGVVLLE+L+ RK+V+K R QR ++LVEWARPML D  KL RI+DP LEG+YS  G RK
Sbjct:   276 SFGVVLLEMLTARKAVEKYRAQRGRNLVEWARPMLKDPNKLERIIDPSLEGKYSVEGIRK 335

Query:   332 AAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVP 377
             AAALAYQCLSH PK RPTM+TVVKTLEP+ D  D I  G FV+ VP
Sbjct:   336 AAALAYQCLSHNPKSRPTMTTVVKTLEPILDLKD-IQNGPFVYIVP 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
 Identities = 199/312 (63%), Positives = 236/312 (75%)

Query:    54 EDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVA 113
             +DL  +    N+ +FT  E+K+ T+ F     LGEGGFG V+KG ID+ +R G ++  VA
Sbjct:    64 KDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRVGFKSTKVA 123

Query:   114 VKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLF 173
             +K L+ EG QG REWL EV +LGQL HP+LVKLIGYCCE++HRLLVYEYM  GSLE  LF
Sbjct:   124 IKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMGSLEKHLF 183

Query:   174 RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             RR   +L W+ RMKIAL AAKGLAFLH AE+ +IYRD K +NILLD  Y AKLSDFGLAK
Sbjct:   184 RRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAKLSDFGLAK 243

Query:   234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
             DGP GD THVSTRVMGT GYAAPEYVMTGHLTS SDVY FGV+LLE+L G++++DKSR  
Sbjct:   244 DGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRAMDKSRAC 303

Query:   294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
             RE +LVEWARP+LN  +KL RI+DPR++GQY      K A LAYQCLS  PK RP M+ V
Sbjct:   304 REHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKGRPLMNHV 363

Query:   354 VKTLEPLKDFDD 365
             V+ LE LKD  D
Sbjct:   364 VEVLETLKDDGD 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
 Identities = 211/335 (62%), Positives = 258/335 (77%)

Query:    45 SNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDK-- 102
             S+ S+  +SE+L+IS   S+L  FT  +LK++T++F   + LGEGGFG V KG+I++   
Sbjct:   110 SSSSTPVISEELNIS---SHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGT 166

Query:   103 --LRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY 160
               ++PG     VAVK L+ +GLQGH+EWL E+ FLG L HP+LVKL+GYC E++ RLLVY
Sbjct:   167 APVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVY 225

Query:   161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLD 219
             E+MPRGSLEN LFRR S+ LPWS RMKIALGAAKGL+FLH+ A KPVIYRDFK SNILLD
Sbjct:   226 EFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 284

Query:   220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLE 279
             +DY AKLSDFGLAKD P+   THVSTRVMGT GYAAPEYVMTGHLTS SDVYSFGVVLLE
Sbjct:   285 ADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 344

Query:   280 LLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQC 339
             +L+GR+S+DK+RP  E +LVEWARP L D R+  R++DPRLEG +S  GA+K   LA QC
Sbjct:   345 MLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQC 404

Query:   340 LSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVF 374
             LS  PK RP MS VV+ L+PL    D +A  ++ F
Sbjct:   405 LSRDPKIRPKMSDVVEALKPLPHLKD-MASSSYYF 438

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
 Identities = 205/326 (62%), Positives = 247/326 (75%)

Query:    45 SNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDK-- 102
             S  S+  +S +L  S   S L +F   +LK+ T++F   + LGEGGFG V KG+I++   
Sbjct:    71 SGSSTPLMSGELKYS---SKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 127

Query:   103 --LRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY 160
               ++PG     VAVK L+ +GLQGH+EWL E+ FLG L HP LVKL+GYC EE+ RLLVY
Sbjct:   128 APVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVY 186

Query:   161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLD 219
             E+MPRGSLEN LFRR ++ LPWS RMKIALGAAKGLAFLH+ AEKPVIYRDFK SNILLD
Sbjct:   187 EFMPRGSLENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 245

Query:   220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLE 279
              +Y AKLSDFGLAKD P+   +HVSTRVMGT GYAAPEYVMTGHLT+ SDVYSFGVVLLE
Sbjct:   246 GEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLE 305

Query:   280 LLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQC 339
             +L+GR+SVDKSRP  EQ+LVEW RP L D ++  R++DPRLEG YS  GA+KA  +A QC
Sbjct:   306 ILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQC 365

Query:   340 LSHRPKQRPTMSTVVKTLEPLKDFDD 365
             L+   K RP MS VV+ L+PL +  D
Sbjct:   366 LNRDSKARPKMSEVVEALKPLPNLKD 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 199/323 (61%), Positives = 241/323 (74%)

Query:    47 PSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL--R 104
             PS+    EDL    A + L  FT  ELK  T +F     LG GGFG+V+KGFI + L  +
Sbjct:    43 PSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQ 102

Query:   105 PGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM 163
                +  PVAVK  D +   QGHREWL EVIFLGQL HP+LVKLIGYCCE+ HR+L+YEYM
Sbjct:   103 EVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYM 162

Query:   164 PRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT 223
              RGS+EN LF R  + L W+ RMKIA GAAKGLAFLH+A+KPVIYRDFK SNILLD DY 
Sbjct:   163 ARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYN 222

Query:   224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             AKLSDFGLAKDGP GD +HVSTR+MGT GYAAPEY+MTGHLT  SDVYSFGVVLLELL+G
Sbjct:   223 AKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTG 282

Query:   284 RKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHR 343
             RKS+DKSRP REQ+L++WA P+L + +K+  I+DP++  +Y     +KAA LAY CL+  
Sbjct:   283 RKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRN 342

Query:   344 PKQRPTMSTVVKTLEPLKDFDDD 366
             PK RP M  +V +LEPL+  +++
Sbjct:   343 PKARPLMRDIVDSLEPLQATEEE 365

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.28.85.1 hypothetical protein (445 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	455
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-30
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-26
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-25
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-25
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-25
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-24
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-21
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-04

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  188 bits (481), Expect = 5e-57
 Identities = 92/278 (33%), Positives = 132/278 (47%), Gaps = 33/278 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V+KG +  K   G +   VAVK L  +   Q   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGKLKGK--GGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KL+G C EEE   +V EYM  G L + L R+    L  S  +  AL  A+G+ +L    K
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLES--K 121

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV-STRV----MGTQGYAAPEYV 259
             I+RD  A N L+  +   K+SDFGL++D  + D       ++    M      APE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM------APESL 175

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
             G  TS SDV+SFGV+L E+ +  +      P    S  E    +L   +  G  +   
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE----VLEYLKN-GYRLPQ- 224

Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                      +   L  QC +  P+ RPT S +V+ L
Sbjct: 225 -----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  187 bits (478), Expect = 1e-56
 Identities = 94/278 (33%), Positives = 133/278 (47%), Gaps = 32/278 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V+KG +  K     +   VAVK L  +   Q   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTLKGK--GDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KL+G C EEE  ++V EYMP G L + L +     L  S  +  AL  A+G+ +L    K
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--K 122

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST-----RVMGTQGYAAPEYV 259
             I+RD  A N L+  +   K+SDFGL++D  + D   V       R M      APE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM------APESL 176

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
             G  TS SDV+SFGV+L E+ +  +      P    S  E    +L   +K G  +   
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE----VLEYLKK-GYRLPKP 226

Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                      +   L  QC +  P+ RPT S +V+ L
Sbjct: 227 ------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (445), Expect = 8e-52
 Identities = 92/279 (32%), Positives = 133/279 (47%), Gaps = 34/279 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V+KG +            VAVK L      +   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTLKGD--GEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L+G C + E   +V EYMP G L + L R++   L     +++AL  AKG+ +L    K
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES--K 121

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST------RVMGTQGYAAPEY 258
             ++RD  A N L+  +   K+SDFGL++D  E D            + M      APE 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------APES 175

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +  G  TS SDV+SFGV+L E+ +  +      P    S  E    +L D    G  + P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLED----GYRL-P 224

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           R E    E        L  QC ++ P+ RPT S +V+ L
Sbjct: 225 RPENCPDEL-----YELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  171 bits (436), Expect = 2e-50
 Identities = 93/286 (32%), Positives = 131/286 (45%), Gaps = 39/286 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           LGEG FG V+KG +  K     +   VAVK L  +  +  R ++L E   + +L HP++V
Sbjct: 3   LGEGAFGEVYKGKLKGK---DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSL-------ENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           +L+G C EEE   LV EYM  G L                 +L     +  A+  AKG+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG----- 252
           +L    K  ++RD  A N L+  D   K+SDFGL++D  + D          T G     
Sbjct: 120 YLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLPIR 172

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           + APE +  G  TS SDV+SFGV+L E+ +   +     P    S  E    +L   RK 
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEE----VLEYLRKG 223

Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            R+  P+ E    E        L   C    P+ RPT S +V+ LE
Sbjct: 224 YRL--PKPEYCPDEL-----YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  169 bits (431), Expect = 3e-50
 Identities = 79/275 (28%), Positives = 115/275 (41%), Gaps = 63/275 (22%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LGEGGFG V+              + VA+K +  E      E  L E+  L +L HP++V
Sbjct: 1   LGEGGFGTVYLARDKKT------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KL G   +E H  LV EY   GSL+  L +     L     ++I L   +GL +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLK-DLLKENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 205 PVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-TG 262
            +I+RD K  NILLDSD    KL+DFGL+K             ++GT  Y APE ++  G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKG 169

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
           + +  SD++S GV+L EL                                          
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                   +   L  + L   P++RP+   +++ L
Sbjct: 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  156 bits (397), Expect = 7e-45
 Identities = 80/275 (29%), Positives = 123/275 (44%), Gaps = 32/275 (11%)

Query: 84  NFLGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHP 141
             LGEG FG V+               + VA+K +  + ++  RE  L E+  L +L+HP
Sbjct: 5   EKLGEGSFGKVYLARDKKTG-------KLVAIKVIKKKKIKKDRERILREIKILKKLKHP 57

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++V+L     +E+   LV EY   G L + L +R  +S     R          L +LH 
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSALEYLHS 115

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
             K +++RD K  NILLD D   KL+DFGLA+         ++T V GT  Y APE ++ 
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWARPMLNDARKLGRIMDPRL 320
                  D++S GV+L ELL+G+       P   +  L+E  + +        +   P  
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGK-----PKPPFPPP 219

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           E   S      A  L  + L   P++R T    ++
Sbjct: 220 EWDISPE----AKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (398), Expect = 7e-45
 Identities = 87/271 (32%), Positives = 128/271 (47%), Gaps = 32/271 (11%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG G FG V+K              + VAVK      E  +  +    E+  L +L HP+
Sbjct: 7   LGSGSFGTVYKAKHKGTG-------KIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +V+LI    +++H  LV EY   G L + L       L      KIAL   +GL +LH  
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH-- 115

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
              +I+RD K  NILLD +   K++DFGLAK       + ++T V GT  Y APE ++ G
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGG 173

Query: 263 -HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
                  DV+S GV+L ELL+G+                    +L+  + + RI+ P LE
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPLE 220

Query: 322 GQYSE--TGARKAAALAYQCLSHRPKQRPTM 350
               +  +G+ +A  L  +CL+  P +RPT 
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTA 251

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (334), Expect = 1e-35
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           F     +G+GGFG V+K     +       + VA+K + LE  +   + + E+  L + +
Sbjct: 2   FEILEKIGKGGFGEVYKA-RHKRTG-----KEVAIKVIKLESKEKKEKIINEIQILKKCK 55

Query: 140 HPHLVKLIG-YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           HP++VK  G Y  ++E   +V E+   GSL+  L +  + +L  S    +     KGL +
Sbjct: 56  HPNIVKYYGSYLKKDE-LWIVMEFCSGGSLK-DLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH     +I+RD KA+NILL SD   KL DFGL+    +    +    ++GT  + APE 
Sbjct: 114 LH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEV 168

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGR 284
           +        +D++S G+  +EL  G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  130 bits (328), Expect = 1e-34
 Identities = 90/292 (30%), Positives = 135/292 (46%), Gaps = 31/292 (10%)

Query: 83  SNFLGEGGFGAVHKG---FIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQL 138
              LGEG FG V       + D    G Q   VAVK+L+  G + HR ++  E+  L  L
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDN--TGEQ---VAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 139 RHPHLVKLIGYCCEEEHR---LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            H ++VK  G  CE+       L+ EY+P GSL + L +R+   +     +  +    KG
Sbjct: 64  DHENIVKYKG-VCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKG 121

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST--RVMGTQGY 253
           + +L    +  I+RD  A NIL++S+   K+SDFGLAK  PE  D +            Y
Sbjct: 122 MDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            APE + T   +S SDV+SFGV L EL + G  S  +S P     ++  A+  +   R L
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPS--QSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 313 GRIMD----PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             + +    PR      E        L   C    P+ RP+ + ++  ++ L
Sbjct: 237 ELLKEGERLPRPPSCPDEV-----YDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  125 bits (316), Expect = 4e-33
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 34/220 (15%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLG 136
            ++    LG G FG+V+     D        + +AVK+++L G           E+  L 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKD------TGELMAVKSVELSGDSEEELEALEREIRILS 54

Query: 137 QLRHPHLVKLIGYCCEEE--HRLLVYEYMPRGSL----------ENQLFRRYSVSLPWST 184
            L+HP++V+  G   +EE     +  EY+  GSL             + R+Y       T
Sbjct: 55  SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-------T 107

Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
           R  +     +GLA+LH     +++RD K +NIL+DSD   KL+DFG AK   + +    +
Sbjct: 108 RQIL-----EGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
             V GT  + APE +        +D++S G  ++E+ +G+
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 3e-32
 Identities = 71/207 (34%), Positives = 106/207 (51%), Gaps = 31/207 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQLRHPHL 143
           +G+G FG V  G          + Q VAVK L  D    Q    +L E   +  LRHP+L
Sbjct: 14  IGKGEFGDVMLGD--------YRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNL 62

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+L+G   +     +V EYM +GSL + L  R    +  + ++  AL   +G+ +L   E
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--E 120

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPEY 258
           K  ++RD  A N+L+  D  AK+SDFGLAK+  +G D+          G     + APE 
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS----------GKLPVKWTAPEA 170

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GR 284
           +     ++ SDV+SFG++L E+ S GR
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 1e-30
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 47/288 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V +G +     PG +   VA+K L        R ++LTE   +GQ  HP+++
Sbjct: 12  IGGGEFGEVCRGRL---KLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G   +    +++ EYM  GSL+ +  R           + +  G A G+ +L  +E 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLD-KFLRENDGKFTVGQLVGMLRGIASGMKYL--SEM 125

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEY 258
             ++RD  A NIL++S+   K+SDFGL++   + + T+       T+G      + APE 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAPEA 179

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM----LNDARKLG 313
           +     TS SDV+SFG+V+ E++S G           E+   + +       + D  +L 
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYG-----------ERPYWDMSNQDVIKAVEDGYRLP 228

Query: 314 RIMD-PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             MD P     Y          L   C      +RPT S +V TL+ +
Sbjct: 229 PPMDCP--SALYQ---------LMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  117 bits (294), Expect = 5e-30
 Identities = 88/287 (30%), Positives = 128/287 (44%), Gaps = 31/287 (10%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPH 142
           NFLG G FG V++G   D L PG     VAVK L      Q  +E+L E   +    HP+
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQL-----FRRYSVSLPWSTRMKIALGAAKGLA 197
           +VKL+G C   E + ++ E M  G L + L      R     L     + I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 198 FLHDAEKPVIYRDFKASNILL-----DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           +L       I+RD  A N L+     D+D   K+ DFGLA+D  + D        +    
Sbjct: 121 YLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK 311
           + APE ++ G  T+ SDV+SFGV++ E+L+ G++      P    +  E    +L     
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ------PYPALNNQE----VLQHVTA 228

Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            GR+  P            K   L   C +  P +RPT   + + L+
Sbjct: 229 GGRLQKPE-------NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 7e-30
 Identities = 92/279 (32%), Positives = 131/279 (46%), Gaps = 36/279 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG+V KG     L    +   VAVK L       G +E+L E   + QL HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +LIG  C+ E  +LV E  P G L  +  ++    +P S   ++A   A G+A+L    K
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPL-LKYLKKRR-EIPVSDLKELAHQVAMGMAYLE--SK 114

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPEYV 259
             ++RD  A N+LL + + AK+SDFG+++    G D + +T    T G     + APE +
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECI 170

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
             G  +S SDV+S+GV L E  S G K      P  E    E    ML    +L R   P
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAK------PYGEMKGAE-VIAMLESGERLPR---P 220

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
               Q          ++   C  +RP+ RPT S +  T 
Sbjct: 221 EECPQE-------IYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 1e-29
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 28/283 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG+G FG V++G     +  G     VA+K + +   ++   E+L E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGLAKG-VVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQL--------FRRYSVSLPWSTRMKIALGAAKGL 196
           +L+G     +  L+V E M +G L++ L                     +++A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+L  A K  ++RD  A N ++  D T K+ DFG+ +D  E D      + +    + AP
Sbjct: 133 AYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +  G  T+ SDV+SFGVVL E+ +        +P +  S  E  + +++     G  +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQPYQGLSNEEVLKFVID-----GGHL 240

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP 359
           D        E    K   L   C  + PK RPT   +V +L+ 
Sbjct: 241 D------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-29
 Identities = 78/274 (28%), Positives = 123/274 (44%), Gaps = 27/274 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           +G+G FG V+KG +            VAVK          +  +L E   L Q  HP++V
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KLIG C +++   +V E +P GSL   L R+    L     ++++L AA G+ +L    K
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE--SK 112

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             I+RD  A N L+  +   K+SDFG++++   G  T           + APE +  G  
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
           TS SDV+S+G++L E  S         P    S  +  R  +    ++     P  +   
Sbjct: 173 TSESDVWSYGILLWETFSL-----GDTPYPGMSNQQ-TRERIESGYRM-----PAPQLCP 221

Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            E        L  QC ++ P+ RP+ S +   L+
Sbjct: 222 EEI-----YRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 5e-29
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 20/210 (9%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQ 137
           +   + +G G FG V+KG     L  G     VA+K + LE +  +  +  + E+  L  
Sbjct: 2   YQLGDLIGRGAFGVVYKGL---NLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLKN 55

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAAKG 195
           L+HP++VK IG     +   ++ EY   GSL   +  F  +  SL  +  +   L   +G
Sbjct: 56  LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QG 111

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LA+LH  E+ VI+RD KA+NIL   D   KL+DFG+A      D +     V+GT  + A
Sbjct: 112 LAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMA 167

Query: 256 PEYV-MTGHLTSMSDVYSFGVVLLELLSGR 284
           PE + M+G  T+ SD++S G  ++ELL+G 
Sbjct: 168 PEVIEMSGASTA-SDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (281), Expect = 3e-28
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           F+    LG G FG V +G   +++        VA+K L  + L   +++  EV  L +LR
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRV-------RVAIKILKSDDLLKQQDFQKEVQALKRLR 60

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           H HL+ L   C   E   ++ E M +GSL   L       LP ++ + +A   A+G+A+L
Sbjct: 61  HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGDDTHVSTRVMGTQGYAA 255
              E+  I+RD  A NIL+  D   K++DFGLA+    D     D  +  +      + A
Sbjct: 121 E--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTA 172

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLS 282
           PE    G  ++ SDV+SFG++L E+ +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (281), Expect = 5e-28
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 18/212 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V+KG +       L A  VA+K L      +  +E+  E   +  L+HP++V
Sbjct: 13  LGEGAFGKVYKGELT-GPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MKIAL 190
            L+G C +E+   +++EY+  G L   L R    S   +                + IA+
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             A G+ +L  +    ++RD  A N L+    T K+SDFGL++D    D   V ++ +  
Sbjct: 132 QIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
             +  PE ++ G  T+ SD++SFGVVL E+ S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  110 bits (276), Expect = 2e-27
 Identities = 83/287 (28%), Positives = 122/287 (42%), Gaps = 38/287 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGL-QAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G FG V++G    + R G      VAVK L +    Q   ++L E + + +  H ++
Sbjct: 14  LGHGAFGEVYEGLY--RGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRMK----IALGAAKGLAF 198
           V+LIG   E   R ++ E M  G L++ L   R     P S  MK     A   AKG  +
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 199 LHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L   E   I+RD  A N LL        AK++DFG+A+D           R M    +  
Sbjct: 132 LE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE--QSLVEWAR--PMLNDARK 311
           PE  + G  TS +DV+SFGV+L E+ S        R  +E  + +    R  P       
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGP 249

Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           + RIM                      C  H P+ RP  +T+++ ++
Sbjct: 250 VYRIMT--------------------DCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  109 bits (275), Expect = 3e-27
 Identities = 85/278 (30%), Positives = 135/278 (48%), Gaps = 15/278 (5%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LGEG FG V   +  D    G   + VAVK L  E  Q +   W  E+  L  L H ++V
Sbjct: 12  LGEGHFGKVSL-YCYDPANDG-TGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 145 KLIGYCCEEEHR---LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           K  G CC E+      L+ EY+P GSL + L  ++ ++L  +  +  A    +G+A+LH 
Sbjct: 70  KYKG-CCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNL--AQLLLFAQQICEGMAYLH- 124

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH-VSTRVMGTQGYAAPEYVM 260
             +  I+RD  A N+LLD+D   K+ DFGLAK  PEG + + V         + A E + 
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDV+SFGV L ELL+      +S P++ + ++   +  +   R L  +++  +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVR-LIELLERGM 241

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                +   ++   L   C     K RPT  +++  L+
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 31/278 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLV 144
           LG+G FG V +G   +    G +  PVAVK L  + L     ++L E   +  L H +L+
Sbjct: 3   LGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G        ++V E  P GSL ++L +        ST    A+  A G+ +L    K
Sbjct: 60  RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SK 116

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST---RVMGTQGYAAPEYVMT 261
             I+RD  A NILL SD   K+ DFGL +  P+ +D +V     +V     + APE + T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174

Query: 262 GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
              +  SDV+ FGV L E+ + G +               WA   L+ ++ L +I D   
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP--------------WAG--LSGSQILKKI-DKEG 217

Query: 321 EG-QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           E  +  E   +    +  QC +H P  RPT + + + L
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 20/223 (8%)

Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G FG V+KG +I +  +  +   PVA+K L +    + ++E L E   +  + HPH+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKI---PVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           V+L+G C   +   L+ + MP G L      ++        L W  ++      AKG+++
Sbjct: 72  VRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           L   EK +++RD  A N+L+ +    K++DFGLAK     +  + +        + A E 
Sbjct: 125 LE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE 300
           ++    T  SDV+S+GV + EL++ G K  +         L+E
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  105 bits (265), Expect = 7e-26
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V  G     L P    + VAVK L +       +++  E   L   +H ++V
Sbjct: 13  LGEGAFGKVFLGECY-HLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS-------------VSLPWSTRMKIALG 191
           K  G C E +  ++V+EYM  G L N+  R +                L  S  ++IA+ 
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A G+ +L  A +  ++RD    N L+  D   K+ DFG+++D    D   V    M   
Sbjct: 131 IASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +  PE +M    T+ SDV+SFGVVL E+ +
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  110 bits (277), Expect = 7e-26
 Identities = 78/227 (34%), Positives = 116/227 (51%), Gaps = 17/227 (7%)

Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           +G+L+HP++VKLIG C  E+   L++EY+   +L +++ R    +L W  R KIA+G AK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLR----NLSWERRRKIAIGIAK 791

Query: 195 GLAFLHDAEKP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            L FLH    P V+  +     I++D      L    L+  G    DT    +   +  Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDT----KCFISSAY 844

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
            APE   T  +T  SD+Y FG++L+ELL+G+   D        S+VEWAR   +D   L 
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCH-LD 902

Query: 314 RIMDPRLEGQYS--ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             +DP + G  S  +    +   LA  C +  P  RP  + V+KTLE
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  105 bits (264), Expect = 1e-25
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)

Query: 86  LGEGGFGAVH-------KGFIDDKLRPG---LQAQPVAVKNLDLEGLQGHR-EWLTEVIF 134
           LGEG FG VH       + F +              VAVK L  +     R ++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY----------SVSLPWST 184
           L +L  P++ +L+G C  +    ++ EYM  G L NQ  +++          S SL +ST
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSFST 131

Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
            + +A   A G+ +L       ++RD    N L+  +YT K++DFG++++    D   V 
Sbjct: 132 LLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            R      + A E V+ G  T+ SDV++FGV L E+L+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 78/279 (27%), Positives = 119/279 (42%), Gaps = 42/279 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH G    K R  +    VA+K +  EG     +++ E   + +L HP+LV+
Sbjct: 12  LGSGQFGVVHLG----KWRGKID---VAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA----KGLAFLHD 201
           L G C ++    +V EYM  G L N L  R           +  L       + + +L  
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRER-----KGKLGTEWLLDMCSDVCEAMEYLE- 117

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEY 258
                I+RD  A N L+  D   K+SDFGLA+     DD + S+   GT+    +A PE 
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL--DDQYTSS--QGTKFPVKWAPPEV 172

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
                 +S SDV+SFGV++ E+ S  K   +     E         ++       R+  P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---------VVESVSAGYRLYRP 223

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           +L          +   + Y C   +P+ RP    ++  L
Sbjct: 224 KL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 45/293 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHPH 142
           LGEG FG+V +G +    +       VAVK + L+    + E   +L+E   +    HP+
Sbjct: 7   LGEGEFGSVMEGQLS---QDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPN 62

Query: 143 LVKLIGYCCEEEHR------LLVYEYMPRGSLENQLFRRY----SVSLPWSTRMKIALGA 192
           ++KLIG C E          +++  +M  G L + L           LP  T +K  +  
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD---DTHVSTRVMG 249
           A G+ +L  + +  I+RD  A N +L  D T  ++DFGL+K    GD      ++   M 
Sbjct: 123 ALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK--MP 178

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
            + + A E +     TS SDV++FGV + E+         +R Q     VE    + +  
Sbjct: 179 VK-WIAIESLADRVYTSKSDVWAFGVTMWEIA--------TRGQTPYPGVENHE-IYDYL 228

Query: 310 RKLGRIMDPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           R   R+  P   L+  Y          L Y C    PK RPT + + + LE +
Sbjct: 229 RHGNRLKQPEDCLDELY---------DLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (263), Expect = 4e-25
 Identities = 87/291 (29%), Positives = 126/291 (43%), Gaps = 31/291 (10%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFL 135
           S+     LGEG FG V+              + VA+K L  +     +E    L E+  L
Sbjct: 1   SYRILRKLGEGSFGEVYLA---------RDRKLVALKVLAKKLESKSKEVERFLREIQIL 51

Query: 136 GQLRHP-HLVKLIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAA 193
             L HP ++VKL  +  +E    LV EY+  GSLE+ L        L  S  + I     
Sbjct: 52  ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYT-AKLSDFGLAK----DGPEGDDTHVSTRVM 248
             L +LH   K +I+RD K  NILLD D    KL DFGLAK     G       + +  +
Sbjct: 112 SALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 249 GTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
           GT GY APE ++     + +S SD++S G+ L ELL+G        P   +         
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL------PPFEGEKNSSATSQT 223

Query: 306 LNDARKLG-RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           L    +L    +   L     E  ++ A+ L  + L+  PK R + S+ + 
Sbjct: 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  103 bits (258), Expect = 5e-25
 Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 30/280 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V +G +     PG +   VA+K L     +  R ++L+E   +GQ  H +++
Sbjct: 13  IGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G   + +  +++ EYM  G+L+ +  R +         + +  G A G+ +L D   
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALD-KYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN- 127

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
             ++RD  A NIL++S+   K+SDFGL++   D PEG  T    ++     + APE +  
Sbjct: 128 -YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAY 184

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-PRL 320
              TS SDV+SFG+V+ E++S  +     RP  + S  E  +  +ND  +L   MD P  
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGE-----RPYWDMSNHEVMKA-INDGFRLPAPMDCPSA 238

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             Q           L  QC      +RP    +V  L+ L
Sbjct: 239 VYQ-----------LMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (257), Expect = 5e-25
 Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 34/275 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG V  G+  +K +       VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-------VAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQ 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E     LV+E+M  G L + L R         T + + L   +G+A+L  +   
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +++PE     
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDDQYTSST--GTKFPVKWSSPEVFSFS 176

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K+  ++R   E         ++       R+  PRL  
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---------VVETINAGFRLYKPRLAS 227

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           Q           L   C   RP+ RP+ S ++  L
Sbjct: 228 QS-------VYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  103 bits (258), Expect = 6e-25
 Identities = 88/300 (29%), Positives = 130/300 (43%), Gaps = 46/300 (15%)

Query: 86  LGEGGFGAVHKGFIDD-KLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHL 143
           LGEG FG V K      K R G     VAVK L         R+ L+E   L Q+ HPH+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTT--VAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQL--------------FRRYSVSL------PWS 183
           +KL G C ++   LL+ EY   GSL + L                R S  L        +
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 184 TRMKI--ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
               I  A   ++G+ +L  AE  +++RD  A N+L+      K+SDFGL++D  E D  
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE 300
              ++      + A E +     T+ SDV+SFGV+L E+++ G        P+R  +L+ 
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL- 242

Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                     K G  M+        E  + +   L   C    P +RPT + + K LE +
Sbjct: 243 ----------KTGYRME------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (255), Expect = 9e-25
 Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 36/274 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FGAV +G            Q VAVKN+  +     + +L E   + +L H +LV+
Sbjct: 14  IGEGEFGAVLQG--------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVR 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G         +V E M +G+L N L  R    +     ++ +L  A+G+ +L    K 
Sbjct: 64  LLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKK 120

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           +++RD  A NIL+  D  AK+SDFGLA+ G  G D    +++     + APE +     +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN---SKL--PVKWTAPEALKHKKFS 175

Query: 266 SMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
           S SDV+S+GV+L E+ S GR       P  + SL E     + +  + G  M+P      
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA------PYPKMSLKE-----VKECVEKGYRMEP------ 218

Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            E        L   C    PK+RP+   + + LE
Sbjct: 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 9/198 (4%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           +GEG FG V++G         +    VAVK          RE +L E   + Q  HPH+V
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKI---AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KLIG    E    +V E  P G L + L +    SL  ++ +  +   +  LA+L    K
Sbjct: 71  KLIG-VITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES--K 126

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S    KL DFGL++   E +  + +++      + APE +     
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 265 TSMSDVYSFGVVLLELLS 282
           TS SDV+ FGV + E+L 
Sbjct: 186 TSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 59/160 (36%), Positives = 80/160 (50%), Gaps = 14/160 (8%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCC--EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           LTE   L ++ HP +VKL  +     EE   LV EY P G L + L +    S   +   
Sbjct: 41  LTERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY 98

Query: 187 --KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
             +I L     L +LH     +IYRD K  NILLD+D   KL+DFGLAK+         +
Sbjct: 99  AAEIVLA----LEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TN 151

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           T   GT  Y APE ++        D +S GV+L E+L+G+
Sbjct: 152 TFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (251), Expect = 3e-24
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 29/278 (10%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQ 137
           F   N +G+G FG V K      +      +  A+K +DL  +      E + E   L +
Sbjct: 2   FEILNKIGKGSFGVVFK------VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAK 55

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L   ++++      ++    +V EY   G L   L  +    LP     +  +    GLA
Sbjct: 56  LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
            LH   K +++RD K+ N+ LD+    K+ D G+AK     D+T+ +  ++GT  Y +PE
Sbjct: 116 HLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPE 171

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
                     SDV++ GVVL E  +G+   D      + +L+           K+ R + 
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRGVF 218

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           P +   YS+    + A L  QCL+   +QRP    +++
Sbjct: 219 PPVSQMYSQ----QLAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 6e-24
 Identities = 70/203 (34%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G  +           VAVK L   G      +L E   + +LRH  LV+
Sbjct: 14  LGAGQFGEVWMGTWNGTT-------KVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQ 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L   C EEE   +V EYM +GSL + L       L     + +A   A+G+A+L    + 
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRN 123

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD  A NIL+  +   K++DFGLA+     +D   + R  G +    + APE    G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWTAPEAANYG 179

Query: 263 HLTSMSDVYSFGVVLLELLS-GR 284
             T  SDV+SFG++L E+++ GR
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 7e-24
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 61/284 (21%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK--NLDLEGLQGH---REWLTEVIFLGQLR 139
            LG G FG+V++G   D           AVK  +L  +G  G    ++   E+  L +L+
Sbjct: 7   LLGSGSFGSVYEGLNLDD------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS-----TRMKIALGAAK 194
           HP++V+ +G   EE++  +  E +P GSL   L ++Y  S P       TR  +      
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL-KKYG-SFPEPVIRLYTRQIL-----L 113

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM-----G 249
           GL +LHD  +  ++RD K +NIL+D++   KL+DFG+AK         V          G
Sbjct: 114 GLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKG 163

Query: 250 TQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP--QREQSLVEWARPML 306
           +  + APE +   G     +D++S G  +LE+ +G+       P  Q E     +     
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP------PWSQLEGVAAVF----- 212

Query: 307 NDARKLGRIMD-PRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
               K+GR  + P +     +  + +A     +CL   P  RPT
Sbjct: 213 ----KIGRSKELPPI----PDHLSDEAKDFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 99.3 bits (247), Expect = 2e-23
 Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 14/229 (6%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFI---DDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEV 132
                    LG G FG VHKG      D ++      PVA+K + D  G Q  +E    +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKI-----PVAIKTIQDRSGRQTFQEITDHM 60

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           + +G L H ++V+L+G C     +L V +  P GSL + + R++  SL     +   +  
Sbjct: 61  LAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQI 118

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           AKG+ +L   E  +++R+  A NILL SD   +++DFG+A      D  +  +       
Sbjct: 119 AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE 300
           + A E ++ G  T  SDV+S+GV + E++S G +     RP     L+E
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 98.1 bits (244), Expect = 3e-23
 Identities = 69/199 (34%), Positives = 106/199 (53%), Gaps = 12/199 (6%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHL 143
            LG+G FG V KG + DK        PVAVK    +  Q  + ++L+E   L Q  HP++
Sbjct: 2   LLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           VKLIG C + +   +V E +P G   + L R+    L     +K AL AA G+A+L    
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE--S 111

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           K  I+RD  A N L+  +   K+SDFG+++   +G  +    + +  + + APE +  G 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGR 170

Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+S+G++L E  S
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 84/283 (29%), Positives = 119/283 (42%), Gaps = 45/283 (15%)

Query: 83  SNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLR 139
            N +G G FG V+    +D         + +AVK + ++       +E   E+  L  L+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDT-------GELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57

Query: 140 HPHLVKLIGYCCEEEHRLLVY---EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           HP+LVK  G    E HR  VY   EY   G+LE  L   +   L         L   +GL
Sbjct: 58  HPNLVKYYGV---EVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGL 112

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST--RVMGTQGYA 254
           A+LH     +++RD K +NI LD +   KL DFG A        T       + GT  Y 
Sbjct: 113 AYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 255 APEYV----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
           APE +      GH  +  D++S G V+LE+ +G+      RP  E    E+         
Sbjct: 171 APEVITGGKGKGHGRAA-DIWSLGCVVLEMATGK------RPWSELD-NEFQI-----MF 217

Query: 311 KLGRIMDPRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
            +G    P +    Q S  G         +CL   PK+RPT S
Sbjct: 218 HVGAGHKPPIPDSLQLSPEGKD----FLDRCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 49/281 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           +G+G FG V+      +   G   +   +K +DL  +      + L EV  L +L HP++
Sbjct: 8   IGKGSFGKVYLV---RRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS--VSLPWSTRMKIALGAAKGLAFLHD 201
           +K      E+    +V EY   G L  ++ ++       P    +   +     L +LH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE---- 257
             + +++RD K  NI L S+   KL DFG++K           T V GT  Y +PE    
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQN 177

Query: 258 --YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
             Y         SD++S G VL EL + +   +                +L  A K   I
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHPFE-------------GENLLELALK---I 215

Query: 316 MD---PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
           +    P +  QYS     +   L    L   P++RP+++ +
Sbjct: 216 LKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 81/292 (27%), Positives = 126/292 (43%), Gaps = 47/292 (16%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL-EGLQGH-REWLTEVIFLGQLRHPH 142
            +GEG +G V+K       R  L  + VA+K + L    +G  +  L E+  L +L HP+
Sbjct: 6   KIGEGTYGVVYKA------RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN 59

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLEN--QLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           ++KL+     +    LV+E+M      +  +L +     LP S          +GLAF H
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTH-VSTRVMGTQGYAAPE 257
                +++RD K  N+L++++   KL+DFGLA+    P    TH V TR      Y APE
Sbjct: 116 SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPE 168

Query: 258 --YVMTGHLTSMSDVYSFGVVLLELLS------GRKSVDK----------SRPQREQSLV 299
                 G+ T + D++S G +  ELLS      G+  +D+            P+      
Sbjct: 169 LLLGDKGYSTPV-DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
             AR       K   +  P+L    S     +A  L  Q L + P +R T  
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASP----QALDLLSQMLHYDPHKRITAE 275

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 10/203 (4%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPH 142
             +G+G FG V+ G + D      Q    AVK+L+ +  L+   ++L E I +    HP+
Sbjct: 1   RVIGKGHFGCVYHGTLID---SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 143 LVKLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++ L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYV 259
           A K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E +
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
            T   T+ SDV+SFGV+L EL++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           +GEG  G V K         G   + VA+K + L  L+G    + L E+  L   +HP++
Sbjct: 8   IGEGAHGIVFKAKD---RETG---ETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           VKL+         +LV EYMP   L   L R     LP +          KG+A++H   
Sbjct: 62  VKLLDVFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG- 262
             +++RD K +N+L+ +D   K++DFGLA+   E +    S +V  T+ Y APE ++ G 
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE-LLYGA 175

Query: 263 -HLTSMSDVYSFGVVLLELLSGR 284
                  D+++ G +  ELL+G 
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 78/287 (27%), Positives = 134/287 (46%), Gaps = 29/287 (10%)

Query: 86  LGEGGFGAVH----KGFID--DKLRPGLQAQP--VAVKNLDLEGLQGHR-EWLTEVIFLG 136
           LGEG FG VH    +G  +   +  P    QP  VAVK L  +  +  R ++L E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YSV--------SLPWSTRM 186
           +L++P++++L+G C  ++   ++ EYM  G L   L +R   S         S+  +  +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
            +A+  A G+ +L  A    ++RD    N L+ + YT K++DFG++++   GD   +  R
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML 306
            +    + A E ++ G  T+ SDV++FGV L E+ +  K    S    EQ +        
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFR 250

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
           N  R++     P       +        L  +C S   K RPT + +
Sbjct: 251 NQGRQIYLSQTPLCPSPVFK--------LMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.4 bits (237), Expect = 4e-22
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 12/201 (5%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V  G +  KL PG +  PVA+K L     +  R ++L+E   +GQ  HP+++
Sbjct: 12  IGAGEFGEVCSGRL--KL-PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            L G   + +  ++V EYM  GSL+  L R++         + +  G A G+ +L D   
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKYLSDMG- 126

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
             ++RD  A NIL++S+   K+SDFGL++   D PE   T    ++     + APE +  
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAY 183

Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              TS SDV+S+G+V+ E++S
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 79/269 (29%), Positives = 120/269 (44%), Gaps = 32/269 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLV 144
           LG G  G V K       RP    + +AVK + LE      ++ L E+  L +   P++V
Sbjct: 9   LGAGNSGVVSKVLH----RP--TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
              G         +  EYM  GSL+ ++ +     +P     KIA+   KGL +LH+  K
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            +I+RD K SNIL++S    KL DFG++    +  ++   T V GT  Y APE +     
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV-GTSSYMAPERIQGNDY 176

Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD---PRL- 320
           +  SD++S G+ L+EL +GR                   P       L  I++   PRL 
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEPPPRLP 225

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPT 349
            G++S             CL   P++RP+
Sbjct: 226 SGKFSP----DFQDFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 94.2 bits (235), Expect = 7e-22
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT---EVIFLGQLRHP 141
            LG+G  G V+K       +P    +  A+K + ++G +  R+ L    + +   +   P
Sbjct: 8   VLGQGSSGVVYKVR----HKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SP 59

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++VK  G   +E    +V EYM  GSL +    +    +P      IA    KGL +LH 
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLAD--LLKKVGKIPEPVLAYIARQILKGLDYLH- 116

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEY 258
            ++ +I+RD K SN+L++S    K++DFG++K   +  +  +T V     GT  Y +PE 
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGR 284
           +     +  +D++S G+ LLE   G+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.2 bits (234), Expect = 9e-22
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 14/203 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPH 142
           +G G FG V +G    +L+ PG +   VA+K L   G      R++L+E   +GQ  HP+
Sbjct: 12  IGAGEFGEVCRG----RLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           ++ L G   +    +++ E+M  G+L++ L R+          + +  G A G+ +L  +
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL--S 123

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYV 259
           E   ++RD  A NIL++S+   K+SDFGL++   +       T  +G +    + APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                TS SDV+S+G+V+ E++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQG-HREWLTEVIFLGQL 138
             LGEG +  V+K    DK       + VA+K + L    E   G +   L E+  L +L
Sbjct: 6   KKLGEGTYAVVYKA--RDKET----GRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           +HP+++ L+     + +  LV+E+M    LE ++ +  S+ L  +      L   +GL +
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH     +++RD K +N+L+ SD   KL+DFGLA+      +  ++ +V+ T+ Y APE 
Sbjct: 118 LHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAPEL 173

Query: 259 VM-TGHLTSMSDVYSFGVVLLELLSGR 284
           +    H     D++S G +  ELL   
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 79/293 (26%), Positives = 127/293 (43%), Gaps = 41/293 (13%)

Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L    L   +++  E   L  L+H H+
Sbjct: 13  LGEGAFGKV---FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV---------------SLPWSTRMKI 188
           VK  G C + +  ++V+EYM  G L N+  R +                  L  S  + I
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A   A G+ +L  A +  ++RD    N L+ ++   K+ DFG+++D    D   V    M
Sbjct: 129 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
               +  PE +M    T+ SDV+SFGV+L E+ +  K          Q   + +   + +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK----------QPWFQLSNTEVIE 236

Query: 309 ARKLGRIMD-PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               GR+++ PR+         ++   +   C    P+QR  +  + K L  L
Sbjct: 237 CITQGRVLERPRV-------CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 93.7 bits (234), Expect = 1e-21
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK----NLDLEGLQGHREWLTEVIFLGQLRHP 141
           LGEG +G V+K    DK       + VA+K    + + EG+      L E+  L +L+HP
Sbjct: 7   LGEGTYGVVYKAR--DKK----TGEIVALKKIRLDNEEEGIP--STALREISLLKELKHP 58

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++VKL+     E    LV+EY     L+     +    L  +    I     +GLA+ H 
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKK-YLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYV 259
               +++RD K  NIL++ D   KL+DFGLA+    P    TH    V+ T  Y APE +
Sbjct: 117 HR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEIL 170

Query: 260 MTGHLTSMS-DVYSFGVVLLELLSGR 284
           +     S + D++S G +  E+++G+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 78/277 (28%), Positives = 128/277 (46%), Gaps = 36/277 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   + +L H  LV+
Sbjct: 12  LGTGQFGVVKYG----KWR---GQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    +V EYM  G L N L R +      S  +++     +G+A+L    K 
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQ 120

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD  A N L+D     K+SDFGL++     DD + S+  +G++    ++ PE ++  
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVLLYS 176

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
             +S SDV++FGV++ E+ S G+   ++         V              R+  P L 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL----------RLYRPHL- 225

Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                  + K  A+ Y C   + ++RPT   ++ ++E
Sbjct: 226 ------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V +G  ++         PVAVK L   G    +++L E   + +LRHP L++
Sbjct: 14  LGAGQFGEVWEGLWNN-------TTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L   C  EE   +V E M  GSL   L      +L     + +A   A G+A+L    + 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQN 123

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD-DTHVSTRVMGTQGYAAPEYVMTGHL 264
            I+RD  A N+L+  +   K++DFGLA+   E   +     +      + APE  +    
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRF 181

Query: 265 TSMSDVYSFGVVLLELLS-GR 284
           +  SDV+SFG++L E+++ GR
Sbjct: 182 SIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 22/214 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ-AQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGE  FG ++KG +     PG+  AQ VA+K L D+   Q   E+  E   + +L HP++
Sbjct: 13  LGECAFGKIYKGHL---YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR---------------YSVSLPWSTRMKI 188
           V L+G   +E+   +++EY+ +G L   L  R                  SL     + I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A+  A G+ +L  +    +++D  A NIL+      K+SD GL+++    D   V  + +
Sbjct: 130 AIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
               +  PE +M G  +S SD++SFGVVL E+ S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 10/199 (5%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG + +G +  KL P  +  PVA+  L      +  R +L E + LGQ  H ++V
Sbjct: 13  LGTGRFGELCRGCL--KL-PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G        ++V EYM  G+L++ L R++   L     M +  G A G+ +L  +E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYL--SEM 126

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFG-LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
             +++   A  +L++SD   K+S F  L +D  E   T +S +      +AAPE +   H
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAIQYHH 184

Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFG+V+ E++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G+ +           VA+K+L  +G      +L E   + QL+HP LV+
Sbjct: 14  LGAGQFGEVWMGYYNGH-------TKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +E    ++ EYM  GSL + L     + L  +  + +A   A+G+AF+    K 
Sbjct: 66  LYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKN 122

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            I+RD +A+NIL+      K++DFGLA+                 +G      + APE +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLAR-------LIEDNEYTAREGAKFPIKWTAPEAI 175

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GR 284
             G  T  SDV+SFG++L E+++ GR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 91.9 bits (228), Expect = 4e-21
 Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 13/224 (5%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           LG G FG V KG    K+R   +   VA+K L  E  +  R E + E   + QL +P++V
Sbjct: 3   LGSGNFGCVKKGVY--KMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           ++IG  CE E  +LV E    G L N+        +  S  +++    + G+ +L    K
Sbjct: 59  RMIG-VCEAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLE--GK 114

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTG 262
             ++RD  A N+LL + + AK+SDFGL+K     DD++   R  G     + APE +   
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM 305
             +S SDV+S+G+ + E  S G+K   K +     S +E  + +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 81/284 (28%), Positives = 120/284 (42%), Gaps = 38/284 (13%)

Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L        +++  E   L  L+H H+
Sbjct: 13  LGEGAFGKV---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--------------LPWSTRMKIA 189
           V+  G C E    L+V+EYM  G L N+  R +                 L     + IA
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A G+ +L  A    ++RD    N L+      K+ DFG+++D    D   V  R M 
Sbjct: 129 SQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
              +  PE ++    T+ SD++SFGVVL E+ +  K     +P  + S  E A   +   
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK-----QPWYQLSNTE-AIECITQG 240

Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
           R+L R   PR       T   +  A+   C    P+QR  +  +
Sbjct: 241 RELER---PR-------TCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 7e-21
 Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 46/280 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +  +     + +L E   + QLRH +LV+
Sbjct: 14  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63

Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--AN 121

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGH 263
             ++RD  A N+L+  D  AK+SDFGL K+     DT  +  +      + APE +    
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 175

Query: 264 LTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
            ++ SDV+SFG++L E+ S GR              V + R  L D       + PR+E 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD-------VVPRVEK 214

Query: 323 QYSETGARKAAALAY----QCLSHRPKQRPTMSTVVKTLE 358
            Y          + Y    QC       RP+   + + LE
Sbjct: 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.1 bits (229), Expect = 7e-21
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK------NLDLEGLQGHREWLTEVIFLGQLR 139
           LGEG  G+V K     +L+        A+K      N DL      ++ L E+      +
Sbjct: 9   LGEGAGGSVTKC----RLKNT--GMIFALKTITTDPNPDL-----QKQILRELEINKSCK 57

Query: 140 HPHLVKLIGYCCEEEHRLL--VYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKG 195
            P++VK  G   +E    +    EY   GSL++   +          ++  KIA    KG
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGYA 254
           L++LH   + +I+RD K SNILL      KL DFG++ +       T       GT  Y 
Sbjct: 118 LSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYM 170

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE +     +  SDV+S G+ LLE+   R
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 92.3 bits (229), Expect = 7e-21
 Identities = 84/304 (27%), Positives = 139/304 (45%), Gaps = 54/304 (17%)

Query: 86  LGEGGFGAVHKGFIDD--------------KLRPGLQAQPVAVKNLDLEGLQGHR-EWLT 130
           LGEG FG VH   + +              K RP L    VAVK L  +  +  R ++L 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL----VAVKILRPDANKNARNDFLK 68

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV------------ 178
           EV  L +L+ P++++L+G C +E+   ++ EYM  G L NQ    + +            
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVP 127

Query: 179 ------SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
                 ++ +S+ + +AL  A G+ +L  +    ++RD    N L+  + T K++DFG++
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP 292
           ++   GD   +  R +    + A E ++ G  T+ SDV++FGV L E+L   K       
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 293 QREQSLVEWARPMLNDARK---LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
             EQ ++E A     D  +   L R   P  +G Y          L  QC S   ++RP+
Sbjct: 246 TDEQ-VIENAGEFFRDQGRQVYLFR-PPPCPQGLYE---------LMLQCWSRDCRERPS 294

Query: 350 MSTV 353
            S +
Sbjct: 295 FSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.8 bits (228), Expect = 8e-21
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGL-QAQP---VAVKNLDLEG-LQGHREWLTEVIFLGQLRH 140
           +G+G FG V +        PGL   +P   VAVK L  E       ++  E   + +  H
Sbjct: 13  IGQGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------- 185
           P++VKL+G C   +   L++EYM  G L   L  R   +    +                
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 186 -----MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD 240
                + IA   A G+A+L  +E+  ++RD    N L+  +   K++DFGL+++    D 
Sbjct: 128 SCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              S        +  PE +     T+ SDV+++GVVL E+ S
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 90.8 bits (225), Expect = 9e-21
 Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 42/281 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL------DLEGLQGHREWLTEVIFLGQLR 139
           +G G FG V  G    +LR      PVAVK+       DL+      ++L E   L Q  
Sbjct: 3   IGRGNFGEVFSG----RLRA--DNTPVAVKSCRETLPPDLKA-----KFLQEARILKQYS 51

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++V+LIG C +++   +V E +  G     L R     L     +++   AA G+ +L
Sbjct: 52  HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT--QGYAAPE 257
               K  I+RD  A N L+      K+SDFG++++  E D  + ST  M      + APE
Sbjct: 111 E--SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPE 166

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
            +  G  +S SDV+SFG++L E  S G         Q+ +  +E          +  R+ 
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE----------QGVRLP 216

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
            P       E        L  +C  + P QRP+ STV + L
Sbjct: 217 CP-------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 34/285 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLV 144
           LG+G FG V++G   D ++   + + VAVK ++    L+   E+L E   +      H+V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSV----SLPWSTRMKIALGA--AKGL 196
           +L+G   + +  L+V E M  G L++ L   R  +       P + +  I + A  A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E D      + +    + AP
Sbjct: 133 AYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +  G  T+ SD++SFGVVL E+                SL E     L++ + L  +M
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 235

Query: 317 DPRLEGQY---SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           D    G Y    +    +   L   C    PK RPT   +V  L+
Sbjct: 236 D----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG  G V+K         G   + VA+K + L   Q     + E++ +   +HP++V 
Sbjct: 27  IGEGASGEVYKAT---DRATG---KEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
                   +   +V EYM  GSL + +  +  V +       +     +GL +LH   + 
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLH--SQN 136

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           VI+RD K+ NILL  D + KL+DFG A    +      S  V+GT  + APE V+     
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VIKRKDY 193

Query: 266 SMS-DVYSFGVVLLELLSG 283
               D++S G++ +E+  G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 77/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH G    K R  ++   VA+K ++ EG     +++ E   + +L HP LV+
Sbjct: 12  LGSGQFGVVHLG----KWRAQIK---VAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C +++   +V E+M  G L N L +R    L     + +     +G+ +L      
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLE--RNS 120

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD  A N L+ S    K+SDFG+ +     DD + S+   G +    ++ PE     
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSS--SGAKFPVKWSPPEVFNFS 176

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ +  K      P  ++S  E    M++   +L R   P+L  
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGK-----MPFEKKSNYEVVE-MISRGFRLYR---PKLAS 227

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                       + Y C   +P+ RPT + +++ +
Sbjct: 228 MT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 60/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQL-RHP 141
           +GEG F  V       +       +  A+K LD   L   +       E   L +L  HP
Sbjct: 9   IGEGSFSTVVLAK---EKETN---KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 142 HLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
            ++KL  Y  ++E  L  V EY P G L   + +  S+     TR   A      L +LH
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE-ILLALEYLH 119

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM------------ 248
              K +I+RD K  NILLD D   K++DFG AK          +                
Sbjct: 120 S--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 249 ------GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
                 GT  Y +PE +        SD+++ G ++ ++L+G+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 80/295 (27%), Positives = 136/295 (46%), Gaps = 36/295 (12%)

Query: 86  LGEGGFGAVH-------KGFIDDKLR---PGLQAQPVAVKNLDLEGLQGHR-EWLTEVIF 134
           LGEG FG VH       + F+D        G Q   VAVK L  +  +  R ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY----------SVSLPWST 184
           + +L+ P++++L+  C   +   ++ EYM  G L NQ   R+           V++ +ST
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISYST 131

Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
            + +A   A G+ +L       ++RD    N L+  +YT K++DFG++++   GD   + 
Sbjct: 132 LIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP 304
            R +    + + E ++ G  T+ SDV++FGV L E+L+  K    S+   EQ ++E    
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248

Query: 305 MLNDARKLGRIMDPRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
              D  +   +  P L  +  Y          L   C     K+RP+   +  TL
Sbjct: 249 FFRDQGRQVYLPKPALCPDSLYK---------LMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LGEG +G+V+K    +        Q VA+K + +E     +E + E+  L Q   P++VK
Sbjct: 11  LGEGSYGSVYKAIHKE------TGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
             G   +     +V EY   GS+ + + +  + +L       I     KGL +LH  +K 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK- 120

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD KA NILL+ +  AKL+DFG++  G   D       V+GT  + APE +      
Sbjct: 121 -IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 266 SMSDVYSFGVVLLELLSGR 284
           + +D++S G+  +E+  G+
Sbjct: 178 NKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L        +++  E   L  L+H H+
Sbjct: 13  LGEGAFGKV---FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS------------VSLPWSTRMKIALG 191
           VK  G C E +  ++V+EYM  G L N+  R +               L  S  + IA  
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A G+ +L  A +  ++RD    N L+  +   K+ DFG+++D    D   V    M   
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +  PE +M    T+ SDV+S GVVL E+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 77/290 (26%), Positives = 112/290 (38%), Gaps = 46/290 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN-LDLEGLQG-HREWLTEVIFLGQLRHPHL 143
           +GEG +G V K       R     + VA+K   + E  +   +  L EV  L QLRH ++
Sbjct: 9   VGEGAYGVVLK------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V L      +    LV+EY+ R  LE  L       LP            + +A+ H   
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCH--S 118

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE----YV 259
             +I+RD K  NIL+      KL DFG A+       + ++  V  T+ Y APE      
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGR------KSVDK---------SRPQREQSLVEWARP 304
             G      DV++ G ++ ELL G         +D+           P   Q L      
Sbjct: 178 NYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL------ 228

Query: 305 MLNDARKLG-RIMDPR----LEGQYSETGARKAAALAYQCLSHRPKQRPT 349
             ++ R  G    +P     LE +Y    +  A      CL   PK+R T
Sbjct: 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 38/275 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHLV 144
           +G+G FG V+K       R     Q VA+K +DLE  +   E +  E+ FL Q R P++ 
Sbjct: 9   IGKGSFGEVYKAID---KRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G   +     ++ EY   GS  + L +     L  +    I      GL +LH+  K
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGK--LDETYIAFILREVLLGLEYLHEEGK 119

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAAPEYVMT 261
             I+RD KA+NILL  +   KL+DFG++     G  T   ++    +GT  + APE +  
Sbjct: 120 --IHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
                 +D++S G+  +EL  G   +    P R   L+    P             P LE
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-------------PSLE 219

Query: 322 G-QYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           G ++S+      +     CL+  PK+RP+   ++K
Sbjct: 220 GNKFSKPFKDFVS----LCLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 31/277 (11%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ K  G   ++    ++ EY+  GS  + L          +T ++  L   KGL +
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 116

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +      S +D++S G+  +EL  G     +  P +   L+    P             P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------P 219

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEG YS    +        CL+  P  RPT   ++K
Sbjct: 220 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           + LG G +G V++G      +  L    VAVK L  + ++   E+L E   + +++HP+L
Sbjct: 12  HKLGGGQYGEVYEGVWK---KYSLT---VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 64

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +
Sbjct: 65  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--K 122

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVM 260
           K  I+RD  A N L+  ++  K++DFGL++      DT+  T   G +    + APE + 
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY--TAHAGAKFPIKWTAPESLA 178

Query: 261 TGHLTSMSDVYSFGVVLLEL 280
               +  SDV++FGV+L E+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 31/277 (11%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V+KG ID++ +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 6   FTKLERIGKGSFGEVYKG-IDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ +  G   +     ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 60  DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDY 116

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH   K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 117 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +        +D++S G+  +EL  G        P R   L+    P             P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------P 219

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEGQYS+       A    CL+  P+ RPT   ++K
Sbjct: 220 TLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 82/281 (29%), Positives = 126/281 (44%), Gaps = 39/281 (13%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     Q VA+K +DLE  +   E +  E+  L Q 
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL----FRRYSVSLPWSTRMKIALGAAK 194
             P++ K  G   +     ++ EY+  GS  + L    F  + ++    T +K  L   K
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA----TMLKEIL---K 112

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL +LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + 
Sbjct: 113 GLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
           APE +      S +D++S G+  +EL  G        P R   L+    P          
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---------- 218

Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              P L G++S    +        CL+  P  RPT   ++K
Sbjct: 219 ---PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 16/157 (10%)

Query: 133 IFLGQLRHPHLVKLIGYCC--EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST--RMKI 188
           +     +HP L +L  + C   ++    V EY+  G L   + R      P +     +I
Sbjct: 48  VLALAGKHPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI 105

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
            LG    L FLH  E+ +IYRD K  N+LLDS+   K++DFG+ K+G  G  T  ++   
Sbjct: 106 VLG----LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157

Query: 249 GTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
           GT  Y APE +++      + D ++ GV+L E+L+G+
Sbjct: 158 GTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 62/182 (34%), Positives = 87/182 (47%), Gaps = 15/182 (8%)

Query: 112 VAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLEN 170
           VA+K +DLE  Q    E   EV  + Q  HP++VK        +   LV  Y+  GSL +
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88

Query: 171 QLFRRYSVS-LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF 229
            +   Y    L  +    +     KGL +LH   +  I+RD KA NILL  D + K++DF
Sbjct: 89  IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADF 146

Query: 230 G----LAKDGPEGDDTH-VSTRVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLS 282
           G    LA     GD T  V    +GT  + APE VM         +D++SFG+  +EL +
Sbjct: 147 GVSASLADG---GDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELAT 202

Query: 283 GR 284
           G 
Sbjct: 203 GA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 77/281 (27%), Positives = 116/281 (41%), Gaps = 27/281 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLTEVIFLGQLRHPH 142
           LG G FG V           G +   V VK L     E LQ   E+  E+    +L H +
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGE-TLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKN 69

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLE-----NQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           +V+L+G C E E   ++ EY   G L+      +         P ST+ K+AL     L 
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
             H +    ++RD  A N L+ S    K+S   L+KD     + +     +    + APE
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLAPE 188

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            V     ++ SDV+SFGV++ E+ +          Q E          L+D   L R+  
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPF-----YGLSDEEVLNRLQA 233

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +LE    E    +   L  +C +  PK RP+ S +V  L 
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 15/204 (7%)

Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHP 141
           LG G FG V +   +   K    ++   VAVK L        RE L +E+  +  L  H 
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMK---VAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++V L+G C      L++ EY   G L N L R+    L     +  +   AKG+AFL  
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL-- 157

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV---STRVMGTQGYAAPEY 258
           A K  I+RD  A N+LL      K+ DFGLA+D    D  +V   + R+     + APE 
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKWMAPES 214

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS 282
           +     T  SDV+S+G++L E+ S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.7 bits (212), Expect = 7e-19
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLT---EVIFLGQ 137
             LG+G +G V+ G  +       Q Q +AVK ++L+    L   +E+     EV  L  
Sbjct: 6   EVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L+H ++V+ +G C ++    +  E++P GS+ + +  R+   LP     K       G+A
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFG-PLPEPVFCKYTKQILDGVA 116

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD----GPEGDDTHVSTRVMGTQGY 253
           +LH+    V++RD K +N++L  +   KL DFG A+     G  G  +++   + GT  +
Sbjct: 117 YLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
            APE +        SD++S G  + E+ +G+  +           +   R ++       
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM------- 227

Query: 314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
               PRL   +S      A      CL+    +RP+
Sbjct: 228 ----PRLPDSFSAA----AIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 12/160 (7%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E+  L  L H ++V+ +G+   EE+  +  EY+P GS+     R Y        R     
Sbjct: 58  EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRF-FTE 115

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
              +GLA+LH   K +++RD KA N+L+D+D   K+SDFG++K   + DD + + + M  
Sbjct: 116 QVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSM 170

Query: 251 QG---YAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRK 285
           QG   + APE + +     ++  D++S G V+LE+ +GR+
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.4 bits (214), Expect = 7e-19
 Identities = 88/295 (29%), Positives = 134/295 (45%), Gaps = 41/295 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 12  LGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   LV EY+P GSL + L +++   L     +  A    KG+ +L 
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYL- 124

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  ++RD    NIL++S+   K+ DFGL K  P+  + +   R  G     + APE 
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK-VREPGESPIFWYAPES 182

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSR-PQRE-----------QSLVEWARPML 306
           +     +  SDV+SFGVVL EL +     DKS  P  E           Q +V     +L
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
            +  +L     P   G  +E       A+  +C ++ P QRP+ S +   +E ++
Sbjct: 240 KNNGRL-----PAPPGCPAEI-----YAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.9 bits (212), Expect = 7e-19
 Identities = 74/294 (25%), Positives = 138/294 (46%), Gaps = 28/294 (9%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEV 132
           +V  +  + S  LG+G FG V++G     ++   + + VA+K ++       R E+L E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 60

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-------RYSVSLPWSTR 185
             + +    H+V+L+G   + +  L++ E M RG L++ L             + P   +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 186 M-KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
           M ++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +D  E D     
Sbjct: 121 MIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP 304
            + +    + +PE +  G  T+ SDV+SFGVVL E+                +L E    
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 223

Query: 305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +++ + L  +M+  L  +  +        L   C  + PK RP+   ++ +++
Sbjct: 224 GMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 50/221 (22%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW------LTEVIFLGQLR 139
           +GEG +G V+K       + G   + VA+K + +E    + +       + E+  L +LR
Sbjct: 7   IGEGTYGQVYKA---RNKKTG---ELVALKKIRME----NEKEGFPITAIREIKLLQKLR 56

Query: 140 HPHLVKLIGYCCEEEHR--LLVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           HP++V+L      +      +V+EYM     G L++               +K      K
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------------PEVKFTESQIK 103

Query: 195 --------GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
                   GL +LH     +++RD K SNIL+++D   KL+DFGLA+      ++   T 
Sbjct: 104 CYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTN 160

Query: 247 VMGTQGYAAPEYVMTGHLTSMS---DVYSFGVVLLELLSGR 284
            + T  Y  PE ++    T      D++S G +L EL  G+
Sbjct: 161 RVITLWYRPPELLL--GATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 10/170 (5%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L +L HP LV L     +EE+  LV + +  G L   L ++   S     ++K 
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKF 104

Query: 189 ALGA-AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +      L +LH   K +I+RD K  NILLD      ++DF +A        T   T  
Sbjct: 105 WICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TST 159

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD-KSRPQREQ 296
            GT GY APE +     +   D +S GV   E L G++     SR  R+Q
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 70/202 (34%), Positives = 97/202 (48%), Gaps = 24/202 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLGQLRHPH 142
           +G G FGAV+  F  D        + VA+K +   G Q + +W   + EV FL QLRHP+
Sbjct: 23  IGHGSFGAVY--FARDVR----TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
            ++  G    E    LV EY   GS  + +   +   L       I  GA +GLA+LH  
Sbjct: 77  TIEYKGCYLREHTAWLVMEYC-LGSASD-ILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           E+  I+RD KA NILL    T KL+DFG A    P       +   +GT  + APE ++ 
Sbjct: 135 ER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVILA 185

Query: 262 ---GHLTSMSDVYSFGVVLLEL 280
              G      DV+S G+  +EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 85/294 (28%), Positives = 120/294 (40%), Gaps = 45/294 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLGQL 138
           LGEG FG V K      L    +   VAVK L       DL  L    E +  +   G+ 
Sbjct: 20  LGEGAFGQVVKAEAVG-LDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI---GK- 74

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR------YSVSLPWSTRMKI---- 188
            H +++ L+G C +E    +V EY   G+L + L  R       S   P      +    
Sbjct: 75  -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 189 ----ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
               A   A+G+ FL  A K  I+RD  A N+L+  D+  K++DFGLA+D    D    +
Sbjct: 134 LVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP 304
           T       + APE +     T  SDV+SFGV+L E+ +   S     P  E         
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------- 242

Query: 305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            L    K G  M+            ++   L   C    P QRPT   +V+ L+
Sbjct: 243 -LFKLLKEGYRMEKPQNCT------QELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 47/285 (16%)

Query: 80  FSSSNFLGEGGFGAVHK-GFIDDKLRPGLQAQPVAVKNLDLEGL-QGHRE-WLTEVIFLG 136
           F     LG+G +G+V+K   + D        Q  A+K +DL  + Q  RE  + E+  L 
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDN-------QFYALKEVDLGSMSQKEREDAVNEIRILA 54

Query: 137 QLRHPHLVK-----LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRM--KI 188
            + HP+++      L G      ++L +V EY P G L   + +R         +   +I
Sbjct: 55  SVNHPNIISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
            +   +GL  LH  E+ +++RD K++NILL ++   K+ D G++K   +     ++   +
Sbjct: 109 FIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQI 162

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
           GT  Y APE       +  SD++S G +L E+ +     +             AR M + 
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDL 209

Query: 309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
             K+ R   P +   YS    +         L  +PK RP    +
Sbjct: 210 RYKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.8 bits (204), Expect = 7e-18
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 66  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 122

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 175

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GR 284
           + G  T  SDV+SFG++L EL + GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 16/203 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFLGQLRHPH 142
           LG+GGFG V    +          +  A K LD   L+  +G +  L E   L ++    
Sbjct: 1   LGKGGFGEVCACQVKAT------GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 143 LVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           +V L  Y  E +  L LV   M  G L+  ++       P +  +  A     GL  LH 
Sbjct: 55  IVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH- 112

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            ++ ++YRD K  N+LLD     ++SD GLA +   G          GT GY APE +  
Sbjct: 113 -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQG 168

Query: 262 GHLTSMSDVYSFGVVLLELLSGR 284
                  D ++ G  L E+++GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 33/276 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G+ ++  +       VAVK L   G    + +L E   +  L+H  LV+
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +EE   ++ EYM +GSL + L       +     +  +   A+G+A++    K 
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 123

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD +A+N+L+      K++DFGLA+     +D   + R  G +    + APE +  G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAR-EGAKFPIKWTAPEAINFG 179

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             T  SDV+SFG++L E+++  K      P    S V         A + G  M PR+E 
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKI---PYPGMSNSDVM-------SALQRGYRM-PRMEN 228

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              E        +   C   + ++RPT   +   L+
Sbjct: 229 CPDEL-----YDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 35/279 (12%)

Query: 86  LGEGGFG--AVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHP 141
           LG+G FG   +++   DD L        V  K ++L  L  +  R+ L E++ L  L+HP
Sbjct: 8   LGKGAFGEATLYRRTEDDSL--------VVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           +++    +  ++   L+  EY   G+L +++ R+          +         ++++H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           A   +++RD K  NI L      KL DFG++K    G +  ++  V+GT  Y +PE    
Sbjct: 120 AG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQG 175

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE-QSLVEWARPMLNDARKLGRIMDPRL 320
                 SD+++ G VL ELL+ +++ D + P      +V+     +        I     
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS---- 231

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP 359
                         L +  L   P++RPT   V+     
Sbjct: 232 --------------LVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 37/295 (12%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQ 137
           F+    LG+G FG+V +  +  K   G   Q VAVK L  D+       E+L E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQL--KSEDG-SFQKVAVKMLKADIFSSSDIEEFLREAACMKE 57

Query: 138 LRHPHLVKLIGYCCEEEHR------LLVYEYMPRGSLENQLFRRY----SVSLPWSTRMK 187
             HP+++KLIG       +      +++  +M  G L   L          +LP  T ++
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
             +  A G+ +L  + K  I+RD  A N +L+ + T  ++DFGL+K    GD        
Sbjct: 118 FMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + A E +     T+ SDV++FGV + E++        +R Q   + VE +  + N
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM--------TRGQTPYAGVENSE-IYN 226

Query: 308 DARKLGRIMDPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
              K  R+  P   LE  Y          L  QC S  PK RP+   +   LE +
Sbjct: 227 YLIKGNRLKQPPDCLEDVYE---------LMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 42/272 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G  G V+K +         +   V V  LD+  ++  ++ ++E+  L +   P+++ 
Sbjct: 9   LGHGNGGTVYKAYH----LLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIG 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
             G    E    +  E+M  GSL+  ++R+    +P     +IA+   KGL +L   +  
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLWSLK-- 115

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           +++RD K SN+L+++    KL DFG++          ++   +GT  Y APE +      
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYG 171

Query: 266 SMSDVYSFGVVLLELLSGR-------KSVDKSRP-QREQSLVEWARPMLNDARKLGRIMD 317
             SDV+S G+  +EL  GR       K+     P Q  Q +V+   P+L           
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV--------- 222

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
               GQ+SE    K      QC+  +PK+RP 
Sbjct: 223 ----GQFSE----KFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 25/213 (11%)

Query: 86  LGEGGFGAVHKGF---------IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
           +G G FG+V+ G          +     P + A     K   L+ L        E+  L 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAR------EIALLK 61

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           +L+H ++V+ +G   + +H  +  EY+P GS+   L   Y  +   +          KGL
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYG-AFEETLVRNFVRQILKGL 119

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-----VMGTQ 251
            +LH+  + +I+RD K +NIL+D+    K+SDFG++K   E +     T      + G+ 
Sbjct: 120 NYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQGSV 176

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            + APE V     T  +D++S G +++E+L+G+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 27/221 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G FG V+KG     +  G   + PVA+K L +  G + + E++ E + +  + HPHL
Sbjct: 15  LGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           V+L+G C     +L V + MP G L     E++      + L W  ++      AKG+ +
Sbjct: 72  VRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMY 124

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAA 255
           L   E+ +++RD  A N+L+ S    K++DFGLA+   EGD+   +    G +    + A
Sbjct: 125 LE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNAD--GGKMPIKWMA 179

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
            E +     T  SDV+S+GV + EL++ G K  D   P RE
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 20/226 (8%)

Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLT 130
           E+ ++T  F     LGE  FG V+KG +     PG Q Q VA+K L D        E+  
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLKDKAEGPLREEFKH 57

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR----- 185
           E +   +L+HP++V L+G   +E+   +++ Y     L   L  R   S   ST      
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 186 ---------MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
                    + I    A G+ FL  +   V+++D    N+L+      K+SD GL ++  
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
             D   +    +    + +PE +M G  +  SD++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 80/285 (28%), Positives = 123/285 (43%), Gaps = 41/285 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V  G    +   G+    V VK L           +L EV    +L HP+++
Sbjct: 3   IGNGWFGKVLLG----EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           + +G C E    LLV E+ P G L+N L   R  V+      +  ++A   A GL +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLA-----KDGPEGDDTH-VSTRVMGTQGYAA 255
           A+   I+ D    N  L +D + K+ D+GLA     +D     D H V  R      + A
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLA 170

Query: 256 PEYV-------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
           PE V       +    T  S+++S GV + EL +   + D+  P      V   + +   
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQV-LKQVVREQ 226

Query: 309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
             KL +   P+L+ +YS+   R    + +  L   P+ RPT   V
Sbjct: 227 DIKLPK---PQLDLKYSD---RWYEVMQFCWLD--PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL----DLEGLQGHREWLTEVIFLGQLRHP 141
           LG G FG V KG    K++     + VAVK L    +   L+   E L E   + QL +P
Sbjct: 3   LGSGNFGTVKKGMY--KMKKS--EKTVAVKILKNDNNDPALKD--ELLREANVMQQLDNP 56

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++V++IG  CE E  +LV E    G L   L +   V+    T  ++    + G+ +L  
Sbjct: 57  YIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT--ELVHQVSMGMKYLE- 112

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT--QGYAAPEYV 259
            E   ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                +S SDV+SFGV++ E  S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 33/219 (15%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPH 142
           + +GEG FG V K  I    + GL+      +  +      HR++  E+  L +L  HP+
Sbjct: 13  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 143 LVKLIGYCCEEEHRLLVY---EYMPRGSLENQLFR--------------RYSVSLPWSTR 185
           ++ L+G C   EHR  +Y   EY P G+L + L +                + +L     
Sbjct: 70  IINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  A   A+G+ +L  ++K  I+RD  A NIL+  +Y AK++DFGL++    G + +V  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179

Query: 246 RVMGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           + MG     + A E +     T+ SDV+S+GV+L E++S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 46/291 (15%)

Query: 86  LGEGGFGAVHKGFI---DDKLRPGLQAQPVAV-KNLDLEGLQGHREWLTEVIFLGQLRHP 141
           LGEG FG+V +G +   D  L+  ++   +A+    ++E      ++L+E + + +  HP
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME------DFLSEAVCMKEFDHP 60

Query: 142 HLVKLIGYCCEEEHR------LLVYEYMPRGSLENQLFRRYS------VSLPWSTRMKIA 189
           ++++LIG C +          +++  +M  G L + L   YS        LP    +K  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL--YSRLGDCPQYLPTQMLVKFM 118

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A G+ +L  + K  I+RD  A N +L+ +    ++DFGL+K    GD          
Sbjct: 119 TDIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
              + A E +     T+ SDV+SFGV + E+         +R Q     VE +  + +  
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEI--------ATRGQTPYPGVENSE-IYDYL 227

Query: 310 RKLGRIMDPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           R+  R+  P   L+G YS         L   C    PK RP+  T+   LE
Sbjct: 228 RQGNRLKQPPDCLDGLYS---------LMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQLRHPHLV 144
           LGEG FG V     D         + VAVK+L  E    H   L  E+  L  L H ++V
Sbjct: 12  LGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 145 KLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           K  G C E+      L+ E++P GSL+  L R  +  +    ++K A+   KG+ +L   
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYL--G 126

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR--VMGTQGYAAPEYVM 260
            +  ++RD  A N+L++S++  K+ DFGL K   E D  + + +  +     + APE ++
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 261 TGHLTSMSDVYSFGVVLLELLS 282
                  SDV+SFGV L ELL+
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 51/165 (30%), Positives = 89/165 (53%), Gaps = 19/165 (11%)

Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR 185
           ++ L E+  + + R P++V   G    E +  +  E+M  GSL+ +++++    +P    
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD-RIYKKGG-PIPVEIL 105

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD------ 239
            KIA+   +GL +L++  + +++RD K SNIL++S    KL DFG++     G+      
Sbjct: 106 GKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIA 159

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           DT V     GT  Y +PE +  G  T  SDV+S G+ ++EL  G+
Sbjct: 160 DTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 71/291 (24%), Positives = 114/291 (39%), Gaps = 52/291 (17%)

Query: 84  NFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLT-EVIFL 135
             +G+G FG V K      G I            +  K +D   +    ++ L  EV  L
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKI------------LVWKEIDYGNMTEKEKQQLVSEVNIL 53

Query: 136 GQLRHPHLVKLIGYCCEEEHRLL--VYEYMPRGSLEN--QLFRRYSVSLPWSTRMKIALG 191
            +L+HP++V+      +  ++ L  V EY   G L    Q  ++    +      +I   
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 192 AAKGLAFLHDAEKP---VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD---THVST 245
               L   H+   P   V++RD K +NI LD++   KL DFGLAK          T+V  
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-- 171

Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
              GT  Y +PE +        SD++S G ++ EL +         P         AR  
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP------PFT-------ARNQ 215

Query: 306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT 356
           L  A K+      R+  +YS         +    L+  P +RP+   +++ 
Sbjct: 216 LQLASKIKEGKFRRIPYRYSSE----LNEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K         GL A   A K + +E  +   +++ E+  L + +HP++V 
Sbjct: 13  LGDGAFGKVYKA---QHKETGLFA---AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      E    ++ E+   G+L++ +       L       +     + L FLH     
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS--HK 123

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           VI+RD KA NILL  D   KL+DFG++           +   +GT  + APE V      
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181

Query: 266 S-----MSDVYSFGVVLLELLSGR 284
                  +D++S G+ L+EL    
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 29/217 (13%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHP 141
           + +GEG FG V K  I    + GL+    A+K + +      HR++  E+  L +L  HP
Sbjct: 1   DVIGEGNFGQVLKARIK---KDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 56

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSL------------ENQLFRRYSVSLPWSTR--MK 187
           +++ L+G C    +  L  EY P G+L            +       S +   S++  + 
Sbjct: 57  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  ++K  I+RD  A NIL+  +Y AK++DFGL++    G + +V  + 
Sbjct: 117 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 169

Query: 248 MGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           MG     + A E +     T+ SDV+S+GV+L E++S
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 29/217 (13%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHP 141
           + +GEG FG V +  I    + GL+    A+K L +      HR++  E+  L +L  HP
Sbjct: 8   DVIGEGNFGQVIRAMIK---KDGLKMN-AAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------------FRRYSVSLPWSTR--MK 187
           +++ L+G C    +  +  EY P G+L + L             + +  +   +++  ++
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A G+ +L  +EK  I+RD  A N+L+  +  +K++DFGL++    G++ +V  + 
Sbjct: 124 FASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KT 176

Query: 248 MGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           MG     + A E +     T+ SDV+SFGV+L E++S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 60/168 (35%), Positives = 80/168 (47%), Gaps = 24/168 (14%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSV-----SLPW 182
           LTE   L Q + P++VKL  Y  + +  L LV EY+P G L        S+     SL  
Sbjct: 41  LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDL-------ASLLENVGSLDE 92

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG------P 236
                        L +LH     +I+RD K  NIL+DS+   KL+DFGL+K G       
Sbjct: 93  DVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150

Query: 237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
             DD     R++GT  Y APE V+ G   S + D +S G +L E L G
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 46/161 (28%), Positives = 86/161 (53%), Gaps = 15/161 (9%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA- 189
           E+  + +L HPH+++++G  CE+ H  L  E+M  GS+ + L  +Y     +   + I  
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYG---AFKEAVIINY 108

Query: 190 -LGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFG----LAKDGPEGDDTHV 243
                +GL++LH+ +  +I+RD K +N+L+DS     +++DFG    LA  G    +   
Sbjct: 109 TEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--F 164

Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
             +++GT  + APE +         DV+S G V++E+ + +
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G  +   +       VAVK L   G      +L E   + +LRH  LV+
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L      +L     + +A   A G+A++      
Sbjct: 66  LYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 122

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            I+RD +++NIL+      K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 175

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GR 284
           + G  T  SDV+SFG++L EL++ GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLGQLRHPH 142
           +G G FGAV+  F  +        + VAVK +   G Q + +W   + EV FL QL+HP+
Sbjct: 29  IGHGSFGAVY--FATN----SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
            ++  G   +E    LV EY   GS  + L   +   L       I  GA +GLA+LH  
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT- 261
               I+RD KA NILL      KL+DFG A      +        +GT  + APE ++  
Sbjct: 141 NM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAM 192

Query: 262 --GHLTSMSDVYSFGVVLLEL 280
             G      DV+S G+  +EL
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 58/169 (34%), Positives = 87/169 (51%), Gaps = 29/169 (17%)

Query: 131 EVIFLGQLR-HPHLVKLIGYCCEEEHR--LLVYEYMP-------RGSLENQLFRRYSVSL 180
           E++FL +L  HP++VKL+     E  +   LV+EYM        R ++   + +RY    
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY---- 111

Query: 181 PWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPE 237
                  I     K L ++H     VI+RD K SNILL+SD   KL+DFGLA+   +  E
Sbjct: 112 -------IMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
             +  V T  + T+ Y APE ++ G    T   D++S G +L E+L G+
Sbjct: 163 NPENPVLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 58/303 (19%)

Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           LG G  G V K      G I  +    L+ +P A++N          + + E+  L +  
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP-AIRN----------QIIRELKVLHECN 57

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
            P++V   G    +    +  E+M  GSL+ Q+ ++    +P +   KI++   +GL +L
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAG-RIPENILGKISIAVLRGLTYL 115

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
            +  K +++RD K SNIL++S    KL DFG++    +  D+  ++ V GT+ Y +PE +
Sbjct: 116 REKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERL 170

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
              H T  SD++S G+ L+E+  GR  +    P  +   +E    M       G   +  
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAKELE---AMFGRPVSEGEAKESH 223

Query: 320 LEGQYSETGARKAAA----LAY-----------------------QCLSHRPKQRPTMST 352
                    + +  A    L Y                       +CL   PK+R  +  
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283

Query: 353 VVK 355
           + K
Sbjct: 284 LTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 40/279 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVIFLGQLRH--- 140
           +G G +GAV++G            + VA+K  NLD            EV  L QLR    
Sbjct: 9   IGRGAYGAVYRGKHV------PTGRVVALKIINLDTPDDDVSDIQ-REVALLSQLRQSQP 61

Query: 141 PHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPW-STRMKIALGAAKGLAF 198
           P++ K  G    +  RL ++ EY   GS+   L +   ++  + S  ++  L A   L +
Sbjct: 62  PNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVA---LKY 116

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H     VI+RD KA+NIL+ +    KL DFG+A    +   +   +  +GT  + APE 
Sbjct: 117 IHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEV 172

Query: 259 VMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
           +  G    + +D++S G+ + E+ +G          R   L+  ++P             
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------- 219

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT 356
           PRLE        R+  A    CL   PK+R +   ++K+
Sbjct: 220 PRLEDNGYSKLLREFVAA---CLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHPH 142
           LG G FG V       + +     +  A+K L    +   ++    L E   L  +RHP 
Sbjct: 9   LGTGSFGRVMLV----RHKGS--GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 143 LVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWST--RMKIALGAAKGLAFL 199
           LV L G   +++  L LV EY+P G L + L +      P +     ++ L     L +L
Sbjct: 63  LVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYL 117

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM---GTQGYAAP 256
           H  +  ++YRD K  N+LLDSD   K++DFG AK         V  R     GT  Y AP
Sbjct: 118 HSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAP 167

Query: 257 EYVM-TGHLTSMSDVYSFGVVLLELLSG 283
           E ++  G+     D ++ G+++ E+L+G
Sbjct: 168 EIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 81/301 (26%), Positives = 128/301 (42%), Gaps = 74/301 (24%)

Query: 86  LGEGGFGAVHKGFI----DDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQL 138
           LG+G F  ++KG +    D  +    Q   V +K L       HR    +      + QL
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRMKIALGAAKGLA 197
            H HLVKL G C  +E+ ++V EY+  G L+  L R + +VSL W  ++ +A   A  L 
Sbjct: 59  SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 198 FLHDAEKPVIYRDFKASNILL-----DSDYT--AKLSDFG-----LAKDGPEGDDTHVST 245
           +L D  K +++ +    NIL+     +  Y    KLSD G     L+++           
Sbjct: 116 YLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP---- 169

Query: 246 RVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLEL-------LSGRKSVDKSRPQREQ 296
                  + APE +  G   LT  +D +SFG  LLE+       LS   S +K R  ++Q
Sbjct: 170 -------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ 222

Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT 356
             +    PM + A                     + A L  QC ++ P +RP+   +++ 
Sbjct: 223 HRL----PMPDCA---------------------ELANLINQCWTYDPTKRPSFRAILRD 257

Query: 357 L 357
           L
Sbjct: 258 L 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   +       VA+K L   G      +L E   + +LRH  LV 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-------VAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 66  LYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN-- 122

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            I+RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 175

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GR 284
           + G  T  SDV+SFG++L EL++ GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 54/147 (36%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 140 HPHLVKLIGYCC--EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           HP L  L  YC    +E+   V EY+  G L   +   +   LP +T    A     GL 
Sbjct: 55  HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQ 110

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           FLH   K ++YRD K  NILLD+D   K++DFG+ K+   GD    +    GT  Y APE
Sbjct: 111 FLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPE 166

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGR 284
            ++     +  D +SFGV+L E+L G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)

Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           LG G  G V K      G I  +    L+ +P A++N  +  LQ           L +  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-AIRNQIIRELQ----------VLHECN 61

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
            P++V   G    +    +  E+M  GSL+  L  + +  +P     K+++   +GLA+L
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
            +  + +++RD K SNIL++S    KL DFG++  G   D   ++   +GT+ Y +PE +
Sbjct: 120 REKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 174

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
              H +  SD++S G+ L+EL  GR  +    P  ++    + RP+++        + PR
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGEEGEPHSISPR 232

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLG 136
           FS    +G G FGAV+        R    ++ VA+K +   G Q + +W   + EV FL 
Sbjct: 17  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           +LRHP+ ++  G    E    LV EY   GS  + L   +   L       +  GA +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+LH     +I+RD KA NILL      KL DFG A           +   +GT  + AP
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVGTPYWMAP 180

Query: 257 EYVMT---GHLTSMSDVYSFGVVLLEL 280
           E ++    G      DV+S G+  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 86  LGEGGFGAVH--KGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW--LTEVIFLGQLRHP 141
           +G G FG VH  +   D KL        V +K + +E +          E   L  L HP
Sbjct: 8   VGRGAFGIVHLCRRKADQKL--------VIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++++      E++  ++V EY P G+L   + +R +  L   T +   +     LA  H 
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL--LALHHV 117

Query: 202 AEKPVIYRDFKASNILLDSDYT-AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
             K +++RD K  NILLD      K+ DFG++K       +   T V+GT  Y +PE   
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174

Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVD 288
                  SD+++ G VL EL S +++ +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQLRHPHLV 144
           +GEG  G V    I      G Q   VAVK +DL   Q  RE L  EV+ +   +HP++V
Sbjct: 27  IGEGSTGIVC---IATDKSTGRQ---VAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIV 79

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKGLAF 198
           ++       +   +V E++  G+L +         +   TRM       + L   K L+F
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLAVLKALSF 130

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH   + VI+RD K+ +ILL SD   KLSDFG         +      ++GT  + APE 
Sbjct: 131 LH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSG 283
           +      +  D++S G++++E++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 86  LGEGGFGAVH--KGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--EVIFLGQLRHP 141
           +GEG FG ++  K   D +           +K +DL  +    +  +  EVI L +++HP
Sbjct: 8   IGEGSFGKIYLAKAKSDSE--------HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++V       E     +V EY   G L  ++ R+  V       +   +  + GL  +HD
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 202 AEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
             + +++RD K+ NI L  +   AKL DFG+A+     D   ++   +GT  Y +PE   
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQ 175

Query: 261 TGHLTSMSDVYSFGVVLLEL 280
                + +D++S G VL EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 73/203 (35%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--EVIFLGQLRHPHL 143
           LG+G FG V   F+  K+      Q  A+K L    L+      T  E   L ++ HP +
Sbjct: 4   LGQGSFGKV---FLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 144 VKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAKGLAFLHD 201
           VKL  Y  + E +L L+ +++ RG     LF R S  + ++   +K  L A   LA  H 
Sbjct: 61  VKL-HYAFQTEGKLYLILDFL-RGG---DLFTRLSKEVMFTEEDVKFYL-AELALALDHL 114

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV-M 260
               +IYRD K  NILLD +   KL+DFGL+K+  + +    S    GT  Y APE V  
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNR 172

Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
            GH  S +D +SFGV++ E+L+G
Sbjct: 173 RGHTQS-ADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 37/291 (12%)

Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    + +                 + 
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 145 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 252

Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 253 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 22/218 (10%)

Query: 80  FSSSNFLGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQ 137
           F     LG G FG V+KG +I +  +  +   PVA+K L +    + ++E L E   +  
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKEILDEAYVMAS 65

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALGA 192
           + +PH+ +L+G C     +L + + MP G L     E++        L W  ++      
Sbjct: 66  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 118

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTRVMGTQ 251
           AKG+ +L   E+ +++RD  A N+L+ +    K++DFGLAK  G +  + H     +  +
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 177 -WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 29/210 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+KG      R     Q VA+K + LE    G+      + E+  L +L+HP
Sbjct: 8   IGEGTYGVVYKG------RNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHP 59

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA------KG 195
           ++V L     +E    L++E++   S++    ++Y  SLP    M   L  +      +G
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFL---SMD---LKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           + F H   + V++RD K  N+L+D+    KL+DFGLA+    G    V T  + T  Y A
Sbjct: 114 ILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRA 169

Query: 256 PEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
           PE ++     S   D++S G +  E+ + +
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 22/157 (14%)

Query: 140 HPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLP------WSTRMKIALGA 192
           HP LV L   C + E RL  V E++  G L   + R+    LP      +S  + +AL  
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALN- 110

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
                FLH  E+ +IYRD K  N+LLD++   KL+D+G+ K+G    DT  ++   GT  
Sbjct: 111 -----FLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPN 161

Query: 253 YAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVD 288
           Y APE ++ G     S D ++ GV++ E+++GR   D
Sbjct: 162 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 14/202 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ---GHREWLTEVIFLGQLRHPH 142
           LG+GGFG V    + +        +  A K LD + L+   G +  L E   L ++  P 
Sbjct: 1   LGKGGFGEVCAVQVKNT------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +V L      + H  LV   M  G L+  ++      L     +  +     G+  LH  
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
           +  ++YRD K  N+LLD     +LSD GLA +  +G      T+  GT GY APE +   
Sbjct: 115 D--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEE 169

Query: 263 HLTSMSDVYSFGVVLLELLSGR 284
             +   D ++ G  + E+++GR
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-----REWLTEVIFLGQLRH 140
           LG+G FG V+  +  D  R       +AVK +  +               E+  L  L+H
Sbjct: 10  LGQGAFGRVYLCYDVDTGRE------LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
             +V+  G   ++E   +  EYMP GS+++QL + Y  +L  +   K      +G+ +LH
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYG-ALTETVTRKYTRQILEGVEYLH 121

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVSTRVMGTQGYAAPEY 258
                +++RD K +NIL DS    KL DFG +K         T + + V GT  + +PE 
Sbjct: 122 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE- 177

Query: 259 VMTGH-LTSMSDVYSFGVVLLELLS 282
           V++G      +DV+S G  ++E+L+
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLG 136
           F+    +G G FGAV+        R     + VA+K +   G Q + +W   + EV FL 
Sbjct: 27  FTDLREIGHGSFGAVYFA------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           +++HP+ ++  G    E    LV EY   GS  + L   +   L       I  GA +GL
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGL 138

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+LH     +I+RD KA NILL      KL+DFG A      +        +GT  + AP
Sbjct: 139 AYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAP 190

Query: 257 EYVMT---GHLTSMSDVYSFGVVLLEL 280
           E ++    G      DV+S G+  +EL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 7/150 (4%)

Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           L +  HP +VKL     ++++  ++ EY   G L   L  R      ++ R  IA     
Sbjct: 47  LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA-CVVL 104

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
              +LH   + +IYRD K  N+LLDS+   KL DFG AK    G  T       GT  Y 
Sbjct: 105 AFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYV 159

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D +S G++L ELL+GR
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 7e-15
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQL-R 139
           LG+G FG+V+          G   + VA+K +     +    W     L EV  L +L  
Sbjct: 7   LGDGTFGSVYLA---RNKETG---ELVAIKKM----KKKFYSWEECMNLREVKSLRKLNE 56

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++VKL     E +    V+EYM  G+L   +  R       S    I     +GLA +
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD--THVSTRVMGTQGYAAPE 257
           H       +RD K  N+L+      K++DFGLA++         +VSTR      Y APE
Sbjct: 116 HKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPE 168

Query: 258 YVMTGHLTSMS---DVYSFGVVLLELLSGR 284
            ++    TS S   D+++ G ++ EL + R
Sbjct: 169 ILL--RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFLG 136
           +F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L 
Sbjct: 1   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 54

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK-- 194
           +L HP++VKL+     E    LV+E++      +Q  +++  + P S    I L   K  
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFL------HQDLKKFMDASPLS---GIPLPLIKSY 105

Query: 195 ------GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
                 GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  +
Sbjct: 106 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 161

Query: 249 GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            T  Y APE ++   + ++  D++S G +  E+++ R
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQLRHPHL 143
           +GEG +G V K       R     Q VA+K      +     +  L E+  L QL+HP+L
Sbjct: 9   IGEGSYGVVFK------CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V LI     +    LV+EY    ++ N+L  +    +P     KI     + + F H  +
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDH-TVLNEL-EKNPRGVPEHLIKKIIWQTLQAVNFCH--K 118

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDT-HVSTRVMGTQGYAAPEYVM 260
              I+RD K  NIL+      KL DFG A+   GP  D T +V+TR      Y APE ++
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE-LL 172

Query: 261 TGHLT--SMSDVYSFGVVLLELLSG 283
            G        DV++ G V  ELL+G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 53/157 (33%), Positives = 73/157 (46%), Gaps = 17/157 (10%)

Query: 133 IFL--GQLRHPHLVKLIGYCC--EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           IF      RHP LV L  + C   E+H   V EY   G L   +         +S    +
Sbjct: 52  IFETANSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDV-----FSEPRAV 104

Query: 189 ALGAAK--GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
              A    GL +LH  E  ++YRD K  N+LLD++   K++DFGL K+G    D   ST 
Sbjct: 105 FYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST- 160

Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             GT  + APE +     T   D +  GV++ E+L G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 26/248 (10%)

Query: 110 QPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL-VYEYMPR 165
             VA+K L  +  +   +   +  E     +L HP++V L+         L  V+EY+P 
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 166 GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDY 222
            +L   L      +LP     ++ L     LA  H+    +++RD K  NI++       
Sbjct: 64  RTLREVL--AADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRP 119

Query: 223 TAKLSDFGLAKDGPEGDDTHV-----STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVL 277
            AK+ DFG+    P   D  V     +T V+GT  Y APE +    +T  SD+Y++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 278 LELLSGRKSVDKSRPQ----REQSLVEWARPMLNDARKLGRIM------DPRLEGQYSET 327
           LE L+G++ V  +       ++ S V+ + P       LG+++      DPR     +  
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPA 239

Query: 328 GARKAAAL 335
            A +  AL
Sbjct: 240 LAERFRAL 247

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 84  NFL---GEGGFGAV----HKGFIDDKLRP-GLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           NFL   G+G FG V     KG   D+L    +  + V +++ D+E        + E   L
Sbjct: 3   NFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVIIQDDDVECT------MVEKRVL 54

Query: 136 GQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
                P  +  +  C +   RL  V EY+  G L   + +      P +     A   A 
Sbjct: 55  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--AAEIAI 112

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM-GTQGY 253
           GL FLH   K +IYRD K  N++LD++   K++DFG+ K+   G  T   TR   GT  Y
Sbjct: 113 GLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDY 167

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
            APE +         D ++FGV+L E+L+G+   D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHLV 144
           LGEG +  V+KG      R     + VA+K + L+  +G     + E+  + +L+H ++V
Sbjct: 8   LGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY------SVSLPWSTRMKIALGAAKGLAF 198
           +L      E   +LV+EYM     +  L ++Y        +L  +T         KG+AF
Sbjct: 62  RLHDVIHTENKLMLVFEYM-----DKDL-KKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
            H  E  V++RD K  N+L++     KL+DFGLA+      +T  +  V  T  Y AP+ 
Sbjct: 116 CH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDV 171

Query: 259 VMTGHLTSMS-DVYSFGVVLLELLSGR 284
           ++     S S D++S G ++ E+++GR
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 52/150 (34%), Positives = 73/150 (48%), Gaps = 14/150 (9%)

Query: 139 RHPHLVKLIGYCC--EEEHRLLVYEYMPRGSL--ENQLFRRYSVSLPWSTRMKIALGAAK 194
            HP L  L  +C    +EH   V EY+  G L    Q   R+  +       +I  G   
Sbjct: 54  EHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG--- 108

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
            L FLH  +K +IYRD K  N+LLD D   K++DFG+ K+   G+    ++   GT  Y 
Sbjct: 109 -LQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE +         D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 79/291 (27%), Positives = 123/291 (42%), Gaps = 37/291 (12%)

Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL--RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +        L   + + ++  +H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPN-KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHK 78

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR------YSV--------SLPWSTRMK 187
           +++ L+G C ++    ++ EY  +G+L   L  R      YS          L +   + 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A +  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 139 CAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----------LF 246

Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +  +C    P QRPT   +V+ L+
Sbjct: 247 KLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLRHP 141
           LGEG FG V+K     +++ G     VA+K + +    +G       L E+  L +L+HP
Sbjct: 16  LGEGTFGEVYKAR---QIKTGRV---VALKKILMHNEKDGF--PITALREIKILKKLKHP 67

Query: 142 HLVKLIGYCCEE-----EHRLLVYEYMP------RGSLENQLFRRYSVSLPWSTRMKIAL 190
           ++V LI    E        R  VY   P       G LEN      SV L  S      L
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-----SVKLTESQIKCYML 122

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---------DGPEGDDT 241
              +G+ +LH  E  +++RD KA+NIL+D+    K++DFGLA+          G  G  T
Sbjct: 123 QLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 242 HVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
              T ++ T+ Y  PE ++     T+  D++  G V  E+ + R
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 53/150 (35%), Positives = 76/150 (50%), Gaps = 8/150 (5%)

Query: 140 HPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           +P LV L   C +   RL LV EY+  G L   + R+    LP       A      L F
Sbjct: 55  NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNF 111

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  E+ +IYRD K  N+LLD+D   KL+D+G+ K+G    DT  ++   GT  Y APE 
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEI 167

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           +         D ++ GV++ E+++GR   D
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 69/208 (33%), Positives = 91/208 (43%), Gaps = 28/208 (13%)

Query: 86  LGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE----WLTEVIFLGQ 137
           +G+G FG V    HK   D K          AVK L  + +   +E         + L  
Sbjct: 3   IGKGSFGKVLLAKHK--ADGKF--------YAVKVLQKKAILKKKEQKHIMAERNVLLKN 52

Query: 138 LRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI-ALGAAKG 195
           ++HP LV L  Y  +   +L  V +Y+  G L   L R  S   P   R +  A   A  
Sbjct: 53  VKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASA 108

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L +LH     +IYRD K  NILLDS     L+DFGL K+G E   T  ++   GT  Y A
Sbjct: 109 LGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           PE +         D +  G VL E+L G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G FG V+KG +I D     +   PVA+K L +    + ++E L E   +  +  P++
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKI---PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            +L+G C     +L V + MP G L + + R     +     +   +  AKG+++L +  
Sbjct: 72  CRLLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPE--GDDTHVSTRVMGTQGYAAPE 257
             +++RD  A N+L+ S    K++DFGLA+    D  E   D   V  + M      A E
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM------ALE 181

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
            ++    T  SDV+S+GV + EL++ G K  D   P RE
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 8/157 (5%)

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLL-VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           +F     HP LV L   C + E RL  V EY+  G L   + R+    LP       +  
Sbjct: 48  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAE 104

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            +  L +LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G    DT  ++   GT 
Sbjct: 105 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTP 160

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
            Y APE +         D ++ GV++ E+++GR   D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 31/220 (14%)

Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   + +  DK RP  Q   VAVK L       DL  L    E L ++I   
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKDLADLISEME-LMKLIG-- 75

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR------YSVSLPWSTRMKI-- 188
             +H +++ L+G C +E    ++ EY  +G+L   L  R      Y+  +      ++  
Sbjct: 76  --KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 189 ------ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                 A   A+G+ +L    +  I+RD  A N+L+  D   K++DFGLA+   + D   
Sbjct: 134 KDLVSCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            ++       + APE +     T  SDV+SFG+++ E+ +
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 43/277 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHLV 144
           LG+G +G+V+K       RP      +A+K + LE  +    + + E+  L +   P++V
Sbjct: 9   LGKGNYGSVYKVL----HRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--LPWSTRMKIALGAAKGLAFLHDA 202
              G    E    +  EYM  GSL+ +L+     +  +P     +I     KGL FL + 
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE- 120

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD-DTHVSTRVMGTQGYAAPEYVMT 261
           E  +I+RD K +N+L++ +   KL DFG++     G+    ++   +G Q Y APE + +
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKS 175

Query: 262 GHL------TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           G        T  SDV+S G+ +LE+  GR       P+   ++            +L  I
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFA----------QLSAI 222

Query: 316 MD---PRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
           +D   P L   YS+     A     +CL+  P +RPT
Sbjct: 223 VDGDPPTLPSGYSDD----AQDFVAKCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 30/274 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V     +   +       VAVK +   G      +L E   +  L+H  LVK
Sbjct: 14  LGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +E    ++ E+M +GSL + L        P    +  +   A+G+AF+   ++ 
Sbjct: 66  LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 122

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD +A+NIL+ +    K++DFGLA+   + + T         + + APE +  G  T
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFT 181

Query: 266 SMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
             SDV+SFG++L+E+++ GR       P    S  E  R +    R              
Sbjct: 182 IKSDVWSFGILLMEIVTYGRI------PYPGMSNPEVIRALERGYRM-----------PR 224

Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            E    +   +  +C  +RP++RPT   +   L+
Sbjct: 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           I + Q   P++ KL      +++  LV EY+  G   + +     +   W+   +     
Sbjct: 49  IMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEV 106

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
             G+  LH   + +I+RD K  N+L+D     KL+DFGL+++G        + + +GT  
Sbjct: 107 VLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPD 158

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y APE ++      MSD +S G V+ E L G
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 53/148 (35%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 139 RHPHLVKLIGYCC-EEEHRLL-VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           +HP L  L  +CC + + RL  V EY+  G L  Q+ R      P S      +  A  L
Sbjct: 54  KHPFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--L 109

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            FLH     VIYRD K  NILLD++   KL+DFG+ K+G     T  +T   GT  Y AP
Sbjct: 110 MFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAP 165

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           E +         D ++ GV++ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 21/155 (13%)

Query: 135 LGQLRHPHLVKLIGYCCEEEHRLL--VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           L ++ HP +++L  +  E + R L  + EY+P G L + L  R S     ST +  A   
Sbjct: 55  LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEI 110

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMG 249
              L +LH   K ++YRD K  NILLD +   KL+DFG AK         +  R   + G
Sbjct: 111 VCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK--------LRDRTWTLCG 160

Query: 250 TQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSG 283
           T  Y APE +   GH  ++ D ++ G+++ E+L G
Sbjct: 161 TPEYLAPEVIQSKGHNKAV-DWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 42/279 (15%)

Query: 80  FSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           F   + LG G  G V K      G I  +    L+ +P A++N  +  LQ          
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQ---------- 55

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +   P++V   G    +    +  E+M  GSL+  L  + +  +P     K+++   
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVI 113

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           KGL +L +  K +++RD K SNIL++S    KL DFG++  G   D   ++   +GT+ Y
Sbjct: 114 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSY 168

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
            +PE +   H +  SD++S G+ L+E+  GR  +                    DA++L 
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP-----------------DAKELE 211

Query: 314 RIMDPRLEGQYSETG-ARKAAALAYQCLSHRPKQRPTMS 351
            +    +EG  +E+  + +         S+ P  RP M+
Sbjct: 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMA 250

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 56/159 (35%), Positives = 69/159 (43%), Gaps = 12/159 (7%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           LTE   L   RHP L  L  Y  +   RL  V EY   G L   L R    S     R  
Sbjct: 43  LTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF- 99

Query: 188 IALGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              GA     L +LH     V+YRD K  N++LD D   K++DFGL K+G     T    
Sbjct: 100 --YGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 153

Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
              GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+   ID         Q VA+K ++L+        + E++ + + +HP++V 
Sbjct: 27  IGQGASGTVYTA-IDVAT-----GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA------KGLAFL 199
            +      +   +V EY+  GSL + +           T M     AA      + L FL
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFL 131

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           H  +  VI+RD K+ NILL  D + KL+DFG  A+  PE       + ++GT  + APE 
Sbjct: 132 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           V         D++S G++ +E++ G        P R   L+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 78

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS---TRM------- 186
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S    R+       
Sbjct: 79  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136

Query: 187 ----KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 137 KDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194

Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +T       + APE +     T  SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 77/274 (28%), Positives = 122/274 (44%), Gaps = 32/274 (11%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFL 135
           +F     LG+GGFG V       ++R     +  A K L+   ++  +G    L E   L
Sbjct: 1   TFRHYRVLGKGGFGEVCAC----QVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKRIL 54

Query: 136 GQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
            ++    +V L  Y  E +  L LV   M  G L+   F  Y++  P     +    AA+
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFDEQRAIFYAAE 110

Query: 195 GLAFLHDAEKP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
               L D ++  ++YRD K  NILLD     ++SD GLA   PEG+   V  RV GT GY
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGY 167

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
            APE +     T   D +  G ++ E++ G+    K + + ++  V+  R +  D     
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRVKED----- 220

Query: 314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
                  + +YSE  +  A ++    L+  PK+R
Sbjct: 221 -------QEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFL 135
           +F     LG+GGFG V       ++R     +  A K L+   ++  +G    L E   L
Sbjct: 1   TFRQYRVLGKGGFGEVCAC----QVRA--TGKMYACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 136 GQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
            ++    +V L  Y  E +  L LV   M  G L+  ++            +  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  LH  ++ ++YRD K  NILLD     ++SD GLA   PEG    +  RV GT GY 
Sbjct: 114 GLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 168

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
           APE V     T   D ++ G +L E+++G+    + + + ++  VE             R
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------------R 215

Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
           ++   ++ +YSE  +  A +L    L   PK+R
Sbjct: 216 LVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.4 bits (169), Expect = 4e-13
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 10/210 (4%)

Query: 109 AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL 168
            Q VA+K ++L+        + E++ + +L++P++V  +      +   +V EY+  GSL
Sbjct: 44  GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103

Query: 169 ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD 228
            + +       +  +    +     + L FLH  +  VI+RD K+ N+LL  D + KL+D
Sbjct: 104 TDVV---TETCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTD 158

Query: 229 FGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
           FG  A+  PE   +  ST V GT  + APE V         D++S G++ +E++ G    
Sbjct: 159 FGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Query: 288 DKSRPQREQSLVEW-ARPMLNDARKLGRIM 316
               P R   L+     P L +  KL  I 
Sbjct: 216 LNENPLRALYLIATNGTPELQNPEKLSPIF 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 22/254 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG  G V         R     + VAVK +DL   Q       EV+ +   +H ++V+
Sbjct: 29  IGEGSTGIVCIA------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +       E   ++ E++  G+L + + +     L       +     + L +LH   + 
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH--SQG 137

Query: 206 VIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           VI+RD K+ +ILL  D   KLSDFG    ++KD P+         ++GT  + APE +  
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISR 191

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  D++S G++++E++ G        P Q  + L +   P L +A K+  ++   L
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251

Query: 321 EGQYSETGARKAAA 334
           E   +     +A A
Sbjct: 252 ERMLTREPQERATA 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 53/152 (34%), Positives = 70/152 (46%), Gaps = 8/152 (5%)

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI-ALG 191
           + L  L+HP LV L       E    V +Y+  G L   L R      P   R +  A  
Sbjct: 48  VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAAE 104

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A  + +LH     +IYRD K  NILLDS     L+DFGL K+G E ++T  ++   GT 
Sbjct: 105 VASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTP 160

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            Y APE +         D +  G VL E+L G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 81/278 (29%), Positives = 120/278 (43%), Gaps = 40/278 (14%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFL 135
           +F     LG+GGFG V       ++R     +  A K L+   ++  +G    L E   L
Sbjct: 1   TFRQYRVLGKGGFGEVCAC----QVRA--TGKMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 136 GQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
            ++    +V L  Y  E +  L LV   M  G L+   F  Y++  P     +    AA+
Sbjct: 55  EKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFEEERALFYAAE 110

Query: 195 ---GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
              GL  LH   +  +YRD K  NILLD     ++SD GLA   PEG+   +  RV GT 
Sbjct: 111 ILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTV 165

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV--DKSRPQREQSLVEWARPMLNDA 309
           GY APE +     T   D +  G ++ E++ G+      K + +RE    E  R +L   
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE----EVDRRVLET- 220

Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
                      E  YS   + +A ++    L+  PKQR
Sbjct: 221 -----------EEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 55/229 (24%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-------WLTEV 132
           F   N +GEG +G V++       R     + VA+K + ++      E        L E+
Sbjct: 9   FEKLNRIGEGTYGIVYRA------RDTTSGEIVALKKVRMD-----NERDGIPISSLREI 57

Query: 133 IFLGQLRHPHLVKL---------------IGYCCEEEHRLLVYEYMPRGSLENQLFRRYS 177
             L  LRHP++V+L               + YC ++   LL  + MP    E+Q+     
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQV----- 110

Query: 178 VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                     + L   +GL +LH  E  +I+RD K SN+LL      K++DFGLA+    
Sbjct: 111 --------KCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TY 158

Query: 238 GDDTHVSTRVMGTQGYAAPEYV--MTGHLTSMSDVYSFGVVLLELLSGR 284
           G      T  + T  Y APE +   T + T++ D+++ G +L ELL+ +
Sbjct: 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 16/149 (10%)

Query: 140 HPHLVKLIGYCCEE--EHRLLVYEYMPRGSL--ENQLFRRYSVSLPWSTRMKI-ALGAAK 194
           HP L +L  YCC +  +    V E++  G L    Q  RR+        R +  A     
Sbjct: 55  HPFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEITS 107

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
            L FLHD  K +IYRD K  N+LLD +   KL+DFG+ K+G     T  ++   GT  Y 
Sbjct: 108 ALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE +         D ++ GV+L E+L G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 60/186 (32%), Positives = 76/186 (40%), Gaps = 41/186 (22%)

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS----TR 185
            E   L     P +VKL     +EEH  LV EYMP G L N L R+       +      
Sbjct: 50  AERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE 109

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT---- 241
           + +AL +   L F+H        RD K  NIL+D+D   KL+DFGL K   +  D     
Sbjct: 110 LVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 242 ------------------HVSTRVM-----GTQGYAAPEYVMTGH-LTSMSDVYSFGVVL 277
                             H   RV      GT  Y APE V+ G       D +S GV+L
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVIL 220

Query: 278 LELLSG 283
            E+L G
Sbjct: 221 YEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 6/145 (4%)

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +P L  L      +EH   V E++  G L   +  +    L  +T    A     GL FL
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFL 112

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H   K +IYRD K  N++LD D   K++DFG+ K+   GD+   ++   GT  Y APE +
Sbjct: 113 H--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEIL 168

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGR 284
                T   D +SFGV+L E+L G+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 8/203 (3%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
            LG+G FG V+  +  D  R  L A+ V       E  +       E+  L  L+H  +V
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRE-LAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 145 KLIGYCCEEEHRLLV--YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +  G   +   + L    EYMP GS+++QL + Y  +L  S   K      +G+++LH  
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYG-ALTESVTRKYTRQILEGMSYLHS- 124

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVMT 261
              +++RD K +NIL DS    KL DFG +K       +    R V GT  + +PE +  
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 262 GHLTSMSDVYSFGVVLLELLSGR 284
                 +DV+S G  ++E+L+ +
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 26/204 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V+K       R     + VA+K + LE          E+  L + RHP++V 
Sbjct: 11  IGSGTYGDVYKA------RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL---GAAKGLAFLHDA 202
             G     +   +V EY   GSL++     Y V+    + ++IA       KGLA+LH  
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDI----YQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAAPEYV 259
           E   I+RD K +NILL  D   KL+DFG++        T    +    +GT  + APE  
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 260 ---MTGHLTSMSDVYSFGVVLLEL 280
                G      D+++ G+  +EL
Sbjct: 174 AVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 60/230 (26%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-----DLEGLQGHREWLTEVIFLGQL 138
             +G G +G V      DK       + VA+K +     DL  +   R  L E+  L  L
Sbjct: 6   KPIGSGAYGVVCSAV--DKRTG----RKVAIKKISNVFDDL--IDAKRI-LREIKLLRHL 56

Query: 139 RHPHLVKLI-----GYCCEEEHRLLVYEYMP---------RGSLEN--------QLFRRY 176
           RH +++ L+         +     +V E M             L +        Q+ R  
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR-- 114

Query: 177 SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DG 235
                             GL +LH A   VI+RD K SNIL++S+   K+ DFGLA+   
Sbjct: 115 ------------------GLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154

Query: 236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           P+ D+    T  + T+ Y APE +++    T   D++S G +  ELL+ +
Sbjct: 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 26/225 (11%)

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLT 130
           + ++    + S+ L EG FG +  G + D+     + + V VK +      +Q     L 
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTL-LLQ 57

Query: 131 EVIFLGQLRHPHLVKLIGYCCEE-EHRLLVYEYMPRGSLENQLFR-RYS---VSLPWSTR 185
           E   L  L H +++ ++  C E+ E   ++Y YM  G+L+  L + R          ST+
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 186 --MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPE----- 237
             + +A+  A G+++LH  ++ VI++D  A N ++D +   K++D  L++D  P      
Sbjct: 118 QLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175

Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           GD+ +   + M      A E ++    +S SDV+SFGV+L EL++
Sbjct: 176 GDNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 29/272 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           +GEG FG   K  +      G Q     +K +++  +      E   EV  L  ++HP++
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQ---YVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+      E  +  +V +Y   G L  ++  +  V  P    +   +     L  +HD  
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-- 119

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           + +++RD K+ NI L  D T KL DFG+A+         ++   +GT  Y +PE      
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
             + SD+++ G VL E+ + + + +             A  M N   K+ R   P +   
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFE-------------AGNMKNLVLKIIRGSYPPVSSH 224

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           YS         L  Q     P+ RP+++++++
Sbjct: 225 YSY----DLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 36/266 (13%)

Query: 83  SNFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH 140
            +F+  GEG  G V    I  +   G Q   VAVK +DL   Q       EV+ +    H
Sbjct: 25  DSFIKIGEGSTGIV---CIATEKHTGKQ---VAVKKMDLRKQQRRELLFNEVVIMRDYHH 78

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAK 194
            ++V +       +   +V E++  G+L +         +   TRM       + L   +
Sbjct: 79  ENVVDMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLSVLR 129

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGT 250
            L++LH+  + VI+RD K+ +ILL SD   KLSDFG    ++K+ P+         ++GT
Sbjct: 130 ALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKSLVGT 181

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWARPMLNDA 309
             + APE +      +  D++S G++++E++ G        P Q  + + +   P + D+
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS 241

Query: 310 RKLGRIMDPRLEGQYSETGARKAAAL 335
            K+  ++   L+       +++A A 
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQ 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 16/200 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K         G  A   A K ++ +  +   +++ E+  L    HP++VK
Sbjct: 20  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G    +    ++ E+ P G+++  +       L       I     + L +LH     
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLH--SMK 130

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           +I+RD KA N+LL  D   KL+DFG++    +      S   +GT  + APE VM   + 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMK 188

Query: 266 SM-----SDVYSFGVVLLEL 280
                  +D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 57/159 (35%), Positives = 74/159 (46%), Gaps = 11/159 (6%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           LTE   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    +S    
Sbjct: 43  LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRA 97

Query: 188 IALGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              GA     L +LH +EK V+YRD K  N++LD D   K++DFGL K+G +  D     
Sbjct: 98  RFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMK 154

Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
              GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.1 bits (163), Expect = 2e-12
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 16/233 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+              Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  PE       + ++GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 193

Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRIM 316
               D++S G++ +E++ G        P R   L+     P L +  KL  I 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLTEVIFLGQLRHPH 142
           +G+G F  V+K          L  + VA+K +   ++   +  ++ L E+  L QL HP+
Sbjct: 10  IGKGQFSVVYKA------ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           ++K +    E     +V E    G L   +  F++    +P  T  K  +     L  +H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
              K +++RD K +N+ + +    KL D GL +       T  +  ++GT  Y +PE + 
Sbjct: 124 --SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIH 179

Query: 261 TGHLTSMSDVYSFGVVLLEL 280
                  SD++S G +L E+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 37/94 (39%), Positives = 59/94 (62%), Gaps = 6/94 (6%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTRVMGTQG 252
           +GL ++H A   V++RD K SN+LL+++   K+ DFGLA+   PE D T   T  + T+ 
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 253 YAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGR 284
           Y APE ++   G+  ++ D++S G +L E+LS R
Sbjct: 175 YRAPEIMLNSKGYTKAI-DIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 25/231 (10%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQA-----QPVAVKNLDLEGLQGHREWLTEVI 133
            F+    LG+G FG V     + K    L A     + V +++ D+E        + E  
Sbjct: 1   DFNFLMVLGKGSFGKVM--LAERKGTDELYAIKILKKDVVIQDDDVECT------MVEKR 52

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
            L     P  +  +  C +   RL  V EY+  G L   + +      P +  +  A   
Sbjct: 53  VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA--VFYAAEI 110

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP-EGDDTHVSTRVM-GT 250
           + GL FLH   + +IYRD K  N++LDS+   K++DFG+ K+   +G    V+TR   GT
Sbjct: 111 SVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGT 164

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD-KSRPQREQSLVE 300
             Y APE +         D +++GV+L E+L+G+   D +   +  QS++E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 40/282 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLG-QLR 139
           LG G FG V+K    +  +  L  + + V N      +  R+      ++EV  +  QLR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYM---PRGSLENQL---FRRYSVSLPWSTRMKIALGAA 193
           HP++V+      E +   +V + +   P G   N L    +R++    W+  +++ L   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQG 252
             L +LH  EK +++RD   +NI+L  D    ++DFGLAK   PE       T V+GT  
Sbjct: 126 --LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----LTSVVGTIL 178

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           Y+ PE V        +DV++FG +L ++ +                  ++  ML+ A K+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------LQPPFYSTNMLSLATKI 225

Query: 313 -GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
              + +P  EG YSE        +   CL+   + RP +  V
Sbjct: 226 VEAVYEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 48/230 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL----------DLEGLQGHREWLTEVIFL 135
           LG+GG+G V   F   K+      +  A+K L          D    +  R  L  V   
Sbjct: 4   LGKGGYGKV---FQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV--- 57

Query: 136 GQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRR----YSVSLPWSTRMKIAL 190
              +HP +V LI Y  +   +L L+ EY+  G L   L R        +  + + + +AL
Sbjct: 58  ---KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMG 249
                    H  ++ +IYRD K  NILLD+    KL+DFGL K+   EG  TH      G
Sbjct: 114 E--------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCG 162

Query: 250 TQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSG---------RKSVDK 289
           T  Y APE +M +GH  ++ D +S G ++ ++L+G         +K++DK
Sbjct: 163 TIEYMAPEILMRSGHGKAV-DWWSLGALMYDMLTGAPPFTAENRKKTIDK 211

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 139 RHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           R P LV L  Y  + + +L L+ +Y+  G L   L++R   +    + +++ +     LA
Sbjct: 63  RCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIV-LA 117

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAA 255
             H  +  +IYRD K  NILLDS+    L+DFGL+K+    E +  +      GT  Y A
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMA 174

Query: 256 PEYVMT---GHLTSMSDVYSFGVVLLELLSG 283
           PE +     GH     D +S GV+  ELL+G
Sbjct: 175 PEVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 36/276 (13%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFL 135
           +F     LG+GGFG V         +     +  A K L+   ++  +G    L E   L
Sbjct: 1   TFRHYRVLGKGGFGEVCA------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 54

Query: 136 GQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
            ++    +V L  Y  E +  L LV   M  G L+   F  Y++  P     +    AA+
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK---FHIYNMGNPGFDEERAVFYAAE 110

Query: 195 ---GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
              GL  LH   + ++YRD K  NILLD     ++SD GLA + PEG+   +  RV GT 
Sbjct: 111 ITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRV-GTV 165

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK 311
           GY APE V     T   D +  G ++ E++ G+    + + + ++  VE  R +  D  +
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKEDQEE 223

Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
                       YSE  +  A ++  Q L+  P  R
Sbjct: 224 ------------YSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 37/92 (40%), Positives = 57/92 (61%), Gaps = 4/92 (4%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL +LH A   +++RD K  N+L++S+   K+ DFGLA+   E D++   T+ + TQ Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYY 170

Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE +M + H TS  D++S G +  ELL  R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 54/152 (35%), Positives = 72/152 (47%), Gaps = 8/152 (5%)

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           + L  ++HP LV L  Y  +   +L  V +++  G L   L R  S   P   R   A  
Sbjct: 48  VLLKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-E 104

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A  L +LH     ++YRD K  NILLDS     L+DFGL K+G    DT  +T   GT 
Sbjct: 105 IASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTP 160

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            Y APE +      +  D +  G VL E+L G
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 16/233 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+       +  G   Q VA+K ++L+        + E++ + + ++P++V 
Sbjct: 27  IGQGASGTVYTAI---DIATG---QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSNQ-- 135

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  PE   +  ST V GT  + APE V     
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRIM 316
               D++S G++ +E++ G        P R   L+     P L +  +L  + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 72/244 (29%), Positives = 103/244 (42%), Gaps = 45/244 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFLGQLRHPH 142
           +G+GG+G V   F+  K   G   + VA+K +    L  L   R  LTE   L   +   
Sbjct: 9   VGQGGYGQV---FLAKKKDTG---EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 143 LVKLIGYCCEEEHRLLVYEYMP----------RGSLENQLFRRYSVSLPWSTRMKIALGA 192
           LVKL+    ++E+  L  EY+P           G L     R Y         M  A+ A
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM------AEMFEAVDA 116

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
              L ++H        RD K  N L+D+    KL+DFGL+K          +  V+G+  
Sbjct: 117 LHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPD 163

Query: 253 YAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQRE-QSLVEWA----RPML 306
           Y APE V+ G     + D +S G +L E L G      S P    ++L  W     RP+ 
Sbjct: 164 YMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222

Query: 307 NDAR 310
           +D R
Sbjct: 223 DDPR 226

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 7e-12
 Identities = 67/204 (32%), Positives = 89/204 (43%), Gaps = 17/204 (8%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHP 141
            LG+G FG V        +R     +  A+K L  E +    E    LTE   L   RHP
Sbjct: 2   LLGKGTFGKV------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 142 HLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
            L  L  Y  + + RL  V EY+  G L   L R    S    TR   A      L +LH
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-RTRFYGA-EIVSALDYLH 112

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
             +  ++YRD K  N++LD D   K++DFGL K+G    D        GT  Y APE + 
Sbjct: 113 SGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGTPEYLAPEVLE 168

Query: 261 TGHLTSMSDVYSFGVVLLELLSGR 284
                   D +  GVV+ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 17/202 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN-LDLEGLQGHREW-LTEVIFLGQLRHPHL 143
           +GEG +G V K       +     Q VA+K  L+ E  +  ++  + E+  L QLRH +L
Sbjct: 9   VGEGSYGMVMK------CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V LI     ++   LV+E++    L++    +Y   L  S   K      +G+ F H   
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--T 261
             +I+RD K  NIL+      KL DFG A+      +  V T  + T+ Y APE ++  T
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDT 176

Query: 262 GHLTSMSDVYSFGVVLLELLSG 283
            +  ++ D+++ G ++ E+L+G
Sbjct: 177 KYGRAV-DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 26/205 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K         G+ A   A K +D +  +   +++ E+  L    HP++VK
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLA---AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+     E +  ++ E+   G+++  +       L       +     + L +LH+ +  
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK-- 123

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAAPEYVMTG 262
           +I+RD KA NIL   D   KL+DFG++       +T    R    +GT  + APE VM  
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 263 HLTS-------MSDVYSFGVVLLEL 280
             TS        +DV+S G+ L+E+
Sbjct: 179 --TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 45/234 (19%)

Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREW 128
           + +L++  + F     +G G FG V        +R     Q  A+K L   E ++     
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQL------VRHKSSKQVYAMKLLSKFEMIKR---- 84

Query: 129 LTEVIFLGQLRH-------PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
            ++  F  + R          +V+L     ++++  +V EYMP G L N L   Y +   
Sbjct: 85  -SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEK 142

Query: 182 WS----TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAK 233
           W+      + +AL A   + F+H        RD K  N+LLD     KL+DFG    +  
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMDA 194

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSG 283
           +G    DT V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 195 NGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 44/217 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQLRH 140
           +GEG +G V+K       R  L  + VA+K + LE      E      + E+  L +L H
Sbjct: 7   IGEGTYGVVYKA------RDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNH 57

Query: 141 PHLVKLIGYCCEEEHRL-LVYEYM-----------PRGSLENQLFRRYSVSLPWSTRMKI 188
           P++V+L+      E++L LV+E++           P   L+  L + Y   L        
Sbjct: 58  PNIVRLLD-VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL-------- 108

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
                +G+A+ H     V++RD K  N+L+D +   KL+DFGLA+    G      T  +
Sbjct: 109 ----LQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEV 160

Query: 249 GTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
            T  Y APE ++     S   D++S G +  E+++ R
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 14/150 (9%)

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           P++VK  GY   +    +  E M   +  ++L +R    +P     K+ +   K L +L 
Sbjct: 74  PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD--DTHVSTRVMGTQGYAAPEY 258
           + +  VI+RD K SNILLD+    KL DFG++     G   D+   TR  G   Y APE 
Sbjct: 132 E-KHGVIHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDSKAKTRSAGCAAYMAPER 185

Query: 259 VMTGHLTS----MSDVYSFGVVLLELLSGR 284
           +            +DV+S G+ L+EL +G+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 70/321 (21%), Positives = 123/321 (38%), Gaps = 77/321 (23%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-----EVIFLGQLR 139
            +G G +G V+K     K + G   +  A+K    +G +     ++     E+  L +L+
Sbjct: 7   CIGRGTYGRVYKA----KRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELK 60

Query: 140 HPHLVKLIGYCCEEEHRL--LVYEYMPRGSLENQLF-------RRYSVSLPWSTRMKIAL 190
           H ++V L+    E   +   L+++Y      E+ L+       +   VS+P S    +  
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKLSDFGLAK--DGP-----EGD 239
               G+ +LH     V++RD K +NIL+  +       K+ D GLA+  + P     + D
Sbjct: 116 QILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 240 DTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR-------KSVDKSR 291
                  V+ T  Y APE ++   H T   D+++ G +  ELL+           + KS 
Sbjct: 174 ------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227

Query: 292 P-QREQ--------------------SLVEWARPMLNDARKLGRIMDPRLEGQYSETGAR 330
           P QR+Q                     + E+    L    K        L     +    
Sbjct: 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT--LMKDFKTKTYPSNSLAKWMEKHKKP 285

Query: 331 KAAA--LAYQCLSHRPKQRPT 349
            +    L  + L + P +R T
Sbjct: 286 DSQGFDLLRKLLEYDPTKRIT 306

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 69/269 (25%), Positives = 105/269 (39%), Gaps = 51/269 (18%)

Query: 110 QPVAVKNLDLEGL--------QGHREWLTEVIFLGQL-----------RHPHLVKLIGYC 150
           +P AVK +D+EG+        Q     L    F   +           R+P  V +I   
Sbjct: 58  EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA-- 115

Query: 151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRD 210
                  LV +Y   G L  ++  R   +  +       L     LA  H   K +I+RD
Sbjct: 116 -------LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168

Query: 211 FKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDV 270
            K++NILL S+   KL DFG +K         V     GT  Y APE       +  +D+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM 228

Query: 271 YSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS---ET 327
           +S GV+L ELL+ +                  RP   D   +  +M   L G+Y     +
Sbjct: 229 FSLGVLLYELLTLK------------------RPF--DGENMEEVMHKTLAGRYDPLPPS 268

Query: 328 GARKAAALAYQCLSHRPKQRPTMSTVVKT 356
            + +   +    LS  PK+RP+ S ++  
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 53/159 (33%), Positives = 72/159 (45%), Gaps = 12/159 (7%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           +TE   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++    
Sbjct: 43  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERA 97

Query: 188 IALGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G     T  + 
Sbjct: 98  RFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 154

Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
              GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 155 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 37/282 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPG-LQAQPVAVKNLDLEGLQGHREWLTEVIF-----LGQLR 139
           LG+G F  + KG   +    G L    V +K LD    + HR + +E  F     + QL 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD----KSHRNY-SESFFEAASMMSQLS 57

Query: 140 HPHLVKLIGYC-CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           H HLV   G C C +E  ++V EY+  GSL+  L +  ++ +  S ++++A   A  L F
Sbjct: 58  HKHLVLNYGVCVCGDES-IMVQEYVKFGSLDTYLKKNKNL-INISWKLEVAKQLAWALHF 115

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAP 256
           L D  K + + +  A N+LL  +   K  +    K    G    V  + +  +   +  P
Sbjct: 116 LED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173

Query: 257 EYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           E +    +L+  +D +SFG  L E+ SG                +     L+  +KL + 
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQKKL-QF 217

Query: 316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
            + R   Q       + A L  QC+ + P  RP+   +++ L
Sbjct: 218 YEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLTEVIFL 135
           +F     +G G F  V++          L   PVA+K +   DL   +   + + E+  L
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLL 56

Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAA 193
            QL HP+++K      E+    +V E    G L   +  F++    +P  T  K  +   
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
             L  +H   + V++RD K +N+ + +    KL D GL +       T  +  ++GT  Y
Sbjct: 117 SALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLEL 280
            +PE +        SD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 52/158 (32%), Positives = 79/158 (50%), Gaps = 10/158 (6%)

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           TE   L  +R    +  + Y  + + +L L+ +Y+  G L   L +R          ++I
Sbjct: 53  TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQI 109

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
             G    LA  H  +  +IYRD K  NILLDS+    L+DFGL+K+  E D+   +    
Sbjct: 110 YSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFC 167

Query: 249 GTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSG 283
           GT  Y AP+ V     GH  ++ D +S GV++ ELL+G
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAV-DWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIF 134
           F     +GEG +G V+K       R     + VA+K + L+     +E      + E+  
Sbjct: 9   FDIIGQIGEGTYGQVYKA------RDKDTGELVALKKVRLDN---EKEGFPITAIREIKI 59

Query: 135 LGQLRHPHLVKLIGYCCEEEHRL----------LVYEYMPR---GSLENQL--FRRYSVS 179
           L QL H ++V L     +++  L          LV+EYM     G LE+ L  F    + 
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 180 LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
               + MK  L   +GL + H   K  ++RD K SNILL++    KL+DFGLA+     +
Sbjct: 120 ----SFMKQLL---EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
               + +V+ T  Y  PE ++       + DV+S G +L EL + +
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 20/230 (8%)

Query: 112 VAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
           VAVK +DL   Q       EV+ +   +H ++V++       +   +V E++  G+L + 
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 106

Query: 172 LFRRYSVSLPWSTRMK------IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK 225
                   +   TRM       + L   K L+ LH   + VI+RD K+ +ILL  D   K
Sbjct: 107 --------IVTHTRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVK 156

Query: 226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRK 285
           LSDFG         +      ++GT  + APE +         D++S G++++E++ G  
Sbjct: 157 LSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214

Query: 286 SVDKSRPQREQSLV-EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAA 334
                 P +   ++ +   P L +  K+   +   L+       A++A A
Sbjct: 215 PYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 48/151 (31%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW----STRMKIALGAAKGL 196
           P +V+L     ++++  +V EYMP G L N L   Y V   W    +  + +AL A   +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
             +H        RD K  N+LLD     KL+DFG      E       T V GT  Y +P
Sbjct: 162 GLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212

Query: 257 EYVMT----GHLTSMSDVYSFGVVLLELLSG 283
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 35/284 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLTEVIFLGQLRHPH 142
           +G G F  V++          L  +PVA+K +   ++   +  ++ + E+  L QL HP+
Sbjct: 10  IGRGQFSEVYRATCL------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           ++K +    E+    +V E    G L   +  F++    +P  T  K  +     +  +H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
              + V++RD K +N+ + +    KL D GL +       T  +  ++GT  Y +PE + 
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIH 179

Query: 261 TGHLTSMSDVYSFGVVLLEL--LSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
                  SD++S G +L E+  L      DK               + +  +K+ +   P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-------------LFSLCQKIEQCDYP 226

Query: 319 RLEGQ-YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
            L  + YSE    K   L   C+   P QRP +  V +  + + 
Sbjct: 227 PLPTEHYSE----KLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 38/228 (16%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREW----------L 129
             LGEG +G V K   D         + VA+K + +      +   R+           L
Sbjct: 15  AHLGEGTYGKVEKA-YDTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
            E+  + +++H +++ L+    E +   LV + M    L+  + R+  + L  S    I 
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCIL 125

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--------DGPEGDDT 241
           L    GL  LH      ++RD   +NI ++S    K++DFGLA+        D    D+T
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 242 HVSTRVMG----TQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
                 M     T  Y APE +M         D++S G +  ELL+G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 78  QSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLT 130
             F     LG G FG V    HKG            +  A+K L   ++  ++  +    
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKG----------TGEYYAIKCLKKREILKMKQVQHVAQ 67

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E   L +L HP +V ++    +E     + E++  G L   L  R +   P    +    
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFP--NDVAKFY 123

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            A   LAF +   K +IYRD K  N+LLD+    K++DFG AK  P+   T     + GT
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGT 178

Query: 251 QGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSG 283
             Y APE + + GH  ++ D ++ GV+L E ++G
Sbjct: 179 PEYLAPEVIQSKGHGKAV-DWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 29/226 (12%)

Query: 86  LGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           LG+G FG V     KG  D+     +  + V +++ D+E        + E   L     P
Sbjct: 8   LGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECT------MVEKRVLALSGKP 60

Query: 142 HLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
             +  +  C +   RL  V EY+  G L  Q+ +      P +  +  A   A GL FLH
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA--VFYAAEIAIGLFFLH 118

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGDDTHVSTRVM-GTQGYAA 255
              K +IYRD K  N++LDS+   K++DFG+ K    DG       V+T+   GT  Y A
Sbjct: 119 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-------VTTKTFCGTPDYIA 169

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD-KSRPQREQSLVE 300
           PE +         D ++FGV+L E+L+G+   + +   +  QS++E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V  G ++    P   AQ V VK L +   +Q   ++L E      L+H +L+
Sbjct: 3   IGNGWFGKVILGEVNSGYTP---AQ-VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQL---FRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           + +G C E    LLV E+ P G L+  L    +   ++   +T  ++A   A GL  LH 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH- 117

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            +   I+ D    N LL +D T K+ D+GL+ +  + D      ++     + APE V  
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 262 GH-------LTSMSDVYSFGVVLLELL 281
            H        T  S+V+S GV + EL 
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 26/209 (12%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG+G +G V+    +  ++R       +A+K +     +  +    E+     L+H ++V
Sbjct: 16  LGKGTYGIVYAARDLSTQVR-------IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIV 68

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI-ALGAAKGLAFLHDAE 203
           + +G   E     +  E +P GSL   L  ++         +        +GL +LHD +
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 204 KPVIYRDFKASNILLDSDYTA--KLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPE 257
             +++RD K  N+L+++ Y+   K+SDFG    LA   P       +    GT  Y APE
Sbjct: 129 --IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPE 179

Query: 258 YVMTGH--LTSMSDVYSFGVVLLELLSGR 284
            +  G     + +D++S G  ++E+ +G+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 49/227 (21%)

Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEV 132
            T  +     +G G FG V         R  L  Q VA+K + ++        +    E+
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSA------RDQLTGQNVAIKKI-MKPFSTPVLAKRTYREL 60

Query: 133 IFLGQLRHPHLVKL----------IGYCCE----EEHRLLVYEYMPRGSLENQLFRRYSV 178
             L  LRH +++ L          I +  E    + HRLL         LE Q F +Y  
Sbjct: 61  KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL-----TSRPLEKQ-FIQY-- 112

Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
                          +GL ++H A   V++RD K SNIL++ +   K+ DFGLA+     
Sbjct: 113 ---------FLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161

Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
              +VSTR      Y APE ++T     +  D++S G +  E+L G+
Sbjct: 162 MTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 85  FLGEGGFGAVHKGFIDDKLR----------PGLQAQPVAVKNLDLEGLQGHREWLTEVIF 134
            LG G FG V+  +  D  R          P  Q     V  L+            E+  
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE-----------CEIQL 57

Query: 135 LGQLRHPHLVKLIGYCCE--EEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           L  LRH  +V+  G C    EE +L ++ EYMP GS+++QL + Y       TR +    
Sbjct: 58  LKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTR-RYTRQ 114

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE--GDDTHVSTRVMG 249
             +G+++LH     +++RD K +NIL DS    KL DFG +K         T + + V G
Sbjct: 115 ILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTG 171

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T  + +PE +        +DV+S    ++E+L+
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 13/207 (6%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREW-LTEVIFLGQ 137
           F     +GEG +G V K       R     + VA+K   D E  +  +E  L E+  L  
Sbjct: 3   FEVLGVVGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRT 56

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L+  ++V+L           LV+EY+ +  LE  L       +P            K + 
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIH 114

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +  +++RD K  N+L+  +   KL DFG A++  EG + +  T  + T+ Y +PE
Sbjct: 115 WCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPE 171

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGR 284
            ++        D++S G +L EL  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 52/174 (29%), Positives = 75/174 (43%), Gaps = 29/174 (16%)

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           A+G+ FL  A +  I+RD  A NILL  +   K+ DFGLA+D  +  D            
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS------VDKSRPQREQSLVEWARPML 306
           + APE +     T+ SDV+SFGV+L E+ S   S      +++   QR +       P  
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPEN 301

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               ++ RIM                      C    PK+RPT S +V+ L  L
Sbjct: 302 ATP-EIYRIM--------------------LACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)

Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW--- 128
           + K+  + F+    LG G FG V      ++  P     PVA+K  +   +   ++    
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFP-----PVAIKRFEKSKIIKQKQVDHV 78

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
            +E   L  + HP  V L G   +E +  LV E++  G  E   F R +   P    +  
Sbjct: 79  FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFP--NDVGC 134

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
              A   L F +     ++YRD K  N+LLD D   K++DFG AK         V TR  
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTY 186

Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE ++       +D ++ G+ + E+L G
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--EVIFLGQLR---H 140
           +G G +G V+K       R       VA+K++ ++  +      T  EV  L +L    H
Sbjct: 8   IGVGAYGTVYKA------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 141 PHLVKLIGYCC-----EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           P++V+L+  C       E    LV+E++ +  L   L +     LP  T   +     +G
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS-TRVMGTQGYA 254
           L FLH     +++RD K  NIL+ S    KL+DFGLA+         ++ T V+ T  Y 
Sbjct: 121 LDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYR 174

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELL 281
           APE ++     +  D++S G +  E+ 
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 88/354 (24%), Positives = 139/354 (39%), Gaps = 62/354 (17%)

Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           + +L++  + +     +G G FG V    +  K    + A  +  K   ++       W 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW- 91

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW----STR 185
            E   +     P +V+L     ++ +  +V EYMP G L N L   Y V   W    +  
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 150

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDT 241
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    DT
Sbjct: 151 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 242 HVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            V     GT  Y +PE + +    G+     D +S GV L E+L G        P    S
Sbjct: 203 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADS 251

Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRP-----------KQ 346
           LV     ++N    L    D  +        +++A  L    L+ R            K+
Sbjct: 252 LVGTYSKIMNHKNSLTFPDDNDI--------SKEAKNLICAFLTDREVRLGRNGVEEIKR 303

Query: 347 RPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKET 400
                      E L+D        T    VP  SS+ D +N +D++E + ++ET
Sbjct: 304 HLFFKNDQWAWETLRD--------TVAPVVPDLSSDIDTSNFDDIEEDKGEEET 349

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 63/230 (27%), Positives = 93/230 (40%), Gaps = 23/230 (10%)

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           +E+  L    H  +VK       ++  LL+ EY   G L  Q+ +R    LP+       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
           L     LA      + +++RD K++NI L      KL DFG +K   +     V++   G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
           T  Y APE       +  +D++S GV+L ELL+  +   K   QRE              
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-KGPSQRE-------------- 278

Query: 310 RKLGRIMDPRLEGQYSETG---ARKAAALAYQCLSHRPKQRPTMSTVVKT 356
                IM   L G+Y       +    AL    LS  P  RPT   ++ T
Sbjct: 279 -----IMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323

Length = 478

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 39/279 (13%)

Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--EVIFL 135
           Q +     +GEG +G V K      L+ G   + VA+K + ++  +      T  EV  L
Sbjct: 1   QQYECVAEIGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVL 55

Query: 136 GQLR---HPHLVKLIGYCC----EEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
             L    HP++V+L   C     + E +L LV+E++ +  L   L +     +P  T   
Sbjct: 56  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 114

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           +     +GL FLH     V++RD K  NIL+ S    KL+DFGLA+           T V
Sbjct: 115 MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSV 169

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
           + T  Y APE ++     +  D++S G +  E+        + +P    S         +
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-------RRKPLFRGS---------S 213

Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ 346
           D  +LG+I+D  + G   E    +  AL  Q    +  Q
Sbjct: 214 DVDQLGKILD--VIGLPGEEDWPRDVALPRQAFHSKSAQ 250

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 33/234 (14%)

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-------MKIAL 190
           L+HP++++ +G C E    LLV+EY   G L     + Y     W  R        ++A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDL-----KSYLSQEQWHRRNSQLLLLQRMAC 106

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             A G+  +H  +   ++ D    N  L SD T K+ D+G+     + D           
Sbjct: 107 EIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 251 QGYAAPEYV-------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR 303
             + APE V       +T   T  S+V++ GV L EL       + ++P    S  E   
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVLN 219

Query: 304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
            ++ D  +  ++  P+LE  YSE   R    L +  LS  P++R T   V + L
Sbjct: 220 HVIKD--QQVKLFKPQLELPYSE---RWYEVLQFCWLS--PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 37/218 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLV 144
           +GEG +G V+K     K       Q VA+K +D+       E   E   L +   HP++ 
Sbjct: 14  IGEGTYGKVYKA-RHKKT-----GQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIA 66

Query: 145 KLIG------YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGA 192
              G          ++   LV E    GS+ + L +          R+K      I    
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKG---LRKKGKRLKEEWIAYILRET 122

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR--VMGT 250
            +GLA+LH  E  VI+RD K  NILL  +   KL DFG++       D+ +  R   +GT
Sbjct: 123 LRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGRRNTFIGT 176

Query: 251 QGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSG 283
             + APE +           + SDV+S G+  +EL  G
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 39/98 (39%), Positives = 53/98 (54%), Gaps = 10/98 (10%)

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ- 251
           A+G+ FL  A K  I+RD  A N+LL     AK+ DFGLA+D    D  +V   V G   
Sbjct: 222 AQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYV---VKGNAR 275

Query: 252 ---GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS 286
               + APE +     T  SDV+S+G++L E+ S  KS
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 45/129 (34%), Positives = 61/129 (47%), Gaps = 15/129 (11%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  +H+  + V+YRD K +NILLD     ++SD GLA D  +    H S   +GT GY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYM 162

Query: 255 APEYVMTG-HLTSMSDVYSFGVVLLELLSGR------KSVDKSRPQR--EQSLVEWARPM 305
           APE +  G    S +D +S G +L +LL G       K+ DK    R      VE     
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222

Query: 306 LNDARKLGR 314
             + R L  
Sbjct: 223 SPELRSLLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 26/210 (12%)

Query: 83  SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN----LDLEGLQGHREWLTEVIFLGQL 138
              +GEG +G V+K       R     + VA+K     L  EG+      L E+  L QL
Sbjct: 4   LAEIGEGAYGTVYKA------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQL 55

Query: 139 R---HPHLVKLIGYC--CEEEHRL---LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
               HP++V+L+  C     +  L   LV+E++ +  L   L +     LP  T   +  
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
              +G+ FLH     +++RD K  NIL+ SD   K++DFGLA+           T V+ T
Sbjct: 115 QLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVT 169

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLEL 280
             Y APE ++     +  D++S G +  EL
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 10/93 (10%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A   +I+RD K SNI ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181

Query: 254 AAPEYVMT--GHLTSMSDVYSFGVVLLELLSGR 284
            APE +M    H     D++S G ++ ELL+G+
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 8/106 (7%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQ 251
           GL ++H A   V++RD K  N+L+++D   K+ DFGLA+   + P  +   + T  + T+
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173

Query: 252 GYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
            Y APE +++    T   DV+S G +L ELL GRK V K +   +Q
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 51/153 (33%), Positives = 71/153 (46%), Gaps = 10/153 (6%)

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI-AL 190
           + L  ++HP LV L  +  +   +L  V +Y+  G L   L R      P   R +  A 
Sbjct: 48  VLLKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAA 103

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             A  L +LH     ++YRD K  NILLDS     L+DFGL K+  E + T  ++   GT
Sbjct: 104 EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGT 159

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             Y APE +         D +  G VL E+L G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 11/158 (6%)

Query: 130 TEVIFLGQLRH-PHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           TE   L  +R  P LV L  Y  + E +L L+ +Y+  G +   L++R + S      ++
Sbjct: 53  TERNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVR 108

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
              G    LA  H  +  ++YRD K  NILLDS+    L+DFGL+K+    ++   +   
Sbjct: 109 FYSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSF 166

Query: 248 MGTQGYAAPEYV--MTGHLTSMSDVYSFGVVLLELLSG 283
            GT  Y APE +    GH  ++ D +S G+++ ELL+G
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHRE---WLTEVIFLGQLR 139
            LG+G FG V+  +  D  R       +AVK +  D E  +  +E      E+  L  L 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRE------LAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 140 HPHLVKLIGYCCEEEHRLL--VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           H  +V+  G   +   R L    E+MP GS+++QL + Y       TR K      +G++
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTR-KYTRQILEGVS 120

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAP 256
           +LH     +++RD K +NIL DS    KL DFG +K       +    + V GT  + +P
Sbjct: 121 YLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           E +        +D++S G  ++E+L+ +
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 27/207 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V K       +     + VA+K + L    EG+      L E+  L +L+H 
Sbjct: 8   IGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 59

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA----LGAAKGLA 197
           ++V+L      ++   LV+EY       +Q  ++Y  S       +I         KGLA
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           F H     V++RD K  N+L++ +   KL+DFGLA+    G      +  + T  Y  P+
Sbjct: 114 FCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPD 169

Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSG 283
            +    L S S D++S G +  EL + 
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 35/232 (15%)

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            + Q+ H HL  + G C      ++V E++  G L+    R+    +P + ++ +A   A
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKEKGRVPVAWKITVAQQLA 127

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLD----SDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
             L++L D  K +++ +  A NILL     ++ T+   KLSD G++      ++     R
Sbjct: 128 SALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----R 180

Query: 247 VMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
           V     + APE V  G  L++ +D +SFG  LLE+       D   P +E++  E  R  
Sbjct: 181 VERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVPLKERTPSEKERFY 234

Query: 306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                K  R+ +P           ++ A L  QCL++ P QRP+  T+++ L
Sbjct: 235 ----EKKHRLPEP---------SCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 16/217 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           LGEG +  V KG      R  L    VA+K + LE  +G     + EV  L  L+H ++V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGLAFLHDAE 203
            L      ++   LV+EY+ +   + + +     ++     +KI L    +GLA+ H   
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--R 122

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-TG 262
           + V++RD K  N+L++     KL+DFGLA+       T+ +  V  T  Y  P+ ++ + 
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSS 180

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
             ++  D++  G +  E+ SGR     S  + E  L+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LA  H  +  ++YRD K  NILLD+     L DFGL+K     + T  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 256 PEYVM--TGHLTSMSDVYSFGVVLLELLSG 283
           PE ++   G+ T   D +S GV++ E+  G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 14/128 (10%)

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD--DTHVS 244
           KIA+   K L +LH     VI+RD K SN+L++ +   KL DFG++     G   D+   
Sbjct: 107 KIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAK 160

Query: 245 TRVMGTQGYAAPEYV----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ--SL 298
           T   G + Y APE +            SDV+S G+ ++EL +GR   D  +   +Q   +
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220

Query: 299 VEWARPML 306
           VE   P L
Sbjct: 221 VEEPSPQL 228

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 17/166 (10%)

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           AKG++FL  A K  I+RD  A NILL      K+ DFGLA+D     +  V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           + APE +     T  SDV+S+G++L E+ S   S     P   +        M+ +    
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-----KMIKEGY-- 334

Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            R++ P       E    +   +   C    P +RPT   +V+ +E
Sbjct: 335 -RMLSP-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 24/221 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           LGEG +  V KG      R  L    VA+K + LE  +G     + EV  L  L+H ++V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 145 KLIGYCCEEEHRLLVYEYMP---RGSLEN--QLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
            L      E    LV+EY+    +  L+N   L   ++V +             +GL++ 
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-------FMFQLLRGLSYC 119

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H  ++ +++RD K  N+L++     KL+DFGLA+       T+ +  V  T  Y  P+ +
Sbjct: 120 H--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175

Query: 260 M-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           + +   ++  D++  G +L E+ +GR     S  + E  L+
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 33/192 (17%)

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP----WSTRMKIALGAAKGL 196
           P++V L  Y   E+   LV ++   G L + + +  ++       W+  M +AL A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
             LH   + ++ RD   +NILLD     +L+ F    +  +  D      +     Y AP
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP---QREQSL--VEW----ARPML- 306
           E       T   D +S G +L ELL+G K++ +  P       +L   EW    AR +L 
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSLLQ 210

Query: 307 -----NDARKLG 313
                N   +LG
Sbjct: 211 QLLQFNPTERLG 222

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 4/124 (3%)

Query: 160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
           Y+      ++N L    S  L     +      A+G+ FL  A K  ++RD  A N+LL 
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271

Query: 220 SDYTAKLSDFGLAKDGPEGDDTHVST-RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLL 278
                K+ DFGLA+D    D  +VS         + APE +     T++SDV+S+G++L 
Sbjct: 272 QGKIVKICDFGLARDIMH-DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 279 ELLS 282
           E+ S
Sbjct: 331 EIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  LH  ++ +IYRD K  N+LLD+D   ++SD GLA +  +G     +    GT G+ 
Sbjct: 109 GLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFM 164

Query: 255 APEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
           APE ++ G     S D ++ GV L E+++ R
Sbjct: 165 APE-LLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 2/90 (2%)

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           A+G+ FL  A +  I+RD  A NILL  +   K+ DFGLA+D  +  D            
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           + APE +     T+ SDV+SFGV+L E+ S
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 29/171 (16%)

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           AKG+ FL  A +  I+RD  A NILL  +   K+ DFGLA+D  +  D            
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS------VDKSRPQREQSLVEWARPML 306
           + APE +     T  SDV+SFGV+L E+ S   S      +D+   +R +       P  
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 306

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                   ++D                     C    P QRPT S +V+ L
Sbjct: 307 TTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 67/276 (24%), Positives = 100/276 (36%), Gaps = 47/276 (17%)

Query: 112 VAVKNLDLEG--------LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEY 162
           VAVK ++L+         LQ       E+I   QL+HP+++         +  L +V   
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQ------EIITSRQLQHPNILP-YVTSFIVDSELYVVSPL 80

Query: 163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           M  GS E+ L   +   LP      I       L ++H   K  I+R  KAS+ILL  D 
Sbjct: 81  MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDG 138

Query: 223 TAKLSDF----GLAKDGPEGDDTHVSTR-VMGTQGYAAPEYV---MTGHLTSMSDVYSFG 274
              LS       + K G      H   +  +    + +PE +   + G+    SD+YS G
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVG 197

Query: 275 VVLLELLSGRKSVDKSRPQREQSLVEWAR---PMLNDARKLGRIMDPRLEGQYSETGARK 331
           +   EL +G   V        Q L+E  R   P L D        D   + + S      
Sbjct: 198 ITACELANG--HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNN 255

Query: 332 AAA---------------LAYQCLSHRPKQRPTMST 352
             +                   CL   P+ RP+ S 
Sbjct: 256 RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 7/90 (7%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  +H+  + V+YRD K +NILLD     ++SD GLA D  +    H S   +GT GY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYM 162

Query: 255 APEYVMTG-HLTSMSDVYSFGVVLLELLSG 283
           APE +  G    S +D +S G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 59/233 (25%), Positives = 111/233 (47%), Gaps = 32/233 (13%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           +   +S+   N +G G FG V++    D       ++ VA+K +    LQ  +    E++
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDT------SEKVAIKKV----LQDPQYKNRELL 111

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRL--------LVYEYMPRGSLEN-QLFRRYSVSLPWST 184
            +  L H +++ L  Y   E  +         +V E++P+   +  + + R + +LP   
Sbjct: 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL 171

Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDDTHV 243
               +    + LA++H   K + +RD K  N+L+D + +T KL DFG AK+   G     
Sbjct: 172 VKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--- 226

Query: 244 STRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLE------LLSGRKSVDK 289
           S   + ++ Y APE ++   + T+  D++S G ++ E      + SG+ SVD+
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Length = 440

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 12/98 (12%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD---THVSTRVMGT 250
           +GL ++H A   V++RD K SN+LL+++   K+ DFGLA+   E  D    +V TR    
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---- 172

Query: 251 QGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSV 287
             Y APE ++     T+  DV+S G +  ELL GRK +
Sbjct: 173 -WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 25/176 (14%)

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD--DTHVS 244
           KIA+   K L +L +  K +I+RD K SNILLD +   KL DFG++     G   D+   
Sbjct: 111 KIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164

Query: 245 TRVMGTQGYAAPEYVMTGHLTSM---SDVYSFGVVLLELLSGRKSVDKSRPQREQ-SLVE 300
           TR  G + Y APE +           SDV+S G+ L E+ +G+    K     +Q + V 
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224

Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT 356
              P          I+    E ++S +           CL     +RP    +++ 
Sbjct: 225 KGDP---------PILSNSEEREFSPSFVN----FINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+K       R  +  + +A+K + L    EG+      + E+  L +++H 
Sbjct: 10  IGEGTYGVVYKA------RDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHG 61

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM-KIAL-GAAKGLAFL 199
           ++V+L      E+   LV+EY+    L+ +     S     + R+ K  L    +G+A+ 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 200 HDAEKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           H     V++RD K  N+L+D      KL+DFGLA+    G      T  + T  Y APE 
Sbjct: 119 H--SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEI 174

Query: 259 VM-TGHLTSMSDVYSFGVVLLELLSGR 284
           ++ + H ++  D++S G +  E+++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 51/155 (32%), Positives = 69/155 (44%), Gaps = 6/155 (3%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L Q+  P +V L       E   LV  ++  G L + L R     L   +R + 
Sbjct: 41  LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARF 97

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
              A    A  +  +  VIYRD K  NILLD      L DFGL K   + DD   +    
Sbjct: 98  YT-AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFC 154

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           GT  Y APE ++    T   D ++ GV+L E+L+G
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           LGEG +  V+KG      R  L    VA+K + LE  +G     + EV  L  L+H ++V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLE-----NQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
            L      E+   LV+EY+ +   +           ++V L             +GL + 
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYC 120

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H   + V++RD K  N+L++     KL+DFGLA+       T+ +  V  T  Y  P+ +
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176

Query: 260 M-TGHLTSMSDVYSFGVVLLELLSGR 284
           + +   ++  D++  G +  E+ +GR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 39/233 (16%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-------ENQLFRRYSVSLPWS 183
           E + L +++HP++V        + H  +V EY   G L         +LF   ++ L W 
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWF 106

Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDT 241
            +M         L   H  EK V++RD K+ NI L  +   KL DFG A+    P     
Sbjct: 107 VQM--------CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---A 155

Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW 301
           +  T V GT  Y  PE        + SD++S G +L EL + +       P +  S   W
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK------HPFQANS---W 205

Query: 302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
              +L    K+ +     L   YS     +  +L  Q     P+ RP+ +T++
Sbjct: 206 KNLIL----KVCQGSYKPLPSHYS----YELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 26/208 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   + D +LR     Q VAVK L    + L   R    E+  L  ++H ++
Sbjct: 23  VGSGAYGSVCSAY-DTRLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 144 VKLI-----GYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           + L+         E  + + LV   M  G+  N + +   +S      +   L   +GL 
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQL--LRGLK 132

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   +    +V+TR      Y APE
Sbjct: 133 YIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185

Query: 258 YVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            ++   H     D++S G ++ ELL G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 19/161 (11%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KI 188
           E+  L  + HP++VK            ++ E+M  GSLE               +    +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI--------ADEQFLADV 173

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A     G+A+LH   + +++RD K SN+L++S    K++DFG+++   +  D   S+  +
Sbjct: 174 ARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--V 229

Query: 249 GTQGYAAPEYVMTGHLTSM-----SDVYSFGVVLLELLSGR 284
           GT  Y +PE + T            D++S GV +LE   GR
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 40/279 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V+K       R     +  A+K + LE  +       E+I +   +H ++V 
Sbjct: 17  IGSGTYGDVYKA------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL---GAAKGLAFLHDA 202
             G     +   +  E+   GSL++     Y V+ P S   +IA       +GL +LH  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDI----YHVTGPLS-ESQIAYVSRETLQGLYYLHSK 125

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT- 261
            K  ++RD K +NILL  +   KL+DFG++           S   +GT  + APE     
Sbjct: 126 GK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVE 181

Query: 262 --GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV---EWARPMLNDARKLGRIM 316
             G    + D+++ G+  +EL   +  +    P R   L+    +  P L D  K     
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW---- 237

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                       +          L+  PK+RPT   +++
Sbjct: 238 ------------SNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V+K      L  G  A   AVK + LE          E+  + + +H ++V 
Sbjct: 17  VGSGTYGDVYKA---RNLHTGELA---AVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL---GAAKGLAFLHDA 202
             G     E   +  EY   GSL++     Y V+ P S  ++IA       +GLA+LH  
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDI----YHVTGPLS-ELQIAYVCRETLQGLAYLHSK 125

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-- 260
            K  ++RD K +NILL  +   KL+DFG+A           S   +GT  + APE     
Sbjct: 126 GK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVE 181

Query: 261 -TGHLTSMSDVYSFGVVLLEL 280
             G    + D+++ G+  +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 14/218 (6%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLV 144
           LGEG +  V+KG         +  Q VA+K + ++  +G     + E   L  L+H ++V
Sbjct: 13  LGEGSYATVYKGI------SRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            L      +E    V+EYM    L   + +      P++ R+       +GLA++H   +
Sbjct: 67  LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH--GQ 122

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-TGH 263
            +++RD K  N+L+      KL+DFGLA+       T+ S  V  T  Y  P+ ++    
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW 301
            +S  D++  G + +E+L G+ +        EQ    W
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 28/187 (14%)

Query: 152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS------TRMKIALGAAKGLAFLHDAEKP 205
           ++++  LV EY P G L + L  RY               + +A+ +   + ++H     
Sbjct: 72  DKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH----- 125

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY--VMTGH 263
              RD K  N+L+D     KL+DFG A      +    S   +GT  Y APE    M G 
Sbjct: 126 ---RDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 264 LTSMSDV----YSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
                 V    +S GV+  E++ GR       P  E +  +    ++N  R L    DP+
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRS------PFHEGTSAKTYNNIMNFQRFLKFPEDPK 235

Query: 320 LEGQYSE 326
           +   + +
Sbjct: 236 VSSDFLD 242

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 16/150 (10%)

Query: 142 HLVKLIGY---CCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           +++K+ G+     ++  RL L+ EY  RG L   L       L + T++ +A+   KGL 
Sbjct: 79  NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLY 136

Query: 198 FLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            L+    KP  Y++  + + L+  +Y  K+   GL K        +V+  V     Y + 
Sbjct: 137 NLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSY 189

Query: 257 EYVMT--GHLTSMSDVYSFGVVLLELLSGR 284
           + +       T   D+YS GVVL E+ +G+
Sbjct: 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 56/187 (29%), Positives = 72/187 (38%), Gaps = 37/187 (19%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           LTE   L  L HP L  L      E +  LV +Y P G L   L R+    L        
Sbjct: 49  LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV---A 105

Query: 189 ALGAAK---GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK------------ 233
              AA+    L +LH     ++YRD K  NILL       LSDF L+K            
Sbjct: 106 RFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 234 --DGPEGDDTH----------VSTRVM---GTQGYAAPEYVM-TGHLTSMSDVYSFGVVL 277
              G      +           S R     GT+ Y APE +   GH  S  D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222

Query: 278 LELLSGR 284
            E+L G 
Sbjct: 223 YEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 31/96 (32%), Positives = 55/96 (57%), Gaps = 8/96 (8%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVSTRVMGTQ 251
           +GL ++H A   VI+RD K SN+L++ D   ++ DFG+A+       +  +  T  + T+
Sbjct: 118 RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 252 GYAAPE--YVMTGHLTSMSDVYSFGVVLLELLSGRK 285
            Y APE    +  + T++ D++S G +  E+L GR+
Sbjct: 176 WYRAPELLLSLPEYTTAI-DMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++  V+ T+ Y 
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYR 184

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 16/190 (8%)

Query: 104 RPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM 163
           +PG Q  PV +K     G +G    L E + L  + HP ++++           +V  + 
Sbjct: 87  KPG-QPDPVVLK----IGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139

Query: 164 PRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT 223
               L   L +R S  LP    + I     +GL +LH   + +I+RD K  NI ++    
Sbjct: 140 -SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQ 195

Query: 224 AKLSDFGLAK-DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
             + D G A+          ++    GT    APE +      S +D++S G+VL E+L+
Sbjct: 196 VCIGDLGAAQFPVVAPAFLGLA----GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Query: 283 GRKSVDKSRP 292
              ++ +  P
Sbjct: 252 YPSTIFEDPP 261

Length = 357

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 8/92 (8%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+      D+ ++  V+ T+ Y
Sbjct: 129 KGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT----DSEMTGYVV-TRWY 181

Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H T   D++S G ++ E+L+G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 40/193 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-------WLTEVIFLGQL 138
           +G+G FG V K       R     Q VA+K + +E      E        L E+  L  L
Sbjct: 20  IGQGTFGEVFKA------RHKKTKQIVALKKVLME-----NEKEGFPITALREIKILQLL 68

Query: 139 RHPHLVKLIGYCCEE---EHR-----LLVYEYMPR---GSLENQLFRRYSVSLP-WSTRM 186
           +H ++V LI  C  +    +R      LV+E+      G L N+  +    +L      M
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVM 125

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVS 244
           K+ L    GL ++H  +  +++RD KA+NIL+  D   KL+DFGLA+     +    +  
Sbjct: 126 KMLL---NGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 245 TRVMGTQGYAAPE 257
           T  + T  Y  PE
Sbjct: 181 TNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.6 bits (128), Expect = 5e-08
 Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 43/290 (14%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL- 138
           F     +G G +G V+KG      R     Q  A+K +D+ G +   E   E+  L +  
Sbjct: 8   FELVELVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYS 60

Query: 139 RHPHLVKLIGYCCE------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
            H ++    G   +      ++   LV E+   GS+ + +      +L       I    
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR--VMGT 250
            +GL+ LH  +  VI+RD K  N+LL  +   KL DFG++       D  V  R   +GT
Sbjct: 121 LRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGT 174

Query: 251 QGYAAPEYVMTGHLTSM-----SDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
             + APE +             SD++S G+  +E+  G   +    P R   L+      
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----- 229

Query: 306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                   R   PRL+   S+  ++K  +    CL     QRPT   ++K
Sbjct: 230 --------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 12/180 (6%)

Query: 108 QAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLI-GYCCEEEHRLLVYEYMPRG 166
           Q + V VK      + G +    E+  L  + H  ++ LI  Y      +  V   MP+ 
Sbjct: 118 QRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAY----RWKSTVCMVMPKY 168

Query: 167 SLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL 226
             +   +   S  LP    + I     + LA+LH   + +I+RD K  NI LD    A L
Sbjct: 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVL 226

Query: 227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS 286
            DFG A       DT       GT    +PE +      + +D++S G+VL E+     +
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 45/232 (19%)

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV-SLPWSTRMKIALGAAKG 195
           Q+ H H+V L G C  +   ++V E++  G L+  + R+  V + PW  + K+A   A  
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASA 117

Query: 196 LAFLHDAEKPVIYRDFKASNILL-----DSDYTA--KLSDFGLAKDGPEGDDTHVSTRVM 248
           L++L D  K +++ +    NILL     D +     KLSD G+           V +R  
Sbjct: 118 LSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQE 167

Query: 249 GTQ--GYAAPEYVM-TGHLTSMSDVYSFGVVLLEL-LSGRKSV-DKSRPQREQSLVEWAR 303
             +   + APE V  + +L+  +D +SFG  L E+  +G   + DK+  ++E+       
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM 227

Query: 304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            +    ++L  +M                      C+++ P QRP    +++
Sbjct: 228 LVTPSCKELADLMT--------------------HCMNYDPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 54/179 (30%), Positives = 75/179 (41%), Gaps = 32/179 (17%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGDDTHVSTRVMG 249
           + L ++H A   V +RD K  NIL ++D   K+ DFGLA+    D P        T  + 
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVA 168

Query: 250 TQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGR-----KSVDKS---------RPQ 293
           T+ Y APE   +     T   D++S G +  E+L+G+     K+V             P 
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228

Query: 294 REQ-SLV--EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
            E  S V  E AR  L+  RK      P    Q        A  L  + L+  PK RPT
Sbjct: 229 PETISRVRNEKARRYLSSMRK----KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 37/197 (18%)

Query: 112 VAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-------------- 157
           VAVK + L   Q  +  L E+  + +L H ++VK+          L              
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 158 LVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS 214
           +V EYM       LE          L             +GL ++H A   V++RD K +
Sbjct: 93  IVQEYMETDLANVLEQGPLSEEHARL-------FMYQLLRGLKYIHSAN--VLHRDLKPA 143

Query: 215 NILLDS-DYTAKLSDFGLAKDGPEGDDTHVS-----TRVMGTQGYAAPEYVMT-GHLTSM 267
           N+ +++ D   K+ DFGLA+      D H S     +  + T+ Y +P  +++  + T  
Sbjct: 144 NVFINTEDLVLKIGDFGLARIV----DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199

Query: 268 SDVYSFGVVLLELLSGR 284
            D+++ G +  E+L+G+
Sbjct: 200 IDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 28/229 (12%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L QL+HP++V        E+  L +V  +   G L ++L  +    LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
           +  A  L +LH  EK +++RD K  N+ L      K+ D G+A+      D  +++ ++G
Sbjct: 109 VQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIG 164

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
           T  Y +PE          SDV++ G  + E+ + + + +    +   SLV          
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA---KDMNSLVY--------- 212

Query: 310 RKLGRIMD---PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
               RI++   P +   YS     +   L    LS RP++RP++ ++++
Sbjct: 213 ----RIIEGKLPPMPKDYS----PELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST-RVMGTQ 251
           A G+ FL  A K  ++RD  A N+L+      K+ DFGLA+D    D  ++S        
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLPL 305

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            + APE +     T++SDV+SFG++L E+ +
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 43/219 (19%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQL 138
           N + EG +G V++    DK       + VA+K L +E     +E      L E+  L +L
Sbjct: 11  NRIEEGTYGVVYRA--RDKK----TGEIVALKKLKMEK---EKEGFPITSLREINILLKL 61

Query: 139 RHPHLVKLIGYCCEE-------EHRLLVYEYMP---RGSLEN--QLFRRYSVSLPWSTRM 186
           +HP++V +     +E       +   +V EY+    +  +E   Q F +  V       M
Sbjct: 62  QHPNIVTV-----KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK----CLM 112

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
              L    G+A LHD    +++RD K SN+LL++    K+ DFGLA+    G      T+
Sbjct: 113 LQLL---SGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQ 165

Query: 247 VMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           ++ T  Y APE ++     ++  D++S G +  ELL+ +
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 60/224 (26%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQLRH 140
           LGEG +  V+KG      R  L  Q VA+K + LE    H E      + E   L  L+H
Sbjct: 13  LGEGSYATVYKG------RSKLTGQLVALKEIRLE----HEEGAPFTAIREASLLKDLKH 62

Query: 141 PHLVKLIGYCCEEEHRLLVYEYM-----------PRG-SLEN------QLFRRYSVSLPW 182
            ++V L      ++   LV+EY+             G S+ N      QL R        
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------- 114

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                       GLA+ H   + V++RD K  N+L+      KL+DFGLA+       T+
Sbjct: 115 ------------GLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160

Query: 243 VSTRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGR 284
            +  V  T  Y  P+ ++  T + TS+ D++  G +  E+ +GR
Sbjct: 161 SNEVV--TLWYRPPDVLLGSTEYSTSL-DMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQ 137
           S+     LGEG +  V+KG      +  +  + VA+K + L+  +G     + E   L  
Sbjct: 6   SYEKLEKLGEGSYATVYKG------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG 59

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L+H ++V L      +E   LV+EY+       Q   ++   L             +GL+
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYVHTDLC--QYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           ++H  ++ +++RD K  N+L+      KL+DFGLA+   +   +H  +  + T  Y  P+
Sbjct: 118 YIH--QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173

Query: 258 YVM-TGHLTSMSDVYSFGVVLLELLSG 283
            ++ +   ++  D++  G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            GL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+      D  ++  V+ T+ Y
Sbjct: 128 CGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA----DAEMTGYVV-TRWY 180

Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ E+L+G+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH-PHLV 144
           +GEG +G V+K    DK    L A       +D EG+      L E+  L  L    ++V
Sbjct: 9   IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64

Query: 145 KLIGYCCEEEHR-----LLVYEYMPRG--SLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           +L+     EE        LV+EY+        +   R     LP  T         KG+A
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDG--PEGDDTHVSTRVMGTQGYA 254
             H  +  V++RD K  N+L+D      K++D GL +    P    TH     + T  Y 
Sbjct: 125 HCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWYR 178

Query: 255 APEYVMTG-HLTSMSDVYSFGVVLLELLSG 283
           APE ++   H ++  D++S G +  E+   
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPG-----LQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH 140
           LG+G FG V+    D K         L+  PV   N + E +Q +     E   L +L H
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPN-ETVQAN----QEAQLLSKLDH 61

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAAKGLAF 198
           P +VK      E +   ++ EY     L+ +L   +    +L  +   +  +    G+ +
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H  ++ +++RD KA NI L ++   K+ DFG+++      D  ++T   GT  Y +PE 
Sbjct: 122 MH--QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEA 176

Query: 259 VMTGHLTSMSDVYSFGVVLLEL 280
           +      S SD++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+         + T  + T+ Y 
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)

Query: 129 LTEVIFLGQLR-HPHLVKLIGYCCEEEH-RL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
           L E+  L +L  HP++++LI    + +  RL LV+E M     E    R+    LP    
Sbjct: 45  LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRV 102

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
                   K L  +H     + +RD K  NIL+  D   KL+DFG  +           T
Sbjct: 103 KSYMYQLLKSLDHMH--RNGIFHRDIKPENILIK-DDILKLADFGSCRG---IYSKPPYT 156

Query: 246 RVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLS 282
             + T+ Y APE ++T G+     D+++ G V  E+LS
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++  V+ T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYR 192

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 46/192 (23%), Positives = 71/192 (36%), Gaps = 54/192 (28%)

Query: 135 LGQLRHPHLVKLIGYCC--EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI---- 188
           L +  +P +VKL  Y    +E +  L+ EY+P G +   L ++ + +    TR  I    
Sbjct: 55  LAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETI 111

Query: 189 -ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-------------- 233
            A+ +   L ++H        RD K  N+LLD+    KLSDFGL                
Sbjct: 112 LAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 234 DGPEGDDTHVSTR----------------------VMGTQGYAAPEYVMTGHLTSMSDVY 271
                 +                             +GT  Y APE  +        D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 272 SFGVVLLELLSG 283
           S GV++ E+L G
Sbjct: 224 SLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 63/258 (24%), Positives = 103/258 (39%), Gaps = 59/258 (22%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQG-HREWLTEVIFLGQLRHPH 142
           +G+GG G V+  +  D +     ++ VA+K +  DL       + +L E      L HP 
Sbjct: 10  IGKGGMGEVYLAY--DPV----CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 143 LVKLIGYCCEEEHRLLVYEYMP--RGSLENQLFR--RYSVSLPWSTRMKIALGA------ 192
           +V +   C + +    VY  MP   G     L +      SL      K ++GA      
Sbjct: 64  IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 193 --AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGDDTHVST--- 245
                + ++H   K V++RD K  NILL       + D+G A  K   E D   +     
Sbjct: 121 KICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 246 -----------RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS---------GRK 285
                      +++GT  Y APE ++    +  +D+Y+ GV+L ++L+         GRK
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 286 SVDKSR--------PQRE 295
              +          P RE
Sbjct: 239 ISYRDVILSPIEVAPYRE 256

Length = 932

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 23/160 (14%)

Query: 140 HPHLVKLIGYCCEE--EHRLLVYEYMPRGSLENQLFRRYSVSLPWST-RMKIALGAAKGL 196
           +P +V +  +C  E   H  +V EY+  G     L  +   +LP    RM  A      L
Sbjct: 60  NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFA-ETVLAL 114

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG--------PEGD---DTH--V 243
            +LH+    +++RD K  N+L+ S    KL+DFGL+K G         EG    DT   +
Sbjct: 115 EYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             +V GT  Y APE ++        D ++ G++L E L G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTR---- 185
           E++ LG+L H +++K+     EE  R     YM     +  L+   Y  +  W  R    
Sbjct: 213 EILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 186 -----MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD 240
                MK  L A   + ++HD  K +I+RD K  NI L+ D    L DFG A    E + 
Sbjct: 268 QTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKER 321

Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  +GT    +PE +       ++D++S G++LL++LS
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 52/192 (27%), Positives = 77/192 (40%), Gaps = 49/192 (25%)

Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP-- 181
           G R W+T + +  Q              +E +  LV +Y   G L   L  ++   LP  
Sbjct: 58  GDRRWITNLHYAFQ--------------DENNLYLVMDYYVGGDLLT-LLSKFEDRLPED 102

Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAK 233
               +   M +A+ +   L ++H        RD K  N+LLD +   +L+DFG    L  
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLA 154

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           DG     T  S   +GT  Y +PE +       G      D +S GV + E+L G     
Sbjct: 155 DG-----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET--- 206

Query: 289 KSRPQREQSLVE 300
              P   +SLVE
Sbjct: 207 ---PFYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 43/300 (14%)

Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           L+ L+     F     +G G +G V+KG      R     Q  A+K +D+   +   E  
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTEDE-EEEIK 60

Query: 130 TEVIFLGQL-RHPHLVKLIGYCCE------EEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182
            E+  L +   H ++    G   +      ++   LV E+   GS+ + +      +L  
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                I     +GLA LH  +  VI+RD K  N+LL  +   KL DFG++       D  
Sbjct: 121 DWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRT 174

Query: 243 VSTR--VMGTQGYAAPEYVMTGH-----LTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE 295
           V  R   +GT  + APE +             SD++S G+  +E+  G   +    P R 
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234

Query: 296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             L+    P             P+L+   S+  ++K       CL      RP+   ++K
Sbjct: 235 LFLIPRNPP-------------PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 63/272 (23%), Positives = 103/272 (37%), Gaps = 59/272 (21%)

Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GH----REWLTEV 132
           + F S   +G G FG V    +  K    + A  +  K   LE  Q GH    R+ L E 
Sbjct: 1   EDFESLKVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP----WSTRMKI 188
             L       +VK+     ++ +  L+ E++P G +   L ++ +++      +     +
Sbjct: 59  DSL------WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT------- 241
           A+ +   L F+H        RD K  N+LLDS    KLSDFGL     +   T       
Sbjct: 113 AIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN 164

Query: 242 --------------------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGV 275
                                      ++   +GT  Y APE  M      + D +S GV
Sbjct: 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224

Query: 276 VLLELLSGRKSVDKSRPQRE-QSLVEWARPML 306
           ++ E+L G        PQ   + ++ W   ++
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKVMNWKETLI 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 61/256 (23%), Positives = 94/256 (36%), Gaps = 58/256 (22%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-----GHREWLTEVIF 134
           F S   +G G FG V    +  K    + A  +  K   LE  Q       R+ L E   
Sbjct: 3   FESLKVIGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-- 58

Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP----WSTRMKIAL 190
                   +VK+     ++ +  L+ E++P G +   L ++ ++S      +     +A+
Sbjct: 59  ----DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA---------------KDG 235
            A   L F+H        RD K  N+LLD+    KLSDFGL                   
Sbjct: 115 DAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 236 PEGDDT------------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVL 277
           P  D +                   ++   +GT  Y APE  M      + D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 278 LELLSGRKSVDKSRPQ 293
            E+L G        PQ
Sbjct: 227 YEMLIGYPPFCSETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 38/218 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQL-RHPHL 143
           +G+G +G V+K  + +K + G  A   AVK LD +  +    E   E   L  L  HP++
Sbjct: 30  IGKGTYGKVYK--VTNK-KDGSLA---AVKILDPISDVDEEIE--AEYNILQSLPNHPNV 81

Query: 144 VKLIGYCCEEEHRL-----LVYEYMPRGS---LENQLFRRYSVSLPWSTRMKIALGAAKG 195
           VK  G   + +  +     LV E    GS   L   L       L  +    I  GA  G
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLG 140

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV-----MGT 250
           L  LH+    +I+RD K +NILL ++   KL DFG++           STR+     +GT
Sbjct: 141 LQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTSVGT 191

Query: 251 QGYAAPEYVMTGHLTSMS-----DVYSFGVVLLELLSG 283
             + APE +        S     DV+S G+  +EL  G
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 35/171 (20%)

Query: 152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLP------WSTRMKIALGAAKGLAFLHDAEKP 205
           +E +  LV +Y   G L   L  ++   LP      +   M +A+ +   L ++H     
Sbjct: 72  DENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH----- 125

Query: 206 VIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
              RD K  N+LLD +   +L+DFG    + +DG     T  S+  +GT  Y +PE +  
Sbjct: 126 ---RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQA 177

Query: 262 -----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                G      D +S GV + E+L G        P   +SLVE    ++N
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 36/185 (19%)

Query: 144 VKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLP------WSTRMKIALGAAKGL 196
           +  + Y  ++E+ L LV +Y   G L   L  ++   LP      +   M IA+ +   L
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQG 252
            ++H        RD K  NIL+D +   +L+DFG    L +DG     T  S+  +GT  
Sbjct: 122 HYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168

Query: 253 YAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
           Y +PE +       G      D +S GV + E+L G        P   +SLVE    ++N
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKIMN 222

Query: 308 DARKL 312
              + 
Sbjct: 223 HKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 6/158 (3%)

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           TE   L  + HP +++L G     +   L+   +PR   +   +     ++     + I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
               + + +LH  E  +I+RD KA NI ++      L DFG A   P   + +      G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
           T    APE +         D++S G+VL E+ +   S+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 71/339 (20%), Positives = 118/339 (34%), Gaps = 103/339 (30%)

Query: 152 EEEHRLLVYEYMPRGSLENQLFR----RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVI 207
           ++++   V +Y+P G + + L R       ++  +   +  A+ +   + F+H       
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH------- 124

Query: 208 YRDFKASNILLDSDYTAKLSDFGL--------------AKDGPEGDDTHVSTR------- 246
            RD K  NIL+D D   KL+DFGL              + D    D    S         
Sbjct: 125 -RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 247 ------------------------VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                                   ++GT  Y APE ++    T + D +S GV+L E+L 
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243

Query: 283 GRKSVDKSRPQREQ-SLVEWA-----------RPMLND-ARKLGRIMDPRLEGQYSETGA 329
           G+       P   Q  ++ W             P  +D   KL R  + RL     + GA
Sbjct: 244 GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRL----GKNGA 299

Query: 330 RKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNE 389
            +  A  +                 KT++   D     A      T PT++SN D  + +
Sbjct: 300 DEIKAHPF----------------FKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPD 343

Query: 390 DLKECEAKKETKKEKGNHRQNHKLHNDIVNGRRRHMRSP 428
            L   + K+                ND +NG  ++ + P
Sbjct: 344 KLWSDDDKEGN-------------VNDTLNGWYKNGKHP 369

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 68/214 (31%)

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR---------RYSVSLPWSTRMKIALGAA 193
           +VKL     ++++   V +Y+P G + + L R         R+ ++      + +A+ + 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-----ELTLAIESV 117

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA-------------------KD 234
             + F+H        RD K  NIL+D D   KL+DFGL                    +D
Sbjct: 118 HKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 235 GPEGDD-----------------------TH---VSTRVMGTQGYAAPEYVMTGHLTSMS 268
             E  D                        H   ++  ++GT  Y APE ++    T + 
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229

Query: 269 DVYSFGVVLLELLSGRKSVDKSRPQREQ-SLVEW 301
           D +S GV+L E+L G+       P   Q  ++ W
Sbjct: 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 60/268 (22%), Positives = 92/268 (34%), Gaps = 88/268 (32%)

Query: 207 IYRDFKASNILLDSDYTAKLSDFGLA-------------------KDGPEGDDTHVS--- 244
           I+RD K  NIL+D D   KL+DFGL                    +D  E  +       
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 245 --------------TRVM-----GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
                          R +     GT  Y APE ++ TG+ T + D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 241

Query: 285 KSVDKSRP-QREQSLVEW------------ARPMLNDARKLGRIMDPRLEGQYSETGARK 331
                  P + +  ++ W            +R   +   +L    + RL       G   
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRL-------GKNG 294

Query: 332 AAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDI----AIGTFVFTVPTESSNNDKNN 387
           A  +         K  P    +        DF   I    A      T PT++SN D  +
Sbjct: 295 ADEI---------KAHPFFKGI--------DFASLIRRQKAPYIPKITHPTDTSNFDPVD 337

Query: 388 NEDLKECEAKKETK----KEKGNHRQNH 411
            E L+  ++ + +     K     R  H
Sbjct: 338 PEKLRSDDSGESSPDRNVKPNNRKRTEH 365

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V+K     K + G   +  A+K ++  G+        E+  L +L+HP+++ 
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62

Query: 146 LIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYS------VSLPWSTRMKIALGAAKGLA 197
           L         R   L+++Y          F R S      V LP      +      G+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYT----AKLSDFGLAK--DGPEGDDTHVSTRVMGTQ 251
           +LH     V++RD K +NIL+  +       K++D G A+  + P      +   V+ T 
Sbjct: 123 YLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 252 GYAAPEYVMTG-HLTSMSDVYSFGVVLLELLS 282
            Y APE ++   H T   D+++ G +  ELL+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V+K     K + G   +  A+K ++  G+        E+  L +L+HP+++ 
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62

Query: 146 LIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYS------VSLPWSTRMKIALGAAKGLA 197
           L         R   L+++Y          F R S      + LP S    +      G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYT----AKLSDFGLAK--DGPEGDDTHVSTRVMGTQ 251
           +LH     V++RD K +NIL+  +       K++D G A+  + P      +   V+ T 
Sbjct: 123 YLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 252 GYAAPEYVMTG-HLTSMSDVYSFGVVLLELLS 282
            Y APE ++   H T   D+++ G +  ELL+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 19/186 (10%)

Query: 112 VAVKNLDLEGL-QGHREWL-TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLE 169
           V V+  DLE   + H + L  EV+     RHP+++             ++  +M  GS  
Sbjct: 28  VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87

Query: 170 NQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD- 228
           + L   +   +  +    I  GA +GL +LH  +   I+R+ KAS+IL+  D    LS  
Sbjct: 88  SLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGL 145

Query: 229 ---FGLAKDGPEG----DDTHVSTRVMGTQGYAAPEYV---MTGHLTSMSDVYSFGVVLL 278
              + L ++G +     D    ST V     + +PE +   + G+    SD+YS G+   
Sbjct: 146 SHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGY-NVKSDIYSVGITAC 201

Query: 279 ELLSGR 284
           EL +GR
Sbjct: 202 ELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 9/108 (8%)

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
           A  GL  LH      I+RD K +NILL ++   KL DFG++               +GT 
Sbjct: 133 ALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTP 188

Query: 252 GYAAPEYV-----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR 294
            + APE +     +     +  DV+S G+  +EL  G   +    P R
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 43/177 (24%), Positives = 61/177 (34%), Gaps = 61/177 (34%)

Query: 158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA-----LGAAKGLAFLHDAEKPVIYRDFK 212
           L+ E++P G L   L + Y       TR  +A     + A   L F+H        RD K
Sbjct: 78  LIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIH--------RDIK 128

Query: 213 ASNILLDSDYTAKLSDFGL---------------------AKDGPEGDDTHV-------- 243
             NIL+D     KLSDFGL                      K+  +  ++          
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188

Query: 244 -----------STRVM-----GTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
                      + R+M     GT  Y APE +          D +S G ++ E L G
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	455
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
smart00090	237	RIO RIO-like kinase.	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.37
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.37
KOG1243	690	consensus Protein kinase [General function predict	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.77
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.75
PRK09902	216	hypothetical protein; Provisional	98.71
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.53
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.44
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.31
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.11
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.1
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.05
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.96
PRK10593	297	hypothetical protein; Provisional	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.89
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.81
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.8
PRK05231	319	homoserine kinase; Provisional	97.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.64
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.61
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.52
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.36
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.33
PLN02236	344	choline kinase	97.13
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.06
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.02
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.86
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.82
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.76
PLN02756	418	S-methyl-5-thioribose kinase	96.72
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.66
KOG2270	520	consensus Serine/threonine protein kinase involved	96.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.46
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.39
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.35
PTZ00384	383	choline kinase; Provisional	96.09
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.06
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.92
PRK12396	409	5-methylribose kinase; Reviewed	95.79
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.61
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.23
PTZ00296	442	choline kinase; Provisional	94.67
PRK11768	325	serine/threonine protein kinase; Provisional	94.6

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-53  Score=417.40  Aligned_cols=289  Identities=61%  Similarity=0.990  Sum_probs=251.8

Q ss_pred             CCcccchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc
Q 012832           64 NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL  143 (455)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI  143 (455)
                      ..+.|++.++..+|++|...+.||+|+||.||+|.+.+       +..||||++.........+|.+|+.+|.+++|||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            67789999999999999999999999999999998765       36899998876543315569999999999999999


Q ss_pred             ccEEEEEEeCC-eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC-CCeEEeccCCCCEEEcCC
Q 012832          144 VKLIGYCCEEE-HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE-KPVIYRDFKASNILLDSD  221 (455)
Q Consensus       144 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-~~iiHrDlkp~Nill~~~  221 (455)
                      |+++|||.+.+ ..+||+|||++|+|.++|.......++|..+++||.++|.||+|||... ++||||||||+|||||++
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999999998 5999999999999999998764338899999999999999999999854 379999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      +.+||+|||+|+..+.. .....+...||.+|+|||++..+..+.++||||||++|+||++|+.|.+...+.....++.|
T Consensus       214 ~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            99999999999776542 11111111799999999999999999999999999999999999999987766667779999


Q ss_pred             hhhhhHhhhhhcccCCCccc-CCCCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          302 ARPMLNDARKLGRIMDPRLE-GQYSE-TGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      +.+.+... .+.+++|+.+. ..++. .....+..++.+|++.+|.+||+|.++++.|+.+.
T Consensus       293 ~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  293 AKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            98877765 88899999987 66664 57778999999999999999999999999985543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-52  Score=387.99  Aligned_cols=257  Identities=27%  Similarity=0.376  Sum_probs=213.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..+.+..+.||+|..|+||++      .++.+++.+|+|++..+ .....+++.+|+++++..+|||||.+||.|..+..
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKV------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEE------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            345667888999999999999      45668999999999544 33455778999999999999999999999999994


Q ss_pred             -EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          156 -RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       156 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                       ..|+||||++|+|.+++...  +.+++.....++.+|++||.|||.. ..||||||||+||||+..|.|||||||++..
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence             99999999999999987654  6799999999999999999999962 3399999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCc--cchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP--QREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ....    ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+  .....+..            
T Consensus       229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~------------  292 (364)
T KOG0581|consen  229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC------------  292 (364)
T ss_pred             hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH------------
Confidence            6543    34558899999999999999999999999999999999999999976411  11111111            


Q ss_pred             cccCCCcccCCCCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSE-TGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                       .+.+.. +...+. .++.++++++..||++||.+|||+.|+++|-+-.
T Consensus       293 -~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  293 -AIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             -HHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence             122211 122333 3788999999999999999999999999995433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=388.67  Aligned_cols=258  Identities=26%  Similarity=0.363  Sum_probs=209.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-------hHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-------GHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      ..+-|.+.+.||+|+||.|-+|+      .+.+++.||||+++.....       ......+|+++|++|+|||||++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~------e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAY------EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEE------EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence            34568889999999999999995      3457999999998654221       2233568999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC---CceE
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAK  225 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~---~~~k  225 (455)
                      ++..++..||||||++||+|.+.+..+  +.+.+..-..++.|++.|+.|||++|  |+||||||+|||+..+   ..+|
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEE
Confidence            999999999999999999999999876  56777788899999999999999977  9999999999999766   7899


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCC---CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH---LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      |+|||+|+...+.   ..+.+.|||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.......  .+.+..
T Consensus       320 ItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI  394 (475)
T KOG0615|consen  320 ITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQI  394 (475)
T ss_pred             ecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHH
Confidence            9999999987643   3456689999999999998764   3458899999999999999999997643221  111110


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         ...    ..    .+........+.++.+||.+||..||++|||+.|+++|.|.
T Consensus       395 ---~~G----~y----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~  440 (475)
T KOG0615|consen  395 ---LKG----RY----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF  440 (475)
T ss_pred             ---hcC----cc----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence               000    00    11123345678899999999999999999999999999664

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-50  Score=400.00  Aligned_cols=251  Identities=26%  Similarity=0.377  Sum_probs=214.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..|...++||+|||+.||.+...      .++..||+|++...   .....+.+.+|+++.+.|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDL------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEc------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            56999999999999999999543      46889999999653   3344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      +.|||.|+|..++|..++.++  +.+++.++..++.||+.||.|||+++  |||||||..|+||+++.+|||+|||||..
T Consensus        92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeee
Confidence            999999999999999988744  78999999999999999999999977  99999999999999999999999999998


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ....+..  ..+.||||.|.|||++....++..+||||+||+||.||+|+|||+...-.      +....+.    ..  
T Consensus       168 le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------ety~~Ik----~~--  233 (592)
T KOG0575|consen  168 LEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------ETYNKIK----LN--  233 (592)
T ss_pred             ecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------HHHHHHH----hc--
Confidence            7655433  34489999999999999999999999999999999999999999864221      1111111    10  


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            .-.+|...+.++.+||.++|+.+|.+|||+++|+.|-.
T Consensus       234 ------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F  271 (592)
T KOG0575|consen  234 ------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF  271 (592)
T ss_pred             ------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence                  11234466788999999999999999999999999843

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-50  Score=379.29  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=208.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..+|.+.+.||.|+||+||+|.+++      ++..||||.+...  .....+-+..|+.+|+.++|||||.+++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            4678889999999999999996544      5789999998766  4455566789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC------CceEEcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD------YTAKLSD  228 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~------~~~kL~D  228 (455)
                      .+|||||||.||+|.++|..+  ..+++.++..++.||+.||++||+.+  ||||||||+||||+..      -.+||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999999999999876  58999999999999999999999966  9999999999999764      4689999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ||+|+.+.+...   ..+.||++.|||||+++.+.|+.|+|+||+|+++|++++|++||+...+.+....+...      
T Consensus       159 FGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~------  229 (429)
T KOG0595|consen  159 FGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG------  229 (429)
T ss_pred             cchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc------
Confidence            999998875433   34589999999999999999999999999999999999999999876554333222111      


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                               ......++...+....+|+...++.+|.+|-++.+...+
T Consensus       230 ---------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  230 ---------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             ---------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                     111112233334455678888888888888877776655

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-50  Score=393.32  Aligned_cols=259  Identities=33%  Similarity=0.542  Sum_probs=212.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCccccc-EEEEeccccchhh--HHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQP-VAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ...+.+.+.||.|+||+||+|.+.        ++. ||||++.......  ...|.+|+.+|.+++|||||+++|+|..+
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            344455566999999999999664        445 9999987543322  56899999999999999999999999988


Q ss_pred             C-eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCC
Q 012832          154 E-HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGL  231 (455)
Q Consensus       154 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGl  231 (455)
                      . .++|||||+++|+|.+++.......+++..++.++.|||+||.|||+.++ ||||||||+||||+.++ ++||+|||+
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcc
Confidence            7 79999999999999999987545789999999999999999999999655 99999999999999998 999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccc--cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ++......  ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||....+.....            
T Consensus       191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~------------  256 (362)
T KOG0192|consen  191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS------------  256 (362)
T ss_pred             ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH------------
Confidence            98654422  1123367999999999999  5689999999999999999999999998765411110            


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          .+........++..++..+..||.+||..+|..||++.+++..|+.+..
T Consensus       257 ----~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  257 ----AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ----HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                0111122333444578889999999999999999999999999987654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-50  Score=364.94  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEE-EEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIG-YCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~-~~~~~  153 (455)
                      ..+|.+.+.||.|+||+||++.      +..++..||.|.+..+..  ...+.+..|+.+|++|+|||||++++ .+.++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~------~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~   91 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQ------CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED   91 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEee------eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence            3467888999999999999994      455788999999876543  44567889999999999999999999 44444


Q ss_pred             Ce-EEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC--eEEeccCCCCEEEcCCCceEEcc
Q 012832          154 EH-RLLVYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAAKGLAFLHDAEKP--VIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 ~~-~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      .. ++||||||++|+|...|..  .....+++.++|+++.|++.||..+|..-+.  |+||||||.||+|+.+|.+||+|
T Consensus        92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            44 8999999999999998853  3457899999999999999999999983333  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |||++.+...  +......+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+..-      ......    
T Consensus       172 fGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~K----  239 (375)
T KOG0591|consen  172 FGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKK----  239 (375)
T ss_pred             chhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHH----
Confidence            9999987543  2234457899999999999999999999999999999999999999987522      111111    


Q ss_pred             hhhhcccCCCcccCCCC-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ARKLGRIMDPRLEGQYS-ETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         +..   .. ....+ ...+.++..|+..|+..||+.||+...++..+
T Consensus       240 ---I~q---gd-~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  240 ---IEQ---GD-YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ---HHc---CC-CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence               111   11 11223 66788999999999999999999855555443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=371.59  Aligned_cols=253  Identities=27%  Similarity=0.384  Sum_probs=211.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +..++|.+.++||+|+||+||.+...      .+++.+|+|+++....   ...+....|..+|..++||+||+++..|+
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKK------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEc------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            45688999999999999999999544      4789999999976543   33466788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      +.+.+|||+||+.||.|.-+|.+.  ..+++..+..++..|+.||.|||+.+  ||||||||+|||||.+|+++|+||||
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEecccc
Confidence            999999999999999999998765  68999999999999999999999966  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ++.....+..  +.++|||+.|||||++.+..|+..+|+||||+++|||++|.+||...+..      .+...+...   
T Consensus       172 ~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~---  240 (357)
T KOG0598|consen  172 CKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKG---  240 (357)
T ss_pred             chhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcC---
Confidence            9965554333  44589999999999999999999999999999999999999999865432      222222111   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC----CHHHHHHh
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP----TMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP----t~~ell~~  356 (455)
                             . ...++...+.++++++.++|..+|++|.    ++.+|.+|
T Consensus       241 -------k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  241 -------K-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             -------c-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                   1 1112333567899999999999999995    56666665

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-49  Score=382.65  Aligned_cols=258  Identities=33%  Similarity=0.459  Sum_probs=216.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ...+.+.+.||+|-||.||+|.++..       ..||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|..++.+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-------~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-------TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-------CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            33455678899999999999987653       37999998754 34457788999999999999999999999998999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      +||||||+.|+|.++|....+..+...+.+.++.|||+||+||.+++  +|||||.+.||||+++..+||+|||||+.. 
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-  353 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLI-  353 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccccc-
Confidence            99999999999999999866788999999999999999999999966  999999999999999999999999999943 


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .++.........-...|+|||++..+.++.+||||||||+||||+| |+.|+.+....+....++               
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le---------------  418 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE---------------  418 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh---------------
Confidence            3333223333345668999999999999999999999999999999 999998765433332222               


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        ...+-..|..||.++.+||..||..+|++|||++.+...|+.+..
T Consensus       419 --~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  419 --RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence              222334577899999999999999999999999999888876643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.5e-49  Score=356.54  Aligned_cols=266  Identities=26%  Similarity=0.366  Sum_probs=210.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      +.|+....+|+|+||.||++      +++.+|+.||||++...  +..-.+-.++|+.+|++|+|+|+|.++.+|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KC------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKC------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEe------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            35778889999999999999      56778999999998432  22333556899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||+|||+. ++.+.|... ...++...+.+++.|++.|+.|+|+++  ||||||||+||||+.+|.+||||||+|+..
T Consensus        76 lhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   76 LHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhh
Confidence            9999999966 555556554 457889999999999999999999987  999999999999999999999999999987


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hhhhHhhhhh-
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RPMLNDARKL-  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~-  312 (455)
                      ...+.  ..+..+.|.||.|||.+.| ..|+..+||||+||++.||++|.+.|.+.+..++...+... .+++.....+ 
T Consensus       152 ~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  152 SAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             cCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence            64332  3556789999999999988 57999999999999999999999999998766555544422 1111111111 


Q ss_pred             ------cccC--CC----cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          313 ------GRIM--DP----RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       313 ------~~~~--~~----~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                            ..+.  .+    .++..|+ ..+.-+.+|+..||+.||++|++.++++.|
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                  0000  00    1111222 234478899999999999999999999988

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-48  Score=374.84  Aligned_cols=256  Identities=27%  Similarity=0.341  Sum_probs=214.2

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh---HHHHHHHHHHHhcC-CCCCcccEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEVIFLGQL-RHPHLVKLIGY  149 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~~~  149 (455)
                      ....++|.+++.||.|+|++|++|+      ++.+++.||||++...-...   ..-...|-++|..| .||+|++|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~------~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAR------EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEee------ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            4567899999999999999999994      34578999999986543321   12345788899999 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      |.++..+|+|+||+++|+|.++|.+.  +.|++..+..++.+|+.||+|||++|  ||||||||+|||||.+|+++|+||
T Consensus       143 FQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  143 FQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             eecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeec
Confidence            99999999999999999999999876  68999999999999999999999977  999999999999999999999999


Q ss_pred             CCccCCCCCCCc---------cc--eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH
Q 012832          230 GLAKDGPEGDDT---------HV--STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL  298 (455)
Q Consensus       230 Gla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~  298 (455)
                      |.|+.+......         ..  ...++||..|.+||++..+..+..+|||+||||||+|+.|.+||.+.++...   
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---  295 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---  295 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---
Confidence            999876543221         11  1448999999999999999999999999999999999999999987643211   


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         .+.+          +.  +.-.+++..+..+.+|+.++|..||++|+|.++|.+|.
T Consensus       296 ---FqkI----------~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 ---FQKI----------QA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ---HHHH----------HH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence               1111          11  12245666678899999999999999999999999984

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-47  Score=367.94  Aligned_cols=268  Identities=26%  Similarity=0.325  Sum_probs=213.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .+.|+.++.||+|.||.||+|      ++..+++.||+|++.++.  ........+||.||++|+||||+++.+...+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkA------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKA------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEe------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            456888999999999999999      445678999999997765  34446678999999999999999999998877 


Q ss_pred             -CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          154 -EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       154 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                       ..+|||+|||+. +|.-++. .....|++.++..++.||+.||+|||..+  |+|||||.+|||||.+|.+||+|||||
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             CceEEEEEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccce
Confidence             689999999965 8887654 44678999999999999999999999966  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-----hhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-----PML  306 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-----~~~  306 (455)
                      +++....... .+..+-|.||.|||++.|. .|+..+|+||+||||.||+.|++.|.+..+..+...+--.-     ..+
T Consensus       266 r~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9876655443 4456789999999999875 59999999999999999999999999987665555443110     000


Q ss_pred             Hhhhhhc--ccCCCccc-----CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          307 NDARKLG--RIMDPRLE-----GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       307 ~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      . ..++.  ..+.+...     .+.....+..+.+|+..+|..||.+|.|+.+++++
T Consensus       345 ~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  345 P-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             c-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            0 00111  11111100     00122345678899999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=363.97  Aligned_cols=258  Identities=28%  Similarity=0.421  Sum_probs=208.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE--  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  154 (455)
                      ..+|...+.||+|+||.||++...+      ++...|||.+........+.+.+|+.+|.+|+|||||+++|......  
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~   89 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKK------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREND   89 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecC------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence            4568889999999999999996544      37889999987664333566889999999999999999999754444  


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~  233 (455)
                      .++++|||+++|+|.+++....+ .+++..+..++.||++||+|||+++  ||||||||+||||+. ++.+||+|||++.
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccc
Confidence            68999999999999999887655 8999999999999999999999866  999999999999999 7999999999998


Q ss_pred             CCCCCCC-ccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCC-CccchhhHHHhhhhhhHhhh
Q 012832          234 DGPEGDD-THVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKS-RPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       234 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~-~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ....... ........||+.|||||++..+ ...+++|||||||++.||+||.+||... ..      ..+.        
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~~~~--------  232 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------AEAL--------  232 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------HHHH--------
Confidence            7653111 1112336799999999999864 3445999999999999999999999753 11      1110        


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        ..+........++...+.++.+++.+|+..+|++|||+.++++|...
T Consensus       233 --~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  233 --LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             --HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence              01111111225667788899999999999999999999999999543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=365.71  Aligned_cols=269  Identities=25%  Similarity=0.324  Sum_probs=216.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHH-HHHHHHHHhcCC-CCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLR-HPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||.|+||.||+|.      ...++..||||.++.......+- -++|+..|++|+ ||||+++.+++.+.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~------~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAK------SKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEee------ecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            35689999999999999999994      34467789999987544332221 258999999999 99999999999888


Q ss_pred             C-eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          154 E-HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       154 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      + .+++||||| ..+|++++..+ ...|++..+..|+.||+.||+|+|.+|  +.|||+||+||||..+..+||+|||+|
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccc
Confidence            8 999999999 57999988877 789999999999999999999999988  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccc-cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-----hhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-----PML  306 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-----~~~  306 (455)
                      +......   ..+..+.|.||.|||++. .+.|+.+.|+|++|||++|+.+-++.|.+.++.++...+.-+.     ..+
T Consensus       158 Rev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  158 REVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             cccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            9765433   355678999999999885 5679999999999999999999999999887655544433110     011


Q ss_pred             HhhhhhcccCCCcccC-------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDPRLEG-------QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .....+...|+-.++.       ..-..++.++.+||.+||..||++|||+.++++|.
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1112222233322221       12233678999999999999999999999999984

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=355.80  Aligned_cols=266  Identities=27%  Similarity=0.370  Sum_probs=218.1

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH-HHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ...+.|.+...||.|..+.||+|....      ++..||||+++.+..... ..+.+|+..|+.++||||++++..|..+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIP------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecc------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            346789999999999999999996544      568999999988766554 7788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ..+|+||.||.+|++.+.+...+...+++..+..|..++++||.|||.+|  .||||||+.||||+.+|.|||+|||++.
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeee
Confidence            99999999999999999999988889999999999999999999999977  9999999999999999999999999987


Q ss_pred             CCCCCCCccc-e-eccccCCCCcCccccc--cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          234 DGPEGDDTHV-S-TRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       234 ~~~~~~~~~~-~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      .....+.... . ....||++|||||+++  ...|+.|+||||||++.+||.+|..||..+.+.....+.-...+..   
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~---  251 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT---  251 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC---
Confidence            6554442211 1 4578999999999964  3569999999999999999999999999887654332211111100   


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        .   .-..+...-....+..+..++..||+.||.+|||+++++++
T Consensus       252 --~---~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 --L---LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             --c---ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence              0   00001111122345578999999999999999999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=370.01  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=218.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ..|.....||+|+.|.||.|.      ...+++.||||++++......+-+++|+.+|+..+|+|||.+++.|...+.+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~------~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVAR------KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhcchhhhccccccceeeee------eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            457788899999999999994      34467789999998887777788899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +|||||+||+|.|.+...   .+++.++..|+.+++.||+|||..+  |||||||.+|||++.+|.+||+|||++.+...
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999988654   5899999999999999999999976  99999999999999999999999999998776


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ....  ..+.+|||.|||||++....|++++||||||++++||+-|.+||-...+.+...++..               +
T Consensus       422 ~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---------------n  484 (550)
T KOG0578|consen  422 EQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------N  484 (550)
T ss_pred             ccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---------------c
Confidence            5542  4558899999999999999999999999999999999999999976555444433321               1


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ....-..++..+..+.+|+.+||+.|+++||++.|||+|
T Consensus       485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            122334466678899999999999999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=338.15  Aligned_cols=249  Identities=27%  Similarity=0.365  Sum_probs=209.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||.|+||.|.++.      .+.++..+|+|+++....   ...+...+|..+|+.+.||+++++++.+.+.
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr------~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~  116 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVR------EKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN  116 (355)
T ss_pred             hhhhhheeeeccCccceEEEEE------EccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence            4679999999999999999984      455688999999986643   3345577899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +++||||||++||.|..++.+.  ..+++..+..+|.||+.||+|||+.+  |++|||||+|||||.+|.+||+|||+|+
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceE
Confidence            9999999999999999998664  68999999999999999999999977  9999999999999999999999999999


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....     +-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||....+.      .....++..     
T Consensus       193 ~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~-----  256 (355)
T KOG0616|consen  193 RVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEG-----  256 (355)
T ss_pred             EecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhC-----
Confidence            86543     44589999999999999999999999999999999999999999876552      222222221     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCC-----CCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR-----PTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R-----Pt~~ell~~L~  358 (455)
                           .  -.+|.-.+.++.+|+..+|+.|-.+|     +-..+|..|-+
T Consensus       257 -----~--v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~w  299 (355)
T KOG0616|consen  257 -----K--VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPW  299 (355)
T ss_pred             -----c--ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcc
Confidence                 1  12455556789999999999999999     23445555533

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.7e-46  Score=333.25  Aligned_cols=267  Identities=28%  Similarity=0.378  Sum_probs=214.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .+|...+.||+|.||.||+|.      +..+++.||||+++.....  -....++|+..|+.++|+||+.++++|.+.+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~------d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKAR------DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEE------ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            467888999999999999995      3457899999999765332  23557899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      +.||+||++ .+|+..|..+ ...+....+..++.++++||+|||.+.  |+||||||.|+||+.+|.+||+|||+|+.+
T Consensus        76 l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            999999995 5999877654 467888999999999999999999977  999999999999999999999999999988


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--hhhH-----
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--PMLN-----  307 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~~~~-----  307 (455)
                      ...+...  +..+-|.+|.|||++.|. .|+..+|+||.|||+.||+.|.+-|.+.+..++...+-.+.  +...     
T Consensus       152 ~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  152 GSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            7655432  224789999999999775 59999999999999999999999999887655554443221  1111     


Q ss_pred             ----hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          308 ----DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       308 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          +-.++...-.+.+. .+...++.++.+|+..||..||.+|++++|+++|-
T Consensus       230 ~~lpdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             cccccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence                11111111112222 24445567789999999999999999999999983

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=362.89  Aligned_cols=257  Identities=27%  Similarity=0.365  Sum_probs=211.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc----ch-hhHHHHHHHHHHHhcCC-CCCcccEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GL-QGHREWLTEVIFLGQLR-HPHLVKLIG  148 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~  148 (455)
                      ...+.|.+.+.||+|+||.|++|..      ..++..||+|+++..    .. .....+.+|+.+++.++ ||||++++.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~------~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKH------RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeee------ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            3467899999999999999999954      445789999987653    11 23345568999999999 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-CceEEc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLS  227 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL~  227 (455)
                      ++......++||||+.||+|.+++..  ...+.+..+..++.|++.|++|||+.+  |+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEe
Confidence            99999999999999999999999987  468888999999999999999999977  9999999999999999 999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCC-CC-ccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LT-SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |||++.....  ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.......      .+.+
T Consensus       164 DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------~~ki  235 (370)
T KOG0583|consen  164 DFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------YRKI  235 (370)
T ss_pred             ccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------HHHH
Confidence            9999997741  112345589999999999999877 75 789999999999999999999986432111      1111


Q ss_pred             hHhhhhhcccCCCcccCCCCHHH-HHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETG-ARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .          ..  .-.++... +.++.+|+.+||..+|.+|+|+.+|+.+-|...
T Consensus       236 ~----------~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  236 R----------KG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             h----------cC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1          11  11223333 788999999999999999999999998765543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.1e-46  Score=362.33  Aligned_cols=248  Identities=31%  Similarity=0.442  Sum_probs=214.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|      +.+.+.+.||+|.++....  .+.+.+.+|+++++.++||||+.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKg------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKG------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeec------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            57888999999999999999      5677899999999976544  334668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      +|+|.||+.| +|..+|...  ..++++.+..++.+++.||.|||+++  |+|||+||.|||++.+|.+|++|||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999966 999988664  78999999999999999999999977  999999999999999999999999999976


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..  .+.+.+...|||.|||||+..++.|+..+|+||+||++||++.|++||-...      +......+..+       
T Consensus       151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d-------  215 (808)
T KOG0597|consen  151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD-------  215 (808)
T ss_pred             cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC-------
Confidence            55  3455667889999999999999999999999999999999999999996432      22222222221       


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        +   ..++...+..+.+++..+|.+||..|.|..+++.|
T Consensus       216 --~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  216 --P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             --C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence              1   12345677889999999999999999999999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-47  Score=359.63  Aligned_cols=250  Identities=27%  Similarity=0.392  Sum_probs=213.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..|+....||+|+||.||+|.      +..+++.||+|+++.+... ..+++.+|+.+|..++++||.++|+.+..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~------d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAI------DNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeee------eccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            457778999999999999995      3457889999999887544 457788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      +++||||.||++.+.+...  ..+.+..+..++.+++.||.|||..+  .+|||||+.|||+..+|.+||+|||++.+..
T Consensus        87 wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999988543  45578888889999999999999977  9999999999999999999999999998876


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  ..+++||+.|||||++....|+.++||||||++.+||.+|.+||....+.+...++.             +-.
T Consensus       163 ~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~  227 (467)
T KOG0201|consen  163 NTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSA  227 (467)
T ss_pred             chhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCC
Confidence            54433  356899999999999998899999999999999999999999998877644332221             122


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .|.    +...+++.+.+|+..||..+|+.||++.++++|
T Consensus       228 PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 PPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            233    334556779999999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=357.17  Aligned_cols=259  Identities=25%  Similarity=0.328  Sum_probs=211.9

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      +...++|.++++||+|+||.||+|.      .+.+|..+|+|+++....   ......+.|..+|...++|+||++|..|
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLar------Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLAR------KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEE------EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            5567899999999999999999994      455899999999976543   3446678899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      .+.+++||||||++||++..+|...  ..|++..+..++.+++.|++.||+.|  +|||||||+|+|||..|++||+|||
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeecccc
Confidence            9999999999999999999988765  68999999999999999999999977  9999999999999999999999999


Q ss_pred             CccCCCC----------------------CCCcc----ce-------------------eccccCCCCcCccccccCCCC
Q 012832          231 LAKDGPE----------------------GDDTH----VS-------------------TRVMGTQGYAAPEYVMTGHLT  265 (455)
Q Consensus       231 la~~~~~----------------------~~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~  265 (455)
                      |+.-...                      .+...    ..                   ...+|||-|||||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9852110                      00000    00                   015799999999999999999


Q ss_pred             ccCchhhHHHHHHHHHhCCCCCCCCCccchh-hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCC
Q 012832          266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQ-SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRP  344 (455)
Q Consensus       266 ~~~DvwslG~il~ell~G~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P  344 (455)
                      ..+|+|||||||||||.|-+||....+..-- .++.|.               ..+...-...++.++.+||.+||. ||
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~~~~s~eA~DLI~rll~-d~  430 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEEVDLSDEAKDLITRLLC-DP  430 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCcCcccHHHHHHHHHHhc-CH
Confidence            9999999999999999999999887664321 122221               111111223345889999999999 99


Q ss_pred             CCCC---CHHHHHHhcc
Q 012832          345 KQRP---TMSTVVKTLE  358 (455)
Q Consensus       345 ~~RP---t~~ell~~L~  358 (455)
                      ++|.   .++||.+|..
T Consensus       431 ~~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  431 ENRLGSKGAEEIKKHPF  447 (550)
T ss_pred             HHhcCcccHHHHhcCCc
Confidence            9996   6899998854

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-45  Score=362.04  Aligned_cols=268  Identities=28%  Similarity=0.408  Sum_probs=207.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||.||+|..... .....+..||||++.... ......+.+|+.+|..+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGI-DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEecc-CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            4567899999999999999999965321 123456789999986432 23345688999999999 89999999998876


Q ss_pred             CC-eEEEEEEecCCCChHHHHhhcC-------------------------------------------------------
Q 012832          153 EE-HRLLVYEYMPRGSLENQLFRRY-------------------------------------------------------  176 (455)
Q Consensus       153 ~~-~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  176 (455)
                      .. ..++||||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            44 5889999999999999886531                                                       


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCC
Q 012832          177 -----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ  251 (455)
Q Consensus       177 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~  251 (455)
                           ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 124778888999999999999999966  9999999999999999999999999998654322221122245678


Q ss_pred             CCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHH
Q 012832          252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGAR  330 (455)
Q Consensus       252 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (455)
                      .|+|||++.+..++.++|||||||++|||++ |..||........  ...   . +..         . .....+..++.
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~---~-~~~---------~-~~~~~~~~~~~  304 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ---R-LKD---------G-TRMRAPENATP  304 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH---H-Hhc---------C-CCCCCCCCCCH
Confidence            8999999999999999999999999999997 9999976432111  110   0 000         0 01112334567


Q ss_pred             HHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          331 KAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       331 ~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .+.+|+.+||+.+|++|||+.++++.|+.+.
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.8e-46  Score=380.20  Aligned_cols=269  Identities=29%  Similarity=0.465  Sum_probs=227.5

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ++...+....+.||+|+||+||+|..... ......+.||||.++..... ...+|.+|+++|..|+|||||+|+|+|.+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l-~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGL-LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCC-CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            34556677788899999999999976543 34456788999999876555 77899999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcC--------CC----CCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRY--------SV----SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS  220 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~  220 (455)
                      ++.++||+|||..|||.++|..+.        +.    +++..+.+.||.|||.||+||-++.  +|||||..+|+||.+
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGE  638 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceecc
Confidence            999999999999999999997643        12    2788899999999999999999876  999999999999999


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHH
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLV  299 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~  299 (455)
                      +..|||+||||++.....+..+....-.-.++||+||.|..+.|+.+||||||||+|||+++ |..||.+....+....+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            99999999999998777666555444455789999999999999999999999999999998 99999876543322222


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .                ...+ -..++.||.++.+||..||+.+|.+||++.+|-..|+..-.
T Consensus       719 ~----------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  719 R----------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             H----------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            2                1112 34688899999999999999999999999999999876643

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=366.05  Aligned_cols=253  Identities=28%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCC-CCCcccEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLR-HPHLVKLIG  148 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~  148 (455)
                      ..+..++|.+.++||+|+||+|+++...      .+++.+|||+++.+..   .+.+..+.|..|+.... ||+++.++.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELK------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEc------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence            4566789999999999999999999554      4678999999987643   44566788988888776 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      +|...+++|+||||+.||++..+..   ...+++..+..++..|+.||+|||+++  |||||||.+|||||.+|.+||+|
T Consensus       437 ~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  437 CFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             ccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecc
Confidence            9999999999999999999654332   358999999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ||+++.....+.  .+.++||||.|||||++.+..|+..+|+|||||+|||||.|..||.+.++...-+-      ++.+
T Consensus       512 FGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds------I~~d  583 (694)
T KOG0694|consen  512 FGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS------IVND  583 (694)
T ss_pred             cccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HhcC
Confidence            999998764444  35669999999999999999999999999999999999999999997654321111      1111


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHh
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKT  356 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~  356 (455)
                                  ...||..++.++.+||.++|..+|++|.-+     ++|.+|
T Consensus       584 ------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  584 ------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             ------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence                        224577778999999999999999999755     555555

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-45  Score=363.41  Aligned_cols=251  Identities=26%  Similarity=0.357  Sum_probs=213.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .+-|.+++-||.|+-|.|-+|      ++..+|+.+|||++....   ......+.+|+.+|+.+.||||+.+|+++.+.
T Consensus        11 iGpwkLgkTLG~Gstg~vrla------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~   84 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLA------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK   84 (786)
T ss_pred             ccceeccccccCCCCceehhh------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence            356899999999999999999      667799999999986541   12234466899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      .++|+|.||++||.|++++..+  +.+++.++.+++.||+.|+.|+|..+  |+||||||+|+|||..+++||+|||+|.
T Consensus        85 ~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   85 QHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             ceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceee
Confidence            9999999999999999999876  68999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .-.++.   ...+-||.+.|.|||++.|..| +.++||||.|||||.||+|+.||+..+.......+.            
T Consensus       161 Le~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~------------  225 (786)
T KOG0588|consen  161 LEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ------------  225 (786)
T ss_pred             cccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH------------
Confidence            655443   2445799999999999999987 578999999999999999999998543221111111            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          .  -.-+.|..++.++++|+.+||..||+.|.|+++|++|.+
T Consensus       226 ----~--G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  226 ----R--GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             ----c--CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence                0  011335667889999999999999999999999999954

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=339.89  Aligned_cols=278  Identities=25%  Similarity=0.340  Sum_probs=218.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecc--ccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-  152 (455)
                      ....|...+.||+|+||.|+.|..      +.++..||||++.  +......++..+|+.+|+.++|+||+.+++++.. 
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~------~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKD------KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             ccceecccccccCcceeeEEEEEE------cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            345677789999999999999954      4467999999987  6666677888999999999999999999998865 


Q ss_pred             ----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          153 ----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       153 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                          -...|+|+|+| +.+|...|..+  ..+....+..+++|+++||+|+|+++  |+||||||+|+|++.+..+||+|
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEecc
Confidence                35689999999 67999888654  45999999999999999999999988  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh-
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML-  306 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~-  306 (455)
                      ||+|+...........+..+.|.+|.|||++.. ..|+...||||+|||+.||++|++-|.+.+...+..++...-... 
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            999998754322333456789999999998854 579999999999999999999999999887655555443221100 


Q ss_pred             -------H------hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh--cccccCCCC
Q 012832          307 -------N------DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT--LEPLKDFDD  365 (455)
Q Consensus       307 -------~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~--L~~~~~~~~  365 (455)
                             .      ....+.......+..-+ +.....+.+|+.+||..||.+|+|++|.+.|  |..+.+..+
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d  321 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED  321 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence                   0      00111111111111112 2456789999999999999999999999999  455544443

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=337.84  Aligned_cols=253  Identities=28%  Similarity=0.379  Sum_probs=214.8

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh---HHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      ++..++|...++||+|.||.|.++      +.+.+++.+|+|+++.+....   ...-+.|-.+|+..+||++..+...|
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILC------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEE------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            456789999999999999999998      567789999999998765433   34456799999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+.+|+||||..||.|.-+|.+.  ..+++.....+...|+.||.|||+.+  ||+||||.+|+|+|.+|++||+|||
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecc
Confidence            9999999999999999999887664  67888899999999999999999966  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      |++.....+.+  +.++||||.|+|||++....|++++|+|.+||++|||+||+.||...+....-.++-..        
T Consensus       314 LCKE~I~~g~t--~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------  383 (516)
T KOG0690|consen  314 LCKEEIKYGDT--TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------  383 (516)
T ss_pred             cchhcccccce--eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------
Confidence            99876554443  56699999999999999999999999999999999999999999765443333322210        


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHh
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKT  356 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~  356 (455)
                                .-.+|...+.++..|+.-+|..||.+|.     .+.||.+|
T Consensus       384 ----------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 ----------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ----------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                      1235666778899999999999999995     56677665

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-44  Score=332.49  Aligned_cols=270  Identities=23%  Similarity=0.281  Sum_probs=212.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      +.|+..+.|++|+||.||+|      +++.++..||+|+++.+...  .--..++|+.+|.+++|||||.+-.+....  
T Consensus        76 ~efe~lnrI~EGtyGiVYRa------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRA------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEe------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            56888899999999999999      56778999999999765321  123457999999999999999998876543  


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..|||||||+ -+|..++... ...+...++..++.|++.||+|||.+.  |+||||||+|+|++..|.+||+|||+|+
T Consensus       150 d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhh
Confidence            57999999995 4899887765 368889999999999999999999988  9999999999999999999999999999


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--------h
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--------P  304 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--------~  304 (455)
                      .+...  ....+..+-|.+|.|||++.+. .|+...|+||+|||+.||+++++.|.+.....+.+.+-..-        +
T Consensus       226 ~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            87654  2335567889999999999875 59999999999999999999999999887765555443110        1


Q ss_pred             hhHhhh-----hhcccCCCcccCCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          305 MLNDAR-----KLGRIMDPRLEGQYSET-GARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       305 ~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      -+....     .........+...|... .+....+|+..+|..||.+|.|+++.++|=+.
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F  364 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF  364 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence            000000     00111111122222222 45678899999999999999999999998433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=356.40  Aligned_cols=243  Identities=29%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      ..-.+-||+|+.|.||+|.+.        ++.||||+++.-.       ..++.-|++|+||||+.|.|+|.....+|||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            344577999999999999654        4689999875221       2478899999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      ||||..|-|+..|...  ..+.....+.|..+||.||.|||.+.  |||||||.-||||+.+..|||+|||.++......
T Consensus       191 MEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             eeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            9999999999988654  67888899999999999999999977  9999999999999999999999999998765442


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                       +  ...++||..|||||+|.+.+.+.|+|||||||+|||||||..||..-+.    .-+.|.            +-...
T Consensus       267 -T--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG------------VGsNs  327 (904)
T KOG4721|consen  267 -T--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG------------VGSNS  327 (904)
T ss_pred             -h--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe------------ccCCc
Confidence             1  2348899999999999999999999999999999999999999964321    112221            12223


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      +.-..+..||+.+.-|+++||...|..||++.+|+.||+..
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            34456788899999999999999999999999999998644

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.3e-44  Score=343.82  Aligned_cols=254  Identities=26%  Similarity=0.388  Sum_probs=205.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|...+.||+|+||.||+|....      +++.||+|.+.....   .....+.+|+.++..++|+||+++++++...+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            37788999999999999996433      578999998864332   223457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999999999998886654557899999999999999999999966  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....   .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.   .      .   +
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~------~---~  217 (285)
T cd05631         153 PEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---R------R---V  217 (285)
T ss_pred             CCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---H------H---h
Confidence            33221   223579999999999999999999999999999999999999998654321111110   0      0   0


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTL  357 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L  357 (455)
                      .  .....++...+.++.+|+.+||..+|++||+     ++++++|-
T Consensus       218 ~--~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         218 K--EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             h--cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence            0  0111234445678999999999999999997     89998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-44  Score=338.08  Aligned_cols=259  Identities=27%  Similarity=0.325  Sum_probs=213.9

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH---HHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---REWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .+..+.|++.+.||.|.-|+||++.+.+      +...+|+|+++.......   .+...|-+||..++||.++.+|+.+
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRG------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecC------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            4455678899999999999999996544      458899999987655433   4456799999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ..+...|+|||||+||+|..+++++.+..+++..+..++..++.||+|||..|  ||+|||||+||||.++|++.|+||.
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecc
Confidence            99999999999999999999999999999999999999999999999999977  9999999999999999999999999


Q ss_pred             CccCCCCC--------------------------------CCc----------------------cceeccccCCCCcCc
Q 012832          231 LAKDGPEG--------------------------------DDT----------------------HVSTRVMGTQGYAAP  256 (455)
Q Consensus       231 la~~~~~~--------------------------------~~~----------------------~~~~~~~gt~~y~aP  256 (455)
                      |+..+...                                ...                      -....++||-.|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            97643110                                000                      001126799999999


Q ss_pred             cccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHH
Q 012832          257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALA  336 (455)
Q Consensus       257 E~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (455)
                      |++.|...+.++|+|+|||++|||+.|..||.+.....-  +              ..++...+.-.-....+..+.+||
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l--------------~NIv~~~l~Fp~~~~vs~~akDLI  368 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--L--------------RNIVGQPLKFPEEPEVSSAAKDLI  368 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--H--------------HHHhcCCCcCCCCCcchhHHHHHH
Confidence            999999999999999999999999999999988654221  1              111222222111225567899999


Q ss_pred             HHHhccCCCCCCC----HHHHHHh
Q 012832          337 YQCLSHRPKQRPT----MSTVVKT  356 (455)
Q Consensus       337 ~~cl~~~P~~RPt----~~ell~~  356 (455)
                      +++|.+||.+|..    +.||.+|
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHhccChhhhhccccchHHhhcC
Confidence            9999999999998    8899887

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.1e-44  Score=350.70  Aligned_cols=245  Identities=28%  Similarity=0.357  Sum_probs=200.2

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      +.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+|+.++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREK------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            46999999999999543      357899999986432   233456778999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  150 (323)
T cd05571          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC
Confidence            999999999988654  57899999999999999999999976  99999999999999999999999999975432221


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                        .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+      .          ..  
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~----------~~--  210 (323)
T cd05571         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L----------ME--  210 (323)
T ss_pred             --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------H----------cC--
Confidence              123367999999999999999999999999999999999999999754321111000      0          00  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                      ...++...+.++.+|+.+||..||++||     ++.++++|-+
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence            1123344567889999999999999999     8999998843

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.9e-43  Score=343.59  Aligned_cols=271  Identities=26%  Similarity=0.424  Sum_probs=207.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCC----------CCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcc
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLR----------PGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~----------~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv  144 (455)
                      ..++|.+.+.||+|+||.||+|.+.+...          ....+..||+|.+.... .....++.+|+.+|..++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            34678999999999999999997643210          12345579999986543 23446788999999999999999


Q ss_pred             cEEEEEEeCCeEEEEEEecCCCChHHHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeE
Q 012832          145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY-----------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVI  207 (455)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ii  207 (455)
                      ++++++...+..++||||+.+|+|.+++....                 ...+++..++.++.||+.||.|||+.+  |+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iv  160 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FV  160 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence            99999999999999999999999999886532                 124677889999999999999999976  99


Q ss_pred             EeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh--CCC
Q 012832          208 YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS--GRK  285 (455)
Q Consensus       208 HrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--G~~  285 (455)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  |..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986544332222233456889999999998899999999999999999987  556


Q ss_pred             CCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          286 SVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       286 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ||......   .............       ........+..++..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus       241 p~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDE---QVIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHH---HHHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            77654321   1222111111100       000011123345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-44  Score=346.18  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=205.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++.....   .....+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            46889999999999999999543      3578899999864322   33456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            999999999999999988654  46889999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........      ..+...      
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~------~~i~~~------  213 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY------EKILAG------  213 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhC------
Confidence            5432     12357999999999999989999999999999999999999999765332111      111100      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~~  359 (455)
                            ...++...+..+.+|+.+||+.||.+||+     ++++++|.+.
T Consensus       214 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         214 ------KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             ------CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence                  01123334567899999999999999995     9999998554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=348.83  Aligned_cols=257  Identities=24%  Similarity=0.279  Sum_probs=207.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...+      +++.||||++....   ......+.+|+.++..++||||+++++++...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            468899999999999999996543      56789999986542   233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..||||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            999999999999999988654  46889999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.          ....
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----------~~~~  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----------YWKE  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----------hccc
Confidence            543     1233679999999999999999999999999999999999999998654322111110          0001


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .+............+.++.+|+.+||..+|.+||++.++++|.+.
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~  260 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF  260 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence            111111111112346788999999999999999999999998543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-44  Score=318.27  Aligned_cols=254  Identities=27%  Similarity=0.355  Sum_probs=215.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +.++|.+++.||+|-||.||+|+.      +.+.-.||+|++.....   ...+.+.+|++|-..|+||||+++|++|.+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlare------kks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLARE------KKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             chhhccccccccCCccccEeEeee------ccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            457899999999999999999954      44677899999865432   334668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....||++||..+|+|...|.......+++.....++.|+|.||.|+|.  +.||||||||+|+|++..+.+||+|||-+
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            9999999999999999999987777889999999999999999999998  45999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ...+..    ...+.|||..|.+||...+..++..+|+|++|+++||++.|.+||.......   .   .+.+..     
T Consensus       172 V~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---t---YkrI~k-----  236 (281)
T KOG0580|consen  172 VHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---T---YKRIRK-----  236 (281)
T ss_pred             eecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---H---HHHHHH-----
Confidence            876532    2445899999999999999999999999999999999999999998654211   1   111110     


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                             +.-.++...+.++.++|.+||..+|.+|.+..+++.|.+-
T Consensus       237 -------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  237 -------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             -------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence                   1123346667889999999999999999999999998654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-43  Score=346.73  Aligned_cols=269  Identities=24%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|++.+.||+|+||.||++...      .++..||+|.+.... ......+.+|+.+|+.++||||+++++++...+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHK------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEEC------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            3578999999999999999999543      357789999987543 233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.++|+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999999988654  4688999999999999999999973 1399999999999999999999999999976


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh-----
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA-----  309 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~-----  309 (455)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.  .+.....     
T Consensus       154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~  227 (331)
T cd06649         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPH  227 (331)
T ss_pred             ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCcc
Confidence            54322    223569999999999999999999999999999999999999997543221111000  0000000     


Q ss_pred             ---------------------------hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          310 ---------------------------RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       310 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                                                 .....+.............+.++.+|+.+||+.||++|||+.++++|.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                                       00000000000111112346789999999999999999999999998543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-43  Score=354.85  Aligned_cols=267  Identities=27%  Similarity=0.388  Sum_probs=208.3

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      .+..++|.+.+.||+|+||.||+|.+... ....++..||||+++... ......+.+|+.+|..+ +||||++++++|.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGL-FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEecc-ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34456899999999999999999965321 123356689999986433 23445688999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC-------------------------------------------------------
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY-------------------------------------------------------  176 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  176 (455)
                      ..+..++||||+++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999886432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          177 ------------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       177 ------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                                        ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              124778889999999999999999966  999999999999999999999999999865443


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....+    +..         
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~---------  332 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKE---------  332 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHh---------
Confidence            32222222345678999999999999999999999999999998 889987543211  11111    100         


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                       ......+...+.++.+|+.+||+.+|++|||+.+|++.|+.
T Consensus       333 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         333 -GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence             00111122345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-44  Score=340.38  Aligned_cols=265  Identities=28%  Similarity=0.354  Sum_probs=210.1

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------------hhHHHHHHHHHHHhcCC
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------------QGHREWLTEVIFLGQLR  139 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~  139 (455)
                      ....+.|.+.+.||+|.||.|-+|..      ...++.||||++.....              ...+...+|+.+|++|+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~------~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARD------EVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEee------cCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            44568899999999999999999943      44688999999853211              11256789999999999


Q ss_pred             CCCcccEEEEEEeC--CeEEEEEEecCCCChHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          140 HPHLVKLIGYCCEE--EHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       140 h~nIv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      |||||+|+.+..+.  +.+|||+|||..|.+...   ..... +.+.++++++.+++.||+|||.++  ||||||||+|+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNL  241 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNL  241 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhhe
Confidence            99999999998765  579999999999988642   22234 899999999999999999999988  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCC---ccceeccccCCCCcCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDD---THVSTRVMGTQGYAAPEYVMTGH----LTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                      ||+++|++||+|||++...+....   ........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-.
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            999999999999999986643321   11123368999999999997743    36678999999999999999999975


Q ss_pred             CCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCCC
Q 012832          290 SRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDD  365 (455)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~~  365 (455)
                      ...      ....          .++.+..+.-...+....++.+||.+||++||+.|.+..+|..|.+-......
T Consensus       322 ~~~------~~l~----------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  322 DFE------LELF----------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             chH------HHHH----------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            422      1111          12333334333334557789999999999999999999999999887766543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.2e-44  Score=350.13  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=205.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|....      +++.||+|++....   ......+.+|+.+|+.++||||+++++++...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKG------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            4678999999999999999996543      57889999986432   23345678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+.+|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            9999999999999999988764  56888999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+....      ..+.       
T Consensus       167 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~-------  228 (329)
T PTZ00263        167 KVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------EKIL-------  228 (329)
T ss_pred             EcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------HHHh-------
Confidence            654322     2357999999999999999999999999999999999999999754332111      0000       


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~~  359 (455)
                         ...  ..++...+..+.+|+.+||+.||.+||+     +.+++.|.+.
T Consensus       229 ---~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f  274 (329)
T PTZ00263        229 ---AGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF  274 (329)
T ss_pred             ---cCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence               010  1123334567899999999999999986     7999988543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-44  Score=349.46  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=216.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|..+++||+|+||.+++.      +++..+..||+|.+.....  ...+..++|+.++++++|||||.+++.|..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lv------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLV------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhh------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            367889999999999999988      4555677999999876543  33346789999999999999999999999988


Q ss_pred             e-EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          155 H-RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       155 ~-~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      . ++|||+||+||+|.+.|.+..+..+++..+..|+.|++.|+.|||+..  |+|||||+.|||++.++.|+|+|||+|+
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhh
Confidence            8 999999999999999999887889999999999999999999999755  9999999999999999999999999999


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .......  ......||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+..   .++.             
T Consensus       155 ~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~-------------  216 (426)
T KOG0589|consen  155 ILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL-------------  216 (426)
T ss_pred             hcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH-------------
Confidence            8776542  234478999999999999999999999999999999999999999865432   1111             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      +++. ......+...+.++..|+..||..+|..||++.+++.+
T Consensus       217 ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1111 11234456677889999999999999999999999987

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=337.63  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=212.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH---HHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---REWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..+|++.+.||+|.||.|-+|+      +...|..||||.+..+...+.   -.+.+|++||..|+||||+.+|.+|...
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~------e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAY------EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehh------hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            4679999999999999999983      345688999999976655444   4467899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +...|||||..+|.|+|++..+  ..+++.++..++.||..|+.|+|.++  ++|||||.+|||+|.|+++||+||||+.
T Consensus       126 dKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhh
Confidence            9999999999999999999876  68999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .+....   ...++||++.|.+||++.|.+| ++.+|-|||||+||.|+.|..||++.+...   ++.            
T Consensus       202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr------------  263 (668)
T KOG0611|consen  202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR------------  263 (668)
T ss_pred             hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH------------
Confidence            765433   3456899999999999999887 678999999999999999999999864321   111            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       ++....   .+.+..|.++.-||.+||-.+|++|.|+.+|..|-|
T Consensus       264 -QIs~Ga---YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  264 -QISRGA---YREPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             -Hhhccc---ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence             111111   112334567888999999999999999999999854

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9e-44  Score=355.64  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=209.2

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      ....++|.+.+.||+|+||.||+|...... ....+..||||++..... .....+.+|+.+++.+ +|+||++++++|.
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLG-KEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCC-cccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            345568999999999999999999753321 123456799999865432 3345678999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC-------------------------------------------------------
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY-------------------------------------------------------  176 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  176 (455)
                      .....++||||+++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999886431                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccc
Q 012832          177 -------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV  243 (455)
Q Consensus       177 -------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~  243 (455)
                                   ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++..........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                         124678889999999999999999966  99999999999999999999999999986544322222


Q ss_pred             eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..||........  ...    ..          ......
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~----~~----------~~~~~~  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYK----MV----------KRGYQM  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHH----HH----------HcccCc
Confidence            222345678999999998999999999999999999997 9999975432110  000    00          001111


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            12223457899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-43  Score=339.63  Aligned_cols=245  Identities=19%  Similarity=0.301  Sum_probs=199.3

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh---HHHHHHHHHHHhcCCCCCcccEEEEEEe----CCeE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEVIFLGQLRHPHLVKLIGYCCE----EEHR  156 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~  156 (455)
                      ..||+|++|.||+|.+        +++.||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEE--------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            6799999999999965        35789999987543322   4667799999999999999999999876    3578


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+++|+|.+++...  ..+++...+.++.+++.||.|||+. +  ++||||||+|||++.++.+||+|||+++..
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            9999999999999998764  5788899999999999999999973 5  889999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....     ....||..|+|||++.+  ..++.++|||||||++|||++|..||........   ..   ...       
T Consensus       174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~---~i~-------  235 (283)
T PHA02988        174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD---LII-------  235 (283)
T ss_pred             cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHH-------
Confidence            3321     12468999999999976  6799999999999999999999999986532211   11   000       


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         ........+..++..+.+|+.+||+.+|++|||+.++++.|+.++
T Consensus       236 ---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        236 ---NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ---hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence               001111233356778999999999999999999999999988764

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=355.53  Aligned_cols=274  Identities=31%  Similarity=0.451  Sum_probs=221.4

Q ss_pred             cchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcc
Q 012832           68 FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv  144 (455)
                      +....+.+..++..+.+.||+|+||.||+|.+..+.  ......||||..+..   ......++++|+++|++++|||||
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~--~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKN--GFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecC--CceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            344556667778888899999999999999876531  111223999998753   356678899999999999999999


Q ss_pred             cEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      ++||++.....++||||+|.||+|.++|.+.. ..++..+...++.++|.||+|||+.+  +|||||.++|+|++.++.+
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeE
Confidence            99999999999999999999999999998764 37999999999999999999999955  9999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhh
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      ||+|||+++........  .....-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........     
T Consensus       302 KISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k-----  374 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK-----  374 (474)
T ss_pred             EeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH-----
Confidence            99999999876421111  101124578999999999999999999999999999999 8889987644311111     


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                                 +.........+...|.++..++.+||..+|++||||.++.+.|+.+....
T Consensus       375 -----------I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  375 -----------IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             -----------HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                       11112233345567888999999999999999999999999988775543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=355.96  Aligned_cols=269  Identities=26%  Similarity=0.419  Sum_probs=213.7

Q ss_pred             cchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCccc
Q 012832           68 FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVK  145 (455)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~  145 (455)
                      .+..++.+..+.+.+...||+|.||+||+|.+-.         .||||+++.+..  +..+.|.+|+.+|++-+|.||+-
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc---------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence            4457778888888999999999999999996643         599999976644  44577999999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      |+|+|..+.. .||+.+|+|-+|+.+|.-. ...|...+.+.|+.||++||.|||.  ++|||||||..||++.+++.||
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEE
Confidence            9999998877 9999999999999988754 3578888999999999999999999  5599999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      |+||||+..-..-..........|...|||||++..   .+|+..+||||||||+|||++|..||.....+  +-+....
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmVG  606 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMVG  606 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEec
Confidence            999999864221111111222458889999999964   46999999999999999999999999843221  1111000


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      +..          +.+. .......++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus       607 rG~----------l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGY----------LMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccc----------cCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            000          0011 112345678899999999999999999999999997776644

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-43  Score=345.44  Aligned_cols=245  Identities=26%  Similarity=0.348  Sum_probs=199.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      +.||+|+||.||++..      ..++..||+|++....   ......+.+|+.+|+.++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVRE------KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            4699999999999954      3457899999986432   233456788999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        75 Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~  150 (328)
T cd05593          75 EYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA  150 (328)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCccc
Confidence            999999999888654  56899999999999999999999976  99999999999999999999999999875432211


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+                ...  
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~----------------~~~--  210 (328)
T cd05593         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----------------LME--  210 (328)
T ss_pred             --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh----------------ccC--
Confidence              123367999999999999999999999999999999999999999754321111000                000  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                      ...++...+.++.+|+.+||..+|++||     ++.++++|.+
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            1123344567889999999999999997     8999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9e-43  Score=334.92  Aligned_cols=263  Identities=30%  Similarity=0.483  Sum_probs=212.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...... .......||+|.+..... .....+.+|+.++..++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPN-ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCC-CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            357889999999999999999765432 134557899999864432 334568899999999999999999999999899


Q ss_pred             EEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYS--------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      .+++|||+++|+|.+++.....              ..+++..++.++.|++.||+|||+.+  ++|+||||+|||++.+
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~  160 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEG  160 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCC
Confidence            9999999999999999876421              45788899999999999999999966  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~  300 (455)
                      +.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   ...
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986544332222334567889999999998899999999999999999998 999997654321   111


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..              ........+..++.++.+|+.+||+.+|++||++.+|+++|+.
T Consensus       238 ~i--------------~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MI--------------RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH--------------HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            10              0011112345567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.9e-43  Score=344.41  Aligned_cols=246  Identities=29%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      +.||+|+||.||++..      ..++..||+|++....   ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVRE------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            4699999999999954      3357899999986432   223455678999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      ||+++|+|..++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........
T Consensus        75 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          75 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            999999999887654  47899999999999999999999976  99999999999999999999999999875432221


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+      .          ..  
T Consensus       151 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~----------~~--  210 (323)
T cd05595         151 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------L----------ME--  210 (323)
T ss_pred             c--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------h----------cC--
Confidence            1  22357999999999999999999999999999999999999999754322111100      0          00  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhccc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEP  359 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~  359 (455)
                      ...++...+.++.+|+.+||..+|++||     ++.++++|-+.
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~  254 (323)
T cd05595         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  254 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence            0123344567889999999999999998     89999988543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.6e-43  Score=337.74  Aligned_cols=269  Identities=22%  Similarity=0.300  Sum_probs=204.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....  ......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            46899999999999999999653      356789999986432  2234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++++.|..+. .. ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~-~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLE-EM-PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99999999887666443 22 356899999999999999999999976  999999999999999999999999999875


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hhhhHh------
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RPMLND------  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~~~~~------  308 (455)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|++||...........+... .+....      
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            433221 122357999999999999989999999999999999999999999865432221111110 000000      


Q ss_pred             -hhhhcccCCCcc------cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 -ARKLGRIMDPRL------EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 -~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                       .........+..      ...+....+..+.+|+.+||+.+|++|||++++++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence             000000000000      0111223467799999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.2e-43  Score=332.21  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=208.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+|.+.+.||+|+||.||+|.+...   ...+..||+|.++.... .....+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLP---SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecC---CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            346789999999999999999976432   23567899999875432 33456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++|+|||.+..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999999988654 347899999999999999999999866  99999999999999999999999998765


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....          .
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----------~  222 (266)
T cd05064         157 DKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----------E  222 (266)
T ss_pred             ccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----------H
Confidence            422211 11112345678999999999999999999999999999775 999997653321   11110          0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..    .....+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       223 ~~----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 DG----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            00    11122445677899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.7e-43  Score=346.02  Aligned_cols=252  Identities=25%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|.....     .+..||+|++....   ......+.+|+.+++.++||||+++++++..
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNE-----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECC-----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            456799999999999999999965431     23579999885432   2334567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....++||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCC
Confidence            99999999999999999988764  46899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......     .....||+.|+|||++.+..++.++|||||||++|||++|.+||....+...      ...+.      
T Consensus       179 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~------  241 (340)
T PTZ00426        179 KVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKIL------  241 (340)
T ss_pred             eecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHh------
Confidence            865332     1235799999999999998899999999999999999999999976433110      00010      


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~  359 (455)
                          ..  ...++...+..+.+++.+||+.+|++|+     +++++++|.+.
T Consensus       242 ----~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        242 ----EG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             ----cC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence                00  0112334456788999999999999995     89999998543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=340.82  Aligned_cols=243  Identities=28%  Similarity=0.341  Sum_probs=197.5

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||+|+||.||+|...+      ++..||+|++....   ......+..|+.+|+.++||||+++++++...+..++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRD------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            7999999999996433      56789999986432   23345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++.......  
T Consensus        75 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  148 (312)
T cd05585          75 INGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--  148 (312)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--
Confidence            9999999988654  56899999999999999999999966  99999999999999999999999999975433221  


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........          .  ..
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~----------~--~~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ----------E--PL  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc----------C--CC
Confidence            123467999999999999999999999999999999999999999754321      11111111          0  11


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCC---CHHHHHHhcc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRP---TMSTVVKTLE  358 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RP---t~~ell~~L~  358 (455)
                      .++...+.++.+|+.+||..+|++||   ++.+++.|.+
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence            23344567889999999999999997   4678887743

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.7e-43  Score=336.06  Aligned_cols=269  Identities=23%  Similarity=0.332  Sum_probs=203.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||.|+||.||+|...      .++..||+|+++.... .....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC   77 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            457999999999999999999543      3578899999865432 233467789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++ |+|.+++... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          78 LTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             EEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            999999996 5898887654 345788999999999999999999966  999999999999999999999999999754


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--------hhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--------PML  306 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--------~~~  306 (455)
                      ......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....        +..
T Consensus       154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         154 SVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             cCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence            332211  223568999999998865 568999999999999999999999998755432222111100        000


Q ss_pred             HhhhhhcccCCCcccCC----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDPRLEGQ----YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ...........+.....    .....+.++.+|+.+||..||.+|||+.++++|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence            00001111111111000    0112356789999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.7e-43  Score=343.85  Aligned_cols=268  Identities=27%  Similarity=0.397  Sum_probs=208.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||.||+|...+. ....+++.||+|++.... ......+..|+.++..+ +|+||++++++|..
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGI-EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEecccccc-ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            4456899999999999999999964331 233456889999986443 23345678899999999 79999999998865


Q ss_pred             C-CeEEEEEEecCCCChHHHHhhcCC------------------------------------------------------
Q 012832          153 E-EHRLLVYEYMPRGSLENQLFRRYS------------------------------------------------------  177 (455)
Q Consensus       153 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  177 (455)
                      . ..++++|||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 568899999999999998864321                                                      


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCC
Q 012832          178 -----VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG  252 (455)
Q Consensus       178 -----~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~  252 (455)
                           ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++................++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                 26789999999999999999999966  99999999999999999999999999987644322222223456788


Q ss_pred             CcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHH
Q 012832          253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARK  331 (455)
Q Consensus       253 y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (455)
                      |+|||++.+..++.++|||||||++|||++ |..||........  +..    .+.      .    ......+...+.+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~------~----~~~~~~~~~~~~~  304 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLK------E----GTRMRAPEYATPE  304 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHh------c----cCCCCCCccCCHH
Confidence            999999999999999999999999999998 9999975432111  110    000      0    0011112334567


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          332 AAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       332 ~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      +.+++.+||+.+|++||++.+++++|..+.
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            899999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-42  Score=358.00  Aligned_cols=254  Identities=22%  Similarity=0.277  Sum_probs=206.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      .|.+.+.||+|+||.||+|....     ..+..||+|.+..........+..|+.+|+.++||||+++++++...+..||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~-----~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGS-----DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcC-----CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            48889999999999999995432     1256789998766655555667889999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          159 VYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||++....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999999999988643  2346888899999999999999999966  9999999999999999999999999998764


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...   ....         
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~---~~~~---------  285 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ---QVLY---------  285 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh---------
Confidence            4332222344679999999999999999999999999999999999999997543211   111   0000         


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .. ...++...+.++.+|+.+||..+|++||++.+++.+
T Consensus       286 -~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        286 -GK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -CC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence             00 011233455789999999999999999999999875

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.5e-43  Score=343.67  Aligned_cols=245  Identities=28%  Similarity=0.344  Sum_probs=198.7

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      +.||+|+||.||++..      ..++..||+|++....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKE------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            4699999999999854      3467899999986532   223456678999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+ .+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            999999999887654  468999999999999999999997 45  9999999999999999999999999987543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.                .. 
T Consensus       151 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~----------------~~-  211 (325)
T cd05594         151 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----------------ME-  211 (325)
T ss_pred             cc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh----------------cC-
Confidence            11  223579999999999999999999999999999999999999997543221111100                00 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                       ...++...+.++.+|+.+||+.+|++|+     ++.++++|.+
T Consensus       212 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         212 -EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence             1122334567789999999999999996     9999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-42  Score=331.28  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=209.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..+|.+.+.||+|+||.||+|...+. .+......||||.+...... ....+.+|+++|+.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHL-EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccc-cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            45688899999999999999976442 22345678999998755443 45778999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          156 RLLVYEYMPRGSLENQLFRRY------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                      .++||||+++++|.+++....            ...+++..+..++.|++.||.|||+.+  ++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~  160 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCe
Confidence            999999999999999987542            245788899999999999999999976  999999999999999999


Q ss_pred             eEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 012832          224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~  302 (455)
                      ++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence            99999999976533322222223456789999999999999999999999999999998 999986543321   11111


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .             .. .....+...+..+.+++.+||..+|++||++.++++.|+
T Consensus       238 ~-------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 T-------------QG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H-------------cC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            0             00 011123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-42  Score=349.15  Aligned_cols=269  Identities=23%  Similarity=0.385  Sum_probs=211.0

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCC-CCCcccEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLR-HPHLVKLIGYC  150 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~  150 (455)
                      +.+..++|.+.+.||+|+||.||+|..... .....+..||||++..... ...+.+.+|+.+|+.+. ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGL-SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEccc-CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            345577899999999999999999975431 1223355799999865432 33467889999999996 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC------------------------------------------------------
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY------------------------------------------------------  176 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  176 (455)
                      ......|||||||++|+|.++|....                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999999886531                                                      


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          177 ----------------------------------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       177 ----------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                                                              ...+++..+..++.|++.||+|||+.+  |+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Ni  268 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhE
Confidence                                                    124778888999999999999999966  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccch
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE  295 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~  295 (455)
                      |++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986543322222223457789999999999899999999999999999997 9999975422110


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                        ...    ...          .......+..++.++.+++.+||..+|++|||+.+|.+.|+.+
T Consensus       349 --~~~----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 --FYN----KIK----------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --HHH----HHh----------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence              000    000          0011122345567899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=359.65  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=219.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEE-EE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGY-CC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~-~~  151 (455)
                      .+...++++.++|.+|||+.||+|....      .+..||+|++-..+....+.+.+|+++|+.|+ |+|||.+++. ..
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVK------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecC------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4566778899999999999999996654      23789999987777788888999999999998 9999999993 22


Q ss_pred             e------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          152 E------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       152 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      .      .-.++|+||||.||.|-|++..+....|.+.++++|+.++++|+++||....+|||||||-+||||+.++..|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            1      1357899999999999999998887889999999999999999999999999999999999999999999999


Q ss_pred             EccCCCccCCCCCCCccc-------eeccccCCCCcCcccc---ccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccch
Q 012832          226 LSDFGLAKDGPEGDDTHV-------STRVMGTQGYAAPEYV---MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE  295 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~  295 (455)
                      |||||.|......-....       .-...-|+.|.|||.+   .+..++.|+|||+|||+||-|+....||+.....  
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--  264 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--  264 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence            999999874332221100       0013368999999988   4678999999999999999999999999865321  


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                                        .|++..+.-...+.++..+.+||..||+.+|++||++-+++..+..+....
T Consensus       265 ------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 ------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                              234444444445678899999999999999999999999999876665443

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-42  Score=340.65  Aligned_cols=269  Identities=23%  Similarity=0.322  Sum_probs=205.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|++.+.||+|+||.||+|...      .++..+|+|.+.... ......+.+|+.+++.++|+||+++++++...+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHK------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEEC------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence            4578999999999999999999543      356789999886542 233466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999999988654  4688899999999999999999973 1399999999999999999999999999876


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-----------
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-----------  303 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-----------  303 (455)
                      .....    .....||..|+|||++.+..++.++|||||||++|+|++|+.||................           
T Consensus       154 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             hhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence            53321    223569999999999998889999999999999999999999997543221111000000           


Q ss_pred             -----------------hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          304 -----------------PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       304 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                                       +..........+.............+.++.+|+.+||+.||++|||+.++++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                             000000000000000000000112356789999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=369.13  Aligned_cols=269  Identities=30%  Similarity=0.437  Sum_probs=219.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+....+.||+|+||.||.|.+.+..- ......||||.+... ..+...+|++|..+|+.++|||||+++|+|....
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~-~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPG-SVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCC-CccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            34566778999999999999999876422 222567999998644 4567788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRY-----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      ..+|++|||+||+|..+|.+..     ...+.....+.++.|||+|+.||++..  +|||||.++|+||+....|||+||
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999997641     356888999999999999999999955  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |+|+.....+.........-...|||||.+..+.++.|+|||||||+|||+++ |..||...+..+....+.      . 
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~-  919 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------E-  919 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------h-
Confidence            99996554443332222233468999999999999999999999999999999 899998655432221111      0 


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                              ..  .-+.+..||..+.++|.+||+.+|++||++..|++.+..+....
T Consensus       920 --------gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  920 --------GG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             --------CC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                    11  22346778899999999999999999999999999877665443

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-42  Score=339.85  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=198.0

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHH---hcCCCCCcccEEEEEEeC
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFL---GQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~  153 (455)
                      |.+.+.||+|+||.||+|...      .+++.||||+++...   ......+..|+.++   +.++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            677899999999999999543      357889999986432   22234556665554   567899999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...|+||||+++|+|..++..   ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999999887753   46899999999999999999999976  9999999999999999999999999987


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........      .+..      
T Consensus       150 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~------  215 (324)
T cd05589         150 EGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVN------  215 (324)
T ss_pred             cCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh------
Confidence            5433222  1234679999999999999999999999999999999999999997654321111      0100      


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                          .  ...++...+..+.+++.+||..+|.+||     ++.+++++.+
T Consensus       216 ----~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~  259 (324)
T cd05589         216 ----D--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF  259 (324)
T ss_pred             ----C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence                0  0112344567789999999999999999     6888888743

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=340.35  Aligned_cols=254  Identities=26%  Similarity=0.289  Sum_probs=216.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh---hHHHHHHHHHHHhcCC-CCCcccEEEEEEe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ---GHREWLTEVIFLGQLR-HPHLVKLIGYCCE  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~  152 (455)
                      ...|.+.+.||.|.||.||++.      ++.+++.+|+|.+......   ....+.+|+.+|+.+. |||||.+++++..
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~------~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~  107 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCR------EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED  107 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEE------ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence            4578889999999999999994      3456899999999765443   3457889999999999 9999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC----CceEEcc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD----YTAKLSD  228 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~----~~~kL~D  228 (455)
                      ....++|||+|.||.|.+.|...   .+++..+..++.|++.++.|||+.|  |+||||||+|+|+...    +.++++|
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEee
Confidence            99999999999999999999876   3999999999999999999999977  9999999999999543    5799999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.........+.        
T Consensus       183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~--------  251 (382)
T KOG0032|consen  183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL--------  251 (382)
T ss_pred             CCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--------
Confidence            999998765   223455899999999999999999999999999999999999999998765432221111        


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            ..+..+...+.+..+..+.+++..||..||.+|+|+.++++|.|
T Consensus       252 ------~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  252 ------RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             ------cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                  01223445556677889999999999999999999999999966

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=317.53  Aligned_cols=256  Identities=24%  Similarity=0.332  Sum_probs=211.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .+.|++-+.||+|.|+.||++      .+..+|+.+|+|+++...  ....+++.+|+.|.+.|+|||||++.+.+....
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRC------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             chhhhHHHHHccCchHHHHHH------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            467888899999999999987      456688999999886432  235678889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~DfGl  231 (455)
                      ..|||+|+|.|++|..-|..+  ..+++..+-..+.||+++|.|+|.++  |||||+||+|+|+..   .--+||+|||+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccce
Confidence            999999999999998777665  46778888899999999999999977  999999999999954   44699999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      |.....+   ..-....|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+..+....+.      ..   
T Consensus       160 Ai~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~------~g---  227 (355)
T KOG0033|consen  160 AIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK------AG---  227 (355)
T ss_pred             EEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh------cc---
Confidence            9987622   22344789999999999999999999999999999999999999998643322211111      11   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                           +-.+.+.+.+..++++.+|+.+||..||.+|.|+.|.++|-|-
T Consensus       228 -----~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  228 -----AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             -----ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence                 1122333445667889999999999999999999999999654

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-42  Score=330.16  Aligned_cols=264  Identities=24%  Similarity=0.426  Sum_probs=207.2

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|++.+.||+|+||.||+|.+..... ...+..||||++.... .....++.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456789999999999999999997643221 2345779999885432 23445688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRY--------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      ...++||||+++|+|.+++....        ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence            99999999999999999886532        123567888999999999999999966  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      |+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......   .....  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV--  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH--
Confidence            999999876543322211222356788999999998899999999999999999999 788987643321   11100  


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .          ... ....+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus       235 -~----------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 -M----------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -H----------cCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence             0          000 01123345677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-42  Score=338.00  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||++....   ....++.||||++....    ......+..|+.+|+.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVT---GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcc---cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            679999999999986432   12457889999986432    12234567899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999988654  46788889999999999999999976  9999999999999999999999999987543322


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||........      ...+          ... 
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~----------~~~-  215 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKI----------LKG-  215 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHH----------HcC-
Confidence            1  12335799999999999988899999999999999999999999976533211      0000          011 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                       ...++...+..+.+|+.+||+.+|++||     ++.+++.|-+
T Consensus       216 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         216 -KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence             1122334567789999999999999999     8999998854

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=346.37  Aligned_cols=256  Identities=23%  Similarity=0.300  Sum_probs=202.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+|..++||||+++++++....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            47899999999999999999543      357889999986432   233355778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeeccccee
Confidence            999999999999999988764  46899999999999999999999976  99999999999999999999999999875


Q ss_pred             CCCCCCcc------------------------------------ceeccccCCCCcCccccccCCCCccCchhhHHHHHH
Q 012832          235 GPEGDDTH------------------------------------VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLL  278 (455)
Q Consensus       235 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  278 (455)
                      ........                                    .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            43211000                                    011246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 012832          279 ELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---MSTVVK  355 (455)
Q Consensus       279 ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt---~~ell~  355 (455)
                      ||++|..||..........      .+..    .    ...+........+.++.+|+.+||. +|.+|++   +.+++.
T Consensus       231 el~~G~~Pf~~~~~~~~~~------~i~~----~----~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYR------KIIN----W----KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHH------HHHc----C----CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999997654321110      0000    0    0001101111345678899999996 9999997   999998


Q ss_pred             hcc
Q 012832          356 TLE  358 (455)
Q Consensus       356 ~L~  358 (455)
                      |-+
T Consensus       296 h~~  298 (364)
T cd05599         296 HPF  298 (364)
T ss_pred             CCC
Confidence            854

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-42  Score=346.73  Aligned_cols=256  Identities=24%  Similarity=0.274  Sum_probs=199.5

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|.+.+.||+|+||.||+|...      .++..||||++....   ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            5888999999999999999543      357899999986432   2334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.++|+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999999988764  46888999999999999999999966  999999999999999999999999997532


Q ss_pred             CCCCC---------------------------------------------ccceeccccCCCCcCccccccCCCCccCch
Q 012832          236 PEGDD---------------------------------------------THVSTRVMGTQGYAAPEYVMTGHLTSMSDV  270 (455)
Q Consensus       236 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  270 (455)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             000123579999999999998899999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHh--ccCCCCCC
Q 012832          271 YSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCL--SHRPKQRP  348 (455)
Q Consensus       271 wslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl--~~~P~~RP  348 (455)
                      |||||++|||++|..||....+......+      ..    .    ...+........+.++.+|+.+|+  ..+|..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i------~~----~----~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKV------IN----W----ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHH------Hc----c----ccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999999999999999765432111100      00    0    000111111234567889998855  45555699


Q ss_pred             CHHHHHHhcc
Q 012832          349 TMSTVVKTLE  358 (455)
Q Consensus       349 t~~ell~~L~  358 (455)
                      ++.+++.|-+
T Consensus       298 ~~~~~l~hp~  307 (381)
T cd05626         298 GADDIKAHPF  307 (381)
T ss_pred             CHHHHhcCcc
Confidence            9999999844

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.4e-42  Score=326.82  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=209.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..+|.+.+.||+|+||.||+|.+.+      .+..||+|.+..+. .....+.+|+.+++.++|+||+++++++..+...
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEec------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            4568888999999999999997643      46789999886443 3356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++.......+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            99999999999999987665567899999999999999999999966  9999999999999999999999999998654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........   ..          .+.  
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~----------~~~--  219 (263)
T cd05052         156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE----------LLE--  219 (263)
T ss_pred             cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----------HHH--
Confidence            32211 1111234678999999999999999999999999999998 9999976432111   00          000  


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                        .......+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus       220 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 --KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              1112223445667899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.8e-42  Score=337.28  Aligned_cols=263  Identities=23%  Similarity=0.359  Sum_probs=207.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..+|++.+.||+|+||.||+|.+...  .......||+|.+.... ....+++.+|+.+++.++||||++++++|... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecC--CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            46799999999999999999976542  12234569999986443 34456788999999999999999999998764 5


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence            78999999999999988764 346888999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||+.......   ..    ...       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~----~~~-------  225 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILE-------  225 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHh-------
Confidence            54332221222345678999999999999999999999999999997 9999976432111   11    000       


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                         .......+..++.++.+++.+||..+|.+||++.+++..|..+..
T Consensus       226 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         226 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ---CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence               001111223445678999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-42  Score=331.44  Aligned_cols=266  Identities=27%  Similarity=0.416  Sum_probs=213.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..+|.+.+.||+|+||.||+|..... ........+++|.+..........+.+|+.+++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNL-SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeecc-CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            45688889999999999999965432 12234567999998766655567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      ++||||+++++|.+++....              ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence            99999999999999987542              234789999999999999999999966  99999999999999999


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~  301 (455)
                      .++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||.......   ....
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~  237 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC  237 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999976544332222233457889999999999999999999999999999998 999986543321   1110


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .             ... .....+..++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       238 ~-------------~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 I-------------TQG-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             H-------------hCC-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            0             000 0111223456789999999999999999999999999987743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5e-42  Score=330.96  Aligned_cols=267  Identities=27%  Similarity=0.414  Sum_probs=212.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||++...+. .....+..+|+|.+..........+.+|+.+++.++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccC-CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            346789999999999999999965332 1223456799999876555556778999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          156 RLLVYEYMPRGSLENQLFRRY-----------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      .++||||+++++|.+++....           ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcE
Confidence            999999999999999886432           134899999999999999999999966  9999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhh
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      +|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |.+||.......   ..... 
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i-  235 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI-  235 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-
Confidence            9999999986543322222223446788999999998899999999999999999998 999997543221   11100 


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                                  .... ....+...+.++.+|+.+||+.+|.+|||+.+++..|+.+..
T Consensus       236 ------------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         236 ------------TQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             ------------HcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                        0000 001122345679999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-42  Score=343.87  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|++.+.||+|+||.||+|..      ..+++.||||++....   ......+..|+.++..++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQK------KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEE------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4789999999999999999954      3357899999986432   223355778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..||||||++||+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            999999999999999988764  57899999999999999999999966  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHH
Q 012832          235 GPEGDDT---------------------------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL  281 (455)
Q Consensus       235 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  281 (455)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                 0012357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhc--cCCCCCCCHHHHHHhc
Q 012832          282 SGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLS--HRPKQRPTMSTVVKTL  357 (455)
Q Consensus       282 ~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~~P~~RPt~~ell~~L  357 (455)
                      +|..||....+......      +..    ...  ...++.  ....+.++.+++.+++.  .++..||++++|++|-
T Consensus       231 ~G~~Pf~~~~~~~~~~~------i~~----~~~--~~~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp  294 (363)
T cd05628         231 IGYPPFCSETPQETYKK------VMN----WKE--TLIFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP  294 (363)
T ss_pred             hCCCCCCCCCHHHHHHH------HHc----CcC--cccCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence            99999976543211110      000    000  000111  11234677888888664  2333568999999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-42  Score=329.91  Aligned_cols=261  Identities=29%  Similarity=0.430  Sum_probs=207.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+|++.+.||+|+||.||+|....  .+...+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYL--PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEec--CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            568888999999999999997533  123456789999986433 33346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          157 LLVYEYMPRGSLENQLFRRY---------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      ++||||+++++|.+++....               ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC
Confidence            99999999999999886432               134788889999999999999999966  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~  300 (455)
                      +.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......   ....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            9999999999986543332222233456778999999988889999999999999999998 99998754321   1111


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ...              .......+..++..+.+++.+||+.+|.+||++.+++++|..
T Consensus       238 ~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVR--------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH--------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            110              000111233456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-42  Score=340.35  Aligned_cols=269  Identities=24%  Similarity=0.344  Sum_probs=199.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC---
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE---  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  153 (455)
                      +|.+.+.||+|+||.||+|...      .++..||||.+...  .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            4788999999999999999543      35789999988632  223345678999999999999999999987543   


Q ss_pred             --CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          154 --EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       154 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                        ...|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCcc
Confidence              2479999999 57899888654  46899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCc-cceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-h-h--
Q 012832          232 AKDGPEGDDT-HVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-R-P--  304 (455)
Q Consensus       232 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~-~--  304 (455)
                      ++........ .......||+.|+|||++.+  ..++.++|||||||++|||++|++||...........+... . +  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9864332211 11233579999999999876  67899999999999999999999999765432221111100 0 0  


Q ss_pred             -----hh-HhhhhhcccCCCcccCCC---CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          305 -----ML-NDARKLGRIMDPRLEGQY---SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       305 -----~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           +. .........+.......+   ....+..+.+++.+||..+|++|||+.++++|-+
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence                 00 000000000111111111   1123567889999999999999999999999843

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.1e-42  Score=333.41  Aligned_cols=268  Identities=22%  Similarity=0.307  Sum_probs=200.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++..... .....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            468999999999999999999543      3578899999865432 223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+ .++|.+++... ...++...+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            99999999 46888877654 356888999999999999999999976  999999999999999999999999998754


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH-------
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN-------  307 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~-------  307 (455)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........  ..........       
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  229 (303)
T cd07869         154 SVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTW  229 (303)
T ss_pred             cCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhc
Confidence            32221  1233568999999999865 4588899999999999999999999986533211  1110000000       


Q ss_pred             -hhhhhcccCCCcccCCCCH---------HHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 -DARKLGRIMDPRLEGQYSE---------TGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 -~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       ............+....+.         ..+..+.+|+.+||+.||++|||+.++++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~  290 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY  290 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence             0000000000000000000         12356889999999999999999999999844

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-42  Score=339.19  Aligned_cols=258  Identities=27%  Similarity=0.325  Sum_probs=203.8

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  153 (455)
                      +|++.+.||+|+||.||++....   +..++..||+|++....    ......+..|+.++..++ |+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT---GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc---cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            48889999999999999986432   23467889999986432    223355778999999995 99999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++|+|.+++..+  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999988664  46899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+  ...+.      
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~------  224 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL------  224 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHh------
Confidence            65433222 12236799999999999865 4788999999999999999999999754322111111  00000      


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                        ..++    .++...+..+.+++.+||..+|++||     +++++++|.+
T Consensus       225 --~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         225 --KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             --cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence              0111    22334567789999999999999999     7889998854

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-43  Score=346.15  Aligned_cols=257  Identities=28%  Similarity=0.318  Sum_probs=206.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+..|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            46889999999999999999543      3578999999865422   33456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999998765  57899999999999999999999966  99999999999999999999999999986


Q ss_pred             CCCCC---------------------------CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCC
Q 012832          235 GPEGD---------------------------DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       235 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~  287 (455)
                      .....                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54432                           001122356999999999999999999999999999999999999999


Q ss_pred             CCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHhccc
Q 012832          288 DKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-MSTVVKTLEP  359 (455)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-~~ell~~L~~  359 (455)
                      ..........      .+..    .    ...+........+.++.+|+.+||. +|.+||+ +.++++|.+.
T Consensus       231 ~~~~~~~~~~------~i~~----~----~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         231 YSDTLQETYN------KIIN----W----KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             CCCCHHHHHH------HHhc----c----CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            7654221110      0000    0    0111111111246789999999997 9999999 9999998543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.5e-42  Score=331.35  Aligned_cols=269  Identities=25%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcC---CCCCcccEEEEEEe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL---RHPHLVKLIGYCCE  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~  152 (455)
                      ++|.+.+.||+|+||.||+|....     ..+..||+|.+.....  .....+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK-----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC-----CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            368899999999999999996432     2357899998864322  2233455677776655   69999999998852


Q ss_pred             -----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          153 -----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       153 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                           ....++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEc
Confidence                 456899999995 69999887765567899999999999999999999966  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhhh-h
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WARP-M  305 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~~-~  305 (455)
                      |||++.......   ......||+.|+|||++.+..++.++|||||||++|||++|.+||...........+. .... .
T Consensus       153 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         153 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             cccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            999997654321   2233579999999999998899999999999999999999999998754322211111 0000 0


Q ss_pred             hHhhh---hh-cccCCCccc---CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          306 LNDAR---KL-GRIMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       306 ~~~~~---~~-~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .....   .. .....+...   .......+..+.+|+.+||+.+|++|||+.++++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp  288 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  288 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence            00000   00 000000000   011123456788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.3e-42  Score=338.06  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=199.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCC-CcccEEEEEEeCC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHP-HLVKLIGYCCEEE  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~  154 (455)
                      +|.+.+.||+|+||.||+|....      +++.||||++....   ......+..|..++..+.|+ +|+.+++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            57889999999999999996433      56789999986432   23345677899999999764 6888999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            999999999999999888654  46889999999999999999999966  99999999999999999999999999875


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....   +         
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~---i---------  213 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQS---I---------  213 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH---H---------
Confidence            332221  1233679999999999999999999999999999999999999997653211   1110   0         


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHhc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKTL  357 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~L  357 (455)
                       ..  ....++...+.++.+++.+||..+|.+|++.     .++++|.
T Consensus       214 -~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp  258 (324)
T cd05587         214 -ME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA  258 (324)
T ss_pred             -Hc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence             00  0112334456788999999999999999986     6777763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=324.27  Aligned_cols=267  Identities=23%  Similarity=0.281  Sum_probs=205.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCC-cccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPH-LVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~  154 (455)
                      ..|...+.||+|+||+||+|..      +.+++.||+|++..+...  .....++|+-+|+.|+|+| |+.+++++....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~------~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARS------KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEE------ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            4466677799999999999954      456789999998765432  3355689999999999999 999999998877


Q ss_pred             ------eEEEEEEecCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          155 ------HRLLVYEYMPRGSLENQLFRRYS--VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       155 ------~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                            .++|||||+ ..+|..++.....  ..++...+..++.||+.||+|||+++  |+||||||+||||+..|.+||
T Consensus        85 ~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             cccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEee
Confidence                  889999999 5699999877643  36777889999999999999999977  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--  303 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--  303 (455)
                      +|||+|+...-...  ..+..++|.+|.|||++.+. .|+...||||+|||++||+++++.|.+.....+...+--..  
T Consensus       162 aDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  162 ADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             eccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            99999996543322  24456799999999999887 69999999999999999999999999877643333222110  


Q ss_pred             hh---hHhhhhhcccCCCccc-----CCCCHHHH---HHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          304 PM---LNDARKLGRIMDPRLE-----GQYSETGA---RKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       304 ~~---~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      +.   +.....+... +..+.     ..+....+   .+..+++.+||+.+|.+|.|+..++.|
T Consensus       240 P~e~~Wp~v~~~~~~-k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDY-KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccc-cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00   0000000000 00011     01111111   378899999999999999999999998

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-42  Score=331.20  Aligned_cols=255  Identities=27%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      +|++.+.||+|+||.||++...      .++..||+|++.....   .....+.+|+.+++.++||||+++++.+..++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            4788899999999999999543      3577899999864322   223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999998887655567899999999999999999999966  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....   .....|++.|+|||++.+..++.++|||||||++|||++|..||...........+.      ..   +   
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~------~~---~---  217 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE------RR---V---  217 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH------HH---h---
Confidence            33221   123579999999999998899999999999999999999999997643221111000      00   0   


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                       . .....++...+..+.+|+.+||..||++||     ++.++++|.+
T Consensus       218 -~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         218 -K-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             -h-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence             0 011123344567789999999999999999     8889988843

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-42  Score=329.48  Aligned_cols=255  Identities=35%  Similarity=0.551  Sum_probs=200.3

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEE
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      +.+.||.|+||.||+|.+..  .....+..|+||.+.... ......+.+|+..+++++||||++++|++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            45789999999999998874  234567899999996533 334678999999999999999999999999888899999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      ||+++|+|.++|.......+++..++.|+.||+.||+|||+.+  ++|+||+++|||++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            9999999999998875678999999999999999999999966  99999999999999999999999999987633322


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ........+...|+|||.+....++.++||||||+++|||++ |..||.......   .....    .   .       .
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~----~---~-------~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL----K---Q-------G  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH----H---T-------T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----c---c-------c
Confidence            222223457788999999999889999999999999999999 789986543211   11110    0   0       0


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .....+..++..+.+++.+||..+|++|||+.+|++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11122344567899999999999999999999999865

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=326.80  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=213.0

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      -|.+...||+|+||.||+|      -++.+|+.||||.+..+  .+.++++.|+.++++++.|++|++||.+.....+|+
T Consensus        34 VFDi~~KLGEGSYGSV~KA------IH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKA------IHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHhcCCcchHHHHH------HHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            4677888999999999999      45568999999998655  456889999999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      |||||..|++.+.+..+ .+++.+.++..++...+.||+|||...  -||||||+.|||++.+|.+||+|||+|.++...
T Consensus       106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99999999999987655 579999999999999999999999966  799999999999999999999999999876432


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                      -  -...++.||+.|||||++..-.|+.++||||||++..||.-|++||....+.+....+.               .+|
T Consensus       183 M--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~P  245 (502)
T KOG0574|consen  183 M--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TKP  245 (502)
T ss_pred             H--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CCC
Confidence            2  12345889999999999999999999999999999999999999998765543221111               011


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ...-.-++..+.++.++++.||..+|++|-|+.++++|
T Consensus       246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11112356678899999999999999999999999998

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.2e-42  Score=337.50  Aligned_cols=245  Identities=26%  Similarity=0.369  Sum_probs=196.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .++..||||++....   ......+..|..++..+ +||||+++++++...+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLK------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEc------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            46999999999999643      357789999986432   23345567888888776 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            9999999999888654  56899999999999999999999966  9999999999999999999999999987543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..   .+..          . 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~---~i~~----------~-  211 (320)
T cd05590         151 K--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE---AILN----------D-  211 (320)
T ss_pred             C--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH---HHhc----------C-
Confidence            1  12346799999999999999999999999999999999999999976543211   11   1110          0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHhcc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTM------STVVKTLE  358 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~------~ell~~L~  358 (455)
                       ...++...+.++.+|+.+||+.||++||++      +++++|-+
T Consensus       212 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         212 -EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence             011233356788999999999999999998      77887743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.4e-42  Score=337.52  Aligned_cols=245  Identities=27%  Similarity=0.373  Sum_probs=197.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .+++.||||++....   ......+..|..++..+ +||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELK------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEEC------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            46999999999999643      357789999986532   23335567888888866 799999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            9999999999888654  56889999999999999999999976  9999999999999999999999999987543322


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .+..          . 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~---~i~~----------~-  211 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE---SILH----------D-  211 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH---HHHc----------C-
Confidence            2  1233679999999999999899999999999999999999999998654321   111   1110          0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCC-------CHHHHHHhcc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRP-------TMSTVVKTLE  358 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RP-------t~~ell~~L~  358 (455)
                       ...++...+.++.+|+.+||..+|++||       ++.++++|.+
T Consensus       212 -~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         212 -DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence             0112333457889999999999999999       8889988843

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.6e-42  Score=335.81  Aligned_cols=243  Identities=26%  Similarity=0.389  Sum_probs=193.2

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhc-CCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQ-LRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|....      +++.||||++....   ......+..|..++.. .+||||+++++++......++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999996543      56789999986432   1223445567777765 4799999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||++||+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            9999999999888654  46899999999999999999999966  9999999999999999999999999997543322


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ..   .+.          .  
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~---~i~----------~--  210 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FD---SIL----------N--  210 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HH---HHH----------c--
Confidence              122346799999999999998999999999999999999999999976532111   10   000          0  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHHh
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMS-TVVKT  356 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~-ell~~  356 (455)
                      ....++...+.++.+|+.+||+.+|.+||++. ++++|
T Consensus       211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            01123344567789999999999999999875 66665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-42  Score=346.07  Aligned_cols=255  Identities=24%  Similarity=0.287  Sum_probs=199.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++|+||+++++.+...+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            5888999999999999999543      357889999986432   2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++|||||++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999999999988654  46888999999999999999999976  999999999999999999999999997532


Q ss_pred             CCCCC---------------------------------------------ccceeccccCCCCcCccccccCCCCccCch
Q 012832          236 PEGDD---------------------------------------------THVSTRVMGTQGYAAPEYVMTGHLTSMSDV  270 (455)
Q Consensus       236 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  270 (455)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            10000                                             000122479999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-
Q 012832          271 YSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-  349 (455)
Q Consensus       271 wslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-  349 (455)
                      |||||++|||++|.+||....+......+      ..        ....+........+.++.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i------~~--------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKV------IN--------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHH------Hc--------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            99999999999999999765432111100      00        0011111112234567888888876 59999987 


Q ss_pred             --HHHHHHhcc
Q 012832          350 --MSTVVKTLE  358 (455)
Q Consensus       350 --~~ell~~L~  358 (455)
                        +.++++|-.
T Consensus       297 ~~~~ei~~hp~  307 (382)
T cd05625         297 NGADEIKAHPF  307 (382)
T ss_pred             CCHHHHhcCCC
Confidence              999998843

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.6e-42  Score=324.98  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=207.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|++.+.||+|+||.||+|...+       +..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNN-------STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecC-------CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45689999999999999999996543       3569999876433 235678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.......+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceec
Confidence            999999999999999997766677899999999999999999999966  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .....          ..
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----------~~  219 (261)
T cd05072         154 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----------QR  219 (261)
T ss_pred             CCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----------Hc
Confidence            432211 1122346778999999998889999999999999999998 999997543221   11110          00


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..    ........+.++.+++.+||..+|++||+++++++.|+.
T Consensus       220 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 GY----RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CC----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            00    111123355778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=323.73  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=209.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|.+...   ......||||.++... .....++.+|+.+++.++||||+++++++.....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLP---GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccC---CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            46799999999999999999976542   2235679999886543 2344678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||++...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999999887643 47899999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....          ..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----------~~  223 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----------ED  223 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----------Hc
Confidence            53222222222345678999999998899999999999999999998 999986543211   11110          00


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                          ......+..++..+.+|+.+||+.+|++||++.+++++|+.+
T Consensus       224 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 ----GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                001112234567789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=345.32  Aligned_cols=257  Identities=21%  Similarity=0.246  Sum_probs=199.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            46889999999999999999543      357889999885432   223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|+||||++||+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999999988654  56889999999999999999999976  99999999999999999999999999863


Q ss_pred             CCCCCCc------------c---------------------------------ceeccccCCCCcCccccccCCCCccCc
Q 012832          235 GPEGDDT------------H---------------------------------VSTRVMGTQGYAAPEYVMTGHLTSMSD  269 (455)
Q Consensus       235 ~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  269 (455)
                      .......            .                                 .....+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            2211000            0                                 001246999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCC--
Q 012832          270 VYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR--  347 (455)
Q Consensus       270 vwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R--  347 (455)
                      ||||||++|||++|.+||..........      .+..    ..    ..+.-.-....+.++.+|+.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~------~i~~----~~----~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYR------KIIN----WR----ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHH------HHHc----cC----CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999997654321111      0000    00    000000011245678999999997 67665  


Q ss_pred             -CCHHHHHHhccc
Q 012832          348 -PTMSTVVKTLEP  359 (455)
Q Consensus       348 -Pt~~ell~~L~~  359 (455)
                       +++.+++.|.+.
T Consensus       296 r~~~~~~l~hp~~  308 (377)
T cd05629         296 RGGAHEIKSHPFF  308 (377)
T ss_pred             CCCHHHHhcCCCc
Confidence             699999998543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.1e-42  Score=336.82  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=198.4

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .+++.||+|+++...   ......+..|..++..+ +||||+++++++......|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELK------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            46999999999999643      357889999987532   22335577899999888 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            9999999999887654  57999999999999999999999966  9999999999999999999999999987532222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccc--hhhHHHhhhhhhHhhhhhcccCC
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR--EQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||+......  ......+....+         ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~  219 (329)
T cd05588         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LE  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------Hc
Confidence            1  1234679999999999999999999999999999999999999997432211  111111111110         01


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCC------HHHHHHhcc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPT------MSTVVKTLE  358 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt------~~ell~~L~  358 (455)
                      .  ...++...+.++.+++.+||..+|.+||+      +.++++|-+
T Consensus       220 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05588         220 K--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF  264 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence            1  01223345677899999999999999997      688888744

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-42  Score=343.09  Aligned_cols=265  Identities=19%  Similarity=0.218  Sum_probs=199.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ...+|.+.+.||+|+||.||+|...      .+++.||+|....      ..+.+|+.+|+.++||||+++++++.....
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDN------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEEC------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            3467999999999999999999543      3578899997532      346789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++|||++ +++|..++...  ..+++..++.++.||+.||+|||+.+  ||||||||+|||++.++.++|+|||++...
T Consensus       158 ~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        158 TCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             eEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            99999999 57898887654  46889999999999999999999976  999999999999999999999999999754


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccc-----hhhHHHhhhhh-----
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR-----EQSLVEWARPM-----  305 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~-----~~~~~~~~~~~-----  305 (455)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.......     ...+.......     
T Consensus       233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        233 VDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            322211 1233679999999999999999999999999999999999998864322110     00000000000     


Q ss_pred             ---------hHhh--hhhcc-cCCCcccCC--CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 ---------LNDA--RKLGR-IMDPRLEGQ--YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ---------~~~~--~~~~~-~~~~~~~~~--~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                               +...  ..... ...+.....  .....+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence                     0000  00000 000000000  01134668899999999999999999999999854

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-42  Score=335.58  Aligned_cols=244  Identities=27%  Similarity=0.378  Sum_probs=194.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhc-CCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQ-LRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .++..||+|.++...   ......+..|..++.. ++||||+++++++...+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELK------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            46999999999999643      357889999986532   1233456678888775 4899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+.+|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++......
T Consensus        75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            9999999999888654  56888999999999999999999976  9999999999999999999999999987532222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   ......       .    ...  
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~-------~----~~~--  212 (316)
T cd05620         151 N--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI-------R----VDT--  212 (316)
T ss_pred             C--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH-------H----hCC--
Confidence            1  133467999999999999999999999999999999999999999754321   111100       0    001  


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-HHHHHhc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTM-STVVKTL  357 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-~ell~~L  357 (455)
                        ..++...+.++.+|+.+||+.||++||++ +++++|.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~  249 (316)
T cd05620         213 --PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHP  249 (316)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence              12233355778999999999999999998 4677663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=355.53  Aligned_cols=259  Identities=25%  Similarity=0.299  Sum_probs=207.2

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ....++|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+|..++|+||+++++.+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRV------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEc------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            345679999999999999999999543      357899999986543  234456788999999999999999988765


Q ss_pred             eCC--------eEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          152 EEE--------HRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       152 ~~~--------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      ..+        .+++||||+++|+|.+++..+.  ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC
Confidence            432        3689999999999999886532  356889999999999999999999966  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      +.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|..||.......      .
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~  253 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------V  253 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------H
Confidence            9999999999986543322222344679999999999999999999999999999999999999997643211      1


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ......          . .....+...+.++.+|+.+||..+|.+||++.+++++.
T Consensus       254 ~~~~~~----------~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        254 MHKTLA----------G-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             HHHHhc----------C-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            111100          0 01123445567899999999999999999999999873

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-42  Score=340.73  Aligned_cols=253  Identities=25%  Similarity=0.301  Sum_probs=197.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+|...+.||+|+||.||+|...      .+++.||||++..... .....+.+|+.+|+.++|+||+++++++...+..
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            45777889999999999999643      3567899999854332 3346688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++|+|.+.      ....+..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++....
T Consensus       148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999999999998653      23566778899999999999999976  9999999999999999999999999998654


Q ss_pred             CCCCccceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+...          
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----------  287 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----------  287 (353)
T ss_pred             cccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----------
Confidence            3221  1223579999999998743     2345689999999999999999999974322111111110          


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ...    ......+..++.++.+||.+||..+|++|||+.++++|-+..
T Consensus       288 ~~~----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~  332 (353)
T PLN00034        288 ICM----SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL  332 (353)
T ss_pred             Hhc----cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence            000    001122334567899999999999999999999999985543

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.8e-42  Score=324.74  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=211.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ...+|.+.+.||.|+||.||+|...+       +..+|+|.+..........+..|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            34578899999999999999996533       56899999877666566778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.......+++..+..++.|++.||.|||+.+  |+|+||+|+|||++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhc
Confidence            999999999999999998766667899999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......   .        
T Consensus       155 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~--------  218 (261)
T cd05148         155 KEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI---T--------  218 (261)
T ss_pred             CCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH---H--------
Confidence            432211  122346778999999988889999999999999999998 89999764321   111110   0        


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         .......+..++..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       219 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 ---AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               011112234556788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-42  Score=346.51  Aligned_cols=256  Identities=23%  Similarity=0.266  Sum_probs=200.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .+|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+.+|+.++|+||+++++.+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            36899999999999999999543      3578999999864322   23455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999999998664  46888999999999999999999976  99999999999999999999999999753


Q ss_pred             CCCCCC-----------------------------------------ccceeccccCCCCcCccccccCCCCccCchhhH
Q 012832          235 GPEGDD-----------------------------------------THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSF  273 (455)
Q Consensus       235 ~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  273 (455)
                      ......                                         .......+||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            210000                                         000112579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC---CH
Q 012832          274 GVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP---TM  350 (455)
Q Consensus       274 G~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP---t~  350 (455)
                      ||++|||++|..||....+......+.          ..    ...+........+.++.+++.+|+ .+|.+|+   ++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~----------~~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVI----------NW----ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHh----------cc----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            999999999999998654322111100          00    001111112234567888998876 5999999   99


Q ss_pred             HHHHHhcc
Q 012832          351 STVVKTLE  358 (455)
Q Consensus       351 ~ell~~L~  358 (455)
                      .++++|-+
T Consensus       296 ~ell~h~~  303 (376)
T cd05598         296 DEIKAHPF  303 (376)
T ss_pred             HHHhCCCC
Confidence            99999844

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.2e-42  Score=345.22  Aligned_cols=260  Identities=22%  Similarity=0.241  Sum_probs=204.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      ....++|.+.+.||+|+||.||+|...      .++..||+|++....   ......+..|+.+++.++||||+++++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHK------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            345678999999999999999999543      357889999986432   22334567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ......++||||++||+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEecc
Confidence            9999999999999999999988543   5788889999999999999999966  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      ++......... .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||........      ...+.
T Consensus       188 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~  260 (370)
T cd05596         188 TCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIM  260 (370)
T ss_pred             ceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHH
Confidence            99765432211 12335799999999998653    478999999999999999999999976432111      00111


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~~  359 (455)
                      ..        ...+........+.++.+|+.+||..+|.+  ||++.++++|.+.
T Consensus       261 ~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         261 DH--------KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             cC--------CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence            00        000111111234678899999999999988  9999999999543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-42  Score=336.41  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=199.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      +|.+.+.||+|+||.||+|...      .++..||+|++.....   .....+..|..++..+ +|++|+++++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            5788999999999999999643      3567899999864322   2234466788888777 4899999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            999999999999999888654  46889999999999999999999976  99999999999999999999999999975


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||........   ..   .+.        
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~---~i~--------  214 (323)
T cd05616         151 NMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ---SIM--------  214 (323)
T ss_pred             cCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HH---HHH--------
Confidence            432221  12346799999999999999999999999999999999999999976543211   11   000        


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHh
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKT  356 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~  356 (455)
                        ..  ...++...+.++.+|+.+||+.+|.+|++.     .++++|
T Consensus       215 --~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         215 --EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --hC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence              00  112334456788999999999999999985     667665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.4e-42  Score=328.30  Aligned_cols=262  Identities=26%  Similarity=0.387  Sum_probs=207.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+|.+.+.||+|+||.||+|...+. .....+..||+|++...... ....+..|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecC-CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4577788999999999999976542 12334678999998754332 345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      ++++||+.+++|.+++....              ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCC
Confidence            99999999999999885321              234788889999999999999999976  99999999999999999


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~  301 (455)
                      .+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.......   ....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEM  238 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999886544332222233456789999999988889999999999999999998 888887543211   1111


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .   .          +. ....++..++..+.+|+.+||+.+|++||++.+|+..|+.
T Consensus       239 i---~----------~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 I---R----------NR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H---H----------cC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            0   0          00 0112344567789999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-41  Score=325.68  Aligned_cols=263  Identities=27%  Similarity=0.402  Sum_probs=209.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ...+|...+.||+|+||.||+|...+. .....+..+|+|.+..........+.+|+.+++.++|+||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecC-CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            345788899999999999999865331 2234566899998876655666788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYS-------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      .++||||+++++|.+++.....             ..+++..++.++.|++.||+|||+.+  |+||||||+|||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~  159 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCC
Confidence            9999999999999998875421             35788999999999999999999966  99999999999999999


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~  301 (455)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||............. 
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-
Confidence            999999999976543322122223446788999999999999999999999999999998 999986543221111000 


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                  .    ......+..++..+.+|+.+||+.+|.+||++.++++.|+
T Consensus       239 ------------~----~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 ------------Q----GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ------------c----CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                        0    0011122345677899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.7e-42  Score=333.50  Aligned_cols=243  Identities=28%  Similarity=0.422  Sum_probs=193.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhc-CCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQ-LRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|....      ++..||||++....   ......+..|..++.. ++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            469999999999996543      56789999986542   1233445667778775 4899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            9999999999988654  46888999999999999999999976  9999999999999999999999999987543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   +....       .    ...+ 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i-------~----~~~~-  213 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI-------R----MDNP-  213 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH-------H----hCCC-
Confidence            1  1234679999999999999999999999999999999999999997643221   11110       0    0011 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHHh
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMS-TVVKT  356 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~-ell~~  356 (455)
                         .++...+.++.+++.+||+.+|.+||++. ++++|
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence               12233456789999999999999999997 67665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=330.74  Aligned_cols=268  Identities=26%  Similarity=0.368  Sum_probs=211.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      .+..++|.+.+.||+|+||.||+|..... .....+..||+|.++... ....+.+.+|+.+++.+ +|+||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecC-CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            34556899999999999999999975321 223456789999886443 23345688999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..++||||+.+|+|.+++.......+++.++..++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||+
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999999987654455899999999999999999999966  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +................++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ....    ..   
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~----~~---  258 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL----IK---  258 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH----HH---
Confidence            986544322111222346788999999999999999999999999999998 9999875432111  1110    00   


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                             .......+...+.++.+++.+||..+|++|||+.++++.|..+
T Consensus       259 -------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 -------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   0011112223456799999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=321.66  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=206.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|++.+.||+|+||.||+|....       +..||+|.+.... .....+.+|+.+++.++|+||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE   74 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence            345679999999999999999996432       3579999986543 23466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            9999999999999999987765567899999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+             .
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------------~  218 (261)
T cd05068         153 IKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-------------D  218 (261)
T ss_pred             ccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------------H
Confidence            6432111 1111223457999999998899999999999999999999 99999764322111000             0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .    ......+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus       219 ~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         219 Q----GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             c----CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0    01111233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=307.99  Aligned_cols=268  Identities=25%  Similarity=0.336  Sum_probs=214.5

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +.+..++|.+.+.||+|||.-||++      .+..++..||+|++.....++.+..++|++..++++||||++++++...
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLV------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeee------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            3456789999999999999999998      3556788999999988877888889999999999999999999987654


Q ss_pred             CC-----eEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          153 EE-----HRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       153 ~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      +.     ..||+++|...|+|.+.+....  +..+++.++++|+.+|++||++||+...+++||||||.|||+.+.+.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            43     4899999999999999987653  4478999999999999999999999888899999999999999999999


Q ss_pred             EccCCCccCCCCCCCcc-------ceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccch
Q 012832          226 LSDFGLAKDGPEGDDTH-------VSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE  295 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~  295 (455)
                      |.|||.+...+-.-...       .-..-..|..|.|||.+.   +...+.++|||||||+||+|+.|..||+..-. ..
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~G  248 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QG  248 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cC
Confidence            99999998654221110       011134789999999985   45688999999999999999999999975321 11


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .++             .-.+.++.+..+-....+..+.+|++.||+.||.+||++.+++.+++.+
T Consensus       249 gSl-------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  249 GSL-------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             CeE-------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            100             0011111222222233678899999999999999999999999988765

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-41  Score=335.16  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=196.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .+++.||+|++...   .......+..|+.++..+ +||||+++++++......++|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            46999999999999643      35778999998643   223344567888888776 799999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|..++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            9999999999887654  57899999999999999999999976  9999999999999999999999999997543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccc--hhhHHHhhhhhhHhhhhhcccCC
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR--EQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+.....         ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~  219 (329)
T cd05618         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LE  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hc
Confidence            1  1233679999999999999999999999999999999999999996422111  111111111100         00


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCC------HHHHHHhc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPT------MSTVVKTL  357 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt------~~ell~~L  357 (455)
                      .  ...++...+..+.+|+.+||..+|++||+      +.++++|-
T Consensus       220 ~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05618         220 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  263 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence            0  11234445677899999999999999998      57888774

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-41  Score=326.80  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=198.2

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||+|+||.||++...      .+++.||+|.+.....   .....+..|+.+++.++|+||+++++++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMR------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEc------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            799999999999543      3578999999864332   2235567899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          163 MPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       163 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      +++|+|.+++...  ....+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999999877542  2356899999999999999999999966  99999999999999999999999999976543322


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                      .  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  ....          .+...  
T Consensus       153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~----------~~~~~--  216 (280)
T cd05608         153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQ----------RILND--  216 (280)
T ss_pred             c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHH----------hhccc--
Confidence            1  233579999999999999999999999999999999999999997543221110  0000          01111  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTL  357 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L  357 (455)
                      ...++...+..+.+++.+||+.+|++||     +++++++|-
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~  258 (280)
T cd05608         217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP  258 (280)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence            1123445667899999999999999999     788898874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-41  Score=327.32  Aligned_cols=263  Identities=29%  Similarity=0.435  Sum_probs=207.0

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +|.+.+.||+|+||.||+|..... ........+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecC-CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            478889999999999999976432 1122345689998764432 33467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRY----------------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASN  215 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~N  215 (455)
                      +||||+.+|+|.+++....                      ...+++..++.++.|++.||+|||+.+  |+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence            9999999999999876421                      134788899999999999999999966  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccc
Q 012832          216 ILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQR  294 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~  294 (455)
                      ||+++++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543322211222456778999999988889999999999999999998 999997654321


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         +..+.              ........+..++.++.+++.+||+.+|++||++.++++.|+.+.
T Consensus       238 ---~~~~~--------------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 ---LFNLL--------------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ---HHHHH--------------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence               11111              001111223345578999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-41  Score=324.59  Aligned_cols=263  Identities=26%  Similarity=0.381  Sum_probs=205.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|.+...  +......|++|.+..... ....++..|+..++.+.||||+++++++. ...
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPE--GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCC--CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            35788899999999999999976432  112234688888754322 33456778888999999999999999875 456


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .+++|||+++|+|.+++... ...+++..+..++.||+.||+|||+.+  ++||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            78999999999999998754 357899999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............|+..|+|||.+.++.++.++|||||||++|||++ |..||....+......+.       .      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~------  226 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------K------  226 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------C------
Confidence            54333222334567889999999998899999999999999999998 999997654322111110       0      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          ......+..++..+.+++.+||..+|++|||+.++++.|..+..
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         227 ----GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                00001122245678889999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-41  Score=333.52  Aligned_cols=244  Identities=28%  Similarity=0.409  Sum_probs=197.3

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .++..||||++....   ......+..|..++..+ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELK------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999643      356789999986432   23345567888888877 699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            9999999999887654  47899999999999999999999966  9999999999999999999999999987533222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .+.          .. 
T Consensus       151 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~---~i~----------~~-  211 (318)
T cd05570         151 VT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ---SIL----------ED-  211 (318)
T ss_pred             Cc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH---HHH----------cC-
Confidence            11  233579999999999999999999999999999999999999997543211   111   000          00 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHhc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKTL  357 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~L  357 (455)
                       ...++...+..+.+|+.+||..+|++||++     .+++++-
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence             011233456788999999999999999999     8888874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4e-42  Score=338.26  Aligned_cols=256  Identities=22%  Similarity=0.238  Sum_probs=203.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|+++....   .....+..|+.+++.++|+||+++++++....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            46889999999999999999543      3578899999875432   23455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeE
Confidence            999999999999999988664 347899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccc------cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVM------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ....... ......||+.|+|||++.      +..++.++|||||||++|||++|..||........      ...+...
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~  224 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNF  224 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcC
Confidence            5433222 223357999999999986      45678999999999999999999999976433211      1111100


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ..    .+........+.++.+|+..||. +|++|||+.+++.|-+
T Consensus       225 ----~~----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         225 ----QR----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             ----CC----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence                00    00001112345778999999998 9999999999998844

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-41  Score=323.73  Aligned_cols=263  Identities=28%  Similarity=0.405  Sum_probs=206.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .+++|.+.+.||+|+||.||+|.+.... ....+..||+|.+.... ......+..|+.+++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRD-GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCC-CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            4567999999999999999999765421 11256789999886443 333456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC---ceEE
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYS-----VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY---TAKL  226 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~---~~kL  226 (455)
                      ..++||||+++++|.+++.....     ..+++..++.++.||+.||+|||+.+  ++||||||+|||++.++   .++|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence            99999999999999998866431     35889999999999999999999976  99999999999998654   6999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........+.     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-----  235 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-----  235 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence            99999986533222111112334568999999998999999999999999999997 999997644321111100     


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                  .......+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus       236 ------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 ------------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                        00111223445678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-41  Score=327.68  Aligned_cols=268  Identities=27%  Similarity=0.390  Sum_probs=211.5

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +.+..++|.+.+.||+|+||.||+|...... .......+|+|.+.... .....++.+|+.++..+ +|+||+++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLD-NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCC-CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4556678999999999999999999765421 12345689999886532 23445688999999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRR--------------YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      ......++||||+++|+|.+++...              ....+++..++.++.|++.||+|||+.+  |+||||||+||
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Ni  163 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNV  163 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeE
Confidence            9999999999999999999998642              2356889999999999999999999866  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccch
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE  295 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~  295 (455)
                      |++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999987544322221222345678999999988899999999999999999997 9999875432211


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ....                 ........+..++..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus       244 ~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 FKLL-----------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHH-----------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1100                 00011112334567899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=319.99  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-----hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ++|.+.+.||+|+||.||.|...      .++..||+|.+.....     .....+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            57999999999999999999543      3467899998754321     223567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccc
Confidence            99999999999999999988654  46888999999999999999999976  999999999999999999999999998


Q ss_pred             cCCCCCCCccc-eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHV-STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.........  ..           
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~-----------  218 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI--FK-----------  218 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH--HH-----------
Confidence            76543221111 12356889999999999988999999999999999999999999654221110  00           


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         .........++...+..+.+++.+||..+|.+|||+.+++++.+
T Consensus       219 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         219 ---IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             ---HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence               00111122334456678899999999999999999999998853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.6e-42  Score=341.62  Aligned_cols=262  Identities=22%  Similarity=0.260  Sum_probs=203.7

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      .+....++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHK------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            34455678999999999999999999543      357889999985422   223345778999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      ++..+...|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999988543   5788999999999999999999966  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      ||++......... .....+||+.|+|||++.+.    .++.++|||||||++|+|++|..||........      ...
T Consensus       186 FG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~  258 (370)
T cd05621         186 FGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSK  258 (370)
T ss_pred             cccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence            9999865432221 12346799999999999754    378899999999999999999999976432111      001


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhccc
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLEP  359 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~~  359 (455)
                      +....        ..+........+..+.+++..||..++.+  ||++.++++|.+.
T Consensus       259 i~~~~--------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         259 IMDHK--------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             HHhCC--------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence            11000        00111111234677889999999855543  8999999999553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-43  Score=340.50  Aligned_cols=250  Identities=32%  Similarity=0.439  Sum_probs=206.8

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH---HHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---REWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|.-.+-||.|+||.||-|      ++..+.+.||||++...+.+..   ++++.|+.+|++++|||++.+-|+|..+..
T Consensus        27 lf~dLrEIGHGSFGAVYfA------rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEe------eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            4777888999999999998      3455788999999987665444   567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .||||||| -|+-.|++.-. .+++-+.++..|+.+.+.||+|||+++  .||||||+.|||+++.|.|||+|||.|...
T Consensus       101 aWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhc
Confidence            99999999 56777766533 468889999999999999999999988  999999999999999999999999999766


Q ss_pred             CCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .+.      ..++|||.|||||+|.   .+.|+.++||||||+++.||.-.+||+-..+.....-  .           +
T Consensus       177 ~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY--H-----------I  237 (948)
T KOG0577|consen  177 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H-----------I  237 (948)
T ss_pred             Cch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH--H-----------H
Confidence            543      2378999999999985   5789999999999999999999999976543321111  1           1


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ...-.|.+.   ....+..+++|+..||++-|.+|||.+++++|---+
T Consensus       238 AQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  238 AQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             HhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence            111123332   456678899999999999999999999999985433

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=324.27  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=209.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|...... ....+..||+|.+.... ......+.+|+.+|+.++|+||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVV-KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccC-CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            4568899999999999999999765421 13356789999986443 234456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          155 HRLLVYEYMPRGSLENQLFRRY--------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                      ..++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEE
Confidence            9999999999999999986532        224678899999999999999999866  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+.   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~---  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV---  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH---
Confidence            99999986544332222233457889999999988889999999999999999998 999997543321   11111   


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .         . ......+..++..+.+++.+||..+|++|||+.+++..|+
T Consensus       235 -~---------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 -I---------D-GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -h---------c-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             0         0 0011123334678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-41  Score=333.56  Aligned_cols=244  Identities=27%  Similarity=0.363  Sum_probs=193.1

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHH-HHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVI-FLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      .+++.||||++.....   .....+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            46999999999999643      3578999999864322   22334455544 56789999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            9999999999888654  57889999999999999999999976  9999999999999999999999999987543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ....+..          ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~----------~~  212 (323)
T cd05575         151 K--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN----------KP  212 (323)
T ss_pred             C--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc----------CC
Confidence            1  1234679999999999999999999999999999999999999997643211      1111110          00


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCH----HHHHHhc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTM----STVVKTL  357 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~----~ell~~L  357 (455)
                        ...+...+..+.+++.+||+.+|.+||++    .+++++.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~  252 (323)
T cd05575         213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV  252 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence              11223346778999999999999999987    4776664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-41  Score=319.82  Aligned_cols=259  Identities=29%  Similarity=0.459  Sum_probs=203.8

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe--
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH--  155 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--  155 (455)
                      |.+.+.||+|+||.||+|.....   ......||+|.+....  ......+.+|+..++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD---DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC---CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56788999999999999976432   2245789999987543  2334578899999999999999999998866554  


Q ss_pred             ----EEEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          156 ----RLLVYEYMPRGSLENQLFRRY----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       156 ----~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                          .++||||+++|+|..++....    ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEEC
Confidence                799999999999998885432    246889999999999999999999966  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~---  229 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR---  229 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence            9999986544332211222345678999999988889999999999999999999 88998654321   1111110   


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                                .. .....+..++..+.+++.+||..+|.+|||+.+++++|+.+
T Consensus       230 ----------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 ----------HG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------cC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      00 01112344567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-41  Score=318.14  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=197.2

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|....      +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEec------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            369999999999996533      46789999875432 33446788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..........
T Consensus        75 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            9999999988654 346889999999999999999999866  9999999999999999999999999987643321111


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE  321 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (455)
                      ......++..|+|||.+.++.++.++|||||||++|||++ |..||...........+                 .....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-----------------~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-----------------EQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-----------------HcCCC
Confidence            1111223457999999999899999999999999999998 88998654321111100                 00111


Q ss_pred             CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...+...+..+.+|+.+||..+|++|||+.++++.|.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1233445678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.2e-42  Score=334.74  Aligned_cols=246  Identities=27%  Similarity=0.343  Sum_probs=197.4

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      +.||+|+||.||++....   +..++..||+|++.....  .....+..|+.+|+.++||||+++++++......|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKIT---GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEec---cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            579999999999985432   234678999999865432  223456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~  241 (455)
                      |+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          79 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999999988654  46899999999999999999999976  99999999999999999999999999986543221 


Q ss_pred             cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc
Q 012832          242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE  321 (455)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (455)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   .+.          ..  .
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~---~i~----------~~--~  214 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MT---MIL----------KA--K  214 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HH---HHH----------cC--C
Confidence             12336799999999999988899999999999999999999999976432111   10   000          00  1


Q ss_pred             CCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHh
Q 012832          322 GQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKT  356 (455)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~  356 (455)
                      ..++...+.++.+|+.+||+.+|++||+     +.+++++
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            1223345677899999999999999999     4556555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-41  Score=332.72  Aligned_cols=251  Identities=26%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|....      .++.||+|++.....   .....+..|+.++..+ +||||+.+++++......++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            469999999999996543      577899999875422   2335577899999888 599999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|..++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            9999999999887654  47899999999999999999999966  9999999999999999999999999987533222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+......         .. 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~-  218 (327)
T cd05617         151 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL---------EK-  218 (327)
T ss_pred             C--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH---------hC-
Confidence            1  12346799999999999999999999999999999999999999975432221111111111110         00 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCC------HHHHHHhc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPT------MSTVVKTL  357 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt------~~ell~~L  357 (455)
                       ...++...+..+.+++.+||..+|++||+      ++++++|-
T Consensus       219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence             11233445577899999999999999998      46887773

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-41  Score=318.88  Aligned_cols=251  Identities=27%  Similarity=0.445  Sum_probs=200.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ++|.+.+.||+|+||.||+|.+.+       +..+|+|.+.... .....+.+|+.+|+.++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            468888999999999999996543       3479999876432 33467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|||+++....
T Consensus        76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999999999886543 36889999999999999999999966  99999999999999999999999999986543


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ......       ..... 
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~-------~~~~~-  220 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMIS-------RGFRL-  220 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH-------CCCCC-
Confidence            2211 1112335678999999998889999999999999999999 999997543211   111110       00000 


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                            ..+...+..+.+++.+||..+|++||++.++++.|
T Consensus       221 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 ------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                  11222346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-41  Score=339.57  Aligned_cols=264  Identities=22%  Similarity=0.265  Sum_probs=205.3

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKL  146 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~  146 (455)
                      +.++....++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~  108 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  108 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEEC------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3445566789999999999999999999543      457889999985422   2233456789999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          147 IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                      ++++......++||||+++|+|.+++...   .++...+..++.||+.||+|||+.+  |+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999988643   5788899999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      +|||++......... .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||........      .
T Consensus       184 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~  256 (371)
T cd05622         184 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------Y  256 (371)
T ss_pred             EeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------H
Confidence            999999865432221 12346799999999998754    378999999999999999999999976433111      1


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhccc
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLEP  359 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~~  359 (455)
                      ..+...       . ..+........+..+.+++..||...+.+  ||++.++++|.+.
T Consensus       257 ~~i~~~-------~-~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         257 SKIMNH-------K-NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             HHHHcC-------C-CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            111100       0 00111112245677899999999844433  7899999999654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-41  Score=341.29  Aligned_cols=268  Identities=22%  Similarity=0.372  Sum_probs=209.5

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLR-HPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  151 (455)
                      .+..++|.+.+.||+|+||.||+|.+... .....+..||+|++..... ...+.+++|+.+|..+. ||||+++++++.
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGL-SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCC-CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            44556788899999999999999976432 1234567899999975432 23456889999999998 999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCC------------------------------------------------------
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYS------------------------------------------------------  177 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  177 (455)
                      .....++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCC
Q 012832          178 ------------------------------------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASN  215 (455)
Q Consensus       178 ------------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~N  215 (455)
                                                                ..+++..++.++.|++.||+|||+.+  |+||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcce
Confidence                                                      23567778899999999999999865  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccc
Q 012832          216 ILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQR  294 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~  294 (455)
                      ||++.++.++|+|||+++...............|+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986543222111223457889999999998889999999999999999998 899986543211


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .  ...    .+          ........+..++.++.+|+.+||..+|.+||++.+|++.|+.+
T Consensus       350 ~--~~~----~~----------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 Q--FYN----AI----------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             H--HHH----HH----------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1  000    00          00111122334567899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-41  Score=328.73  Aligned_cols=270  Identities=23%  Similarity=0.366  Sum_probs=212.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCC-CCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      .+..++|.+.+.||+|+||.||+|.+.... .....+..||+|.+.... .....++.+|+.+++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            345678899999999999999999753211 122345689999886432 34456788999999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      ......++||||+.+|+|.+++....              ...+++..+..++.||+.||.|||+.+  |+||||||+||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni  168 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNV  168 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceE
Confidence            99999999999999999999987642              235788889999999999999999976  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccch
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE  295 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~  295 (455)
                      |++.++.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999987654333222223456788999999998889999999999999999998 7888865432111


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                         ..   . +..          ......+..++..+.+|+.+||..+|.+|||+.++++.|..+..
T Consensus       249 ---~~---~-~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         249 ---FK---L-LKE----------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ---HH---H-HHc----------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence               11   0 000          00111233456789999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-42  Score=334.25  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=210.5

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCC-CCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLR-HPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~  150 (455)
                      .+....|++.+.||+||.+.||++.-.+       .+.||+|++...  +.+...-|.+|+..|.+|+ |.+|+.+|+|-
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE  429 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD-------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE  429 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC-------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence            4566789999999999999999985433       356777766433  3445567899999999998 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ..++.+||||||- ..+|..+|.++. ..++...+..+..|++.++.++|++|  |||.||||.|+|+- .|.+||+|||
T Consensus       430 v~d~~lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  430 VTDGYLYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             ccCceEEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeec
Confidence            9999999999986 569999887764 34443478889999999999999988  99999999999984 5799999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccC-----------CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-----------HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      +|.....+.........+||+.||+||++...           ..++++||||||||||+|+.|++||...         
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------  575 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------  575 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------
Confidence            99988877666666678999999999999532           2568899999999999999999999632         


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHH-HHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGAR-KAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                            .+...++..+++|.....|+..-+. ++.++|+.||..||++||++.++|+|
T Consensus       576 ------~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  576 ------INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  2233456667787666566554433 39999999999999999999999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-42  Score=321.73  Aligned_cols=268  Identities=24%  Similarity=0.361  Sum_probs=204.0

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC----
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE----  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----  154 (455)
                      .|...+++|.|+||.||.|.+..      +++.||||++-.+..-    --+|+++|+.++|||||+++.+|....    
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            46778999999999999997654      3789999987543221    136999999999999999998886432    


Q ss_pred             -eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-CceEEccCC
Q 012832          155 -HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFG  230 (455)
Q Consensus       155 -~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL~DfG  230 (455)
                       +..+|||||+ .+|.+.+...  .+..++.-.+.-++.||++||+|||+.+  |+||||||.|+|||.+ |.+||||||
T Consensus        95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCC
Confidence             4568999995 5999888642  2467888889999999999999999966  9999999999999975 999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--hhhH
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--PMLN  307 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~~~~  307 (455)
                      .|+....+...   .....|..|.|||.+.|. .|+.+.||||.||++.||+.|++-|.+.+...+..++.-..  +.-.
T Consensus       172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence            99987655443   235678999999999875 59999999999999999999999999876544443332111  1111


Q ss_pred             hhhh---------hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh--cccccC
Q 012832          308 DARK---------LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT--LEPLKD  362 (455)
Q Consensus       308 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~--L~~~~~  362 (455)
                      +...         ...+....+..-+....+.++.+|+.++|..+|.+|.++.+++.|  +..+++
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            1110         111111111112445567899999999999999999999999988  444433

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-41  Score=322.75  Aligned_cols=272  Identities=30%  Similarity=0.430  Sum_probs=205.7

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--CeE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--EHR  156 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  156 (455)
                      |.+.+.||+|+||.||++.+..  .....+..||+|.+..... .....+.+|+.+|+.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDP--ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcc--ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            3888999999999999876532  2234577899999875432 3456688999999999999999999987654  468


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999988653   5899999999999999999999966  9999999999999999999999999998665


Q ss_pred             CCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++|..||....... ............ ...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMT-VVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccc-hhhhhhh
Confidence            432211 1122345677999999988889999999999999999999999986532211 111111100000 0011111


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .+.......+..++..+.+++.+||+.+|++|||+.+++..|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111112223445678899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.3e-41  Score=331.84  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEE  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  154 (455)
                      +|...+.||+|+||.||+|...      .++..||+|++....   ......+..|..++..+. |++|+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            4778899999999999999543      357889999986432   223355678888888886 577888999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccc
Confidence            999999999999999988654  46899999999999999999999966  99999999999999999999999999875


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .+..       
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~~-------  215 (323)
T cd05615         151 HMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---SIME-------  215 (323)
T ss_pred             cCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-------
Confidence            433221  1233569999999999999999999999999999999999999997653321   111   1110       


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHh
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKT  356 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~  356 (455)
                         .  ...++...+.++.+++.+||+.+|.+|++.     .++++|
T Consensus       216 ---~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         216 ---H--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ---C--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence               0  112334456788999999999999999974     566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-41  Score=330.00  Aligned_cols=268  Identities=26%  Similarity=0.385  Sum_probs=209.6

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCC-CCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+.||+|+||.||+|....... .......+|+|.+.... .....++..|+.+++.+ +||||+++++++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            345679999999999999999997543211 12344679999987542 33446688899999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYS--------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nil  217 (455)
                      .....++||||+++|+|.+++.....              ..+++.+++.++.|++.||+|||+.+  ++||||||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil  172 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL  172 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheE
Confidence            99999999999999999999976421              35788999999999999999999966  999999999999


Q ss_pred             EcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchh
Q 012832          218 LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQ  296 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~  296 (455)
                      ++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--  250 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--  250 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence            99999999999999976543222111222335578999999998889999999999999999998 888986543211  


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                       ...   . ..          .......+...+.++.+|+.+||..+|.+|||+.++++.|+.+.
T Consensus       251 -~~~---~-~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 -LFK---L-LK----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             -HHH---H-HH----------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence             111   0 00          01111223445678999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=346.72  Aligned_cols=267  Identities=22%  Similarity=0.342  Sum_probs=197.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      ...+|.+.+.||+|+||.||+|...+      ++..||||++....    ....+|+.+|+.++||||+++++++...  
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICID------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            45689999999999999999996543      56789999875332    2234699999999999999999876432  


Q ss_pred             ------CeEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ce
Q 012832          154 ------EHRLLVYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TA  224 (455)
Q Consensus       154 ------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~  224 (455)
                            ..+++||||++ ++|.+++..  .....+++..+..++.||+.||+|||+.+  |+||||||+||||+.++ .+
T Consensus       134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCce
Confidence                  24679999996 578776653  23467899999999999999999999966  99999999999998654 79


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhh
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWA  302 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~  302 (455)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+ ...
T Consensus       211 kL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  287 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL  287 (440)
T ss_pred             eeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999986543322   2235789999999998764 6899999999999999999999999865432211111 100


Q ss_pred             -hhhhHhhh----hh-----cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          303 -RPMLNDAR----KL-----GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       303 -~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .+......    ..     ..+....+...++...+.++.+|+.+||..+|.+|||+.++++|-+
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence             00000000    00     0001111112233345678999999999999999999999999844

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.7e-41  Score=323.22  Aligned_cols=270  Identities=28%  Similarity=0.412  Sum_probs=209.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCC----------CCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCccc
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKL----------RPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVK  145 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~----------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~  145 (455)
                      ..+|.+.+.||+|+||.||+|...+..          ........||+|.+..... .....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467999999999999999999764321          1122346799999875432 34567889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRY---------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      +++++..+...++||||+.+++|.+++....         ...+++..++.++.|++.||+|||+.+  |+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence            9999999999999999999999999987643         126899999999999999999999976  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCCCccc
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS--GRKSVDKSRPQR  294 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--G~~p~~~~~~~~  294 (455)
                      +++.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999986544332222333557889999999988889999999999999999998  67787653321 


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ...........       ..........+..++.++.+|+.+||+.+|.+|||+.+|++.|+
T Consensus       241 --~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 --QVIENAGHFFR-------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHhccc-------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              11111111000       00111111123345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.7e-41  Score=320.18  Aligned_cols=256  Identities=24%  Similarity=0.336  Sum_probs=203.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|....      ++..||+|++..........+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            4579999999999999999996433      4678999998755444455678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||++....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999999988654  46889999999999999999999966  9999999999999999999999999998653


Q ss_pred             CCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....  ......|+..|+|||.+.   ...++.++|||||||++|||++|..||....+.......  .         ..
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~---------~~  224 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--S---------KS  224 (267)
T ss_pred             cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--e---------cC
Confidence            3211  112356899999999884   345788999999999999999999998644321110000  0         00


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....+...  .....+..+.+++.+||..+|++|||+++++++|
T Consensus       225 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00011111  1123456889999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.1e-41  Score=319.34  Aligned_cols=258  Identities=25%  Similarity=0.416  Sum_probs=199.3

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC----
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE----  153 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~----  153 (455)
                      |.+.+.||+|+||.||+|.+...    .....||+|.++..  .......+..|+.+++.++|+||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~----~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQD----DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccC----CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            45678999999999999976442    12246999987643  234456788999999999999999999987532    


Q ss_pred             --CeEEEEEEecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 --EHRLLVYEYMPRGSLENQLFRR----YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 --~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                        ...++||||+.+|+|.+++...    ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEEC
Confidence              2468999999999999887432    2245789999999999999999999966  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      |||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   ....    +
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----L  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----H
Confidence            9999987543322111222346778999999999999999999999999999999 889997543211   1110    0


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ...        .  ....+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       228 ~~~--------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQG--------N--RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcC--------C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000        0  0112234556789999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.4e-41  Score=316.42  Aligned_cols=251  Identities=26%  Similarity=0.394  Sum_probs=206.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|....      ++..|++|.+...  .......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            47788999999999999996543      4678999988643  234456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++.......+++..++.++.+++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999988765568899999999999999999999866  9999999999999999999999999988654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|++.|+|||++.+..++.++|+|||||++++|++|..||......   ....   ..          .
T Consensus       153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~----------~  214 (256)
T cd08529         153 DNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL---KI----------I  214 (256)
T ss_pred             Cccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH----------H
Confidence            43221  22356899999999999999999999999999999999999999765421   1111   00          0


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .. .....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       215 ~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 RG-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cC-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            00 1112233456789999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-41  Score=324.07  Aligned_cols=266  Identities=27%  Similarity=0.431  Sum_probs=207.6

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|.+.+.||+|+||.||+|...+... ...+..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456789999999999999999997654321 2345689999876443 23345678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRY--------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      ...++||||+++|+|.+++....        ...+.+..+..++.|++.||.|||+.+  |+||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999986532        123456778899999999999999966  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      |+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......   .....  
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV--  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--
Confidence            999999986543332222222346778999999998899999999999999999998 788987543211   11100  


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                                 .+.. ....+..++..+.+++.+||+.+|++|||+.++++.|...
T Consensus       235 -----------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 -----------MDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -----------HcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                       0000 0112233457899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-41  Score=324.23  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|+..+.||+|+||.||+|...      .+++.||+|.+.....   .....+.+|+.+++.++|+||+++++.+...+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            3677889999999999999543      3578999998864322   223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999999999999999887655557899999999999999999999966  999999999999999999999999998764


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....   .....||..|+|||++.+..++.++|||||||++|+|++|..||.............   ....        
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~--------  218 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVK--------  218 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhh--------
Confidence            33221   123469999999999999999999999999999999999999997643211111110   0000        


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                         .....++...+.++.+|+.+||+.+|++|||     +.++++|-+
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         219 ---EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             ---hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence               0011223345567899999999999999999     889998844

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6e-41  Score=319.33  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=207.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|....      ++..||||.+...   .......+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            578999999999999999996433      4678999987532   2333456789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+  ++|+||+|+|||++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999887532  2345788999999999999999999966  999999999999999999999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......    ...+...       +
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-------~  220 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-------I  220 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-------H
Confidence            86543221  112246889999999999888999999999999999999999998643221    1111100       0


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..   ...........+..+.+++.+||..+|++||++.++++.|..++
T Consensus       221 ~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         221 EQ---CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hc---CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            00   01111123345678999999999999999999999999987763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-41  Score=333.68  Aligned_cols=269  Identities=28%  Similarity=0.378  Sum_probs=205.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||.||+|.+... ....+++.||||+++.... .....+.+|+.+|..+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccC-CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            4457899999999999999999964321 2234678899999865432 3345688999999999 68999999998865


Q ss_pred             C-CeEEEEEEecCCCChHHHHhhcC-------------------------------------------------------
Q 012832          153 E-EHRLLVYEYMPRGSLENQLFRRY-------------------------------------------------------  176 (455)
Q Consensus       153 ~-~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  176 (455)
                      . ...++||||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 46789999999999999886531                                                       


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceec
Q 012832          177 ----------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR  246 (455)
Q Consensus       177 ----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~  246 (455)
                                ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                      123677888999999999999999966  99999999999999999999999999986543222111222


Q ss_pred             cccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCC
Q 012832          247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS  325 (455)
Q Consensus       247 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (455)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||........  ....    ..      .....    ..+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~------~~~~~----~~~  304 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR----LK------EGTRM----RAP  304 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHH----Hh------ccCCC----CCC
Confidence            346678999999998899999999999999999997 9999975432111  1100    00      00000    111


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       326 ~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ...+.++.+++.+||+.+|++|||+.+|+++|+.+.+
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2234578999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-41  Score=331.88  Aligned_cols=239  Identities=27%  Similarity=0.370  Sum_probs=189.1

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHH-HHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEV-IFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      ..++.||+|++.....   .....+..|. .+++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~fg~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHK------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            46999999999999643      3467899999864321   2223444444 456789999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            9999999999988654  46788889999999999999999976  9999999999999999999999999997543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.......   ...   .+..          . 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~----------~-  211 (325)
T cd05602         151 G--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILN----------K-  211 (325)
T ss_pred             C--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHH---HHHh----------C-
Confidence            1  1234679999999999999999999999999999999999999997543221   111   1110          0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMST  352 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~e  352 (455)
                       ...+....+..+.+++.+||+.+|.+||++.+
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         212 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             -CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence             11123345677899999999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.6e-41  Score=321.94  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=194.4

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||+|+||.||++...      .+++.||+|.+.....   .....+..|+++++.++||||+++++++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVK------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEc------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            799999999999543      3578999999864322   2233456799999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      ++|++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999998887665567889999999999999999999966  9999999999999999999999999987654322   


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      ......||..|+|||++.+..++.++|||||||++|||++|..||.........  ........          ......
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~----------~~~~~~  217 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL----------EDEVKF  217 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh----------cccccc
Confidence            123356999999999999888999999999999999999999999754321111  11111110          111110


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVK  355 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~  355 (455)
                       .....+.++.+|+.+||+.+|.+||++.++++
T Consensus       218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             -ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence             11234567899999999999999999966553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=338.51  Aligned_cols=265  Identities=23%  Similarity=0.312  Sum_probs=210.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-C-----CCcccEEEEEEe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-H-----PHLVKLIGYCCE  152 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~  152 (455)
                      +|.+.++||+|+||.|.+|+.      ..+++.||||+++... .-..+...|+.+|..|+ |     -|||+++++|..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d------~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYD------HKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEe------cCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            688999999999999999964      3478999999997443 33455567999999997 4     389999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC--CCceEEccCC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS--DYTAKLSDFG  230 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~--~~~~kL~DfG  230 (455)
                      .+++|||+|.+ ..+|+++|..+.-..++...+..|+.||+.||.+||..+  |||+||||+||||..  ...+||+|||
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecc
Confidence            99999999999 679999999888788999999999999999999999877  999999999999965  3479999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-----hh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-----PM  305 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-----~~  305 (455)
                      .|......-.     +.+-+..|.|||+|.|.+|+.+.|+||||||++||++|.+.|.+.++.+....+.-..     .+
T Consensus       337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9987654322     3567888999999999999999999999999999999999999887665544433111     11


Q ss_pred             hHhhhhhcccCCC----------------------------------------cccCCCCHHHHHHHHHHHHHHhccCCC
Q 012832          306 LNDARKLGRIMDP----------------------------------------RLEGQYSETGARKAAALAYQCLSHRPK  345 (455)
Q Consensus       306 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~li~~cl~~~P~  345 (455)
                      ++...+...+++.                                        .+...........+.+++.+||..||.
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence            1111111111111                                        000011112345789999999999999


Q ss_pred             CCCCHHHHHHhcc
Q 012832          346 QRPTMSTVVKTLE  358 (455)
Q Consensus       346 ~RPt~~ell~~L~  358 (455)
                      +|+|..+.++|-+
T Consensus       492 ~R~tp~qal~Hpf  504 (586)
T KOG0667|consen  492 ERITPAQALNHPF  504 (586)
T ss_pred             hcCCHHHHhcCcc
Confidence            9999999999943

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-41  Score=322.42  Aligned_cols=275  Identities=26%  Similarity=0.361  Sum_probs=206.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--C
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--E  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~  154 (455)
                      ..+|.+.+.||+|+||.||+|....  .+...+..||+|.+..........+.+|+.+++.++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDP--LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecC--CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            3578899999999999999996532  12345778999998766656667888999999999999999999987543  4


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            689999999999999988654 346899999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCccc-eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH---hhh
Q 012832          235 GPEGDDTHV-STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN---DAR  310 (455)
Q Consensus       235 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~---~~~  310 (455)
                      ......... .....++..|+|||++.+..++.++|||||||++|||++|..|+......    ..........   ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  233 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence            654322111 11122445699999999888999999999999999999988776432210    0000000000   000


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .+...+........+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00001111111122344567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-40  Score=316.09  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=198.7

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      .||+|+||.||+|.+..    ..++..+|+|+++...  ......+..|+.+++.++||||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM----KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEec----CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            58999999999996543    2346789999986443  234567889999999999999999999875 4567999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||.|||++.++.++|+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999999988654  46889999999999999999999966  9999999999999999999999999998654332211


Q ss_pred             -ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          243 -VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       243 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                       ......++..|+|||.+....++.++|||||||++|||++ |..||.......   .....              ....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i--------------~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMI--------------ESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--------------HCCC
Confidence             1112335678999999988889999999999999999998 999997643221   11111              0111


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ....+..++.++.+||.+||+.+|++||++.+|.+.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1123445667899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.1e-41  Score=317.83  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=205.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...+       ++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNG-------HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QE   73 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCC-------CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cC
Confidence            345789999999999999999996432       56799998864433 3467889999999999999999999874 56


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceee
Confidence            7899999999999999987766667899999999999999999999866  99999999999999999999999999976


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++ |.+||........   ....          .
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----------~  217 (260)
T cd05067         152 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNL----------E  217 (260)
T ss_pred             cCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----------H
Confidence            5422211 1122346788999999998899999999999999999999 9999975432211   1100          0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .    ......+...+.++.+++.+||..+|++||++++++..|+.
T Consensus       218 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 R----GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             c----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0    01111233345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=322.72  Aligned_cols=270  Identities=25%  Similarity=0.416  Sum_probs=204.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCC--------CCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKL--------RPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLI  147 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~--------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~  147 (455)
                      ..+|.+.+.||+|+||.||++......        ........||+|.+.... ......+.+|+++++.++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            457999999999999999998643210        011223458999986542 23345688999999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEE
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRRY----------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nil  217 (455)
                      +++......++||||+.+++|.+++....          ...+++..++.++.|++.||+|||+.+  ++||||||+|||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEE
Confidence            99999999999999999999999886532          124688899999999999999999976  999999999999


Q ss_pred             EcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCCCccch
Q 012832          218 LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS--GRKSVDKSRPQRE  295 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--G~~p~~~~~~~~~  295 (455)
                      ++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999976543322222222446778999999998899999999999999999998  667776543211 


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        .+.........       .........+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus       241 --~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 --VIENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              11111000000       0000111122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=327.15  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=217.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..-|.+.+-||+|.|..|-+|      ++..+|..||||+++.....  ....+.+|+..|+.++|||||++|.+...+.
T Consensus        17 AGLYDLekTlG~GHFAVVKLA------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLA------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT   90 (864)
T ss_pred             eeeehhhhhhcCCceehhhhh------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence            356888999999999999998      67889999999999765443  3456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE-cCCCceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL-DSDYTAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill-~~~~~~kL~DfGla~  233 (455)
                      .+|||+|+-++|+|+|+|.+. ...+.++.+.+++.||+.|+.|+|+..  +|||||||+||.+ ..-|-|||.|||++.
T Consensus        91 KlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccc
Confidence            999999999999999999876 468899999999999999999999966  9999999999877 557899999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT-SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .+.++..   .++.||...|.|||++.|..|+ +++||||||||||.|+||++||...+.                ...+
T Consensus       168 kf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETL  228 (864)
T KOG4717|consen  168 KFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETL  228 (864)
T ss_pred             cCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhh
Confidence            8766543   3457999999999999999886 578999999999999999999975432                3344


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..+||-..  ..|...+.++.+||..||..||.+|.+.++|..+-|
T Consensus       229 TmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  229 TMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             hhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence            44555433  357788899999999999999999999999998844

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-41  Score=330.83  Aligned_cols=244  Identities=27%  Similarity=0.355  Sum_probs=191.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHH-HHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVI-FLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...      ..+..||+|++.....   .....+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999643      3578899999864322   22334555554 67889999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|...+...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            9999999999887653  56888999999999999999999966  9999999999999999999999999987543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......      ....+.          .. 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~----------~~-  211 (321)
T cd05603         151 E--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNIL----------HK-  211 (321)
T ss_pred             C--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHh----------cC-
Confidence            1  1234679999999999998899999999999999999999999997643211      111110          11 


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCH----HHHHHhc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTM----STVVKTL  357 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~----~ell~~L  357 (455)
                       ...++...+..+.+++.+||+.+|.+||+.    .+++++.
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~  252 (321)
T cd05603         212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV  252 (321)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence             112233445678999999999999999875    3665554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.7e-41  Score=317.54  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=201.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...+       +..||+|.+.... .....+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI   74 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence            3468888999999999999996533       2359999886443 2346788999999999999999999999988899


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||+++...
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            99999999999999887643 36899999999999999999999966  9999999999999999999999999987654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....   ..       ..
T Consensus       152 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~-------~~  217 (256)
T cd05113         152 DDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEK---VS-------QG  217 (256)
T ss_pred             CCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH---Hh-------cC
Confidence            32211 1112345678999999998889999999999999999998 999997543211   1110   00       00


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .    ....+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       218 ~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 L----RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C----CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0    01112223578899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.4e-41  Score=322.04  Aligned_cols=252  Identities=27%  Similarity=0.388  Sum_probs=201.9

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      |+..+.||+|+||.||+|....      +++.||+|.+.....   .....+.+|+.+|+.++|+||+.+++.+..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            6778899999999999996433      577899999864432   2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999999998887655557999999999999999999999966  9999999999999999999999999987643


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ....   .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.  ..       ..   
T Consensus       154 ~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~-------~~---  218 (285)
T cd05632         154 EGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RR-------VL---  218 (285)
T ss_pred             CCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh-------hh---
Confidence            3221   123579999999999998899999999999999999999999997543211111110  00       00   


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~  356 (455)
                      .  ....++...+..+.+|+..||+.+|++||+     +.+++.+
T Consensus       219 ~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         219 E--TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             c--cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            0  011223345567899999999999999999     7788776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-40  Score=319.79  Aligned_cols=264  Identities=23%  Similarity=0.341  Sum_probs=205.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+|.+.+.||+|+||.||+|.+....  ......||+|++.... ......+.+|+.++..++|+||+++++++.. .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDG--ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCC--CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            3567889999999999999999764421  1223468999986543 2345678899999999999999999999875 4


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..+++|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceee
Confidence            578999999999999988654 346899999999999999999999966  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............+++.|+|||.+.+..++.++|||||||++|||++ |..||+......   ...+..          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----------  225 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----------  225 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----------
Confidence            643322211122345678999999998899999999999999999998 999997543211   111110          


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .    ......+..++.++.+++.+||..+|++||++.++++.|..+..
T Consensus       226 ~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         226 K----GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             C----CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0    00111123456778999999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.8e-41  Score=336.07  Aligned_cols=268  Identities=25%  Similarity=0.341  Sum_probs=202.2

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC--
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE--  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  154 (455)
                      +|++.+.||+|+||.||+|...      .+++.||||.+...  .......+.+|+.+|+.++|+||+++++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            4788999999999999999543      35788999988542  2334467889999999999999999999998776  


Q ss_pred             ---eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          155 ---HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       155 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                         ..|+||||+. ++|.+.+...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999995 6888877543  57899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--hhhH-
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--PMLN-  307 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~~~~-  307 (455)
                      ++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+....  +... 
T Consensus       150 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9865432221 12234689999999998774 47899999999999999999999998765443322221100  0000 


Q ss_pred             ------hhh-hh-cccCCC-ccc--CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 ------DAR-KL-GRIMDP-RLE--GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ------~~~-~~-~~~~~~-~~~--~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            ... .+ .....+ ...  .......+.++.+|+.+||+.||++|||+.++++|.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  290 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY  290 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence                  000 00 000000 000  0112233567899999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-40  Score=316.68  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=203.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|++.+.||+|+||.||+|...+       +..||+|.+..... ....+.+|+.+++.++|+||+++++++. ...
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNG-------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecC-------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            45678999999999999999995433       45699998865433 3456889999999999999999999875 556


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.......+++..+..++.+++.||+|||+.+  |+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeec
Confidence            899999999999999987655567899999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.......   .....          . 
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----------~-  217 (260)
T cd05070         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV----------E-  217 (260)
T ss_pred             cCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----------H-
Confidence            432211 1122345678999999988889999999999999999999 899997543211   11110          0 


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         .......+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus       218 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 ---RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               011112234456789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.9e-41  Score=320.67  Aligned_cols=266  Identities=25%  Similarity=0.367  Sum_probs=210.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-  152 (455)
                      +..++|.+.+.||+|+||.||+|...+.  ....+..|++|.+... .......+.+|+.+++.++|+||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~--~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDE--KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecC--CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4567899999999999999999976542  1234678999988643 23345668899999999999999999998776 


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYS------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                      ....+++++|+++|+|.+++.....      ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence            4678999999999999999876432      46889999999999999999999966  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||....+..   ...+.   
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---  232 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL---  232 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH---
Confidence            99999986644332222223456778999999998889999999999999999998 999997643321   11111   


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                       ..          .........++..+.+++.+||..+|++|||+.++++.|..+.
T Consensus       233 -~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 -KD----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -Hc----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             00          0111112334577899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.8e-41  Score=331.61  Aligned_cols=243  Identities=28%  Similarity=0.362  Sum_probs=191.6

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHH-HHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVI-FLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|..      ..+++.||+|++....   ......+..|.. +++.++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKR------KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            4699999999999954      3357899999986432   222344555554 56789999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+.+|+|..++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            9999999999887654  57899999999999999999999966  9999999999999999999999999987543222


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........      ......          ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~----------~~  212 (325)
T cd05604         151 D--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH----------KP  212 (325)
T ss_pred             C--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc----------CC
Confidence            1  12346799999999999999999999999999999999999999976432111      111110          00


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHH----HHHHh
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMS----TVVKT  356 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~----ell~~  356 (455)
                      +  ......+..+.+++.+||..+|.+||++.    ++++|
T Consensus       213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         213 L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            0  11223456788999999999999999875    66665

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-41  Score=337.05  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=200.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+..|+.++..++|+||+++++.+...+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            46888999999999999999543      357889999986432   223456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||++||+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            999999999999999988654  56899999999999999999999966  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHH
Q 012832          235 GPEGDDT---------------------------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL  281 (455)
Q Consensus       235 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  281 (455)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4221100                                 0011357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC---CHHHHHHhcc
Q 012832          282 SGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP---TMSTVVKTLE  358 (455)
Q Consensus       282 ~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP---t~~ell~~L~  358 (455)
                      +|.+||....+......      +..    ....  ..++.  ....+.++.+|+.+|+ .+|.+|+   ++.++++|-+
T Consensus       231 tG~~Pf~~~~~~~~~~~------i~~----~~~~--~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         231 IGYPPFCSETPQETYRK------VMN----WKET--LVFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             cCCCCCCCCCHHHHHHH------HHc----CCCc--eecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            99999976543211110      000    0000  00111  1123567888998877 4999998   4788888843

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-40  Score=315.52  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=204.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +|.+.+.||+|+||.||++..      ..++..||+|.++.. .....+.+.+|+.+++.++|+||+++++.+......+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQH------VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEE------cCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            478889999999999999954      345788999988543 2334566788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++|+|.+++.......++...++.++.|++.||.|||+++  |+|+||||+|||++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999887655567899999999999999999999976  99999999999999999999999999976543


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........   ..   ...          .
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~---~~~----------~  214 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---IL---KVC----------Q  214 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HH---HHh----------c
Confidence            222  12335689999999999988899999999999999999999999975432111   00   000          0


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       ......+...+..+.+|+.+||..+|++|||+.+++..
T Consensus       215 -~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 -GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             00111233455678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-40  Score=324.00  Aligned_cols=269  Identities=24%  Similarity=0.320  Sum_probs=205.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|.+.+.||+|+||.||+|...      .++..+|+|.+..... .....+.+|++++..++||||+++++++..++..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            36889999999999999999543      3567899998865422 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ .+  ++||||||+|||++.++.++|+|||++...
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            9999999999999998654  568899999999999999999997 35  999999999999999999999999998755


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh-------
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND-------  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~-------  308 (455)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|..||.....................       
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            3321    22357899999999998888999999999999999999999999754322111111000000000       


Q ss_pred             -------------hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          309 -------------ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       309 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                                   ....................+.++.+|+.+||..+|++|||+.+++++.+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  291 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK  291 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence                         0000000000000000112456799999999999999999999999996543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=332.69  Aligned_cols=267  Identities=28%  Similarity=0.420  Sum_probs=218.9

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      ..+.+..+.....+.||.|.||.||.|.+.+..  +...-.||||..+.+ .....+.|+.|.-+|++++||||++++|+
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence            344455566677889999999999999987742  344566999998764 44557889999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      |.+ ...|||||+++-|.|..+|..+ ...++......++.||+.||+|||+..  +|||||...||||....-|||+||
T Consensus       460 ~~e-~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  460 CVE-QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             eec-cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeeccc
Confidence            975 4689999999999999999876 468899999999999999999999944  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |+++........+.+ ...-.+.|||||.+.-..++.++|||.||||+||++. |..||.+-...+.             
T Consensus       536 GLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------------  601 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------------  601 (974)
T ss_pred             chhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------------
Confidence            999987665544333 3345678999999999999999999999999999987 9999987533211             


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         +.. +...-+-+.|+.||..+..|+.+||+.+|.+||++.+|...|..+.
T Consensus       602 ---I~~-iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  602 ---IGH-IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             ---EEE-ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence               111 1222233568889999999999999999999999999888765443

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=315.39  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=200.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      .+|++.+.||+|+||.||+|....       ...+|+|.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-------KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-------CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            458889999999999999995432       3579999875432 23456788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||+++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999999999887543 36899999999999999999999976  99999999999999999999999999976543


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ..          ..... 
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----------~~~~~-  217 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE----------SVSAG-  217 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH----------HHHcC-
Confidence            2111 1111234567999999998899999999999999999999 8999975433211   11          00001 


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         .....+..++..+.+++.+||..+|++|||+.++++.|
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               11122334567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-40  Score=325.17  Aligned_cols=269  Identities=25%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCC-CCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      ...++|.+.+.||+|+||.||+|....... .......||+|.+.... .....++..|+.+++.+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            345678899999999999999996532111 12345679999886432 23456688999999999 5999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nil  217 (455)
                      .....++||||+++|+|.+++....              ...+++..+..++.|++.||.|||+.+  |+||||||+|||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil  166 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL  166 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence            9899999999999999999987642              235788899999999999999999966  999999999999


Q ss_pred             EcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchh
Q 012832          218 LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQ  296 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~  296 (455)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999986543222111122234568999999998899999999999999999999 89999754322111


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ..+       .          .......+..++.++.+++.+||..+|++|||+.++++.|+.+..
T Consensus       247 ~~~-------~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 KLL-------R----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHH-------H----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            110       0          001112234456788999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=314.63  Aligned_cols=251  Identities=29%  Similarity=0.478  Sum_probs=206.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||.|+||.||+|..        .++.||+|.+..... ....+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~--------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY--------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP   74 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe--------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence            356788999999999999999953        256899999876544 46778899999999999999999999998899


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccc
Confidence            999999999999999987765557899999999999999999999976  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .....     ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +....          . 
T Consensus       153 ~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----------~-  213 (256)
T cd05039         153 SQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----------E-  213 (256)
T ss_pred             ccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----------h-
Confidence            33221     2345678999999988889999999999999999997 999997543211   11100          0 


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         .......+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus       214 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         214 ---KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               001112233456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-40  Score=335.55  Aligned_cols=271  Identities=21%  Similarity=0.204  Sum_probs=204.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ...+|.+.+.||+|+||.||++...+    ...+..||+|.+...     ....+|+.+|+.++||||+++++++.....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~----~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHG----DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcC----CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            45679999999999999999986433    235678999987543     234579999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++|||++ +++|.+++..  ...+++..++.++.||+.||.|||+.+  ||||||||+|||++.++.++|+|||++...
T Consensus       161 ~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        161 VCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99999999 5688888843  357899999999999999999999966  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhhhh---------
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPM---------  305 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~~~~---------  305 (455)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......... ......         
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            5433322233467999999999999999999999999999999999999999765432211111 100000         


Q ss_pred             ------hHhhhhhcccCCCcccC-CC--CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          306 ------LNDARKLGRIMDPRLEG-QY--SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       306 ------~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                            ............+.... ..  ....+.++.++|.+||..+|.+|||+.+++.|-+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                  00000000000000000 00  012346788999999999999999999999995543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-40  Score=319.29  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=200.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHL------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI   74 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEc------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence            36788899999999999999543      357889999986542 33446688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|..+      ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          75 SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999999999998653      24788889999999999999999976  9999999999999999999999999997653


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhh-HHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS-LVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  315 (455)
                      ...    .....||..|+|||++.+..++.++|||||||++|+|++|..||.......... ........       ...
T Consensus       147 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~  215 (279)
T cd06619         147 NSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-------VDE  215 (279)
T ss_pred             ccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-------hcc
Confidence            321    223579999999999999899999999999999999999999996532211110 00100000       000


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..+.+   .....+.++.+++.+||+.+|++||++++++++.+.
T Consensus       216 ~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         216 DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence            01111   112234678999999999999999999999998544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.5e-41  Score=319.57  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=201.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC-
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE-  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-  153 (455)
                      ..+.|++.+.||+|+||.||+|....      +++.||+|.+.... .....+.+|+.++..+ +|+||+++++++... 
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            45678899999999999999996533      56789999986543 3345678899999998 699999999998753 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           ...++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEcc
Confidence                 46899999999999999887655567899999999999999999999966  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      ||++........  ......|++.|+|||++.     +..++.++|||||||++|||++|..||....+.......    
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----  228 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----  228 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence            999976433211  123357999999999986     345888999999999999999999999654322111100    


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                               ...   .........++.++.+|+.+||..+|.+|||+.++++|-
T Consensus       229 ---------~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  270 (272)
T cd06637         229 ---------PRN---PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP  270 (272)
T ss_pred             ---------hcC---CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence                     000   011111223456789999999999999999999999873

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-40  Score=322.03  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..+|.+.+.||+|+||.||+|...      ..+..||+|.+..........+.+|+.+++.+.|+||+++++.+......
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDV------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEEC------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            367999999999999999999543      35678999998766655667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999999998854   35788999999999999999999966  9999999999999999999999999987654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|+|++|..||....+...  ...+.             .
T Consensus       168 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~-------------~  230 (296)
T cd06654         168 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA-------------T  230 (296)
T ss_pred             ccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh-------------c
Confidence            32211  1224689999999999988899999999999999999999999975443211  00000             0


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ........+...+..+.+++.+||..+|++||++.+++++-
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~  271 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence            00011122344567789999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-40  Score=321.69  Aligned_cols=260  Identities=26%  Similarity=0.388  Sum_probs=203.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  155 (455)
                      ++|++.+.||+|+||.||+|...+.    .....+++|.++.. .....+.+.+|+.++.++ +||||+++++++.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD----GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC----CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            5788999999999999999976442    12234788887632 333456788999999999 69999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      .++||||+++++|.+++....              ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC
Confidence            999999999999999986532              135788999999999999999999966  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~  300 (455)
                      +.+||+|||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||........   ..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~  229 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE  229 (297)
T ss_pred             CeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            9999999999864322111   111223557999999998889999999999999999997 9999976533211   10


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                         .       ...    ......+..++..+.+|+.+||..+|.+|||+.++++.|..+...
T Consensus       230 ---~-------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         230 ---K-------LPQ----GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             ---H-------Hhc----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               0       000    111122334567889999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.9e-40  Score=319.92  Aligned_cols=270  Identities=26%  Similarity=0.436  Sum_probs=205.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCC----------CCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCccc
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKL----------RPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVK  145 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~----------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  145 (455)
                      .++|++.+.||+|+||.||++...+..          ........||+|++.... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457999999999999999998543210          112234579999987543 334467889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS---------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      +++++...+..++||||+++|+|.+++.....         ..+++..+..++.|++.||+|||+.+  |+||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence            99999999999999999999999998876421         24677889999999999999999966  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCCCccc
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS--GRKSVDKSRPQR  294 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--G~~p~~~~~~~~  294 (455)
                      |++.++.++|+|||++................++..|++||...++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222222345678999999888889999999999999999998  778886543221


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         .+...........       .......+..++..+.+|+.+||+.+|++||++.+|++.|.
T Consensus       242 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ---VIENTGEFFRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHHHHHHHhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               1111111110000       00001112335578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-40  Score=315.31  Aligned_cols=249  Identities=28%  Similarity=0.419  Sum_probs=201.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE-eCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC-EEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~  155 (455)
                      ..+|.+.+.||+|+||.||+|..        .+..||+|.+....  ....+.+|+.+++.++|+||+++++++. ....
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            35788999999999999999843        25679999886433  3456889999999999999999999765 4467


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceec
Confidence            899999999999999987765556899999999999999999999976  999999999999999999999999998764


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ....     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......   ......            
T Consensus       153 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~------------  212 (256)
T cd05082         153 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV------------  212 (256)
T ss_pred             cccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH------------
Confidence            3322     12345678999999998889999999999999999997 99998654221   111110            


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        ........+..++..+.+++.+||..+|++|||+.++++.|+.
T Consensus       213 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         213 --EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              0011112334556789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-40  Score=315.98  Aligned_cols=259  Identities=22%  Similarity=0.335  Sum_probs=206.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .++..+|||.+...   ......++.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            46888999999999999999543      34678999987542   2233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999999988642  2356899999999999999999999976  999999999999999999999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......    .....       ..
T Consensus       154 ~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~-------~~  220 (267)
T cd08229         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK-------KI  220 (267)
T ss_pred             hccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhh-------hh
Confidence            765433221  223568999999999998889999999999999999999999996542210    01100       01


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .....   ........+..+.+++.+||..+|.+|||+.+|++.+..+
T Consensus       221 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         221 EQCDY---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             hcCCC---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11111   1111234567899999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-40  Score=330.55  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|..      ..++..||||++...  .......+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   92 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFD------TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEE------cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            357899999999999999999954      335789999998643  233446678999999999999999999988654


Q ss_pred             C------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 E------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      .      ..|+||||+++ +|.+.+.    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          93 KSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             CCccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEe
Confidence            3      57999999954 6666553    24788899999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-H------
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-E------  300 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~------  300 (455)
                      |||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .      
T Consensus       166 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  242 (359)
T cd07876         166 DFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS  242 (359)
T ss_pred             cCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            999997643321   123357899999999999999999999999999999999999999865432111000 0      


Q ss_pred             --hhhhhhHhhhhhcccCCCccc----------------CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          301 --WARPMLNDARKLGRIMDPRLE----------------GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       301 --~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        +............. -.+...                .......+..+.+|+.+||..||++|||+.|+++|.+
T Consensus       243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         243 AEFMNRLQPTVRNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHHHHHHHHh-hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence              00000000000000 000000                0011123467899999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=312.05  Aligned_cols=253  Identities=33%  Similarity=0.508  Sum_probs=205.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-HHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|......   ..+..||+|.+....... ...+.+|+.++..++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46999999999999765421   346789999987654433 57788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          163 MPRGSLENQLFRRY-------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       163 ~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      +++++|.+++....       ...+++..++.++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987642       367899999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....   ..       .
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~---~~-------~  222 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEY---LR-------K  222 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH---HH-------c
Confidence            55432222333568899999999988899999999999999999999 699997653211   1110   00       0


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ......+..++.++.+++.+||..+|.+|||+.+++++|+
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                0111223445678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-40  Score=316.07  Aligned_cols=256  Identities=29%  Similarity=0.423  Sum_probs=203.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||+|...+       ...||+|.+..... ....+.+|+.+++.++|+||+++++.+. ...
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP   74 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecC-------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCC
Confidence            45679999999999999999996433       23599999874332 3456889999999999999999999874 456


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeec
Confidence            899999999999999997655556889999999999999999999966  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........   ..   ..       ..
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~---~~-------~~  218 (262)
T cd05071         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD---QV-------ER  218 (262)
T ss_pred             cccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HH---HH-------hc
Confidence            433221 1122346778999999988899999999999999999999 8889875432111   10   00       00


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                          ......+...+..+.+|+.+||+.+|++||++.++++.|+..
T Consensus       219 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                001122344567889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.7e-40  Score=314.58  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=193.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|.+.+    ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS----GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            358999999999997543    23456799998865432 3345688899999999999999999999998999999999


Q ss_pred             cCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          163 MPRGSLENQLFRRY---SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       163 ~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      +++|+|.+++....   ....++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999986532   234567778889999999999999966  9999999999999999999999999997543332


Q ss_pred             CccceeccccCCCCcCccccccC-------CCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTG-------HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      .........|+..|+|||++.+.       .++.++|||||||++|||++ |..||.........   ...   ..  ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~---~~--~~  226 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT---VR--EQ  226 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH---hh--cc
Confidence            22222235678899999998642       35789999999999999996 99999754332111   100   00  00


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ......+.+    ....+..+.+++..|| .+|++|||+.+|+..|+
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            011111111    2233456888999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-40  Score=324.75  Aligned_cols=271  Identities=23%  Similarity=0.320  Sum_probs=203.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|.++.... .....+.+|+.+++.++||||+++++++..++.
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSK------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS   78 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEec------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe
Confidence            367999999999999999999543      3567899999865432 233457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          79 LTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             EEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceec
Confidence            999999996 5888877554 345788999999999999999999976  999999999999999999999999999754


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--------hhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--------PML  306 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--------~~~  306 (455)
                      ......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....        +.+
T Consensus       155 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         155 SVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             CCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence            332211  223468999999998865 458899999999999999999999997665432222221100        000


Q ss_pred             HhhhhhcccCCCcccC----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 NDARKLGRIMDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .........-.+....    ......+.++.+|+.+||..||.+|||+.++++|.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence            0000000000000000    0112345678999999999999999999999998543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-40  Score=316.44  Aligned_cols=256  Identities=32%  Similarity=0.492  Sum_probs=202.1

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|...+.......+..||||.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999765533233445789999875433 23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-----ceEEccCCCc
Q 012832          163 MPRGSLENQLFRRY-----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-----TAKLSDFGLA  232 (455)
Q Consensus       163 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-----~~kL~DfGla  232 (455)
                      +++++|.+++....     ...+++..++.++.|++.||.|||+.+  ++|+||+|+|||++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999987532     234788999999999999999999866  99999999999999877     8999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ................++..|+|||++.++.++.++|||||||++|+|++ |..||.......   .....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~---------  226 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV---------  226 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---------
Confidence            76543322222222456789999999999999999999999999999998 999997543211   11110         


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ........+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       227 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 -----TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -----hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                 000111223445678899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.8e-41  Score=343.86  Aligned_cols=272  Identities=22%  Similarity=0.306  Sum_probs=197.0

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC------CCCccc
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR------HPHLVK  145 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~  145 (455)
                      ++....++|.+.+.||+|+||.||+|....      .++.||||+++... .....+..|+.++..++      |.+|++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRK------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcC------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            344567889999999999999999996433      46789999985322 22234455666666654      456888


Q ss_pred             EEEEEEeC-CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCC-
Q 012832          146 LIGYCCEE-EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDY-  222 (455)
Q Consensus       146 ~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~-  222 (455)
                      +++++... ...|+|||++ |++|.+++.+.  ..+++..+..++.||+.||+|||+ .+  ||||||||+|||++.++ 
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDT  270 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCc
Confidence            88888764 5789999998 78999888664  578999999999999999999997 36  99999999999998765 


Q ss_pred             ---------------ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCC
Q 012832          223 ---------------TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       223 ---------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~  287 (455)
                                     .+||+|||++......     ....+||+.|+|||++.+..|+.++|||||||++|||++|++||
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                           4999999988643221     23367999999999999999999999999999999999999999


Q ss_pred             CCCCccchhhHHHhhh-h----hh-----Hhhhhhc---ccCCCcccC----------CC-CHHHHHHHHHHHHHHhccC
Q 012832          288 DKSRPQREQSLVEWAR-P----ML-----NDARKLG---RIMDPRLEG----------QY-SETGARKAAALAYQCLSHR  343 (455)
Q Consensus       288 ~~~~~~~~~~~~~~~~-~----~~-----~~~~~~~---~~~~~~~~~----------~~-~~~~~~~~~~li~~cl~~~  343 (455)
                      +..........+.... .    +.     .....+.   ..+.+....          .. .......+.+||.+||..|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            8765433222221110 0    00     0000000   000000000          00 0011346789999999999


Q ss_pred             CCCCCCHHHHHHhcccc
Q 012832          344 PKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       344 P~~RPt~~ell~~L~~~  360 (455)
                      |++|||+.|+++|-+..
T Consensus       426 P~~R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        426 RQKRLNARQMTTHPYVL  442 (467)
T ss_pred             hhhCCCHHHHhcCcccc
Confidence            99999999999995543

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=337.10  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=210.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +-|.++.-||.|+||.||+|..      +.++-..|.|++........++++-|++||..++||+||++++.|..++.+|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~n------ket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVN------KETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhc------ccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            3477888899999999999943      3456677889998888888899999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      |+.|||.||-+...+.. .+..+.+.++.-+++|++.||.|||+.+  |||||||+.|||++-+|.++|+|||++.....
T Consensus       106 iliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchh
Confidence            99999999988876554 4678999999999999999999999976  99999999999999999999999999865322


Q ss_pred             CCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                        .......++|||.|||||+..     ..+|+.++||||||++|.||..+.+|....++.+..-.+.            
T Consensus       183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia------------  248 (1187)
T KOG0579|consen  183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------------  248 (1187)
T ss_pred             --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh------------
Confidence              112234489999999999885     4679999999999999999999999987655433221111            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .--.|.+  --|...+..+.+++.+||..||..||++.++++|.+
T Consensus       249 -KSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf  291 (1187)
T KOG0579|consen  249 -KSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF  291 (1187)
T ss_pred             -hcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence             0011111  124556788999999999999999999999999843

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-40  Score=326.55  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=195.9

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .....+|.+.+.||+|+||.||+|....      ++..||+|+....      ....|+.+++.++|+||+++++++...
T Consensus        62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~  129 (357)
T PHA03209         62 VVASLGYTVIKTLTPGSEGRVFVATKPG------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG  129 (357)
T ss_pred             hhhhcCcEEEEEecCCCCeEEEEEEECC------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC
Confidence            3455689999999999999999996433      4678999975432      234689999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+ .++|.+++... ...+++..+..++.||+.||.|||+.+  ||||||||+|||++.++.++|+|||++.
T Consensus       130 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        130 AITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             CeeEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCcccc
Confidence            9999999999 56888887654 457899999999999999999999976  9999999999999999999999999997


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-h---hhhhHhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-A---RPMLNDA  309 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-~---~~~~~~~  309 (455)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||+++..|+-...+......... .   ...+...
T Consensus       206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~  282 (357)
T PHA03209        206 FPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL  282 (357)
T ss_pred             ccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence            533221   12235699999999999999999999999999999999986555422222111111000 0   0000000


Q ss_pred             ----hhhc---------ccCC--CcccCCC-------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          310 ----RKLG---------RIMD--PRLEGQY-------SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       310 ----~~~~---------~~~~--~~~~~~~-------~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ..+.         .+++  ......+       ....+.++.+||.+||+.||++|||+.|+++|-+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~  353 (357)
T PHA03209        283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM  353 (357)
T ss_pred             ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence                0000         0000  0000000       0123456778999999999999999999999843

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-40  Score=320.76  Aligned_cols=265  Identities=24%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcC---CCCCcccEEEEEEe-
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL---RHPHLVKLIGYCCE-  152 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~-  152 (455)
                      +|.+.+.||+|+||.||+|...      .+++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            4788899999999999999543      3578999998864322  1223455677766655   69999999998764 


Q ss_pred             ----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          153 ----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       153 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                          ....++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECc
Confidence                245799999996 58988887655566899999999999999999999976  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH-HHhhhhhhH
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL-VEWARPMLN  307 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~-~~~~~~~~~  307 (455)
                      ||++........   .....||..|+|||++.+..++.++|||||||++|+|++|.+||........... .......  
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~--  226 (288)
T cd07863         152 FGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP--  226 (288)
T ss_pred             cCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC--
Confidence            999986543221   2235689999999999988999999999999999999999999976543221111 1100000  


Q ss_pred             hhhhhcc-------cCCCcc---cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          308 DARKLGR-------IMDPRL---EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       308 ~~~~~~~-------~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....+..       ...+..   .....+..+..+.+|+.+||+.||++|||+.+++.|-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            0000000       000000   0011223456789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.4e-40  Score=312.15  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=197.2

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecC
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMP  164 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  164 (455)
                      ||+|+||.||+|.+...    ..+..||+|++..... .....+.+|+.+++.++||||+++++++. ....++||||++
T Consensus         3 ig~G~~g~v~~~~~~~~----~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           3 LGSGNFGCVKKGVYKMR----KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             cCCCCcccEEEEEEecC----CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            89999999999976431    2345699999865432 33466889999999999999999999875 457899999999


Q ss_pred             CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccc-
Q 012832          165 RGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV-  243 (455)
Q Consensus       165 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~-  243 (455)
                      +++|.+++... ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++|+|||++........... 
T Consensus        78 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99999988643 357899999999999999999999966  99999999999999999999999999976543322111 


Q ss_pred             eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ....              ......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~--------------~~~~~~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFI--------------EQGKRL  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH--------------HCCCCC
Confidence            111234678999999988889999999999999999996 9999976533211   1100              011112


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..+..++.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23445568899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.1e-42  Score=306.52  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=207.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcCC-CCCcccEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQLR-HPHLVKLI  147 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~-h~nIv~~~  147 (455)
                      -..|...+.||.|..+.|-++.      ++.+++.+|+|++.....        ...+.-.+|+.||+++. ||+|+.+.
T Consensus        16 y~~y~pkeilgrgvss~vrRci------~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCI------HKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhh------hcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            3567888999999999998873      455788999998854221        11234567999999986 99999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      +++..+...++|+|.|+.|.|.|+|...  ..+++.....|+.|+.+|++|||..+  ||||||||+|||++++.+++|+
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEe
Confidence            9999999999999999999999999775  68999999999999999999999966  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccc------cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      |||+|....++..   ....||||+|+|||.+.      ...|+..+|+|++|||||.|+.|.+||-.........+   
T Consensus       166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~---  239 (411)
T KOG0599|consen  166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRM---  239 (411)
T ss_pred             ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHH---
Confidence            9999998877543   34589999999999984      34688999999999999999999999953221111111   


Q ss_pred             hhhhhHhhhhhcccCCC--cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          302 ARPMLNDARKLGRIMDP--RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                                   ++..  .+..+-..+.+.+..+||.+||+.||.+|.|+.|++.|-..
T Consensus       240 -------------ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  240 -------------IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             -------------HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence                         1111  12222344567789999999999999999999999998544

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-40  Score=316.09  Aligned_cols=262  Identities=25%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .+++|...+.||+|+||.||+|.....   ......+|+|.++... ......+..|+.+++.++|+||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMP---GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            356788899999999999999976432   1224579999986542 334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++..
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999999988654 357899999999999999999999976  99999999999999999999999999976


Q ss_pred             CCCCCCccce-eccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTHVS-TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   .+       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~---~i-------  223 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK---AI-------  223 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---HH-------
Confidence            5433221111 11223457999999998889999999999999999997 999996543211   111   00       


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..    ......+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus       224 ~~----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 ND----GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             hc----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00    011122334567789999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-40  Score=316.95  Aligned_cols=246  Identities=26%  Similarity=0.393  Sum_probs=192.2

Q ss_pred             cccccCCeeEEEEEEcCCC------------------CCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccE
Q 012832           85 FLGEGGFGAVHKGFIDDKL------------------RPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKL  146 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~  146 (455)
                      .||+|+||.||+|.+....                  ........||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999753211                  1223345699999876555555678889999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----
Q 012832          147 IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----  222 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----  222 (455)
                      ++++......++||||+++|+|..++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999887643 357889999999999999999999865  99999999999997643    


Q ss_pred             ---ceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHH-hCCCCCCCCCccchhh
Q 012832          223 ---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELL-SGRKSVDKSRPQREQS  297 (455)
Q Consensus       223 ---~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-~G~~p~~~~~~~~~~~  297 (455)
                         .++|+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               4899999998654322      11357889999998865 56899999999999999995 6999997654321111


Q ss_pred             HHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..       ..        ...+    +.....++.+++.+||+.+|++|||+.++++.|.
T Consensus       233 ~~-------~~--------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 FY-------EK--------KHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-------Hh--------ccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            10       00        0011    1122356889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-40  Score=315.67  Aligned_cols=260  Identities=25%  Similarity=0.414  Sum_probs=205.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+|.+.+.||+|+||.||+|.....   ......||||.+... .......|..|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLP---GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecC---CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4578899999999999999976542   123457999998654 233456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999988654 356899999999999999999999966  9999999999999999999999999987654


Q ss_pred             CCCCccceec-cc--cCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          237 EGDDTHVSTR-VM--GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       237 ~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......... ..  ++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+..         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~---------  225 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE---------  225 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH---------
Confidence            3222111111 11  2457999999999999999999999999999886 99999754322   1111110         


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                       ..    .....+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus       226 -~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 -QD----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -cC----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00    11112234567789999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=314.20  Aligned_cols=257  Identities=30%  Similarity=0.435  Sum_probs=207.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...+       +..||||.+.... ....++.+|+.+++.++|+||+++++++....
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE   74 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence            356789999999999999999996432       3569999887543 33467889999999999999999999999888


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++.......+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECcccccee
Confidence            9999999999999999998766567899999999999999999999976  99999999999999999999999999876


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ...... .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......   ......          .
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~----------~  218 (261)
T cd05034         153 IEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV----------E  218 (261)
T ss_pred             ccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----------H
Confidence            543211 11112335678999999998889999999999999999998 99999654321   111110          0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..    .....+...+.++.+++.+||..+|.+||++.++++.|+.
T Consensus       219 ~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 RG----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             cC----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            00    1111223346789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-40  Score=318.77  Aligned_cols=263  Identities=25%  Similarity=0.421  Sum_probs=206.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|..... .+...+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEccc-CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            456799999999999999999975421 123356789999986543 233466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRY--------------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS  214 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~  214 (455)
                      ..++||||+++|+|.+++....                    ...+++..++.++.|++.||+|||+.+  ++||||||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~  159 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR  159 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence            9999999999999999986432                    124778889999999999999999966  999999999


Q ss_pred             CEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCcc
Q 012832          215 NILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQ  293 (455)
Q Consensus       215 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~  293 (455)
                      |||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543322111222345678999999998899999999999999999997 88888654321


Q ss_pred             chhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .   .....    .         +... ...+...+.++.+|+.+||+.+|.+|||+.|+++.|+
T Consensus       240 ~---~~~~~----~---------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 E---VIYYV----R---------DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H---HHHHH----h---------cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1   11100    0         0000 0123345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-40  Score=316.50  Aligned_cols=255  Identities=23%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|.++.........+.+|+.+++.++||||+++++++...+..
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNV------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEc------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            457888899999999999999543      35678999998766555556678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9999999999999988654  47899999999999999999999976  9999999999999999999999999987553


Q ss_pred             CCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ...  .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+........           ..
T Consensus       158 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-----------~~  224 (267)
T cd06645         158 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-----------KS  224 (267)
T ss_pred             Ccc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-----------cc
Confidence            221  1123357999999999874   4568899999999999999999999986543221110000           00


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ....+....  ....+..+.+++.+||..+|++|||+.++++|
T Consensus       225 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         225 NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000111110  11234578899999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=326.43  Aligned_cols=258  Identities=20%  Similarity=0.214  Sum_probs=199.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||++...      .+++.||+|++....   ......+.+|+.++..++|+||+++++++....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            47889999999999999999543      356789999986422   223355778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999988653 356899999999999999999999966  99999999999999999999999999876


Q ss_pred             CCCCCCccceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ....... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||........      ...+....
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~  224 (331)
T cd05597         152 LLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK  224 (331)
T ss_pred             cCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence            5433221 1222469999999999863     4578899999999999999999999975432111      11111000


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~  358 (455)
                          .  ...+. ......+..+.+++.+||...+++  ||++.++++|-+
T Consensus       225 ----~--~~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         225 ----E--HFQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             ----C--cccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence                0  00011 111225677899999988654443  789999999954

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-40  Score=315.40  Aligned_cols=255  Identities=31%  Similarity=0.474  Sum_probs=201.7

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHH--HHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR--EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      |++.+.||+|+||.||++...      .+++.||+|++.........  ....|+.+++.++||||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEEC------CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            567889999999999999544      35678999999766543332  3456999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++++|.+++...  ..+++..++.++.|++.||++||+.+  |+|+||||+|||++.++.++|+|||.+.....
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence            999999999999999733  57899999999999999999999976  99999999999999999999999999975411


Q ss_pred             CCCccceeccccCCCCcCccccc-cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .  ........||..|+|||++. +..++.++||||||+++|+|++|..||................   ......    
T Consensus       151 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~----  221 (260)
T PF00069_consen  151 N--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---KRPLPS----  221 (260)
T ss_dssp             T--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---HTHHHH----
T ss_pred             c--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---cccccc----
Confidence            1  11233467899999999998 7889999999999999999999999998652222222221110   000000    


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          ...........+.+++.+||+.+|++||++.+++++-
T Consensus       222 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  222 ----SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             ----HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             ----cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence                0000011137899999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-40  Score=331.06  Aligned_cols=267  Identities=22%  Similarity=0.304  Sum_probs=199.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|..      ...++.||||.+...  .......+.+|+.+++.++||||+++++++...
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   88 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYD------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEe------cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence            457899999999999999999953      345788999998643  223346678899999999999999999988644


Q ss_pred             ------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 ------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                            ...++||||++ ++|.+.+..    .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          89 KSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEe
Confidence                  35799999995 467666643    4788899999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hh-----
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EW-----  301 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~-----  301 (455)
                      |||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......... ..     
T Consensus       162 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (355)
T cd07874         162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_pred             eCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998643321   123357999999999999999999999999999999999999999765432111100 00     


Q ss_pred             ----------hhhhhHhhhhhcccCCCc------c--cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          302 ----------ARPMLNDARKLGRIMDPR------L--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       302 ----------~~~~~~~~~~~~~~~~~~------~--~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                ................+.      .  ........+.++.+|+.+||..||++|||+.++++|.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~  313 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY  313 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence                      000000000000000000      0  00112223467899999999999999999999999843

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-40  Score=324.86  Aligned_cols=270  Identities=24%  Similarity=0.364  Sum_probs=210.4

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCC-CcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRP-GLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      .+...+|.+.+.||+|+||.||+|......+. ......||+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            44456799999999999999999975432111 1234579999886432 23456788999999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      ......++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+  |+||||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni  165 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNV  165 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceE
Confidence            99999999999999999999987542              234788889999999999999999966  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccch
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE  295 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~  295 (455)
                      |++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999986543322211222335678999999999999999999999999999998 8899875432111


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ..      .+ .          .......+..++.++.+|+.+||+.+|++|||+.++++.|+.+..
T Consensus       246 ~~------~~-~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         246 FK------LL-K----------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HH------HH-H----------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            11      00 0          001111233445688999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-40  Score=321.25  Aligned_cols=253  Identities=23%  Similarity=0.382  Sum_probs=207.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..+|++.+.||.|+||.||+|..      ..+++.||+|.+..........+.+|+.+++.++||||+++++++......
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAID------VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEE------cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            35699999999999999999954      335788999998766555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++...   .+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            9999999999999987543   5899999999999999999999976  9999999999999999999999999987654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|+..|+|||.+.+..++.++|||||||++|+|++|..||....+......+.      .         
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~------~---------  229 (296)
T cd06655         167 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T---------  229 (296)
T ss_pred             ccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h---------
Confidence            33221  223468999999999998889999999999999999999999997654322111100      0         


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ........+...+..+.+++.+||..+|.+||++.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~  270 (296)
T cd06655         230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (296)
T ss_pred             cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence            00001112334556789999999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.4e-40  Score=310.96  Aligned_cols=253  Identities=29%  Similarity=0.451  Sum_probs=202.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|.+...   ......||||.+..... .....+.+|+.+++.++||||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS---GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecC---CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            4689999999999976442   22344799999977665 556778999999999999999999999988 889999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++.......+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999987754357899999999999999999999966  9999999999999999999999999998765432211


Q ss_pred             -ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          243 -VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       243 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                       ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....   ....        ..  
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~---~~~~--------~~--  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKK---IDKE--------GE--  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHhc--------CC--
Confidence             1112457889999999998899999999999999999998 999997543321   1110   0000        00  


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....+...+..+.+++.+||..+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11122345678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-40  Score=337.14  Aligned_cols=266  Identities=21%  Similarity=0.218  Sum_probs=197.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ...|.+.+.||+|+||.||+|....      .++.||||....      ..+.+|+.+|+.++|+||+++++++...+..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            4579999999999999999996433      467899996432      2356899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++|||++ .++|.+++... ...+++..++.++.||+.||.|||+.+  ||||||||+||||+.++.++|+|||+++...
T Consensus       236 ~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            9999999 57898887654 246899999999999999999999966  9999999999999999999999999998654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCcc--------chhhHHHhhhhhhH-
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ--------REQSLVEWARPMLN-  307 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~--------~~~~~~~~~~~~~~-  307 (455)
                      ............||..|+|||++.+..++.++|||||||+||||++|..|+-.....        .....+........ 
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            332222223467999999999999999999999999999999999988664322110        00111111100000 


Q ss_pred             -----------hhh-hhcccCCCcccCCCC---HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 -----------DAR-KLGRIMDPRLEGQYS---ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 -----------~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                 ... .......+.......   .....++.+|+.+||+.||.+|||+.|+++|-+
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence                       000 000000000000000   022347889999999999999999999999843

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-40  Score=322.31  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=202.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  153 (455)
                      ..++|++.+.||+|+||.||+|.+.+.    .....+|+|.+... .......+.+|+.++..+ +|+||+++++++...
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccC----CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            356889999999999999999975431    12235678776532 233446788899999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                      +..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+  |+||||||+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~  158 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG  158 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec
Confidence            99999999999999999886542              235788999999999999999999866  99999999999999


Q ss_pred             CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhH
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSL  298 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~  298 (455)
                      .++.++|+|||++........   .....++..|+|||++.+..++.++|||||||++|||++ |..||.......   .
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~  232 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L  232 (303)
T ss_pred             CCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H
Confidence            999999999999864321111   111234668999999988889999999999999999998 999997543221   1


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ...          ...    ......+...+..+.+|+.+||+.+|++||++.+++..|..+.
T Consensus       233 ~~~----------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         233 YEK----------LPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             HHH----------Hhc----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            110          000    0111122234567899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-40  Score=316.36  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      |++.+.||+|+||.||+|...      .++..+++|.+..........+.+|+.+++.++||||+++++++......++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            577888999999999999543      35678999998766556667788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++++|..++... ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            9999999998877543 357899999999999999999999976  9999999999999999999999999987643321


Q ss_pred             CccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .  ......|+..|+|||++.     +..++.++|||||||++|+|++|.+||....+...  .....           .
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~-----------~  222 (282)
T cd06643         158 Q--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----------K  222 (282)
T ss_pred             c--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHh-----------h
Confidence            1  122356899999999984     44578899999999999999999999975432111  11100           0


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...+.  ...+...+.++.+|+.+||..+|.+||++.+++++.+
T Consensus       223 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         223 SEPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             cCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            00011  1122334578999999999999999999999998854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-40  Score=315.08  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=194.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCC-CcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRP-GLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|........ ......||+|.+........+.+..|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            3699999999999975432211 334567999988765555567788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc--------eEEccCCCccC
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT--------AKLSDFGLAKD  234 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~--------~kL~DfGla~~  234 (455)
                      +++|+|.+++... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.        ++|+|||++..
T Consensus        81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999988754 246889999999999999999999966  999999999999987654        69999999875


Q ss_pred             CCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCC-CCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR-KSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ....      ....++..|+|||++.+ ..++.++|||||||++|+|++|. +||....+......       ...    
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~----  220 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED----  220 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc----
Confidence            4332      22468899999999976 45899999999999999999984 66654332111100       000    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                              ...++.....++.+|+.+||+.+|++|||++++++.|+
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    01122233467899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.1e-40  Score=312.12  Aligned_cols=260  Identities=22%  Similarity=0.353  Sum_probs=207.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|.++..   .......+.+|+.+++.++|+||+++++++....
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            57999999999999999999654      24678999987532   2233567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ..++||||+++|+|.+++...  ....+++..+..++.+++.||.|||+.+  |+||||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999988642  2356889999999999999999999976  999999999999999999999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .........  .....|++.|+|||.+.+..++.++|||||||++|+|++|..||......    .......       .
T Consensus       154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-------~  220 (267)
T cd08224         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-------I  220 (267)
T ss_pred             eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-------h
Confidence            765432211  22256899999999999888999999999999999999999999654311    1111100       0


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..   ...........+..+.+++.+||..+|++|||+.+|++.|..+.
T Consensus       221 ~~---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         221 EK---CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hc---CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00   00111112245678899999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-40  Score=312.34  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=192.5

Q ss_pred             ccccccCCeeEEEEEEcCCCC------CCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLR------PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +.||+|+||.||+|....+..      .......||+|.+..........+..|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999997643211      11234568999887655555567888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc-------eEEccCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT-------AKLSDFG  230 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~-------~kL~DfG  230 (455)
                      +||||+++|+|..++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999998877543 346899999999999999999999966  999999999999986654       8999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccc-cCCCCccCchhhHHHHHHHHH-hCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELL-SGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ++......      ....|+..|+|||.+. +..++.++|||||||++|||+ .|..||...........       .  
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~--  222 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y--  222 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H--
Confidence            98755322      1245888999999886 466899999999999999998 58888865322110000       0  


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                              ....  ......+.++.+|+.+||+.+|.+||++.+|+++|+
T Consensus       223 --------~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 --------EGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --------hcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                    0000  011123467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-40  Score=310.35  Aligned_cols=252  Identities=33%  Similarity=0.479  Sum_probs=199.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|.+...   ...+..||+|.+..... .....+.+|+.+++.+.|+||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK---SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeecc---CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            4699999999999976442   12447899999875543 34567889999999999999999999875 4567999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++|+|.+++...  ..+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999999765  37899999999999999999999976  9999999999999999999999999998654433211


Q ss_pred             c-eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          243 V-STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       243 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                      . .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||......   ....+...              ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~--------------~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES--------------GE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc--------------CC
Confidence            1 111234568999999998899999999999999999998 99999764321   11111100              00


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ....+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122344567889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-40  Score=313.29  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh---------hHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ---------GHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      +|.+...||+|+||.||+|...      ..+..||+|.+......         ....+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEec------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            4788899999999999999643      24678999987543221         22457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +......++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999999999988654  56888999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCc----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          230 GLAKDGPEGDDT----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       230 Gla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |+++........    .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......  . +      
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~------  221 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--A-I------  221 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--H-H------
Confidence            998866422111    01122458899999999998889999999999999999999999997542211  0 0      


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                          .......    ....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       222 ----~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         222 ----FKIGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ----HHHhccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                0011111    112334456788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=315.84  Aligned_cols=264  Identities=23%  Similarity=0.359  Sum_probs=207.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+|.+.+.||+|+||.||+|...+.  .......||+|.+..... .....+.+|+.+++.++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPE--GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecC--CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            346788899999999999999976542  122344699998865533 344678899999999999999999999887 7


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++.
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCccccc
Confidence            889999999999999988764 345899999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............++..|+|||.+....++.++|||||||++|||++ |..||+......   .....   .       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---~-------  225 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLL---E-------  225 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH---h-------
Confidence            654332211122234678999999988889999999999999999998 999997653211   11100   0       


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          .......+..++..+.+++.+||..+|.+||++.++++.|..+..
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         226 ----KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                000111223345678899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.3e-40  Score=311.92  Aligned_cols=254  Identities=29%  Similarity=0.411  Sum_probs=202.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+...||+|+||.||+|....       +..+|+|.+.... .....+.+|+.+++.++|+||+++++++. ....
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNG-------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcC-------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            4568899999999999999996533       2358999876433 23466889999999999999999999875 4568


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+|||++.++.++|+|||++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            99999999999999997665566899999999999999999999966  9999999999999999999999999997653


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ...+.          .. 
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----------~~-  218 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----------ER-  218 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----------Hc-
Confidence            32211 1122346778999999998889999999999999999999 999997643211   11110          00 


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         ......+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 ---GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01112233456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=310.59  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=206.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ++|.+.+.||.|+||.||+|....      ++..+|+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            578899999999999999995433      45789999987665556678889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      ++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++.....
T Consensus        77 l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999987654 257889999999999999999999976  99999999999999999999999999876543


Q ss_pred             CCCccceeccccCCCCcCccccccC---CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTG---HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...  ......|+..|+|||.+.+.   .++.++|||||||++|+|++|.+||....+.......  .          ..
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~----------~~  219 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--S----------KS  219 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----------hc
Confidence            221  12235689999999999776   7899999999999999999999999765432111100  0          00


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .+.+. ........+.++.+++.+||..+|.+|||+.+++.+
T Consensus       220 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         220 NFPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cCCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00100 111234456789999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.4e-40  Score=311.46  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=203.0

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-CCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-EEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~  155 (455)
                      +|.+.+.||+|+||.||++...      ..++.||+|.+....  ......+.+|+.+++.++|+||+++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            4888999999999999999543      346789999986543  2344567889999999999999999998764 446


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.......+++.++..++.+++.||+|||+.+  |+||||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            799999999999999987755567899999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....  ......|++.|+|||++.+..++.++|||||||++++|++|+.||+......      .......        
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~--------  216 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIE--------  216 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHh--------
Confidence            33221  2233568999999999999999999999999999999999999997543211      1111100        


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        . .....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       217 --~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 --G-KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --c-CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              0 0112234456789999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.1e-40  Score=316.55  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=203.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+.|++.+.||.|+||.||+|...      .++..||+|.+..........+.+|+.+++.++|+||+++++.+..+...
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNK------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL   84 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEEC------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence            366999999999999999999543      35678999998776666677788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|..++.+. ...+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999998876543 356899999999999999999999976  9999999999999999999999999987543


Q ss_pred             CCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ....  ......|+..|+|||++.     ...++.++|||||||++|+|++|.+||....+...  ....          
T Consensus       162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~----------  227 (292)
T cd06644         162 KTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKI----------  227 (292)
T ss_pred             cccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHH----------
Confidence            2211  122356899999999985     34468899999999999999999999975432110  0110          


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .....+.  ...+...+.++.+++.+||..+|++||++.+++++
T Consensus       228 -~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         228 -AKSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -hcCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0000111  11233445678999999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6e-40  Score=312.80  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=205.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..+|.+.+.||+|+||.||+|.....   ......+|+|.++... ......+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLP---GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecC---CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            45788999999999999999965321   1234579999886543 2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++... ...+++.+++.++.|++.||.|||+.+  ++||||||+|||++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999988754 346899999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccc-eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          236 PEGDDTHV-STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       236 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ........ .....++..|+|||.+.+..++.++|+|||||++||+++ |..||.......   .....          .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----------~  223 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----------E  223 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----------h
Confidence            54322111 111234568999999998899999999999999999886 999997543321   11111          0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..    .....+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       224 ~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 EG----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CC----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            00    01112234467789999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.1e-40  Score=309.98  Aligned_cols=252  Identities=23%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|+..+.||.|+||.||.+...      ..+..+++|.+....  ......+.+|+.+++.++|+||+++++++.+....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            5888999999999999988533      357789999876542  34456688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999987765567899999999999999999999976  9999999999999999999999999998654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..........      ..          .
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~----------~  214 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KI----------V  214 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH----------H
Confidence            4331  1233568999999999988889999999999999999999999997543211100      00          0


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ...+. ......+.++.+++.+||..+|.+||++.++++++
T Consensus       215 ~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         215 QGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            00111 11234567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=316.83  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||.|+||.||+|....      ++..||+|.+..........+..|+.+++.++|+||+++++++..+...
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKE------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL   77 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcC------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence            4578999999999999999996533      4678999998776666667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          78 WILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             EEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            9999999999999987653 346899999999999999999999976  9999999999999999999999999987653


Q ss_pred             CCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      .....  .....|++.|+|||.+.     ...++.++|||||||++|+|++|.+||.........  ..+          
T Consensus       155 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~----------  220 (280)
T cd06611         155 STLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKI----------  220 (280)
T ss_pred             ccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHH----------
Confidence            32211  22356899999999875     345778999999999999999999999765332111  110          


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .....+.+  ..+...+.++.+++.+||..+|.+||++.+++++-+
T Consensus       221 -~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         221 -LKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             -hcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence             00000111  113345678899999999999999999999998843

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.6e-40  Score=320.55  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=207.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..+|.+.+.||+|+||.||+|...      ..+..||+|.+........+.+.+|+.+++.++|+||+++++++......
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDI------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEEC------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            367999999999999999999543      35778999998766555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999999998854   35788999999999999999999976  9999999999999999999999999987654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||....+.......               ..
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---------------~~  229 (297)
T cd06656         167 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------------AT  229 (297)
T ss_pred             CCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---------------cc
Confidence            33211  22356899999999999888999999999999999999999999764332111000               00


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ........+...+..+.+|+.+||..+|++||++.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP  270 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            00011112334557788999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-40  Score=354.84  Aligned_cols=256  Identities=23%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ...++|.+.+.||+|+||.||+|...      ..+..||+|.+....  ......+..|+.+|+.|+|||||+++++|..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHK------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEEC------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            34578999999999999999999643      357789999886543  2334668899999999999999999998865


Q ss_pred             C--CeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCeEEeccCCCCEEEcC---
Q 012832          153 E--EHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAE-----KPVIYRDFKASNILLDS---  220 (455)
Q Consensus       153 ~--~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~iiHrDlkp~Nill~~---  220 (455)
                      .  ..+||||||+++|+|.++|....  ...+++..++.|+.||+.||+|||+.+     .+||||||||+||||+.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence            4  56899999999999999887532  356899999999999999999999854     45999999999999964   


Q ss_pred             --------------CCceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCC
Q 012832          221 --------------DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGR  284 (455)
Q Consensus       221 --------------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~  284 (455)
                                    .+.+||+|||++........   .....||+.|+|||++.+  ..++.++||||||||||||++|.
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                          34589999999986543221   223579999999999864  45889999999999999999999


Q ss_pred             CCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          285 KSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       285 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .||.......  .++.   .       +...  +.+.   ....+.++.+||..||..+|.+||++.+++.+
T Consensus       241 ~PF~~~~~~~--qli~---~-------lk~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        241 TPFHKANNFS--QLIS---E-------LKRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCCCcCCcHH--HHHH---H-------HhcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            9997543211  1111   0       0000  1111   12235778999999999999999999999976

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.3e-40  Score=310.61  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...+       +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. .
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   73 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E   73 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence            456789999999999999999996432       3469999876432 234678899999999999999999999877 7


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceee
Confidence            7899999999999999997765667889999999999999999999866  99999999999999999999999999976


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... ......++..|+|||++.+..++.++|+|||||++|++++ |..||........   ..+.    .      
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~------  217 (260)
T cd05073         152 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL----E------  217 (260)
T ss_pred             ccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----h------
Confidence            5432211 1222346678999999998889999999999999999998 9999975432211   1110    0      


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          .......+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus       218 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         218 ----RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                001111223456779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-40  Score=329.17  Aligned_cols=266  Identities=20%  Similarity=0.285  Sum_probs=199.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|..      ...++.||||++...  .......+.+|+.+++.++||||+++++++... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYD------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEE------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            57899999999999999999954      335778999998643  233446678899999999999999999987543 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           ...|+||||++ ++|.+.+..    .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875          97 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             cccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEe
Confidence                 35799999995 577776643    4788899999999999999999966  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-------
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-------  301 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-------  301 (455)
                      ||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+..       
T Consensus       170 fG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         170 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             CCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998653321   12335799999999999999999999999999999999999999976543221111100       


Q ss_pred             -----hhhhhHh-hhhhcc--------cCCCc---ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          302 -----ARPMLND-ARKLGR--------IMDPR---LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       302 -----~~~~~~~-~~~~~~--------~~~~~---~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ..+.... ......        .....   ............+.+|+.+||..||.+|||+.++++|-+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence                 0000000 000000        00000   000111223457899999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-39  Score=311.52  Aligned_cols=254  Identities=26%  Similarity=0.343  Sum_probs=191.2

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEec
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM  163 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  163 (455)
                      .||+|+||.||+|.....    .....+|+|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            589999999999965432    245678999875443 233456789999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          164 PRGSLENQLFRRYS---VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       164 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      ++|+|.+++.....   ...++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999876432   23467788899999999999999976  99999999999999999999999999875433222


Q ss_pred             ccceeccccCCCCcCcccccc-------CCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          241 THVSTRVMGTQGYAAPEYVMT-------GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||........   ...   ....  ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~---~~~~--~~  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQ---VVRE--QD  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHH---Hhhc--cC
Confidence            111222446778999998743       356889999999999999999 7888865432111   000   0000  00


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .....    ...+...+..+.+++..|| .+|++|||+.+|++.|
T Consensus       228 ~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 IKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            01111    1223345567788999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-40  Score=317.17  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=205.5

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEE
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLI  147 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~  147 (455)
                      ++.++....+.|++.+.||.|+||.||+|....      .++.||+|++.... .....+..|+.++..+ +|+||++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcC------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            445555667899999999999999999996533      46789999886543 2345677899999988 699999999


Q ss_pred             EEEEe------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          148 GYCCE------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       148 ~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      +++..      ....++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.+
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~  157 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN  157 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC
Confidence            99853      457899999999999999887765567888889999999999999999976  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchh
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ  296 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~  296 (455)
                      +.++|+|||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||....+....
T Consensus       158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            9999999999875432211  122356899999999885     346888999999999999999999999654322111


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ..+                ............++.++.+|+.+||..+|.+|||+.+++++
T Consensus       236 ~~~----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 FLI----------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhH----------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            100                00111111122356789999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=334.44  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=206.2

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecC
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMP  164 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  164 (455)
                      +||+|.||+||.|.      +..+...+|||-+........+-+..|+.+-+.|+|.|||+++|.+.+++..-|.||-++
T Consensus       582 VLGKGTYG~VYA~R------D~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAAR------DMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeec------cccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            59999999999994      455778899999987777777788999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCccCCCCCCCc
Q 012832          165 RGSLENQLFRRYSVSL--PWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       165 ~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~~~~~~~~~  241 (455)
                      ||+|.++|...- +++  ++.+.-.+..||++||.|||++.  |||||||-+||||+. .|.+||+|||.+++....+  
T Consensus       656 GGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--  730 (1226)
T KOG4279|consen  656 GGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--  730 (1226)
T ss_pred             CCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCC--
Confidence            999999887653 355  77888889999999999999977  999999999999965 7999999999998765433  


Q ss_pred             cceeccccCCCCcCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          242 HVSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ..+.++.||..|||||++..+  .|+.++|||||||++.||.||++||-.........+.            .+   --.
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk------------VG---myK  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK------------VG---MYK  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh------------hc---cee
Confidence            335568899999999999765  4999999999999999999999999654322111110            00   001


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .....|...+.++.++|.+|+..+|.+||++.+++..
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            2345678889999999999999999999999999875

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.1e-40  Score=326.15  Aligned_cols=258  Identities=20%  Similarity=0.219  Sum_probs=199.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||++...      .+++.||+|++....   ......+..|..++..++|+||+.+++++...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            47899999999999999999543      356789999986422   223345778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|+||||++||+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceee
Confidence            999999999999999988753 346889999999999999999999966  99999999999999999999999999976


Q ss_pred             CCCCCCccceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ....... ......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||........      ...+... 
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~-  223 (331)
T cd05624         152 MNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNH-  223 (331)
T ss_pred             ccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcC-
Confidence            5433221 1223579999999999875     5688999999999999999999999975432111      0000000 


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~  358 (455)
                           .....+. ......+.++.+++.+||...+++  |++++++++|.+
T Consensus       224 -----~~~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         224 -----EERFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             -----CCcccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence                 0000111 111234678899999999876554  468999998854

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=314.00  Aligned_cols=250  Identities=27%  Similarity=0.386  Sum_probs=205.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|.+.+.||.|+||.||+|....      ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..+...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            368889999999999999996533      57889999987553 33445678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++|+||+++++|.+++...   .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999988653   7899999999999999999999966  9999999999999999999999999998765


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+....   .          .+....
T Consensus       150 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~---~----------~~~~~~  214 (274)
T cd06609         150 STMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---F----------LIPKNN  214 (274)
T ss_pred             cccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH---H----------HhhhcC
Confidence            4321  122356899999999999888999999999999999999999999754321110   0          000001


Q ss_pred             CCcccCCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSET-GARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~-~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .+.    .... .+.++.+++.+||..+|++|||+++++++-
T Consensus       215 ~~~----~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         215 PPS----LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             CCC----CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence            111    1112 556789999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.2e-40  Score=322.31  Aligned_cols=267  Identities=20%  Similarity=0.241  Sum_probs=198.2

Q ss_pred             Cccccccc--CCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           82 SSNFLGEG--GFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        82 ~~~~LG~G--~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +.++||+|  +||+||++..      ..+++.||+|.++...  ......+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARY------KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEee------cccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            46789999  7899999854      3468899999987543  233355678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++++|||.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999987665567899999999999999999999976  99999999999999999999999987543321


Q ss_pred             CCCc-----cceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH---
Q 012832          238 GDDT-----HVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN---  307 (455)
Q Consensus       238 ~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~---  307 (455)
                      ....     .......++..|+|||++.+  ..++.++|||||||++|||++|..||........  ..........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccc
Confidence            1110     01112357788999999976  4589999999999999999999999975432111  0000000000   


Q ss_pred             -----hhhhhc-----ccCC-----------------CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 -----DARKLG-----RIMD-----------------PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 -----~~~~~~-----~~~~-----------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ....+.     ...+                 ......+....+..+.+|+.+||+.||++|||+.+++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                 000000     0000                 00001122334568899999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-40  Score=315.58  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=207.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|++.+.||+|+||.||+|....      .+..||+|++.... ......+.+|+++++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIP------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN   77 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcC------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence            4578889999999999999996533      46789999876443 2345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .++||||+++++|.+++...  ..+++..+..++.+++.||.|||+ ++  ++||||+|+||+++.++.++|+|||++..
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999999999887653  468999999999999999999996 35  99999999999999999999999999875


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccch-----hhHHHhhhhhhHhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE-----QSLVEWARPMLNDA  309 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~-----~~~~~~~~~~~~~~  309 (455)
                      .....    .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     .....+.....   
T Consensus       154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  226 (284)
T cd06620         154 LINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV---  226 (284)
T ss_pred             hhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh---
Confidence            43221    1235789999999999888999999999999999999999999976443211     11111111111   


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                             ............+.++.+|+.+||..+|++|||+.++++++..++.
T Consensus       227 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         227 -------QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             -------hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                   1000100112256789999999999999999999999998766543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.9e-40  Score=320.86  Aligned_cols=266  Identities=22%  Similarity=0.303  Sum_probs=189.6

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--CCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--EEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~  160 (455)
                      ...||+|+||.||+|...+    ...+..||+|.+.....  ...+.+|+.+|+.++||||+++++++..  ....++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~----~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD----GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEcc----CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            4679999999999996543    23567899998864432  3456789999999999999999998854  45689999


Q ss_pred             EecCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE----cCCCceEEccC
Q 012832          161 EYMPRGSLENQLFRRY-------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYTAKLSDF  229 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill----~~~~~~kL~Df  229 (455)
                      ||+ +++|.+++....       ...+++..+..++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+||
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            999 568888765321       235889999999999999999999976  9999999999999    45678999999


Q ss_pred             CCccCCCCCCCc-cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchh------hHHHh
Q 012832          230 GLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ------SLVEW  301 (455)
Q Consensus       230 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~------~~~~~  301 (455)
                      |+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.........      .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            999865432211 112336789999999999774 5899999999999999999999999754321110      00000


Q ss_pred             hhhh--------hHhhhhhc-------ccCCC-----ccc---CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          302 ARPM--------LNDARKLG-------RIMDP-----RLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       302 ~~~~--------~~~~~~~~-------~~~~~-----~~~---~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....        +.......       .....     .+.   ..........+.+|+.+||+.||.+|||++|+++|-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            0000        00000000       00000     000   000001124678999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.6e-40  Score=312.50  Aligned_cols=262  Identities=26%  Similarity=0.357  Sum_probs=206.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|...+.   ......||||...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSP---ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecC---CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            346788999999999999999976442   1234579999886554 3455678899999999999999999998865 5


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.+++.||+|||+.+  ++|+||||+|||++.++.++|+|||++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeee
Confidence            578999999999999998654 346899999999999999999999966  99999999999999999999999999976


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.             
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------------  222 (270)
T cd05056         157 LEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------------  222 (270)
T ss_pred             cccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------------
Confidence            5443211 1112335568999999988889999999999999999986 999997654321111000             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ...    ....+..++..+.+++.+||..+|++|||+.+++..|+.+..
T Consensus       223 ~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         223 NGE----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             cCC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            000    111234456789999999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-40  Score=315.23  Aligned_cols=274  Identities=26%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--C
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--E  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~  154 (455)
                      ..|.+.+.||+|+||.||++.+..  .....+..||+|.++... ......+.+|+.+++.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEcc--CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            457889999999999999996543  234567889999986443 33446788999999999999999999998775  5


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||++|++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence            689999999999999988654 246899999999999999999999966  99999999999999999999999999986


Q ss_pred             CCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-h-hhhhhHhhhh
Q 012832          235 GPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-W-ARPMLNDARK  311 (455)
Q Consensus       235 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~  311 (455)
                      ....... .......|+..|+|||.+.+..++.++|||||||++|||+++..|+........ .... . ......... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-  236 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-KMIGPTHGQMTVTRLV-  236 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-hhcccccccccHHHHH-
Confidence            5433221 112234577789999999888899999999999999999998776432110000 0000 0 000000000 


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                        ..+........+..++..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       237 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 --RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             --HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence              00000011112334567899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-39  Score=305.97  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=196.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ++||+|+||.||+|...       .+..||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            36999999999999643       246799998865432 2345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++... ...+++..++.++.+++.||.|||+.+  ++||||+|+||+++.++.++|+|||++......... 
T Consensus        74 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  149 (250)
T cd05085          74 VPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-  149 (250)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence            9999999988654 346789999999999999999999976  999999999999999999999999998754322111 


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE  321 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (455)
                      ......++..|+|||++.+..++.++||||||+++|++++ |..||........   ...          ...    ...
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~----------~~~----~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQ----------VEK----GYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHH----------HHc----CCC
Confidence            1111235678999999998889999999999999999998 9999975432211   110          000    011


Q ss_pred             CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...+..++..+.+++.+||..+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1223345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-40  Score=326.39  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||||.+....  ......+.+|+.+|+.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDT------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA   86 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEEC------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence            3578999999999999999999543      357789999986432  22345577899999999999999999887543


Q ss_pred             ------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 ------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                            ...+++|+++ +++|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          87 TSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEc
Confidence                  3478999998 8899887643   46899999999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhh-h
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWAR-P  304 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~~-~  304 (455)
                      |||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ .... +
T Consensus       161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07878         161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP  235 (343)
T ss_pred             CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999865432     223579999999999876 56899999999999999999999999764432111100 0000 0


Q ss_pred             ---hhH-----hhhh----hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          305 ---MLN-----DARK----LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       305 ---~~~-----~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         ...     ....    +.......+. ......+..+.+|+.+||..||.+|||+.+++.|-+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~  301 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF  301 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence               000     0000    0000000000 0001123457899999999999999999999998543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.6e-40  Score=323.93  Aligned_cols=258  Identities=20%  Similarity=0.223  Sum_probs=199.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||++....      +++.||+|++....   ......+..|+.++..++|+||+++++++....
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            478899999999999999996543      46789999985322   222344778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhee
Confidence            999999999999999998653 346899999999999999999999966  99999999999999999999999999876


Q ss_pred             CCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||........      ...+... 
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~-  223 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNH-  223 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCC-
Confidence            433222 1123357999999999986     34688999999999999999999999975432111      1111100 


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~  358 (455)
                           .....+. .....++.++.+|+.+||..++.+  |+++.++++|-+
T Consensus       224 -----~~~~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         224 -----KERFQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             -----CccccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence                 0000011 111234678899999999765544  689999999843

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-39  Score=311.84  Aligned_cols=261  Identities=26%  Similarity=0.351  Sum_probs=206.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|.+...||+|+||.||+|...... .......|++|.+...... ....+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIE-EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCC-cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            57889999999999999999765431 2344567999988654433 456788999999999999999999999988999


Q ss_pred             EEEEEecCCCChHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          157 LLVYEYMPRGSLENQLFRRYS-------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      ++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999876531       25899999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....      
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~------  231 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL------  231 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH------
Confidence            998754322111 1222456788999999988889999999999999999998 888886432211   11100      


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                             ....+....+..++..+.+++.+||..+|.+|||+.+++..|.
T Consensus       232 -------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 -------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   0011111123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.6e-40  Score=314.79  Aligned_cols=268  Identities=22%  Similarity=0.280  Sum_probs=199.8

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|++.+.||+|+||.||+|....      ++..||+|.+....  ......+.+|+.+++.++||||+++++++..+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            47888999999999999996533      46789999886442  22345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||+|+|||++.++.++|+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999996 68888876543 257899999999999999999999966  999999999999999999999999998754


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-H-hhh------hhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-E-WAR------PML  306 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~-~~~------~~~  306 (455)
                      .....  ......+++.|+|||++.+. .++.++|||||||++|+|++|++||............ . +..      +..
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            33211  12224678999999988654 4788999999999999999999999765332111000 0 000      000


Q ss_pred             HhhhhhcccCCC---cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDP---RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ............   ..........+.++.+++.+||..||.+|||+.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~  283 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP  283 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence            000000000000   000011123467788999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-39  Score=308.39  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...+      .+..||+|.+.....  ...+.+|+.+++.++|+||+++++++......
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   73 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL   73 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcC------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence            3678999999999999999996543      367899999865432  57788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      +++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        74 ~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            9999999999999988643 357899999999999999999999976  9999999999999999999999999998764


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|..||....+......             .....
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~  215 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKP  215 (256)
T ss_pred             cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCC
Confidence            4321  12235589999999999988999999999999999999999999976433211100             00000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .+  ....+...+.++.+++.+||+.+|++|||+.+++.+
T Consensus       216 ~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         216 PP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            01  111233456789999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-39  Score=312.15  Aligned_cols=252  Identities=27%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..|+..+.||.|+||.||+|...      .++..||+|.+.... ......+.+|+.+++.+.|+||+++++++......
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDN------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEc------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            35778889999999999999543      346789999886543 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++|+|.+++..   ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999999998854   36888999999999999999999866  9999999999999999999999999997654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ....  ......++..|+|||++.+..++.++|+|||||++|||++|..||....+......                 .
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----------------~  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-----------------I  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-----------------h
Confidence            3321  12234688999999999988899999999999999999999999976543211110                 0


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ............+..+.+++.+||..+|++||++.+++++...
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            1111223455677889999999999999999999999998443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=326.74  Aligned_cols=244  Identities=23%  Similarity=0.286  Sum_probs=190.0

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcC---CCCCcccEEEEEEeCCeEEEE
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQL---RHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      ||+|+||.||+|..      ..++..||||++.....   .....+..|..++..+   +||||+++++++......|+|
T Consensus         1 lG~G~~g~Vy~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRK------KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEE------CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            79999999999954      34578999999864322   2223345566666655   699999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            9999999999888654  57899999999999999999999976  9999999999999999999999999987543322


Q ss_pred             CccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                      ..  ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..........      .+..        ...
T Consensus       151 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~------~i~~--------~~~  214 (330)
T cd05586         151 KT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR------NIAF--------GKV  214 (330)
T ss_pred             CC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH------HHHc--------CCC
Confidence            21  2346799999999998764 48999999999999999999999997643211100      0000        001


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCC----CHHHHHHhcc
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRP----TMSTVVKTLE  358 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RP----t~~ell~~L~  358 (455)
                      .+.   ....+.++.+++.+||..+|.+||    ++.++++|.+
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence            111   112456788999999999999998    6888888744

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=308.77  Aligned_cols=246  Identities=32%  Similarity=0.483  Sum_probs=199.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ++|.+.+.||+|+||.||+|.        ..+..||+|.+....  ....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--------~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--------YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--------cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            568899999999999999883        246679999986542  345688999999999999999999998654 579


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999999999999987765557899999999999999999999966  99999999999999999999999999875432


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ..     .....+..|+|||.+.+..++.++|+|||||++|+|++ |.+||...........+       .      .  
T Consensus       153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~------~--  212 (254)
T cd05083         153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------E------K--  212 (254)
T ss_pred             cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------h------C--
Confidence            21     11334678999999998899999999999999999997 99999765432111100       0      0  


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ......+...+..+.+++.+||..+|++||++.+++..|+
T Consensus       213 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         213 --GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             --CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence              0111123345678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=341.53  Aligned_cols=265  Identities=26%  Similarity=0.450  Sum_probs=220.4

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ++......+.++||.|-||.||+|.+...   ......||||.++... .....+|+.|+.||.+++||||++|.|+...
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~p---gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLP---GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCC---CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            34456678899999999999999977643   3446789999998653 4556789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....+||+|||++|+|+.+|..+. ..+.+-+..-++.+|+.||.||-+.+  +|||||.+.||||+.+..+|++||||+
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999999998775 56999999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceecccc--CCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          233 KDGPEGDDTHVSTRVMG--TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      +...++... .+++.-|  ..+|.|||+|....++.++||||||++|||.++ |..||-.....   +.+.         
T Consensus       779 Rvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIk---------  845 (996)
T KOG0196|consen  779 RVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIK---------  845 (996)
T ss_pred             eecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHH---------
Confidence            976544322 2222223  468999999999999999999999999999987 99997554332   2221         


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                           .++..+.-..|.+||..+..||..||++|-.+||.+.+|+.+|.++..
T Consensus       846 -----aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  846 -----AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             -----HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                 112233334577889999999999999999999999999999987744

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-39  Score=310.42  Aligned_cols=258  Identities=21%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++++.....||+|+||.||+|...+      ++..||+|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLS------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN   77 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecC------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence            4456677777889999999999996433      4678999988766666667889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSL--PWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFG  230 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfG  230 (455)
                      +..++||||+++++|.+++.... ..+  ++..+..++.|++.||+|||+.+  |+||||||+||+++. ++.++|+|||
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecch
Confidence            99999999999999999887542 234  77888899999999999999866  999999999999976 6799999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ++........  ......|++.|+|||++.+..  ++.++||||||+++|+|++|..||........   ..+....   
T Consensus       155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~---  226 (268)
T cd06624         155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGM---  226 (268)
T ss_pred             hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhh---
Confidence            9876543222  122245899999999986643  78899999999999999999999965322110   1110000   


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                               ......++...+.++.+++.+||+.+|.+|||+.+++.|-
T Consensus       227 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         227 ---------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             ---------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence                     0011123444567899999999999999999999999873

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=306.32  Aligned_cols=248  Identities=30%  Similarity=0.459  Sum_probs=198.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +.||+|+||.||+|...+       ++.||+|.+...... ....+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            469999999999996432       578999988655433 456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +.+++|.+++... ...+++..+..++.+++.||+|||+++  ++||||+|+|||++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            9999999988654 346788999999999999999999976  9999999999999999999999999997654221111


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE  321 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (455)
                      ......++..|+|||.+.++.++.++|||||||++|+|++ |..||...........+.                 ....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-----------------~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-----------------SGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-----------------cCCC
Confidence            1111234667999999998899999999999999999999 888886654321111110                 0011


Q ss_pred             CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1223445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.6e-40  Score=349.29  Aligned_cols=262  Identities=20%  Similarity=0.325  Sum_probs=202.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++....   .....++.+|+.+++.++||||+++++++.+.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            57999999999999999999643      357889999986432   233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          155 HRLLVYEYMPRGSLENQLFRRY---------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      ..++||||++||+|.+++....         ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         133556778899999999999999966  99999999999999999999


Q ss_pred             EccCCCccCCCCCCC----------------ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          226 LSDFGLAKDGPEGDD----------------THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       226 L~DfGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                      |+|||++........                .......+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521110                0011225699999999999999999999999999999999999999975


Q ss_pred             CCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHhcccccC
Q 012832          290 SRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-TMSTVVKTLEPLKD  362 (455)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-t~~ell~~L~~~~~  362 (455)
                      ......    ... .         ....+... ......+..+.+++.+||..+|++|| +++++++.|+....
T Consensus       234 ~~~~ki----~~~-~---------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRKI----SYR-D---------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhhh----hhh-h---------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            322110    000 0         00011000 01123456788999999999999996 56667776665533

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=311.19  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=195.4

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeEEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      ++||+|+||.||+|...+.    .....+|+|.+... .......+.+|+.++.++ +||||+++++++......++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCC----CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3699999999999976442    12245788887643 234456788999999999 79999999999999999999999


Q ss_pred             ecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          162 YMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      |+++|+|.+++....              ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.++|+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEEC
Confidence            999999999986532              124788999999999999999999966  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      |||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   .  
T Consensus       155 dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~--  223 (270)
T cd05047         155 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---K--  223 (270)
T ss_pred             CCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---H--
Confidence            9999863321111   111234567999999988889999999999999999997 999996543211   111   0  


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                           ..    .......+...+.++.+|+.+||..+|.+|||+.+++..|..+
T Consensus       224 -----~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         224 -----LP----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -----Hh----CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                 00    0011112233456789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-39  Score=309.37  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=201.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc------hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG------LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +|.+.+.||+|+||.||+|...       ++..+|+|.+....      ......+.+|+++|+.++|+||+++++++..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            4788999999999999999532       36789999876432      1223557889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....++||||+++++|.+++.+.  ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999999999999998654  46789999999999999999999976  999999999999999999999999998


Q ss_pred             cCCCCCCC----ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          233 KDGPEGDD----THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       233 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ........    ........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+       ..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GA  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------hh
Confidence            75432111    11122356899999999999888999999999999999999999999754321110000       00


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                          ..    ......+...+.++.+++.+||..+|.+||++.+++++
T Consensus       223 ----~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 ----HR----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ----cc----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                00    00112233456778999999999999999999999876

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.8e-40  Score=313.86  Aligned_cols=275  Identities=28%  Similarity=0.387  Sum_probs=208.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEe--CC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCE--EE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~  154 (455)
                      ..|.+.+.||+|+||.||+|.+...  +..++..||||.+...... ....+.+|+.+++.+.|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL--GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC--CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            4677889999999999999976542  2345788999998755443 45778999999999999999999999877  55


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            7899999999999999887642 35899999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhhhhhHhhhhh
Q 012832          235 GPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  312 (455)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++|..|+............. .......   .+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  235 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT---RL  235 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH---HH
Confidence            65332211 1112345667999999988899999999999999999999999986532211000000 0000000   00


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ...+........+..++.++.+|+.+||..+|.+|||+.++++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000111111112334567899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-39  Score=308.91  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=197.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-----hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-----LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      .+|...+.||+|+||.||+|...      .++..||+|.+....     ......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            47899999999999999999543      357789999875432     1233567889999999999999999998865


Q ss_pred             C--CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          153 E--EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       153 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      .  ...+++|||+++++|.+++...  ..+++...+.++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCC
Confidence            3  5788999999999999988654  45788999999999999999999866  9999999999999999999999999


Q ss_pred             CccCCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          231 LAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       231 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ++......... .......|+..|+|||.+.+..++.++|||||||++|||++|..||.........  .          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~--~----------  219 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI--F----------  219 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--H----------
Confidence            98754321111 1112245899999999999888999999999999999999999999754221100  0          


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                          ..........++...+..+.+++ .||..+|++||++.++++|
T Consensus       220 ----~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         220 ----KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ----HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                00001111233444556777888 6888999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.8e-40  Score=314.98  Aligned_cols=263  Identities=25%  Similarity=0.327  Sum_probs=202.9

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIG  148 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~  148 (455)
                      +..+....++|.+.+.||+|+||.||+|...      ..+..+|+|++.... .....+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNK------KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEEC------CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            3444557789999999999999999999543      356789999875432 2235577899999999 6999999999


Q ss_pred             EEE-----eCCeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          149 YCC-----EEEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       149 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      ++.     .....++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+  |+||||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~  160 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC
Confidence            874     345689999999999999887532  2356888999999999999999999966  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchh
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ  296 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~  296 (455)
                      +.++|+|||++.........  .....|++.|+|||++..     ..++.++|||||||++|+|++|..||....+....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~  238 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL  238 (286)
T ss_pred             CCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence            99999999998765432211  223469999999998853     45788999999999999999999999754321110


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ..           ......+.  ...+...+.++.+|+.+||+.+|++|||+.++++++.
T Consensus       239 --~~-----------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         239 --FK-----------IPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             --hh-----------ccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence              00           00000010  1112234567899999999999999999999999853

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=324.37  Aligned_cols=267  Identities=26%  Similarity=0.440  Sum_probs=219.4

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-HHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ++......+.+.||+|-||.|.++....       +..||||.++.+.... ..+|.+|+.+|.+|+||||+.++|+|..
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            3445667888999999999999996543       5789999998765544 4889999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ++.++||||||+.|+|.++|..+....+.-...+.|+.||+.||+||.+.+  +|||||.+.|||+++++++||+|||++
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccc
Confidence            999999999999999999998875444455667789999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS--GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +....++..+...+.+-..+|||+|.+..+.++.++|||+||+++||+++  ...||.....   ...++....++... 
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~-  760 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQ-  760 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCC-
Confidence            98777776666666677889999999999999999999999999999865  7788865432   12222222222111 


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                            ........|..|+..+.++|.+||..+-++||+++++..+|..
T Consensus       761 ------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  761 ------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence                  1111123466788999999999999999999999999988764

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-39  Score=317.12  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=204.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+|...+.||+|+||.||+|......  ......||+|.+..... ....++.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEG--ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCC--CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            3467888999999999999999764421  12234689998865432 3334688999999999999999999998654 


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccc
Confidence            467999999999999988654 346889999999999999999999966  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+.    ...    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~----  227 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKG----  227 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCC----
Confidence            543322212222446788999999998899999999999999999997 999997543211   11111    000    


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          .  ....+..++..+.+++..||..+|++||++.++++.|..+..
T Consensus       228 ----~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         228 ----E--RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ----C--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                0  001122345678999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.2e-40  Score=317.22  Aligned_cols=271  Identities=23%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||.|+||.||+|...      .++..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~   78 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSK------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   78 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEc------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCe
Confidence            357899999999999999999543      3567899999864432 233457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||++...
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          79 LTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             EEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            999999996 6898887654 346889999999999999999999976  999999999999999999999999999754


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--h---hhHh-
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--P---MLND-  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~---~~~~-  308 (455)
                      ......  .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+....  +   .+.. 
T Consensus       155 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         155 SIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             CCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence            332211  2234578999999988654 57889999999999999999999997654322111111000  0   0000 


Q ss_pred             --hhhhcccCCCcccC----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          309 --ARKLGRIMDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       309 --~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        .........+....    ......+..+.+|+.+||..+|.+|||+.++++|-+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence              00000000000000    1112345678999999999999999999999998544

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=325.69  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=219.7

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      .++....+....+.||.|.||.||.|.|..      ..-.||||.++.+. ...++|+.|+.+|+.++|||+|+++|+|.
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKk------yslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeec------cceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            344444556667889999999999998865      34579999997554 45788999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      .+...|||+|||..|+|.++|.+.....++.-..+.++.||..||+||..  +++|||||.+.|+||.++..||++||||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccch
Confidence            99999999999999999999998877788888889999999999999997  4599999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++....+..+- -....-.+.|.|||.+....++.++|||+|||+|||+.| |..||.+.+......++           
T Consensus       412 sRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-----------  479 (1157)
T KOG4278|consen  412 SRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-----------  479 (1157)
T ss_pred             hhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-----------
Confidence            99876543221 111123568999999999999999999999999999988 88899875432222222           


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                            ...+.-.-++.||..+..||..||..+|.+||++.++-+.|+.+..
T Consensus       480 ------EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  480 ------EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ------hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                  2233334577889999999999999999999999999999987754

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.2e-39  Score=307.66  Aligned_cols=254  Identities=30%  Similarity=0.452  Sum_probs=194.4

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEE-eCCeEEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCC-EEEHRLLVYE  161 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~lv~e  161 (455)
                      +.||+|+||.||+|...+.   ......||+|.+... .......+.+|+.+++.++||||+++++++. .+...++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS---DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecC---CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            4689999999999976432   224567999987532 3344567889999999999999999999875 4556899999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~  241 (455)
                      |+.+|+|.+++.... ..+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++........
T Consensus        78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999999886542 34677788899999999999999966  999999999999999999999999999754332111


Q ss_pred             --cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          242 --HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       242 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                        .......++..|+|||.+.+..++.++|||||||++|||++ |.+||.......   ....   ..       ...  
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~---~~-------~~~--  219 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY---LL-------QGR--  219 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---Hh-------cCC--
Confidence              01112346778999999988899999999999999999999 466675432211   1110   00       000  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                        ....+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus       220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              1111223456789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=318.82  Aligned_cols=256  Identities=27%  Similarity=0.338  Sum_probs=206.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh---hHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ---GHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...+      +++.||+|.+......   ....+..|+++++.++|+||+++++.+....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            368889999999999999996543      5678999998654332   4456888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999887665667899999999999999999999976  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCC
Q 012832          235 GPEGDDT---------------------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       235 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~  287 (455)
                      .......                           .......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                           0111246899999999999888999999999999999999999999


Q ss_pred             CCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC----HHHHHHhc
Q 012832          288 DKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT----MSTVVKTL  357 (455)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt----~~ell~~L  357 (455)
                      ........  +..              +.............+..+.+++.+||..+|++||+    +.+++.+-
T Consensus       233 ~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         233 KGSNRDET--FSN--------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             CCCchHHH--HHH--------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            76543211  000              01111111111125678999999999999999999    99998873

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.9e-39  Score=304.66  Aligned_cols=256  Identities=33%  Similarity=0.513  Sum_probs=204.4

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      |++.+.||.|+||.||+|...+.  ....+..||+|.+...... ....+..|+.++..++|+||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGL--SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCC--CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            45778899999999999976542  1134578999998755433 45678899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999987654333899999999999999999999966  999999999999999999999999999876544


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ..... ....+++.|+|||.+.+..++.++|||||||++++|++ |.+||.......   .....       .   ... 
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~-------~---~~~-  221 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL-------K---KGY-  221 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-------h---cCC-
Confidence            22211 12337889999999988889999999999999999998 888887532211   11100       0   000 


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         ....+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               1112233567899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-39  Score=312.80  Aligned_cols=256  Identities=26%  Similarity=0.385  Sum_probs=202.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|++.+.||+|+||.||+|...      .++..||+|.+... .......+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence            36888999999999999999543      35788999988654 223346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+++++|..++.... ...+++..+..++.+++.||.|||+. .+|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999988876531 23689999999999999999999963 23999999999999999999999999998765


Q ss_pred             CCCCCccceeccccCCCCcCccccccC------CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG------HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ....    .....|++.|+|||.+.+.      .++.++|||||||++|+|++|..||............          
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----------  219 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL----------  219 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----------
Confidence            3221    2234688999999998554      3588999999999999999999999754321111000          


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .   .+.. ......+..++.++.+|+.+||..+|++||++.+++.+.+
T Consensus       220 ~---~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         220 S---AIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             H---HHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence            0   0011 0111233446778999999999999999999999998744

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6e-40  Score=314.50  Aligned_cols=249  Identities=26%  Similarity=0.372  Sum_probs=202.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      .|+..+.||+|+||.||+|...      .++..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDN------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW   78 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEc------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence            4666788999999999999643      346789999986543 233456889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++++|.+++..   ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999999999988754   46889999999999999999999866  99999999999999999999999999976543


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...  ......|+..|+|||++.+..++.++|||||||++|||++|..||....+...   ...              ..
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~--------------~~  214 (277)
T cd06642         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL--------------IP  214 (277)
T ss_pred             cch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh--------------hh
Confidence            221  12224688999999999998999999999999999999999999865432111   000              00


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ...........+..+.+++.+||..+|++||++.+++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            1111122334567789999999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.8e-39  Score=307.39  Aligned_cols=258  Identities=28%  Similarity=0.397  Sum_probs=207.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|++.+.||.|+||.||+|....      .+..+|+|++.... ......+.+|+.+|+.++|+||+++++.+......
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            478999999999999999996543      46789999986543 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+  |+|+||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999876533 56899999999999999999999976  999999999999999999999999998766


Q ss_pred             CCCCCcc--ceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          236 PEGDDTH--VSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       236 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......  ......|+..|+|||++... .++.++|+|||||++|+|++|..||........  ......         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~---------  221 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ---------  221 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc---------
Confidence            5433221  22335689999999998877 789999999999999999999999976543211  111100         


Q ss_pred             cccCCCcccCCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          313 GRIMDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       313 ~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        ...+.+.... ....+..+.+++.+||..+|++||++.++++|
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         222 --NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0011111111 12456788999999999999999999999987

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-39  Score=305.83  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|....      +++.+|+|.+....  ......+.+|+.+|+.++||||+++++.+......
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            47888999999999999986533      57889999986542  23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-CceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL~DfGla~~~  235 (455)
                      ++||||+++++|.+++.......+++..+..++.+++.||+|||+.+  |+|+||+|+||+++.+ +.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999998765567899999999999999999999966  9999999999999864 56899999999866


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ....   .          
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~---~----------  213 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLK---I----------  213 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHH---H----------
Confidence            44322   122568999999999998889999999999999999999999997653321   1110   0          


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ... .....+...+.++.+++.+||..+|++|||+.+++.+
T Consensus       214 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            000 0112233456788999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-39  Score=308.73  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=201.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch----------hhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL----------QGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      +|.+.+.||+|+||.||+|...      .+++.||+|.+.....          ...+.+..|+.+++.++|+||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeec------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            4778899999999999999543      3577899998753211          11245678999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      ++......++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999988665  57888999999999999999999966  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      ||++................|+..|+|||.+....  ++.++|+||||+++|+|++|..||.......  .....     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-----  224 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKL-----  224 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHh-----
Confidence            99997654322111123356899999999987654  8899999999999999999999996432210  00000     


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                           ........+........+..+.+++.+||..+|.+|||+.++++|.
T Consensus       225 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         225 -----GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             -----hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence                 0000111112222234567899999999999999999999999884

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-41  Score=317.92  Aligned_cols=258  Identities=28%  Similarity=0.403  Sum_probs=216.3

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .+..+.|+.-++||+||||.||-+...      .+|+.+|.|.++...   .......++|-.+|.+++.++||.+-..|
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvr------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVR------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEe------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            445577999999999999999988554      478999999886443   33445578899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+.+|+||..|.||+|.-+|.......+++..+..++.+|+.||++||+..  ||+|||||+|||+|+.|++.|+|+|
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccc
Confidence            99999999999999999999898877789999999999999999999999966  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ||...+.+...   ...+||.+|||||++.+..|+...|+|||||++|||+.|+.||...........++  +..+    
T Consensus       333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~----  403 (591)
T KOG0986|consen  333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTL----  403 (591)
T ss_pred             eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHh----
Confidence            99988765443   22489999999999999999999999999999999999999997543322211111  0111    


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHh
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKT  356 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~  356 (455)
                              .....|++..+.++.+|++.+|+.||++|.     .++++.+|
T Consensus       404 --------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  404 --------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             --------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                    123456788889999999999999999997     45677776

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-39  Score=306.82  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=204.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|++.+.||+|+||.||++...      ..++.||+|.+....  .....++.+|+.+++.++||||+++++++......
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            4788999999999999998543      346789999886432  23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999887655556889999999999999999999976  9999999999999999999999999997654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|++.|+|||++.+..++.++|+|||||++++|++|..||.......      ......          
T Consensus       153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~----------  214 (256)
T cd08218         153 STVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII----------  214 (256)
T ss_pred             cchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh----------
Confidence            32211  223468999999999998889999999999999999999999997532211      110100          


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ... ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       215 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         215 RGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            000 111233456789999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.9e-39  Score=305.84  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=190.5

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEec
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM  163 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  163 (455)
                      .||+|+||.||+|...+.    .....+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD----TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcC----CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999965332    123457778765443 334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc
Q 012832          164 PRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       164 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~  241 (455)
                      ++|+|.+++....  ...++...+..++.||+.||+|||+.+  ++||||||+|||++.++.++|+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999987642  234667778899999999999999966  999999999999999999999999998643222211


Q ss_pred             cceeccccCCCCcCcccccc-------CCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          242 HVSTRVMGTQGYAAPEYVMT-------GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .......|+..|+|||++..       ..++.++|||||||++|||++ |..||.......   .   ....+.  ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~--~~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---V---LNHVIK--DQQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHh--hccc
Confidence            11233568899999998743       245789999999999999997 577886543211   1   111111  1111


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...++.+.    ...+..+.+++..|| .+|++||++.++++.|.
T Consensus       228 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            12223332    224466788999999 68999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-39  Score=316.29  Aligned_cols=266  Identities=23%  Similarity=0.293  Sum_probs=189.2

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--CCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--EEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~  160 (455)
                      ...||+|+||.||+|...+    ..++..||+|.+....  ....+.+|+.+|+.++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~----~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKD----GKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecC----CCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            3579999999999997543    2356789999886443  23456789999999999999999998854  45789999


Q ss_pred             EecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE----cCCCceEEccC
Q 012832          161 EYMPRGSLENQLFRR-------YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYTAKLSDF  229 (455)
Q Consensus       161 e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill----~~~~~~kL~Df  229 (455)
                      ||+. ++|.+++...       ....+++..+..++.||+.||.|||+.+  |+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9995 5887776432       1235788899999999999999999966  9999999999999    55679999999


Q ss_pred             CCccCCCCCCCc-cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccch-------hhHHH
Q 012832          230 GLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE-------QSLVE  300 (455)
Q Consensus       230 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~-------~~~~~  300 (455)
                      |+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|.+||........       ..+..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            999865432211 112235789999999998764 589999999999999999999999975432110       00000


Q ss_pred             hhhh-------hhHhhhhhccc------------CCCccc---CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          301 WARP-------MLNDARKLGRI------------MDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       301 ~~~~-------~~~~~~~~~~~------------~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....       .+.........            ....+.   ..........+.+|+.+||..||.+|||+.|+++|-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence            0000       00000000000            000000   000111234678899999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.3e-39  Score=306.45  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-----hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-----LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      .+|.+.+.||+|+||.||.|...      .++..||||.+....     ......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            57899999999999999999543      357789999875322     1234567889999999999999999998866


Q ss_pred             C--CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          153 E--EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       153 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      .  ...++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+  |+|+||+|+|||++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCc
Confidence            3  4678999999999999988654  45788889999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          231 LAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       231 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ++......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ...         
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~---------  220 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK---------  220 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH---------
Confidence            98754322111 112235689999999999888899999999999999999999999965322110  000         


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                           ..........+...+..+.+++.+|| .+|++||++++++++.
T Consensus       221 -----~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~  262 (265)
T cd06652         221 -----IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHT  262 (265)
T ss_pred             -----HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCc
Confidence                 00011112234555677889999999 4999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-39  Score=307.53  Aligned_cols=256  Identities=23%  Similarity=0.396  Sum_probs=204.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc------hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG------LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +|+..+.||+|+||.||+|..      ..++..||+|++....      ......+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEE------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            478889999999999999853      3357889999986432      1234668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGL  231 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGl  231 (455)
                      .+..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccc
Confidence            99999999999999999988654  46889999999999999999999976  99999999999998775 699999999


Q ss_pred             ccCCCCCCCc--cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          232 AKDGPEGDDT--HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       232 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      +.........  .......|+..|+|||.+.+..++.++|||||||++++|++|..||.............         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------  221 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---------  221 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---------
Confidence            8765433111  11223568999999999988889999999999999999999999997543221111110         


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          ...........+...+.++.+++.+||..+|.+||++.+++++-
T Consensus       222 ----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~  265 (268)
T cd06630         222 ----KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP  265 (268)
T ss_pred             ----HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence                00001112234455677899999999999999999999999873

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.3e-39  Score=304.24  Aligned_cols=245  Identities=27%  Similarity=0.424  Sum_probs=192.2

Q ss_pred             ccccccCCeeEEEEEEcCCCCC----CcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRP----GLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||+|+||.||+|...+....    ......|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4699999999999987653211    223356888887654433 6778899999999999999999999988 778999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-------ceEEccCCCc
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-------TAKLSDFGLA  232 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-------~~kL~DfGla  232 (455)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999887653 27889999999999999999999866  99999999999999887       7999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccC--CCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ......      ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.........   .+.    .. 
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~----~~-  221 (259)
T cd05037         156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY----QD-  221 (259)
T ss_pred             cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH----hc-
Confidence            865431      124577889999999876  78999999999999999999 57777654321111   100    00 


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                             ....    +......+.+++.+||..+|.+|||+.++++.|+
T Consensus       222 -------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 -------QHRL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------CCCC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   0000    1111267889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=311.83  Aligned_cols=268  Identities=26%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|++.+.||+|+||.||+|...+      +++.||+|.++...  ......+.+|+.+++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            368899999999999999996543      46789999886432  2334668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++++.|..++..  ...+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            9999999988666654433  245889999999999999999999976  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-hhhHhhhh--
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-PMLNDARK--  311 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-~~~~~~~~--  311 (455)
                      ...... ......|+..|+|||++.+. .++.++||||||+++|+|++|.+||................ ........  
T Consensus       151 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            544321 22335689999999999888 78999999999999999999999997653322111111000 00000000  


Q ss_pred             -----hc--ccCCC----cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          312 -----LG--RIMDP----RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       312 -----~~--~~~~~----~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                           ..  .....    .....++..++.++.+|+.+||..+|++|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                 00  00000    00111233347889999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-39  Score=311.51  Aligned_cols=248  Identities=27%  Similarity=0.397  Sum_probs=204.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|....      .++.||+|++....   ......+.+|+++++.++||||+++++++....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            468899999999999999996543      46889999885432   233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||+|.||||+.++.++|+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999988765  57899999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ....     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ...   ...        
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~--------  211 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYE---KIL--------  211 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHh--------
Confidence            6443     223568999999999988889999999999999999999999997544211   000   000        


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                        ..  ...++...+..+.+++.+||..+|.+||     ++.++++|-+
T Consensus       212 --~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         212 --EG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             --cC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence              00  1112333457889999999999999999     8889988743

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.5e-39  Score=306.35  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=200.4

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC---
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE---  154 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---  154 (455)
                      |.+.+.||+|+||.||+|....   +..++..||||++....  ......+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS---EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec---cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            5678899999999999997543   23457889999886442  334566889999999999999999999886542   


Q ss_pred             ---eEEEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          155 ---HRLLVYEYMPRGSLENQLFRRY----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       155 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                         ..+++++|+.+|+|.+++....    ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEEC
Confidence               2478999999999998775322    235788899999999999999999866  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      |||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |.+||......   ....+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---
Confidence            9999986543322111222345678999999998889999999999999999999 88998754321   1111100   


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .    .   ..  +  ..+...+..+.+++.+||..+|++||++.+++..|+.+
T Consensus       230 ~----~---~~--~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 K----G---NR--L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             c----C---Cc--C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0    0   00  0  11223456899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.1e-39  Score=309.03  Aligned_cols=268  Identities=25%  Similarity=0.317  Sum_probs=201.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|++.+.||+|+||.||+|...      ..++.||+|++....  ....+.+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            46888999999999999999643      357889999875432  1233557789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++++.|..++..  ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceec
Confidence            9999999998888766543  246899999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhhhhhHhhhhh-
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WARPMLNDARKL-  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~-  312 (455)
                      ......  .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+. ............ 
T Consensus       151 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            443321  223468899999999876 457899999999999999999999998654322211111 000000000000 


Q ss_pred             ------cccCCCcccC-----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          313 ------GRIMDPRLEG-----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       313 ------~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                            .....+....     ......+..+.+|+.+||..+|++||++.+++.|.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence                  0000000000     00122356789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=307.84  Aligned_cols=255  Identities=28%  Similarity=0.388  Sum_probs=201.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      .+++|.+.+.||+|+||.||+|...      .+++.+++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHK------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEEC------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            4688999999999999999999643      3467899999875543 346688999999999 6999999999987644


Q ss_pred             ------eEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          155 ------HRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       155 ------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                            ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEE
Confidence                  4899999999999999886543  467899999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      +|||++........  ......|+..|+|||++..     ..++.++|||||||++|+|++|..||........  ... 
T Consensus       155 ~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-  229 (275)
T cd06608         155 VDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK-  229 (275)
T ss_pred             CCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH-
Confidence            99999876533221  1223568999999998753     3467899999999999999999999975432111  000 


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                         +.       ....+.+  ..+...+.++.+|+.+||..+|++|||+.+++++
T Consensus       230 ---~~-------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 ---IP-------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---hh-------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               00       0001111  1123356789999999999999999999999987

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.1e-39  Score=304.00  Aligned_cols=249  Identities=27%  Similarity=0.445  Sum_probs=202.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-----hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-----LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +|...+.||+|+||.||+|....      .+..|++|.+....     ......+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            47788999999999999996542      46789999875433     22446688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999988654  46889999999999999999999977  9999999999999999999999999988


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||.......  ....+.          
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~----------  215 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIG----------  215 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHH----------
Confidence            654332   123356899999999987776 8999999999999999999999997543211  111000          


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       ..   .....++...+..+.+++.+||..+|.+||++.+++.+
T Consensus       216 -~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         216 -RS---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -hc---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             00   00112233456778999999999999999999999987

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-39  Score=311.72  Aligned_cols=253  Identities=23%  Similarity=0.371  Sum_probs=205.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|.+..........+.+|+.+++.++||||+++++.+......
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDV------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEc------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            367899999999999999999543      24678999998765555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            9999999999999988653   5788899999999999999999976  9999999999999999999999999987654


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.............               .
T Consensus       167 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---------------~  229 (293)
T cd06647         167 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------------T  229 (293)
T ss_pred             ccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---------------c
Confidence            33221  223468999999999988889999999999999999999999997643321110000               0


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ........+...+..+.+++.+||..+|.+||++.+++.|-
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            00001112333456789999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-39  Score=313.92  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=201.5

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      |.....||+|+||.||+|...      ..+..||+|.+..........+.+|+.++..++||||+++++++......++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREK------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEc------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            444557999999999999543      35678999998765555566788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++++|.+++..   ..+++..++.++.|++.||+|||+.+  |+||||+|+|||++.++.++|+|||++.......
T Consensus        97 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999999987644   36889999999999999999999976  9999999999999999999999999987543322


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ..  .....|+..|+|||++.+..++.++|||||||++|||++|..||....+....   ...          .....+.
T Consensus       172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~----------~~~~~~~  236 (297)
T cd06659         172 PK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRL----------RDSPPPK  236 (297)
T ss_pred             cc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----------hccCCCC
Confidence            11  22356899999999999888999999999999999999999999754322111   100          0000000


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        .......+..+.+++.+||+.+|.+||++.+++++-..
T Consensus       237 --~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~  274 (297)
T cd06659         237 --LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL  274 (297)
T ss_pred             --ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence              01122345678899999999999999999999998443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.6e-39  Score=304.41  Aligned_cols=252  Identities=28%  Similarity=0.468  Sum_probs=200.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ..+|++.+.||+|+||.||+|.+.+       +..+|+|.+.... .....+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-------KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI   74 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-------CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence            3468888999999999999996532       4579999886433 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+.+++|.+++... ...+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999999999988654 246789999999999999999999976  9999999999999999999999999987653


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..... ......++..|+|||.+.++.++.++||||||+++|||++ |..||.......   ...       ........
T Consensus       152 ~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~-------~~~~~~~~  220 (256)
T cd05112         152 DDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE-------TINAGFRL  220 (256)
T ss_pred             cCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH-------HHhCCCCC
Confidence            32111 1112335678999999998889999999999999999998 999997543211   111       00000011


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .       .+...+..+.+|+.+||..+|++|||+.++++.|
T Consensus       221 ~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 Y-------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             C-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1       1222357799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-39  Score=314.11  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=201.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      .|.....||+|+||.||++...      .++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEK------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEEC------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            3444567999999999998543      3567899999876555556678899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      ||||+++++|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+||+++.++.++|+|||++......
T Consensus        97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            9999999999987743   35889999999999999999999976  999999999999999999999999998754332


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                      ..  ......|+..|+|||.+.+..++.++|||||||++|||++|..||...........             ....+.+
T Consensus       172 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~~~~  236 (292)
T cd06658         172 VP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------IRDNLPP  236 (292)
T ss_pred             cc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhcCCC
Confidence            21  12235689999999999888899999999999999999999999975433211100             0111111


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .+..  ....+..+.+++.+||..+|.+|||+.+++++-
T Consensus       237 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~  273 (292)
T cd06658         237 RVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQHP  273 (292)
T ss_pred             cccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence            1111  123456788999999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.3e-39  Score=309.22  Aligned_cols=263  Identities=27%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEE
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLI  147 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~  147 (455)
                      ++.++....++|.+.+.||+|+||.||+|...      ..++.+|+|++.... .....+.+|+.+++.+ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNK------KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEEC------CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            34444556789999999999999999999643      357789999886432 2235567899999998 799999999


Q ss_pred             EEEEeC-----CeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC
Q 012832          148 GYCCEE-----EHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS  220 (455)
Q Consensus       148 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~  220 (455)
                      +++...     ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+  |+||||||+||+++.
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~  163 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTT  163 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcC
Confidence            998754     3589999999999999987542  2456899999999999999999999966  999999999999999


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC-----CCCccCchhhHHHHHHHHHhCCCCCCCCCccch
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE  295 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~  295 (455)
                      ++.++|+|||++.........  .....|+..|+|||.+...     .++.++|||||||++|+|++|+.||....+...
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~  241 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT  241 (291)
T ss_pred             CCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence            999999999998865432211  1224689999999988643     368899999999999999999999975432111


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        +..+.           ....+.+  ..+...+..+.+|+.+||+.+|++||++.++++|-
T Consensus       242 --~~~~~-----------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         242 --LFKIP-----------RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             --HHHHh-----------cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence              11110           0000111  11233446789999999999999999999999873

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=326.47  Aligned_cols=256  Identities=28%  Similarity=0.420  Sum_probs=213.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +...+.++||+|+||.|++|.|+.-   ..+...||||.+..+... ...+|++|+.+|.+|+|+|+++|||+..+ ...
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~p---sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQP---SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCC---CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            3455678899999999999998762   345568999999766543 66889999999999999999999999987 678


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      .||||+++.|+|.+.|.+.....|.......++.|||.||.||-+..  +|||||...|+||.....|||+||||.+-+.
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999999999998866678888899999999999999999855  9999999999999999999999999999887


Q ss_pred             CCCCccceec-cccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          237 EGDDTHVSTR-VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       237 ~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...+...... ..-...|+|||.+....++.++|||+|||++|||++ |..||-+-........+               
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i---------------  328 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI---------------  328 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc---------------
Confidence            7665543322 234568999999999999999999999999999998 88999876543222211               


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        |..-.-.-+..|++++++++..||.++|.+|||+..|.+.
T Consensus       329 --D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  329 --DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             --cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence              2111223467789999999999999999999999999743

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.3e-39  Score=308.39  Aligned_cols=269  Identities=24%  Similarity=0.318  Sum_probs=203.5

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|....      .+..||+|++....  ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            47888999999999999996533      47789999986543  23346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886543 57899999999999999999999976  9999999999999999999999999998665


Q ss_pred             CCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhh-------hhhhH
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWA-------RPMLN  307 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~-------~~~~~  307 (455)
                      .... .......|+..|+|||.+.+. .++.++|||||||++|+|++|.+||...........+ ...       ++...
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence            4332 112335689999999998654 4689999999999999999998888654432111100 000       00000


Q ss_pred             hhhhhcccCCCccc----CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 DARKLGRIMDPRLE----GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .......+..+...    .......+..+.+++.+||..+|.+|||+.+++.|.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence            00000000000000    0111234578899999999999999999999998843

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.4e-39  Score=311.51  Aligned_cols=255  Identities=24%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||++..      ...++.||+|.+.....   .....+.+|+.+++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRH------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEE------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            3688899999999999999954      34578899998865432   23456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||++|++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999998654  46899999999999999999999976  99999999999999999999999999874


Q ss_pred             CCCCCCc-------------cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          235 GPEGDDT-------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       235 ~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      .......             .......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+......   .. 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~---~~-  226 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FG-  226 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-
Confidence            2111000             011124678899999999888899999999999999999999999975432211   00 


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHHhc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---MSTVVKTL  357 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt---~~ell~~L  357 (455)
                        ....     .....+.    .....+.++.+++.+||+.+|++||+   +.+++++.
T Consensus       227 --~~~~-----~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         227 --QVIS-----DDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             --HHHh-----cccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence              0000     0000111    11235677899999999999999998   45666653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.2e-39  Score=311.47  Aligned_cols=268  Identities=21%  Similarity=0.269  Sum_probs=197.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|...      .++..||+|.+.....  .....+.+|+.+++.++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            4788899999999999999643      3577899999864322  2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999995 5888877543 356899999999999999999999976  9999999999999999999999999998653


Q ss_pred             CCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccc-hhhHHH-hhh-hhhHhhhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQR-EQSLVE-WAR-PMLNDARKL  312 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~-~~~~~~-~~~-~~~~~~~~~  312 (455)
                      .....  .....++..|+|||++.+.. ++.++|||||||++|+|++|..|+....... ....+. ... +........
T Consensus       151 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         151 IPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            32211  12246789999999987654 7899999999999999999988864322211 100000 000 000000000


Q ss_pred             cccCC----Cccc-----CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMD----PRLE-----GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~----~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....+    +...     .+.....+.++.+|+.+||+.+|.+|||+.++++|.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            00000    0000     1112234578899999999999999999999998743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.4e-39  Score=303.40  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--CC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--EE  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~  154 (455)
                      +|.+.+.||.|+||.||+|...      .++..||+|.+....  ......+..|+.+++.++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            4788899999999999999543      356789999886433  2334567889999999999999999998764  45


Q ss_pred             eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhh-----hCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          155 HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLH-----DAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      ..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||     +.+  ++|+||+|+||+++.++.++|+
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEe
Confidence            689999999999999988653  2457899999999999999999999     655  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |||++.........  .....|++.|+|||.+.+..++.++|+||||+++++|++|..||......   ......     
T Consensus       153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~-----  222 (265)
T cd08217         153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI-----  222 (265)
T ss_pred             cccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH-----
Confidence            99999876543321  22356899999999999888999999999999999999999999865321   111110     


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                               .......++...+..+.+++.+||..+|++||++.+|+++
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 ---------KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                     0011122344556789999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-38  Score=301.88  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=208.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|.+.+.||+|+||.||+|....      +++.||+|++..... .....+.+|+..+..++|+||+++++++......
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            368889999999999999996543      578899999876544 4457788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||+ .+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999999998765  578999999999999999999998 77  999999999999999999999999999866


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ......  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...............             
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------  215 (264)
T cd06623         151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-------------  215 (264)
T ss_pred             ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-------------
Confidence            443322  12356899999999999889999999999999999999999999765421111111111             


Q ss_pred             CCCcccCCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          316 MDPRLEGQYSET-GARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       316 ~~~~~~~~~~~~-~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .... ....+.. .+..+.+++.+||..+|++||++.+++++
T Consensus       216 ~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         216 CDGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             hcCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0111 1112233 56789999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4e-39  Score=306.26  Aligned_cols=257  Identities=28%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|+..+.||.|+||.||+|...      .+++.||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence            36788899999999999999653      357889999886543 24456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999999887543 578899999999999999999998 67  999999999999999999999999998755


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....    ....|+..|+|||.+.+..++.++|||||||++|+|++|..||....... ...........       ..
T Consensus       152 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-------~~  219 (265)
T cd06605         152 VNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-------NE  219 (265)
T ss_pred             HHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-------cC
Confidence            32211    11568999999999999999999999999999999999999996542111 11111111110       01


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..+.+.   ....+.++.+++.+||..+|++|||+.+++.+-+
T Consensus       220 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  259 (265)
T cd06605         220 PPPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF  259 (265)
T ss_pred             CCCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence            111111   1115677999999999999999999999998843

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.6e-39  Score=309.74  Aligned_cols=256  Identities=26%  Similarity=0.341  Sum_probs=196.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHH-HhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIF-LGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|++.+.||+|+||.||+|..      ..++..||+|.++.... .....+..|+.+ ++.++||||+++++++..+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRH------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEE------cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            4688999999999999999954      34578999999865422 233455566665 666789999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          156 RLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .++||||++ |+|.+++...  ....+++..++.++.|++.||+|||+. +  ++||||||+|||++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999995 6888877643  235689999999999999999999985 5  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCcccccc----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      .......   ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||....... ..+..    ..  
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~----~~--  221 (283)
T cd06617         152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQ----VV--  221 (283)
T ss_pred             ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHH----HH--
Confidence            8653321   1222568999999998865    456889999999999999999999996432110 00000    00  


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                           ....+.+.   ....+.++.+++.+||..+|.+||++.+++++-+..
T Consensus       222 -----~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  265 (283)
T cd06617         222 -----EEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE  265 (283)
T ss_pred             -----hcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence                 00111111   123467899999999999999999999999985443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.2e-39  Score=310.22  Aligned_cols=266  Identities=24%  Similarity=0.327  Sum_probs=201.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-----hHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-----GHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +|.+.+.||+|+||.||+|....      +++.||||.+......     ....+..|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            47788899999999999996433      4779999998654322     234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+ +|+|.+++.... ..+++..++.++.||+.||.|||+.+  |+|+||+|+|||++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 899999886543 46899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhh-hhhHh--
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WAR-PMLND--  308 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~-~~~~~--  308 (455)
                      ........  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+. ... +....  
T Consensus       151 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            76443221  222457889999998865 457899999999999999999988887654322111110 000 00000  


Q ss_pred             -hhhhcccCCCccc-----CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 -ARKLGRIMDPRLE-----GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 -~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .............     .......+..+.+++.+||..+|++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0000000000000     01123346788999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-40  Score=324.59  Aligned_cols=247  Identities=21%  Similarity=0.373  Sum_probs=196.8

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc----cchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe-
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH-  155 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-  155 (455)
                      .....||+|+|-+||+|++..      +|..||=-.++.    ......++|..|+.+|+.|+||||+++|.+|.+... 
T Consensus        43 k~~evLGrGafKtVYka~De~------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEE------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             ehhhhcccccceeeeeccccc------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence            445679999999999996543      455665333322    233445789999999999999999999999987765 


Q ss_pred             -EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCcc
Q 012832          156 -RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAK  233 (455)
Q Consensus       156 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~  233 (455)
                       ..+|+|++..|+|..|+.+.  ..++...+..|+.||++||.|||++.+||||||||.+||+|++ .|.|||+|+|||.
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence             78899999999999998776  5677789999999999999999999999999999999999987 4899999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .......    ...+|||.|||||.+. ..|+..+||||||+||+||+|+.-||..     ..+....++....      
T Consensus       195 l~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~S------  258 (632)
T KOG0584|consen  195 LLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTS------  258 (632)
T ss_pred             Hhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHc------
Confidence            7654332    2268999999999887 7899999999999999999999999852     2222333332221      


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                          ...+..+......++.+||.+||.. .++|||+.|||++
T Consensus       259 ----GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  259 ----GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                1112222222245788999999999 9999999999987

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-38  Score=304.87  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=201.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      -|.+.+.||+|+||.||+|...      ..+..||||.+.... ......+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   78 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDN------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   78 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEEC------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence            3677889999999999999543      346789999876443 233456888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+++++|.+++..   ..+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999999999988754   36889999999999999999999966  99999999999999999999999999876543


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+             .    
T Consensus       154 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~----  214 (277)
T cd06641         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------------P----  214 (277)
T ss_pred             chh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-------------h----
Confidence            221  122356899999999998888999999999999999999999999754321111000             0    


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ...........+.++.+++.+||..+|.+||++.++++|-
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            0011122334567789999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-39  Score=307.56  Aligned_cols=267  Identities=23%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|+..+.||.|+||.||+|...      .++..||||.+.....  .....+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            4788999999999999999643      3577899998864432  2235678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999995 68998887665667899999999999999999999976  9999999999999999999999999987553


Q ss_pred             CCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccchhh-HHHhhh-------hhhH
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS-LVEWAR-------PMLN  307 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~-~~~~~~-------~~~~  307 (455)
                      .....  .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||.......... ......       +...
T Consensus       152 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         152 VPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            32211  22245788999999887644 6889999999999999999999997654221110 000000       0000


Q ss_pred             hh----hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          308 DA----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       308 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ..    ..........+. ......+.++.+++.+||+.||++|||+.++++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  282 (284)
T cd07860         230 SLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP  282 (284)
T ss_pred             HHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence            00    000000000000 01122346788999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-38  Score=305.70  Aligned_cols=250  Identities=24%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      .|...+.||+|+||.||+|...      ..+..||+|++..........+.+|+.+++.++||||+++++++...+..++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            3555678999999999999543      2467899999876555555668899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      |+||+++++|.+++..   ..+++..+..++.|++.||+|||+++  |+||||+|+||+++.++.++|+|||++......
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999999999998865   46888999999999999999999977  999999999999999999999999988754332


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                      ..  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+....      ..       ......+
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~-------~~~~~~~  233 (285)
T cd06648         169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KR-------IRDNLPP  233 (285)
T ss_pred             Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HH-------HHhcCCC
Confidence            21  122356899999999998888999999999999999999999999754321111      00       0000011


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ...  .+...+..+.+++.+||..+|++|||+.+++++
T Consensus       234 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         234 KLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            111  122245679999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=307.78  Aligned_cols=269  Identities=23%  Similarity=0.300  Sum_probs=197.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      ..+..||||.+...... ....+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT   77 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence            367999999999999999999643      34678999998644322 22446789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++..
T Consensus        78 ~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          78 LTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            999999996 59998876543 47889999999999999999999976  999999999999999999999999998754


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh--h----hhhHh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA--R----PMLND  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~--~----~~~~~  308 (455)
                      ......  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.............+.  .    ..+..
T Consensus       154 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         154 SVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             CCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence            322111  122357889999999875 45889999999999999999999999755421111000000  0    00000


Q ss_pred             hhhhcccCCCccc-------CCCCHHH--HHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ARKLGRIMDPRLE-------GQYSETG--ARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ~~~~~~~~~~~~~-------~~~~~~~--~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .............       .......  ..++.+++.+||+.+|++|||+.+++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence            0000000000000       0000011  25778999999999999999999998874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.8e-39  Score=305.49  Aligned_cols=250  Identities=25%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      +|.+.+.||.|+||.||+|...      .++..||+|.+.....   .....+.+|+.+++.++||||+++++++.....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            5788999999999999999543      3577899999864332   345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999988765  57889999999999999999999977  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............    .          
T Consensus       151 ~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~----------  213 (258)
T cd05578         151 TPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----K----------  213 (258)
T ss_pred             CCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----H----------
Confidence            54321   223568999999999988889999999999999999999999998654321111111    0          


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH--HHHHHh
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM--STVVKT  356 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~--~ell~~  356 (455)
                      ... ....++...+..+.+++.+||..+|.+||++  .+++++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            000 1223344556889999999999999999999  787765

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-38  Score=301.76  Aligned_cols=255  Identities=22%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc----------chhhHHHHHHHHHHHhc-CCCCCcccEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----------GLQGHREWLTEVIFLGQ-LRHPHLVKLI  147 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~~~  147 (455)
                      +|.+.+.||+|+||.||+|.....     .+..+|+|.+...          ......++.+|+.++.. ++||||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            478889999999999999975431     3578999987532          12233557788888865 7899999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      +++...+..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+. .+++|+||+|+|||++.++.++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEE
Confidence            9999999999999999999999887542  245688999999999999999999952 2399999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|.+||........   ..   ..
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~---~~  225 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT---KI  225 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH---HH
Confidence            99999998654432   12335689999999999988899999999999999999999999965432111   10   00


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                .............+..+.+++.+||+.+|++||++.++..++.
T Consensus       226 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 ----------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                      0000111111234567899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-38  Score=303.88  Aligned_cols=260  Identities=26%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--C
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--E  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~  154 (455)
                      ++|...+.||.|+||.||+|....      +++.+|+|.+..... .....+.+|+++++.++||||+++++++...  .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            368888999999999999996543      568899998864432 3456688999999999999999999988654  4


Q ss_pred             eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ..++||||+++++|.+++...  ....++...+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccc
Confidence            689999999999999877542  2356788899999999999999999976  999999999999999999999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCc--cchhhHHHhhhhhhHhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP--QREQSLVEWARPMLNDAR  310 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~--~~~~~~~~~~~~~~~~~~  310 (455)
                      ........    ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ........+...      
T Consensus       153 ~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  222 (287)
T cd06621         153 GELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN------  222 (287)
T ss_pred             cccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc------
Confidence            75433221    224688899999999988999999999999999999999999976532  111111221110      


Q ss_pred             hhcccCCCcccCCCC--HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          311 KLGRIMDPRLEGQYS--ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          ...+.+.....  ...+..+.+++.+||..+|.+|||+.+++++-+.
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         223 ----MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             ----CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence                00111111111  2245778999999999999999999999998543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.7e-38  Score=305.29  Aligned_cols=269  Identities=25%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      +.+|.+.+.||+|+||.||+|....      ++..||+|.+..... .....+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            4679999999999999999996433      467899999865432 223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999995 6887776544 246788889999999999999999976  999999999999999999999999998754


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh---h---hhHh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR---P---MLND  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~---~---~~~~  308 (455)
                      ......  .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.............|..   +   ....
T Consensus       154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            332211  2224579999999998764 57889999999999999999999997654321111000100   0   0000


Q ss_pred             hhhhcccCCCcc----cCCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ARKLGRIMDPRL----EGQY-----SETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ~~~~~~~~~~~~----~~~~-----~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ...+........    ....     ....+..+.+++.+||..+|++|||+.+++.|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~  289 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP  289 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence            000000000000    0000     001145788999999999999999999999873

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.2e-39  Score=308.30  Aligned_cols=257  Identities=25%  Similarity=0.330  Sum_probs=197.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  155 (455)
                      ++|...+.||+|+||.||++...      .++..||+|.+..... .....+.+|+.++.++. |+||+++++++..+..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~   77 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHK------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD   77 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEEC------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence            35566788999999999998543      3578999998865432 34456788999999996 9999999999999999


Q ss_pred             EEEEEEecCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          156 RLLVYEYMPRGSLENQL---FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+++|||+. ++|.++.   .......+++..+..++.+++.||+|||+. .+|+||||||+|||++.++.++|+|||++
T Consensus        78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            999999985 5665533   223346789999999999999999999973 23999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccC---CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTG---HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ........   .....|+..|+|||++.+.   .++.++|||||||++|+|++|..||.....     ....       .
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~-------~  220 (288)
T cd06616         156 GQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ-------L  220 (288)
T ss_pred             HHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH-------H
Confidence            76533221   1224689999999999776   689999999999999999999999975421     1110       0


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ........+.+........+.++.+|+.+||..+|++|||+.+++++-
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~  268 (288)
T cd06616         221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP  268 (288)
T ss_pred             hhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            000001112222222334667899999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-38  Score=301.52  Aligned_cols=252  Identities=24%  Similarity=0.413  Sum_probs=203.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|....      .+..||+|.+.....  .....+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            47888999999999999996543      467899999865421  2345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGla~~~  235 (455)
                      ++||||+++++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999987765556899999999999999999999976  99999999999998875 5699999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ......  .....|++.|+|||++.+..++.++|+|||||++++|++|..||.......      +.....         
T Consensus       153 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~---------  215 (257)
T cd08225         153 NDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC---------  215 (257)
T ss_pred             cCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh---------
Confidence            432211  222468999999999988889999999999999999999999997543211      111000         


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                       ...+ .......+.++.+++.+||..+|++|||+.+++++-
T Consensus       216 -~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         216 -QGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             -cccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence             0011 112233456799999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.7e-39  Score=309.42  Aligned_cols=268  Identities=24%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|++.+.||+|+||.||+|...+      .++.||+|.+.....  .....+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            468889999999999999996543      467899998754322  234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|..+....  ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99999999998888765432  45899999999999999999999976  999999999999999999999999998765


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhhhhhHhhhh--
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WARPMLNDARK--  311 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~~~~~~~~~--  311 (455)
                      .....  ......|+..|+|||++.+ ..++.++|||||||++|||++|.+||...........+. +..........  
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            43321  1233568999999999875 347889999999999999999999997543211111110 00000000000  


Q ss_pred             -----hcccCCCccc-----CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          312 -----LGRIMDPRLE-----GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       312 -----~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                           ......+...     .......+..+.+|+.+||..+|++||++.+++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  284 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE  284 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence                 0000000000     001223467899999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.3e-38  Score=299.68  Aligned_cols=254  Identities=29%  Similarity=0.426  Sum_probs=202.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|....      .+..||+|.+......  ....+..|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            57888999999999999996533      4678999998755443  567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++|+||+++++|.+++...  ..+++..+..++.+++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999999988654  45788899999999999999999976  9999999999999999999999999998764


Q ss_pred             CCCCccc--eeccccCCCCcCccccccCC---CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          237 EGDDTHV--STRVMGTQGYAAPEYVMTGH---LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       237 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      .......  .....|+..|+|||++.+..   ++.++||||||+++|+|++|..||........  ... .         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~-~---------  218 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMF-H---------  218 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHH-H---------
Confidence            4332211  11246889999999998766   88999999999999999999999975431110  000 0         


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ......+.++  .....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       219 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         219 VGAGHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HhcCCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000111111  111236778899999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-38  Score=303.97  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=197.6

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||+|+||.||+|...      .++..||+|.+....   ......+..|+.+|+.++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVK------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEc------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            799999999998543      357789999885432   22344567899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  150 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--  150 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--
Confidence            99999999988765557899999999999999999999976  99999999999999999999999999876543211  


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                       .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.  ..          ..  ....
T Consensus       151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~----------~~--~~~~  215 (277)
T cd05577         151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RR----------TL--EMAV  215 (277)
T ss_pred             -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hc----------cc--cccc
Confidence             222458889999999988889999999999999999999999997654321111110  00          00  0111


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTL  357 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L  357 (455)
                      .++...+..+.+++.+||+.+|.+||     ++.+++.|.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~  255 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP  255 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence            23344567889999999999999999     777788774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=303.72  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=200.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCC---CCCcccEEEEEEeCC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLR---HPHLVKLIGYCCEEE  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~  154 (455)
                      .|++.+.||+|+||.||+|....      ++..||+|.+.... ......+.+|+.+++.++   ||||+++++++....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            47788899999999999996533      46789999886542 233456778999999987   999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++...   .+++..++.++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            999999999999999987543   6889999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .......  .....|+..|+|||.+.++ .++.++|+|||||++|+|++|..||.........   ..          ..
T Consensus       151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~----------~~  215 (277)
T cd06917         151 LNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---ML----------IP  215 (277)
T ss_pred             cCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hc----------cc
Confidence            6543321  2235689999999988654 4789999999999999999999999764322111   00          00


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....+.+.   ....+.++.+++.+||..+|++||++.+++++-
T Consensus       216 ~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~  256 (277)
T cd06917         216 KSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKSK  256 (277)
T ss_pred             cCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence            00111111   112457789999999999999999999999873

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-38  Score=306.11  Aligned_cols=264  Identities=16%  Similarity=0.174  Sum_probs=190.0

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH-----------HHHHHHHHHHhcCCCCCc
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-----------REWLTEVIFLGQLRHPHL  143 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nI  143 (455)
                      +..++|.+.+.||+|+||.||+|...+.   ......+|+|+.........           .....++..+..+.|+||
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASD---HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCC---cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            3457899999999999999999975442   11245677776543322111           112334455667889999


Q ss_pred             ccEEEEEEeCC----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          144 VKLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       144 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                      +++++++....    ..+++|+++ ..++.+.+...  ...++..+..++.|++.||+|||+.+  |+||||||+|||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~  160 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD  160 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence            99999766543    457888887 45676655432  34678889999999999999999966  99999999999999


Q ss_pred             CCCceEEccCCCccCCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccc
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR  294 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~  294 (455)
                      .++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999865432211     11122469999999999999999999999999999999999999997653211


Q ss_pred             hhhHHHhhh-hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          295 EQSLVEWAR-PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       295 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .  .+.... ....      .+.....   ....++..+.+++..||..+|++||++.++++.|
T Consensus       241 ~--~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 N--LIHAAKCDFIK------RLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H--HHHHhHHHHHH------Hhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  111000 0000      0111111   1223467899999999999999999999999876

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4e-38  Score=306.62  Aligned_cols=252  Identities=30%  Similarity=0.392  Sum_probs=200.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ...|.+.+.||+|+||.||+|....      .++.||+|.+....   ......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            3568889999999999999996432      46789999885432   23335688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          88 HTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             CeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcce
Confidence            99999999996 6777766543 346899999999999999999999976  9999999999999999999999999987


Q ss_pred             CCCCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      .....      ....|+..|+|||++.   ...++.++||||||+++|||++|.+||...........+.          
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~----------  227 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------  227 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh----------
Confidence            65432      2246889999999884   4568899999999999999999999997543221110000          


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                            ...........++..+.+++.+||..+|++||++.+++.+.+..
T Consensus       228 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         228 ------QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             ------cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                  00001111233567899999999999999999999999885443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4e-38  Score=303.27  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=207.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..+.|+..+.||+|+||.||+|....      .+..||+|++..... ....+.+|+++++.++|+||+++++.+.....
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            45678888999999999999996542      467899999876544 45678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999999987653 47899999999999999999999966  999999999999999999999999998754


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....  ......|+..|++||.+.+..++.++|+|||||++|+|++|..||....+......+  .          ...
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~----------~~~  232 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--T----------TKG  232 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----------hcC
Confidence            43221  122346889999999998888999999999999999999999999754332111100  0          000


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .+..  .....++..+.+++.+||+.+|.+|||+.+++++..
T Consensus       233 -~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         233 -IPPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             -CCCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence             0011  112235678999999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.9e-38  Score=297.28  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=208.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--C
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--E  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~  154 (455)
                      +|...+.||+|+||.||+|....      ++..|++|++.....  .....+.+|+.+++.++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            47788999999999999996543      467899999865542  4456788999999999999999999999988  8


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            8999999999999999887653  8899999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ..............++..|+|||.+.+..++.++||||||+++++|++|..||......     ....          ..
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~----------~~  215 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAAL----------YK  215 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHH----------Hh
Confidence            65543211122356899999999998888999999999999999999999999765410     0000          01


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      +........++...+..+.+++.+||..+|++||++.+++.+-
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence            1111122234445578899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=349.48  Aligned_cols=254  Identities=28%  Similarity=0.380  Sum_probs=205.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +-+|.....||.|.||.||-|..      ..+|...|+|-+......  ....+.+|+.+|..++|||+|++||+-.+.+
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN------~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVN------LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeec------CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence            45788899999999999999854      346889999987654332  2345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..+|.||||+||+|.+.+...  ...++.....+..|++.|++|||++|  ||||||||.||+++.+|.+|++|||.|..
T Consensus      1308 kv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeE
Confidence            999999999999999987543  45666677778899999999999988  99999999999999999999999999986


Q ss_pred             CCCCCCc--cceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          235 GPEGDDT--HVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       235 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ....-.+  ......+||+.|||||++.+   .....++|||||||++.||+||+.||...+.       .|+--     
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIM----- 1451 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIM----- 1451 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHH-----
Confidence            6543211  11223689999999999975   3467899999999999999999999975432       12110     


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ..+    ...-..++|...+.+..+++.+||+.||++|.++.|++++
T Consensus      1452 y~V----~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHV----AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hHH----hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            000    1112345677788899999999999999999999999987

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-38  Score=306.48  Aligned_cols=267  Identities=22%  Similarity=0.307  Sum_probs=200.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      ++|.+.+.||.|+||.||+|....      +++.+|+|.++.....  ....+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            478899999999999999996533      4678999998644322  223467899999999999999999998877  


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||+|+|||++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            88999999996 59998876543 46899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhh-------h
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WAR-------P  304 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~-------~  304 (455)
                      ........  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+. ...       +
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            66543211  2234688999999998764 46889999999999999999999997654322211110 000       0


Q ss_pred             hhHhh-----hhhcccCCCcccCCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          305 MLNDA-----RKLGRIMDPRLEGQYSET-GARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       305 ~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .+...     ..........+...++.. .+..+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000     000000001111122222 36678999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-38  Score=303.63  Aligned_cols=245  Identities=25%  Similarity=0.330  Sum_probs=189.7

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHH---hcCCCCCcccEEEEEEeCCeEEE
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFL---GQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      +||+|+||.||++...      .++..||+|.+.....   .....+.+|..++   ...+||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKA------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEEC------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            4899999999999543      3577899998754321   1122334444433   34479999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            99999999999888654  46899999999999999999999976  999999999999999999999999998754332


Q ss_pred             CCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      .    .....||..|+|||.+.+ ..++.++|||||||++|+|++|..||..............           .    
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----------~----  211 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----------T----  211 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-----------h----
Confidence            1    122469999999999864 5689999999999999999999999975432211111000           0    


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                      .......+...+.++.+++.+||..+|.+||     ++.++++|..
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~  257 (279)
T cd05633         212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF  257 (279)
T ss_pred             hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence            0111223445667899999999999999999     6999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.7e-38  Score=296.82  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||.|+||.||++....      ++..||+|++.....  .....+.+|+++++.++|+|++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            57888999999999999996543      467899999875533  4556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ++||||+++++|.+++....  ...+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999887653  467899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .....  .......|++.|+|||.+.+..++.++|+||||+++++|++|..||.......   ...   ..         
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~---------  215 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---KI---------  215 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---HH---------
Confidence            54432  12233578999999999988889999999999999999999999997653211   000   00         


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .. ......+...+..+.+++.+||..+|++|||+.+++++
T Consensus       216 -~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         216 -LK-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -hc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00 00112233556788999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=298.71  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-----chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-----GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      .+|.+.+.||+|+||.||+|...      .++..||+|.+...     .......+.+|+.+++.++|+||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            57899999999999999999543      35789999987432     12334567889999999999999999999866


Q ss_pred             C--CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          153 E--EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       153 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      .  ...++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccc
Confidence            4  4688999999999999988654  35788999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          231 LAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       231 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      +++........ .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........  ..          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----------  219 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IF----------  219 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HH----------
Confidence            99865321111 111235689999999999988899999999999999999999999975422110  00          


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          ..........++...+..+.+++.+||. +|..||++.+++.|.
T Consensus       220 ----~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         220 ----KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ----HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                0111111223455667889999999999 579999999998873

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.5e-38  Score=313.22  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||||.+...  .......+.+|+.+++.++|+||+++++++...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDT------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEEC------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            4578999999999999999999543      35788999998542  233345677899999999999999999988643


Q ss_pred             ------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 ------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                            ...|+||||+. ++|.+.+..    .++...+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+
T Consensus        88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          88 KSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEc
Confidence                  35799999995 588887753    2888899999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-H------
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-E------  300 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~------  300 (455)
                      |||++........   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+ .      
T Consensus       161 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (353)
T cd07850         161 DFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS  237 (353)
T ss_pred             cCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999986543221   22356899999999999999999999999999999999999999765422111000 0      


Q ss_pred             --hhh---hhhHh-hh--------hhcccCCC----cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          301 --WAR---PMLND-AR--------KLGRIMDP----RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       301 --~~~---~~~~~-~~--------~~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        +..   ..... ..        .+......    ..........+..+.+++.+||+.||++|||+.+++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence              000   00000 00        00000000    000011223466789999999999999999999999884

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.5e-38  Score=294.14  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=205.4

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      +|...+.||+|+||.||+|....      .+..+++|++..........+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   74 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI   74 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            47788999999999999996543      467899999876655556778899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      +|||+++++|.+++.... ..+++..+..++.|++.||+|||..+  ++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999999886642 57899999999999999999999966  999999999999999999999999999876543


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                      ..   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.............             ....+
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~  215 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------------TNGPP  215 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------------hcCCC
Confidence            32   233568999999999998889999999999999999999999997643221111000             00000


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .+.  .....+..+.+++.+||..+|++|||+.+++++
T Consensus       216 ~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 GLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111  111125679999999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=306.56  Aligned_cols=272  Identities=21%  Similarity=0.272  Sum_probs=198.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      .|.+.+.||+|+||.||+|.....    ..+..||+|.+....   ......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            477889999999999999965331    257899999987632   33345677899999999999999999999988  


Q ss_pred             CeEEEEEEecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC----CCceEE
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRY---SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS----DYTAKL  226 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~----~~~~kL  226 (455)
                      ...++||||++ ++|.+++....   ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.    ++.+||
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEE
Confidence            88999999995 57777665332   236889999999999999999999966  999999999999999    899999


Q ss_pred             ccCCCccCCCCCCC-ccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccch-------hh
Q 012832          227 SDFGLAKDGPEGDD-THVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE-------QS  297 (455)
Q Consensus       227 ~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~-------~~  297 (455)
                      +|||++........ ........+|+.|+|||++.+. .++.++|||||||++++|++|.+||........       ..
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999986543322 1112335689999999988764 578999999999999999999999976543220       00


Q ss_pred             HHHhhhhh-------hHhhhhhcccCC---CcccCCCC---------H--HHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          298 LVEWARPM-------LNDARKLGRIMD---PRLEGQYS---------E--TGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       298 ~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~---------~--~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      +......+       ............   ......++         .  ..+.++.+++.+||+.+|++|||+.++++|
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000000       000000000000   00000111         1  334578899999999999999999999987


Q ss_pred             c
Q 012832          357 L  357 (455)
Q Consensus       357 L  357 (455)
                      -
T Consensus       314 ~  314 (316)
T cd07842         314 P  314 (316)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=303.44  Aligned_cols=266  Identities=21%  Similarity=0.265  Sum_probs=200.4

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      |++.+.||.|++|.||+|....      ++..||+|++.....  .....+.+|+.+++.++||||+++++++...+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6778899999999999996533      577899999865432  23356788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+ +++|.+++.......+++..++.++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++.....
T Consensus        75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            999999 569999887665457899999999999999999999966  99999999999999999999999999976533


Q ss_pred             CCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH-HHhhhhhh-------Hh
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL-VEWARPML-------ND  308 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~-~~~~~~~~-------~~  308 (455)
                      ....  .....++..|+|||++.+. .++.++|||||||++|+|++|.+||........... ........       ..
T Consensus       152 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         152 PVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             Cccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            2211  1223578899999988664 578899999999999999999999976543221110 00000000       00


Q ss_pred             ----hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ----ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          .......... .........+..+.+++.+||+.+|.+|||+.+++.+-
T Consensus       230 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~  281 (283)
T cd07835         230 LPDYKPTFPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP  281 (283)
T ss_pred             chhhhhhccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence                0000000000 00111233456789999999999999999999999773

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-38  Score=326.27  Aligned_cols=279  Identities=18%  Similarity=0.212  Sum_probs=192.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCC-------------CcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRP-------------GLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH  142 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~-------------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  142 (455)
                      ..++|.+.+.||+|+||.||+|.+......             ......++.|.+. ........+.+|+.+|+.++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            357899999999999999999865431100             0001111222222 12223456789999999999999


Q ss_pred             cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY---SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       143 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                      |+++++++...+..|+||+++ +++|.+++....   ........+..++.||+.||+|||+.+  ||||||||+||||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~  301 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN  301 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence            999999999999999999999 567877765432   122335567789999999999999966  99999999999999


Q ss_pred             CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCC-CCCCCCccchhhH
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRK-SVDKSRPQREQSL  298 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~-p~~~~~~~~~~~~  298 (455)
                      .++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|.. ||..........+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999865433221 1223679999999999999999999999999999999999875 4443322212222


Q ss_pred             HHhhhhhhHhh-------hhhcccCCCc-c---cCCCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          299 VEWARPMLNDA-------RKLGRIMDPR-L---EGQYS-----ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       299 ~~~~~~~~~~~-------~~~~~~~~~~-~---~~~~~-----~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ...........       ..+...+... +   ...++     ...+.++.+++.+||..||.+|||+.|++.|-+.
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            21111000000       0000000000 0   00000     1124567788999999999999999999998543

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=312.46  Aligned_cols=265  Identities=24%  Similarity=0.337  Sum_probs=197.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  154 (455)
                      +++|.+.+.||+|+||.||+|...      .+++.||||.+... .......+.+|+.+++.++|+||+++++++.... 
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            468999999999999999999543      35788999998642 2234456788999999999999999999876543 


Q ss_pred             ----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          155 ----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       155 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                          ..++||||+. ++|.+.+..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECccc
Confidence                5799999995 588877643   46899999999999999999999977  9999999999999999999999999


Q ss_pred             CccCCCCCCCc-cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          231 LAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       231 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ++......... .......||..|+|||.+.+ ..++.++|||||||++|+|++|++||...........   ....+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~~~~  228 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGVLGT  228 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCC
Confidence            99765432211 11223568999999998754 5689999999999999999999999976432111100   0000000


Q ss_pred             --hhhhcccCCCc-----------ccC---CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 --ARKLGRIMDPR-----------LEG---QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 --~~~~~~~~~~~-----------~~~---~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        ...+..+....           ...   ......+.++.+++.+||+.+|++|||+.++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              00000000000           000   0011235678999999999999999999999999

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-37  Score=305.01  Aligned_cols=252  Identities=28%  Similarity=0.404  Sum_probs=199.8

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|...+.||+|+||.||+|....      .+..||+|.+....   ......+.+|+.+++.++|||++++++++..+..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcC------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            47788999999999999996433      46789999886432   2334568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+. |+|.+.+... ...+++..+..++.+++.||.|||+.+  |+||||+|+||+++.++.++|+|||++...
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            999999996 5787766543 356899999999999999999999976  999999999999999999999999998754


Q ss_pred             CCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ...      ....|++.|+|||++.   .+.++.++|||||||++|+|++|..||..........  .    ...     
T Consensus       176 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~----~~~-----  238 (317)
T cd06635         176 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H----IAQ-----  238 (317)
T ss_pred             CCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--H----HHh-----
Confidence            332      2246899999999974   4568899999999999999999999986542211100  0    000     


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                           ...........+..+.+++.+||+.+|.+||++.++++++..+..
T Consensus       239 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         239 -----NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             -----ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                 000111123345678999999999999999999999999766543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.8e-38  Score=298.65  Aligned_cols=246  Identities=27%  Similarity=0.375  Sum_probs=199.4

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||.|+||.||+|....      ++..||+|++.....   .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKS------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            7999999999996532      578899999864322   3346688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++...  ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--  148 (262)
T cd05572          75 CLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--  148 (262)
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc--
Confidence            9999999988764  45889999999999999999999966  99999999999999999999999999987654321  


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                       .....|+..|++||.+.+..++.++|+||||+++|+|++|..||.......    .....          .+.......
T Consensus       149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~----------~~~~~~~~~  213 (262)
T cd05572         149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYN----------DILKGNGKL  213 (262)
T ss_pred             -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHH----------HHhccCCCC
Confidence             122468999999999988889999999999999999999999997654211    11111          011111122


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                      .++...+.++.+++.+||..+|++||+     +.++++|-+
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence            234444678999999999999999999     899988743

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.2e-38  Score=304.36  Aligned_cols=268  Identities=22%  Similarity=0.297  Sum_probs=198.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|.+.....  .....+.+|+.+++.++||||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            57889999999999999999543      3577899998864432  233567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCccC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  234 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~~  234 (455)
                      .++||||++ ++|.+++.......+++..+..++.||+.||+|||+.+  ++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999995 68888876655555788888999999999999999966  999999999999985 56799999999976


Q ss_pred             CCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhh-hhh---hHh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWA-RPM---LND  308 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~-~~~---~~~  308 (455)
                      ......  ......|++.|+|||++.+. .++.++|||||||++|+|++|.+||............ ... .+.   +..
T Consensus       153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            433211  12234678999999988664 5789999999999999999999999765432111110 000 000   000


Q ss_pred             hhhhccc--CCCcccC----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 ARKLGRI--MDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 ~~~~~~~--~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ...+...  ..+....    ......+.++.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000  0000000    0122345678999999999999999999999987

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=302.55  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh---HHHHHHHHHHHhcCC-CCCcccEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEVIFLGQLR-HPHLVKLIGYC  150 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~~~~~~  150 (455)
                      +...+|....+||+|+||.|.+|      ..+.+.+.+|||+++.+....   .+--+.|-.+|.... -|.++.++.+|
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLa------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLA------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             eeecccceEEEeccCccceeeee------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            44568999999999999999998      456678899999997654322   222356788887775 67899999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ..-+.+|+||||+.||+|.-.|++-  ..+.+..++.+|..|+.||-|||+.|  ||+||||..|||++.+|.+||+|||
T Consensus       420 QTmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  420 QTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             hhhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecc
Confidence            9999999999999999999888765  57888899999999999999999966  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +++.....+.+  +.+++|||.|+|||++...+|+..+|+|||||+||||+.|++||++.+...   +..          
T Consensus       496 mcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~----------  560 (683)
T KOG0696|consen  496 MCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ----------  560 (683)
T ss_pred             cccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----------
Confidence            99876554443  556999999999999999999999999999999999999999999865432   111          


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT  349 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt  349 (455)
                         .+++.  .-.|+...+.++.+++...|...|.+|.-
T Consensus       561 ---aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  561 ---AIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---HHHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence               11222  23567888899999999999999999953

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.4e-38  Score=304.92  Aligned_cols=268  Identities=23%  Similarity=0.273  Sum_probs=196.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  154 (455)
                      ++|++.+.||+|+||.||+|....      +++.||||.+.....  .....+.+|+.+++.+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            468899999999999999996533      567899998765432  23356788999999995 699999999988766


Q ss_pred             e-----EEEEEEecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceE
Q 012832          155 H-----RLLVYEYMPRGSLENQLFRRY---SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAK  225 (455)
Q Consensus       155 ~-----~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~k  225 (455)
                      .     .|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||+.+  |+||||+|+|||++. ++.++
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEE
Confidence            5     8999999975 8988876543   246899999999999999999999966  999999999999998 89999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWAR  303 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~~  303 (455)
                      |+|||++.........  .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+ ....
T Consensus       152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  229 (295)
T cd07837         152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG  229 (295)
T ss_pred             EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998755332111  122357889999998865 45789999999999999999999999765432211100 0000


Q ss_pred             -h---hhHhhhhhcccC-----CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          304 -P---MLNDARKLGRIM-----DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       304 -~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       +   .+..........     .+.......+..+.++.++|.+||..+|.+||++.+++.|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0   000000000000     0000000112346778999999999999999999999987

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=336.63  Aligned_cols=264  Identities=24%  Similarity=0.265  Sum_probs=216.9

Q ss_pred             cchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcc
Q 012832           68 FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv  144 (455)
                      ..+.+++...++|.+.++||+|+||.|.++      +.+.+++.||+|+++.-.   .....-|..|..+|..-+.+-|+
T Consensus        65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lV------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv  138 (1317)
T KOG0612|consen   65 KKVKELRLKAEDFEILKVIGRGAFGEVALV------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV  138 (1317)
T ss_pred             HHHHHHhCCHHhhHHHHHhcccccceeEEE------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence            346677888899999999999999999998      445678999999986532   23345578899999999999999


Q ss_pred             cEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      .++..|.++.++|||||||+||+|..++.+. . .+|+..+..++..|+.||.-||+.|  +|||||||+|||||..|++
T Consensus       139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~-~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKF-D-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             HHHHHhcCccceEEEEecccCchHHHHHhhc-C-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcE
Confidence            9999999999999999999999999987654 3 7999999999999999999999977  9999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccc----c-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM----T-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      ||+|||.+.....++.. .....+|||-|.|||++.    + +.|++.+|+||+||++|||+.|..||..      ..++
T Consensus       215 kLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslv  287 (1317)
T KOG0612|consen  215 KLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLV  287 (1317)
T ss_pred             eeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHH
Confidence            99999999877655443 344578999999999995    3 5699999999999999999999999963      3344


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCC--HHHHHHHHHHHHHHhccCCCCCCC---HHHHHHhccc
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYS--ETGARKAAALAYQCLSHRPKQRPT---MSTVVKTLEP  359 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~P~~RPt---~~ell~~L~~  359 (455)
                      .-+..+.+...          .-.||  ...+.++.+||.+.+. +|+.|..   ++++..|..+
T Consensus       288 eTY~KIm~hk~----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  288 ETYGKIMNHKE----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             HHHHHHhchhh----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence            44443333211          11222  3367889999998875 6777877   9999999544

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6e-38  Score=305.13  Aligned_cols=271  Identities=24%  Similarity=0.302  Sum_probs=197.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||.+.....  .....+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHK------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEEC------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            457999999999999999999543      3578999998754322  22344568999999999999999999987654


Q ss_pred             --------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          155 --------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       155 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                              ..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+++  ++|+||+|+||+++.++.++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEE
Confidence                    4599999995 5888877543 346899999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCc--cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          227 SDFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       227 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      +|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...........+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999765432211  112234678899999988664 47889999999999999999999997765433322222111


Q ss_pred             hhh-----HhhhhhcccCCCcccCCC---------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          304 PML-----NDARKLGRIMDPRLEGQY---------SETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       304 ~~~-----~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ...     .........-...+....         .......+.+|+.+||..+|.+|||+.++++|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence            000     000000000000000000         001234677999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=315.18  Aligned_cols=256  Identities=24%  Similarity=0.307  Sum_probs=211.6

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      .....|.+.+.||+|.|+.|.+|..      ..++..||||.++....  ...+.+.+|+.+|+.|+|||||+++.+...
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~------~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARH------ILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEe------cCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            3456799999999999999999954      44688999999976533  333568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      +..+|+||||+.+|.+++++...  ..+.+..+..++.|+..|++|||+..  |||||||++||||+.+.++||+|||++
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS  202 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFS  202 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccc
Confidence            99999999999999999999876  45666888999999999999999955  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ..+....   ...+.+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++..-.....-+            
T Consensus       203 ~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------------  267 (596)
T KOG0586|consen  203 TFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------------  267 (596)
T ss_pred             eeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------------
Confidence            9876443   2345899999999999998776 67899999999999999999999975432111111            


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                          +...+  .++.-.+.++.+||.++|.++|.+|++++++.++-|...
T Consensus       268 ----l~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  268 ----LRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             ----eeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence                00111  122333467789999999999999999999999866443

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9e-38  Score=300.19  Aligned_cols=266  Identities=23%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +|++.+.||.|+||.||+|...      .++..||||.+...... ....+.+|+.+++.++|+||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            5888999999999999999643      35778999998755332 3455678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          158 LVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      +||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++....
T Consensus        75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999997 58888876543 246899999999999999999999966  9999999999999999999999999997543


Q ss_pred             CCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhh-hhh---hHhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWA-RPM---LNDAR  310 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~-~~~---~~~~~  310 (455)
                      ....  ......++..|++||.+.+. .++.++|||||||++|+|++|..||...........+ ... .+.   +....
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3211  12224578999999988664 5788999999999999999999999765432211111 000 000   00000


Q ss_pred             hhcccCCCcc-------cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          311 KLGRIMDPRL-------EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       311 ~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ..... ....       ...+.+..+..+.+++.+||+.+|.+||++.+++++
T Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         230 QLPEY-KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCchh-cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000 0000       011122346778999999999999999999999976

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-37  Score=298.57  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeC--Ce
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEE--EH  155 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~  155 (455)
                      |.+.+.||+|+||.||+|...      .++..||+|.+.... ........+|+.++..+. |+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEc------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            567889999999999999543      356789999886432 122234457888898886 99999999999887  88


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+.+  ++||||+|+||+++. +.++|+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999996 5888877654 247899999999999999999999966  999999999999999 99999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccc-cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh------
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND------  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~------  308 (455)
                      .....   .....++..|+|||++. +..++.++|||||||++|||++|.+||...+....   +.+.......      
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence            43221   12246899999999764 45578899999999999999999999976543221   1111100000      


Q ss_pred             -hhhhcccCCCcccC-------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 -ARKLGRIMDPRLEG-------QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 -~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                       ........+.....       ......+..+.+|+.+||..+|++||++.+++++-
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~  280 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP  280 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence             00000000000000       01123468899999999999999999999999873

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.5e-38  Score=302.63  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=198.6

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ...||+|+||.||+|...      .++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        25 ~~~lg~g~~g~v~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          25 FIKIGEGSTGIVCIATVK------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             HHHcCCCCCeEEEEEEEc------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            356999999999999543      35789999998665555566788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++..   ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--  171 (292)
T cd06657          99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  171 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence            999999987643   35788999999999999999999976  99999999999999999999999999875543221  


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+.             ....+.+. 
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-------------~~~~~~~~-  237 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------------DNLPPKLK-  237 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hhCCcccC-
Confidence            1223568999999999988889999999999999999999999997543221111110             00111111 


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .....+..+.+++.+||..+|.+||++.+++++
T Consensus       238 -~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence             112345678899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.3e-38  Score=308.87  Aligned_cols=269  Identities=27%  Similarity=0.357  Sum_probs=199.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||+|++...  .......+.+|+.+++.+ +||||+++++++..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDR------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEc------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            3567999999999999999999643      24678999987432  223345577899999999 99999999998865


Q ss_pred             C--CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          153 E--EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       153 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      .  ...++||||++ ++|.+++...   .+++..+..++.|++.||+|||+.+  |+||||+|+|||++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeecc
Confidence            4  36899999996 5998877543   6788899999999999999999966  9999999999999999999999999


Q ss_pred             CccCCCCCCCc---cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh-
Q 012832          231 LAKDGPEGDDT---HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM-  305 (455)
Q Consensus       231 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~-  305 (455)
                      ++.........   .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99865443321   12233568999999998865 45789999999999999999999999765433221111110000 


Q ss_pred             -------hH--hhhh-hcccCCCc--ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          306 -------LN--DARK-LGRIMDPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       306 -------~~--~~~~-~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                             +.  .... +..+....  .........+.++.+++.+||+.+|++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   00  0000 00000000  0011112256789999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.7e-38  Score=304.14  Aligned_cols=271  Identities=25%  Similarity=0.289  Sum_probs=200.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|.+......  ....+.+|+.+++.++|+||+++++++... 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDT------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEEC------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            467999999999999999999643      35788999998644322  123456899999999999999999998765 


Q ss_pred             -CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          154 -EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       154 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                       +..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++
T Consensus        80 ~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcccee
Confidence             56899999995 5888877653 357899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh----hh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP----ML  306 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~----~~  306 (455)
                      .........  .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+... ..    .+
T Consensus       156 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            876443211  122346888999999865 45889999999999999999999999865443222211100 00    00


Q ss_pred             HhhhhhcccCCCcccCC-------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 NDARKLGRIMDPRLEGQ-------YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .........-...+...       .....+..+.++|.+||+.||++|||+.+++.|-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            00000000000000000       001135678899999999999999999999998554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=292.71  Aligned_cols=249  Identities=29%  Similarity=0.460  Sum_probs=204.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|.+.+.||+|+||.||+|...      ..++.||+|.+.....  .....+.+|++++..++|+||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            4788899999999999999543      3467899999876543  4556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999988665  57899999999999999999999866  9999999999999999999999999998765


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....|+..|+|||...+..++.++||||||+++|+|++|..||........    .+     ...    .  
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~-----~~~----~--  213 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LF-----RIV----Q--  213 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HH-----HHh----c--
Confidence            43321  2235689999999999888889999999999999999999999975432100    00     000    0  


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        .....++...+..+.+++.+||..+|++|||+.+++.+
T Consensus       214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence              01112334456788999999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=290.11  Aligned_cols=259  Identities=24%  Similarity=0.251  Sum_probs=203.3

Q ss_pred             hcCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe-
Q 012832           76 TTQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE-  152 (455)
Q Consensus        76 ~~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-  152 (455)
                      .+++|++. ++||-|--|.|-.++      ++.+++.+|+|++...     ....+|+++--.. .|||||.+++++.+ 
T Consensus        59 itedY~is~qvLG~GinGkV~~C~------~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCV------HKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             chhhheehhhhhccccCCceEEEE------eccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            45667665 679999999999884      4568999999998422     3345777765544 49999999998754 


Q ss_pred             ---CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEE
Q 012832          153 ---EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKL  226 (455)
Q Consensus       153 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL  226 (455)
                         ...+.+|||.|+||.|...+..+....+++.++..|+.||+.|+.|||+.+  |.||||||+|+|.+.   |..+||
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEe
Confidence               467889999999999999999998889999999999999999999999977  999999999999965   557999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||+|+......   ...+.+-|+.|.|||++....|+..+|+||+||++|-|++|-+||.......   +..-.+.-+
T Consensus       206 tDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI  279 (400)
T KOG0604|consen  206 TDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRI  279 (400)
T ss_pred             cccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHh
Confidence            9999999755322   2344789999999999999999999999999999999999999997543210   000000000


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                             ..-.-.++..-....+..+.++|+.+|..+|.+|.|+++++.|-+-.
T Consensus       280 -------~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  280 -------RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             -------hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence                   00011122222345678899999999999999999999999996544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-37  Score=306.43  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=196.1

Q ss_pred             cccccc--CCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEG--GFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G--~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      ..||+|  +||+||+|..      ...++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARH------TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEE------cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            346666  9999999954      34678999999865432  2346678899999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+.+++|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++++|||.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            99999999999888765567899999999999999999999866  9999999999999999999999998654322211


Q ss_pred             Ccc-----ceeccccCCCCcCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh--------
Q 012832          240 DTH-----VSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP--------  304 (455)
Q Consensus       240 ~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~--------  304 (455)
                      ...     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||........  .......        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccc
Confidence            110     01112356779999999763  478999999999999999999999976532211  1110000        


Q ss_pred             -hhHhhh--------hh--------------cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          305 -MLNDAR--------KL--------------GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       305 -~~~~~~--------~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       ......        ..              .......+.......++..+.+|+.+||+.+|++|||+.++++|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence             000000        00              0000111122223456778999999999999999999999999844

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.4e-38  Score=295.01  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=204.4

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +|++.+.||+|+||.||++...      .+++.+|+|.+....  ......+.+|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            4788899999999999998543      356789999986532  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ++||||+++++|.+++....  ...+++..++.++.|++.||+|||+.+  ++|+||+|.||+++.++.++|+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhh
Confidence            99999999999999886632  356889999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .....    .....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...........+               
T Consensus       153 ~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---------------  213 (256)
T cd08530         153 LKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---------------  213 (256)
T ss_pred             hccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------
Confidence            65431    22246899999999999888999999999999999999999999765432111000               


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .. ......+...+.++.+++.+||..+|++||++.+++++
T Consensus       214 -~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         214 -QR-GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -hc-CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             00 11112334566789999999999999999999999987

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.3e-38  Score=308.51  Aligned_cols=266  Identities=23%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      ..+|.+.+.||+|+||.||+|..      ..++..||||.+...  .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKN------SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEe------cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            45799999999999999999954      336789999988643  223345677899999999999999999987644 


Q ss_pred             ----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          154 ----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       154 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                          ...++||||+ +++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||||+|||++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          78 REAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             ccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcC
Confidence                3479999999 47898887653  57899999999999999999999966  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhhhhhH
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WARPMLN  307 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~~~~~  307 (455)
                      |++........  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+. .......
T Consensus       153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         153 GLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             ccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99986544321  1223568999999998865 468999999999999999999999997653221111110 0000000


Q ss_pred             -------------hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          308 -------------DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       308 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                                   ..........+.+. ...+.++.++.+++.+||+.+|++|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                         00000000001000 1122356778999999999999999999999999

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-37  Score=297.52  Aligned_cols=245  Identities=25%  Similarity=0.331  Sum_probs=189.6

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHH---HHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEV---IFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      +||+|+||.||+|...      .+++.||+|.+.....   .....+..|.   ..++...||||+.+++++...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKA------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEe------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            4899999999998543      3577899998864322   1112233343   34455679999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      ||||+.||+|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            99999999999887653  57899999999999999999999976  999999999999999999999999998754332


Q ss_pred             CCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      .    .....|+..|+|||.+.++ .++.++||||+||++|+|++|..||.............           ..... 
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~-  214 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MTLTM-  214 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-----------Hhhcc-
Confidence            1    1224699999999999754 68999999999999999999999997643221111000           00001 


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                         ...++...+.++.+++.+||..+|.+||     ++.+++++-+
T Consensus       215 ---~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~  257 (278)
T cd05606         215 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF  257 (278)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence               1122334467899999999999999999     9999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.3e-39  Score=292.34  Aligned_cols=281  Identities=23%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-C
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-E  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~  153 (455)
                      ...|+.+..||+|.||.||+|.-.+. . ......+|||.++-+  .........+|+.+++.++||||+.+..++.. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~-n-~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNT-N-DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccC-C-cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            35688999999999999999954432 1 112457999998654  12223556799999999999999999998876 7


Q ss_pred             CeEEEEEEecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC----CceEE
Q 012832          154 EHRLLVYEYMPRGSLENQLFRR---YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD----YTAKL  226 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~----~~~kL  226 (455)
                      ..++|++||.+. +|...|.-.   ....+|...+..|+.||+.|+.|||++.  |+||||||.||||..+    |.|||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEe
Confidence            889999999965 888877532   2357899999999999999999999988  9999999999999887    99999


Q ss_pred             ccCCCccCCCCCCCcc-ceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccch-------hh
Q 012832          227 SDFGLAKDGPEGDDTH-VSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE-------QS  297 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~-------~~  297 (455)
                      +|||+++.+...-... ....++-|.+|.|||++.|. .|+.+.|||++|||+.||++-.+.|.+......       ..
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999765432221 23346789999999999875 599999999999999999999999976542211       11


Q ss_pred             HHHhhh----h---hhHhhhhhcccCC--Cccc-CCCCH-----------HHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          298 LVEWAR----P---MLNDARKLGRIMD--PRLE-GQYSE-----------TGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       298 ~~~~~~----~---~~~~~~~~~~~~~--~~~~-~~~~~-----------~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      +.....    +   .+.+..++.+.-+  ..++ ..+..           .-+....+|+.++|..||.+|.|+++.+++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            111000    0   0000001000000  0000 00110           012347899999999999999999999998


Q ss_pred             cccccC
Q 012832          357 LEPLKD  362 (455)
Q Consensus       357 L~~~~~  362 (455)
                      .-+..+
T Consensus       338 ~yF~~d  343 (438)
T KOG0666|consen  338 PYFTED  343 (438)
T ss_pred             cccccC
Confidence            655443

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.7e-37  Score=301.50  Aligned_cols=266  Identities=21%  Similarity=0.263  Sum_probs=197.4

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      .+.+.+|.|+++.||++        ..+++.||||++...  .......+.+|+.+++.++|+||+++++++...+..++
T Consensus         5 ~i~~~~~~~~~v~~~~~--------~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (314)
T cd08216           5 LIGKCFEDLMIVHLAKH--------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV   76 (314)
T ss_pred             hhhHhhcCCceEEEEEe--------cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEE
Confidence            34445566666666654        236789999998654  33445678899999999999999999999999999999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      +|||+++|+|.+++.......+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||.+......
T Consensus        77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~  154 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH  154 (314)
T ss_pred             EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccc
Confidence            999999999999998766667899999999999999999999976  999999999999999999999999998754332


Q ss_pred             CCc-----cceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh----hhhH
Q 012832          239 DDT-----HVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR----PMLN  307 (455)
Q Consensus       239 ~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~----~~~~  307 (455)
                      ...     .......++..|+|||++.+  ..++.++|||||||++|||++|..||........  ......    ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  232 (314)
T cd08216         155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLD  232 (314)
T ss_pred             cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccc
Confidence            211     11223457889999999876  3588999999999999999999999975432211  111000    0000


Q ss_pred             ------hhhhhc--------ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 ------DARKLG--------RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ------~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            ......        ...............+.++.+|+.+||..+|++|||+.++++|..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence                  000000        000001111233445678899999999999999999999999843

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.8e-38  Score=309.22  Aligned_cols=271  Identities=21%  Similarity=0.316  Sum_probs=201.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe---
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE---  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  152 (455)
                      .+|.+.+.||+|+||.||+|...      .++..||+|++....  ......+.+|+.+|+.++||||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDT------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEc------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            68999999999999999999543      357899999986532  2334567789999999999999999988753   


Q ss_pred             -CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          153 -EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       153 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                       ....++||||+. ++|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEeccccc
Confidence             356899999994 6898887543  45899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCc--cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh--hh--
Q 012832          232 AKDGPEGDDT--HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA--RP--  304 (455)
Q Consensus       232 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~--~~--  304 (455)
                      +.........  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+...  .+  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            9765432221  11223578999999999865 45889999999999999999999999765432221111100  00  


Q ss_pred             -hhH-----hhhhhcccCCCccc---CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          305 -MLN-----DARKLGRIMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       305 -~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                       .+.     ..............   .......+.++.+++.+||+.+|.+||++.+++.+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence             000     00000000000000   01112346789999999999999999999999998543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=293.48  Aligned_cols=243  Identities=25%  Similarity=0.318  Sum_probs=189.1

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHH-hcCCCCCcccEEEEEEeCCeEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFL-GQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.||.|+||.||+|...      ..++.||+|.+.....   .....+..|..++ ...+|+||+++++++...+..++|
T Consensus         2 ~~l~~g~~~~v~~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKR------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEec------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            56999999999999543      3467899999864332   1223344454444 455899999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            9999999999988654  46889999999999999999999976  99999999999999999999999999876433  


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........   ..   .....        ...
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~~~--------~~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FD---NILSR--------RIN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhc--------ccC
Confidence                1224689999999999888899999999999999999999999975432211   00   00000        001


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCH---HHHHHh
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTM---STVVKT  356 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~---~ell~~  356 (455)
                      ........++..+.+++.+||..+|++||++   .+++.|
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            1112233456789999999999999999965   566665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.4e-37  Score=294.12  Aligned_cols=248  Identities=20%  Similarity=0.233  Sum_probs=192.7

Q ss_pred             HhcCCCCCcccc--cccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~L--G~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      ...++|.+.+.+  |+|+||.||++..      ..++..+|+|.+........     |+.....+ +||||+++++.+.
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~------~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKH------KPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEE------cCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            334677777776  9999999999853      33577899998764322211     22222222 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFG  230 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfG  230 (455)
                      ..+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++ .++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999999988665  37899999999999999999999976  99999999999999988 99999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++......      ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... .....+...      
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~------  222 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR------  222 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh------
Confidence            98765322      12468999999999999899999999999999999999999997443211 111111110      


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHhc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-MSTVVKTL  357 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-~~ell~~L  357 (455)
                           ..  .........+..+.+++.+||+.+|.+||+ ++++++|-
T Consensus       223 -----~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        223 -----QQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             -----hc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence                 00  011223356678999999999999999996 69999873

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-37  Score=295.70  Aligned_cols=243  Identities=27%  Similarity=0.387  Sum_probs=195.3

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||.|+||.||+|....      +++.||+|.+.....   .....+.+|+.+++.++||||+++++.+......|+||||
T Consensus         1 lg~g~~~~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKS------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            6999999999996533      478899999865433   3446688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc-
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-  241 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~-  241 (455)
                      +++++|.+++...  ..+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++......... 
T Consensus        75 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999988764  37899999999999999999999976  999999999999999999999999998765433211 


Q ss_pred             -----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          242 -----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       242 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                           .......++..|+|||.+.+..++.++||||||+++|+|++|..||........   ..   ...          
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~----------  214 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQ---NIL----------  214 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHh----------
Confidence                 112235688999999999888899999999999999999999999976542211   10   000          


Q ss_pred             CCcccCCCCHH--HHHHHHHHHHHHhccCCCCCCCH---HHHHHh
Q 012832          317 DPRLEGQYSET--GARKAAALAYQCLSHRPKQRPTM---STVVKT  356 (455)
Q Consensus       317 ~~~~~~~~~~~--~~~~~~~li~~cl~~~P~~RPt~---~ell~~  356 (455)
                      ....  ..+..  .+..+.+++.+||+.+|++|||+   .+++++
T Consensus       215 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         215 NGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             cCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            0000  11111  36788999999999999999999   666665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.6e-38  Score=298.92  Aligned_cols=252  Identities=26%  Similarity=0.351  Sum_probs=205.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEE  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  153 (455)
                      ++|.+.+.||+|+||.||+|....      +++.||+|++....   ......+..|+.+++.+. |+||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            468899999999999999996543      57889999986532   233456788999999999 99999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCcccc
Confidence            9999999999999999988764  47999999999999999999999976  9999999999999999999999999988


Q ss_pred             CCCCCCCc------------------cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccch
Q 012832          234 DGPEGDDT------------------HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE  295 (455)
Q Consensus       234 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~  295 (455)
                      ........                  .......|+..|+|||++.+..++.++||||||+++++|++|..||........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            65443211                  112235688999999999888899999999999999999999999986542110


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH----HHHHHhc
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM----STVVKTL  357 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~----~ell~~L  357 (455)
                         ..   ...            .....++...+..+.+++.+||..+|.+||++    .++++|.
T Consensus       231 ---~~---~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         231 ---FQ---KIL------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             ---HH---HHH------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence               00   000            01112334446778999999999999999999    8998874

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=284.20  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=198.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  154 (455)
                      .++...+..||.|+.|.|+++...      .++..+|||.+...+ .....+++..+.++...+ +|+||+.+|+|..+.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~r------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFR------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEc------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            344556677999999999999654      467899999986543 344566777777776665 999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++.||.| +..++.++. +...++|+..+-++...++.||.||-+ ..+|||||+||+|||+|..|++||||||++.+
T Consensus       165 dV~IcMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  165 DVFICMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             hHHHHHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccce
Confidence            999999999 445665544 445689999999999999999999976 23499999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ......   .++..|-+.|||||.+.-   ..|+.++||||||++++||.||+-||.+-...-  ...   ..+++    
T Consensus       242 lvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~l---tkvln----  309 (391)
T KOG0983|consen  242 LVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVL---TKVLN----  309 (391)
T ss_pred             eecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHH---HHHHh----
Confidence            654332   344679999999999964   468999999999999999999999998743211  100   01111    


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                         -..|.+++.  ..++..+.+++..||..|+.+||.+.++++|
T Consensus       310 ---~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 ---EEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---cCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               112333322  2267789999999999999999999999998

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.9e-37  Score=298.84  Aligned_cols=246  Identities=29%  Similarity=0.415  Sum_probs=195.2

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      |...+.||+|+||.||+|..      ..++..||+|.+.....   .....+.+|+.+++.++||||+++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATN------SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEE------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            56677899999999999954      33578899999864322   3335678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999995 6787776543 356899999999999999999999976  9999999999999999999999999986533


Q ss_pred             CCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..      ....|+..|+|||++.   +..++.++|||||||++|+|++|.+||.............             
T Consensus       173 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-------------  233 (313)
T cd06633         173 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------  233 (313)
T ss_pred             CC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------------
Confidence            21      2356899999999984   4568889999999999999999999987543211111000             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ..   ..........+..+.+|+.+||+.+|.+||++.+++.+-
T Consensus       234 ~~---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~  274 (313)
T cd06633         234 QN---DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD  274 (313)
T ss_pred             hc---CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            00   001111223446789999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.4e-37  Score=299.53  Aligned_cols=251  Identities=29%  Similarity=0.387  Sum_probs=198.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|...+.||+|+||.||+|....      .+..||+|.+...   ......++.+|+.+++.++|+|++++++++.....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence            46777889999999999996433      4678999987542   22334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+. |+|.+.+... ...+++..+..++.|++.||.|||+.+  ++||||+|+|||++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999999995 6888776543 346889999999999999999999866  999999999999999999999999998765


Q ss_pred             CCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ...      ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||..........  .+.          
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~----------  227 (308)
T cd06634         166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA----------  227 (308)
T ss_pred             cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh----------
Confidence            432      2246899999999974   3567889999999999999999999986542211110  000          


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                       .   ...........+..+.+|+.+||..+|++||++.+++++.+...
T Consensus       228 -~---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         228 -Q---NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -h---cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence             0   00111112345677899999999999999999999999965543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=295.30  Aligned_cols=263  Identities=24%  Similarity=0.303  Sum_probs=196.9

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcC---CCCCcccEEEEEEeCC
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL---RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~  154 (455)
                      |.+.+.||+|+||.||+|....      ++..||+|.+.....  .....+.+|+.+++.+   +|+||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            5678899999999999996543      467899999864322  2234456777776655   5999999999998877


Q ss_pred             e-----EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          155 H-----RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       155 ~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      .     .+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEecc
Confidence            6     999999996 58998887655557899999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH-h
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN-D  308 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~-~  308 (455)
                      |++........   .....++..|+|||++.+..++.++|||||||++|+|++|.+||..........  .+...... .
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCC
Confidence            99976543321   122457899999999999899999999999999999999999997654322111  11000000 0


Q ss_pred             hhhhc-------ccCCCccc---CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 ARKLG-------RIMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 ~~~~~-------~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .....       ........   .......+..+.+++.+||+.+|.+||++.+++.|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00000       00000000   11122345778899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-37  Score=299.88  Aligned_cols=270  Identities=24%  Similarity=0.266  Sum_probs=200.2

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ...++|++.+.||+|+||.||+|....      +++.||+|.++....  .....+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            456789999999999999999996543      467899999865432  233456789999999999999999998876


Q ss_pred             CC----------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          153 EE----------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       153 ~~----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      ..          ..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence            54          78999999965 777766554 347899999999999999999999976  99999999999999999


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      .+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~  232 (302)
T cd07864         154 QIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR  232 (302)
T ss_pred             cEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999999866443321 1222356889999998865 3578899999999999999999999976543222111111


Q ss_pred             hhhhhHhhhhhcccCCCc-------------ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          302 ARPMLNDARKLGRIMDPR-------------LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .... ........+....             .........+..+.+++.+||..+|.+||++.+++.+
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGS-PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCC-CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000 0000000000000             0000111246789999999999999999999999977

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=316.06  Aligned_cols=260  Identities=25%  Similarity=0.364  Sum_probs=215.9

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc-cchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL-EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      ....++||+|+||+||+|.+..+  ...-..+||||++.. .......+++.|+-+|.+|+|||+++++|+|.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe--ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE--GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC--CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34568899999999999998775  344567899999853 34456688999999999999999999999998766 789


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      |++|+++|+|.|++..+ ...+-....+.|..||++||.|||.+.  +|||||..+||||..-..+|+.|||+++....+
T Consensus       775 vtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999999765 457777889999999999999999866  999999999999999999999999999987776


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      +.........-.+.|||-|.+....|+.++|||||||++|||+| |..|+++.....-.++                 +.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-----------------le  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-----------------LE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-----------------Hh
Confidence            65544333445678999999999999999999999999999998 9999987643222211                 11


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ...+-.-++.++.++..+|.+||..|+..||+++++...+..+..
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            122223477888999999999999999999999999988766543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.8e-38  Score=329.55  Aligned_cols=253  Identities=31%  Similarity=0.460  Sum_probs=191.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe---
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE---  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  152 (455)
                      ..+|+...+||+||||.||++      +++..|..||||++.... ......+.+|+..|++|+|||||+++..+.+   
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkV------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKV------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEE------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            467889999999999999998      556789999999997664 3334567899999999999999999864320   


Q ss_pred             --------------------------------------------------------------------------------
Q 012832          153 --------------------------------------------------------------------------------  152 (455)
Q Consensus       153 --------------------------------------------------------------------------------  152 (455)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 012832          153 ----------------------------E--------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL  196 (455)
Q Consensus       153 ----------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L  196 (455)
                                                  +        ..+||-||||+..+|.+++.++.... .....|.++.+|++||
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGL  710 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHH
Confidence                                        0        12688999998877777776552211 4578899999999999


Q ss_pred             HHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC----------------CCCCccceeccccCCCCcCccccc
Q 012832          197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP----------------EGDDTHVSTRVMGTQGYAAPEYVM  260 (455)
Q Consensus       197 ~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~  260 (455)
                      +|+|++|  ||||||||.||+++.++.|||+|||+|....                ........+..+||.-|+|||++.
T Consensus       711 aYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  711 AYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            9999977  9999999999999999999999999998621                001111234578999999999997


Q ss_pred             cC---CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC--CCCHHHHHHHHHH
Q 012832          261 TG---HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG--QYSETGARKAAAL  335 (455)
Q Consensus       261 ~~---~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  335 (455)
                      +.   .|+.|+|+||||+|++||+.   ||...  ..             ....+..+-+..++.  .+.......-+.+
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--ME-------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--ME-------------RASILTNLRKGSIPEPADFFDPEHPEEASL  850 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCch--HH-------------HHHHHHhcccCCCCCCcccccccchHHHHH
Confidence            64   49999999999999999997   45432  11             111111112222222  2233334456789


Q ss_pred             HHHHhccCCCCCCCHHHHHHh
Q 012832          336 AYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       336 i~~cl~~~P~~RPt~~ell~~  356 (455)
                      |.+|+++||++|||+.|+|+.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhhc
Confidence            999999999999999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=297.86  Aligned_cols=274  Identities=27%  Similarity=0.444  Sum_probs=203.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhc--CCCCCcccEEEEEEeCC-
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ--LRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~-  154 (455)
                      ....+..+||+|.||.||+|.+.        ++.||||++...   ..+.|.+|-+|...  ++|+||++|++.-.... 
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            44566788999999999999554        478999998754   44567777777665  57999999999876555 


Q ss_pred             ---eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-------CCCCeEEeccCCCCEEEcCCCce
Q 012832          155 ---HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-------AEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       155 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-------~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                         .++||++|.+.|+|.++|..+   .++|....+++..+++||+|||+       +.++|+|||||..||||..++.+
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence               789999999999999999876   79999999999999999999997       34569999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccccCC-CC-----ccCchhhHHHHHHHHHhCCCCCCC-CCccchhh
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LT-----SMSDVYSFGVVLLELLSGRKSVDK-SRPQREQS  297 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~ell~G~~p~~~-~~~~~~~~  297 (455)
                      .|+|||||..+.........-..+||.+|||||++.+.. +.     .+.||||+|.+||||++...-++. ..+.-...
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            999999999877654443344478999999999997643 22     368999999999999997655532 11111111


Q ss_pred             HH-Hh-hhhhhHhhh--hhcccCCCcccCCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCCC
Q 012832          298 LV-EW-ARPMLNDAR--KLGRIMDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDD  365 (455)
Q Consensus       298 ~~-~~-~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~~  365 (455)
                      +- +. ..|-+.+..  .+.+...|.++..+ ......-+.+.++.||++||+.|.|+.=+.+.+..+....+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            11 00 011111111  12222333333222 11345678899999999999999999988888776654443

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=297.05  Aligned_cols=267  Identities=25%  Similarity=0.314  Sum_probs=199.9

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--Ce
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--EH  155 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~  155 (455)
                      |.+.+.||.|+||.||+|...+      .++.+|+|.+....  ......+.+|+.+++.++|+||+++++++...  ..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            5678899999999999996543      46789999987553  23345678899999999999999999999888  88


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++ ++|.+++... ...+++..++.++.|++.||+|||+.+  ++|+||+|+|||++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            999999996 5888877654 257899999999999999999999966  999999999999999999999999999866


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hhh-hHhhhhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RPM-LNDARKL  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~  312 (455)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|||++|..||...........+... ... .......
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            543321 1222457889999998765 45789999999999999999999999765532221111100 000 0000000


Q ss_pred             cc-----------cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          313 GR-----------IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       313 ~~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ..           .....+...+...++..+.+++.+||..+|.+||++.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence            00           0000000111111367889999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=305.61  Aligned_cols=267  Identities=21%  Similarity=0.315  Sum_probs=196.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..+|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDK------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeC------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            468999999999999999999543      357899999886432  223356788999999999999999999886542


Q ss_pred             ------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          155 ------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       155 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                            ..++||||+. ++|..++    ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          88 SGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             cCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEee
Confidence                  4699999995 5776654    236899999999999999999999976  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh---
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP---  304 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~---  304 (455)
                      ||+++.....     .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....   
T Consensus       161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (342)
T cd07879         161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  235 (342)
T ss_pred             CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999764332     123468899999999876 4588999999999999999999999986543221111110000   


Q ss_pred             -hh-H---h--hhhhcccCCCcccCC---CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh--ccccc
Q 012832          305 -ML-N---D--ARKLGRIMDPRLEGQ---YSETGARKAAALAYQCLSHRPKQRPTMSTVVKT--LEPLK  361 (455)
Q Consensus       305 -~~-~---~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~--L~~~~  361 (455)
                       .+ .   .  .......+.......   ..+..+..+.+|+.+||+.+|.+||++.+++.|  ++.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence             00 0   0  000000000000000   011235678899999999999999999999988  44443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-37  Score=304.08  Aligned_cols=272  Identities=22%  Similarity=0.303  Sum_probs=202.7

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccE
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKL  146 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~  146 (455)
                      ...++....++|.+.+.||+|+||.||+|...      .+++.||+|++....  ......+.+|+.+++.++||||+++
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~   81 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL   81 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEc------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence            44556667799999999999999999999543      357889999986432  2234567789999999999999999


Q ss_pred             EEEEEeC------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC
Q 012832          147 IGYCCEE------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS  220 (455)
Q Consensus       147 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~  220 (455)
                      ++++...      ...+++++++ +++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~  155 (345)
T cd07877          82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcC
Confidence            9987543      3468889887 8899887754   35899999999999999999999977  999999999999999


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      ++.++|+|||++......     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+
T Consensus       156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998764322     223568999999998866 56889999999999999999999999754432211111


Q ss_pred             Hhhhh-----hh---Hh------hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          300 EWARP-----ML---ND------ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       300 ~~~~~-----~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .....     ..   ..      ...+.......+. ......+.++.+++.+||..+|.+||++.+++.|-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            00000     00   00      0000000000000 001123567899999999999999999999999854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=296.20  Aligned_cols=266  Identities=26%  Similarity=0.310  Sum_probs=202.0

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      |.+.+.||.|++|.||+|...      ..++.+|+|.+......  ....+..|+.+|+.++|+||+++++++......+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcC------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            567788999999999999543      35788999988654322  3466788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            9999996 48888776542 57899999999999999999999977  99999999999999999999999999976654


Q ss_pred             CCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh--hhhhHhhhhhc-
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA--RPMLNDARKLG-  313 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~-  313 (455)
                      ...  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.-.  .+......... 
T Consensus       151 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         151 PVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             Ccc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            331  12234688899999998876 7899999999999999999999999765432221111000  00000000000 


Q ss_pred             -------ccCC--CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          314 -------RIMD--PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       314 -------~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                             .+..  ...........+.++.+++.+||..+|.+||++.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~  281 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP  281 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence                   0000  0000112234567899999999999999999999999873

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.2e-37  Score=294.40  Aligned_cols=256  Identities=27%  Similarity=0.333  Sum_probs=199.0

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch----hhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL----QGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  153 (455)
                      +|++.+.||+|+||.||+|.....   ..++..||+|++.....    .....+.+|+.++..+ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~---~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG---HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC---CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            478889999999999999864321   23578899999864321    2335677899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||+|+|||++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999988764  46888999999999999999999966  9999999999999999999999999997


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ........ ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||........  ........      
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~------  224 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRI------  224 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHh------
Confidence            65432211 12235689999999998753  467899999999999999999999964322111  11111110      


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHh
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~  356 (455)
                          +..  ...++...+..+.+++.+||..+|++||     ++.+++.+
T Consensus       225 ----~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         225 ----LKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ----hcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                000  1123344567789999999999999997     77888877

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=314.30  Aligned_cols=267  Identities=26%  Similarity=0.391  Sum_probs=199.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC---
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE---  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  153 (455)
                      ..|...+.||+||||.||+|      +++.+|..||||.++... ....+.+.+|+++|++|+|+|||+++++-...   
T Consensus        13 y~W~~~e~LG~Ga~g~V~rg------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRG------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             cceeehhhhcCCccceeeee------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            45677788999999999999      567789999999987543 34456788999999999999999999875443   


Q ss_pred             ---CeEEEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc----CCCceE
Q 012832          154 ---EHRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD----SDYTAK  225 (455)
Q Consensus       154 ---~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~----~~~~~k  225 (455)
                         ....+|||||.||+|...+.+- ....+++.+.+.+..+++.||.|||+++  ||||||||.||++-    +.-..|
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEe
Confidence               3468999999999999998754 3468999999999999999999999977  99999999999982    333579


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      |+|||.|+....+.   .....+||..|.+||++.. ..|+..+|.|||||++|+..||..||...........+.|...
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~  241 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII  241 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence            99999999876544   3555889999999999985 7899999999999999999999999976543322111222110


Q ss_pred             h-------------hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC--CHHHHHHhc
Q 012832          305 M-------------LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP--TMSTVVKTL  357 (455)
Q Consensus       305 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP--t~~ell~~L  357 (455)
                      .             .+.+..+...+.  .+..........+-.++..+|..+|++|-  .+.++...+
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP--~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~  307 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLP--QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV  307 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCC--CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence            0             000000000110  12223333444556677778888999987  554444443

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-37  Score=304.99  Aligned_cols=268  Identities=24%  Similarity=0.320  Sum_probs=202.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC--
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE--  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  154 (455)
                      +|.+.+.||.|+||.||+|....      ++..||||.+....  ......+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            57889999999999999996433      47889999886543  334567889999999999999999999987775  


Q ss_pred             ---eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          155 ---HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       155 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                         ..|+||||+. ++|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||.|||++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999996 5888887554  47899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCc-cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-hhhhhHh
Q 012832          232 AKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLND  308 (455)
Q Consensus       232 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-~~~~~~~  308 (455)
                      +......... .......|+..|+|||++.+. .++.++|||||||++|+|++|.+||...........+.- .......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            9876543210 112335689999999999887 789999999999999999999999976653221111110 0000000


Q ss_pred             ------hhhhccc---CCCcc---cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ------ARKLGRI---MDPRL---EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ------~~~~~~~---~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                            .......   .....   ........+..+.+++.+||+.+|.+||++.+++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  290 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP  290 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence                  0000000   00000   0011222467789999999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=292.71  Aligned_cols=266  Identities=26%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~  157 (455)
                      |.+.+.||+|+||.||+|...+      ++..||||.+..... .......+|+..++.++ |+||+++++++..++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            5678899999999999997544      367899998754322 22233457999999999 999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||+ +|+|.+++.......+++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 889999887665457899999999999999999999976  99999999999999999999999999986543


Q ss_pred             CCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhhh----hhHhhhh
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARP----MLNDARK  311 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~~~----~~~~~~~  311 (455)
                      ...   .....|+..|+|||++.+ ..++.++|+||||+++++|++|.+||............ .+...    .+.....
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   123568999999998854 45789999999999999999999999765432221111 00000    0000000


Q ss_pred             hcccCCCcccC-------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          312 LGRIMDPRLEG-------QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       312 ~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      +...++..+..       ......+.++.+++.+||+.+|++|||+.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~  281 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP  281 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence            11111111110       11112256789999999999999999999998873

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8e-37  Score=341.19  Aligned_cols=261  Identities=32%  Similarity=0.504  Sum_probs=204.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ..|...++||+|+||.||+|...      ..+..||||.+......    ...|+.++++++|||||+++++|......+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSI------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEEC------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            46778889999999999999653      34678999988643221    124688999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      +||||+++|+|.+++.     .++|..+..++.|++.||+|||.. .++|+||||||+||+++.++..++. ||.+....
T Consensus       760 lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            9999999999999884     378999999999999999999954 3559999999999999998887775 66554332


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ..      ....||+.|+|||++.+..++.++|||||||++|||++|+.||+.... .......|.+..... ......+
T Consensus       834 ~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~  905 (968)
T PLN00113        834 TD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWI  905 (968)
T ss_pred             cC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhhee
Confidence            11      123689999999999999999999999999999999999999964322 233455555433221 1222334


Q ss_pred             CCcccC--CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          317 DPRLEG--QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       317 ~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ++.+..  ........++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            444432  2344556678899999999999999999999999987744

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.4e-37  Score=301.11  Aligned_cols=269  Identities=23%  Similarity=0.285  Sum_probs=194.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeC--
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEE--  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--  153 (455)
                      +|.+.+.||+|+||.||+|.....    ..+..||+|.+...  .......+.+|+.+++.+. ||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET----SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC----CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            478889999999999999965431    12678999987642  2223456788999999994 99999999875432  


Q ss_pred             --CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          154 --EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       154 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                        ...+++|+|+ +++|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus        77 ~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              4578999999 46898887543  57899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCc--cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-h------
Q 012832          232 AKDGPEGDDT--HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-W------  301 (455)
Q Consensus       232 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~------  301 (455)
                      +.........  .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+. .      
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211  11223578999999998765 468999999999999999999999997644211110000 0      


Q ss_pred             --hhhhhHh-h----hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          302 --ARPMLND-A----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       302 --~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        ...+... .    ..........+. ......+..+.+++.+||+.+|.+|||+.+++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~  293 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP  293 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence              0000000 0    000000000000 11112356789999999999999999999999883

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.5e-37  Score=296.99  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=196.4

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCC-CCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLR-HPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~  152 (455)
                      ...++|.+.+.||+|+||.||+|....      +++.||||.+..... .....+..|+.++..+. |+||+++++++..
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKK------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECC------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            345778999999999999999996543      467899999864332 23445667777666665 9999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ....++||||+ +++|.+++... ...+++..+..++.|++.||+|||+ .+  |+||||+|+||+++.++.++|+|||+
T Consensus        86 ~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          86 DSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             CCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECcccc
Confidence            99999999998 55777766543 3478999999999999999999997 35  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH----LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      +........   .....|+..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... ...+..    ...
T Consensus       162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~~  233 (296)
T cd06618         162 SGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK----ILQ  233 (296)
T ss_pred             chhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH----Hhc
Confidence            876543221   12245788999999987553    788999999999999999999999643211 000000    000


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .       ..+.+.  ....++.++.+|+.+||..+|.+||++.+++.+.+
T Consensus       234 ~-------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         234 E-------EPPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             C-------CCCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            0       001111  11134577899999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.5e-37  Score=299.89  Aligned_cols=271  Identities=25%  Similarity=0.302  Sum_probs=196.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||.+......  ....+.+|+++++.++||||+++++++....
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            578999999999999999999643      35678999988543222  2245678999999999999999999875433


Q ss_pred             --------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          155 --------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       155 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                              ..++||||+. ++|...+... ...+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence                    4699999995 5777766543 457999999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCc---------cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchh
Q 012832          227 SDFGLAKDGPEGDDT---------HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ  296 (455)
Q Consensus       227 ~DfGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~  296 (455)
                      +|||++.........         ...+...|++.|+|||.+.+. .++.++|||||||++|||++|.+||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999765432211         111224678899999988654 5889999999999999999999999765543222


Q ss_pred             hHHHhh-hh----hhHhhhhhcccCC----CcccCC---CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          297 SLVEWA-RP----MLNDARKLGRIMD----PRLEGQ---YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       297 ~~~~~~-~~----~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ..+... ..    .......+....+    ......   ........+.+++.+||..+|.+|||+.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~  309 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP  309 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence            211110 00    0000000000000    000000   0011235788999999999999999999999873

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.2e-37  Score=306.09  Aligned_cols=269  Identities=22%  Similarity=0.294  Sum_probs=197.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC---
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE---  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  153 (455)
                      ..+|.+.+.||.|+||.||+|...      .++..||+|.+........+.+.+|+.+++.++||||+++++++...   
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            367999999999999999999543      35789999998766555567788999999999999999999766543   


Q ss_pred             -----------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-C
Q 012832          154 -----------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-D  221 (455)
Q Consensus       154 -----------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~  221 (455)
                                 ...++||||++ ++|.+++..   ..+++..+..++.||+.||.|||+.+  |+||||||+||+++. +
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCC
Confidence                       35799999996 689887753   36889999999999999999999976  999999999999974 5


Q ss_pred             CceEEccCCCccCCCCCCCc-cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      +.++|+|||++......... .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||....+.......
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67899999999765322111 11122468899999998754 56888999999999999999999999765432222111


Q ss_pred             HhhhhhhH--hhh----hhcccCC-Cccc-----CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          300 EWARPMLN--DAR----KLGRIMD-PRLE-----GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       300 ~~~~~~~~--~~~----~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....+...  ...    .....+. ....     .......+.++.+|+.+||..+|.+|||+.+++.|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~  301 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP  301 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence            11000000  000    0000000 0000     001123456788999999999999999999999883

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.8e-37  Score=302.15  Aligned_cols=271  Identities=24%  Similarity=0.308  Sum_probs=198.7

Q ss_pred             CCCC-CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh--------------HHHHHHHHHHHhcCCCCC
Q 012832           78 QSFS-SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--------------HREWLTEVIFLGQLRHPH  142 (455)
Q Consensus        78 ~~~~-~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~n  142 (455)
                      ++|. +.+.||.|+||.||+|...      ..++.||||.+.......              ...+.+|+.+++.++|+|
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDT------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEEC------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            4554 4578999999999999543      357889999875432221              124678999999999999


Q ss_pred             cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       143 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      |+++++++...+..++||||+. |+|.+++...  ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCC
Confidence            9999999999999999999995 6899888653  46889999999999999999999966  99999999999999999


Q ss_pred             ceEEccCCCccCCCCCCC------------ccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          223 TAKLSDFGLAKDGPEGDD------------THVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                      .++|+|||++........            ........+++.|+|||.+.+. .++.++|||||||++|+|++|.+||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999876541110            0011124578899999998764 468999999999999999999999976


Q ss_pred             CCccchhhHHH-hhhhh----hHhhhhhc------ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          290 SRPQREQSLVE-WARPM----LNDARKLG------RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       290 ~~~~~~~~~~~-~~~~~----~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .........+. .....    +.......      ......+. ......+.++.+++.+||+.+|++|||+.+++.+.+
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            54322111110 00000    00000000      00000000 011223567899999999999999999999999855


Q ss_pred             cc
Q 012832          359 PL  360 (455)
Q Consensus       359 ~~  360 (455)
                      .-
T Consensus       316 ~~  317 (335)
T PTZ00024        316 FK  317 (335)
T ss_pred             cC
Confidence            43

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-37  Score=302.53  Aligned_cols=264  Identities=21%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||||.+...  .......+.+|+.+|+.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDR------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEEC------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            4678999999999999999999543      35788999988543  222345678999999999999999999988655


Q ss_pred             C------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 E------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      .      ..++||||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          87 LSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEe
Confidence            3      458999999 7899887753   46899999999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH-HHhh---
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL-VEWA---  302 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~-~~~~---  302 (455)
                      |||++......     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||........... ....   
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999865332     122468899999999876 4588999999999999999999999976532111100 0000   


Q ss_pred             -----hhhh-----HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          303 -----RPML-----NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       303 -----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                           ..+.     .....+.......+ .......+..+.+++.+||..+|++|||+.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~  299 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP  299 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                 0000     00000000000000 011223456789999999999999999999999873

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.2e-37  Score=289.82  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc---c--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL---E--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~---~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +|.+.+.||+|+||.||++....      .+..+++|+++.   .  .......+..|+.+++.++||||+++++++...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            47888999999999999986433      233455554432   1  112334566789999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+  ++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCc
Confidence            9999999999999999888642  3457899999999999999999999966  999999999999975 5699999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      .....       
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~-------  216 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLR-------  216 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-------
Confidence            876543322  122356889999999998888999999999999999999999999643211      10000       


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ..   . ......+...+.++.+++.+||..+|++||++.+++++
T Consensus       217 ~~---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         217 IV---E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HH---c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            00   0 01112344566789999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-36  Score=293.31  Aligned_cols=257  Identities=27%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  153 (455)
                      +|.+.+.||+|+||.||++.....   ...+..||||++....    ......+..|+.++..+ +||||+++++.+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG---HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc---ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            477889999999999999865321   2346789999886432    12335577899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||+|.||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999999988654  46888999999999999999999866  9999999999999999999999999987


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ......... .....|+..|+|||.+.+..  ++.++||||||+++|+|++|..||.........  .........    
T Consensus       154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~----  226 (288)
T cd05583         154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILK----  226 (288)
T ss_pred             ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHc----
Confidence            654432211 12246899999999987655  788999999999999999999999643221111  111111100    


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         .     ....+...+..+.+++.+||+.+|++|||+.++...|
T Consensus       227 ---~-----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         227 ---S-----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             ---c-----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence               0     1122334556789999999999999999977665544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-36  Score=299.22  Aligned_cols=266  Identities=23%  Similarity=0.284  Sum_probs=199.2

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ...+++|.+.+.||.|+||.||+|...      .++..||||.+....  ......+..|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   79 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQ------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI   79 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEEC------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence            346788999999999999999999543      357889999875422  223456778999999999999999999886


Q ss_pred             e-CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          152 E-EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       152 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      . ....++||||+ +++|.+++..   ..++...+..++.|++.||+|||+.+  |+||||+|+|||++.++.++|+|||
T Consensus        80 ~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          80 SPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccc
Confidence            5 45789999999 6789887753   35788888999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhh------
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWA------  302 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~------  302 (455)
                      ++.......     ....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+ ...      
T Consensus       154 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         154 LARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             cccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            997543221     22467889999998866 56899999999999999999999999765432111111 000      


Q ss_pred             --hhhhHhhhhhcccCCCcccCC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          303 --RPMLNDARKLGRIMDPRLEGQ-----YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       303 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        ...... ....-.........     .....+..+.+++.+||+.+|++|||+.+++.+-
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         229 VINTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             HHHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence              000000 00000000000011     1123457899999999999999999999999983

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=305.41  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=214.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ...++.++.-||-||||.|=++....      ....+|+|+++..   .....+.+..|-.+|..++.|+||++|-.|.+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNS------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecc------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            34567777889999999999985543      2235788877644   33445667889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ..++||+||-|-||.|+..|..+  ..+...+...++..+++|++|||+.+  ||+|||||+|+|++.+|.+||.|||+|
T Consensus       492 ~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  492 SKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFA  567 (732)
T ss_pred             chhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhH
Confidence            99999999999999999988765  67888899999999999999999966  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      +....+..   +-++||||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++..-.+++--.-.        
T Consensus       568 Kki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------  636 (732)
T KOG0614|consen  568 KKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------  636 (732)
T ss_pred             HHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------
Confidence            98766543   3458999999999999999999999999999999999999999998877654444321111        


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~~  359 (455)
                              ...+|..++..+.+||++++..+|.+|.-     +.+|.+|-|.
T Consensus       637 --------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  637 --------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             --------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence                    12456667788999999999999999975     7888888554

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=300.48  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=204.8

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      .++||+|.||+||-|      .+..+|+.||||+++....  .....+.+|+.||.+++||+||.+-..|+..+..++||
T Consensus       569 devLGSGQFG~VYgg------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGG------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecc------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            578999999999998      4556899999999865432  23356789999999999999999999999999999999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC---CceEEccCCCccCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPE  237 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~---~~~kL~DfGla~~~~~  237 (455)
                      |-+ .|+..+.|.......+++..-..+..||+.||.|||..+  |+|+||||+|||+...   .++||||||.|+...+
T Consensus       643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            999 557766776666788999988899999999999999855  9999999999999653   4799999999998876


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...   ...++|||.|+|||++.+..|.+.-|+||+|||+|--+.|..||+..+...++  ++           ...+|.
T Consensus       720 ksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQ-----------NAaFMy  783 (888)
T KOG4236|consen  720 KSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQ-----------NAAFMY  783 (888)
T ss_pred             hhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hh-----------cccccc
Confidence            543   34478999999999999999999999999999999999999999765432111  11           112333


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      |.   ......+.++.+||..+|+..-++|-+....+.|.|
T Consensus       784 Pp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  784 PP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             CC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence            22   223456678999999999999999999999988854

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=291.08  Aligned_cols=266  Identities=26%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      |+..+.||+|+||.||+|...      .+++.||+|.+....  ......+..|+.+++.++|+||+++++++......+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeec------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            566788999999999999543      357899999987543  233456778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999996 69999887643 46899999999999999999999976  99999999999999999999999999986544


Q ss_pred             CCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhhh----hhHhhhh
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARP----MLNDARK  311 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~~~----~~~~~~~  311 (455)
                      ....  .....++..|+|||.+.+. .++.++|||||||++|||++|.+||...........+ .....    .+.....
T Consensus       151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Cccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            3221  2224567889999998776 7899999999999999999999999765422111100 00000    0000000


Q ss_pred             h---cccCCC---cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          312 L---GRIMDP---RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       312 ~---~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .   ......   .......+..+..+.+++.+||..+|++||++.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence            0   000000   000011112356899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=312.17  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=212.6

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYC  150 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~  150 (455)
                      .+...++-|.+...||.|.+|.||++.      +...++.+|+|+++.+.. ..+++..|.++|+.+. |||++.+||++
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k------~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGR------HVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEe------eeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            334456789999999999999999994      445678889998865543 3455667899998885 99999999998


Q ss_pred             Ee-----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          151 CE-----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       151 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      ..     ++.+|||||||.||+..|++....+..+.|..+..|+..++.||.+||.+.  +||||||-.|||++.++.||
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEE
Confidence            53     478999999999999999998877888999999999999999999999866  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      |+|||++.+....-  ....+.+||+.|||||++.-     ..|+.++|+||||++..||.-|.+|+-...+.+..-++.
T Consensus       164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip  241 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  241 (953)
T ss_pred             Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence            99999998764322  22344789999999999964     358889999999999999999999997766543222111


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                                     -+|...-.-+...+.++.++|..||..|..+||++.++++|
T Consensus       242 ---------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  242 ---------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                           12222223366778999999999999999999999999988

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-37  Score=302.58  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|....      ++..||||++...  .......+.+|+.+++.++|+||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTK------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECC------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            35789999999999999999996533      5678999988643  222345677899999999999999999887665


Q ss_pred             Ce------EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 EH------RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ~~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      +.      .++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEc
Confidence            54      89999999 7799988764   46899999999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH-Hhhh--
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWAR--  303 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~-~~~~--  303 (455)
                      |||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+ ....  
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~  235 (343)
T cd07851         161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP  235 (343)
T ss_pred             ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence            99999865432     122468899999998865 36789999999999999999999999765432211110 0000  


Q ss_pred             ------hhh-Hhhhhh----cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          304 ------PML-NDARKL----GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       304 ------~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            .+. ......    .....+.+.. .....+.++.+++.+||..+|.+|||+.++++|-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~  300 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY  300 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence                  000 000000    0000000000 01123578999999999999999999999999843

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=283.10  Aligned_cols=242  Identities=31%  Similarity=0.397  Sum_probs=196.8

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      ||.|+||.||++....      .++.||+|.+.....   .....+..|+.+++.++|+||+++++.+......++||||
T Consensus         1 lg~G~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKD------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            7999999999996533      467899998865432   2345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcc
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH  242 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~  242 (455)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--  148 (250)
T cd05123          75 APGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--  148 (250)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--
Confidence            9999999988765  36899999999999999999999966  99999999999999999999999999986544321  


Q ss_pred             ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   ....   ...          .  ...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~----------~--~~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYE---KIL----------K--DPL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHh----------c--CCC
Confidence            123356899999999998888999999999999999999999999754321   1111   000          0  011


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCCH---HHHHHhc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPTM---STVVKTL  357 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt~---~ell~~L  357 (455)
                      .++...+..+.+++.+||..+|++||++   .++++|.
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~  248 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHP  248 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCC
Confidence            2333446788999999999999999999   7777763

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=316.31  Aligned_cols=270  Identities=27%  Similarity=0.448  Sum_probs=214.6

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCC-CcccccEEEEeccccch-hhHHHHHHHHHHHhcCC-CCCcccEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRP-GLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLR-HPHLVKLIG  148 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~  148 (455)
                      .+++..++..+.+.||+|.||.|++|........ ......||||.++.... .....+..|+.+|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            3455566677778999999999999986543222 12367899999874433 45677899999999996 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCC
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRY------S--------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS  214 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~  214 (455)
                      +|......++|+||+..|+|.+++....      .        ..+.....+.++.|||.||+||++..  +|||||.++
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaR  447 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAAR  447 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhh
Confidence            9999999999999999999999997654      0        13888899999999999999999844  999999999


Q ss_pred             CEEEcCCCceEEccCCCccCCCCCCCccceecccc--CCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCC
Q 012832          215 NILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG--TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSR  291 (455)
Q Consensus       215 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~  291 (455)
                      ||||+.+..+||+|||+|+.....+..... .-.|  ...|||||.+....|+.++||||||++|||+++ |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            999999999999999999976554433211 1223  335999999999999999999999999999999 889997632


Q ss_pred             ccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          292 PQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..  ..+..+              +.+...-..|..|+.++.++|..||..+|++||++.++.+.|+.+
T Consensus       527 ~~--~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PT--EELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cH--HHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11  111111              122223344667788999999999999999999999999998774

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.5e-36  Score=319.37  Aligned_cols=147  Identities=26%  Similarity=0.314  Sum_probs=129.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|....      .+..||||++....   ......+..|+.++..++|+||+++++++...
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   76 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA   76 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence            3678999999999999999996543      57789999986432   22335678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...||||||+.|++|.+++...  ..+++..++.++.||+.||+|||..+  ||||||||+||||+.++.++|+|||+++
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999988654  46888999999999999999999966  9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-38  Score=280.22  Aligned_cols=255  Identities=24%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  156 (455)
                      +.+-...||.|+||+|++-      .++..++..|||++..... ....+++.|.+...+- ++||||++||.+..++..
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKM------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             hHHHHHHhcCCcchhhhhh------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            3444567999999999987      5667899999999976654 5566788888766554 599999999999999999


Q ss_pred             EEEEEecCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          157 LLVYEYMPRGSLENQL---FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ||.||+| ..+|..+.   ..-....+++..+-+|+.-.+.||.||-.. ..|||||+||+||||+..|.+||||||++.
T Consensus       139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchH
Confidence            9999999 55765432   223356789999999999999999999763 349999999999999999999999999987


Q ss_pred             CCCCCCCccceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ++...   ...+.-.|-..|||||.+..  ..|+.++||||||++|||+.||..|+.+-..     +.+......     
T Consensus       217 qLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-----  283 (361)
T KOG1006|consen  217 QLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-----  283 (361)
T ss_pred             hHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-----
Confidence            65432   12333568999999999964  3589999999999999999999999975422     111110000     


Q ss_pred             hcccCCCcccC-CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          312 LGRIMDPRLEG-QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       312 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                        .--.|.+.. .-.-..+..+..++..||.+|-+.||.+.+++++
T Consensus       284 --~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  284 --IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              000111111 1112346778999999999999999999999886

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=278.43  Aligned_cols=263  Identities=25%  Similarity=0.315  Sum_probs=202.7

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      .+.||+|+++.|--+.      ...++..||||+++........+..+|++++...+ |+||+.++++|.++...|||||
T Consensus        83 ~e~LGeGAyasVqtcv------~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE  156 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCV------SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE  156 (463)
T ss_pred             HHHhcCccceeeeeee------eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence            3679999999998773      34578899999998876667778899999999997 9999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC---ceEEccCCCccCCCCC
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEG  238 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~---~~kL~DfGla~~~~~~  238 (455)
                      -|.||+|...|.++  ..+++.++-.+..+|+.||.|||..|  |.||||||+|||.....   -+||+||.|.......
T Consensus       157 Km~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  157 KMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             cccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999999876  67999999999999999999999855  99999999999997654   4899999997643222


Q ss_pred             CC-----ccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH-
Q 012832          239 DD-----THVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN-  307 (455)
Q Consensus       239 ~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~-  307 (455)
                      ..     +....+.+|+..|||||+..     ...|+.++|+||||||+|-|++|-+||.+.-..+    ..|-+.... 
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~Cr  308 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEVCR  308 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCccH
Confidence            21     11123468999999999873     3458999999999999999999999997643211    111110000 


Q ss_pred             -hhhhhcc-cCCC--cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          308 -DARKLGR-IMDP--RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       308 -~~~~~~~-~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                       ....+.+ +-+.  .++..-...++.++.+|+..+|..++.+|.++.++++|.+.
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~  364 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV  364 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence             0000100 1111  11222234567889999999999999999999999998553

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.3e-36  Score=280.71  Aligned_cols=226  Identities=22%  Similarity=0.242  Sum_probs=180.7

Q ss_pred             cCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCCh
Q 012832           89 GGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL  168 (455)
Q Consensus        89 G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  168 (455)
                      |.||.||++..      ..+++.||+|.+.....     +..|...+....||||+++++++...+..++||||+++|+|
T Consensus         4 g~~~~v~~~~~------~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMD------TRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEE------ccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            89999999954      44678899999865431     23445555556799999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccc
Q 012832          169 ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM  248 (455)
Q Consensus       169 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  248 (455)
                      .+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++.......     ....
T Consensus        73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~  143 (237)
T cd05576          73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA  143 (237)
T ss_pred             HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence            9988765  35899999999999999999999966  9999999999999999999999999886543321     2245


Q ss_pred             cCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHH
Q 012832          249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG  328 (455)
Q Consensus       249 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (455)
                      ++..|+|||.+.+..++.++||||+||++|||++|..|+......                  .    ........+...
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~----~~~~~~~~~~~~  201 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------I----NTHTTLNIPEWV  201 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------c----ccccccCCcccC
Confidence            677899999998888999999999999999999999887532110                  0    000011123345


Q ss_pred             HHHHHHHHHHHhccCCCCCCCH-----HHHHHh
Q 012832          329 ARKAAALAYQCLSHRPKQRPTM-----STVVKT  356 (455)
Q Consensus       329 ~~~~~~li~~cl~~~P~~RPt~-----~ell~~  356 (455)
                      +..+.+++.+||+.||++||++     +++++|
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            5778999999999999999986     677665

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=256.36  Aligned_cols=267  Identities=22%  Similarity=0.289  Sum_probs=203.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .|...+.||+|.||+||+|      ++..+.+.||+|.+..++.  ......++|+.+|+.++|.|||+++++...+..+
T Consensus         3 ~ydkmekigegtygtvfka------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKA------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEec------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            4566778999999999999      4566789999998865432  2335678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      -+|+||| ..+|..+... ....+..+.+..++.|+++||.|+|+++  ++||||||.|+||+.+|.+||+|||+++.+.
T Consensus        77 tlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   77 TLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            9999999 5688876554 4578899999999999999999999977  9999999999999999999999999998754


Q ss_pred             CCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHh--hhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLND--ARKL  312 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  312 (455)
                      -.-  ......+-|.+|.+|.++.+.. |+...|+||.|||+.||.. |++.|.+.+-.++...+-|.......  ...+
T Consensus       153 ipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             Cce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            321  2233356799999999998765 8889999999999999987 77778877554444333332211111  0111


Q ss_pred             cccCCCcccCCCC---------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          313 GRIMDPRLEGQYS---------ETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       313 ~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....+-....-|+         +.....-++|+.++|.-+|..|.+++..+++.
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            1111111111111         22233457899999999999999999999874

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=284.58  Aligned_cols=267  Identities=24%  Similarity=0.336  Sum_probs=203.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC--C----CcccEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH--P----HLVKLIGY  149 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv~~~~~  149 (455)
                      ..++|.+...+|+|.||.|-.+++..      ++..||||+++.-. .-.+..+-|+++|.++.+  |    -+|.+.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRE------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecC------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            47899999999999999999986443      37899999986322 223345679999999952  2    36777888


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---------
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---------  220 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---------  220 (455)
                      |.-.++.|||+|.+ |-+++++|..+.-.++|...+..++.|++.+++|||+.+  ++|.||||+|||+.+         
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEecc
Confidence            99999999999999 779999999887789999999999999999999999977  999999999999821         


Q ss_pred             -----------CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          221 -----------DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       221 -----------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                                 +..++|+|||.|....+..     ...+.|..|.|||++.+.+++..+||||+||||+||.+|...|..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                       3358999999998765543     236789999999999999999999999999999999999999987


Q ss_pred             CCccchhhHHHhh-hh----hhHhhhh-------------------hcccCCCcccC----CCCHHHHHHHHHHHHHHhc
Q 012832          290 SRPQREQSLVEWA-RP----MLNDARK-------------------LGRIMDPRLEG----QYSETGARKAAALAYQCLS  341 (455)
Q Consensus       290 ~~~~~~~~~~~~~-~~----~~~~~~~-------------------~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~  341 (455)
                      .+......+.+.+ .+    ++.....                   .....+++.+-    ........++.+|+++||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            6533222222111 11    1111100                   01111111100    1122334578999999999


Q ss_pred             cCCCCCCCHHHHHHhc
Q 012832          342 HRPKQRPTMSTVVKTL  357 (455)
Q Consensus       342 ~~P~~RPt~~ell~~L  357 (455)
                      .||.+|+|+.|++.|-
T Consensus       392 fDP~~RiTl~EAL~Hp  407 (415)
T KOG0671|consen  392 FDPARRITLREALSHP  407 (415)
T ss_pred             cCccccccHHHHhcCH
Confidence            9999999999999883

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-38  Score=277.70  Aligned_cols=275  Identities=25%  Similarity=0.343  Sum_probs=205.8

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      ..|.....||+|.||.||+|      +.+.+++.||+|++-.++  ...-...++|+.+|..|+|+|++.++..|...  
T Consensus        17 ~~yek~~kigqGtfgeVFkA------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKA------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHH------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            45666778999999999999      455678889999764432  22234568999999999999999999887432  


Q ss_pred             ------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          154 ------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       154 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                            ...||||.+|+. +|.-+|... ...++..++..++.++..||.|+|...  |+|||+||.|+||+.+|.+||+
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEee
Confidence                  358999999954 888766543 467888999999999999999999977  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCc--cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-
Q 012832          228 DFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-  303 (455)
Q Consensus       228 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-  303 (455)
                      |||+++.+......  ...+..+-|.+|.+||.+.|. .|++..|||+.|||+.||++|.+-+.+........++...- 
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999765443321  223445679999999999875 59999999999999999999999999887666655554221 


Q ss_pred             -------hhhHhhhhhcccCCCccc-CCCCH--H------HHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          304 -------PMLNDARKLGRIMDPRLE-GQYSE--T------GARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       304 -------~~~~~~~~~~~~~~~~~~-~~~~~--~------~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                             +......-+..+--+.+. +++..  +      -.+++.+|+.++|..||.+|+++.+++.|-.+.++
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                   111111111111111111 11110  0      12478899999999999999999999999655544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=285.02  Aligned_cols=282  Identities=30%  Similarity=0.453  Sum_probs=207.3

Q ss_pred             cccccccCCCCcccchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHH
Q 012832           55 DLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIF  134 (455)
Q Consensus        55 ~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~  134 (455)
                      +...|.+++.++.+   --+....+..+.+.||+|.||.||+|.        +.|..||||++...   +++.|.+|.+|
T Consensus       191 ~~~tSGSGSGlplL---VQRTiarqI~L~e~IGkGRyGEVwrG~--------wrGe~VAVKiF~sr---dE~SWfrEtEI  256 (513)
T KOG2052|consen  191 DLETSGSGSGLPLL---VQRTIARQIVLQEIIGKGRFGEVWRGR--------WRGEDVAVKIFSSR---DERSWFRETEI  256 (513)
T ss_pred             hhccCCCCCCchhH---hHHhhhheeEEEEEecCccccceeecc--------ccCCceEEEEeccc---chhhhhhHHHH
Confidence            33445555555432   223345678899999999999999994        56789999998643   33556677777


Q ss_pred             Hh--cCCCCCcccEEEEEEeC----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-----CC
Q 012832          135 LG--QLRHPHLVKLIGYCCEE----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-----AE  203 (455)
Q Consensus       135 l~--~l~h~nIv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~  203 (455)
                      .+  .|+|+||+.|++.-..+    ..+|||++|.+.|+|+|+|.+.   .++....++++..+|.||++||.     +|
T Consensus       257 YqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqg  333 (513)
T KOG2052|consen  257 YQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQG  333 (513)
T ss_pred             HHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCC
Confidence            65  46999999999876444    3689999999999999999874   78889999999999999999995     34


Q ss_pred             CC-eEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc--cceeccccCCCCcCccccccCC------CCccCchhhHH
Q 012832          204 KP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEYVMTGH------LTSMSDVYSFG  274 (455)
Q Consensus       204 ~~-iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG  274 (455)
                      || |.|||||..||||..++.+.|+|+|||.........  ...+..+||.+|||||++...-      .-..+||||||
T Consensus       334 KPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg  413 (513)
T KOG2052|consen  334 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG  413 (513)
T ss_pred             CchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence            44 999999999999999999999999999866554221  1233478999999999996532      12368999999


Q ss_pred             HHHHHHHhC----------CCCCCCCCccchhhHHHhhhhhhHhhhhhc--ccCCCcccCC-CCHHHHHHHHHHHHHHhc
Q 012832          275 VVLLELLSG----------RKSVDKSRPQREQSLVEWARPMLNDARKLG--RIMDPRLEGQ-YSETGARKAAALAYQCLS  341 (455)
Q Consensus       275 ~il~ell~G----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~cl~  341 (455)
                      .++||+...          ++||...-+.+         |.+.+..+..  +.+.|..+.. .+......+..||+.||.
T Consensus       414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~D---------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~  484 (513)
T KOG2052|consen  414 LVLWEIARRCESGGIVEEYQLPYYDVVPSD---------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWY  484 (513)
T ss_pred             HHHHHHHHHhhcCCEehhhcCCcccCCCCC---------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhc
Confidence            999999863          35654332211         1111111111  1122222222 244556788999999999


Q ss_pred             cCCCCCCCHHHHHHhcccccC
Q 012832          342 HRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       342 ~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .+|..|-|+-.|.+.|..+..
T Consensus       485 ~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  485 ANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCchhhhHHHHHHHHHHHHhc
Confidence            999999999999999877754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=299.45  Aligned_cols=244  Identities=26%  Similarity=0.272  Sum_probs=198.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  155 (455)
                      ++.|.+...+|.|+|+.|-.+..      ..+++..++|++.....    +..+|+.++... +||||+++.+.+.+..+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~------~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCES------SPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             chhhccccccCCCCccceeeeec------cccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCce
Confidence            56788888899999999998843      44678899999875522    223567565555 59999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE-cCCCceEEccCCCccC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL-DSDYTAKLSDFGLAKD  234 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill-~~~~~~kL~DfGla~~  234 (455)
                      .|+|||++.|+-|.+.+....   .....+..|+.+|+.|+.|||++|  ||||||||+|||+ ++.++++|+|||.++.
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhh
Confidence            999999999998888776542   223677789999999999999966  9999999999999 5889999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ....     ....+-|..|.|||++....|+.++||||||++||+|++|+.||......     ++              
T Consensus       466 ~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~e--------------  521 (612)
T KOG0603|consen  466 LERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IE--------------  521 (612)
T ss_pred             Cchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HH--------------
Confidence            6554     22346788999999999999999999999999999999999999765332     10              


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ++.....+.+....+..+.+|+.+||+.+|.+||++.++..|-+.
T Consensus       522 i~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  522 IHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            001111233446778899999999999999999999999998655

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=275.80  Aligned_cols=272  Identities=25%  Similarity=0.332  Sum_probs=224.1

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEE
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLI  147 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~  147 (455)
                      ..+++.+...+++...++-+|.||.||.|.+.+.. .-...+.|-+|.++.... -....++.|...|..+.|||+..+.
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd-t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREED-TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccC-CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            46677788889999999999999999999887642 223346677888764433 3345678999999999999999999


Q ss_pred             EEEEeC-CeEEEEEEecCCCChHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC
Q 012832          148 GYCCEE-EHRLLVYEYMPRGSLENQLFRR------YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS  220 (455)
Q Consensus       148 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~  220 (455)
                      +++.++ +..++++.++.-|+|..+|..-      ....+.--+...++.|++.||+|||.++  |||.||.+.|++|++
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence            988654 5678899999999999998721      2345666678889999999999999977  999999999999999


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHH
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLV  299 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~  299 (455)
                      ..++||+|=.+++...+.+.+.....-.....|||||.+.+..|+.++||||||++||||+| |+.|+..-+|......+
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            99999999999999888887776666667789999999999999999999999999999999 99999766654333222


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .                 ...+-.-|.+||+++..+|..||...|++||+++|++.-|..+
T Consensus       512 k-----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 K-----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             h-----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            2                 1222334678999999999999999999999999999887544

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=285.45  Aligned_cols=260  Identities=26%  Similarity=0.373  Sum_probs=202.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--h-----hhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--L-----QGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      .++|-+.++||+|||+.||+|++.      .....||||+...+.  .     .-.....+|..|-+.|+||.||++|++
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl------~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDL------TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhccc------chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            457888899999999999999643      346789999864321  1     112446789999999999999999999


Q ss_pred             EEe-CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceE
Q 012832          150 CCE-EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAK  225 (455)
Q Consensus       150 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~k  225 (455)
                      +.- .+..|-|+|||+|.+|.-+|..+  ..+++.++..|+.||+.||.||.+...+|||-||||.|||+-.   -|.+|
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            864 46788999999999999888765  6789999999999999999999998899999999999999943   47899


Q ss_pred             EccCCCccCCCCCCCc-----cceeccccCCCCcCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCCCccchh
Q 012832          226 LSDFGLAKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTG----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ  296 (455)
Q Consensus       226 L~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~  296 (455)
                      |.||||++........     ..+....||.||++||.+.-+    .++.++||||+|||+|..+.|+.||.....  .+
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQ  691 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQ  691 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HH
Confidence            9999999976554433     234457899999999988543    478899999999999999999999975422  12


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ..+... .+++.       ..  +.-..-+..+.++.++|.+||+..-++|....++..+
T Consensus       692 dILqeN-TIlkA-------tE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  692 DILQEN-TILKA-------TE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HHHhhh-chhcc-------ee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            222110 00100       00  0111123446788999999999999999999999876

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-35  Score=291.88  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=196.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .-|..++-||-|+||.|.++.-.|      +...||.|.+...+.   ........|..||..-+++-||+||..|.+.+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvD------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVD------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecc------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            347778889999999999984333      467899998865433   23345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ++|+||+|++||++..+|.+.  ..|++..+..++..+..|+++.|..|  +|||||||+|||||.+|.+||.||||+.-
T Consensus       703 nLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeecccccc
Confidence            999999999999999998876  67889999999999999999999977  99999999999999999999999999852


Q ss_pred             C---------CCCCCcc----------------c---------------eeccccCCCCcCccccccCCCCccCchhhHH
Q 012832          235 G---------PEGDDTH----------------V---------------STRVMGTQGYAAPEYVMTGHLTSMSDVYSFG  274 (455)
Q Consensus       235 ~---------~~~~~~~----------------~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  274 (455)
                      +         ..++...                .               .-..+||+.|+|||++....|+.-+|+||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            2         1111000                0               0015799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccchhhH-HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC---CH
Q 012832          275 VVLLELLSGRKSVDKSRPQREQSL-VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP---TM  350 (455)
Q Consensus       275 ~il~ell~G~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP---t~  350 (455)
                      ||||||+.|++||-...+...+.. +.|.           ..    +...+....+.++.+||.+++ -+++.|.   -.
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw~-----------~~----l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~  922 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINWR-----------NF----LHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGA  922 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeehh-----------hc----cccccccccCHHHHHHHHHHh-cChhhhhcccch
Confidence            999999999999987766544332 2332           11    222334455667777776654 3556664   34


Q ss_pred             HHHHHh
Q 012832          351 STVVKT  356 (455)
Q Consensus       351 ~ell~~  356 (455)
                      ++|..|
T Consensus       923 d~vKaH  928 (1034)
T KOG0608|consen  923 DQVKAH  928 (1034)
T ss_pred             hhhhcC
Confidence            455555

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=271.58  Aligned_cols=252  Identities=26%  Similarity=0.368  Sum_probs=200.7

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcC-CCCCcccEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQL-RHPHLVKLIGY  149 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~  149 (455)
                      .+..++|.+.++||+|+|..|.++      +.+.+.+.+|+|+++.+-.   .+......|-.+.... +||++|-+..+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLV------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             ccccccceeeeeecCcchhhhhhe------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence            445678999999999999999998      4456789999999865422   2223344566666554 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      |..+..+++|.||++||+|.-.++++  ..+|++.+..+...|+.||.|||+.|  ||+||||..|||+|..|.+||.|+
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeeccc
Confidence            99999999999999999998766654  68999999999999999999999966  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCcc-chhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ-REQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~-~~~~~~~~~~~~~~~  308 (455)
                      |+++.....+++  +.+++|||.|.|||++.+..|+..+|+|+|||+++||+.|+.||+.-... .+.+..++...++  
T Consensus       396 gmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--  471 (593)
T KOG0695|consen  396 GMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--  471 (593)
T ss_pred             chhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--
Confidence            999876655544  56699999999999999999999999999999999999999999753211 1111122221111  


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP  348 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP  348 (455)
                             +...  ..++...+..+..+++.-|.+||.+|.
T Consensus       472 -------lekq--iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  472 -------LEKQ--IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------hhhc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence                   1111  123445556778899999999999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-34  Score=290.22  Aligned_cols=278  Identities=19%  Similarity=0.287  Sum_probs=188.6

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCC----------CCCCcccccEEEEeccccchhhHHHH--------------HH
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDK----------LRPGLQAQPVAVKNLDLEGLQGHREW--------------LT  130 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----------~~~~~~~~~vavK~~~~~~~~~~~~~--------------~~  130 (455)
                      ...++|.+.+.||+|+||.||+|.....          ......+..||||.+........++|              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            4567999999999999999999975321          11233456899999865443322333              34


Q ss_pred             HHHHHhcCCCCCc-----ccEEEEEEe--------CCeEEEEEEecCCCChHHHHhhcCC--------------------
Q 012832          131 EVIFLGQLRHPHL-----VKLIGYCCE--------EEHRLLVYEYMPRGSLENQLFRRYS--------------------  177 (455)
Q Consensus       131 E~~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------  177 (455)
                      |+.++.+++|.++     ++++++|..        ....+|||||+++++|.+++.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777766544     677777643        3568999999999999998864311                    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcC
Q 012832          178 --VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA  255 (455)
Q Consensus       178 --~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~a  255 (455)
                        ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++......... ......+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence              12456778899999999999999966  999999999999999999999999999765432211 1112345899999


Q ss_pred             ccccccCC--------------------C--CccCchhhHHHHHHHHHhCCC-CCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          256 PEYVMTGH--------------------L--TSMSDVYSFGVVLLELLSGRK-SVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       256 PE~~~~~~--------------------~--~~~~DvwslG~il~ell~G~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ||.+....                    |  ..+.||||+||++|+|++|.. ||........ .... ..   .....+
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~-~~---~~~~~~  453 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ-YD---NDLNRW  453 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh-cc---chHHHH
Confidence            99885432                    1  134799999999999999875 6643211110 0000 00   000000


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCC---CCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRP---KQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P---~~RPt~~ell~~L~~~  360 (455)
                      .........-......+....+|+.+||..+|   .+|+|+.|+++|-+..
T Consensus       454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            01111111111233456788999999999766   6899999999996553

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.5e-34  Score=301.35  Aligned_cols=271  Identities=19%  Similarity=0.221  Sum_probs=173.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEE------
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGY------  149 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~------  149 (455)
                      ..++|.+.+.||+|+||.||+|...+..  ...+..||||++......  +.+..+  .+....+.+++.++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~--~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ--SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc--cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            5678999999999999999999765421  133778999987543221  111221  1222222233222221      


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCeEEecc
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSV------------------SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF  211 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDl  211 (455)
                      +......+|||||+.+++|.+++......                  ......+..++.||+.||+|||+.+  |+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence            23556789999999999999988653210                  1112345679999999999999966  999999


Q ss_pred             CCCCEEEcC-CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC----------------------CCCccC
Q 012832          212 KASNILLDS-DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG----------------------HLTSMS  268 (455)
Q Consensus       212 kp~Nill~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  268 (455)
                      ||+|||++. ++.+||+|||+|+....... .......||+.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 68999999999986543222 223446799999999976432                      234567


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc----CC--CCHHHHHHHHHHHHHHhcc
Q 012832          269 DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE----GQ--YSETGARKAAALAYQCLSH  342 (455)
Q Consensus       269 DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~li~~cl~~  342 (455)
                      |||||||+||||+++..+++...    ..+.......-.+...+.....+...    ..  ..........+|+.+||+.
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999999776654210    00000000000000001111111100    00  0011123456899999999


Q ss_pred             CCCCCCCHHHHHHhccc
Q 012832          343 RPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       343 ~P~~RPt~~ell~~L~~  359 (455)
                      ||++|||+.++++|-+.
T Consensus       437 dP~kR~ta~e~L~Hpff  453 (566)
T PLN03225        437 KGRQRISAKAALAHPYF  453 (566)
T ss_pred             CcccCCCHHHHhCCcCc
Confidence            99999999999999443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.3e-33  Score=263.32  Aligned_cols=239  Identities=30%  Similarity=0.403  Sum_probs=193.3

Q ss_pred             CCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-HHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCCh
Q 012832           90 GFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL  168 (455)
Q Consensus        90 ~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  168 (455)
                      +||.||+|....      ++..+|+|++....... ...+.+|+..++.++|+||+++++++......+++|||+.+++|
T Consensus         1 ~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKK------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECC------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            689999996543      46789999987655444 67888999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccc
Q 012832          169 ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM  248 (455)
Q Consensus       169 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  248 (455)
                      .+++....  .+++..++.++.+++.+|.|||+.+  ++|+||+|.||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRG--RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            99886642  3889999999999999999999976  9999999999999999999999999998765532   123356


Q ss_pred             cCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC-CCCHH
Q 012832          249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG-QYSET  327 (455)
Q Consensus       249 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  327 (455)
                      |+..|++||.+.+..++.++||||||+++++|++|..||......  ........             ...... .....
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~-------------~~~~~~~~~~~~  212 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG-------------KPKPPFPPPEWK  212 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh-------------ccCCCCcccccc
Confidence            899999999998888999999999999999999999999753111  11111100             000000 00111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          328 GARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       328 ~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .+.++.+++.+||..+|++||++.+++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            45788999999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=263.64  Aligned_cols=269  Identities=22%  Similarity=0.344  Sum_probs=204.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc--cchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL--EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      .+.+..+.||-|+||.||.++      +...++.||+|++..  ........+.+|+.+|..++|.|++..+++....  
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVT------DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~  126 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVT------DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP  126 (449)
T ss_pred             ccCCCCCcccccceeEEEecc------CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence            456778999999999999873      445688999998752  3344557788999999999999999998876544  


Q ss_pred             ---CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          154 ---EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       154 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                         +.+|+|+|+|. .+|...|..-  ..++...+.-+.+||++||+|||+.+  |+||||||.|+|++.|..+||||||
T Consensus       127 dfFqEiYV~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  127 SFFQELYVLTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             hHHHHHHHHHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccc
Confidence               24678889884 4787766543  57788888899999999999999987  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--hhhH
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--PMLN  307 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~~~~  307 (455)
                      +++.....+..+ .+..+-|..|.|||+++|. .|+.+.||||+|||+.||+..+..|....+.....++.-..  +...
T Consensus       202 LARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  202 LARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             cccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            999765554443 3335679999999999875 59999999999999999999999998888877776654221  1111


Q ss_pred             hh-----hhhcccCC-----CcccC----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 DA-----RKLGRIMD-----PRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ~~-----~~~~~~~~-----~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..     ..-..++.     |.+..    .-+.....+...++.+++..+|++|.+..+.+.++.
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            11     00111111     11111    111223356788899999999999999999988853

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=263.47  Aligned_cols=280  Identities=23%  Similarity=0.289  Sum_probs=201.5

Q ss_pred             CcccchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-----
Q 012832           65 LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-----  139 (455)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----  139 (455)
                      +|.+.+.+. +...+|.+.+.||.|.|++||++++..      ..+.||+|+.+... .-.+..+.|+.+|++++     
T Consensus        66 YHpV~IGD~-F~~gRY~v~rKLGWGHFSTVWLawDtq------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~  137 (590)
T KOG1290|consen   66 YHPVRIGDV-FNGGRYHVQRKLGWGHFSTVWLAWDTQ------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPN  137 (590)
T ss_pred             Cceeecccc-ccCceEEEEEeccccccceeEEEeecc------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCC
Confidence            344434332 234789999999999999999997655      45789999986432 22355678999999884     


Q ss_pred             C---CCcccEEEEEEeC----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccC
Q 012832          140 H---PHLVKLIGYCCEE----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK  212 (455)
Q Consensus       140 h---~nIv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlk  212 (455)
                      |   ..||+|++.|...    .++|||+|++ |-+|..+|....-..+|...+.+|+.||+.||.|||.. .+|||.|||
T Consensus       138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlK  215 (590)
T KOG1290|consen  138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLK  215 (590)
T ss_pred             CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCC
Confidence            3   3699999998754    5899999999 88999999888778999999999999999999999973 469999999


Q ss_pred             CCCEEEcCC-----------C-----------------------------------------------------------
Q 012832          213 ASNILLDSD-----------Y-----------------------------------------------------------  222 (455)
Q Consensus       213 p~Nill~~~-----------~-----------------------------------------------------------  222 (455)
                      |+|||+..+           +                                                           
T Consensus       216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~  295 (590)
T KOG1290|consen  216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE  295 (590)
T ss_pred             cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence            999999211           0                                                           


Q ss_pred             --------------------------------------------------------------------------------
Q 012832          223 --------------------------------------------------------------------------------  222 (455)
Q Consensus       223 --------------------------------------------------------------------------------  222 (455)
                                                                                                      
T Consensus       296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~  375 (590)
T KOG1290|consen  296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA  375 (590)
T ss_pred             ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence                                                                                            


Q ss_pred             ----------------ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCC
Q 012832          223 ----------------TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS  286 (455)
Q Consensus       223 ----------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p  286 (455)
                                      +|||+|||-|.....     ..+.-+-|..|.|||++.+..|+..+||||++|+++||+||...
T Consensus       376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL  450 (590)
T KOG1290|consen  376 SNPLVNPDIPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL  450 (590)
T ss_pred             cccccCCCCCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence                            022222222221100     01112357789999999999999999999999999999999998


Q ss_pred             CCCCCcc----chhhHHH---h--------------hhhhhHhhhhhcccCCCccc---------CCCCHHHHHHHHHHH
Q 012832          287 VDKSRPQ----REQSLVE---W--------------ARPMLNDARKLGRIMDPRLE---------GQYSETGARKAAALA  336 (455)
Q Consensus       287 ~~~~~~~----~~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li  336 (455)
                      |+.....    ++..+..   .              .+.+++....+..+-.-...         -.++.....++.+++
T Consensus       451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL  530 (590)
T KOG1290|consen  451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL  530 (590)
T ss_pred             ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence            8764321    1112111   1              11222222222222221111         146777788999999


Q ss_pred             HHHhccCCCCCCCHHHHHHhccc
Q 012832          337 YQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       337 ~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .-||+.+|++|||+.++++|.+-
T Consensus       531 ~PmLef~PeKR~tA~~cl~hPwL  553 (590)
T KOG1290|consen  531 SPMLEFDPEKRPTAAQCLKHPWL  553 (590)
T ss_pred             HHHHhcCccccccHHHHhcCccc
Confidence            99999999999999999999553

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=244.05  Aligned_cols=205  Identities=27%  Similarity=0.365  Sum_probs=167.3

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      .+..++...+..||+|++|.|=+-      ++..+|+..|+|.+... ..+...++++|+.+.... .+|++|.+||...
T Consensus        42 eV~ad~L~~i~elGrGayG~vekm------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKM------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhhe------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            445566666778999999999765      55668999999998644 234456677888876655 5999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      .+...++.||.| ..+|..+-.+  ..+..+|+..+-+|+..++.||.|||+. ..+||||+||+||||+.+|++|+|||
T Consensus       116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEccc
Confidence            999999999999 5688764433  2367899999999999999999999984 45999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCcccccc----CCCCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                      |++-.+...-   ..+--.|-..|||||.+..    ..|+.++||||||+++.||.+++.||+.
T Consensus       194 GIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  194 GISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            9997654321   1222458889999999854    3699999999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=287.38  Aligned_cols=247  Identities=28%  Similarity=0.391  Sum_probs=187.8

Q ss_pred             CCCCcccccccCCee-EEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGA-VHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~-Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~  156 (455)
                      -|...+++|.|+-|+ ||+|.+.        ++.||||++-.+..   .-..+|+..|+.-+ |||||++++.-.+.+.+
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~  578 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFL  578 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence            356678899999876 8888654        56899998753322   23458999999886 99999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhc-CCC-CCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---C--CceEEccC
Q 012832          157 LLVYEYMPRGSLENQLFRR-YSV-SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---D--YTAKLSDF  229 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~-~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~--~~~kL~Df  229 (455)
                      ||+.|.| ..+|.+++... ... ....-..+.+..|++.||++||+.+  ||||||||.||||+.   +  ..++|+||
T Consensus       579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            9999999 67999999763 111 1111345778999999999999977  999999999999976   2  57999999


Q ss_pred             CCccCCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCCCccchhhHHHhhhhhhH
Q 012832          230 GLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG-RKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       230 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |+++....+... .......||.+|+|||++....-+.++|||||||++|+.++| ..||...-.. +.+       ++.
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------Il~  727 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------ILT  727 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------hhc
Confidence            999987654332 113446799999999999998888899999999999999995 8999753211 111       111


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ....+..     +.  ....+  ++.+||.+|+..+|..||++.+|+.|
T Consensus       728 ~~~~L~~-----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 GNYTLVH-----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             Cccceee-----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1111100     01  11112  78999999999999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.6e-33  Score=272.19  Aligned_cols=275  Identities=23%  Similarity=0.263  Sum_probs=208.5

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC------CCC
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR------HPH  142 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~n  142 (455)
                      .+.-.++...+|.+....|+|-|++|..|.      +...++.||||++..+.. ....=+.|++||++|+      --|
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~------D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRAR------DQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeecc------ccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhH
Confidence            334445677899999999999999999983      445577999999975433 3344468999999996      248


Q ss_pred             cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-
Q 012832          143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-  220 (455)
Q Consensus       143 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-  220 (455)
                      +++|+-.|...+++|||+|-+ ..+|.++|.+.. ...|....+..++.|+..||..|-.++  |+|.||||.||||++ 
T Consensus       496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccC
Confidence            999999999999999999999 679999886542 346777889999999999999999877  999999999999987 


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      ...+||||||.|........+    ...-+..|.|||+|.|..|+...|+||+||+||||.||+..|.+......+.+.-
T Consensus       573 k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            467999999999887665432    2445667999999999999999999999999999999999999876544333322


Q ss_pred             hh-hh----hhHhhhhhcccCC--------------------------C------cccC--CCCH---HHHHHHHHHHHH
Q 012832          301 WA-RP----MLNDARKLGRIMD--------------------------P------RLEG--QYSE---TGARKAAALAYQ  338 (455)
Q Consensus       301 ~~-~~----~~~~~~~~~~~~~--------------------------~------~~~~--~~~~---~~~~~~~~li~~  338 (455)
                      -. .+    ++....-....++                          |      .+.+  .++.   .....+.+|+.+
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            11 11    1110000000000                          1      0000  1222   234578899999


Q ss_pred             HhccCCCCCCCHHHHHHhc
Q 012832          339 CLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       339 cl~~~P~~RPt~~ell~~L  357 (455)
                      ||.+||++|.|..+.|+|.
T Consensus       729 ml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKHP  747 (752)
T ss_pred             HhccChhhcCCHHHHhcCC
Confidence            9999999999999999983

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=8e-33  Score=253.79  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      ..+|.-.+.+|.|.- .|..|      .+...+++||+|.+...  .....++..+|..++..++|+||++++.++.-. 
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAA------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeecccCCCCc-eEEec------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            467888889999988 66655      34557889999987433  334456678899999999999999999998654 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           ...|+||||| .++|...+..    .++..++..|..|++.|++|||+.+  |+||||||+||++..++.+||.|
T Consensus        89 ~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             cHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeecc
Confidence                 3579999999 6699888763    5788899999999999999999988  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-h------
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-W------  301 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~------  301 (455)
                      ||+|+.....   -..+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+......-..+. .      
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            9999865443   23455788999999999999889999999999999999999999998654322111111 0      


Q ss_pred             --hhhhhHhhhhh------------cc-cCCCcccC--CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          302 --ARPMLNDARKL------------GR-IMDPRLEG--QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       302 --~~~~~~~~~~~------------~~-~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        ...+..-....            .+ +.|..+..  +.+...+..+.+++.+||..+|++|.+++++|+|.
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence              00000000000            00 11111111  11223355788999999999999999999999993

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=278.47  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=207.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.....+|+|++|.||++      +++.+++..|+|+++.+......-+.+|+.+++..+|||||.++|.+...+.+
T Consensus        14 ~ddyellqrvgsgTygdvyKa------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKA------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             ccchhheeeecCCcccchhhh------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            467999999999999999999      56678999999999988777777788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      |++||||.||+|++.-+  ....+++.++.......+.||+|||+.+  =+|||||-.|||+++.|.+||+|||.+..+.
T Consensus        88 wicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhh
Confidence            99999999999998543  2467888899999999999999999976  7999999999999999999999999987654


Q ss_pred             CCCCccceeccccCCCCcCcccc---ccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYV---MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..-.  ....+.||+.|||||+.   ..+.|...+|||++|++..||---++|.....+.+...+..            .
T Consensus       164 ati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------------k  229 (829)
T KOG0576|consen  164 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------------K  229 (829)
T ss_pred             hhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------------c
Confidence            3221  13347899999999987   45779999999999999999988888865444433222211            0


Q ss_pred             ccCC-CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          314 RIMD-PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       314 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ...+ +.+.  -......-+.+|++.||..+|++||+++.++.|
T Consensus       230 S~~qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  230 SGFQPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             cCCCCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            0111 1111  122345678899999999999999999988875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.4e-30  Score=233.54  Aligned_cols=212  Identities=36%  Similarity=0.547  Sum_probs=181.8

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecC
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMP  164 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  164 (455)
                      ||+|++|.||++....      .++.+++|++...... ....+.+|+..++.+.|++|+++++++......+++|||+.
T Consensus         1 l~~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKK------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecC------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            6999999999996543      4678999998755432 34668899999999999999999999999899999999999


Q ss_pred             CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCccCCCCCCCccc
Q 012832          165 RGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGDDTHV  243 (455)
Q Consensus       165 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~~~~~~~~~~~  243 (455)
                      +++|.+++.... ..++...+..++.+++.+|++||+.+  ++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            899999886542 46889999999999999999999976  999999999999999 89999999999986644321  1


Q ss_pred             eeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccC
Q 012832          244 STRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG  322 (455)
Q Consensus       244 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (455)
                      .....+...|++||.+... .++.+.|+|++|+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2225588899999999877 888999999999999998                                          


Q ss_pred             CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                             ..+.+++..|+..+|++||++.+++++|
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   2367899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.2e-31  Score=233.68  Aligned_cols=261  Identities=19%  Similarity=0.278  Sum_probs=195.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEE-  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~-  154 (455)
                      .++|++.+.+|+|-++.||.|..      ..+.+.++||+++.-   ....+.+|+.+|..|. ||||++++++..++. 
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~------~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGIN------ITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccc------cCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            46899999999999999999942      345678999998743   3456789999999998 999999999987764 


Q ss_pred             -eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCc
Q 012832          155 -HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLA  232 (455)
Q Consensus       155 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla  232 (455)
                       ...||+||+.+.+...+.     ..+..-.+..++.+++.||.|+|+.|  |+|||+||.|+|||. ...++|+|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             cCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchH
Confidence             467999999887766432     35777788899999999999999977  999999999999986 467999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh-----hh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP-----ML  306 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~-----~~  306 (455)
                      .++-++....   -.+.+..|--||++.. ..|+..-|+|||||++..|+..+.||-.... ....++..+..     +.
T Consensus       181 EFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHH
Confidence            9876654332   2456778899999865 4588899999999999999999999754322 22233332221     11


Q ss_pred             HhhhhhcccCCCcccC---------------CCC-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDPRLEG---------------QYS-ETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~---------------~~~-~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ....+..-.+++.+..               .-. .-...++.+|+.++|..|-.+|||+.|.+.|.
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            1111111112222111               001 11247899999999999999999999999883

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-30  Score=235.70  Aligned_cols=280  Identities=18%  Similarity=0.233  Sum_probs=221.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  155 (455)
                      .-.|.+++.||+|+||.++.|      ..-.++++||||.-....  ....+..|....+.|. .++|+.+|.+..+..+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G------~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLG------KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             cccceeccccccCcceeeecc------cccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            457999999999999999999      445678999999764332  2345667888888776 7999999999988889


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-----CceEEccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-----YTAKLSDFG  230 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-----~~~kL~DfG  230 (455)
                      ..||||++ |-+|+|+ +.-.+..|+..++..+|.|++.-++|+|+..  +|+|||||+|+||...     ..+.|+|||
T Consensus        99 NiLVidLL-GPSLEDL-FD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDL-FDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhhhhhhh-CcCHHHH-HHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEecc
Confidence            99999999 8899985 5556789999999999999999999999966  9999999999999543     468999999


Q ss_pred             CccCCCCCCCccc-----eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          231 LAKDGPEGDDTHV-----STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       231 la~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|+.+........     .....||.+||+...+.|.+.+++.|+.|||-+++++|.|..||.+..........      
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY------  248 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY------  248 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH------
Confidence            9998765543211     22367999999999999999999999999999999999999999886443221111      


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCCCcccccceeeeecC
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPT  378 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~~~  378 (455)
                          .++.+.....-...+....|.++...+...-.++..+-|.++-+.+.+..+.+.......+.++|....
T Consensus       249 ----eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  249 ----EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             ----HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence                112222222222234556788999999999999999999999999988888777777777777776543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=259.46  Aligned_cols=196  Identities=23%  Similarity=0.337  Sum_probs=166.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHH---------HHHHHHHHhcCC---CCCccc
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---------WLTEVIFLGQLR---HPHLVK  145 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~nIv~  145 (455)
                      .+|...+.||+|+||.|++|.+..      ....|+||.+..+..- ...         .-.|+.||..|+   |+||++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~------n~~eVViK~I~KeRIL-~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK  633 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKE------NNYEVVIKMIFKERIL-VDTWVRDRKLGTVPSEIQILATLNKHSHENILK  633 (772)
T ss_pred             ccceeeeeccccccceEEEeeecc------cceEEEeeehhhhhhh-hhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence            368999999999999999996543      4678999988654321 111         235999999998   999999


Q ss_pred             EEEEEEeCCeEEEEEEec-CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          146 LIGYCCEEEHRLLVYEYM-PRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      ++++|++++++||+||-. +|.+|.++|..+  ..+.+.++..|+.|++.|+++||+.+  |||||||-+||.++.+|-+
T Consensus       634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             hhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeE
Confidence            999999999999999976 455999999765  67899999999999999999999987  9999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCC
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVD  288 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~  288 (455)
                      ||+|||.|.....+.    ...+.||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus       710 klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999987544332    234789999999999998887 556799999999999999888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.8e-29  Score=231.86  Aligned_cols=200  Identities=34%  Similarity=0.429  Sum_probs=171.6

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  158 (455)
                      |.+.+.||.|+||.||+|...+      +++.+|+|.+...... ....+.+|+..++.++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            5677889999999999996543      4678999998765544 56778899999999999999999999999899999


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  238 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~  238 (455)
                      ++||+++++|.+++..... .+++..+..++.+++.+|.+||+.+  ++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999999998876421 2788999999999999999999976  999999999999999999999999999876543


Q ss_pred             CCccceeccccCCCCcCcccc-ccCCCCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                      ... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||+.
T Consensus       152 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            211 12335688899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7e-29  Score=242.92  Aligned_cols=264  Identities=23%  Similarity=0.213  Sum_probs=200.8

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC----CCCcccEEEEE-EeC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR----HPHLVKLIGYC-CEE  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----h~nIv~~~~~~-~~~  153 (455)
                      +|.+.+.||+|+||.||+|......     ...+|+|............+..|+.++..+.    .++++.+++.. ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999654421     4578999876543332225677888888886    26899999999 577


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-----CceEEcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-----YTAKLSD  228 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-----~~~kL~D  228 (455)
                      ...||||+.+ |.+|.++........++..+++.++.|++.+|++||+.|  +|||||||+|+++...     ..++|.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence            8899999999 889999776655678999999999999999999999977  9999999999999764     4699999


Q ss_pred             CCCcc--CCCCCCCc---cc---eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          229 FGLAK--DGPEGDDT---HV---STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       229 fGla~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      ||+++  ........   ..   .....||..|+++.++.+...+++.|+||+++++.+|+.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99999  43222211   01   123559999999999999999999999999999999999999997654322211111


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      -.      .       .......+....+.++..++..+-..+..++|.+..+...|......
T Consensus       251 ~~------~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  251 KD------P-------RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HH------h-------hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            00      0       00000002333456778888888889999999999999987665443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=3.2e-29  Score=238.24  Aligned_cols=272  Identities=24%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCC  151 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  151 (455)
                      +....+.|..++.||+|+|+.||+|++...   ......||+|.+.....  ...+.+|+++|..+. +.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            344567899999999999999999976541   34578899998865433  345789999999997 899999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFG  230 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfG  230 (455)
                      .++..++||||++.....++..     .++...+..+++.++.||+++|..|  ||||||||+|+|.+. .+.-.|+|||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEech
Confidence            9999999999999888877653     4667889999999999999999977  999999999999975 4678999999


Q ss_pred             CccCCC-----------------C-CC----------------Ccc--------ceeccccCCCCcCccccccC-CCCcc
Q 012832          231 LAKDGP-----------------E-GD----------------DTH--------VSTRVMGTQGYAAPEYVMTG-HLTSM  267 (455)
Q Consensus       231 la~~~~-----------------~-~~----------------~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~  267 (455)
                      +|....                 . .+                ...        ......||++|.|||++... ..+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997210                 0 00                000        00125699999999999764 47889


Q ss_pred             CchhhHHHHHHHHHhCCCCCCCCCccc--hhhHHHhhh--hhhHhh---------------------hhhccc-CCCc--
Q 012832          268 SDVYSFGVVLLELLSGRKSVDKSRPQR--EQSLVEWAR--PMLNDA---------------------RKLGRI-MDPR--  319 (455)
Q Consensus       268 ~DvwslG~il~ell~G~~p~~~~~~~~--~~~~~~~~~--~~~~~~---------------------~~~~~~-~~~~--  319 (455)
                      +||||.|+|++-+++++.||-......  ...++....  .+...+                     ...... ....  
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            999999999999999999985543211  111111000  000000                     000001 0000  


Q ss_pred             ------ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          320 ------LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       320 ------~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                            ......+..+..+.+|+.+||+.||.+|.|+++.|+|
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                  1112233345588999999999999999999999998

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7e-30  Score=225.85  Aligned_cols=266  Identities=20%  Similarity=0.208  Sum_probs=208.1

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC-CCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH-PHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~  153 (455)
                      +....|.+++.||.|+||.+|.|..      ...|..||||+-...  .....+.-|..+.+.|++ .+|+.+..+..+.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~------i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGIS------ITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeee------ccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            3457899999999999999999953      446889999986533  334557789999999984 7899999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEccCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFG  230 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~DfG  230 (455)
                      .+..|||+++ |-+|++++ .-....++..+++-++-|++.-++|+|..+  +|||||||+|.|..-   ...+.|+|||
T Consensus        84 ~ynvlVMdLL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ccceeeeecc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEecc
Confidence            9999999999 88999855 444678999999999999999999999966  999999999999954   3579999999


Q ss_pred             CccCCCCCCCc-c----ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          231 LAKDGPEGDDT-H----VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       231 la~~~~~~~~~-~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|+.+...... +    ......||.+|.+-.++.+...+++.|+-|+|++|.++..|..||.+..+.......+     
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE-----  234 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE-----  234 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-----
Confidence            99876543221 1    1233679999999999999999999999999999999999999998865432222111     


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                           .+.+..-...........|.++...+..|-..-.++-|++.-+.+.+.-+..
T Consensus       235 -----kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  235 -----KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             -----HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence                 1111111112233455667889999999999999999999888887655543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=227.45  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=186.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEE-EEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGY-CCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~-~~~~~  154 (455)
                      .+.|.+.+.||+|.||.+-++      +++.+.+.+|+|-+.... ....+|.+|+..--.|. |.||+.-|+. |...+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~------eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLA------EHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhHHHHhcccceeeEEee------eccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            367999999999999999999      556678899999886443 44678999998777775 8999988775 56677


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc--CCCceEEccCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAKLSDFGLA  232 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~--~~~~~kL~DfGla  232 (455)
                      .++++|||++.|+|..-+..   ..+-+.....++.|++.||.|+|+.+  +||||||.+||||-  +..++||||||+.
T Consensus        96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccc
Confidence            88899999999999876644   46777788899999999999999954  99999999999993  3458999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccC-----CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      +.....-     ....-+..|.+||.....     ...+.+|||.||+++|..++|.+||... .........|..-.  
T Consensus       171 ~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~--  242 (378)
T KOG1345|consen  171 RKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWL--  242 (378)
T ss_pred             cccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHh--
Confidence            7643221     113356789999987532     2467789999999999999999999843 23333444433211  


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV  354 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell  354 (455)
                            .-..+.++..| ...+..+..+.++-|..+|++|--..+..
T Consensus       243 ------~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  243 ------KRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             ------cccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence                  11122222222 12345677889999999999994444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=6.3e-29  Score=271.17  Aligned_cols=199  Identities=20%  Similarity=0.246  Sum_probs=142.2

Q ss_pred             cCCC-CCcccEEEEE-------EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEE
Q 012832          137 QLRH-PHLVKLIGYC-------CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIY  208 (455)
Q Consensus       137 ~l~h-~nIv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiH  208 (455)
                      .+.| +||++++++|       ......+++|||+ +++|.++|... ...+++.+++.++.||+.||+|||+.+  |||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG--IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence            4455 5778888876       2334677889988 67999998643 356899999999999999999999966  999


Q ss_pred             eccCCCCEEEcC-------------------CCceEEccCCCccCCCCCCC--------------ccceeccccCCCCcC
Q 012832          209 RDFKASNILLDS-------------------DYTAKLSDFGLAKDGPEGDD--------------THVSTRVMGTQGYAA  255 (455)
Q Consensus       209 rDlkp~Nill~~-------------------~~~~kL~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~a  255 (455)
                      |||||+||||+.                   ++.+||+|||+++.......              .......+||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   44566667776653211000              000112468999999


Q ss_pred             ccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHH
Q 012832          256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAAL  335 (455)
Q Consensus       256 PE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (455)
                      ||++.+..|+.++|||||||+||||++|.+|+.....    ......          ...+.+..    . ........+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~----------~~~~~~~~----~-~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLR----------HRVLPPQI----L-LNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHH----------HhhcChhh----h-hcCHHHHHH
Confidence            9999999999999999999999999999888653210    000000          00111111    1 112345688


Q ss_pred             HHHHhccCCCCCCCHHHHHHhcc
Q 012832          336 AYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       336 i~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      +.+||..+|.+||++.++++|.+
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhchh
Confidence            99999999999999999999854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=219.87  Aligned_cols=288  Identities=24%  Similarity=0.355  Sum_probs=221.4

Q ss_pred             hhccccccccccccCCCCCCCCccccccccccCCCCcccchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCccc
Q 012832           30 VKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQA  109 (455)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~  109 (455)
                      -+...+..+++|.+.++..+.+.+.+...+.    +.-+.+..+.       +...|.+...|..|+|        ++++
T Consensus       153 ek~gq~~nripfkdt~wkgtktr~rdatlsr----~~gid~~~ln-------l~tkl~e~hsgelwrg--------rwqg  213 (448)
T KOG0195|consen  153 EKHGQSPNRIPFKDTTWKGTKTRTRDATLSR----YTGIDVSSLN-------LITKLAESHSGELWRG--------RWQG  213 (448)
T ss_pred             HHhCCCCCccccccccccccccccccccccc----ccCcchhhhh-------hhhhhccCCCcccccc--------cccC
Confidence            4556677899999988877666555543331    1112233333       3445889999999988        4566


Q ss_pred             ccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHH
Q 012832          110 QPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK  187 (455)
Q Consensus       110 ~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~  187 (455)
                      ..+++|++......  ..++|..|.-.|+-+.||||++++|.|..+.++.++..||+.|+|+..|....+...+..++++
T Consensus       214 ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~  293 (448)
T KOG0195|consen  214 NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVR  293 (448)
T ss_pred             cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHH
Confidence            78889988765433  2367889999999999999999999999999999999999999999999988777888899999


Q ss_pred             HHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc--cCCCccCCCCCCCccceeccccCCCCcCccccccCC--
Q 012832          188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS--DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH--  263 (455)
Q Consensus       188 i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--  263 (455)
                      ++.++++|++|||+.++-|.---|....++||++.+++|+  |--++.+.         ....-.|.||+||.+...+  
T Consensus       294 faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe---------~gr~y~pawmspealqrkped  364 (448)
T KOG0195|consen  294 FALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---------VGRAYSPAWMSPEALQRKPED  364 (448)
T ss_pred             HHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---------cccccCcccCCHHHHhcCchh
Confidence            9999999999999987644455799999999999887764  32222211         1134578899999997654  


Q ss_pred             -CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhcc
Q 012832          264 -LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSH  342 (455)
Q Consensus       264 -~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  342 (455)
                       .-..+|+|||++++|||.|...||....+......+                --..+...+++..+..+..|+.-|+..
T Consensus       365 ~n~raadmwsfaillwel~trevpfadlspmecgmki----------------aleglrv~ippgis~hm~klm~icmne  428 (448)
T KOG0195|consen  365 LNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------------ALEGLRVHIPPGISRHMNKLMNICMNE  428 (448)
T ss_pred             cchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------------hhccccccCCCCccHHHHHHHHHHhcC
Confidence             345789999999999999999999876554322211                122344566778888999999999999


Q ss_pred             CCCCCCCHHHHHHhccccc
Q 012832          343 RPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       343 ~P~~RPt~~ell~~L~~~~  361 (455)
                      ||.+||.+..++-.|+.+.
T Consensus       429 dpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  429 DPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCcCCCcceehhhHHHhc
Confidence            9999999999999988764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=9.8e-27  Score=207.50  Aligned_cols=167  Identities=26%  Similarity=0.255  Sum_probs=126.5

Q ss_pred             CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCcccee
Q 012832          166 GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST  245 (455)
Q Consensus       166 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~  245 (455)
                      |+|.+++..+ ...+++..++.++.|++.||+|||+.+        ||+|||++.++.+++  ||++.......      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899988754 457999999999999999999999854        999999999999999  99987654321      


Q ss_pred             ccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCC
Q 012832          246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS  325 (455)
Q Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (455)
                       ..||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+    ....   .. ..+. .....
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~----~~~~---~~-~~~~-~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEIL----LNGM---PA-DDPR-DRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHH----HHHh---cc-CCcc-ccccH
Confidence             258999999999999999999999999999999999999996543211 111111    1100   00 0000 00112


Q ss_pred             HHHHH--HHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          326 ETGAR--KAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       326 ~~~~~--~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .....  ++.+++.+||..+|.+||++.++++++..+
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            23333  689999999999999999999999997654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8.6e-26  Score=221.30  Aligned_cols=170  Identities=19%  Similarity=0.120  Sum_probs=129.5

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-----chhhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-----GLQGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      ....++|.+.+.||+|+||.||+|....     ..+..||||++...     .......+.+|+.+|+.++|+||++.+.
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAG-----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcC-----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            4456789999999999999999996432     13556899986532     1123456889999999999999986332


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEecc-CCCCEEEcCCCceEEc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF-KASNILLDSDYTAKLS  227 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDl-kp~Nill~~~~~~kL~  227 (455)
                      .   ....||||||++|++|.. +.     ...   ...++.+++.+|.|||+.+  |+|||| ||+|||++.++.++|+
T Consensus        89 ~---~~~~~LVmE~~~G~~L~~-~~-----~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         89 A---TGKDGLVRGWTEGVPLHL-AR-----PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             E---cCCcEEEEEccCCCCHHH-hC-----ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEE
Confidence            2   245799999999999963 21     111   1467889999999999976  999999 9999999999999999


Q ss_pred             cCCCccCCCCCCCccc------eeccccCCCCcCccccccC
Q 012832          228 DFGLAKDGPEGDDTHV------STRVMGTQGYAAPEYVMTG  262 (455)
Q Consensus       228 DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  262 (455)
                      |||+|+.....+....      .+...+++.|+|||.+...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999986654432111      1346789999999998643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.2e-23  Score=203.75  Aligned_cols=260  Identities=32%  Similarity=0.416  Sum_probs=196.1

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh---hHHHHHHHHHHHhcCCCC-CcccEEEEEEeCCe
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ---GHREWLTEVIFLGQLRHP-HLVKLIGYCCEEEH  155 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~  155 (455)
                      |.+...||.|+||.||++...         ..+++|.+......   ....+.+|+.++..+.|+ +|+++++.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            667788999999999999543         57899988654332   367788999999999988 79999999977777


Q ss_pred             EEEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCCcc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAK  233 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGla~  233 (455)
                      .+++++|+.+++|.+++..... ..+.......++.|++.++.|+|..+  ++|||+||+||+++..+ .++++|||++.
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999966544321 26888999999999999999999977  99999999999999988 79999999998


Q ss_pred             CCCCCCCcc----ceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCcc-chhhHHHhhhhh
Q 012832          234 DGPEGDDTH----VSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ-REQSLVEWARPM  305 (455)
Q Consensus       234 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~-~~~~~~~~~~~~  305 (455)
                      .........    ......||..|+|||.+.+   ..++...|+||+|++++++++|..||...... ..........  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--  228 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL--  228 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH--
Confidence            554433221    2345789999999999987   57889999999999999999999997655421 0011111000  


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                       .....   .................+.+++..|+..+|..|.+.......
T Consensus       229 -~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 -ELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -hcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             00000   000001100012223578899999999999999999887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1e-25  Score=234.67  Aligned_cols=263  Identities=19%  Similarity=0.249  Sum_probs=189.8

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-HHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      ....++|.|++|.|+......... ....+.++++......... ...+..|+.+-..|.|+|++..+..+.+.....-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~-~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK-SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc-cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            467889999999777664332211 1111222232101111111 12256788888899999998877776666555566


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      ||||++ +|..++...  ..+....+-.++.|++.|+.|||++|  |.|||||++|++++.+|.+||+|||.+.......
T Consensus       400 mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999999 999988664  46777889999999999999999987  9999999999999999999999999998665554


Q ss_pred             Cc--cceeccccCCCCcCccccccCCCCcc-CchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          240 DT--HVSTRVMGTQGYAAPEYVMTGHLTSM-SDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       240 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      ..  ......+|+..|+|||++.+..|.+. .||||.|++++.|++|+.||......+.+.. .        .......-
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-~--------~~~~~~~~  545 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-T--------NNYSDQRN  545 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-h--------hccccccc
Confidence            43  55666899999999999999999875 7999999999999999999976544322210 0        00000000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...-........+...+.+|.+||+.+|.+|.|+++|++.-|
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            011111223445778889999999999999999999998633

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1e-23  Score=192.70  Aligned_cols=174  Identities=10%  Similarity=0.104  Sum_probs=133.3

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHH---H------HHHHHHHHhcCCCCCcc
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---E------WLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~nIv  144 (455)
                      .+..++|...++||.|+||.||++..        .+..+|||++.........   .      +.+|+..+.++.|++|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            45678999999999999999998622        2457999998644332222   2      56899999999999999


Q ss_pred             cEEEEEEeC--------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          145 KLIGYCCEE--------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       145 ~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      .+.+++...        ...+|||||++|.+|.++.      .++.    ....+++.+|..||..|  ++|||++|+||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHE
Confidence            999886543        3578999999999998763      1222    34669999999999977  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS  282 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  282 (455)
                      +++.++ ++|+|||...........              ..+.....|+.++|+|+|||++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988 999999988765322111              013344557789999999999877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.3e-22  Score=182.99  Aligned_cols=139  Identities=15%  Similarity=0.123  Sum_probs=106.3

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--h------------------------HHHHHHHHHHHh
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--G------------------------HREWLTEVIFLG  136 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~  136 (455)
                      ...||+|+||.||+|..      . +++.||||+++.....  .                        ......|+..|.
T Consensus         2 ~~~ig~G~~~~Vy~a~~------~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATT------A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEEC------C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            46799999999999953      2 5789999998643211  0                        011235999999


Q ss_pred             cCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCeEEeccCCCC
Q 012832          137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL-HDAEKPVIYRDFKASN  215 (455)
Q Consensus       137 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~iiHrDlkp~N  215 (455)
                      .+.++++.....+...  ..+|||||++|++|...+..  ...++...+..++.|++.+|.|| |+.+  |+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHH
Confidence            9988887544333222  23899999988877654332  24688899999999999999999 6866  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCC
Q 012832          216 ILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~  235 (455)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.7e-23  Score=207.44  Aligned_cols=229  Identities=28%  Similarity=0.351  Sum_probs=181.3

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEEE
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      .+|+|+||.|+++.   +......+..+|+|+++.....  .......|..++...+ ||.++++...+..+...+++++
T Consensus         1 vlg~g~~gkvfLvr---k~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVR---KAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHH---HhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            37999999999762   2223345677888887543221  1124456888899888 9999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~  241 (455)
                      |..||.|...+...  ..+.+.....+...++.+++++|..+  |+|||+|++||+++.+|.+++.|||+++....... 
T Consensus        78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99999998766543  55667777778889999999999977  99999999999999999999999999987654332 


Q ss_pred             cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc
Q 012832          242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE  321 (455)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (455)
                           .|||..|||||++.  .+...+|.||||++++||++|..||..          +...          .++.  ..
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~----------~Il~--~~  203 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMK----------RILK--AE  203 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHH----------HHhh--hc
Confidence                 28999999999998  568899999999999999999999975          0011          1111  12


Q ss_pred             CCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 012832          322 GQYSETGARKAAALAYQCLSHRPKQRPTM  350 (455)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~~P~~RPt~  350 (455)
                      -.++......+.+++.+++..+|..|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            23466777889999999999999999644

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=3.8e-22  Score=199.14  Aligned_cols=219  Identities=26%  Similarity=0.394  Sum_probs=164.1

Q ss_pred             HhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCC
Q 012832          135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS  214 (455)
Q Consensus       135 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~  214 (455)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.....+..+|+.||+|||.... ..|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccc
Confidence            46788999999999999999999999999999999988763 5678888999999999999999998552 289999999


Q ss_pred             CEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCC-------CCccCchhhHHHHHHHHHhCCCCC
Q 012832          215 NILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-------LTSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       215 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell~G~~p~  287 (455)
                      |++++..+.+||+|||+.................-..-|.|||.+.+..       .+.++||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987664211111111122345699999997631       467799999999999999999999


Q ss_pred             CCCCccch-hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          288 DKSRPQRE-QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       288 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      +....... ..++.....      .....+.|.+...  ...+.++..++.+||..+|.+||++.++-..+..+...
T Consensus       159 ~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            76432221 222222111      0111122222211  13445789999999999999999999999988776553

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.6e-21  Score=174.60  Aligned_cols=187  Identities=18%  Similarity=0.137  Sum_probs=138.3

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh----hHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCe
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ----GHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEH  155 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  155 (455)
                      .+...|++|+||+||.+.        ..+.+++.+.+.....-    ....+.+|+++|++|. |++|++++++    ..
T Consensus         5 ~~~~~l~~~~f~~v~~~~--------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR--------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEee--------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            456789999999999762        13567887776543321    1124678999999996 5889999886    34


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEecc-CCCCEEEcCCCceEEccCCCccC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF-KASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDl-kp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .+++|||+.|.+|...+..         ....++.|++.+|.++|++|  |+|||| ||+|||++.++.++|+|||+|..
T Consensus        73 ~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            6999999999988754311         12357789999999999977  999999 79999999999999999999986


Q ss_pred             CCCCCCc----c------c-eeccccCCCCcCccccccC-CCC-ccCchhhHHHHHHHHHhCCCCCCCC
Q 012832          235 GPEGDDT----H------V-STRVMGTQGYAAPEYVMTG-HLT-SMSDVYSFGVVLLELLSGRKSVDKS  290 (455)
Q Consensus       235 ~~~~~~~----~------~-~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~ell~G~~p~~~~  290 (455)
                      .......    .      . .-....++.|++|+...-. ..+ ...++++.|+-+|.++||..++-..
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            5443310    0      0 0113368888888865432 233 5679999999999999999886443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.1e-21  Score=175.44  Aligned_cols=140  Identities=16%  Similarity=0.102  Sum_probs=108.2

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh---------------------h-----HHHHHHHHHHHh
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ---------------------G-----HREWLTEVIFLG  136 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~  136 (455)
                      ...||+|+||.||+|...       +|+.||||++......                     .     ...+..|+..+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            568999999999999532       5789999998654210                     0     112357899999


Q ss_pred             cCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCC
Q 012832          137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASN  215 (455)
Q Consensus       137 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~N  215 (455)
                      .+.|++|.....+....  .+|||||++|+++...+...  ..++......++.|++.+|.+||. .+  |+||||||+|
T Consensus        75 ~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~N  148 (190)
T cd05145          75 RLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYN  148 (190)
T ss_pred             HHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhh
Confidence            99999885544443332  48999999887654332222  457778899999999999999998 77  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCCC
Q 012832          216 ILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~~  236 (455)
                      ||++ ++.++|+|||++....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CCCEEEEEcccceecC
Confidence            9998 7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-22  Score=210.76  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=176.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHH---HHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREW---LTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++...+.||++.|=+|.+|....       | .|+||++-... ....+.+   +.|+. ...+++||++++.-+...+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            57778899999999999985433       3 38999874332 2222333   34444 56678999999988877777


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|||-+|+ .-+|+|.|..+  .-+..-+...|+.|++.||.-+|..|  |+|+|||.+||||+.-+-+.|+||...+.
T Consensus        95 AAylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCC
Confidence            889999999 55999988665  45667788899999999999999977  99999999999999988999999998763


Q ss_pred             C--CCCCCcc---ceeccccCCCCcCccccccC----------C-CCccCchhhHHHHHHHHHh-CCCCCCCCCccchhh
Q 012832          235 G--PEGDDTH---VSTRVMGTQGYAAPEYVMTG----------H-LTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQS  297 (455)
Q Consensus       235 ~--~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~  297 (455)
                      .  ++++...   ...+-..-.+|.|||.+...          . .+++.||||+||+++||++ |++||+..      .
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------Q  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------Q  243 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------H
Confidence            2  2222211   11111223469999988542          1 5788999999999999998 78888632      2


Q ss_pred             HHHhhhhhhHhh-hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          298 LVEWARPMLNDA-RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       298 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      +..+....-.+. ..+..+-|            ..++.|+..|++.||++|.++++.|+.
T Consensus       244 L~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222221100000 11111111            257889999999999999999999986

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=3.2e-21  Score=181.51  Aligned_cols=233  Identities=19%  Similarity=0.253  Sum_probs=147.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCC----------CCccc
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRH----------PHLVK  145 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~nIv~  145 (455)
                      .+.....||.|+|+.||.+++      ..+++.+|+|++....   ....+.+.+|.-....+.+          -.++-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTD------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEE------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            345678899999999999954      4578999999875433   2334555555544444322          12332


Q ss_pred             EEEEEE---------eC---C-----eEEEEEEecCCCChHHHHh---hcCCC--CCCHHHHHHHHHHHHHHHHHhhhCC
Q 012832          146 LIGYCC---------EE---E-----HRLLVYEYMPRGSLENQLF---RRYSV--SLPWSTRMKIALGAAKGLAFLHDAE  203 (455)
Q Consensus       146 ~~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~  203 (455)
                      .++...         ..   .     +.+++|+-+ -++|.+++.   .....  .+....++.+..|+++.+++||..|
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            223221         11   1     346788888 568887654   22221  2334455667799999999999977


Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC--------CCCccCchhhHHH
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG--------HLTSMSDVYSFGV  275 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~  275 (455)
                        +||+||+|+|++++.+|.++|+||+.........    .. ...+..|.+||.....        .++.+.|.|+||+
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence              9999999999999999999999999887643311    11 3456779999977432        4688899999999


Q ss_pred             HHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCC
Q 012832          276 VLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR  347 (455)
Q Consensus       276 il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R  347 (455)
                      ++|.|+||..||+...+......                    . -..+. ..|..+..||..+|+.+|.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~--------------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW--------------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG--------------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc--------------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999986543211110                    1 11223 678889999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.5e-21  Score=182.91  Aligned_cols=197  Identities=20%  Similarity=0.262  Sum_probs=142.8

Q ss_pred             CCCCcccEEEEEEe---------------------------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHH
Q 012832          139 RHPHLVKLIGYCCE---------------------------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG  191 (455)
Q Consensus       139 ~h~nIv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~  191 (455)
                      +|||||++.++|.+                           ...+|+||... ..+|..++..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999987753                           23579999988 56999988765   4555677778999


Q ss_pred             HHHHHHHhhhCCCCeEEeccCCCCEEEc--CC--CceEEccCCCccCCCCCCC----ccceeccccCCCCcCccccccCC
Q 012832          192 AAKGLAFLHDAEKPVIYRDFKASNILLD--SD--YTAKLSDFGLAKDGPEGDD----THVSTRVMGTQGYAAPEYVMTGH  263 (455)
Q Consensus       192 i~~~L~~LH~~~~~iiHrDlkp~Nill~--~~--~~~kL~DfGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~  263 (455)
                      +++|+.|||.+|  |.|||+|.+||||.  ++  ..+.|+|||.+--....+-    .......-|...-||||+....+
T Consensus       350 lLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999988  99999999999993  33  4689999998753222111    11112245888899999886432


Q ss_pred             ------CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHH
Q 012832          264 ------LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY  337 (455)
Q Consensus       264 ------~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (455)
                            .-.++|.|+.|.+.||+++...||....... .+.           ...    ...-....+..++..+++|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~-----------r~Y----qe~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT-----------RTY----QESQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech-----------hhh----hhhhCCCCcccCChHHHHHHH
Confidence                  2358999999999999999999997632211 111           111    111122446677788999999


Q ss_pred             HHhccCCCCCCCHHHHHHhc
Q 012832          338 QCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       338 ~cl~~~P~~RPt~~ell~~L  357 (455)
                      .+|+.||++|++..-..+.|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999887655543

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.3e-20  Score=170.05  Aligned_cols=137  Identities=18%  Similarity=0.165  Sum_probs=105.5

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-----CCCCcccEEEEEEeCC-
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-----RHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~-  154 (455)
                      .-..+||+|+||.||.  ..      ..+.. +||++..........+.+|+.+++.+     .||||++++|++..+. 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HP------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CCcceecCCCceEEEE--CC------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            4467899999999995  21      22333 69988765444567789999999999     5799999999998874 


Q ss_pred             --eEE-EEEEe--cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhhCCCCeEEeccCCCCEEEcC----CCce
Q 012832          155 --HRL-LVYEY--MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL-AFLHDAEKPVIYRDFKASNILLDS----DYTA  224 (455)
Q Consensus       155 --~~~-lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~iiHrDlkp~Nill~~----~~~~  224 (455)
                        ..+ +||||  +.+|+|.+++.+.   .+++.  ..++.+++.++ +|||+++  ||||||||+|||++.    ++.+
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcE
Confidence              433 78999  5579999999552   35544  35678888777 9999977  999999999999974    3489


Q ss_pred             EEccCCCcc
Q 012832          225 KLSDFGLAK  233 (455)
Q Consensus       225 kL~DfGla~  233 (455)
                      +|+||+.+.
T Consensus       149 ~LiDg~G~~  157 (210)
T PRK10345        149 VVCDNIGES  157 (210)
T ss_pred             EEEECCCCc
Confidence            999955443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=4.7e-21  Score=200.31  Aligned_cols=211  Identities=27%  Similarity=0.378  Sum_probs=149.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ...+|..+++|..|++|.||++      +++.+.+++|+|+ ..+...     .+.  +|.....|.+|           
T Consensus        81 ~e~df~~IklisngAygavylv------rh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLV------RHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeee------eccccccchhhcc-cccchh-----hhc--cccccCCccee-----------
Confidence            3468999999999999999998      5566788999954 222111     111  33333344443           


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                                |+-...+..  .+.++...        +.+++|||+.+  |+|||+||+|++|+.-|.+|+.|||+++..
T Consensus       136 ----------gDc~tllk~--~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----------GDCATLLKN--IGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----------chhhhhccc--CCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhh
Confidence                      333332322  23444332        77899999865  999999999999999999999999998754


Q ss_pred             CCCCCcc-------------ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          236 PEGDDTH-------------VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       236 ~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      .....+.             ....++||+.|.|||++....|+..+|+|++|+|+||++-|..||.+..+......+   
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---  270 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---  270 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---
Confidence            3221111             112368999999999999999999999999999999999999999987664332221   


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP  348 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP  348 (455)
                         +.+...+        .+. .+..+.++++++.++|+.+|..|-
T Consensus       271 ---isd~i~w--------pE~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 ---ISDDIEW--------PEE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ---hhhhccc--------ccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence               1221111        111 334457899999999999999994

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.7e-21  Score=204.70  Aligned_cols=201  Identities=22%  Similarity=0.231  Sum_probs=159.4

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC---CCCcccE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR---HPHLVKL  146 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~  146 (455)
                      ..+..+..+.|.+.+.||+|+||.||.|...+       ++.||+|+-+....   -+|.--.+++.+|+   -+-|..+
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHH
Confidence            44456677889999999999999999995433       78999998654322   11222233344444   2445555


Q ss_pred             EEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-------
Q 012832          147 IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-------  219 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-------  219 (455)
                      ..++.-.+.-+||+||.+.|+|.++++  ..+.+++..++.++.|++..++.||.++  |||+||||+|+||.       
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCC
Confidence            555566677799999999999999987  4578999999999999999999999988  99999999999993       


Q ss_pred             CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCC
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR  284 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~  284 (455)
                      ..-.++|+|||.+..+............++|-.+-.+|...|..++.++|.|.|+.+++-||.|+
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            23469999999998665443333455578999999999999999999999999999999999986

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.1e-20  Score=185.46  Aligned_cols=246  Identities=23%  Similarity=0.262  Sum_probs=157.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEE-------EE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIG-------YC  150 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~-------~~  150 (455)
                      ...+.+..+.+++|.+..+.....   ......++.+..+.+.........+++-.+.... |++.+ +.+       .+
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~---~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~-~~d~~~s~~~~~  320 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNN---SSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSI-LEDLRPSLFESS  320 (516)
T ss_pred             cccccccccccccCCchhhhhccc---chhhhhccchhhhccchhhhhhhhhhhhheeccccCCccc-ccCCCCchhhhc
Confidence            344555566666666654422111   1123344445444444222223334444444443 43332 222       11


Q ss_pred             E-----eCCeEEEEEEecCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          151 C-----EEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       151 ~-----~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      .     ...++||.|++|.-.+|.+||.. ......++.....++.|++.|++|     ++.+|||+||.||+...+.++
T Consensus       321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhh
Confidence            1     12358899999999999999974 345667888999999999999999     349999999999999999999


Q ss_pred             EEccCCCccCCCCCC----CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHH
Q 012832          225 KLSDFGLAKDGPEGD----DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLV  299 (455)
Q Consensus       225 kL~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~  299 (455)
                      ||.|||+........    .....+...||.+||+||++.+..|+.++||||||++|+||+. =...++.          
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------  465 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------  465 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------
Confidence            999999987665444    1112334679999999999999999999999999999999997 2222211          


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV  353 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~el  353 (455)
                               ...+..+-+..++..+..+ ..+-..|+.+++...|.+||++-+.
T Consensus       466 ---------~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 ---------IATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ---------HHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence                     0011111111111111111 1234689999999999999954443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=7.1e-19  Score=161.59  Aligned_cols=134  Identities=19%  Similarity=0.222  Sum_probs=110.9

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      +.||+|++|.||+|..        .+..|++|+......        .....+.+|+.++..+.|++|+....++.....
T Consensus         2 ~~l~~G~~~~vy~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEee--------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            5799999999999954        356799997543221        112457789999999999999887777777788


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .++||||++|++|.+++...     .. .+..++.+++.+|.+||+.+  ++|+|++|.|||++ ++.++|+|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            89999999999999987543     11 78889999999999999976  99999999999999 78999999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=4.3e-19  Score=161.55  Aligned_cols=131  Identities=19%  Similarity=0.256  Sum_probs=105.3

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      +||+|+||.||+|.+        .+..|++|.......        ....++.+|+.++..+.|+++.....++......
T Consensus         1 ~ig~G~~~~vy~~~~--------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeec--------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            489999999999952        356799998543211        1125567899999999988776665566667778


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||||++|++|.+++....         ..++.+++.+|.+||+.+  ++|+|++|.|||++ ++.++++|||++...
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEEECCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999999998775421         078999999999999966  99999999999999 789999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=5.5e-19  Score=164.71  Aligned_cols=143  Identities=16%  Similarity=0.095  Sum_probs=108.5

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh------------------------hHHHHHHHHHH
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ------------------------GHREWLTEVIF  134 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~  134 (455)
                      -|.+.+.||+|+||.||+|.+.     ..+++.||||++......                        ....+..|+.+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~-----~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDF-----DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEec-----CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            4889999999999999999521     235789999988643210                        11234679999


Q ss_pred             HhcCCCCC--cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC-eEEecc
Q 012832          135 LGQLRHPH--LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP-VIYRDF  211 (455)
Q Consensus       135 l~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-iiHrDl  211 (455)
                      +..+.+.+  +++++++    ...++||||++|++|.......  ..+....+..++.|++.+|++||.  .+ |+||||
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Di  175 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK--EGELVHGDL  175 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCC
Confidence            99997533  4455543    2348999999988887654322  345556678899999999999998  55 999999


Q ss_pred             CCCCEEEcCCCceEEccCCCccCC
Q 012832          212 KASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       212 kp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4.1e-18  Score=155.07  Aligned_cols=144  Identities=19%  Similarity=0.125  Sum_probs=108.8

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh----------------------hHHHHHH
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ----------------------GHREWLT  130 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~  130 (455)
                      +......|.+.+.||+|+||.||+|...       +++.||||++......                      ....+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQK   82 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHH
Confidence            3333344888899999999999998532       4788999986543200                      0122567


Q ss_pred             HHHHHhcCCCC--CcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEE
Q 012832          131 EVIFLGQLRHP--HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIY  208 (455)
Q Consensus       131 E~~~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiH  208 (455)
                      |+.++..+.|+  .++..++.    ...++||||++|++|......        .....++.+++.++.++|+.+  |+|
T Consensus        83 E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g--i~H  148 (198)
T cd05144          83 EFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG--IIH  148 (198)
T ss_pred             HHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC--CCc
Confidence            88889888877  44555542    345899999999998764321        345678899999999999966  999


Q ss_pred             eccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          209 RDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       209 rDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      |||+|+||+++.++.++|+|||++.....
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=3.3e-18  Score=178.76  Aligned_cols=138  Identities=21%  Similarity=0.260  Sum_probs=110.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc-----c---chhhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL-----E---GLQGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~-----~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      ...|...+.||+|+||.||+|.+..        ..+++|+...     .   .......+.+|+.++..++|++|+..+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            3455678999999999999986543        2344443211     1   1112355788999999999999998888


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      ++......++||||++|++|.+++.          ....++.+++.+|.|||+.+  |+||||||+|||+ .++.++|+|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEe
Confidence            8777778899999999999998774          34678999999999999977  9999999999999 677999999


Q ss_pred             CCCccCC
Q 012832          229 FGLAKDG  235 (455)
Q Consensus       229 fGla~~~  235 (455)
                      ||+++..
T Consensus       471 FGla~~~  477 (535)
T PRK09605        471 FGLGKYS  477 (535)
T ss_pred             CcccccC
Confidence            9999763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.1e-18  Score=182.16  Aligned_cols=261  Identities=23%  Similarity=0.269  Sum_probs=194.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  154 (455)
                      ..|.+.+.||+|+|+.|-+....     ......+|+|.+....  .........|..+-..+. |+|++.+++.....+
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~-----~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNS-----RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhc-----CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence            45677777999999999876322     2234456777665433  222233445777777777 999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCeEEeccCCCCEEEcCCC-ceEEccCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH-DAEKPVIYRDFKASNILLDSDY-TAKLSDFGLA  232 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGla  232 (455)
                      ..+++++|..|+++.+.+........+...+-.++.|+..++.|+| ..+  +.||||||+|.+++..+ .++++|||+|
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhh
Confidence            9999999999999998774322225666778889999999999999 755  99999999999999999 9999999999


Q ss_pred             cCCCC-CCCccceecccc-CCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          233 KDGPE-GDDTHVSTRVMG-TQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       233 ~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ..+.. .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+...... .....|...    .
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~----~  247 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN----K  247 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc----c
Confidence            98777 454444555788 9999999999884 55778999999999999999999998654322 111111100    0


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                              ................+++.+++..+|..|.+.+++...-+
T Consensus       248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~  288 (601)
T KOG0590|consen  248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW  288 (601)
T ss_pred             --------cccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence                    00011123334556788999999999999999999876643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=8.4e-17  Score=138.71  Aligned_cols=135  Identities=21%  Similarity=0.141  Sum_probs=111.3

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC--CCcccEEEEEEeCCeEEEE
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH--PHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv  159 (455)
                      +.+.||+|+++.||++...        +..+++|.......  ...+..|+.++..+.|  .++++++++....+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEec--------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            4577999999999998542        25799998865433  4567889999999986  5899999988877889999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC-CCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE-KPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      |||+.|+.+..+         +......++.+++.+|++||... .+++|+|++|+|||++..+.++++|||.+...
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999988877643         44566778999999999999742 35999999999999999899999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.4e-16  Score=143.40  Aligned_cols=138  Identities=20%  Similarity=0.166  Sum_probs=96.1

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHH----------------------HHHHHHHHhcC
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHRE----------------------WLTEVIFLGQL  138 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l  138 (455)
                      .+.||+|+||.||+|...       .++.||||++......  ....                      ...|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECC-------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            567999999999999532       4678999987543211  1111                      12456666666


Q ss_pred             CCC--CcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCC
Q 012832          139 RHP--HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASN  215 (455)
Q Consensus       139 ~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~N  215 (455)
                      .+.  .+++++++    ...++||||++++.+.........  .. .....++.+++.++.++|. .+  |+||||||+|
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~N  145 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYN  145 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhh
Confidence            543  34555543    235899999998544321111100  11 5678899999999999998 77  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCCCC
Q 012832          216 ILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~~~  237 (455)
                      |+++ ++.++|+|||.+.....
T Consensus       146 ili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEE-CCcEEEEECcccccccC
Confidence            9999 88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=4.7e-16  Score=145.28  Aligned_cols=135  Identities=22%  Similarity=0.159  Sum_probs=101.2

Q ss_pred             cccc-ccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-------------hhhHHHHHHHHHHHhcCCCCCc--ccEE
Q 012832           84 NFLG-EGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-------------LQGHREWLTEVIFLGQLRHPHL--VKLI  147 (455)
Q Consensus        84 ~~LG-~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~~~  147 (455)
                      ..|| .||.|+||.+...        +..+|||.+....             ......+.+|+.++..|.|++|  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            4577 8888888887432        4578888764211             1223457789999999998875  6777


Q ss_pred             EEEEeCC----eEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          148 GYCCEEE----HRLLVYEYMPR-GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       148 ~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      ++.....    ..++||||++| .+|.+++..   ..++..    .+.+++.+|.+||+.|  |+||||||.|||++.++
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~  179 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCC
Confidence            7654332    23599999997 689887754   234433    3678999999999977  99999999999999988


Q ss_pred             ceEEccCCCccCC
Q 012832          223 TAKLSDFGLAKDG  235 (455)
Q Consensus       223 ~~kL~DfGla~~~  235 (455)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=3.9e-15  Score=149.19  Aligned_cols=254  Identities=24%  Similarity=0.292  Sum_probs=189.6

Q ss_pred             cCCCCCcccccc--cCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCC-CCCcccEEEEEE
Q 012832           77 TQSFSSSNFLGE--GGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLR-HPHLVKLIGYCC  151 (455)
Q Consensus        77 ~~~~~~~~~LG~--G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  151 (455)
                      ...|.+.+.+|.  |.+|.||.+....    ...+..+|+|.-+...  ......-++|+...+.++ |+|.++.+..+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            456778889999  9999999984422    4567889999843322  232333356777777776 999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhhCCCCeEEeccCCCCEEEcCC-CceEE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK----GLAFLHDAEKPVIYRDFKASNILLDSD-YTAKL  226 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL  226 (455)
                      ..+..++-+|+| +.+|..+.... ...++...++....+...    ||.++|...  ++|-|+||.||++..+ ..+++
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeec
Confidence            999999999999 67888766543 345788888999999888    999999966  9999999999999999 89999


Q ss_pred             ccCCCccCCCCCCCccc---eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          227 SDFGLAKDGPEGDDTHV---STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      +|||+.......+....   ..+..|...|++||+.. +.++..+|+|++|.++.+..+|..+....-.      ..|. 
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~-  336 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS-  336 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc-
Confidence            99999987766553322   22346888999999765 5688899999999999999998766532200      0011 


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                                ++-.-.+...+......++...+.++++.+|..|++.+.+..+
T Consensus       337 ----------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  337 ----------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ----------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                      0001112333444445566679999999999999999888765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=3.8e-14  Score=143.73  Aligned_cols=139  Identities=20%  Similarity=0.166  Sum_probs=95.0

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH-------------------------------------
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-------------------------------------  125 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------  125 (455)
                      .+.||.|++|.||+|.+.+       |+.||||+.........                                     
T Consensus       122 ~~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             CcceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            4679999999999997643       67899999754311100                                     


Q ss_pred             ---HHHHHHHHHHhcCC-----CCC--cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH-
Q 012832          126 ---REWLTEVIFLGQLR-----HPH--LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK-  194 (455)
Q Consensus       126 ---~~~~~E~~~l~~l~-----h~n--Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-  194 (455)
                         -++.+|+..+..+.     +++  |++++.  ......+|||||++|++|.++..... ...   ....++..++. 
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARS  268 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHH
Confidence               02334555444442     333  233332  22345799999999999988764321 122   23456666655 


Q ss_pred             HHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       195 ~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      .+..+|..|  ++|+|++|.||+++.++.++|+|||++....
T Consensus       269 ~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       269 FLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            467889866  9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1.4e-13  Score=128.04  Aligned_cols=206  Identities=23%  Similarity=0.305  Sum_probs=141.4

Q ss_pred             HHHHhcCCCCCcccEEEEEEeCC-----eEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 012832          132 VIFLGQLRHPHLVKLIGYCCEEE-----HRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEK  204 (455)
Q Consensus       132 ~~~l~~l~h~nIv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  204 (455)
                      +.-|-.+-|.|||+++.++.+..     ...++.|||..|+|..+|.+.  ....+......+|+.||+.||.|||+..+
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            44455667999999999886543     478899999999999999754  34667777788899999999999999999


Q ss_pred             CeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC--CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh
Q 012832          205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD--DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS  282 (455)
Q Consensus       205 ~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  282 (455)
                      +|+|+.+...-|++..+|-+|+.--.-....+.-.  .........|.++|.|||.=.....+..+|||+||++.++|..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999888874211110000000  0001122457889999997666667789999999999999988


Q ss_pred             CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          283 GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       283 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      |..--.......... ....       ..+...-++            .-+.++.+|++..|..||++.+++-|.
T Consensus       278 lEiq~tnseS~~~~e-e~ia-------~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVE-ENIA-------NVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             heeccCCCcceeehh-hhhh-------hheeeccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            764321111100000 0000       000000010            113577899999999999999998873

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=3.5e-13  Score=119.11  Aligned_cols=130  Identities=18%  Similarity=0.041  Sum_probs=94.5

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcc-cEEEEEEeCCeEEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV-KLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e  161 (455)
                      .+.|+.|.++.||++..        .+..|++|....... ....+..|+.++..+.+.+++ +++.+.  ....++|||
T Consensus         3 ~~~l~~G~~~~vy~~~~--------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEE--------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEE
Confidence            45689999999999853        256799998754321 123356789999888765544 555443  334589999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC---CeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK---PVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~---~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      |++|.++.+.       ..   ....++.+++.+|+.||..+.   .++|+|++|.||+++ ++.++|+|||.+..
T Consensus        72 ~i~G~~l~~~-------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          72 FIEGSELLTE-------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ecCCCccccc-------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9999887642       01   113456789999999998651   259999999999999 66899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=2.4e-13  Score=139.59  Aligned_cols=144  Identities=18%  Similarity=0.154  Sum_probs=90.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh---------------------------------
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---------------------------------  124 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------  124 (455)
                      ..|.. +.||+|++|.||+|...+      +|+.||||++...-...                                 
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKD------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECC------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            34666 789999999999997654      47899999986431100                                 


Q ss_pred             -HH------HHHHHHHHHhcCC----CCCcccEEEEEEe-CCeEEEEEEecCCCChHHHHhhcCCC----CCCHHHHHHH
Q 012832          125 -HR------EWLTEVIFLGQLR----HPHLVKLIGYCCE-EEHRLLVYEYMPRGSLENQLFRRYSV----SLPWSTRMKI  188 (455)
Q Consensus       125 -~~------~~~~E~~~l~~l~----h~nIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~l~~~~~~~i  188 (455)
                       .+      ++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.|.+.-.-....    .+....+..+
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence             01      1334444444432    3333332222221 34568999999999998742211111    1222222333


Q ss_pred             HHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----ceEEccCCCccCCCC
Q 012832          189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKLSDFGLAKDGPE  237 (455)
Q Consensus       189 ~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----~~kL~DfGla~~~~~  237 (455)
                      +.|+       ...|  ++|+|++|.||+++.++    .++++|||++.....
T Consensus       273 ~~Qi-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQV-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3333       3445  99999999999999888    999999999987644

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=4e-12  Score=110.26  Aligned_cols=132  Identities=21%  Similarity=0.256  Sum_probs=101.4

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc--------cchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL--------EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++++|+-+.+|.+.+        .+.++++|.-..        +..-...+..+|+.+|..++--+|...+=+..+...
T Consensus         2 ~~i~~GAEa~i~~~~~--------~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--------LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN   73 (204)
T ss_pred             chhhCCcceeEEeeec--------cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence            4689999999998843        344577774311        111122445689999999987777766667778888


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ..|+|||++|..|.+.+...         ...++..+-..+.-||.+|  |||+||.++||++...+ ++++||||+...
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            89999999998998888654         2456777778888999988  99999999999997764 999999999853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.37  E-value=3.1e-13  Score=142.47  Aligned_cols=253  Identities=23%  Similarity=0.257  Sum_probs=176.9

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      ++...+.|.+.+.+-+|+||.++.+      .....+...++|+......   ...+....+-.++-...+|.++...-.
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s  872 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPA------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS  872 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccC------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC
Confidence            4556788999999999999999987      3444555556665432211   112223333344434455666655544


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +......+|||+|+.+++|...+..-  ...+.+-.......+..+++|||...  ++|||++|.|+|+..++..++.||
T Consensus       873 ~~~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~  948 (1205)
T KOG0606|consen  873 FPCRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDF  948 (1205)
T ss_pred             CCCCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcc
Confidence            45567789999999999999877543  34555555667777889999999855  899999999999999999999999


Q ss_pred             CCccCCCCC----C-------------------------CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHH
Q 012832          230 GLAKDGPEG----D-------------------------DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLEL  280 (455)
Q Consensus       230 Gla~~~~~~----~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  280 (455)
                      |+.......    +                         .........||+.|.+||...+......+|+|++|++++|.
T Consensus       949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen  949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred             ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence            843321110    0                         00011225699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc-CCCCHHHHHHHHHHHHHHhccCCCCCCCHH
Q 012832          281 LSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE-GQYSETGARKAAALAYQCLSHRPKQRPTMS  351 (455)
Q Consensus       281 l~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~RPt~~  351 (455)
                      ++|.+||+...+.+..      +.          +..-... ...+...+.++.+++...+..+|.+|-.+.
T Consensus      1029 l~g~pp~na~tpq~~f------~n----------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIF------EN----------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hcCCCCCCCcchhhhh------hc----------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999876543211      11          1111111 112344567789999999999999998776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.37  E-value=6.6e-12  Score=112.58  Aligned_cols=145  Identities=11%  Similarity=0.094  Sum_probs=98.5

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----------------------hhhHHHH----HHHHHHHh
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----------------------LQGHREW----LTEVIFLG  136 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~  136 (455)
                      ...||.|--+.||.|...+.......+..+|||+.+...                      ......+    .+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            456999999999999643210011135689999853200                      0001112    37999999


Q ss_pred             cCCC--CCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCeEEeccCC
Q 012832          137 QLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL-HDAEKPVIYRDFKA  213 (455)
Q Consensus       137 ~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~iiHrDlkp  213 (455)
                      ++..  -+++.++++    ...+|||||+.++.+.......  ..++......+..+++.+|..| |..+  |||+||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            9874  466777764    4568999999664442211111  2344456677889999999998 8876  99999999


Q ss_pred             CCEEEcCCCceEEccCCCccCCC
Q 012832          214 SNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       214 ~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      .|||++ ++.++|+|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=1.3e-11  Score=125.42  Aligned_cols=165  Identities=19%  Similarity=0.204  Sum_probs=125.2

Q ss_pred             cccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHH
Q 012832          107 LQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM  186 (455)
Q Consensus       107 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~  186 (455)
                      ..+.+|.|...+...........+-+..|+.++||||++++..+..++..|||+|.+.  .|..++.+.     ....+.
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~  107 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEVC  107 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHHH
Confidence            3567888887765554334456678899999999999999999999999999999983  677777543     356677


Q ss_pred             HHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCc
Q 012832          187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTS  266 (455)
Q Consensus       187 ~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  266 (455)
                      .-+.||+.||.|||+ ..+++|++|.-+.|+|+..|..||++|.++......+..  .....--..|..|+.+....  -
T Consensus       108 ~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--c
Confidence            788999999999985 245999999999999999999999999998654432210  00011223466676554332  3


Q ss_pred             cCchhhHHHHHHHHHhC
Q 012832          267 MSDVYSFGVVLLELLSG  283 (455)
Q Consensus       267 ~~DvwslG~il~ell~G  283 (455)
                      ..|.|.|||+++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            46999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.6e-12  Score=130.55  Aligned_cols=252  Identities=19%  Similarity=0.135  Sum_probs=178.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHH--HHHHHHHHHhcCC-CCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR--EWLTEVIFLGQLR-HPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~-h~nIv~~~~~~~  151 (455)
                      ....+|..+..||.|.|+.|+....+.     ..+..|++|.+...-.....  .-+.|+.+...+. |.+++.++..+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~-----~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRP-----EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecC-----CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence            344678999999999999999875332     24667888876533222222  2346777777775 889999888888


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-CceEEccCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFG  230 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL~DfG  230 (455)
                      .....|+=-|||+++++...+  .....+.....+.+..|++.++.++|+..  ++|+|+||+||++..+ +..++.|||
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccc
Confidence            888888999999999887655  33356778889999999999999999855  9999999999999876 788999999


Q ss_pred             CccCCCCCCCccceeccccCCCCc--CccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYA--APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      +.........    . ..+.-+++  ++.+.....+..+.|++|||..+.+.++|...-....        .|.      
T Consensus       413 ~~t~~~~~~~----~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~------  473 (524)
T KOG0601|consen  413 CWTRLAFSSG----V-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL------  473 (524)
T ss_pred             cccccceecc----c-ccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce------
Confidence            9864322111    1 22333444  5555556678999999999999999999865322110        010      


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                           .+...... -.+ .....+..+...++..++..||.+.++..+.+...
T Consensus       474 -----~i~~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  474 -----TIRSGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -----eeeccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                 11111111 111 22267788899999999999999999887765543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=3e-11  Score=104.35  Aligned_cols=144  Identities=19%  Similarity=0.203  Sum_probs=108.4

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc--------cchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL--------EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ...+|-+|+-+.|+++.        ..|+.++||.-..        +..-...+..+|+..|.++.--+|.-..-++.+.
T Consensus        11 ~l~likQGAEArv~~~~--------~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--------FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeec--------cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            56789999999999884        4567777875311        1112235567899999998866776555566777


Q ss_pred             CeEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC---ceEEccC
Q 012832          154 EHRLLVYEYMPR-GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY---TAKLSDF  229 (455)
Q Consensus       154 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~---~~kL~Df  229 (455)
                      ..-.|+|||++| -++.+++...............++..|-..+.-||.++  |||+||..+||+|..++   .+.|+||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEee
Confidence            778999999966 38888887765444444444788999999999999977  99999999999996543   4589999


Q ss_pred             CCccCC
Q 012832          230 GLAKDG  235 (455)
Q Consensus       230 Gla~~~  235 (455)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=7.3e-11  Score=108.83  Aligned_cols=142  Identities=20%  Similarity=0.238  Sum_probs=105.6

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCC--CcccEEEEEEeCC---eEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHP--HLVKLIGYCCEEE---HRL  157 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~---~~~  157 (455)
                      +.||.|.++.||++...+       +..+++|....... .....+..|+.++..+.+.  ++++++.+.....   ..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            568999999999985422       46899998754322 1345678899999999763  4677887765532   568


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-----------------------------------  202 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------  202 (455)
                      +||||++|.+|.+.+..   ..++......++.+++.+|..||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999888764421   2456667777788888888888742                                   


Q ss_pred             -------------------CCCeEEeccCCCCEEEcC--CCceEEccCCCccCC
Q 012832          203 -------------------EKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDG  235 (455)
Q Consensus       203 -------------------~~~iiHrDlkp~Nill~~--~~~~kL~DfGla~~~  235 (455)
                                         ...++|+|+.|.|||++.  ++.+.|+||+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                               124799999999999998  667899999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.18  E-value=7.1e-10  Score=109.58  Aligned_cols=214  Identities=16%  Similarity=0.186  Sum_probs=152.5

Q ss_pred             eeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE----eCCeEEEEEEecCC-C
Q 012832           92 GAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC----EEEHRLLVYEYMPR-G  166 (455)
Q Consensus        92 G~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~~lv~e~~~~-g  166 (455)
                      .+.|+++.      ..+|..|++|+++.+..+.......-+++++++.|+|||++.+++.    .+..+++|++|.++ +
T Consensus       290 ~Ttyk~~s------~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  290 ITTYKATS------NVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ceeEeeee------ccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            56788753      3467889999995544443333445688999999999999988775    45678999999975 4


Q ss_pred             ChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          167 SLENQLFRRY-------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       167 ~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +|.++.+...             +...++..+|.++.|+..||.++|+.|  +.-+-|.|.+||++++.+++|+..|...
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEeccccee
Confidence            8887665432             234678899999999999999999988  8889999999999999999999888876


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....+..                +-+.+   -.+-|.=.||.+++.|.||..--......  +..            .  
T Consensus       442 vl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s------------~--  486 (655)
T KOG3741|consen  442 VLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST--QSS------------H--  486 (655)
T ss_pred             eecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch--HHH------------H--
Confidence            5544321                11111   23679999999999999986431111000  000            0  


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                             ...+....+.++++++......++++ -++.+++.+
T Consensus       487 -------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 -------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             -------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                   01123345677888888888888887 677777765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.12  E-value=2.9e-09  Score=102.82  Aligned_cols=267  Identities=16%  Similarity=0.186  Sum_probs=162.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEE------EE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGY------CC  151 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~------~~  151 (455)
                      -...++.||+|+-+.+|-.        . .....+.|+..........+   .+..|... .||-+..-+.+      .-
T Consensus        12 ~i~~gr~LgqGgea~ly~l--------~-e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~   79 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTL--------G-EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG   79 (637)
T ss_pred             ccCCCccccCCccceeeec--------c-hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC
Confidence            3456778999999999953        1 11223456654443332222   23333333 46644331211      11


Q ss_pred             -eCCeEEEEEEecCCCChHHHHhh-----cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          152 -EEEHRLLVYEYMPRGSLENQLFR-----RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       152 -~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                       ......++|..+.|..--..+.+     +.-....|...+..+..++.+.+.||.+|  .+-+|+.++|+||.+++.+.
T Consensus        80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~  157 (637)
T COG4248          80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVV  157 (637)
T ss_pred             CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEE
Confidence             12236788998876522212211     12245679999999999999999999988  88899999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhC-CCCCCCCCccchh-h-
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSG-RKSVDKSRPQREQ-S-  297 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G-~~p~~~~~~~~~~-~-  297 (455)
                      |+|-........ +  ......+|...|.+||.-.     +..-+...|.|.||+++++|+.| +.||.+....... . 
T Consensus       158 LVdsDsfqi~~n-g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p  234 (637)
T COG4248         158 LVDSDSFQINAN-G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP  234 (637)
T ss_pred             EEcccceeeccC-C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence            998765543322 1  1222357999999999764     23446678999999999999986 9999764211000 0 


Q ss_pred             -HHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhcc--CCCCCCCHHHHHHhcccccC
Q 012832          298 -LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSH--RPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       298 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--~P~~RPt~~ell~~L~~~~~  362 (455)
                       ....+...+....+-..-..+.-........+..+..|..+|+..  ++.-|||++.++..|..+.+
T Consensus       235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence             000110111111111111111111112234467788899999974  46789999999988776654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=2.8e-09  Score=100.85  Aligned_cols=124  Identities=15%  Similarity=0.036  Sum_probs=90.3

Q ss_pred             cccEEEEeccccchh-----------hHHHHHHHHHHHhcCCCCCc--ccEEEEEEe-----CCeEEEEEEecCCC-ChH
Q 012832          109 AQPVAVKNLDLEGLQ-----------GHREWLTEVIFLGQLRHPHL--VKLIGYCCE-----EEHRLLVYEYMPRG-SLE  169 (455)
Q Consensus       109 ~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~-----~~~~~lv~e~~~~g-~L~  169 (455)
                      |+.|.||........           ....+.+|+..+..|...+|  +.++++...     ....+||||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            457889965322211           01136789998888864444  345555543     23578999999876 798


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-------CCceEEccCCCccC
Q 012832          170 NQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-------DYTAKLSDFGLAKD  234 (455)
Q Consensus       170 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-------~~~~kL~DfGla~~  234 (455)
                      +++........+......++.+++..+.-||.+|  |+|+|++++|||++.       ++.+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            8875432344556677889999999999999977  999999999999975       46899999998864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=2.4e-09  Score=95.67  Aligned_cols=99  Identities=23%  Similarity=0.223  Sum_probs=65.7

Q ss_pred             HHHHHHHHHhcCCCC--CcccEEEEEEeCCeEEEEEEecC--CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhh
Q 012832          127 EWLTEVIFLGQLRHP--HLVKLIGYCCEEEHRLLVYEYMP--RGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF-LHD  201 (455)
Q Consensus       127 ~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~  201 (455)
                      ...+|+..|..+..-  ++++++++.    ..+|||||++  |..+..+....    +.......++.+++..+.. +|.
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh
Confidence            356799999999866  566776543    3479999998  55555433221    1234556677788875555 578


Q ss_pred             CCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       202 ~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      .|  |||+||.+.|||++++ .+.|+|||.+....
T Consensus       126 ~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  126 AG--IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TT--EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             cC--ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            66  9999999999999887 99999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=8.3e-08  Score=87.70  Aligned_cols=106  Identities=26%  Similarity=0.249  Sum_probs=83.9

Q ss_pred             HHHHHHHHHHhcCCCCC--cccEEEEEEeCC----eEEEEEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 012832          126 REWLTEVIFLGQLRHPH--LVKLIGYCCEEE----HRLLVYEYMPRG-SLENQLFRRYSVSLPWSTRMKIALGAAKGLAF  198 (455)
Q Consensus       126 ~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~  198 (455)
                      ....+|+..+..|..-+  ++..+++.....    ..+||+|++++. +|.+++.....  .+......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            45678888888886443  456666665532    458999999874 79888865322  5666778899999999999


Q ss_pred             hhhCCCCeEEeccCCCCEEEcCCC---ceEEccCCCccCC
Q 012832          199 LHDAEKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDG  235 (455)
Q Consensus       199 LH~~~~~iiHrDlkp~Nill~~~~---~~kL~DfGla~~~  235 (455)
                      ||.+|  |+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99977  99999999999998877   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.77  E-value=5.5e-08  Score=89.71  Aligned_cols=137  Identities=19%  Similarity=0.084  Sum_probs=94.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch----------------------hhHHHHHHHHHHHh
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL----------------------QGHREWLTEVIFLG  136 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  136 (455)
                      -..++..||-|--+.||.|...       .+.++|||.-.....                      .......+|+++|.
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~  164 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ  164 (304)
T ss_pred             HHhhccccccCccceEEEEECC-------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence            3567889999999999999533       477899996432100                      01123467999999


Q ss_pred             cCCCC--CcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCC
Q 012832          137 QLRHP--HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS  214 (455)
Q Consensus       137 ~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~  214 (455)
                      .|...  .|++.+++    +...+||||++|-.|...-       +.....-.++..|++-+.-+-..|  |||+|+.+-
T Consensus       165 ~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSef  231 (304)
T COG0478         165 RLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEF  231 (304)
T ss_pred             HhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchh
Confidence            99755  67777664    3458999999987665422       112223333444444444333445  999999999


Q ss_pred             CEEEcCCCceEEccCCCccCC
Q 012832          215 NILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       215 Nill~~~~~~kL~DfGla~~~  235 (455)
                      |||++++|.++++||--+...
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             eEEEecCCCEEEEeCcccccC
Confidence            999999999999999876543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=4.5e-09  Score=107.56  Aligned_cols=153  Identities=20%  Similarity=0.287  Sum_probs=106.5

Q ss_pred             HHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc-------cceeccccCCCCcCcccccc
Q 012832          189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-------HVSTRVMGTQGYAAPEYVMT  261 (455)
Q Consensus       189 ~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~  261 (455)
                      +.+++.||.|+|.+ .++||+.|.|++|.++.++..||+.|+.+.........       ....-..-...|.|||++.+
T Consensus       105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            33455999999975 45999999999999999999999999987654432110       00011224567999999999


Q ss_pred             CCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHh
Q 012832          262 GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCL  340 (455)
Q Consensus       262 ~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  340 (455)
                      ...+.++|+||+||++|.+.. |+.-+.............              ..+..-...++...|.++.+=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--------------~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--------------NLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--------------cccccccccccccCcHHHHHHHHHHh
Confidence            889999999999999999994 554444332111111100              01111112344667788999999999


Q ss_pred             ccCCCCCCCHHHHHHh
Q 012832          341 SHRPKQRPTMSTVVKT  356 (455)
Q Consensus       341 ~~~P~~RPt~~ell~~  356 (455)
                      ..++.-||++..+...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999988777654

>PRK09902 hypothetical protein; Provisional

Probab=98.71  E-value=1.5e-07  Score=84.71  Aligned_cols=140  Identities=16%  Similarity=0.092  Sum_probs=101.1

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEecccc------chhhHHHHHHHHHHHhcCCCCC--cccEEEEEEe----C
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE------GLQGHREWLTEVIFLGQLRHPH--LVKLIGYCCE----E  153 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~----~  153 (455)
                      -|+||.+.|+...+.        |+.+-+|.-...      -.-....|.+|+..|..|..-+  ++++......    .
T Consensus        26 ~~rgG~SgV~r~~~~--------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~   97 (216)
T PRK09902         26 YRRNGMSGVQCVERN--------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGE   97 (216)
T ss_pred             cCCCCcceEEEEEeC--------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCc
Confidence            577999999986332        235778865311      0224567899999999987433  4444422211    1


Q ss_pred             CeEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc--eEEccCC
Q 012832          154 EHRLLVYEYMPR-GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT--AKLSDFG  230 (455)
Q Consensus       154 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~--~kL~DfG  230 (455)
                      -..+||+|-++| .+|.+++........+......+..+++..+.-||+.|  +.|+|+.+.|||++.++.  +.++||.
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            246899998853 48888876543345567777899999999999999977  999999999999986666  9999999


Q ss_pred             CccCC
Q 012832          231 LAKDG  235 (455)
Q Consensus       231 la~~~  235 (455)
                      -++..
T Consensus       176 k~r~~  180 (216)
T PRK09902        176 KSRRR  180 (216)
T ss_pred             ccchh
Confidence            87653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.70  E-value=7.3e-08  Score=98.76  Aligned_cols=140  Identities=18%  Similarity=0.195  Sum_probs=90.4

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh---------------------------------------
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---------------------------------------  124 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------  124 (455)
                      ..|+.++-|.||+|.+.+       |+.||||+....-...                                       
T Consensus       131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            779999999999998754       7899999964311100                                       


Q ss_pred             -HHHHHHHHHHHhcCC-----CCCc--ccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 012832          125 -HREWLTEVIFLGQLR-----HPHL--VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL  196 (455)
Q Consensus       125 -~~~~~~E~~~l~~l~-----h~nI--v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L  196 (455)
                       .-++.+|..-+.+++     .++|  +++  ++.-.....|+|||++|..+.+...... ..++...+.....++.--.
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V--~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q  280 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKV--YWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQ  280 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEecee--ehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence             011334554444442     2332  222  2223455689999999999988643332 3455444333333332222


Q ss_pred             HHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       197 ~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      -+-  .|  ++|.|..|.||+++.+|.+.+.|||+.....+
T Consensus       281 ~~~--dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLR--DG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHh--cC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222  35  99999999999999999999999999887654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.6e-07  Score=84.69  Aligned_cols=138  Identities=14%  Similarity=0.083  Sum_probs=85.1

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC--cccEEEEEEeCCeEEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH--LVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~e  161 (455)
                      ..||+|..+.||+.          .+..+++|......  ......+|.++++.+..-+  +++.++++...+...+|||
T Consensus         7 ~~i~~G~t~~~y~~----------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            46899999999974          13467888875432  2344678999999887443  4778888877778899999


Q ss_pred             ecCCCC-hHHHH--------------hh----cCC---CCCCHHHHH-HHHH----------HHHH-HHHHhh--hCCCC
Q 012832          162 YMPRGS-LENQL--------------FR----RYS---VSLPWSTRM-KIAL----------GAAK-GLAFLH--DAEKP  205 (455)
Q Consensus       162 ~~~~g~-L~~~l--------------~~----~~~---~~l~~~~~~-~i~~----------~i~~-~L~~LH--~~~~~  205 (455)
                      +++|.+ +...+              ..    -..   ...+..... .+..          .+.. ...+|.  .....
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            998863 21111              00    000   011111100 0000          0011 112222  22334


Q ss_pred             eEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          206 VIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       206 iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ++|+|+.|.||++++++ +.|+||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.53  E-value=1.2e-06  Score=79.38  Aligned_cols=140  Identities=13%  Similarity=0.093  Sum_probs=92.5

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHH---------HHHHHHhcCCC---C
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL---------TEVIFLGQLRH---P  141 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~h---~  141 (455)
                      .+...+|...+++-......|.+-..        .+..+++|..........+.|.         +.+..+..+..   .
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            45667888888888888777776532        3578999987654433333222         33333434432   2


Q ss_pred             CcccEEEEEEe-----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          142 HLVKLIGYCCE-----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       142 nIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      .+..++.+...     ....+|||||++|..|.+..      .++.    .++..++.+|.-||..|  +.|+|+.|+|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcE
Confidence            33333333221     23457899999998887643      1222    24556778899999977  99999999999


Q ss_pred             EEcCCCceEEccCCCccC
Q 012832          217 LLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~  234 (455)
                      +++.+ .++++||+..+.
T Consensus       167 lv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  167 LVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEECC-cEEEEECccccc
Confidence            99865 499999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.52  E-value=9e-09  Score=104.26  Aligned_cols=186  Identities=17%  Similarity=0.142  Sum_probs=130.3

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC-cccEEEEEEeCCeEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH-LVKLIGYCCEEEHRLL  158 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~l  158 (455)
                      +..-+-+++|+++.+|+.+      +..+. ....+.+...     ....-++++|.+++||| .+..++-+..++..++
T Consensus       244 s~~fh~fvK~altknpKkR------ptaek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKR------PTAEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             hHHHHHHHHHHhcCCCccC------CChhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            3444568999999999862      22222 2224443322     33446899999999999 7777888888889999


Q ss_pred             EEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          159 VYEYMPRG-SLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       159 v~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      +|+++.++ +....... ..-.+..-+...+...-++++++||+..  =+|+|    ||+..+ +..++.||+....+..
T Consensus       312 ~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCc
Confidence            99999877 22211110 0112222233445556678999999853  48998    877765 6899999999887655


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD  288 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~  288 (455)
                      ..   ......+|+.|+|||+...+.+..+.|+|++|+-..++--|-+|-.
T Consensus       384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            43   2344779999999999999999999999999987777777776653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=2.5e-06  Score=80.05  Aligned_cols=138  Identities=18%  Similarity=0.095  Sum_probs=81.9

Q ss_pred             ccccCC-eeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEEEec
Q 012832           86 LGEGGF-GAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYEYM  163 (455)
Q Consensus        86 LG~G~f-G~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~  163 (455)
                      |-.|.. ..||+...        .+..+++|......   ...+.+|+.+++.+. +--+++++++....+..++|||++
T Consensus         6 ~~~g~~~~~v~~~~~--------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDG--------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcC--------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            444444 78898731        12478888875432   234567888888875 444667888777666789999999


Q ss_pred             CCCChHHHHh--------h--------cCCC---CCCHH----HHHHHHH--------------------HHHHHHHHhh
Q 012832          164 PRGSLENQLF--------R--------RYSV---SLPWS----TRMKIAL--------------------GAAKGLAFLH  200 (455)
Q Consensus       164 ~~g~L~~~l~--------~--------~~~~---~l~~~----~~~~i~~--------------------~i~~~L~~LH  200 (455)
                      +|.+|.....        .        -...   ..+..    .......                    .+...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9887764321        0        0000   00100    0000000                    0111112221


Q ss_pred             h-----CCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          201 D-----AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       201 ~-----~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .     ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            1     123389999999999999987788999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.2e-06  Score=89.75  Aligned_cols=141  Identities=16%  Similarity=0.109  Sum_probs=88.0

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-------------------------------------H
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-------------------------------------H  125 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~  125 (455)
                      .+.||.-+.|.||+|...+       |+.||||+.+..-...                                     +
T Consensus       166 ~~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E  238 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE  238 (538)
T ss_pred             cchhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence            3679999999999997655       7899999854311100                                     0


Q ss_pred             HHHHHHHHH----HhcCCCCC------cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 012832          126 REWLTEVIF----LGQLRHPH------LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG  195 (455)
Q Consensus       126 ~~~~~E~~~----l~~l~h~n------Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~  195 (455)
                      -+|.+|++-    .+.+.|-+      |+++|-.+  .....|+||||+|..+.|.-.-. ...++...+..-+.++..-
T Consensus       239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLE  315 (538)
T ss_pred             cchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHH
Confidence            112333332    22334444      44444322  34579999999998776643222 2345544444444433322


Q ss_pred             HHHhhhCCCCeEEeccCCCCEEEc----CCCceEEccCCCccCCCC
Q 012832          196 LAFLHDAEKPVIYRDFKASNILLD----SDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       196 L~~LH~~~~~iiHrDlkp~Nill~----~~~~~kL~DfGla~~~~~  237 (455)
                      +=+ + .|  ++|+|-.|.||+++    .++.+.+.|||+......
T Consensus       316 qIf-~-~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIF-K-TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHH-h-cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            222 2 25  99999999999998    367899999999886544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.44  E-value=1e-06  Score=81.63  Aligned_cols=142  Identities=20%  Similarity=0.152  Sum_probs=81.4

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCC--CcccEEEEEEe---CCeEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP--HLVKLIGYCCE---EEHRL  157 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~---~~~~~  157 (455)
                      ++.|+.|..+.||+....+        ..+++|.....  .....+..|..+++.+...  .+++++.+...   ....+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred             CccCCCCCeeeEEEEEECC--------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence            3578999999999984332        37999986544  3456677888888888633  35677765433   33578


Q ss_pred             EEEEecCCCChHH----------------HHhh--cC---CCCCCHHH---------HHHH------------HHHHHH-
Q 012832          158 LVYEYMPRGSLEN----------------QLFR--RY---SVSLPWST---------RMKI------------ALGAAK-  194 (455)
Q Consensus       158 lv~e~~~~g~L~~----------------~l~~--~~---~~~l~~~~---------~~~i------------~~~i~~-  194 (455)
                      ++|++++|..+..                .+..  ..   ...+....         ....            ...+.. 
T Consensus        72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (239)
T PF01636_consen   72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER  151 (239)
T ss_dssp             EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence            9999999887776                1110  00   01111100         0000            011122 


Q ss_pred             HHHHhhh-----CCCCeEEeccCCCCEEEc-CCCceEEccCCCccC
Q 012832          195 GLAFLHD-----AEKPVIYRDFKASNILLD-SDYTAKLSDFGLAKD  234 (455)
Q Consensus       195 ~L~~LH~-----~~~~iiHrDlkp~Nill~-~~~~~kL~DfGla~~  234 (455)
                      .+..++.     ....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2333332     234499999999999999 666678999997753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.31  E-value=1.7e-05  Score=71.61  Aligned_cols=129  Identities=19%  Similarity=0.242  Sum_probs=87.9

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----------------hhhHHHHHHHHHHHhcCC------
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----------------LQGHREWLTEVIFLGQLR------  139 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------  139 (455)
                      -..+||+|+.-.||.-  .       ......||+.....                .....+..+|+.....+.      
T Consensus         5 ~~~~i~~G~~R~cy~H--P-------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~   75 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--P-------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVD   75 (199)
T ss_pred             CCcccccCCCceEEEC--C-------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCc
Confidence            3567999999999952  1       23457889886655                122344555665555444      


Q ss_pred             CCCcccEEEEEEeCCeEEEEEEecCC------CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCC
Q 012832          140 HPHLVKLIGYCCEEEHRLLVYEYMPR------GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKA  213 (455)
Q Consensus       140 h~nIv~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp  213 (455)
                      +.+|.+++|+...+....+|+|.+.+      -+|.+++...   .++. .....+   -+-..||-++.  |+.+|++|
T Consensus        76 ~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L---~~f~~~l~~~~--Iv~~dl~~  146 (199)
T PF10707_consen   76 WSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQAL---DEFKRYLLDHH--IVIRDLNP  146 (199)
T ss_pred             ccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHH---HHHHHHHHHcC--CeecCCCc
Confidence            78999999999999999999998743      2678777433   3443 333333   34455666655  99999999


Q ss_pred             CCEEEcCC---C-ceEEcc
Q 012832          214 SNILLDSD---Y-TAKLSD  228 (455)
Q Consensus       214 ~Nill~~~---~-~~kL~D  228 (455)
                      .||++..+   . .+.|+|
T Consensus       147 ~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccEEEEecCCCceEEEEEe
Confidence            99999542   2 577776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=5.2e-06  Score=76.06  Aligned_cols=151  Identities=19%  Similarity=0.117  Sum_probs=95.2

Q ss_pred             chHHHHHhcCCCCCccc---ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-------------------HH
Q 012832           69 TLAELKVTTQSFSSSNF---LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-------------------HR  126 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~---LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~  126 (455)
                      ++..+.....+..+..+   |+.|--+.||+|..       ..+..+|||+........                   .+
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAET-------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            34444444445555444   55666678999843       246789999864321110                   11


Q ss_pred             H-----HHHHHHHHhcCC--CCCcccEEEEEEeCCeEEEEEEecCCCChH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 012832          127 E-----WLTEVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALGAAKGLAF  198 (455)
Q Consensus       127 ~-----~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~i~~~L~~  198 (455)
                      .     ..+|+.-|.++.  +-.+++.+++.    ...|||||+....+- =.|.   ...+.......+..++++.+.-
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHH
Confidence            1     235777777775  44556666654    347999999443110 0010   1223333566777888888887


Q ss_pred             hhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          199 LHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       199 LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      |-. ++  +||+||..=|||+. ++.+.++|||-|....
T Consensus       182 l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         182 LYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHhcC--cccccchhhheEEE-CCeEEEEECccccccC
Confidence            765 56  99999999999999 7899999999887543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=4.7e-06  Score=72.31  Aligned_cols=130  Identities=17%  Similarity=0.096  Sum_probs=88.9

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcc-cEEEEEEeCCeEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV-KLIGYCCEEEHRLL  158 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~l  158 (455)
                      ....+.||+|++|.||+|.+        .+..+|+|+-..+.  ....+..|+++|..++-.++. ++|.+..    .++
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--------~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i   89 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--------RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFI   89 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--------cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhh
Confidence            34567899999999999954        34589999875443  346678899999999877765 4554443    246


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccC-CCCEEEcCCCceEEccCCCccC
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK-ASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlk-p~Nill~~~~~~kL~DfGla~~  234 (455)
                      .|||+.|-.|.++....     ...    -...+++.---|-..|  |-|..|. |...+|..++.+.|+||.-|..
T Consensus        90 ~me~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          90 RMEYIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            69999988888754321     112    2333444433445445  8899887 5555555555999999999873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=8.2e-06  Score=76.15  Aligned_cols=74  Identities=14%  Similarity=0.099  Sum_probs=47.0

Q ss_pred             cccccccCCe-eEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCC---CcccEEEEEEeC---Ce
Q 012832           83 SNFLGEGGFG-AVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP---HLVKLIGYCCEE---EH  155 (455)
Q Consensus        83 ~~~LG~G~fG-~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~---~~  155 (455)
                      ++.|+.||.. .||+.           +..+++|.....  .....+.+|..+|..+...   -++.+++.....   ..
T Consensus         2 ~~~~~~gG~~n~vy~~-----------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~   68 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPW   68 (235)
T ss_pred             ceeccCCCcccceEEc-----------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCc
Confidence            3567877776 49864           124778875432  2234677899999888632   345555544332   23


Q ss_pred             EEEEEEecCCCChH
Q 012832          156 RLLVYEYMPRGSLE  169 (455)
Q Consensus       156 ~~lv~e~~~~g~L~  169 (455)
                      .+++|++++|.++.
T Consensus        69 ~~~l~~~i~G~~l~   82 (235)
T cd05155          69 PWSVYRWLEGETAT   82 (235)
T ss_pred             ceEEEEeecCCCCC
Confidence            58899999987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.11  E-value=3.7e-05  Score=84.77  Aligned_cols=82  Identities=15%  Similarity=0.176  Sum_probs=56.7

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCC-CCCc--ccEEEEEEeC---Ce
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLR-HPHL--VKLIGYCCEE---EH  155 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~---~~  155 (455)
                      ...|+.|.+..+|+......    .....+++|+..... ......+.+|+.+|+.+. |.+|  ++++.+|.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~----~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNG----GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCC----CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            56789999999998754321    112357788764322 123346779999999996 6665  7888887654   45


Q ss_pred             EEEEEEecCCCCh
Q 012832          156 RLLVYEYMPRGSL  168 (455)
Q Consensus       156 ~~lv~e~~~~g~L  168 (455)
                      .|+||||++|..+
T Consensus       119 ~flVME~v~G~~~  131 (822)
T PLN02876        119 AFYIMEYLEGRIF  131 (822)
T ss_pred             ceEEEEecCCccc
Confidence            7899999987643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.10  E-value=1.2e-05  Score=72.06  Aligned_cols=99  Identities=30%  Similarity=0.362  Sum_probs=79.2

Q ss_pred             HHHHHHhcCCC-CCcccEEEEEEeCCeEEEEEEecCCCChHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 012832          130 TEVIFLGQLRH-PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ---LFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP  205 (455)
Q Consensus       130 ~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  205 (455)
                      .|.-+|+.+.+ +++++++|+|-    .++|.||...+++...   +..  -...+|..+.+||.++++.+.+|+..-.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            58888888885 69999999993    3789999987766421   111  13578999999999999999999863222


Q ss_pred             -eEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          206 -VIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       206 -iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                       +.-.|++|+|+-+++++.+|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence             77789999999999999999999988754

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.05  E-value=6.1e-05  Score=67.54  Aligned_cols=137  Identities=28%  Similarity=0.372  Sum_probs=94.3

Q ss_pred             cCCCCcccchHHHHHhcCCCCCcccccccCC-eeEEEEEEcCCCCCCcccccEEEEecc---ccch--------------
Q 012832           61 AGSNLHVFTLAELKVTTQSFSSSNFLGEGGF-GAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGL--------------  122 (455)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~f-G~Vy~~~~~~~~~~~~~~~~vavK~~~---~~~~--------------  122 (455)
                      .+..+..|+.     .+.+++..+.||.|.- |.||++.+.        +..+|+|++.   ....              
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~--------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~   91 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID--------GRIYALKLFRFWDYTEPDYTRERFAGHETSL   91 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC--------CeEEEEEEeeccccCCCcccccccccccccc
Confidence            3455555555     2378999999999999 999999654        5689999931   1110              


Q ss_pred             ----hhHHHHHHHHHHHhcCC---CCCc--ccEEEEEEeC------------------CeEEEEEEecCCCChHHHHhhc
Q 012832          123 ----QGHREWLTEVIFLGQLR---HPHL--VKLIGYCCEE------------------EHRLLVYEYMPRGSLENQLFRR  175 (455)
Q Consensus       123 ----~~~~~~~~E~~~l~~l~---h~nI--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~  175 (455)
                          .-...|..|.....+|+   +.++  |+++||..-.                  ....||.||++...        
T Consensus        92 ~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------  163 (207)
T PF13095_consen   92 STPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------  163 (207)
T ss_pred             chhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------
Confidence                01123667877777665   5566  8999987432                  12467888876543        


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          176 YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       176 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                         .+    ...-+.+|..-|..+|..|  |+-+|+++.|..     .=+|+|||.+
T Consensus       164 ---~~----~~~~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  164 ---PL----QIRDIPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---cc----chhHHHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence               11    1233566778888999977  999999999986     3478999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.96  E-value=4.4e-05  Score=83.02  Aligned_cols=195  Identities=21%  Similarity=0.240  Sum_probs=136.2

Q ss_pred             HHHHHHHhcCCCCCcccEEEEEEeCCeEE----EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 012832          129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL----LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK  204 (455)
Q Consensus       129 ~~E~~~l~~l~h~nIv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  204 (455)
                      ..|...+.++.|+|++.++.+........    +..++|..-++...+..-  ..++..+...+..++..||+|+|++. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            35677788889999999999876654433    334677777777766543  57788899999999999999999975 


Q ss_pred             CeEEeccCCC---CEEEcCCCceEEc--cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCcc--CchhhHHHHH
Q 012832          205 PVIYRDFKAS---NILLDSDYTAKLS--DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSM--SDVYSFGVVL  277 (455)
Q Consensus       205 ~iiHrDlkp~---Nill~~~~~~kL~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslG~il  277 (455)
                       ..|.-|..+   +--++..+.+.++  ||+.+...+......   ...-+..|.++|......+..+  .|+|.+|..+
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             666655555   4445666677766  999887765443221   1234556888888776655544  7999999999


Q ss_pred             HHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       278 ~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ..+..|..+-....                   ....+++        ........+...+|+..++++|++..+++.+.
T Consensus       383 ~~~~~~~~i~~~~~-------------------~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA-------------------VPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCccccccc-------------------chhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99998865532210                   0001111        11111567788899999999999999999873

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00013  Score=70.50  Aligned_cols=78  Identities=14%  Similarity=0.057  Sum_probs=55.1

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC---CCcccEEEEEEeC---C
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH---PHLVKLIGYCCEE---E  154 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~---~  154 (455)
                      ...+.||+|..+.||.....        +..+++|..+.  ......+..|...|+.|.-   -.++++++++...   +
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--------~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g   86 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--------QGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG   86 (297)
T ss_pred             heeeecCCccceeEEEEEcC--------CCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence            34567999999999986321        23577777432  1123467789999988863   3678899887543   5


Q ss_pred             eEEEEEEecCCCCh
Q 012832          155 HRLLVYEYMPRGSL  168 (455)
Q Consensus       155 ~~~lv~e~~~~g~L  168 (455)
                      ..+||||+++|+++
T Consensus        87 ~~~LVmE~i~G~~~  100 (297)
T PRK10593         87 PDVLLLERLRGVSV  100 (297)
T ss_pred             CeEEEEeccCCEec
Confidence            68999999998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.89  E-value=6.8e-05  Score=70.89  Aligned_cols=137  Identities=18%  Similarity=0.074  Sum_probs=76.4

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEEEEEecC
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLLVYEYMP  164 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~  164 (455)
                      +..|-.+.+|+..        ..+..+++|..........-...+|..+++.+...++ ++++...  .  .++||||++
T Consensus         4 ~~~G~tn~~y~~~--------~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIE--------HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEE--------eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence            5677788999863        1245788887543322111124578888888875444 4455443  2  379999999


Q ss_pred             CCChHHH----------H----hh---cC--CCCCCHH-HHHHHHHHH---------HHHHHHhhhC------CCCeEEe
Q 012832          165 RGSLENQ----------L----FR---RY--SVSLPWS-TRMKIALGA---------AKGLAFLHDA------EKPVIYR  209 (455)
Q Consensus       165 ~g~L~~~----------l----~~---~~--~~~l~~~-~~~~i~~~i---------~~~L~~LH~~------~~~iiHr  209 (455)
                      |..+...          +    .+   ..  ...+... ....+..++         ...+..+-..      ...++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            8765321          1    10   00  1111111 111111111         1112212111      1238999


Q ss_pred             ccCCCCEEEcCCCceEEccCCCccCC
Q 012832          210 DFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       210 Dlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      |+.|.||++++++ +.|+||..+...
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCcC
Confidence            9999999999876 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.81  E-value=0.00021  Score=66.47  Aligned_cols=77  Identities=18%  Similarity=0.092  Sum_probs=46.8

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC-cccEEEEEEeCCeEEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH-LVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e  161 (455)
                      .+.|..|-...+|+....+.     .+..|++|+...... ...+..+|+.++..+...+ .+++++.+.    ..+|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence            35678888899998742210     235788997653221 1122236888888886433 445554332    248999


Q ss_pred             ecCCCChH
Q 012832          162 YMPRGSLE  169 (455)
Q Consensus       162 ~~~~g~L~  169 (455)
                      |++|.++.
T Consensus        73 ~i~G~~l~   80 (235)
T cd05157          73 FIPGRTLE   80 (235)
T ss_pred             eeCCCcCC
Confidence            99987763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.80  E-value=0.0001  Score=71.21  Aligned_cols=141  Identities=16%  Similarity=0.109  Sum_probs=82.5

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC--cccEEEE------EEeCC
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH--LVKLIGY------CCEEE  154 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~~~  154 (455)
                      .+.|..|....+|+....        +..+++|+...   .....+..|+.++..+.+.+  +++++..      ....+
T Consensus        19 i~~i~~G~~n~~y~v~~~--------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeC--------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            567888888899986322        24688998754   22344566787777775332  4455432      23345


Q ss_pred             eEEEEEEecCCCChHH----HHhh-------------cCCCC------CCHHHHH----------HHHHHHHHHHHHhhh
Q 012832          155 HRLLVYEYMPRGSLEN----QLFR-------------RYSVS------LPWSTRM----------KIALGAAKGLAFLHD  201 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~----~l~~-------------~~~~~------l~~~~~~----------~i~~~i~~~L~~LH~  201 (455)
                      ..++||+|++|..+..    .+..             .....      ..|....          .....+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999876532    0000             00000      0111100          011112233444432


Q ss_pred             -----CCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          202 -----AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       202 -----~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                           ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                 123499999999999999987788999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0016  Score=63.58  Aligned_cols=31  Identities=29%  Similarity=0.413  Sum_probs=26.6

Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .++||+|+.|.|||++++...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4599999999999999776668999998864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.64  E-value=0.00034  Score=67.82  Aligned_cols=81  Identities=19%  Similarity=0.158  Sum_probs=49.2

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~  162 (455)
                      +.|..|-...||+....+.......+..+++|+..... ....+..+|+.++..+...++ +++++++. +   .+||||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            45667777789987543211122345789999865432 222334578888888764333 45665553 2   468999


Q ss_pred             cCCCChH
Q 012832          163 MPRGSLE  169 (455)
Q Consensus       163 ~~~g~L~  169 (455)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.61  E-value=0.00095  Score=66.75  Aligned_cols=77  Identities=18%  Similarity=0.101  Sum_probs=51.7

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc------c-hhhHHHHHHHHHHHhcCC---CCCcccEEEEEEe
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE------G-LQGHREWLTEVIFLGQLR---HPHLVKLIGYCCE  152 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~  152 (455)
                      .+.||.|.+..||++...+      .++.|+||.-...      . .....+...|.+.|..+.   ..++++++.+  +
T Consensus        31 ~~elggGn~N~VyrV~~~~------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D  102 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTE------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D  102 (401)
T ss_pred             eeEcCCCceEEEEEEEeCC------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence            3569999999999986432      1247999974311      1 123455667888888764   2457777766  4


Q ss_pred             CCeEEEEEEecCCCC
Q 012832          153 EEHRLLVYEYMPRGS  167 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~  167 (455)
                      .+..++||||+++..
T Consensus       103 ~~~~~lVME~L~~~~  117 (401)
T PRK09550        103 EELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCCEEEEecCCCcc
Confidence            456789999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.52  E-value=0.00047  Score=67.08  Aligned_cols=143  Identities=16%  Similarity=0.093  Sum_probs=80.3

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC--cccEEEEE------EeC
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH--LVKLIGYC------CEE  153 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~------~~~  153 (455)
                      ..+.++.|....+|+....        +..+++|+.....  ....+..|+.++..|...+  +++++...      ...
T Consensus        26 ~i~~~~~G~~n~~y~v~t~--------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD--------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             eccccCCccccceEEEEeC--------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            3566788877899986321        2358888764321  1233455667776664322  44544421      224


Q ss_pred             CeEEEEEEecCCCChH----HHHhh---------cCCCCC-----------CHHHHH------------HHHHHHHHHHH
Q 012832          154 EHRLLVYEYMPRGSLE----NQLFR---------RYSVSL-----------PWSTRM------------KIALGAAKGLA  197 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~----~~l~~---------~~~~~l-----------~~~~~~------------~i~~~i~~~L~  197 (455)
                      +..++||+|++|..+.    +....         .....+           .|....            .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            5678999999886532    10000         000010           011000            00111233455


Q ss_pred             Hhhh-----CCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          198 FLHD-----AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       198 ~LH~-----~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ++..     ...++||+|+.+.||+++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            5532     234599999999999999888778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.36  E-value=2.8e-05  Score=86.32  Aligned_cols=160  Identities=14%  Similarity=0.004  Sum_probs=113.9

Q ss_pred             HHHHHHHHHHhcCCCCCcccEEEEEEe--CCeEEEEEEecCCCChHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHhhh
Q 012832          126 REWLTEVIFLGQLRHPHLVKLIGYCCE--EEHRLLVYEYMPRGSLENQLFRRYSV--SLPWSTRMKIALGAAKGLAFLHD  201 (455)
Q Consensus       126 ~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~--~l~~~~~~~i~~~i~~~L~~LH~  201 (455)
                      +..+.|...++...|+++...+.-...  ....+.+++|+.+|.+.+.|.+....  .+...-+.....+...+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            334556666677789988776654432  23568999999999999988765432  22222222222332445555554


Q ss_pred             C---CCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHH
Q 012832          202 A---EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLL  278 (455)
Q Consensus       202 ~---~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  278 (455)
                      .   +.-.+|+++|+-|.+|..+..+++.++|+.+...+.  ........+++.|++|++...-.++.++|+|..|+.+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            2   333789999999999999999999999999832221  11223356888999999998888999999999999999


Q ss_pred             HHHhCCCCC
Q 012832          279 ELLSGRKSV  287 (455)
Q Consensus       279 ell~G~~p~  287 (455)
                      ++..|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            999888776

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.33  E-value=0.00019  Score=68.28  Aligned_cols=135  Identities=19%  Similarity=0.105  Sum_probs=89.9

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-----hhhH-----------------HHHHHHHHHHh
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-----LQGH-----------------REWLTEVIFLG  136 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~-----------------~~~~~E~~~l~  136 (455)
                      -+++++.||-|--+-||.+...       .|.+.++|...+..     ....                 -...+|+..|+
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk  165 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK  165 (465)
T ss_pred             hhhhccccccccccceEEEecC-------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence            4788999999999999998433       36788888643211     0111                 11346888888


Q ss_pred             cCC-CC-CcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCC
Q 012832          137 QLR-HP-HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS  214 (455)
Q Consensus       137 ~l~-h~-nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~  214 (455)
                      .|. |- -+++.+++.    .-++|||++.|-.|...-.     ..+..++   ...+..-+.-|-.+|  +||+|..--
T Consensus       166 aL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~-----v~d~~~l---y~~lm~~Iv~la~~G--lIHgDFNEF  231 (465)
T KOG2268|consen  166 ALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH-----VEDPPTL---YDDLMGLIVRLANHG--LIHGDFNEF  231 (465)
T ss_pred             HHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee-----cCChHHH---HHHHHHHHHHHHHcC--ceecccchh
Confidence            886 32 245555543    4589999999888765321     1222233   333333344455556  999999999


Q ss_pred             CEEEcCCCceEEccCCCccC
Q 012832          215 NILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       215 Nill~~~~~~kL~DfGla~~  234 (455)
                      ||+|++++.++++||--...
T Consensus       232 Nimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  232 NIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eeEEecCCCEEEeechHhhc
Confidence            99999999999999976543

>PLN02236 choline kinase

Probab=97.13  E-value=0.0042  Score=61.36  Aligned_cols=144  Identities=16%  Similarity=0.086  Sum_probs=80.0

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~  162 (455)
                      ..|-.|-.-.+|+..+...  ....+..|++|+........ -+-.+|+.+++.+..-++ +++++.+..    ..|.+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~--~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTK--EGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCC--CCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC----ceEEEe
Confidence            3455577788998754321  11234678899775432211 122568888888875554 456665532    268999


Q ss_pred             cCCCChHHH----------Hhh------cCC----C-CCCHHHHHHHHHHH-----------------HHHHHHh----h
Q 012832          163 MPRGSLENQ----------LFR------RYS----V-SLPWSTRMKIALGA-----------------AKGLAFL----H  200 (455)
Q Consensus       163 ~~~g~L~~~----------l~~------~~~----~-~l~~~~~~~i~~~i-----------------~~~L~~L----H  200 (455)
                      +++.+|...          +..      ...    . ...+..+..+..++                 ...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987776421          000      000    0 11122222222111                 1111111    1


Q ss_pred             h--CCCCeEEeccCCCCEEEcC-CCceEEccCCCccC
Q 012832          201 D--AEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  234 (455)
Q Consensus       201 ~--~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~~  234 (455)
                      .  ....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1  1224899999999999986 47899999998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.06  E-value=0.0059  Score=59.06  Aligned_cols=121  Identities=19%  Similarity=0.240  Sum_probs=74.0

Q ss_pred             cccEEEEecc--ccchhhHHHHHHHHHHHhcCCCC--CcccEEEEEEeCC--eEEEEEEecCCCChHHHHhhcCCCCCCH
Q 012832          109 AQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHP--HLVKLIGYCCEEE--HRLLVYEYMPRGSLENQLFRRYSVSLPW  182 (455)
Q Consensus       109 ~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~  182 (455)
                      ++.+++. ..  ...........+|+.+++.+.--  -+...+++|.++.  ..|.||+|++|..+.+.+...     + 
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-----~-  120 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-----S-  120 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-----c-
Confidence            5677887 32  12233445556788888877532  2345566666655  669999999885333221110     0 


Q ss_pred             HHHHHHHH-HHHHHHHHhh--------------------------------------------------hCC------CC
Q 012832          183 STRMKIAL-GAAKGLAFLH--------------------------------------------------DAE------KP  205 (455)
Q Consensus       183 ~~~~~i~~-~i~~~L~~LH--------------------------------------------------~~~------~~  205 (455)
                       ...+++. .+++.|+-||                                                  .+-      ..
T Consensus       121 -~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~  199 (321)
T COG3173         121 -LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV  199 (321)
T ss_pred             -chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence             0011122 3344444444                                                  221      14


Q ss_pred             eEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       206 iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      ++|+|+.+.||+++.++-+=++||+++....+
T Consensus       200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            89999999999999988899999999986544

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.02  E-value=0.0013  Score=66.36  Aligned_cols=167  Identities=23%  Similarity=0.277  Sum_probs=93.4

Q ss_pred             HHHHHHHHHHhcCCCCCcccEEEEEEeC-CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 012832          126 REWLTEVIFLGQLRHPHLVKLIGYCCEE-EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK  204 (455)
Q Consensus       126 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  204 (455)
                      ..++..+.+++.+.|+|...++++.... ....+|||++ +.+|++.+..+.   +....          ++  -|  + 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s----------~~--~~--~-   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDES----------LL--AH--G-   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhh----------hc--cc--c-
Confidence            3456678889999999999999886543 4578999999 789999886653   11110          00  11  2 


Q ss_pred             CeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCC
Q 012832          205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR  284 (455)
Q Consensus       205 ~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~  284 (455)
                       +.|-     |       ..+.+| -++...                    |-     ...+|+||||+|.++.++.-|.
T Consensus        88 -~~~~-----~-------~~~~td-~~~t~~--------------------~~-----~~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   88 -VLHL-----N-------IIYITD-HFLTKY--------------------PS-----PIGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -ccee-----h-------hhhccc-cccccC--------------------CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence             3332     1       223333 111000                    10     0114999999999999999987


Q ss_pred             CCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          285 KSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       285 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      .-|......+....+.   ............   .....+-..+......+...|+-..|..||...++.++
T Consensus       129 ~l~~~~~~s~~l~~i~---k~~~~d~~~~~~---a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~  194 (725)
T KOG1093|consen  129 SLEAELTESEYLEILL---KYYTDDQELLST---AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR  194 (725)
T ss_pred             HHHHHHHHHHHHHHHH---HhccCchhHHHH---HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence            6654322211111111   000000000000   00001223345667789999999999999977666554

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.86  E-value=0.0043  Score=59.47  Aligned_cols=75  Identities=17%  Similarity=0.152  Sum_probs=46.5

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC---CCCcccEEEEEEeCCeEE
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR---HPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~  157 (455)
                      ...+.|+.|....+|+..        ..++.+.||+-..   .....|..|.+-|+.|.   --.+++++++....+..+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--------~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--------TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--------TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeEecCCCChhheEEEE--------CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            345679999999999863        2467899998652   22344667888887774   446889999988877789


Q ss_pred             EEEEecCCC
Q 012832          158 LVYEYMPRG  166 (455)
Q Consensus       158 lv~e~~~~g  166 (455)
                      |||||++.+
T Consensus        89 Llle~l~~~   97 (288)
T PF03881_consen   89 LLLEFLEMG   97 (288)
T ss_dssp             EEEE-----
T ss_pred             EEEEeecCC
Confidence            999999866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.82  E-value=0.013  Score=56.11  Aligned_cols=31  Identities=32%  Similarity=0.458  Sum_probs=25.9

Q ss_pred             CeEEeccCCCCEEEcCCCc-eEEccCCCccCC
Q 012832          205 PVIYRDFKASNILLDSDYT-AKLSDFGLAKDG  235 (455)
Q Consensus       205 ~iiHrDlkp~Nill~~~~~-~kL~DfGla~~~  235 (455)
                      .++|+|+.|.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            3899999999999997554 569999988754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.76  E-value=0.019  Score=55.85  Aligned_cols=31  Identities=16%  Similarity=0.164  Sum_probs=28.2

Q ss_pred             CeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       205 ~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ++||+|+.+.|||+++++.+.++||..+...
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            5999999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.72  E-value=0.018  Score=57.58  Aligned_cols=73  Identities=12%  Similarity=0.049  Sum_probs=47.7

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-------hhHHHHHHHHHHHhcCC---CCCcccEEEEEEe
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-------QGHREWLTEVIFLGQLR---HPHLVKLIGYCCE  152 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~  152 (455)
                      .+.||.|..-.||+...        .+..|+||.-.....       ....+...|+..|+.+.   ..++++++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~--------~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--------SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEc--------CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            56789999999998642        124589997541111       12233345667776654   247888888776 


Q ss_pred             CCeEEEEEEecCC
Q 012832          153 EEHRLLVYEYMPR  165 (455)
Q Consensus       153 ~~~~~lv~e~~~~  165 (455)
                       +..+++|||+++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             446889999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.66  E-value=0.024  Score=55.73  Aligned_cols=74  Identities=15%  Similarity=0.091  Sum_probs=45.7

Q ss_pred             cccccCCeeEEEEEEcCCCCCCcccccEEEEeccc-------cchhhHHHHHHHHHHHhcCC--CC-CcccEEEEEEeCC
Q 012832           85 FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL-------EGLQGHREWLTEVIFLGQLR--HP-HLVKLIGYCCEEE  154 (455)
Q Consensus        85 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~  154 (455)
                      .||.|-..-||++...+      .+..|+||.-..       .-.-...+..-|.+.|+...  .| .++++|.  .+++
T Consensus         2 EigdGnlN~VfrV~~~~------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCC------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc
Confidence            47999999999986321      225799996421       11222344456777777664  35 4555543  3455


Q ss_pred             eEEEEEEecCCC
Q 012832          155 HRLLVYEYMPRG  166 (455)
Q Consensus       155 ~~~lv~e~~~~g  166 (455)
                      ...+|||+++..
T Consensus        74 ~~~~vMEdL~~~   85 (370)
T TIGR01767        74 MAVTVMEDLSHH   85 (370)
T ss_pred             cceehHhhCccc
Confidence            667999999643

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.58  E-value=0.017  Score=56.37  Aligned_cols=140  Identities=14%  Similarity=0.074  Sum_probs=88.4

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-----c--------------------hhhHH-HHHHHHHH
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-----G--------------------LQGHR-EWLTEVIF  134 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-----~--------------------~~~~~-~~~~E~~~  134 (455)
                      .+-..|..|--+.||.|+-.+       |..+|||+.+-.     .                    ..... ....|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~d-------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RN  219 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED-------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRN  219 (520)
T ss_pred             ecccccccCccceeEeeecCC-------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHH
Confidence            344668889999999986443       566999985310     0                    00111 12358888


Q ss_pred             HhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCeEEeccCC
Q 012832          135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH-DAEKPVIYRDFKA  213 (455)
Q Consensus       135 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~iiHrDlkp  213 (455)
                      |.+|+.-+|+-.--+..  ....|||+|+. ++=+-.= .-....++...+..+-.+++.-|.-|. .+.  +||.||.-
T Consensus       220 LkRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSE  293 (520)
T KOG2270|consen  220 LKRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSE  293 (520)
T ss_pred             HHHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhh
Confidence            88887666543221111  23479999994 3221100 011245666667777777777777664 334  99999999


Q ss_pred             CCEEEcCCCceEEccCCCccC
Q 012832          214 SNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       214 ~Nill~~~~~~kL~DfGla~~  234 (455)
                      -|+|+- +|.++++|-+-+..
T Consensus       294 fN~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  294 FNLLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             hhheEE-CCEEEEEEcccccc
Confidence            999995 56899999987754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.46  E-value=0.016  Score=56.23  Aligned_cols=30  Identities=23%  Similarity=0.316  Sum_probs=25.8

Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            45899999999999987 6789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.44  E-value=0.015  Score=56.60  Aligned_cols=105  Identities=14%  Similarity=0.139  Sum_probs=71.3

Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ..+.|++|++- |++|.- +     ....++++..|+.+.+..++-+-. .-+.-|||+.-.||||+ +|++-|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence            34678888886 666652 2     245678888898887776666653 45588999999999999 999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHH
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFG  274 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  274 (455)
                      +.....+.       +-....-.|..+.|.. +.+-+||-+-
T Consensus       369 Rl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrlM  402 (488)
T COG5072         369 RLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRLM  402 (488)
T ss_pred             ecccCCce-------eeccccCchhhhcCcc-ceeeeHHHHH
Confidence            95433221       1122234455555433 6666776543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.39  E-value=0.029  Score=55.15  Aligned_cols=77  Identities=13%  Similarity=0.103  Sum_probs=44.7

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEEEEEe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~  162 (455)
                      +.|..|=.-.+|+....+.   ......|++|+....... .-+-.+|..+++.+..-++ +++++++. .   .+|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~---~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEE---NGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCC---CCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehh
Confidence            3355566777887754321   112347888876432221 1112468888888876555 45666552 2   258999


Q ss_pred             cCCCCh
Q 012832          163 MPRGSL  168 (455)
Q Consensus       163 ~~~g~L  168 (455)
                      ++|.+|
T Consensus        92 i~g~~l   97 (330)
T PLN02421         92 INARTL   97 (330)
T ss_pred             hcCCCC
Confidence            987665

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.35  E-value=0.0056  Score=55.97  Aligned_cols=29  Identities=34%  Similarity=0.434  Sum_probs=20.6

Q ss_pred             eEEeccCCCCEEE-cCCCceEEccCCCccC
Q 012832          206 VIYRDFKASNILL-DSDYTAKLSDFGLAKD  234 (455)
Q Consensus       206 iiHrDlkp~Nill-~~~~~~kL~DfGla~~  234 (455)
                      ++|.|+.|.|||+ +.++.++|+||..|..
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            7899999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=96.09  E-value=0.06  Score=53.90  Aligned_cols=82  Identities=12%  Similarity=0.054  Sum_probs=46.2

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcc-cEEEEEEeCCeEEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV-KLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e  161 (455)
                      .+.|..|-...+|++...+........+.|.++..... ....-+-.+|+.+++.+...++. ++++.+.    .++|.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            34566688899998865432111111223555442211 11111124688999999766554 5555553    269999


Q ss_pred             ecCCCChH
Q 012832          162 YMPRGSLE  169 (455)
Q Consensus       162 ~~~~g~L~  169 (455)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.06  E-value=0.031  Score=50.76  Aligned_cols=136  Identities=15%  Similarity=0.119  Sum_probs=80.5

Q ss_pred             cEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHH
Q 012832          111 PVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA  189 (455)
Q Consensus       111 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~  189 (455)
                      +..+|++..-... ...-+..+..++++++  +|+++..=  ..-.+.++.|+|-.-..           .   . ..++
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~---~-~N~i  147 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------N---F-SNFI  147 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------c---h-hHHH
Confidence            3455555322222 3344667888888764  46666521  33346688999843211           1   0 1111


Q ss_pred             HHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCc
Q 012832          190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSD  269 (455)
Q Consensus       190 ~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  269 (455)
                      .-=+.+|.-.|+...+.+|+|..|+|||-|..|.+||.|=+....              .+..|.--|   ....+.++.
T Consensus       148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE  210 (308)
T PF07387_consen  148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAE  210 (308)
T ss_pred             HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHH
Confidence            111466777897767799999999999999999999999775421              111122211   123466677


Q ss_pred             hhhHHHHHHHHHh
Q 012832          270 VYSFGVVLLELLS  282 (455)
Q Consensus       270 vwslG~il~ell~  282 (455)
                      +-+|-.-++++..
T Consensus       211 ~~~fv~s~l~~v~  223 (308)
T PF07387_consen  211 VKVFVKSCLKLVE  223 (308)
T ss_pred             HHHHHHHHHHHHH
Confidence            7676666666665

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.92  E-value=0.088  Score=48.16  Aligned_cols=75  Identities=24%  Similarity=0.290  Sum_probs=50.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC---CCCcccEEEEEEeCCeEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR---HPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      +.+..|..-..|...  +      ...++.||+-   .......|..|+.-|..|.   .-++.+++.+.....+.|+||
T Consensus        22 ~~v~gG~inea~~v~--d------g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          22 EEVSGGDINEAWRLR--D------GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             cccCCccccceeEee--c------CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            345555545555431  1      2457888863   3333455677777666664   457889999999999999999


Q ss_pred             EecCCCChH
Q 012832          161 EYMPRGSLE  169 (455)
Q Consensus       161 e~~~~g~L~  169 (455)
                      ||++-|.+.
T Consensus        91 e~L~~~~~d   99 (286)
T COG3001          91 EYLPTGPLD   99 (286)
T ss_pred             eeccCCCCC
Confidence            999987664

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.79  E-value=0.031  Score=55.72  Aligned_cols=75  Identities=17%  Similarity=0.107  Sum_probs=48.0

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc------cchhhHHHHHHHHHHHhcCC--CC-CcccEEEEEEeC
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL------EGLQGHREWLTEVIFLGQLR--HP-HLVKLIGYCCEE  153 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~  153 (455)
                      .+.||.|--.-||++....      .+..|+||.-..      .-.-...+..-|.+.|+.+.  .| .++++|.  .++
T Consensus        34 ~~eigdGnlN~VfrV~~~~------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc
Confidence            4578999999999985421      135689986421      11223355566888887764  45 4555654  345


Q ss_pred             CeEEEEEEecCC
Q 012832          154 EHRLLVYEYMPR  165 (455)
Q Consensus       154 ~~~~lv~e~~~~  165 (455)
                      +...+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            566899999964

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.61  E-value=0.024  Score=55.98  Aligned_cols=60  Identities=20%  Similarity=0.139  Sum_probs=39.7

Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                      ..||=+|..|-++..++...   ..++.....++.-.+.|+--+--. .+++|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~v-DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIV-DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence            45677788888888777543   455555555555555554433221 2399999999999994

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.23  E-value=0.14  Score=49.24  Aligned_cols=78  Identities=14%  Similarity=0.088  Sum_probs=46.7

Q ss_pred             cccCCeeEEEEEEcC--CCCCCcccccEEEEeccccch-----hhHHHHHHHHHHHhcCC-------------CCCcccE
Q 012832           87 GEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLR-------------HPHLVKL  146 (455)
Q Consensus        87 G~G~fG~Vy~~~~~~--~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~-------------h~nIv~~  146 (455)
                      |.|-.|.+|++.+.-  ..........++||.......     ....-|.+|+.+...+-             ...++++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            778889999987643  223345567799998752111     11233556666554431             1245666


Q ss_pred             EEEEEeCCeEEEEEEecC
Q 012832          147 IGYCCEEEHRLLVYEYMP  164 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~  164 (455)
                      +....++...+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            666655556789998763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00296 choline kinase; Provisional

Probab=94.67  E-value=0.33  Score=49.61  Aligned_cols=82  Identities=9%  Similarity=-0.012  Sum_probs=49.2

Q ss_pred             CcccccccCCeeEEEEEEcCCCC--CCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcc-cEEEEEEeCCeEEE
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLR--PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV-KLIGYCCEEEHRLL  158 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~l  158 (455)
                      ..+.|..|-.-.+|+....+...  ....++.|++++......... .-..|..+++.+...+|. ++++.+.    -+.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence            45667778788899886543211  112356788888643322211 224577777777655554 5565442    357


Q ss_pred             EEEecCCCCh
Q 012832          159 VYEYMPRGSL  168 (455)
Q Consensus       159 v~e~~~~g~L  168 (455)
                      |.+|++|.+|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            8999988754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.60  E-value=0.92  Score=44.43  Aligned_cols=29  Identities=24%  Similarity=0.227  Sum_probs=24.5

Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4489999999999995 4 578999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	455
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-53
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-51
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-40
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-27
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-21
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-20
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-20
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-19
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-19
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-19
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-19
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-19
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-18
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-15
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-15
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-05

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 117/291 (40%), Positives = 169/291 (58%), Gaps = 12/291 (4%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           L +L+  T +F     +G G FG V+KG + D          VA+K    E  QG  E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-------GAKVALKRRTPESSQGIEEFE 83
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMK 187
           TE+  L   RHPHLV LIG+C E    +L+Y+YM  G+L+  L+     ++S+ W  R++
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           I +GAA+GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E D TH+   V
Sbjct: 144 ICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
            GT GY  PEY + G LT  SDVYSFGVVL E+L  R ++ +S P+   +L EWA    N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           +  +L +I+DP L  +      RK    A +CL+   + RP+M  V+  LE
Sbjct: 262 NG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  203 bits (517), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 125/312 (40%), Positives = 181/312 (58%), Gaps = 17/312 (5%)
Query: 53  SEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPV 112
            ED  + L    L  F+L EL+V + +FS+ N LG GGFG V+KG + D          V
Sbjct: 15  EEDPEVHLG--QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLV 65
Query: 113 AVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
           AVK L  E  QG   ++ TEV  +    H +L++L G+C     RLLVY YM  GS+ + 
Sbjct: 66  AVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 125
Query: 172 LFRRYSVSLP--WSTRMKIALGAAKGLAFLHDAEKP-VIYRDFKASNILLDSDYTAKLSD 228
           L  R     P  W  R +IALG+A+GLA+LHD   P +I+RD KA+NILLD ++ A + D
Sbjct: 126 LRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 185
Query: 229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           FGLAK   +  D HV   V GT G+ APEY+ TG  +  +DV+ +GV+LLEL++G+++ D
Sbjct: 186 FGLAK-LMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244
Query: 289 KSRPQREQS--LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ 346
            +R   +    L++W + +L + +KL  ++D  L+G Y +    +   +A  C    P +
Sbjct: 245 LARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 303
Query: 347 RPTMSTVVKTLE 358
           RP MS VV+ LE
Sbjct: 304 RPKMSEVVRMLE 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 116/291 (39%), Positives = 168/291 (57%), Gaps = 12/291 (4%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           L +L+  T +F     +G G FG V+KG + D          VA+K    E  QG  E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-------GAKVALKRRTPESSQGIEEFE 83
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMK 187
           TE+  L   RHPHLV LIG+C E    +L+Y+YM  G+L+  L+     ++S+ W  R++
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           I +GAA+GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E   TH+   V
Sbjct: 144 ICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
            GT GY  PEY + G LT  SDVYSFGVVL E+L  R ++ +S P+   +L EWA    N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           +  +L +I+DP L  +      RK    A +CL+   + RP+M  V+  LE
Sbjct: 262 NG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  199 bits (506), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 123/312 (39%), Positives = 179/312 (57%), Gaps = 17/312 (5%)
Query: 53  SEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPV 112
            ED  + L    L  F+L EL+V + +F + N LG GGFG V+KG + D          V
Sbjct: 7   EEDPEVHLG--QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-------GXLV 57
Query: 113 AVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
           AVK L  E  QG   ++ TEV  +    H +L++L G+C     RLLVY YM  GS+ + 
Sbjct: 58  AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 117
Query: 172 LFRRYSVSLP--WSTRMKIALGAAKGLAFLHDAEKP-VIYRDFKASNILLDSDYTAKLSD 228
           L  R     P  W  R +IALG+A+GLA+LHD   P +I+RD KA+NILLD ++ A + D
Sbjct: 118 LRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177
Query: 229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           FGLAK   +  D HV   V G  G+ APEY+ TG  +  +DV+ +GV+LLEL++G+++ D
Sbjct: 178 FGLAK-LMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 289 KSRPQREQS--LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ 346
            +R   +    L++W + +L + +KL  ++D  L+G Y +    +   +A  C    P +
Sbjct: 237 LARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 347 RPTMSTVVKTLE 358
           RP MS VV+ LE
Sbjct: 296 RPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/318 (34%), Positives = 180/318 (56%), Gaps = 25/318 (7%)
Query: 54  EDLSISLAGSNLHVFTLAELKVTTQSFSS------SNFLGEGGFGAVHKGFIDDKLRPGL 107
           E+ S+ ++ +  H F+  ELK  T +F         N +GEGGFG V+KG++++      
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------ 54
Query: 108 QAQPVAVKNL----DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM 163
               VAVK L    D+   +  +++  E+  + + +H +LV+L+G+  + +   LVY YM
Sbjct: 55  --TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 164 PRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           P GSL ++L     +  L W  R KIA GAA G+ FLH  E   I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 170
Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           TAK+SDFGLA+   +   T + +R++GT  Y APE  + G +T  SD+YSFGVVLLE+++
Sbjct: 171 TAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229
Query: 283 GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSH 342
           G  +VD+ R    Q L++    + ++ + +   +D ++    S T      ++A QCL  
Sbjct: 230 GLPAVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHE 286
Query: 343 RPKQRPTMSTVVKTLEPL 360
           +  +RP +  V + L+ +
Sbjct: 287 KKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/318 (34%), Positives = 179/318 (56%), Gaps = 25/318 (7%)
Query: 54  EDLSISLAGSNLHVFTLAELKVTTQSFSS------SNFLGEGGFGAVHKGFIDDKLRPGL 107
           E+ S+ ++ +  H F+  ELK  T +F         N +GEGGFG V+KG++++      
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------ 54
Query: 108 QAQPVAVKNL----DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM 163
               VAVK L    D+   +  +++  E+  + + +H +LV+L+G+  + +   LVY YM
Sbjct: 55  --TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 164 PRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           P GSL ++L     +  L W  R KIA GAA G+ FLH  E   I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 170
Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           TAK+SDFGLA+   +   T +  R++GT  Y APE  + G +T  SD+YSFGVVLLE+++
Sbjct: 171 TAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229
Query: 283 GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSH 342
           G  +VD+ R    Q L++    + ++ + +   +D ++    S T      ++A QCL  
Sbjct: 230 GLPAVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHE 286
Query: 343 RPKQRPTMSTVVKTLEPL 360
           +  +RP +  V + L+ +
Sbjct: 287 KKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 108/312 (34%), Positives = 174/312 (55%), Gaps = 25/312 (8%)
Query: 60  LAGSNLHVFTLAELKVTTQSFSS------SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVA 113
           ++ +  H F+  ELK  T +F         N +GEGGFG V+KG++++          VA
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVA 52
Query: 114 VKNL----DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLE 169
           VK L    D+   +  +++  E+  + + +H +LV+L+G+  + +   LVY YMP GSL 
Sbjct: 53  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 112
Query: 170 NQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD 228
           ++L     +  L W  R KIA GAA G+ FLH  E   I+RD K++NILLD  +TAK+SD
Sbjct: 113 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISD 170
Query: 229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           FGLA+   +     +  R++GT  Y APE  + G +T  SD+YSFGVVLLE+++G  +VD
Sbjct: 171 FGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 229
Query: 289 KSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP 348
           + R    Q L++    + ++ + +   +D ++    S T      ++A QCL  +  +RP
Sbjct: 230 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRP 286
Query: 349 TMSTVVKTLEPL 360
            +  V + L+ +
Sbjct: 287 DIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 167/307 (54%), Gaps = 25/307 (8%)
Query: 63  SNLHVFTLAELKVTTQSFSS------SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN 116
           +  H F+  ELK  T +F         N  GEGGFG V+KG++++          VAVK 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNT--------TVAVKK 52
Query: 117 L----DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL 172
           L    D+   +  +++  E+    + +H +LV+L+G+  + +   LVY Y P GSL ++L
Sbjct: 53  LAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
Query: 173 -FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL 231
                +  L W  R KIA GAA G+ FLH  E   I+RD K++NILLD  +TAK+SDFGL
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 170
Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSR 291
           A+   +       +R++GT  Y APE  + G +T  SD+YSFGVVLLE+++G  +VD+ R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 292 PQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
               Q L++    + ++ + +   +D +     S T      ++A QCL  +  +RP + 
Sbjct: 230 --EPQLLLDIKEEIEDEEKTIEDYIDKKXNDADS-TSVEAXYSVASQCLHEKKNKRPDIK 286
Query: 352 TVVKTLE 358
            V + L+
Sbjct: 287 KVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 135/279 (48%), Gaps = 31/279 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR--EWLTEVIFLGQLRHPHL 143
           +G G FG VH        R       VAVK L  +     R  E+L EV  + +LRHP++
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDA 202
           V  +G   +  +  +V EY+ RGSL   L +  +   L    R+ +A   AKG+ +LH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
             P+++RD K+ N+L+D  YT K+ DFGL++   +      S    GT  + APE +   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR-LE 321
                SDVYSFGV+L EL + ++      P +  + V +         K  R+  PR L 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---------KCKRLEIPRNLN 265
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            Q         AA+   C ++ P +RP+ +T++  L PL
Sbjct: 266 PQ--------VAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 138/280 (49%), Gaps = 33/280 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR--EWLTEVIFLGQLRHPHL 143
           +G G FG VH        R       VAVK L  +     R  E+L EV  + +LRHP++
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDA 202
           V  +G   +  +  +V EY+ RGSL   L +  +   L    R+ +A   AKG+ +LH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVMT 261
             P+++R+ K+ N+L+D  YT K+ DFGL++       T +S++   GT  + APE +  
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR-L 320
                 SDVYSFGV+L EL + ++      P +  + V +         K  R+  PR L
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---------KCKRLEIPRNL 264
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             Q         AA+   C ++ P +RP+ +T++  L PL
Sbjct: 265 NPQ--------VAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 13  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV+E+M  G L + L R         T + + L   +G+A+L +A   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 121
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +A+PE     
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS--TGTKFPVKWASPEVFSFS 177
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL-- 226
Query: 323 QYSETGARKAAALAYQCLSH----RPKQRPTMSTVVKTLEPLKD 362
                    A+   YQ ++H    RP+ RP  S +++ L  + +
Sbjct: 227 ---------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 134/282 (47%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV+E+M  G L + L R         T + + L   +G+A+L +A   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--S 123
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +A+PE     
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS--TGTKFPVKWASPEVFSFS 179
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL  
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL-- 228
Query: 323 QYSETGARKAAALAYQCLSH----RPKQRPTMSTVVKTLEPL 360
                    A+   YQ ++H    RP+ RP  S +++ L  +
Sbjct: 229 ---------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 18  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV+E+M  G L + L R         T + + L   +G+A+L +A   
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 126
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +A+PE     
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS--TGTKFPVKWASPEVFSFS 182
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL  
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL-- 231
Query: 323 QYSETGARKAAALAYQCLSH----RPKQRPTMSTVVKTLEPLKD 362
                    A+   YQ ++H    RP+ RP  S +++ L  + +
Sbjct: 232 ---------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV+E+M  G L + L R         T + + L   +G+A+L +A   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 123
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +A+PE     
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS--TGTKFPVKWASPEVFSFS 179
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL  
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL-- 228
Query: 323 QYSETGARKAAALAYQCLSH----RPKQRPTMSTVVKTLEPLKD 362
                    A+   YQ ++H    RP+ RP  S +++ L  + +
Sbjct: 229 ---------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 35  IGSGQFGLVHLGY-------WLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV+E+M  G L + L R         T + + L   +G+A+L +A   
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 143
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +A+PE     
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS--TGTKFPVKWASPEVFSFS 199
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL  
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL-- 248
Query: 323 QYSETGARKAAALAYQCLSH----RPKQRPTMSTVVKTLEPLKD 362
                    A+   YQ ++H    RP+ RP  S +++ L  + +
Sbjct: 249 ---------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 134/284 (47%), Gaps = 42/284 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 16  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV E+M  G L + L R         T + + L   +G+A+L +A   
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 124
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD + S+   GT+    +A+PE     
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSS--TGTKFPVKWASPEVFSFS 180
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL  
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL-- 229
Query: 323 QYSETGARKAAALAYQCLSH----RPKQRPTMSTVVKTLEPLKD 362
                    A+   YQ ++H    RP+ RP  S +++ L  + +
Sbjct: 230 ---------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 135/283 (47%), Gaps = 30/283 (10%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G+GGFG VHKG  + DK    +++  +     + E ++  +E+  EV  +  L HP++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KL G         +V E++P G L ++L  + +  + WS ++++ L  A G+ ++ +   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 205 PVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           P+++RD ++ NI L S        AK++DFGL++        H  + ++G   + APE +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198
Query: 260 MTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
                  T  +D YSF ++L  +L+G    D+    + +         +N  R+ G    
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--------FINMIREEG---- 246
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             L     E    +   +   C S  PK+RP  S +VK L  L
Sbjct: 247 --LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 146/317 (46%), Gaps = 41/317 (12%)
Query: 71  AELKVTTQ----SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           A LK TT+      +    +G G FG V+KG +  K   G +  PVA+K L     +  R
Sbjct: 33  AVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQR 90
Query: 127 -EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR 185
            ++L E   +GQ  H ++++L G   + +  +++ EYM  G+L ++  R           
Sbjct: 91  VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQL 149
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTH 242
           + +  G A G+ +L  A    ++RD  A NIL++S+   K+SDFGL++   D PE   T 
Sbjct: 150 VGMLRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
              ++     + APE +     TS SDV+SFG+V+ E+++  +     RP  E S  E  
Sbjct: 208 SGGKI--PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVM 260
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK------- 355
           +  +ND  +L   MD                 L  QC      +RP  + +V        
Sbjct: 261 KA-INDGFRLPTPMD----------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309
Query: 356 ---TLEPLKDFDDDIAI 369
              +L+ L DFD  ++I
Sbjct: 310 APDSLKTLADFDPRVSI 326

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G+GGFG VHKG  + DK    +++  +     + E ++  +E+  EV  +  L HP++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KL G         +V E++P G L ++L  + +  + WS ++++ L  A G+ ++ +   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 205 PVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           P+++RD ++ NI L S        AK++DFG ++        H  + ++G   + APE +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAPETI 198
Query: 260 MTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
                  T  +D YSF ++L  +L+G    D+    + +         +N  R+ G    
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--------FINMIREEG---- 246
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             L     E    +   +   C S  PK+RP  S +VK L  L
Sbjct: 247 --LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G+GGFG VHKG  + DK    +++  +     + E ++  +E+  EV  +  L HP++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KL G         +V E++P G L ++L  + +  + WS ++++ L  A G+ ++ +   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 205 PVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           P+++RD ++ NI L S        AK++DF L++        H  + ++G   + APE +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAPETI 198
Query: 260 MTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
                  T  +D YSF ++L  +L+G    D+    + +         +N  R+ G    
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--------FINMIREEG---- 246
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             L     E    +   +   C S  PK+RP  S +VK L  L
Sbjct: 247 --LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 129/282 (45%), Gaps = 34/282 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V       KL        VAVK +  EG     E+  E   + +L HP LVK
Sbjct: 16  LGSGQFGVV-------KLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
             G C +E    +V EY+  G L N L R +   L  S  +++     +G+AFL   +  
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-- 124
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD  A N L+D D   K+SDFG+ +     DD +VS+  +GT+    ++APE     
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEVFHYF 180
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV++FG+++ E+ S  K         E  L            +  R+  P L  
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL---------KVSQGHRLYRPHL-- 229
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
                 +     + Y C    P++RPT   ++ ++EPL++ D
Sbjct: 230 -----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 139/304 (45%), Gaps = 34/304 (11%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           VF   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 61
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 62  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 180 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 224
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQY---SETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           L E     L++ + L  +MD    G Y    +    +   L   C    PK RPT   +V
Sbjct: 225 LAEQPYQGLSNEQVLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280
Query: 355 KTLE 358
             L+
Sbjct: 281 NLLK 284

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LGEG FG V   +  D    G   + VAVK L  +    HR  W  E+  L  L H H++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 145 KLIGYCCE---EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           K  G CCE   E+   LV EY+P GSL + L  R+S+ L  +  +  A    +G+A+LH 
Sbjct: 80  KYKG-CCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGL--AQLLLFAQQICEGMAYLHS 135
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYV 259
                I+R+  A N+LLD+D   K+ DFGLAK  PEG + +   R  G     + APE +
Sbjct: 136 QH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECL 192
Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                   SDV+SFGV L ELL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 139/304 (45%), Gaps = 34/304 (11%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           VF   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 227
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQY---SETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           L E     L++ + L  +MD    G Y    +    +   L   C    PK RPT   +V
Sbjct: 228 LAEQPYQGLSNEQVLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 355 KTLE 358
             L+
Sbjct: 284 NLLK 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LGEG FG V   +  D    G   + VAVK L  +    HR  W  E+  L  L H H++
Sbjct: 39  LGEGHFGKVSL-YCYDPTNDG-TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 145 KLIGYCCEEEHRL---LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           K  G CCE+       LV EY+P GSL + L  R+S+ L  +  +  A    +G+A+LH 
Sbjct: 97  KYKG-CCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGL--AQLLLFAQQICEGMAYLH- 151
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYV 259
             +  I+RD  A N+LLD+D   K+ DFGLAK  PEG + +   R  G     + APE +
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY-RVREDGDSPVFWYAPECL 209
Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                   SDV+SFGV L ELL+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/203 (38%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LGEG FG V   +  D    G   + VAVK L  +    HR  W  E+  L  L H H++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 145 KLIGYCCE---EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           K  G CCE   E+   LV EY+P GSL + L  R+S+ L  +  +  A    +G+A+LH 
Sbjct: 80  KYKG-CCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGL--AQLLLFAQQICEGMAYLH- 134
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYV 259
             +  I+R+  A N+LLD+D   K+ DFGLAK  PEG + +   R  G     + APE +
Sbjct: 135 -AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECL 192
Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                   SDV+SFGV L ELL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGLA+   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 149
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 152
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 156
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 217 QKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 152
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 151
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 210
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ FL  A 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--AS 151
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E + T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 117/225 (52%), Gaps = 13/225 (5%)
Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           GS   V   A+ ++   + S    +G G FG V  G +  KL P  +   VA+K L +  
Sbjct: 1   GSTQTVHEFAK-ELDATNISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGY 56
Query: 122 LQGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSL 180
            +  R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++    
Sbjct: 57  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQF 115
Query: 181 PWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPE 237
                + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE
Sbjct: 116 TVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 174 AAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 117/225 (52%), Gaps = 13/225 (5%)
Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           GS   V   A+ ++   + S    +G G FG V  G +  KL P  +   VA+K L +  
Sbjct: 18  GSTQTVHEFAK-ELDATNISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGY 73
Query: 122 LQGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSL 180
            +  R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++    
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQF 132
Query: 181 PWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPE 237
                + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE
Sbjct: 133 TVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 190
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 191 AAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 28/301 (9%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           VF   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 227
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           L E     L++ + L  +MD     Q  +    +   L   C    PK RPT   +V  L
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
Query: 358 E 358
           +
Sbjct: 287 K 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 33  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 86
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 87  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 145
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 146 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 203
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 204 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 115/222 (51%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V EYM  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL +   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 141/305 (46%), Gaps = 46/305 (15%)
Query: 64  NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           +LH+    E++V          +G G FG V K     K R    A+ VA+K ++ E  +
Sbjct: 2   SLHMIDYKEIEV-------EEVVGRGAFGVVCKA----KWR----AKDVAIKQIESESER 46
Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
             + ++ E+  L ++ HP++VKL G C       LV EY   GSL N L    +  LP+ 
Sbjct: 47  --KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHG--AEPLPYY 100
Query: 184 TR---MKIALGAAKGLAFLHDAE-KPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEG 238
           T    M   L  ++G+A+LH  + K +I+RD K  N+LL +  T  K+ DFG A D    
Sbjct: 101 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---- 156
Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL 298
             TH+ T   G+  + APE     + +   DV+S+G++L E+++ RK  D          
Sbjct: 157 IQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD---------- 205
Query: 299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            E   P       +     P L     +   +   +L  +C S  P QRP+M  +VK + 
Sbjct: 206 -EIGGPAFRIMWAVHNGTRPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 260
Query: 359 PLKDF 363
            L  +
Sbjct: 261 HLMRY 265

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 34/304 (11%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           V+   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 227
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQY---SETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           L E     L++ + L  +MD    G Y    +    +   L   C    P  RPT   +V
Sbjct: 228 LAEQPYQGLSNEQVLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 355 KTLE 358
             L+
Sbjct: 284 NLLK 287

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 141/305 (46%), Gaps = 46/305 (15%)
Query: 64  NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           +LH+    E++V          +G G FG V K     K R    A+ VA+K ++ E  +
Sbjct: 1   SLHMIDYKEIEV-------EEVVGRGAFGVVCKA----KWR----AKDVAIKQIESESER 45
Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
             + ++ E+  L ++ HP++VKL G C       LV EY   GSL N L    +  LP+ 
Sbjct: 46  --KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHG--AEPLPYY 99
Query: 184 TR---MKIALGAAKGLAFLHDAE-KPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEG 238
           T    M   L  ++G+A+LH  + K +I+RD K  N+LL +  T  K+ DFG A D    
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---- 155
Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL 298
             TH+ T   G+  + APE     + +   DV+S+G++L E+++ RK  D          
Sbjct: 156 IQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD---------- 204
Query: 299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            E   P       +     P L     +   +   +L  +C S  P QRP+M  +VK + 
Sbjct: 205 -EIGGPAFRIMWAVHNGTRPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
Query: 359 PLKDF 363
            L  +
Sbjct: 260 HLMRY 264

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 12/213 (5%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEV 132
           ++     +    +G G FG V  G +  KL PG +  PVA+K L +   +  R ++L E 
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRL--KL-PGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
             +GQ  HP+++ L G   + +  ++V EYM  GSL+    ++          + +  G 
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT-FLKKNDGQFTVIQLVGMLRGI 133
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMG 249
           + G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   T    ++  
Sbjct: 134 SAGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-- 189
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              + APE +     TS SDV+S+G+V+ E++S
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 133/297 (44%), Gaps = 42/297 (14%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           L++     +    +G GGFG V++ F I D++     A   A  + D +  Q       E
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEV-----AVKAARHDPDEDISQTIENVRQE 56
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
                 L+HP+++ L G C +E +  LV E+   G L   L  +    +P    +  A+ 
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQ 113
Query: 192 AAKGLAFLHD-AEKPVIYRDFKASNILLD--------SDYTAKLSDFGLAKDGPEGDDTH 242
            A+G+ +LHD A  P+I+RD K+SNIL+         S+   K++DFGLA++       H
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------WH 167
Query: 243 VSTRVMGTQGYA--APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE 300
            +T++     YA  APE +     +  SDV+S+GV+L ELL+G                 
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------------- 214
Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
             R +   A   G  M+ +L      T     A L   C +  P  RP+ + ++  L
Sbjct: 215 --RGIDGLAVAYGVAMN-KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V   +  D    G   + VAVK L +  G Q    W  E+  L  L H H+V
Sbjct: 17  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 145 KLIGYCCE---EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           K  G CCE   E+   LV EY+P GSL + L  R+ V L  +  +  A    +G+A+LH 
Sbjct: 75  KYKG-CCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGL--AQLLLFAQQICEGMAYLH- 129
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYV 259
             +  I+R   A N+LLD+D   K+ DFGLAK  PEG + +   R  G     + APE +
Sbjct: 130 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECL 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                   SDV+SFGV L ELL+
Sbjct: 188 KECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/203 (39%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V   +  D    G   + VAVK L +  G Q    W  E+  L  L H H+V
Sbjct: 16  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 145 KLIGYCCE---EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           K  G CCE   E+   LV EY+P GSL + L  R+ V L  +  +  A    +G+A+LH 
Sbjct: 74  KYKG-CCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGL--AQLLLFAQQICEGMAYLH- 128
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYV 259
             +  I+R   A N+LLD+D   K+ DFGLAK  PEG + +   R  G     + APE +
Sbjct: 129 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECL 186
Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
                   SDV+SFGV L ELL+
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT 209

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V E M  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 150
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 133/314 (42%), Gaps = 40/314 (12%)
Query: 42  VDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDD 101
           V L NP    L +    SL      VF + E             LGEG +G+V+K    +
Sbjct: 5   VQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK------------LGEGSYGSVYKAIHKE 52
Query: 102 KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE 161
                   Q VA+K + +E     +E + E+  + Q   PH+VK  G   +     +V E
Sbjct: 53  T------GQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104
Query: 162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD 221
           Y   GS+ + + R  + +L       I     KGL +LH   K  I+RD KA NILL+++
Sbjct: 105 YCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK--IHRDIKAGNILLNTE 161
Query: 222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
             AKL+DFG+A  G   D       V+GT  + APE +       ++D++S G+  +E+ 
Sbjct: 162 GHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219
Query: 282 SGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLS 341
            G+       P R   ++                 +P    +  E  +        QCL 
Sbjct: 220 EGKPPYADIHPMRAIFMIP---------------TNPPPTFRKPELWSDNFTDFVKQCLV 264
Query: 342 HRPKQRPTMSTVVK 355
             P+QR T + +++
Sbjct: 265 KSPEQRATATQLLQ 278

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 39/292 (13%)
Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L    L   +++  E   L  L+H H+
Sbjct: 23  LGEGAFGKV---FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLF--------------RRYSVSLPWSTRMKIA 189
           VK  G C + +  ++V+EYM  G L   L               R+    L  S  + IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A G+ +L  A +  ++RD    N L+ ++   K+ DFG+++D    D   V    M 
Sbjct: 140 SQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
              +  PE +M    T+ SDV+SFGV+L E+ +  K          Q   + +   + + 
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK----------QPWFQLSNTEVIEC 247
Query: 310 RKLGRIMD-PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
              GR+++ PR+         ++   +   C    P+QR  +  + K L  L
Sbjct: 248 ITQGRVLERPRV-------CPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 13/225 (5%)
Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           GS   V   A+ ++   + S    +G G FG V  G +  KL P  +   VA+K L +  
Sbjct: 1   GSTQTVHEFAK-ELDATNISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGY 56
Query: 122 LQGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSL 180
            +  R ++L E   +GQ  HP++++L G   + +  ++V E M  GSL++   R++    
Sbjct: 57  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS-FLRKHDAQF 115
Query: 181 PWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPE 237
                + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE
Sbjct: 116 TVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 174 AAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 28/301 (9%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           VF   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
                   + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 183 TAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 227
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           L E     L++ + L  +MD     Q  +    +   L   C    PK RPT   +V  L
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
Query: 358 E 358
           +
Sbjct: 287 K 287

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 15/222 (6%)
Query: 65  LHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
           +H F   EL  T  + S    +G G FG V  G +  KL P  +   VA+K L +   + 
Sbjct: 35  VHEFA-KELDAT--NISIDKVVGAGEFGEVCSGRL--KL-PSKKEISVAIKTLKVGYTEK 88
Query: 125 HR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
            R ++L E   +GQ  HP++++L G   + +  ++V E M  GSL++   R++       
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS-FLRKHDAQFTVI 147
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDD 240
             + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   D PE   
Sbjct: 148 QLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           T    ++     + +PE +     TS SDV+S+G+VL E++S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 145/310 (46%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 4   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 62
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRR 175
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L         
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 176 YSVSLP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             V  P   S  +++A   A G+A+L+ A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYLN-ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 227
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 228 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 284
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 285 ISSIKEEMEP 294

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 118/245 (48%), Gaps = 13/245 (5%)
Query: 45  SNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNF---LGEGGFGAVHKGFIDD 101
           S+ SS  L   + I L+  N  +    +  V   S    +F   +G G FG V+ G + D
Sbjct: 12  SDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD 71
Query: 102 KLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR-LLV 159
                +     AVK+L+ +  +    ++LTE I +    HP+++ L+G C   E   L+V
Sbjct: 72  NDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 128
Query: 160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
             YM  G L N   R  + +      +   L  AKG+ +L  A K  ++RD  A N +LD
Sbjct: 129 LPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLD 185
Query: 220 SDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVL 277
             +T K++DFGLA+D    E    H  T       + A E + T   T+ SDV+SFGV+L
Sbjct: 186 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 245
Query: 278 LELLS 282
            EL++
Sbjct: 246 WELMT 250

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 84  NFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHP 141
             +G G  G V  G    +LR PG +  PVA+K L     +  R ++L+E   +GQ  HP
Sbjct: 55  KIIGSGDSGEVCYG----RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++++L G        ++V EYM  GSL+    R +         + +  G   G+ +L D
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEY 258
                ++RD  A N+L+DS+   K+SDFGL++   D P+   T    ++     + APE 
Sbjct: 170 LG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEA 225
Query: 259 VMTGHLTSMSDVYSFGVVLLELLS 282
           +     +S SDV+SFGVV+ E+L+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 145/310 (46%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   VF   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 59
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRR 175
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L         
Sbjct: 60  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 119
Query: 176 YSVSLP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             V  P   S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 224
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 225 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 281
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 282 ISSIKEEMEP 291

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLV 144
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 24  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP------WSTRMKIALGAAKGL 196
           +L+G   + +  L+V E M  G L++ L   R  + + P          +++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E D      + +    + AP
Sbjct: 143 AYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +  G  T+ SD++SFGVVL E+                SL E     L++ + L  +M
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 245
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           D     Q  +    +   L   C    PK RPT   +V  L+
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 142/301 (47%), Gaps = 32/301 (10%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLT 130
           E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++       R E+L 
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLN 62
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRRYSVSLP--W 182
           E   + +    H+V+L+G   + +  L++ E M RG L++ L           V  P   
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
           S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +D  E D   
Sbjct: 123 SKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
              + +    + +PE +  G  T+ SDV+SFGVVL E+                +L E  
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQP 225
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT----MSTVVKTLE 358
              L++ + L  +M+  L  +  +        L   C  + PK RP+    +S++ + +E
Sbjct: 226 YQGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEME 284
Query: 359 P 359
           P
Sbjct: 285 P 285

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 116/242 (47%), Gaps = 13/242 (5%)
Query: 48  SSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNF---LGEGGFGAVHKGFIDDKLR 104
           SS  L   + I L+  N  +    +  V   S    +F   +G G FG V+ G + D   
Sbjct: 16  SSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG 75
Query: 105 PGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR-LLVYEY 162
             +     AVK+L+ +  +    ++LTE I +    HP+++ L+G C   E   L+V  Y
Sbjct: 76  KKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 132
Query: 163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           M  G L N   R  + +      +   L  AKG+ +L  A K  ++RD  A N +LD  +
Sbjct: 133 MKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKF 189
Query: 223 TAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLEL 280
           T K++DFGLA+D    E    H  T       + A E + T   T+ SDV+SFGV+L EL
Sbjct: 190 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249
Query: 281 LS 282
           ++
Sbjct: 250 MT 251

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 151
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 84  NFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHP 141
             +G G  G V  G    +LR PG +  PVA+K L     +  R ++L+E   +GQ  HP
Sbjct: 55  KIIGSGDSGEVCYG----RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++++L G        ++V EYM  GSL+    R +         + +  G   G+ +L D
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEY 258
                ++RD  A N+L+DS+   K+SDFGL++   D P+   T    ++     + APE 
Sbjct: 170 LG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEA 225
Query: 259 VMTGHLTSMSDVYSFGVVLLELLS 282
           +     +S SDV+SFGVV+ E+L+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 151
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG--AAKGLAFLHD 201
            L+G C   E   L+V  YM  G L N  F R     P + +  I  G   AKG+ +L  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYV 259
           A K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 260 MTGHLTSMSDVYSFGVVLLELLS 282
            T   T+ SDV+SFGV+L EL++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 146
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT 227

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V  G +  KL PG +   VA+K L +   +  R ++L E   +GQ  HP++V
Sbjct: 51  IGAGEFGEVCSGRL--KL-PGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            L G     +  ++V E+M  G+L +   R++         + +  G A G+ +L  A+ 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL--ADM 164
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
             ++RD  A NIL++S+   K+SDFGL++   D PE   T    ++     + APE +  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQY 222
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              TS SDV+S+G+V+ E++S
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 148
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 146/310 (47%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 68
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVS 179
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L   R    +
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 180 LP------WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
            P       S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 233
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 234 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 291 ISSIKEEMEP 300

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 143
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 204 QKFTTKSDVWSFGVLLWELMT 224

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 28/301 (9%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           V+   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 65
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 66  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 125
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++R+  A N ++  D+T K+ DFG+ +D  E
Sbjct: 126 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 183
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 184 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 228
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           L E     L++ + L  +MD     Q  +    +   L   C    P  RPT   +V  L
Sbjct: 229 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287
Query: 358 E 358
           +
Sbjct: 288 K 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D     +     AVK+L+ +  +    ++LTE I +    HP+++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 145 KLIGYCCEEEHR-LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N   R  + +      +   L  AKG+ +L  A 
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--AS 149
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E + T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              T+ SDV+SFGV+L EL++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 28/301 (9%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGH 125
           V+   E +V+ +  +    LG+G FG V++G   D ++ G     VAVK ++    L+  
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRER 64
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   +      H+V+L+G   + +  L+V E M  G L++ L   R  + + P  
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   +++A   A G+A+L+   K  ++R+  A N ++  D+T K+ DFG+ +D  E
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + APE +  G  T+ SD++SFGVVL E+                S
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 227
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           L E     L++ + L  +MD     Q  +    +   L   C    P  RPT   +V  L
Sbjct: 228 LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286
Query: 358 E 358
           +
Sbjct: 287 K 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 145/310 (46%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRR 175
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L         
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 176 YSVSLP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             V  P   S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 226
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 227 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 283
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 284 ISSIKEEMEP 293

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 145/310 (46%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 68
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRR 175
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L         
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 128
Query: 176 YSVSLP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             V  P   S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 233
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 234 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 291 ISSIKEEMEP 300

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V +G +     PG +   VA+K L     +  R E+L+E   +GQ  HP+++
Sbjct: 24  IGAGEFGEVCRGRLK---APGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G        +++ E+M  G+L++   R           + +  G A G+ +L  AE 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDS-FLRLNDGQFTVIQLVGMLRGIASGMRYL--AEM 137
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMT 261
             ++RD  A NIL++S+   K+SDFGL++   E       T  +G +    + APE +  
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              TS SD +S+G+V+ E++S
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 145/306 (47%), Gaps = 32/306 (10%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++       R
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 62
Query: 127 -EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLP-- 181
            E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L   R    + P  
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 123 APPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + +PE +  G  T+ SDV+SFGVVL E+                +
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------AT 225
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT----MSTV 353
           L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    +S++
Sbjct: 226 LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284
Query: 354 VKTLEP 359
            + +EP
Sbjct: 285 KEEMEP 290

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 145/310 (46%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRR 175
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L         
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 176 YSVSLP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             V  P   S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 226
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 227 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 283
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 284 ISSIKEEMEP 293

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 64
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 65  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 124 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 181
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 182 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 229
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 230 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 145/310 (46%), Gaps = 32/310 (10%)
Query: 63  SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL 122
           S   V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++    
Sbjct: 4   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 62
Query: 123 QGHR-EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRR 175
              R E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L         
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 176 YSVSLP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
             V  P   S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +
Sbjct: 123 NPVLAPPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           D  E D      + +    + +PE +  G  T+ SDV+SFGVVL E+             
Sbjct: 181 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------------- 227
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT---- 349
              +L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    
Sbjct: 228 --ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 284
Query: 350 MSTVVKTLEP 359
           +S++ + +EP
Sbjct: 285 ISSIKEEMEP 294

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 60
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 61  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 119
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 120 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 177
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 178 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 225
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 226 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 67
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 68  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 126
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 127 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 184
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 185 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 232
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 233 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 15  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 66
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 67  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 125
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 126 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 183
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 184 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 231
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 232 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 58
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 118 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 176 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 223
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 224 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 59
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 60  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 118
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 119 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 176
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 177 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 224
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 225 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 58
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 118 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 176 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 223
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 224 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 144/306 (47%), Gaps = 32/306 (10%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++       R
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 94
Query: 127 -EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRRYSVS 179
            E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L           V 
Sbjct: 95  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 180 LP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
            P   S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +D  E
Sbjct: 155 APPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + +PE +  G  T+ SDV+SFGVVL E+                +
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------AT 257
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT----MSTV 353
           L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    +S++
Sbjct: 258 LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316
Query: 354 VKTLEP 359
            + +EP
Sbjct: 317 KEEMEP 322

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 64
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 65  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 124 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 181
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 182 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 229
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 230 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 63
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 64  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 122
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 123 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 180
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 181 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 228
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 229 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V +G +     PG +   VA+K L     +  R E+L+E   +GQ  HP+++
Sbjct: 22  IGAGEFGEVCRGRLK---APGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G        +++ E+M  G+L++   R           + +  G A G+ +L  AE 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDS-FLRLNDGQFTVIQLVGMLRGIASGMRYL--AEM 135
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMT 261
             ++RD  A NIL++S+   K+SDFGL++   E       T  +G +    + APE +  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              TS SD +S+G+V+ E++S
Sbjct: 196 RKFTSASDAWSYGIVMWEVMS 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 86  LGEGGFGAVHKGFI--DDKLRPGLQAQPVAVKNL------DLEGLQGHREWLTEVIFLGQ 137
           +G G FG V  G +  D+ L        VAVK+       DL+      ++L E   L Q
Sbjct: 122 IGRGNFGEVFSGRLRADNTL--------VAVKSCRETLPPDLKA-----KFLQEARILKQ 168
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
             HP++V+LIG C +++   +V E +  G       R     L   T +++   AA G+ 
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           +L    K  I+RD  A N L+      K+SDFG++++  +G              + APE
Sbjct: 228 YLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE 285
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
            +  G  +S SDV+SFG++L E  S G         Q+ +  VE          K GR+ 
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRLP 335
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
            P       E        L  QC ++ P QRP+ ST+ + L+ ++
Sbjct: 336 CP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 58
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 118 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 176 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 223
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 224 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 17  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 68
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 69  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 127
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 128 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 185
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 186 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 233
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 234 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 2   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 53
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 54  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 112
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+RD +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 113 IAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 170
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 171 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 218
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 219 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L        +++  E   L  L+H H+
Sbjct: 21  LGEGAFGKV---FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS------------VSLPWSTRMKIALG 191
           VK  G C E +  ++V+EYM  G L N+  R +               L  S  + IA  
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A G+ +L  A +  ++RD    N L+  +   K+ DFG+++D    D   V    M   
Sbjct: 137 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +  PE +M    T+ SDV+S GVVL E+ +
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 142/301 (47%), Gaps = 32/301 (10%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLT 130
           E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++       R E+L 
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLN 64
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRRYSVSLP--W 182
           E   + +    H+V+L+G   + +  L++ E M RG L++ L           V  P   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
           S  +++A   A G+A+L +A K  ++RD  A N ++  D+T K+ DFG+ +D  E D   
Sbjct: 125 SKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
              + +    + +PE +  G  T+ SDV+SFGVVL E+                +L E  
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQP 227
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT----MSTVVKTLE 358
              L++ + L  +M+  L  +  +        L   C  + PK RP+    +S++ + +E
Sbjct: 228 YQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 286
Query: 359 P 359
           P
Sbjct: 287 P 287

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 143/306 (46%), Gaps = 32/306 (10%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           V+   E +V  +  + S  LG+G FG V++G     ++   + + VA+K ++       R
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 59
Query: 127 -EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRRYSVS 179
            E+L E   + +    H+V+L+G   + +  L++ E M RG L++ L           V 
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 180 LP--WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
            P   S  +++A   A G+A+L +A K  ++RD  A N  +  D+T K+ DFG+ +D  E
Sbjct: 120 APPSLSKMIQMAGEIADGMAYL-NANK-FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            D      + +    + +PE +  G  T+ SDV+SFGVVL E+                +
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------AT 222
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT----MSTV 353
           L E     L++ + L  +M+  L  +  +        L   C  + PK RP+    +S++
Sbjct: 223 LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281
Query: 354 VKTLEP 359
            + +EP
Sbjct: 282 KEEMEP 287

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 48/288 (16%)
Query: 86  LGEGGFGAVHKGFI--DDKLRPGLQAQPVAVKNL------DLEGLQGHREWLTEVIFLGQ 137
           +G G FG V  G +  D+ L        VAVK+       DL+      ++L E   L Q
Sbjct: 122 IGRGNFGEVFSGRLRADNTL--------VAVKSCRETLPPDLKA-----KFLQEARILKQ 168
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
             HP++V+LIG C +++   +V E +  G       R     L   T +++   AA G+ 
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST---RVMGTQGYA 254
           +L    K  I+RD  A N L+      K+SDFG++++  E D  + ++   R +  + + 
Sbjct: 228 YLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVK-WT 282
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
           APE +  G  +S SDV+SFG++L E  S G         Q+ +  VE          K G
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGG 332
Query: 314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
           R+  P       E        L  QC ++ P QRP+ ST+ + L+ ++
Sbjct: 333 RLPCP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V  G    +L+ PG +   VA+K L      +  R++L+E   +GQ  HP++
Sbjct: 37  IGVGEFGEVCSG----RLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           + L G   + +  +++ EYM  GSL +   R+          + +  G   G+ +L D  
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEYVM 260
              ++RD  A NIL++S+   K+SDFG+++   D PE   T    ++     + APE + 
Sbjct: 152 --AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIA 207
Query: 261 TGHLTSMSDVYSFGVVLLELLS 282
               TS SDV+S+G+V+ E++S
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMS 229

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V  G +  KL PG +   VA+K L     +  R ++L+E   +GQ  HP+++
Sbjct: 41  IGAGEFGEVCSGHL--KL-PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            L G   +    +++ E+M  GSL++   R+          + +  G A G+ +L D   
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDS-FLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN- 155
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMT 261
             ++RD  A NIL++S+   K+SDFGL++   +       T  +G +    + APE +  
Sbjct: 156 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              TS SDV+S+G+V+ E++S
Sbjct: 215 RKFTSASDVWSYGIVMWEVMS 235

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGL-QGHREWLTE 131
           ++          +G G FG V  G    +L+ PG +   VA+K L      +  R++L+E
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSG----RLKVPGKREICVAIKTLKAGYTDKQRRDFLSE 65
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              +GQ  HP+++ L G   + +  +++ EYM  GSL +   R+          + +  G
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRG 124
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVM 248
              G+ +L D     ++RD  A NIL++S+   K+SDFG+++   D PE   T    ++ 
Sbjct: 125 IGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 181
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
               + APE +     TS SDV+S+G+V+ E++S
Sbjct: 182 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGL-QGHREWLTE 131
           ++          +G G FG V  G    +L+ PG +   VA+K L      +  R++L+E
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSG----RLKVPGKREICVAIKTLKAGYTDKQRRDFLSE 59
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              +GQ  HP+++ L G   + +  +++ EYM  GSL +   R+          + +  G
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRG 118
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVM 248
              G+ +L D     ++RD  A NIL++S+   K+SDFG+++   D PE   T    ++ 
Sbjct: 119 IGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 175
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
               + APE +     TS SDV+S+G+V+ E++S
Sbjct: 176 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E +V  ++      LG G FG V  G+ +   +       VAVK+L  +G      +L E
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAE 54
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
              + QL+H  LV+L     +E   ++  EYM  GSL + L     + L  +  + +A  
Sbjct: 55  ANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 113
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+AF+   E+  I+R+ +A+NIL+    + K++DFGLA+   + + T         +
Sbjct: 114 IAEGMAFIE--ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 171
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDA 309
            + APE +  G  T  SDV+SFG++L E+++ GR      + P+  Q+L           
Sbjct: 172 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------- 219
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  R++ P       +    +   L   C   RP+ RPT   +   LE
Sbjct: 220 ERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 25/288 (8%)
Query: 83  SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHP 141
           +  LGEG FG V++G   +     +    VAVK    +  L    ++++E + +  L HP
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 85
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           H+VKLIG   EEE   ++ E  P G L + L R  + SL   T +  +L   K +A+L  
Sbjct: 86  HIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLES 143
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
                ++RD    NIL+ S    KL DFGL++   E +D + ++       + +PE +  
Sbjct: 144 IN--CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              T+ SDV+ F V + E+LS  K        ++         ++    K  R+  P L 
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDRLPKPDLC 251
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAI 369
                T       L  +C  + P  RP  + +V +L  +   + DIA+
Sbjct: 252 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 292

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 25/288 (8%)
Query: 83  SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHP 141
           +  LGEG FG V++G   +     +    VAVK    +  L    ++++E + +  L HP
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 69
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           H+VKLIG   EEE   ++ E  P G L + L R  + SL   T +  +L   K +A+L  
Sbjct: 70  HIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLES 127
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
                ++RD    NIL+ S    KL DFGL++   E +D + ++       + +PE +  
Sbjct: 128 IN--CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              T+ SDV+ F V + E+LS  K        ++         ++    K  R+  P L 
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDRLPKPDLC 235
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAI 369
                T       L  +C  + P  RP  + +V +L  +   + DIA+
Sbjct: 236 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 276

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 25/288 (8%)
Query: 83  SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHP 141
           +  LGEG FG V++G   +     +    VAVK    +  L    ++++E + +  L HP
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           H+VKLIG   EEE   ++ E  P G L + L R  + SL   T +  +L   K +A+L  
Sbjct: 74  HIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLES 131
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
                ++RD    NIL+ S    KL DFGL++   E +D + ++       + +PE +  
Sbjct: 132 IN--CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              T+ SDV+ F V + E+LS  K        ++         ++    K  R+  P L 
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDRLPKPDLC 239
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAI 369
                T       L  +C  + P  RP  + +V +L  +   + DIA+
Sbjct: 240 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L        +++  E   L  L+H H+
Sbjct: 49  LGEGAFGKV---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--------------LPWSTRMKIA 189
           V+  G C E    L+V+EYM  G L N+  R +                 L     + +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A G+ +L  A    ++RD    N L+      K+ DFG+++D    D   V  R M 
Sbjct: 165 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
              +  PE ++    T+ SDV+SFGVVL E+ +  K     +P  + S  E A   +   
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK-----QPWYQLSNTE-AIDCITQG 276
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           R+L R   PR           +  A+   C    P+QR ++  V   L+ L
Sbjct: 277 RELER---PR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L        +++  E   L  L+H H+
Sbjct: 20  LGEGAFGKV---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--------------LPWSTRMKIA 189
           V+  G C E    L+V+EYM  G L N+  R +                 L     + +A
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A G+ +L  A    ++RD    N L+      K+ DFG+++D    D   V  R M 
Sbjct: 136 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
              +  PE ++    T+ SDV+SFGVVL E+ +  K     +P  + S  E A   +   
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK-----QPWYQLSNTE-AIDCITQG 247
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           R+L R   PR           +  A+   C    P+QR ++  V   L+ L
Sbjct: 248 RELER---PR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 288

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 86  LGEGGFGAVHKGFIDD--KLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG V   F+ +   L P      VAVK L        +++  E   L  L+H H+
Sbjct: 26  LGEGAFGKV---FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--------------LPWSTRMKIA 189
           V+  G C E    L+V+EYM  G L N+  R +                 L     + +A
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A G+ +L  A    ++RD    N L+      K+ DFG+++D    D   V  R M 
Sbjct: 142 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
              +  PE ++    T+ SDV+SFGVVL E+ +  K     +P  + S  E A   +   
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK-----QPWYQLSNTE-AIDCITQG 253
Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           R+L R   PR           +  A+   C    P+QR ++  V   L+ L
Sbjct: 254 RELER---PR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 294

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           +G G FG V  G +  KL PG +   VA+K L     +  R ++L+E   +GQ  HP+++
Sbjct: 15  IGAGEFGEVCSGHL--KL-PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            L G   +    +++ E+M  GSL++   R+          + +  G A G+ +L D   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDS-FLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN- 129
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMT 261
             ++R   A NIL++S+   K+SDFGL++   +       T  +G +    + APE +  
Sbjct: 130 -YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 262 GHLTSMSDVYSFGVVLLELLS 282
              TS SDV+S+G+V+ E++S
Sbjct: 189 RKFTSASDVWSYGIVMWEVMS 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P L       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 78  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 132
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 191
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P L       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 76  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 130
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P L       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 80
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 81  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 135
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 194
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ K  G   ++    ++ EY+  GS  + L          +T ++  L   KGL +
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 139
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 140 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 195
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +      S +D++S G+  +EL  G     +  P +   L+    P             P
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------P 242
Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEG YS    +        CL+  P  RPT   ++K
Sbjct: 243 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P L       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 103
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 104 LIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 158
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 217
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P L       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 79  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 133
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 192
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P L       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 72
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 73  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 127
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 186
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G  G V  G+ +   +       VAVK+L  +G      +L E   + QL+H  LV+
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +E   ++  EYM  GSL + L     + L  +  + +A   A+G+AF+   E+ 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD +A+NIL+    + K++DFGLA+   + + T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYGTFT 188
Query: 266 SMSDVYSFGVVLLELLS-GRKSV-DKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
             SDV+SFG++L E+++ GR      + P+  Q+L            +  R++ P     
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRP----- 232
Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             +    +   L   C   RP+ RPT   +   LE
Sbjct: 233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +  +     + +L E   + QLRH +LV+
Sbjct: 20  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 69
Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 128
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGH 263
             ++RD  A N+L+  D  AK+SDFGL K+     DT  +  +      + APE +    
Sbjct: 129 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAA 181
Query: 264 LTSMSDVYSFGVVLLELLS 282
            ++ SDV+SFG++L E+ S
Sbjct: 182 FSTKSDVWSFGILLWEIYS 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +  +     + +L E   + QLRH +LV+
Sbjct: 29  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 137
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGH 263
             ++RD  A N+L+  D  AK+SDFGL K+     DT  +  +      + APE +    
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 190
Query: 264 LTSMSDVYSFGVVLLELLS 282
            ++ SDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +  +     + +L E   + QLRH +LV+
Sbjct: 14  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63
Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 122
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGH 263
             ++RD  A N+L+  D  AK+SDFGL K+     DT  +  +      + APE +    
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 175
Query: 264 LTSMSDVYSFGVVLLELLS 282
            ++ SDV+SFG++L E+ S
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +  +     + +L E   + QLRH +LV+
Sbjct: 201 IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGH 263
             ++RD  A N+L+  D  AK+SDFGL K+     DT  +  +      + APE +    
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 362
Query: 264 LTSMSDVYSFGVVLLELLS 282
            ++ SDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ K  G   ++    ++ EY+  GS  + L          +T ++  L   KGL +
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 134
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 135 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEV 190
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +      S +D++S G+  +EL  G     +  P +   L+    P             P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------P 237
Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEG YS    +        CL+  P  RPT   ++K
Sbjct: 238 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ K  G   ++    ++ EY+  GS  + L          +T ++  L   KGL +
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 119
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 120 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +      S +D++S G+  +EL  G     +  P +   L+    P             P
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------P 222
Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEG YS    +        CL+  P  RPT   ++K
Sbjct: 223 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P +       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R+YS+ L  ++ +  A   +  LA+L    K
Sbjct: 76  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES--K 130
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P +       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R++S+ L  ++ +  A   +  LA+L    K
Sbjct: 76  LIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES--K 130
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +      S   +  + + APE +     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESINFRRF 189
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ K  G   ++    ++ EY+  GS  + L          +T ++  L   KGL +
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 119
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 120 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +      S +D++S G+  +EL  G     +  P +   L+    P             P
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------P 222
Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEG YS    +        CL+  P  RPT   ++K
Sbjct: 223 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 128/300 (42%), Gaps = 46/300 (15%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHL 143
           LGEG FG V K      K R G     VAVK L         R+ L+E   L Q+ HPH+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----------------------SLP 181
           +KL G C ++   LL+ EY   GSL   L     V                      +L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
               +  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL++D  E D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE 300
              ++      + A E +     T+ SDV+SFGV+L E+++ G        P+R  +L+ 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL- 265
Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                     K G  M      +  +  + +   L  QC    P +RP  + + K LE +
Sbjct: 266 ----------KTGHRM------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 90/325 (27%), Positives = 142/325 (43%), Gaps = 39/325 (12%)
Query: 48  SSTTLSE-DLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG 106
           +ST +++ + + S AG    +  L E  V  ++ +    LG G FG V++G +      G
Sbjct: 2   TSTIMTDYNPNYSFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS-----G 54
Query: 107 LQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE 161
           +   P    VAVK L ++   Q   ++L E + + +L H ++V+ IG   +   R ++ E
Sbjct: 55  MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLE 114
Query: 162 YMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNI 216
            M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD  A N 
Sbjct: 115 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNC 172
Query: 217 LLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSF 273
           LL        AK+ DFG+A+D             M    +  PE  M G  TS +D +SF
Sbjct: 173 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 232
Query: 274 GVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAA 333
           GV+L E+ S       S+  +E         +L      GR MDP       +       
Sbjct: 233 GVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNCPGPVY 276
Query: 334 ALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  QC  H+P+ RP  + +++ +E
Sbjct: 277 RIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 128/300 (42%), Gaps = 46/300 (15%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHL 143
           LGEG FG V K      K R G     VAVK L         R+ L+E   L Q+ HPH+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----------------------SLP 181
           +KL G C ++   LL+ EY   GSL   L     V                      +L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
               +  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL++D  E D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE 300
              ++      + A E +     T+ SDV+SFGV+L E+++ G        P+R  +L+ 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL- 265
Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                     K G  M      +  +  + +   L  QC    P +RP  + + K LE +
Sbjct: 266 ----------KTGHRM------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 128/300 (42%), Gaps = 46/300 (15%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHL 143
           LGEG FG V K      K R G     VAVK L         R+ L+E   L Q+ HPH+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----------------------SLP 181
           +KL G C ++   LL+ EY   GSL   L     V                      +L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
               +  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL++D  E D  
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE 300
              ++      + A E +     T+ SDV+SFGV+L E+++ G        P+R  +L+ 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL- 265
Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                     K G  M      +  +  + +   L  QC    P +RP  + + K LE +
Sbjct: 266 ----------KTGHRM------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 31/277 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+  + +G+G FG V+KG ID+  +     + VA+K +DLE  +   E +  E+  L Q 
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
             P++ +  G   +     ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDY 131
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH   K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + APE 
Sbjct: 132 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +        +D++S G+  +EL  G        P R   L+    P             P
Sbjct: 188 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------P 234
Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            LEGQ+S+       A    CL+  P+ RPT   ++K
Sbjct: 235 TLEGQHSKPFKEFVEA----CLNKDPRFRPTAKELLK 267

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH--A 138
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--- 260
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR-IMDPR 319
           +   +  SDVY+FG+VL EL++G+  +  S       ++E           +GR  + P 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIE----------MVGRGSLSPD 246
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           L    S    R    +A +CL  +  +RP+   ++  +E L
Sbjct: 247 LSKVRSNCPKRMKRLMA-ECLKKKRDERPSFPRILAEIEEL 286

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 119/232 (51%), Gaps = 18/232 (7%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A+L++  ++       LG G FG V+KG     +  G   + PVA+K L +  G + + E
Sbjct: 7   AQLRILKETELKRVKVLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVE 63
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           ++ E + +  + HPHLV+L+G C     +L V + MP G L  +    +  ++     + 
Sbjct: 64  FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCL-LEYVHEHKDNIGSQLLLN 121
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
             +  AKG+ +L   E+ +++RD  A N+L+ S    K++DFGLA+   EGD+   +   
Sbjct: 122 WCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKEYNAD- 177
Query: 248 MGTQ---GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
            G +    + A E +     T  SDV+S+GV + EL++ G K  D   P RE
Sbjct: 178 -GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 126/259 (48%), Gaps = 33/259 (12%)
Query: 49  STTLSEDLSISLAGSNLHVFTLAELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGL 107
            T L E L+ S    N      A+L++  ++       LG G FG V+KG     +  G 
Sbjct: 13  ETELVEPLTPSGTAPNQ-----AQLRILKETELKRVKVLGSGAFGTVYKGIW---VPEGE 64
Query: 108 QAQ-PVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPR 165
             + PVA+K L +  G + + E++ E + +  + HPHLV+L+G C     +L V + MP 
Sbjct: 65  TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPH 123
Query: 166 GSLENQLFRRY-----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS 220
           G L   +          + L W  ++      AKG+ +L   E+ +++RD  A N+L+ S
Sbjct: 124 GCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKS 175
Query: 221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTGHLTSMSDVYSFGVVL 277
               K++DFGLA+   EGD+   +    G +    + A E +     T  SDV+S+GV +
Sbjct: 176 PNHVKITDFGLARLL-EGDEKEYNAD--GGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 232
Query: 278 LELLS-GRKSVDKSRPQRE 295
            EL++ G K  D   P RE
Sbjct: 233 WELMTFGGKPYD-GIPTRE 250

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 141/330 (42%), Gaps = 40/330 (12%)
Query: 44  LSNPSSTTLSEDLS--ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDD 101
           LS   ++T+  D +   S AG    +  L E  V  ++ +    LG G FG V++G +  
Sbjct: 23  LSKLRTSTIMTDYNPNYSFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS- 79
Query: 102 KLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR 156
               G+   P    VAVK L ++   Q   ++L E + + +  H ++V+ IG   +   R
Sbjct: 80  ----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 135
Query: 157 LLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDF 211
            ++ E M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD 
Sbjct: 136 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDI 193
Query: 212 KASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS 268
            A N LL        AK+ DFG+A+D             M    +  PE  M G  TS +
Sbjct: 194 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT 253
Query: 269 DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG 328
           D +SFGV+L E+ S       S+  +E         +L      GR MDP       +  
Sbjct: 254 DTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNC 297
Query: 329 ARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                 +  QC  H+P+ RP  + +++ +E
Sbjct: 298 PGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 141/325 (43%), Gaps = 39/325 (12%)
Query: 48  SSTTLSE-DLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG 106
           +ST +++ + + S AG    +  L E  V  ++ +    LG G FG V++G +      G
Sbjct: 2   TSTIMTDYNPNYSFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS-----G 54
Query: 107 LQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE 161
           +   P    VAVK L ++   Q   ++L E + + +  H ++V+ IG   +   R ++ E
Sbjct: 55  MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 114
Query: 162 YMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNI 216
            M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD  A N 
Sbjct: 115 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNC 172
Query: 217 LLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSF 273
           LL        AK+ DFG+A+D             M    +  PE  M G  TS +D +SF
Sbjct: 173 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 232
Query: 274 GVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAA 333
           GV+L E+ S       S+  +E         +L      GR MDP       +       
Sbjct: 233 GVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNCPGPVY 276
Query: 334 ALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  QC  H+P+ RP  + +++ +E
Sbjct: 277 RIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY    +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH--A 138
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--- 260
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR-IMDPR 319
           +   +  SDVY+FG+VL EL++G+  +  S       ++E           +GR  + P 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIE----------MVGRGSLSPD 246
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           L    S    R    +A +CL  +  +RP+   ++  +E L
Sbjct: 247 LSKVRSNCPKRMKRLMA-ECLKKKRDERPSFPRILAEIEEL 286

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 107/251 (42%), Gaps = 30/251 (11%)
Query: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182
           +  R +L EV  +  L HP+++K IG   +++    + EY+  G+L   + +      PW
Sbjct: 49  ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPW 107
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA------KDGP 236
           S R+  A   A G+A+LH     +I+RD  + N L+  +    ++DFGLA      K  P
Sbjct: 108 SQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 237 EG------DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
           EG       D      V+G   + APE +         DV+SFG+VL E++ GR + D  
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPD 224
Query: 291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
              R           LN    L R   P     +     R        C    P++RP+ 
Sbjct: 225 YLPRTMDF------GLNVRGFLDRYCPPNCPPSFFPITVR--------CCDLDPEKRPSF 270
Query: 351 STVVKTLEPLK 361
             +   LE L+
Sbjct: 271 VKLEHWLETLR 281

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 37/304 (12%)
Query: 69  TLAELK-VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGL 122
           ++++LK V  ++ +    LG G FG V++G +      G+   P    VAVK L ++   
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSE 89
Query: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLP 181
           Q   ++L E + + +L H ++V+ IG   +   R ++ E M  G L++ L   R   S P
Sbjct: 90  QDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 149
Query: 182 WSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKD 234
            S  M     +A   A G  +L   E   I+RD  A N LL        AK+ DFG+A+D
Sbjct: 150 SSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR 294
                        M    +  PE  M G  TS +D +SFGV+L E+ S       S+  +
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267
Query: 295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           E         +L      GR MDP       +        +  QC  H+P+ RP  + ++
Sbjct: 268 E---------VLEFVTSGGR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311
Query: 355 KTLE 358
           + +E
Sbjct: 312 ERIE 315

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 141/330 (42%), Gaps = 40/330 (12%)
Query: 44  LSNPSSTTLSEDLS--ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDD 101
           LS   ++T+  D +   S AG    +  L E  V  ++ +    LG G FG V++G +  
Sbjct: 3   LSKLRTSTIMTDYNPNYSFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS- 59
Query: 102 KLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR 156
               G+   P    VAVK L ++   Q   ++L E + + +  H ++V+ IG   +   R
Sbjct: 60  ----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 115
Query: 157 LLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDF 211
            ++ E M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD 
Sbjct: 116 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDI 173
Query: 212 KASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS 268
            A N LL        AK+ DFG+A+D             M    +  PE  M G  TS +
Sbjct: 174 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT 233
Query: 269 DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG 328
           D +SFGV+L E+ S       S+  +E         +L      GR MDP       +  
Sbjct: 234 DTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNC 277
Query: 329 ARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                 +  QC  H+P+ RP  + +++ +E
Sbjct: 278 PGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P +       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 455
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG   E     ++ E    G L + L  R++S+ L  ++ +  A   +  LA+L    K
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES--K 510
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPEYV 259
             ++RD  A N+L+ S+   KL DFGL++   +      ST    ++G     + APE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESI 564
Query: 260 MTGHLTSMSDVYSFGVVLLELL 281
                TS SDV+ FGV + E+L
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 141/325 (43%), Gaps = 39/325 (12%)
Query: 48  SSTTLSE-DLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG 106
           +ST +++ + + S AG    +  L E  V  ++ +    LG G FG V++G +      G
Sbjct: 2   TSTIMTDYNPNYSFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS-----G 54
Query: 107 LQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE 161
           +   P    VAVK L ++   Q   ++L E + + +  H ++V+ IG   +   R ++ E
Sbjct: 55  MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 114
Query: 162 YMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNI 216
            M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD  A N 
Sbjct: 115 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNC 172
Query: 217 LLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSF 273
           LL        AK+ DFG+A+D             M    +  PE  M G  TS +D +SF
Sbjct: 173 LLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 232
Query: 274 GVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAA 333
           GV+L E+ S       S+  +E         +L      GR MDP       +       
Sbjct: 233 GVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNCPGPVY 276
Query: 334 ALAYQCLSHRPKQRPTMSTVVKTLE 358
            +  QC  H+P+ RP  + +++ +E
Sbjct: 277 RIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQL 138
           F+    +G+G FG V KG ID++ +     Q VA+K +DLE  +   E +  E+  L Q 
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC 78
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL----FRRYSVSLPWSTRMKIALGAAK 194
              ++ K  G   +     ++ EY+  GS  + L    F  + ++    T +K  L   K
Sbjct: 79  DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA----TMLKEIL---K 131
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL +LH  +K  I+RD KA+N+LL      KL+DFG+A  G   D        +GT  + 
Sbjct: 132 GLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 187
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
           APE +      S +D++S G+  +EL  G        P R   L+    P          
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---------- 237
Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              P L G ++++      A    CL+  P  RPT   ++K
Sbjct: 238 ---PTLVGDFTKSFKEFIDA----CLNKDPSFRPTAKELLK 271

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 114/225 (50%), Gaps = 15/225 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           LG G FG+V +G      R   +   VA+K L  +G +     E + E   + QL +P++
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+LIG  C+ E  +LV E    G L   L  +    +P S   ++    + G+ +L   E
Sbjct: 73  VRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE--E 128
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMT 261
           K  ++RD  A N+LL + + AK+SDFGL+K     DD++ + R  G     + APE +  
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 262 GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM 305
              +S SDV+S+GV + E LS G+K   K +     + +E  + M
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 20  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 71  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH--A 126
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--- 260
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR-IMDPR 319
           +   +  SDVY+FG+VL EL++G+  +  S       ++E           +GR  + P 
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIE----------MVGRGSLSPD 234
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           L    S    R    +A +CL  +  +RP+   ++  +E L
Sbjct: 235 LSKVRSNCPKRMKRLMA-ECLKKKRDERPSFPRILAEIEEL 274

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 14/217 (6%)
Query: 73  LKVTTQSFSSSNF-----LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNL-DLEGLQGH 125
           +KV  + F  +       LG G FG VHKG +I +     +   PV +K + D  G Q  
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI---PVCIKVIEDKSGRQSF 59
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR 185
           +     ++ +G L H H+V+L+G C     +L V +Y+P GSL + + R++  +L     
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGPQLL 117
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +   +  AKG+ +L   E  +++R+  A N+LL S    +++DFG+A   P  D   + +
Sbjct: 118 LNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + A E +  G  T  SDV+S+GV + EL++
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLT 130
           K + Q F     LG G FG VH       +R     +  A+K L  E    L+       
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHL------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 55
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E + L  + HP ++++ G   + +   ++ +Y+  G L + L  R S   P       A 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAA 113
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
                L +LH   K +IYRD K  NILLD +   K++DFG AK  P+     V+  + GT
Sbjct: 114 EVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGT 166
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             Y APE V T       D +SFG+++ E+L+G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 123/286 (43%), Gaps = 36/286 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRH 140
           LG G FG V++G +      G+   P    VAVK L ++   Q   ++L E + + +  H
Sbjct: 53  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNH 107
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKG 195
            ++V+ IG   +   R ++ E M  G L++ L   R   S P S  M     +A   A G
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
             +L   E   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 168 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           +  PE  M G  TS +D +SFGV+L E+ S       S+  +E         +L      
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSG 276
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           GR MDP       +        +  QC  H+P+ RP  + +++ +E
Sbjct: 277 GR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 74  KVTTQSFSSSNF-----LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNL-DLEGLQGHR 126
           KV  + F  +       LG G FG VHKG +I +     +   PV +K + D  G Q  +
Sbjct: 22  KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI---PVCIKVIEDKSGRQSFQ 78
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
                ++ +G L H H+V+L+G C     +L V +Y+P GSL + + R++  +L     +
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGPQLLL 136
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
              +  AKG+ +L   E  +++R+  A N+LL S    +++DFG+A   P  D   + + 
Sbjct: 137 NWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                 + A E +  G  T  SDV+S+GV + EL++
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 133/304 (43%), Gaps = 37/304 (12%)
Query: 69  TLAELK-VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGL 122
           ++++LK V  ++ +    LG G FG V++G +      G+   P    VAVK L ++   
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSE 74
Query: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLP 181
           Q   ++L E + + +  H ++V+ IG   +   R ++ E M  G L++ L   R   S P
Sbjct: 75  QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 134
Query: 182 WSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKD 234
            S  M     +A   A G  +L   E   I+RD  A N LL        AK+ DFG+A+D
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR 294
                        M    +  PE  M G  TS +D +SFGV+L E+ S       S+  +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           E         +L      GR MDP       +        +  QC  H+P+ RP  + ++
Sbjct: 253 E---------VLEFVTSGGR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296
Query: 355 KTLE 358
           + +E
Sbjct: 297 ERIE 300

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 123/286 (43%), Gaps = 36/286 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRH 140
           LG G FG V++G +      G+   P    VAVK L ++   Q   ++L E + + +  H
Sbjct: 53  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 107
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKG 195
            ++V+ IG   +   R ++ E M  G L++ L   R   S P S  M     +A   A G
Sbjct: 108 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
             +L   E   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 168 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           +  PE  M G  TS +D +SFGV+L E+ S       S+  +E         +L      
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSG 276
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           GR MDP       +        +  QC  H+P+ RP  + +++ +E
Sbjct: 277 GR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 132
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V          + APE + T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 237
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 238 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 133/304 (43%), Gaps = 37/304 (12%)
Query: 69  TLAELK-VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGL 122
           ++++LK V  ++ +    LG G FG V++G +      G+   P    VAVK L ++   
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSE 74
Query: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLP 181
           Q   ++L E + + +  H ++V+ IG   +   R ++ E M  G L++ L   R   S P
Sbjct: 75  QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP 134
Query: 182 WSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKD 234
            S  M     +A   A G  +L   E   I+RD  A N LL        AK+ DFG+A+D
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR 294
                        M    +  PE  M G  TS +D +SFGV+L E+ S       S+  +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           E         +L      GR MDP       +        +  QC  H+P+ RP  + ++
Sbjct: 253 E---------VLEFVTSGGR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296
Query: 355 KTLE 358
           + +E
Sbjct: 297 ERIE 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 90/330 (27%), Positives = 140/330 (42%), Gaps = 40/330 (12%)
Query: 44  LSNPSSTTLSEDLS--ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDD 101
           LS   ++T+  D +     AG    +  L E  V  ++ +    LG G FG V++G +  
Sbjct: 13  LSKLRTSTIMTDYNPNYCFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS- 69
Query: 102 KLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR 156
               G+   P    VAVK L ++   Q   ++L E + + +  H ++V+ IG   +   R
Sbjct: 70  ----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 125
Query: 157 LLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDF 211
            ++ E M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD 
Sbjct: 126 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDI 183
Query: 212 KASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS 268
            A N LL        AK+ DFG+A+D             M    +  PE  M G  TS +
Sbjct: 184 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT 243
Query: 269 DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG 328
           D +SFGV+L E+ S       S+  +E         +L      GR MDP       +  
Sbjct: 244 DTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNC 287
Query: 329 ARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                 +  QC  H+P+ RP  + +++ +E
Sbjct: 288 PGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 133/304 (43%), Gaps = 37/304 (12%)
Query: 69  TLAELK-VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGL 122
           ++++LK V  ++ +    LG G FG V++G +      G+   P    VAVK L ++   
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSE 66
Query: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLP 181
           Q   ++L E + + +  H ++V+ IG   +   R ++ E M  G L++ L   R   S P
Sbjct: 67  QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 126
Query: 182 WSTRM----KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKD 234
            S  M     +A   A G  +L   E   I+RD  A N LL        AK+ DFG+A+D
Sbjct: 127 SSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 184
Query: 235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR 294
                        M    +  PE  M G  TS +D +SFGV+L E+ S       S+  +
Sbjct: 185 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 244
Query: 295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           E         +L      GR MDP       +        +  QC  H+P+ RP  + ++
Sbjct: 245 E---------VLEFVTSGGR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 288
Query: 355 KTLE 358
           + +E
Sbjct: 289 ERIE 292

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 82  SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRH 140
           S   +G+G FG V+ G   D+ +  +Q    A+K+L  +  +Q    +L E + +  L H
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQC---AIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 141 PHLVKLIGYCCEEE---HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           P+++ LIG     E   H LL   YM  G L  Q  R    +      +   L  A+G+ 
Sbjct: 82  PNVLALIGIMLPPEGLPHVLL--PYMCHGDL-LQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD----DTHVSTRVMGTQGY 253
           +L  AE+  ++RD  A N +LD  +T K++DFGLA+D  + +      H   R+     +
Sbjct: 139 YL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKW 194
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            A E + T   T+ SDV+SFGV+L ELL+
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 90/330 (27%), Positives = 140/330 (42%), Gaps = 40/330 (12%)
Query: 44  LSNPSSTTLSEDLS--ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDD 101
           LS   ++T+  D +     AG    +  L E  V  ++ +    LG G FG V++G +  
Sbjct: 14  LSKLRTSTIMTDYNPNYCFAGKTSSISDLKE--VPRKNITLIRGLGHGAFGEVYEGQVS- 70
Query: 102 KLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR 156
               G+   P    VAVK L ++   Q   ++L E + + +  H ++V+ IG   +   R
Sbjct: 71  ----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 126
Query: 157 LLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKGLAFLHDAEKPVIYRDF 211
            ++ E M  G L++ L   R   S P S  M     +A   A G  +L   E   I+RD 
Sbjct: 127 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDI 184
Query: 212 KASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS 268
            A N LL        AK+ DFG+A+D             M    +  PE  M G  TS +
Sbjct: 185 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKT 244
Query: 269 DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG 328
           D +SFGV+L E+ S       S+  +E         +L      GR MDP       +  
Sbjct: 245 DTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSGGR-MDP------PKNC 288
Query: 329 ARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                 +  QC  H+P+ RP  + +++ +E
Sbjct: 289 PGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 123/286 (43%), Gaps = 36/286 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQP----VAVKNL-DLEGLQGHREWLTEVIFLGQLRH 140
           LG G FG V++G +      G+   P    VAVK L ++   Q   ++L E + + +  H
Sbjct: 79  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRM----KIALGAAKG 195
            ++V+ IG   +   R ++ E M  G L++ L   R   S P S  M     +A   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
             +L   E   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 194 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           +  PE  M G  TS +D +SFGV+L E+ S       S+  +E         +L      
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEFVTSG 302
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           GR MDP       +        +  QC  H+P+ RP  + +++ +E
Sbjct: 303 GR-MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 327 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 436
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 486
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 487 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 233
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 353
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 403
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 404 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P +       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG    E    ++ E    G L + L  R++S+ L  ++ +  A   +  LA+L    K
Sbjct: 76  LIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES--K 130
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ +    KL DFGL++   +      S   +  + + APE +     
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 265 TSMSDVYSFGVVLLELL 281
           TS SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 353
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 403
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 404 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 132
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V          + APE + T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 237
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 238 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G+ ++  +       VAVK L   G    + +L E   +  L+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   ++ EYM +GSL + L       +     +  +   A+G+A++    K 
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 130
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD +A+N+L+      K++DFGLA+   + + T         + + APE +  G  T
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFT 189
Query: 266 SMSDVYSFGVVLLELLS 282
             SDV+SFG++L E+++
Sbjct: 190 IKSDVWSFGILLYEIVT 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 11  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 67
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 125
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 126 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 184 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG FG VH+G       P +       KN   + ++   ++L E + + Q  HPH+VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 455
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           LIG   E     ++ E    G L + L  R++S+ L  ++ +  A   +  LA+L    K
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES--K 510
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPEYV 259
             ++RD  A N+L+ +    KL DFGL++   +      ST    ++G     + APE +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESI 564
Query: 260 MTGHLTSMSDVYSFGVVLLELL 281
                TS SDV+ FGV + E+L
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 233
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 63
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 122 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 121/240 (50%), Gaps = 14/240 (5%)
Query: 53  SEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-P 111
           +E+L    +G   +   L  LK T   F     LG G FG V+KG     +  G + + P
Sbjct: 17  TENLYFQGSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIP 71
Query: 112 VAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLEN 170
           VA+K L +    + ++E L E   +  + +PH+ +L+G C     +L+  + MP G L +
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 130
Query: 171 QLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG 230
            + R +  ++     +   +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG
Sbjct: 131 YV-REHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFG 187
Query: 231 LAK-DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
           LAK  G E  + H     +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 188 LAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V          + APE + T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 243
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 8   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 64
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 122
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 123 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 181 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 28/273 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD +A+NIL+  +   K++DFGLA+   + + T         + + APE  + G  T
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFT 193
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV+SFG++L EL +  +        RE         +L+   +  R+  P       
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP------- 237
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                    L  QC    P++RPT   +   LE
Sbjct: 238 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 28/273 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 67
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 68  LYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 124
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD +A+NIL+  +   K++DFGLA+   + + T         + + APE  + G  T
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFT 183
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV+SFG++L EL +  +        RE         +L+   +  R+  P       
Sbjct: 184 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP------- 227
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                    L  QC    P++RPT   +   LE
Sbjct: 228 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 65
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 124 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 17  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 73
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 74  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 131
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 132 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 190 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 66
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 125 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 1   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 57
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 58  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 115
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 116 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 174 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 122
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 231
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 232 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 65
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 124 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 36  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 87  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 142
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 251
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 252 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 14  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 70
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 129 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 13  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 69
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 70  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 127
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 128 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 186 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 117/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 8   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 64
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYV-REHKDNIGSQYLLN 122
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 123 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 181 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 353
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 403
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 404 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 66
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 125 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 63
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 122 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 70
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 71  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 127
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTAR----QGAKFPIKWTAPEAA 180
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 230
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 231 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 95  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 150
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 259
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 260 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 63
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 122 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 66
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 125 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 66
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 125 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 63
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYV-REHKDNIGSQYLLN 121
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 122 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 15/225 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           LG G FG+V +G      R   +   VA+K L  +G +     E + E   + QL +P++
Sbjct: 344 LGCGNFGSVRQGVY----RMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+LIG  C+ E  +LV E    G L   L  +    +P S   ++    + G+ +L   E
Sbjct: 399 VRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE--E 454
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMT 261
           K  ++R+  A N+LL + + AK+SDFGL+K     DD++ + R  G     + APE +  
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 262 GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM 305
              +S SDV+S+GV + E LS G+K   K +     + +E  + M
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 558

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 18  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPES 188
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 241
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 242 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD  V          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 233
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 25  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 137
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 195
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 248
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 249 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 298

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 23  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 135
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 193
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 246
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 247 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 296

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLG 136
           FS    +G G FGAV+        R    ++ VA+K +   G Q + +W   + EV FL 
Sbjct: 17  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           +LRHP+ ++  G    E    LV EY   GS  + L   +   L       +  GA +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+LH     +I+RD KA NILL      KL DFG A      +        +GT  + AP
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAP 180
Query: 257 EYVMT---GHLTSMSDVYSFGVVLLEL 280
           E ++    G      DV+S G+  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLG 136
           FS    +G G FGAV+        R    ++ VA+K +   G Q + +W   + EV FL 
Sbjct: 56  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           +LRHP+ ++  G    E    LV EY   GS  + L   +   L       +  GA +GL
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+LH     +I+RD KA NILL      KL DFG A           +   +GT  + AP
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAP 219
Query: 257 EYVMT---GHLTSMSDVYSFGVVLLEL 280
           E ++    G      DV+S G+  +EL
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 36  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 148
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 206
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 259
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 260 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 18  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 188
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 241
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 242 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 66
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 67  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 123
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTAR----QGAKFPIKWTAPEAA 176
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 226
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 227 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 24  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 136
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 194
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 247
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 248 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 297

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 21  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 244
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 245 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 68
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 69  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 125
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 178
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 228
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 229 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 17  LGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 129
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 187
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 240
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 241 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 49  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 161
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 219
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 272
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 273 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G       ++ V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ-GYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD  V          + APE + T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +               W    LN ++ L +I      
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE-------------PWIG--LNGSQILHKIDKEGER 243
Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPT 349
               E   +    +  QC +H+P+ RPT
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 36  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 148
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 206
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 259
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 260 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 117/225 (52%), Gaps = 13/225 (5%)
Query: 69  TLAELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGH 125
            +A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + +
Sbjct: 2   AMALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKAN 58
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR 185
           +E L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     
Sbjct: 59  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYL 116
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVS 244
           +   +  A+G+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H  
Sbjct: 117 LNWCVQIAEGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
              +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 175 GGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 22  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 134
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 192
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 245
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 246 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 295

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 16  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 128
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 186
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 239
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 240 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 289

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 18  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 188
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 241
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 242 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           + L   NL+  ++ + ++     +  + LG G +G V+ G           +  VAVK L
Sbjct: 12  VDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKK------YSLTVAVKTL 65
Query: 118 DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS 177
             + ++   E+L E   + +++HP+LV+L+G C  E    +V EYMP G+L + L     
Sbjct: 66  KEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR 124
Query: 178 VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
             +     + +A   +  + +L   +K  I+RD  A N L+  ++  K++DFGL++    
Sbjct: 125 EEVTAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT- 181
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLEL 280
           GD             + APE +     +  SDV++FGV+L E+
Sbjct: 182 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 135/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 19  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L 
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 131
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+R+    NIL++++   K+ DFGL K  P+ D  +   +  G     + APE 
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPES 189
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 242
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 243 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 292

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 262
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 263 KLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + ++RH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 196 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 303
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 304 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 72  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 127
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 236
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 237 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 83
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 144 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 251
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 252 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 296

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 72  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 127
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 236
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 237 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 33/292 (11%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           ++  +S      LG G FG V     +   +       VAVK +   G      +L E  
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEAN 62
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            +  L+H  LVKL     +E    ++ E+M +GSL + L        P    +  +   A
Sbjct: 63  VMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 121
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +G+AF+   ++  I+RD +A+NIL+ +    K++DFGLA+   + + T         + +
Sbjct: 122 EGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-W 178
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            APE +  G  T  SDV+SFG++L+E+++ GR                 + P +  A + 
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----------SNPEVIRALER 227
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
           G  M PR      E    +   +  +C  +RP++RPT   +   L+   DF+
Sbjct: 228 GYRM-PR-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD---DFE 270

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 122
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 231
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 232 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + ++   A G+A++      
Sbjct: 75  LYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN-- 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTAR----QGAKFPIKWTAPEAA 184
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 234
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 235 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 21  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ EY+P GSL + L + ++  +     ++      KG+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYL- 133
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 244
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 245 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 18  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 69  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 124
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 233
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 234 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 86
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 147 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 254
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 255 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 299

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 43  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 94  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 149
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 258
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 259 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 87
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 148 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 255
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 256 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 300

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD  A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLI---EDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY  + +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 95  LLFMGYSTKPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 150
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 259
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 260 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 262
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +G L + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 29/217 (13%)
Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPH 142
           + +GEG FG V K  I    + GL+      +  +      HR++  E+  L +L  HP+
Sbjct: 21  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV---------------SLPWSTRMK 187
           ++ L+G C    +  L  EY P G+L +   R+  V               +L     + 
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  ++K  I+RD  A NIL+  +Y AK++DFGL++    G + +V  + 
Sbjct: 137 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 189
Query: 248 MGT--QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           MG     + A E +     T+ SDV+S+GV+L E++S
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +S                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 262
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 30/286 (10%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           ++  +S      LG G FG V     +   +       VAVK +   G      +L E  
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEAN 235
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            +  L+H  LVKL     +E   ++  E+M +GSL + L        P    +  +   A
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +G+AF+   ++  I+RD +A+NIL+ +    K++DFGLA+   + + T         + +
Sbjct: 295 EGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-W 351
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            APE +  G  T  SDV+SFG++L+E+++ GR       P    S  E  R +    R  
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI------PYPGMSNPEVIRALERGYRM- 404
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                PR      E    +   +  +C  +RP++RPT   +   L+
Sbjct: 405 -----PR-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 245 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 301
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGL   G   +D   + R    QG      + APE  
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGL---GRLIEDNEYTAR----QGAKFPIKWTAPEAA 354
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 355 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 404
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 405 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 129/301 (42%), Gaps = 33/301 (10%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHRE 127
           L ++ +  Q F+    LG+G FG+V +  +  +    ++   VAVK L  D+       E
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK---VAVKMLKADIIASSDIEE 71
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHR------LLVYEYMPRGSLENQLFR----RYS 177
           +L E   + +  HPH+ KL+G       +      +++  +M  G L   L         
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 178 VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
            +LP  T ++  +  A G+ +L  + +  I+RD  A N +L  D T  ++DFGL++    
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
           GD             + A E +     T  SDV++FGV + E++        +R Q   +
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM--------TRGQTPYA 241
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
            +E A  + N      R+  P            +   L YQC S  PKQRP+ + +   L
Sbjct: 242 GIENAE-IYNYLIGGNRLKQP-------PECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
Query: 358 E 358
           E
Sbjct: 294 E 294

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 29/217 (13%)
Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPH 142
           + +GEG FG V K  I    + GL+      +  +      HR++  E+  L +L  HP+
Sbjct: 31  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV---------------SLPWSTRMK 187
           ++ L+G C    +  L  EY P G+L +   R+  V               +L     + 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  ++K  I+RD  A NIL+  +Y AK++DFGL++    G + +V  + 
Sbjct: 147 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 199
Query: 248 MGT--QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           MG     + A E +     T+ SDV+S+GV+L E++S
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 11  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 67
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 125
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG AK  G E  + H    
Sbjct: 126 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 184 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 118/273 (43%), Gaps = 28/273 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + ++   A G+A++      
Sbjct: 75  LYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN-- 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD +A+NIL+  +   K++DFGLA+   + + T         + + APE  + G  T
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTAPEAALYGRFT 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV+SFG++L EL +  +        RE         +L+   +  R+  P       
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP------- 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                    L  QC    P++RPT   +   LE
Sbjct: 235 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 65
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG AK  G E  + H    
Sbjct: 124 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           ++  +S      LG G FG V  G  +   +       VA+K L   G      +L E  
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTK-------VAIKTLK-PGTMSPESFLEEAQ 56
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            + +L+H  LV+L      EE   +V EYM +GSL + L      +L     + +A   A
Sbjct: 57  IMKKLKHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVA 115
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            G+A++       I+RD +++NIL+ +    K++DFGLA+   + + T         + +
Sbjct: 116 AGMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-W 172
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            APE  + G  T  SDV+SFG++L EL++
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     L  G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 14  ALLRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 70
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 129 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +G L + L       L     + +A   A G+A++      
Sbjct: 78  LYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEYV 259
            ++RD +A+NIL+  +   K++DFGLA+     +D   + R    QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTAR----QGAKFPIKWTAPEAA 187
Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
           + G  T  SDV+SFG++L EL +  +        RE         +L+   +  R+  P 
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCP- 237
Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                          L  QC    P++RPT   +   LE
Sbjct: 238 ------PECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 65
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L++ + MP G L + + R +  ++     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG AK  G E  + H    
Sbjct: 124 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+  L +    + ++E
Sbjct: 41  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIMELREATSPKANKE 97
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 98  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 155
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 156 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 214 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 30/280 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY    +   +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH--A 122
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+         R+Q +    R  L+          P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS----------PDL 231
Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               S    +    L  +CL  +  +RP    ++ ++E L
Sbjct: 232 SKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 65
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG AK  G E  + H    
Sbjct: 124 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     L  G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 14  ALLRILKETEFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 70
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H    
Sbjct: 129 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 12/213 (5%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHREWLTEVIFLGQ 137
           F     L  G FG V+KG     +  G + + PVA+K L +    + ++E L E   +  
Sbjct: 17  FKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           + +PH+ +L+G C     +L+  + MP G L + + R +  ++     +   +  AKG+ 
Sbjct: 74  VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTRVMGTQGYAAP 256
           +L D  + +++RD  A N+L+ +    K++DFGLAK  G E  + H     +  + + A 
Sbjct: 132 YLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMAL 188
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
           E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 126/286 (44%), Gaps = 40/286 (13%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           ++  +S      LG G FG V     +   +       VAVK +   G      +L E  
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEAN 229
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            +  L+H  LVKL     +E   ++  E+M +GSL + L        P    +  +   A
Sbjct: 230 VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 288
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +G+AF+   ++  I+RD +A+NIL+ +    K++DFGLA+ G +               +
Sbjct: 289 EGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-----------FPIKW 335
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            APE +  G  T  SDV+SFG++L+E+++ GR                 + P +  A + 
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----------SNPEVIRALER 384
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
           G  M PR      E    +   +  +C  +RP++RPT   +   L+
Sbjct: 385 GYRM-PR-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +F    LK  +Q       LG+G FG+V     D  L     A  VAVK L   G    R
Sbjct: 6   IFEERHLKYISQ-------LGKGNFGSVELCRYD-PLGDNTGAL-VAVKQLQHSGPDQQR 56
Query: 127 EWLTEVIFLGQLRHPHLVKLIG--YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
           ++  E+  L  L    +VK  G  Y    +   LV EY+P G L +   +R+   L  S 
Sbjct: 57  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASR 115
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
            +  +    KG+ +L    +  ++RD  A NIL++S+   K++DFGLAK  P   D +V 
Sbjct: 116 LLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV- 172
Query: 245 TRVMGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            R  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G+ ++  +       VAVK L   G    + +L E   +  L+H  LV+
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +EE   ++ E+M +GSL + L       +     +  +   A+G+A++    K 
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 129
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD +A+N+L+      K++DFGLA+   + + T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFT 188
Query: 266 SMSDVYSFGVVLLELLS 282
             S+V+SFG++L E+++
Sbjct: 189 IKSNVWSFGILLYEIVT 205

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 63
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG AK  G E  + H    
Sbjct: 122 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 43/297 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ---AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG+V     D      LQ    + VAVK L     +  R++  E+  L  L+H +
Sbjct: 21  LGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 143 LVKLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +VK  G C     R   L+ E++P GSL   L +++   +     ++      KG+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEY 258
              K  I+RD    NIL++++   K+ DFGL K  P+ D      +  G     + APE 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA--------- 309
           +     +  SDV+SFGVVL EL +    ++KS+        E+ R + ND          
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----SPPAEFMRMIGNDKQGQMIVFHL 244
Query: 310 ----RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               +  GR+  PR +G   E        +  +C ++   QRP+   +   ++ ++D
Sbjct: 245 IELLKNNGRL--PRPDGCPDEI-----YMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNL-DLEGLQGHRE 127
           A L++  ++ F     LG G FG V+KG     +  G + + PVA+K L +    + ++E
Sbjct: 14  ALLRILKETEFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKE 70
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E   +  + +PH+ +L+G C     +L+  + MP G L + + R +  ++     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGDDTHVSTR 246
             +  AKG+ +L D  + +++RD  A N+L+ +    K++DFG AK  G E  + H    
Sbjct: 129 WCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD 288
            +  + + A E ++    T  SDV+S+GV + EL++ G K  D
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 108/245 (44%), Gaps = 28/245 (11%)
Query: 46  NPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRP 105
           +PS  + +E++ +SLA          + +VT   F     LG+G FG V        ++ 
Sbjct: 124 SPSDNSGAEEMEVSLAKP--------KHRVTMNEFEYLKLLGKGTFGKV------ILVKE 169
Query: 106 GLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYE 161
               +  A+K L  E +    E    LTE   L   RHP L  L  Y  +   RL  V E
Sbjct: 170 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVME 228
Query: 162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGA--AKGLAFLHDAEKPVIYRDFKASNILLD 219
           Y   G L   L R    S     R +   GA     L +LH +EK V+YRD K  N++LD
Sbjct: 229 YANGGELFFHLSRERVFS---EDRARF-YGAEIVSALDYLH-SEKNVVYRDLKLENLMLD 283
Query: 220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLE 279
            D   K++DFGL K+G +  D        GT  Y APE +         D +  GVV+ E
Sbjct: 284 KDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 280 LLSGR 284
           ++ GR
Sbjct: 342 MMCGR 346

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHLV 144
           LGEG FG V     D +       + VAVK+L  E    H  +   E+  L  L H ++V
Sbjct: 29  LGEGHFGKVELCRYDPE--GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 145 KLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           K  G C E+      L+ E++P GSL+  L +  +  +    ++K A+   KG+ +L   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL--G 143
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYVM 260
            +  ++RD  A N+L++S++  K+ DFGL K   E D    + +        + APE +M
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 261 TGHLTSMSDVYSFGVVLLELLS 282
                  SDV+SFGV L ELL+
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +F    LK  +Q       LG+G FG+V     D  L     A  VAVK L   G    R
Sbjct: 7   IFEERHLKYISQ-------LGKGNFGSVELCRYD-PLGDNTGAL-VAVKQLQHSGPDQQR 57
Query: 127 EWLTEVIFLGQLRHPHLVKLIG--YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
           ++  E+  L  L    +VK  G  Y    +   LV EY+P G L +   +R+   L  S 
Sbjct: 58  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASR 116
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
            +  +    KG+ +L    +  ++RD  A NIL++S+   K++DFGLAK  P   D +V 
Sbjct: 117 LLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV- 173
Query: 245 TRVMGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            R  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 17  LGTGQFGVVKYG----KWRG---QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 125
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD + S+R  G++    ++ PE +M  
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSR--GSKFPVRWSPPEVLMYS 181
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L  
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL-- 230
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                 + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 231 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 108/243 (44%), Gaps = 24/243 (9%)
Query: 46  NPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRP 105
           +PS  + +E++ +SLA          + +VT   F     LG+G FG V        ++ 
Sbjct: 127 SPSDNSGAEEMEVSLAK--------PKHRVTMNEFEYLKLLGKGTFGKV------ILVKE 172
Query: 106 GLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYE 161
               +  A+K L  E +    E    LTE   L   RHP L  L  Y  +   RL  V E
Sbjct: 173 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVME 231
Query: 162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD 221
           Y   G L   L R    S   +      + +A  L +LH +EK V+YRD K  N++LD D
Sbjct: 232 YANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH-SEKNVVYRDLKLENLMLDKD 288
Query: 222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
              K++DFGL K+G +  D        GT  Y APE +         D +  GVV+ E++
Sbjct: 289 GHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 346
Query: 282 SGR 284
            GR
Sbjct: 347 CGR 349

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +                 + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 140 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 247
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 248 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHLV 144
           LGEG FG V     D +       + VAVK+L  E    H   L  E+  L  L H ++V
Sbjct: 17  LGEGHFGKVELCRYDPE--GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 145 KLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           K  G C E+      L+ E++P GSL+  L +  +  +    ++K A+   KG+ +L   
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL--G 131
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG--YAAPEYVM 260
            +  ++RD  A N+L++S++  K+ DFGL K   E D    + +        + APE +M
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 261 TGHLTSMSDVYSFGVVLLELLS 282
                  SDV+SFGV L ELL+
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +F    LK  +Q       LG+G FG+V     D  L     A  VAVK L   G    R
Sbjct: 19  IFEERHLKYISQ-------LGKGNFGSVELCRYD-PLGDNTGAL-VAVKQLQHSGPDQQR 69
Query: 127 EWLTEVIFLGQLRHPHLVKLIG--YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
           ++  E+  L  L    +VK  G  Y    +   LV EY+P G L +   +R+   L  S 
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASR 128
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
            +  +    KG+ +L    +  ++RD  A NIL++S+   K++DFGLAK  P   D +V 
Sbjct: 129 LLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV- 185
Query: 245 TRVMGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            R  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 19  LGGGQFGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 71
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 266 SMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
             SDV++FGV+L E+ + G        P +   L+E                D R+E   
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------------KDYRMER-- 231
Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            E    K   L   C    P  RP+ + + +  E +
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +   VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MK 187
           +++ L+G C ++    ++ EY  +G+L   L  R    L +                 + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T  
Sbjct: 155 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV+L E+ +   S     P  E          L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------LF 262
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 29/217 (13%)
Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPH 142
           + +GEG FG V K  I    + GL+      +  +      HR++  E+  L +L  HP+
Sbjct: 28  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV---------------SLPWSTRMK 187
           ++ L+G C    +  L  EY P G+L +   R+  V               +L     + 
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            A   A+G+ +L  ++K  I+R+  A NIL+  +Y AK++DFGL++    G + +V  + 
Sbjct: 144 FAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 196
Query: 248 MGT--QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           MG     + A E +     T+ SDV+S+GV+L E++S
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKG-FIDDKLRPGLQA--QPVAVKNLDLEGLQGHREW 128
           ++K+  + F     LG+G FG V    F        ++A  + V + + D+E     +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L+         HP L  +      +E+   V EY+  G L   +   +   L  +T    
Sbjct: 72  LSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--Y 124
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A     GL FLH   K ++YRD K  NILLD D   K++DFG+ K+   GD    +    
Sbjct: 125 AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFC 180
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 19  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 71
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 72  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 266 SMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
             SDV++FGV+L E+ + G        P +   L+E                D R+E   
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------------KDYRMER-- 231
Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            E    K   L   C    P  RP+ + + +  E +
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 92
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 147
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 92
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 147
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 434
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L ++   
Sbjct: 435 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLEESN-- 489
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 549 FSSKSDVWSFGVLMWEAFS 567

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           LG G FG V +      G  D  L+       VAVK L        +E L +E+  +  L
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSL------PWSTR--MKIA 189
            +H ++V L+G C      L++ EY   G L N L R+    L      P   R  +  +
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D     +  V      
Sbjct: 159 SQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              + APE +     T  SDV+S+G++L E+ S
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 435
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L ++   
Sbjct: 436 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLEESN-- 490
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 90
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 145
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           LG G FG V +      G  D  L+       VAVK L        +E L +E+  +  L
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSL------PWSTR--MKIA 189
            +H ++V L+G C      L++ EY   G L N L R+    L      P   R  +  +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D     +  V      
Sbjct: 167 SQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              + APE +     T  SDV+S+G++L E+ S
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEV 132
           V  ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREI 57
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
             L +L HP++VKL+     E    LV+E++    L+  +       +P           
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 117 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 172
Query: 253 YAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           Y APE ++   + ++  D++S G +  E+++ R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 12  LGTGQFGVVKYG----KWRGQYD---VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 120
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD + S+  +G++    ++ PE +M  
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLMYS 176
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL-- 225
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                 + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 226 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 82
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 83  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 137
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 16  LGTGQFGVVKYG----KWRGQYD---VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 124
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD + S+  +G++    ++ PE +M  
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLMYS 180
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L  
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL-- 229
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                 + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 230 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 17  LGTGQFGVVKYG----KWRG---QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 125
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD + S+  +G++    ++ PE +M  
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLMYS 181
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L  
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL-- 230
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                 + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 231 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 76
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 72
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 127
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 70
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 125
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+ +   +  G     + APE +    
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 67  VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +F    LK  +Q       LG+G FG+V     D  L     A  VAVK L   G    R
Sbjct: 3   IFEERHLKYISQ-------LGKGNFGSVELCRYD-PLGDNTGAL-VAVKQLQHSGPDQQR 53
Query: 127 EWLTEVIFLGQLRHPHLVKLIG--YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
           ++  E+  L  L    +VK  G  Y        LV EY+P G L +   +R+   L  S 
Sbjct: 54  DFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRD-FLQRHRARLDASR 112
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
            +  +    KG+ +L    +  ++RD  A NIL++S+   K++DFGLAK  P   D  V 
Sbjct: 113 LLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV- 169
Query: 245 TRVMGTQG--YAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            R  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 23  LGTGQFGVVKYG----KWRG---QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD + S+  +G++    ++ PE +M  
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLMYS 187
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L  
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL-- 236
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                 + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 237 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYG----KWRGQYD---VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 140
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD + S+  +G++    ++ PE +M  
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSS--VGSKFPVRWSPPEVLMYS 196
Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L  
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL-- 245
Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                 + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 246 -----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQG-HR 126
           ++K   + +   +FLGEG F  V+K       R     Q VA+K + L    E   G +R
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKA------RDKNTNQIVAIKKIKLGHRSEAKDGINR 57
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
             L E+  L +L HP+++ L+     + +  LV+++M    LE  + +  S+ L  S   
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLE-VIIKDNSLVLTPSHIK 115
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
              L   +GL +LH  +  +++RD K +N+LLD +   KL+DFGLAK    G        
Sbjct: 116 AYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXH 171
Query: 247 VMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELL 281
            + T+ Y APE +    +  +  D+++ G +L ELL
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 28/277 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    K R       VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYG----KWRGQYD---VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQ 140
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD  A N L++     K+SDFGL++   + ++T         + ++ PE +M    +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMYSKFS 199
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
           S SD+++FGV++ E+ S  K      P    +  E A  +   A+ L R+  P L     
Sbjct: 200 SKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHI---AQGL-RLYRPHL----- 245
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
              + K   + Y C   +  +RPT   ++  +  + D
Sbjct: 246 --ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 19  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 71
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 266 SMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
             SDV++FGV+L E+ + G        P +   L+E                D R+E   
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------------KDYRMER-- 231
Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            E    K   L   C    P  RP+ + + +  E +
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKG-FIDDKLRPGLQA--QPVAVKNLDLEGLQGHREW 128
           ++K+  + F     LG+G FG V    F        ++A  + V + + D+E     +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L+         HP L  +      +E+   V EY+  G L   +   +   L  +T    
Sbjct: 71  LSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--Y 123
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A     GL FLH   K ++YRD K  NILLD D   K++DFG+ K+   GD    +    
Sbjct: 124 AAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFC 179
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 23/222 (10%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           T + +    FLG+GGF   ++  I D     + A  V  K++ L+  Q  +   TE+   
Sbjct: 24  TMKRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIH 80
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP---WSTRMKIALGA 192
             L +PH+V   G+  +++   +V E   R SL     RR +V+ P   +  R  I    
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---- 136
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGDDTHVSTRVM 248
            +G+ +LH+    VI+RD K  N+ L+ D   K+ DFGLA     DG    D      + 
Sbjct: 137 -QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD------LC 187
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
           GT  Y APE +     +   D++S G +L  LL G+   + S
Sbjct: 188 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 23/222 (10%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           T + +    FLG+GGF   ++  I D     + A  V  K++ L+  Q  +   TE+   
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIH 96
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP---WSTRMKIALGA 192
             L +PH+V   G+  +++   +V E   R SL     RR +V+ P   +  R  I    
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---- 152
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGDDTHVSTRVM 248
            +G+ +LH+    VI+RD K  N+ L+ D   K+ DFGLA     DG    D      + 
Sbjct: 153 -QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD------LC 203
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
           GT  Y APE +     +   D++S G +L  LL G+   + S
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 13  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY PRG +  +L +        +      L  A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--ANALS 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 128 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 181
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 224
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHPHL 143
           LG G FG V +      ++    A  VAVK L        RE L +E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI--------------- 188
           V L+G C      L++ EY   G L N L R+    +   T   I               
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 189 -ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+AFL  A K  I+RD  A NILL      K+ DFGLA+D     +  V    
Sbjct: 150 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+S+G+ L EL S   S     P   +           
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYK 259
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             ++  R++ P       E    +   +   C    P +RPT   +V+ +E
Sbjct: 260 MIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 170
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K R  + A  V  K   LE      +   EV     
Sbjct: 5   EDFEIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 61
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 119
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 120 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 173
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 216
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 217 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 21/227 (9%)
Query: 74  KVTTQSFSSSNF---LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WL 129
           K+   S S+  F   LGE  FG V+KG +     PG Q Q VA+K L  +     RE + 
Sbjct: 19  KLKEISLSAVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST----R 185
            E +   +L+HP++V L+G   +++   +++ Y   G L   L  R   S   ST     
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 186 MKIAL----------GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 235
           +K AL            A G+ +L  +   V+++D    N+L+      K+SD GL ++ 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              D   +    +    + APE +M G  +  SD++S+GVVL E+ S
Sbjct: 196 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 123 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 178
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 123 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 178
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           LG G FG V +      G  D  L+       VAVK L        +E L +E+  +  L
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----------SLPWSTR-- 185
            +H ++V L+G C      L++ EY   G L N L R+  V          +   STR  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D     +  V  
Sbjct: 167 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+S+G++L E+ S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V KG+   K      A  +     +   L+   E L E   + QL +P++V+
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 76
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +IG  CE E  +LV E    G L   L +   V       +++    + G+ +L   E  
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYLE--ESN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ--GYAAPEYVMTGH 263
            ++RD  A N+LL + + AK+SDFGL+K     D+     +  G     + APE +    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 264 LTSMSDVYSFGVVLLELLS 282
            +S SDV+SFGV++ E  S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHPHL 143
           LG G FG V +      ++    A  VAVK L        RE L +E+  L  L  H ++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 105
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI--------------- 188
           V L+G C      L++ EY   G L N L R+    +   T   I               
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 189 -ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+AFL  A K  I+RD  A NILL      K+ DFGLA+D     +  V    
Sbjct: 166 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+S+G+ L EL S   S     P   +           
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYK 275
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             ++  R++ P       E    +   +   C    P +RPT   +V+ +E
Sbjct: 276 MIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR--EWLTEVIFLGQLRHP 141
             LGEG FG+V +G +  +    L+   VAVK + L+        E+L+E   +    HP
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLK---VAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 142 HLVKLIGYCCEEEHR-----LLVYEYMPRGSLENQL-FRRYSVS---LPWSTRMKIALGA 192
           ++++L+G C E   +     +++  +M  G L   L + R       +P  T +K  +  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           A G+ +L  + +  ++RD  A N +L  D T  ++DFGL+K    GD             
Sbjct: 157 ALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLEL 280
           + A E +     TS SDV++FGV + E+
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHPHL 143
           LG G FG V +      ++    A  VAVK L        RE L +E+  L  L  H ++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 107
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI--------------- 188
           V L+G C      L++ EY   G L N L R+    +   T   I               
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 189 -ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+AFL  A K  I+RD  A NILL      K+ DFGLA+D     +  V    
Sbjct: 168 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+S+G+ L EL S   S     P   +           
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYK 277
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             ++  R++ P       E    +   +   C    P +RPT   +V+ +E
Sbjct: 278 MIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 21/227 (9%)
Query: 74  KVTTQSFSSSNF---LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WL 129
           K+   S S+  F   LGE  FG V+KG +     PG Q Q VA+K L  +     RE + 
Sbjct: 2   KLKEISLSAVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST----R 185
            E +   +L+HP++V L+G   +++   +++ Y   G L   L  R   S   ST     
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 186 MKIAL----------GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 235
           +K AL            A G+ +L  +   V+++D    N+L+      K+SD GL ++ 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              D   +    +    + APE +M G  +  SD++S+GVVL E+ S
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           T + +    FLG+GGF   ++  I D     + A  V  K++ L+  Q  +   TE+   
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIH 96
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP---WSTRMKIALGA 192
             L +PH+V   G+  +++   +V E   R SL     RR +V+ P   +  R  I    
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---- 152
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
            +G+ +LH+    VI+RD K  N+ L+ D   K+ DFGLA    E D     T + GT  
Sbjct: 153 -QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKT-LCGTPN 207
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
           Y APE +     +   D++S G +L  LL G+   + S
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 36/225 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGL-QAQP---VAVKNLDLEG-LQGHREWLTEVIFLGQLRH 140
           +GEG FG V +        PGL   +P   VAVK L  E       ++  E   + +  +
Sbjct: 55  IGEGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-----------------RYSVSLP-- 181
           P++VKL+G C   +   L++EYM  G L N+  R                 R  VS P  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 182 ----WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                + ++ IA   A G+A+L  +E+  ++RD    N L+  +   K++DFGL+++   
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            D             +  PE +     T+ SDV+++GVVL E+ S
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           LG G FG V +      G  D  L+       VAVK L        +E L +E+  +  L
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----------SLPWSTR-- 185
            +H ++V L+G C      L++ EY   G L N L R+  V          +   STR  
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D     +  V  
Sbjct: 167 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+S+G++L E+ S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 31/219 (14%)
Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           LG G FG V +      G  D  L+       VAVK L        +E L +E+  +  L
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR------------ 185
            +H ++V L+G C      L++ EY   G L N L R+    L +S              
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 186 --MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV 243
             +  +   A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D     +  V
Sbjct: 167 DLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                    + APE +     T  SDV+S+G++L E+ S
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 100/213 (46%), Gaps = 13/213 (6%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--E 131
           K     F     LG+G FG V   F+  K+      Q  A+K L    L+      T  E
Sbjct: 20  KADPSQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
              L ++ HP +VKL  Y  + E +L L+ +++  G L    F R S  + ++       
Sbjct: 77  RDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY 131
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            A   LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + +    S    GT
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             Y APE V     T  +D +SFGV++ E+L+G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHPHL 143
           LG G FG V +      ++    A  VAVK L        RE L +E+  L  L  H ++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI--------------- 188
           V L+G C      L++ EY   G L N L R+    +   T   I               
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 189 -ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+AFL  A K  I+RD  A NILL      K+ DFGLA+D     +  V    
Sbjct: 173 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+S+G+ L EL S   S     P   +           
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYK 282
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             ++  R++ P       E    +   +   C    P +RPT   +V+ +E
Sbjct: 283 MIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 100/213 (46%), Gaps = 13/213 (6%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--E 131
           K     F     LG+G FG V   F+  K+      Q  A+K L    L+      T  E
Sbjct: 20  KADPSQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
              L ++ HP +VKL  Y  + E +L L+ +++  G L    F R S  + ++       
Sbjct: 77  RDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY 131
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            A   LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + +    S    GT
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             Y APE V     T  +D +SFGV++ E+L+G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 83  SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
           S  +G G FG V+KG    K    +  + + V +   E  Q  R    EV  L + RH +
Sbjct: 41  STRIGSGSFGTVYKG----KWHGDVAVKILKVVDPTPEQFQAFR---NEVAVLRKTRHVN 93
Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           ++  +GY  ++ +  +V ++    SL   L  +          + IA   A+G+ +LH  
Sbjct: 94  ILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH-- 149
Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-- 260
            K +I+RD K++NI L    T K+ DFGLA        +    +  G+  + APE +   
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 261 -TGHLTSMSDVYSFGVVLLELLSG 283
                +  SDVYS+G+VL EL++G
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 57
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV--SLPWSTRMKIALG 191
            L +L HP++VKL+     E    LV+E++   S++ + F   S    +P          
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
             +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T 
Sbjct: 115 LLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 252 GYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            Y APE ++   + ++  D++S G +  E+++ R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 100/213 (46%), Gaps = 13/213 (6%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--E 131
           K     F     LG+G FG V   F+  K+      Q  A+K L    L+      T  E
Sbjct: 21  KADPSQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 77
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
              L ++ HP +VKL  Y  + E +L L+ +++  G L    F R S  + ++       
Sbjct: 78  RDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY 132
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            A   LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + +    S    GT
Sbjct: 133 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 190
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             Y APE V     T  +D +SFGV++ E+L+G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 22  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 132
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 235
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 26  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 26  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV--SLPWSTRMKIALG 191
            L +L HP++VKL+     E    LV+E++   S++ + F   S    +P          
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
             +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T 
Sbjct: 113 LLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 252 GYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            Y APE ++   + ++  D++S G +  E+++ R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 26  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L++ +       +P            
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L+F H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 9   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 65
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 123
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    T +S    GT  Y  PE
Sbjct: 124 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPE 177
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 220
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 221 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 26  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 23  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 236
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 57
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV--SLPWSTRMKIALG 191
            L +L HP++VKL+     E    LV+E++   S++ + F   S    +P          
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQ 114
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
             +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T 
Sbjct: 115 LLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 252 GYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            Y APE ++   + ++  D++S G +  E+++ R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 34  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 86
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 144
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 204 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 247
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 248 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 26  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 25  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 77
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 135
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 238
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           T + +    FLG+GGF   ++  I D     + A  V  K++ L+  Q  +   TE+   
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIH 96
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP---WSTRMKIALGA 192
             L +PH+V   G+  +++   +V E   R SL     RR +V+ P   +  R  I    
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---- 152
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
            +G+ +LH+    VI+RD K  N+ L+ D   K+ DFGLA       D      + GT  
Sbjct: 153 -QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATK--IEFDGERKKXLCGTPN 207
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
           Y APE +     +   D++S G +L  LL G+   + S
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 23  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 236
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 22  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 132
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 235
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 56
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV--SLPWSTRMKIALG 191
            L +L HP++VKL+     E    LV+E++   S++ + F   S    +P          
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQ 113
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
             +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T 
Sbjct: 114 LLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 252 GYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            Y APE ++   + ++  D++S G +  E+++ R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 96/218 (44%), Gaps = 16/218 (7%)
Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE--- 127
           A  +VT   F     LG+G FG V        ++     +  A+K L  E +    E   
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAH 55
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
            LTE   L   RHP L  L  Y  +   RL  V EY   G L   L R    S   +   
Sbjct: 56  TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 114
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
              + +A  L +LH +EK V+YRD K  N++LD D   K++DFGL K+G +  D      
Sbjct: 115 GAEIVSA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKX 169
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
             GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 23  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 75
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 236
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 56
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 116 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 171
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 56
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 116 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 171
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 95/215 (44%), Gaps = 16/215 (7%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLT 130
           +VT   F     LG+G FG V        ++     +  A+K L  E +    E    LT
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 59
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G L   L R    S   +      
Sbjct: 60  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
           + +A  L +LH +EK V+YRD K  N++LD D   K++DFGL K+G +  D        G
Sbjct: 119 IVSA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCG 173
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 28/244 (11%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           + ELK     F   + LG G  G V K      G I  +    L+ +P A++N       
Sbjct: 10  VGELK--DDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKP-AIRN------- 59
Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
              + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P  
Sbjct: 60  ---QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEE 114
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV 243
              K+++   +GLA+L +  + +++RD K SNIL++S    KL DFG++    +     +
Sbjct: 115 ILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 169
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR 303
           +   +GT+ Y APE +   H +  SD++S G+ L+EL  GR  +     +  +++  + R
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAI--FGR 227
Query: 304 PMLN 307
           P+++
Sbjct: 228 PVVD 231

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 170
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 95/215 (44%), Gaps = 16/215 (7%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLT 130
           +VT   F     LG+G FG V        ++     +  A+K L  E +    E    LT
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 57
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G L   L R    S   +      
Sbjct: 58  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
           + +A  L +LH +EK V+YRD K  N++LD D   K++DFGL K+G +  D        G
Sbjct: 117 IVSA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCG 171
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 54
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 58
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 118 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 173
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 170
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 57
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 56
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 116 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 171
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 13  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY PRG +  +L +        +      L  A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--ANALS 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE
Sbjct: 128 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLXGTLDYLPPE 181
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 224
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+    LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLL 56
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 57
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+    LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLL 55
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 228 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 280
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 338
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+R+  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 398 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 441
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G FG V+KG +I D     +   PVA+K L +    + ++E L E   +  +  P++
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKI---PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            +L+G C     +L V + MP G L + + R     L     +   +  AKG+++L D  
Sbjct: 82  SRLLGICLTSTVQL-VTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPE--GDDTHVSTRVMGTQGYAAPE 257
             +++RD  A N+L+ S    K++DFGLA+    D  E   D   V  + M      A E
Sbjct: 140 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM------ALE 191
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
            ++    T  SDV+S+GV + EL++ G K  D   P RE
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 229

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFL 135
           ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +L HP++VKL+     E    LV+E++    L+  +       +P            +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 117 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 256 PEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           PE ++   + ++  D++S G +  E+++ R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 57
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++    L+  +       +P            
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 8   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 122
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 123 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTELCGTLDYLPPE 176
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 219
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--------YSVS------LPW 182
             +H +++ L+G C ++    ++ EY  +G+L   L  R        Y ++      + +
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF 156
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
              +      A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 13  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 128 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 181
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 224
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 11  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 126 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 179
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 222
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLL-VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           +F     HP LV L   C + E RL  V EY+  G L   + R+    LP       +  
Sbjct: 105 VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAE 161
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            +  L +LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G    DT  ++   GT 
Sbjct: 162 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTP 217
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
            Y APE +         D ++ GV++ E+++GR   D
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 8   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 122
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 123 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 176
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 219
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 8   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 122
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE
Sbjct: 123 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 176
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 219
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 8   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 122
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE
Sbjct: 123 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 176
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 219
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLT 130
           +V    +   + LG G FG V  G      +  L    VAVK L+   +  L    +   
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E+  L   RHPH++KL           +V EY+  G L + + +   +    S R+   +
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            +  G+ + H     V++RD K  N+LLD+   AK++DFGL+    +G+    S    G+
Sbjct: 126 LS--GVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GS 178
Query: 251 QGYAAPEYVMTGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
             YAAPE V++G L +    D++S GV+L  LL G    D
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 140 HPHLVKLIGYCCEEEHRLL-VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           HP LV L   C + E RL  V EY+  G L   + R+    LP       +   +  L +
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNY 121
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G    DT  ++   GT  Y APE 
Sbjct: 122 LH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 177
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           +         D ++ GV++ E+++GR   D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 267 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 319
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 320 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 377
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+R+  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                 P + D  ++  +++     +  
Sbjct: 437 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 480
Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    K   L   C    P  RP+ + + +  E +
Sbjct: 481 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 8   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 122
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 123 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCGTLDYLPPE 176
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 219
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLL-VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           +F     HP LV L   C + E RL  V EY+  G L   + R+    LP       +  
Sbjct: 73  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAE 129
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            +  L +LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G    DT  ++   GT 
Sbjct: 130 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTP 185
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
            Y APE +         D ++ GV++ E+++GR   D
Sbjct: 186 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 13  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 128 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 181
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 224
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 68  FTLAELKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEG 121
             L ELK     F   + LG G  G V K      G +  +    L+ +P A++N     
Sbjct: 1   MALGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN----- 52
Query: 122 LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
                + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P
Sbjct: 53  -----QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIP 105
Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
                K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++  G   D+ 
Sbjct: 106 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE- 161
Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            ++   +GT+ Y +PE +   H +  SD++S G+ L+E+  GR
Sbjct: 162 -MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 31/294 (10%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVI 133
           +    +     +G G    V   +   K       + VA+K ++LE  Q    E L E+ 
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPK------KEKVAIKRINLEKCQTSMDELLKEIQ 60
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLF------RRYSVSLPWSTRMK 187
            + Q  HP++V        ++   LV + +  GS+ + +          S  L  ST   
Sbjct: 61  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 120
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD---THVS 244
           I     +GL +LH   +  I+RD KA NILL  D + +++DFG++     G D     V 
Sbjct: 121 ILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 245 TRVMGTQGYAAPEYV--MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
              +GT  + APE +  + G+    +D++SFG+  +EL +G     K  P +   L    
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--- 234
Query: 303 RPMLNDARKLGR-IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             + ND   L   + D  +  +Y ++  RK  +L   CL   P++RPT + +++
Sbjct: 235 --LQNDPPSLETGVQDKEMLKKYGKS-FRKMISL---CLQKDPEKRPTAAELLR 282

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 34  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSH 90
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 148
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    +   T + GT  Y  PE
Sbjct: 149 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 202
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 245
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 246 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 13  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 69
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE
Sbjct: 128 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 181
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 224
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 7   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 63
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 121
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 122 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 175
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 218
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 219 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 9   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 65
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 123
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE
Sbjct: 124 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 177
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 220
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 221 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 25  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSH 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 139
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P    +   T + GT  Y  PE
Sbjct: 140 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 193
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 194 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 236
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 237 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHPHL 143
           LG G FG V         + G+  Q VAVK L  +     RE L +E+  + QL  H ++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQ-VAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQL------FRRYSVSLPWSTRMK---------- 187
           V L+G C       L++EY   G L N L      F    +      R++          
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                 A   AKG+ FL    K  ++RD  A N+L+      K+ DFGLA+D     +  
Sbjct: 172 EDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           V         + APE +  G  T  SDV+S+G++L E+ S
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 140 HPHLVKLIGYCCEEEHRLL-VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           HP LV L   C + E RL  V EY+  G L   + R+    LP       +   +  L +
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNY 125
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G    DT  ++   GT  Y APE 
Sbjct: 126 LH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 181
Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           +         D ++ GV++ E+++GR   D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 12  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 68
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 126
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 127 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 180
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 223
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 224 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 31/294 (10%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVI 133
           +    +     +G G    V   +   K       + VA+K ++LE  Q    E L E+ 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPK------KEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLF------RRYSVSLPWSTRMK 187
            + Q  HP++V        ++   LV + +  GS+ + +          S  L  ST   
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD---THVS 244
           I     +GL +LH   +  I+RD KA NILL  D + +++DFG++     G D     V 
Sbjct: 126 ILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 245 TRVMGTQGYAAPEYV--MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
              +GT  + APE +  + G+    +D++SFG+  +EL +G     K  P +   L    
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--- 239
Query: 303 RPMLNDARKLGR-IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             + ND   L   + D  +  +Y ++  RK  +L   CL   P++RPT + +++
Sbjct: 240 --LQNDPPSLETGVQDKEMLKKYGKS-FRKMISL---CLQKDPEKRPTAAELLR 287

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 11  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE
Sbjct: 126 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 179
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 222
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVI 133
           + ++F     +GEG +G V+K       R  L  + VA+K   LD E        + E+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 57
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L +L HP++VKL+     E    LV+E++ +  L+  +       +P            
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   + ++  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 28/237 (11%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNF------LGEGGFGAVHKGFIDDKLRPGLQAQP 111
           + L   NL+  ++ + +  T+  +  +F      LG+G FG V+K    +K    L    
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA--QNKETSVL---- 64
Query: 112 VAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
            A K +D +  +   +++ E+  L    HP++VKL+     E +  ++ E+   G+++  
Sbjct: 65  AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 172 LFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL 231
           +       L  S    +       L +LHD +  +I+RD KA NIL   D   KL+DFG+
Sbjct: 125 MLE-LERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 232 AKDGPEGDDTHVSTR---VMGTQGYAAPEYVMTGH-----LTSMSDVYSFGVVLLEL 280
           +       +T    R    +GT  + APE VM            +DV+S G+ L+E+
Sbjct: 182 S-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEEDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIF 134
           VT  +F     LG+GGFG V    +      G       ++   ++  +G    L E   
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 135 LGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
           L ++    +V L  Y  E +  L LV   M  G L+  ++       P +  +  A    
Sbjct: 238 LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            GL  LH   + ++YRD K  NILLD     ++SD GLA   PEG    +  RV GT GY
Sbjct: 297 CGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGY 351
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
            APE V     T   D ++ G +L E+++G+    + + + ++  VE             
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------- 398
Query: 314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
           R++    E +YSE  + +A +L  Q L   P +R
Sbjct: 399 RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 28/237 (11%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNF------LGEGGFGAVHKGFIDDKLRPGLQAQP 111
           + L   NL+  ++ + +  T+  +  +F      LG+G FG V+K    +K    L    
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA--QNKETSVL---- 64
Query: 112 VAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
            A K +D +  +   +++ E+  L    HP++VKL+     E +  ++ E+   G+++  
Sbjct: 65  AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 172 LFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL 231
           +       L  S    +       L +LHD +  +I+RD KA NIL   D   KL+DFG+
Sbjct: 125 MLE-LERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 232 AKDGPEGDDTHVSTR---VMGTQGYAAPEYVMTGH-----LTSMSDVYSFGVVLLEL 280
           +       +T    R    +GT  + APE VM            +DV+S G+ L+E+
Sbjct: 182 S-----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 28/237 (11%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNF------LGEGGFGAVHKGFIDDKLRPGLQAQP 111
           + L   NL+  ++ + +  T+  +  +F      LG+G FG V+K    +K    L    
Sbjct: 11  VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA--QNKETSVL---- 64
Query: 112 VAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
            A K +D +  +   +++ E+  L    HP++VKL+     E +  ++ E+   G+++  
Sbjct: 65  AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 172 LFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL 231
           +       L  S    +       L +LHD +  +I+RD KA NIL   D   KL+DFG+
Sbjct: 125 MLE-LERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 232 AKDGPEGDDTHVSTR---VMGTQGYAAPEYVMTGH-----LTSMSDVYSFGVVLLEL 280
           +       +T    R    +GT  + APE VM            +DV+S G+ L+E+
Sbjct: 182 S-----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 115/291 (39%), Gaps = 36/291 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL-RHPHL 143
           LG G FG V +      ++    A  VAVK L        RE L +E+  L  L  H ++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI--------------- 188
           V L+G C      L++ EY   G L N L R+    +   T   I               
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 189 -ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+AFL  A K  I+RD  A NILL      K+ DFGLA+      +  V    
Sbjct: 173 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+S+G+ L EL S   S     P   +           
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------FYK 282
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             ++  R++ P       E    +   +   C    P +RPT   +V+ +E
Sbjct: 283 MIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQ-PVAVKNLDLEGLQG---HREWLTEVIFLGQLRHP 141
           LGEG FG V       KL    + Q  VA+K +  + L+    H     E+ +L  LRHP
Sbjct: 17  LGEGSFGKV-------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           H++KL          ++V EY   G L + +  +  ++     R    +  A      H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               +++RD K  N+LLD +   K++DFGL+    +G+    S    G+  YAAPE V+ 
Sbjct: 129 ----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VIN 180
Query: 262 GHLTS--MSDVYSFGVVLLELLSGRKSVD 288
           G L +    DV+S G+VL  +L GR   D
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 85
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 86  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 143
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 144 KDLVSCTYQLARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 254
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 255 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 301

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIF 134
           VT  +F     LG+GGFG V    +      G       ++   ++  +G    L E   
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 135 LGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
           L ++    +V L  Y  E +  L LV   M  G L+  ++       P +  +  A    
Sbjct: 238 LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            GL  LH   + ++YRD K  NILLD     ++SD GLA   PEG    +  RV GT GY
Sbjct: 297 CGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGY 351
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG 313
            APE V     T   D ++ G +L E+++G+    + + + ++  VE             
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------- 398
Query: 314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
           R++    E +YSE  + +A +L  Q L   P +R
Sbjct: 399 RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 87
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 88  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 145
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 146 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 256
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 257 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 303

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL---EGLQGHREWLT 130
           K+  + +   + LG GG   V+           +    VA+K + +   E  +  + +  
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLA------EDTILNIKVAIKAIFIPPREKEETLKRFER 60
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV    QL H ++V +I    E++   LV EY+   +L   +     +S+   T +    
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSV--DTAINFTN 118
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
               G+   HD    +++RD K  NIL+DS+ T K+ DFG+AK   E   T  +  V+GT
Sbjct: 119 QILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGT 175
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
             Y +PE          +D+YS G+VL E+L G 
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHP 141
           LGEG FG V   +    DK +P  +A  VAVK L  +  +    + ++E+  +  + +H 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 93
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK-------------- 187
           +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +               
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D    +T  
Sbjct: 154 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+SFGV++ E+ +   S     P  E          L 
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----------LF 261
Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 262 KLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 306

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 113/280 (40%), Gaps = 33/280 (11%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 11  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--DDTHVSTRVMGTQGYAA 255
           + H   K VI+RD K  N+LL S    K++DFG +   P    DD      + GT  Y  
Sbjct: 126 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD------LCGTLDYLP 177
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           PE +         D++S GV+  E L G+   + +  Q     +                
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------------- 222
Query: 316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 223 ---RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-- 128
           A  KVT   F     LG+G FG V        +R     +  A+K L  E +    E   
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAH 54
Query: 129 -LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
            +TE   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++   
Sbjct: 55  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEER 109
Query: 187 KIALGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
               GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D    
Sbjct: 110 ARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATM 165
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
               GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 144
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 145 --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 203 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 313
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 314 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 113/280 (40%), Gaps = 33/280 (11%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 34  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSH 90
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 148
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--DDTHVSTRVMGTQGYAA 255
           + H   K VI+RD K  N+LL S    K++DFG +   P    DD      + GT  Y  
Sbjct: 149 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD------LCGTLDYLP 200
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           PE +         D++S GV+  E L G+   + +  Q     +                
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------------- 245
Query: 316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 246 ---RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLRH 140
           LGEG FG V   +           Q VA+K ++ + L     QG  E   E+ +L  LRH
Sbjct: 22  LGEGSFGKVKLAY------HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 73
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           PH++KL      ++  ++V EY     L + + +R  +S   + R    + +A      H
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
                +++RD K  N+LLD     K++DFGL+    +G+    S    G+  YAAPE V+
Sbjct: 133 K----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VI 184
Query: 261 TGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
           +G L +    DV+S GV+L  +L  R   D
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLRH 140
           LGEG FG V   +           Q VA+K ++ + L     QG  E   E+ +L  LRH
Sbjct: 21  LGEGSFGKVKLAY------HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 72
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           PH++KL      ++  ++V EY     L + + +R  +S   + R    + +A      H
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
                +++RD K  N+LLD     K++DFGL+    +G+    S    G+  YAAPE V+
Sbjct: 132 K----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VI 183
Query: 261 TGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
           +G L +    DV+S GV+L  +L  R   D
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 36  LGRGAFGQVIEADAFGIDK---TATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 91
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTRMKI----------- 188
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+ T   +           
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 189 --ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
             +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D      
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                 + APE +     T  SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 110/232 (47%), Gaps = 30/232 (12%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +++    F   + LG G  G V K      G +  +    L+ +P A++N          
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN---------- 49
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV------DKSRP 292
            +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +      + SRP
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRP 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLRH 140
           LGEG FG V   +           Q VA+K ++ + L     QG  E   E+ +L  LRH
Sbjct: 12  LGEGSFGKVKLAY------HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 63
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           PH++KL      ++  ++V EY     L + + +R  +S   + R    + +A      H
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
                +++RD K  N+LLD     K++DFGL+    +G+    S    G+  YAAPE V+
Sbjct: 123 K----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VI 174
Query: 261 TGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
           +G L +    DV+S GV+L  +L  R   D
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---REWLTEVIF 134
           + F   N LG+G F  V++    + +  GL+   VA+K +D + +      +    EV  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--MKIALGA 192
             QL+HP +++L  Y  +  +  LV E    G +   L  R     P+S           
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQI 121
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
             G+ +LH     +++RD   SN+LL  +   K++DFGLA       + H +  + GT  
Sbjct: 122 ITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPN 177
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
           Y +PE          SDV+S G +   LL GR   D
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG-LQAQPVAVKNLDLEGLQGHREWLTEV 132
           K+  + F     LG+GG+G V +         G + A  V  K + +   +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRR----YSVSLPWSTRMK 187
             L +++HP +V LI Y  +   +L L+ EY+  G L  QL R        +  +   + 
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           +ALG        H  +K +IYRD K  NI+L+     KL+DFGL K+     D  V+   
Sbjct: 132 MALG--------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXF 181
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG---------RKSVDK 289
            GT  Y APE +M        D +S G ++ ++L+G         +K++DK
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 9   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 65
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 123
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG-DDTHVSTRVMGTQGYAAP 256
           + H   K VI+RD K  N+LL S    K++DFG +   P    DT     + GT  Y  P
Sbjct: 124 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-----LCGTLDYLPP 176
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +         D++S GV+  E L G+   + +  Q     +                 
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------- 220
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 221 --RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 11  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K+++FG +   P        T + GT  Y  PE
Sbjct: 126 YCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPPE 179
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 222
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 10  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 66
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 124
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K+++FG +   P        T + GT  Y  PE
Sbjct: 125 YCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPPE 178
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 221
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 222 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG-LQAQPVAVKNLDLEGLQGHREWLTEV 132
           K+  + F     LG+GG+G V +         G + A  V  K + +   +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRR----YSVSLPWSTRMK 187
             L +++HP +V LI Y  +   +L L+ EY+  G L  QL R        +  +   + 
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           +ALG        H  +K +IYRD K  NI+L+     KL+DFGL K+     D  V+   
Sbjct: 132 MALG--------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTF 181
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG---------RKSVDK 289
            GT  Y APE +M        D +S G ++ ++L+G         +K++DK
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 86  LGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           LG G FG V +      G  D  L+       VAVK L        +E L +E+  +  L
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSL----------------- 180
            +H ++V L+G C      L++ EY   G L N L R+    L                 
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 181 --PWSTR--MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
             P   R  +  +   A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              +  V         + APE +     T  SDV+S+G++L E+ S
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 29/285 (10%)
Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT 130
           A+ +   + F     LG+G FG V+     +K    + A  V  K   LE      +   
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVY--LAREKNSKFILALKVLFKA-QLEKAGVEHQLRR 57
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV     LRHP++++L GY  +     L+ EY P G++  +L +        +      L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             A  L++ H   K VI+RD K  N+LL S    K++DFG +   P          + GT
Sbjct: 118 --ANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGT 169
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
             Y  PE +         D++S GV+  E L G+   + +  Q             +  +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------DTYK 216
Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           ++ R+     E  + +     A  L  + L H P QRP +  V++
Sbjct: 217 RISRV-----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 114/285 (40%), Gaps = 29/285 (10%)
Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT 130
           A+ +   + F     LG+G FG V+     +K    + A  V  K   LE      +   
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRR 57
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV     LRHP++++L GY  +     L+ EY P G++  +L +        +      L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             A  L++ H   K VI+RD K  N+LL S    K++DFG +   P          + GT
Sbjct: 118 --ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGT 169
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
             Y  PE +         D++S GV+  E L G+   + +  Q     +           
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------- 219
Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                   R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 --------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLT 130
           +V    +   + LG G FG V  G         L    VAVK L+   +  L    +   
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E+  L   RHPH++KL           +V EY+  G L + + +   V    + R+   +
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            +A      H     V++RD K  N+LLD+   AK++DFGL+    +G+    S    G+
Sbjct: 121 LSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 251 QGYAAPEYVMTGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
             YAAPE V++G L +    D++S GV+L  LL G    D
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V        +R     +  A+K L  E +    E    +T
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++      
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARF 109
Query: 190 LGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D       
Sbjct: 110 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXF 165
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 122/296 (41%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++ EY  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   +++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLRH 140
           LGEG FG V   +           Q VA+K ++ + L     QG  E   E+ +L  LRH
Sbjct: 16  LGEGSFGKVKLAY------HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 67
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           PH++KL      ++  ++V EY     L + + +R  +S   + R    + +A      H
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
                +++RD K  N+LLD     K++DFGL+    +G+    S    G+  YAAPE V+
Sbjct: 127 K----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VI 178
Query: 261 TGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
           +G L +    DV+S GV+L  +L  R   D
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 10  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 66
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 124
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE
Sbjct: 125 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPPE 178
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 221
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 222 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +++    F   + LG G  G V K      G +  +    L+ +P A++N          
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN---------- 49
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
            +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           + ELK     F   + LG G  G V K      G +  +    L+ +P A++N       
Sbjct: 62  VGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN------- 111
Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
              + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P  
Sbjct: 112 ---QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQ 166
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV 243
              K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 167 ILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 221
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
           +   +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +
Sbjct: 222 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V        +R     +  A+K L  E +    E    +T
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++      
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARF 109
Query: 190 LGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D       
Sbjct: 110 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXF 165
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V        +R     +  A+K L  E +    E    +T
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 59
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++      
Sbjct: 60  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARF 114
Query: 190 LGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D       
Sbjct: 115 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXF 170
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V        +R     +  A+K L  E +    E    +T
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++      
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARF 109
Query: 190 LGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D       
Sbjct: 110 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXF 165
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V        +R     +  A+K L  E +    E    +T
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++      
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARF 109
Query: 190 LGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D       
Sbjct: 110 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTF 165
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V        +R     +  A+K L  E +    E    +T
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
           E   L   RHP L  L  Y  +   RL  V EY   G    +LF   S    ++      
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARF 109
Query: 190 LGA--AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            GA     L +LH   + V+YRD K  N++LD D   K++DFGL K+G    D       
Sbjct: 110 YGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTF 165
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 11  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE
Sbjct: 126 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPPE 179
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 222
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 11  EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE
Sbjct: 126 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPPE 179
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 222
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           + F     LG+G FG V+     +K    + A  V  K   LE      +   EV     
Sbjct: 8   EDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           LRHP++++L GY  +     L+ EY P G++  +L +        +      L  A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALS 122
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE
Sbjct: 123 YCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPPE 176
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV+  E L G+   + +  Q     +                  
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------------- 219
Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            R+E  + +     A  L  + L H P QRP +  V++
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +++    F   + LG G  G V K      G +  +    L+ +P A++N          
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN---------- 49
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
            +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           + ELK     F   + LG G  G V K      G +  +    L+ +P A++N       
Sbjct: 19  VGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN------- 68
Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
              + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P  
Sbjct: 69  ---QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQ 123
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV 243
              K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 124 ILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 178
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           +   +GT+ Y +PE +   H +  SD++S G+ L+E+  GR
Sbjct: 179 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V K     K R   Q   V V N      +     L EV  L +L HP+++K
Sbjct: 30  LGKGSFGEVLKC----KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +     +V E    G L +++ +R   S   + R  I      G+ ++H  +  
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH--KHN 141
Query: 206 VIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
           +++RD K  NILL+S   D   K+ DFGL+    +  +T +  R+ GT  Y APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-GTAYYIAPE-VLRG 197
Query: 263 HLTSMSDVYSFGVVLLELLSG 283
                 DV+S GV+L  LLSG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           + ELK     F   + LG G  G V K      G +  +    L+ +P A++N       
Sbjct: 27  VGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN------- 76
Query: 124 GHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
              + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P  
Sbjct: 77  ---QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQ 131
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV 243
              K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++  G   D   +
Sbjct: 132 ILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 186
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
           +   +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +++    F   + LG G  G V K      G +  +    L+ +P A++N          
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN---------- 49
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
            +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHK------GFIDDKLRPGLQAQPVAVKNLDLEGLQGHR 126
           +++    F   + LG G  G V K      G +  +    L+ +P A++N          
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRN---------- 49
Query: 127 EWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           + + E+  L +   P++V   G    +    +  E+M  GSL+  L  + +  +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG 107
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           K+++   KGL +L +  K +++RD K SNIL++S    KL DFG++    +     ++  
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSV 287
            +GT+ Y +PE +   H +  SD++S G+ L+E+  GR  +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLT 130
           +V    +   + LG G FG V  G         L    VAVK L+   +  L    +   
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E+  L   RHPH++KL           +V EY+  G L + + +   V    + R+   +
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
            +A      H     V++RD K  N+LLD+   AK++DFGL+    +G+    S    G+
Sbjct: 121 LSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GS 173
Query: 251 QGYAAPEYVMTGHLTS--MSDVYSFGVVLLELLSGRKSVD 288
             YAAPE V++G L +    D++S GV+L  LL G    D
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+              Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  PE   +  ST V GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRI 315
               D++S G++ +E++ G        P R   L+     P L +  KL  I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+              Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  PE       + ++GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRKAY 193
Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRI 315
               D++S G++ +E++ G        P R   L+     P L +  KL  I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++  Y  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TXRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTRMK----------IA 189
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D         
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              + APE +     T  SDV+SFGV+L E+ S
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKT---ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 81
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 108/227 (47%), Gaps = 49/227 (21%)
Query: 89  GGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE--VIFLGQLRHPHLVKL 146
           G FG V K          L  + VAVK   +   Q  + W  E  V  L  ++H ++++ 
Sbjct: 35  GRFGCVWKA--------QLLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQF 83
Query: 147 IGYCCEEEHR--------LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           IG     E R         L+  +  +GSL +  F + +V + W+    IA   A+GLA+
Sbjct: 84  IG----AEKRGTSVDVDLWLITAFHEKGSLSD--FLKANV-VSWNELCHIAETMARGLAY 136
Query: 199 LH-------DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRV 247
           LH       D  KP I +RD K+ N+LL ++ TA ++DFGLA   + G    DTH     
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--- 193
Query: 248 MGTQGYAAPEYVMTGHLTSMS------DVYSFGVVLLELLSGRKSVD 288
           +GT+ Y APE V+ G +          D+Y+ G+VL EL S   + D
Sbjct: 194 VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+K           Q + VA+K + L    EG+      + E+  L +L HP
Sbjct: 29  VGEGTYGVVYKA-------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHP 79
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGLAFLH 200
           ++V LI     E    LV+E+M +     ++       L   +++KI L    +G+A  H
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCH 136
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
             +  +++RD K  N+L++SD   KL+DFGLA+    G      T  + T  Y AP+ +M
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 261 TGHLTSMS-DVYSFGVVLLELLSGR 284
                S S D++S G +  E+++G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+              Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 29  IGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 137
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  PE       + ++GT  + APE V     
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAY 194
Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRI 315
               D++S G++ +E++ G        P R   L+     P L +  KL  I
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TXRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTRMK----------IA 189
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D         
Sbjct: 151 FQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
              + APE +     T  SDV+SFGV+L E+ S
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA---TXRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 92
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR------------MK 187
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+               + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D       
Sbjct: 153 YSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                + APE +     T  SDV+SFGV+L E+ S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+K           Q + VA+K + L    EG+      + E+  L +L HP
Sbjct: 29  VGEGTYGVVYKA-------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHP 79
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGLAFLH 200
           ++V LI     E    LV+E+M +     ++       L   +++KI L    +G+A  H
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCH 136
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
             +  +++RD K  N+L++SD   KL+DFGLA+    G      T  + T  Y AP+ +M
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 261 TGHLTSMS-DVYSFGVVLLELLSGR 284
                S S D++S G +  E+++G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDK---TATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+              Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  PE       + ++GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAY 193
Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRI 315
               D++S G++ +E++ G        P R   L+     P L +  KL  I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKT---ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 81
Query: 141 PHLVKLIGYCCEEEHRLLV-YEYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V K     K R   Q   V V N      +     L EV  L +L HP+++K
Sbjct: 30  LGKGSFGEVLKC----KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +     +V E    G L +++ +R   S   + R  I      G+ ++H  +  
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH--KHN 141
Query: 206 VIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
           +++RD K  NILL+S   D   K+ DFGL+    +  +T +  R+ GT  Y APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-GTAYYIAPE-VLRG 197
Query: 263 HLTSMSDVYSFGVVLLELLSG 283
                 DV+S GV+L  LLSG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V K     K R   Q   V V N      +     L EV  L +L HP+++K
Sbjct: 30  LGKGSFGEVLKC----KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     +     +V E    G L +++ +R   S   + R  I      G+ ++H  +  
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH--KHN 141
Query: 206 VIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
           +++RD K  NILL+S   D   K+ DFGL+    +  +T +  R+ GT  Y APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-GTAYYIAPE-VLRG 197
Query: 263 HLTSMSDVYSFGVVLLELLSG 283
                 DV+S GV+L  LLSG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 34/237 (14%)
Query: 62  GSNLH----VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           G +LH    +F      + +  +     LG+G FG V      DK+      Q  AVK +
Sbjct: 29  GDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKI----TGQECAVKVI 82
Query: 118 DLEGLQGHRE---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR 174
               ++   +    L EV  L QL HP+++KL  +  ++ +  LV E    G L +++  
Sbjct: 83  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 142
Query: 175 RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGL 231
           R   S   + R  I      G+ ++H  +  +++RD K  N+LL+S   D   ++ DFGL
Sbjct: 143 RKRFSEVDAAR--IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 198
Query: 232 AKDGPEGDDTHVSTRV-----MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           +        TH          +GT  Y APE V+ G      DV+S GV+L  LLSG
Sbjct: 199 S--------THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 34/237 (14%)
Query: 62  GSNLH----VFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           G +LH    +F      + +  +     LG+G FG V      DK+      Q  AVK +
Sbjct: 30  GDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKI----TGQECAVKVI 83
Query: 118 DLEGLQGHRE---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR 174
               ++   +    L EV  L QL HP+++KL  +  ++ +  LV E    G L +++  
Sbjct: 84  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 143
Query: 175 RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGL 231
           R   S   + R  I      G+ ++H  +  +++RD K  N+LL+S   D   ++ DFGL
Sbjct: 144 RKRFSEVDAAR--IIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 199
Query: 232 AKDGPEGDDTHVSTRV-----MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           +        TH          +GT  Y APE V+ G      DV+S GV+L  LLSG
Sbjct: 200 S--------THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--E 131
           K     F     LG+G FG V   F+  K+         A+K L    L+      T  E
Sbjct: 24  KADPSHFELLKVLGQGSFGKV---FLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKME 80
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIAL 190
              L  + HP +VKL  Y  + E +L +     RG     LF R S  + ++   +K  L
Sbjct: 81  RDILADVNHPFVVKL-HYAFQTEGKLYLILDFLRG---GDLFTRLSKEVMFTEEDVKFYL 136
Query: 191 GA-AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
              A GL  LH     +IYRD K  NILLD +   KL+DFGL+K+  + +    S    G
Sbjct: 137 AELALGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCG 192
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           T  Y APE V     +  +D +S+GV++ E+L+G
Sbjct: 193 TVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 47/296 (15%)
Query: 86  LGEGGFGAV--HKGFIDDKLRPGLQAQPVAVKNL-------DLEGLQGHREWLTEVIFLG 136
           LGEG FG V   +    DK +P  +A  VAVK L       DL  L    E +     +G
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMK---MIG 98
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--------- 187
             +H +++ L+G C ++    ++  Y  +G+L   L  R    + +S  +          
Sbjct: 99  --KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                     A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D   
Sbjct: 157 KDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            +T       + APE +     T  SDV+SFGV++ E+ +   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 267
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              L    K G  MD             +   +   C    P QRPT   +V+ L+
Sbjct: 268 ---LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 117/283 (41%), Gaps = 35/283 (12%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           T + F     LG+G FG V+     ++    + A  V  K   LE      +   EV   
Sbjct: 10  TLEDFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQ 66
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
             LRHP++++L GY  +     L+ EY P G++  +L ++ S      T   I    A  
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYIT-ELANA 124
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L++ H   K VI+RD K  N+LL S+   K++DFG +   P        T + GT  Y  
Sbjct: 125 LSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR----RTTLCGTLDYLP 178
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ---REQSLVEWARPMLNDARKL 312
           PE +         D++S GV+  E L G    +    Q   R  S VE+  P        
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP-------- 230
Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                      +   GAR    L  + L H   QR T++ V++
Sbjct: 231 ----------DFVTEGARD---LISRLLKHNASQRLTLAEVLE 260

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDK---TATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAVK +D   L     ++   EV  +  L HP++
Sbjct: 15  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + +     Y V+  W   MK     AK       + 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFD-----YLVAHGW---MKEKEARAKFRQIVSAVQ 120
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G+         G+  YAAPE
Sbjct: 121 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 175
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
                       DV+S GV+L  L+SG      S P   Q+L E    +L    ++   M
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKELRERVLRGKYRIPFYM 229
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT---------------LEPLK 361
               E             L  + L   P +R T+  ++K                +EPL 
Sbjct: 230 STDCEN------------LLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 277
Query: 362 DFDD 365
           D+ D
Sbjct: 278 DYKD 281

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDKT---ATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 81
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQL 138
           ++   ++GEG +G V   +  D +R       VA+K +   E     +  L E+  L + 
Sbjct: 45  YTQLQYIGEGAYGMVSSAY--DHVR----KTRVAIKKISPFEHQTYCQRTLREIQILLRF 98
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLA 197
           RH +++ +           +   Y+ +  +E  L++   S  L             +GL 
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAAP 256
           ++H A   V++RD K SN+L+++    K+ DFGLA+   PE D T   T  + T+ Y AP
Sbjct: 159 YIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 257 EYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           E ++     T   D++S G +L E+LS R
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYXQRTLREIKILLR 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 26  LGRGAFGQVIEADAFGIDK---TATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 81
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 142 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 122/304 (40%), Gaps = 61/304 (20%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAVK +D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + + L            RMK     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 182
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
                       DV+S GV+L  L+SG      S P   Q+L E    +L    ++   M
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKELRERVLRGKYRIPFYM 236
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT---------------LEPLK 361
               E             L  + L   P +R T+  ++K                +EPL 
Sbjct: 237 STDCEN------------LLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284
Query: 362 DFDD 365
           D+ D
Sbjct: 285 DYKD 288

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 35  LGRGAFGQVIEADAFGIDK---TATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGL 141
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 44/225 (19%)
Query: 89  GGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE--VIFLGQLRHPHLVKL 146
           G FG V K  + +          VAVK   L   Q  + W +E  +     ++H +L++ 
Sbjct: 26  GRFGCVWKAQLMNDF--------VAVKIFPL---QDKQSWQSEREIFSTPGMKHENLLQF 74
Query: 147 I-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           I     G   E E   L+  +  +GSL + L       + W+    +A   ++GL++LH+
Sbjct: 75  IAAEKRGSNLEVE-LWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHE 130
Query: 202 --------AEKPVI-YRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRVMG 249
                     KP I +RDFK+ N+LL SD TA L+DFGLA   + G    DTH     +G
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ---VG 187
Query: 250 TQGYAAPEYVMTGHLTSMS------DVYSFGVVLLELLSGRKSVD 288
           T+ Y APE V+ G +          D+Y+ G+VL EL+S  K+ D
Sbjct: 188 TRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 142
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 143 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 79
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 140 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 83
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 143
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 144 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 74
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 134
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 135 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTE 131
           + +  +     LG+G FG V      DK+      Q  AVK +    ++   +    L E
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVI--LCKDKI----TGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           V  L QL HP+++KL  +  ++ +  LV E    G L +++  R   S   + R  I   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQ 134
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRV- 247
              G+ ++H  +  +++RD K  N+LL+S   D   ++ DFGL+        TH      
Sbjct: 135 VLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKK 184
Query: 248 ----MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
               +GT  Y APE V+ G      DV+S GV+L  LLSG
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 75
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 135
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 136 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 47/227 (20%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE--VIFLGQLRHPH 142
            +G G +GAV+KG +D++        PVAVK       Q    ++ E  +  +  + H +
Sbjct: 20  LIGRGRYGAVYKGSLDER--------PVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 143 LVKLIGYCCEEE-------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           + + I    +E          LLV EY P GSL   L    S    W +  ++A    +G
Sbjct: 69  IARFI--VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRG 123
Query: 196 LAFLH------DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLA------KDGPEGDDTH 242
           LA+LH      D  KP I +RD  + N+L+ +D T  +SDFGL+      +    G++ +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 243 VSTRVMGTQGYAAPEYVMTGHLT--------SMSDVYSFGVVLLELL 281
            +   +GT  Y APE V+ G +            D+Y+ G++  E+ 
Sbjct: 184 AAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 22/254 (8%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +GEG  G V         R     + VAVK +DL   Q       EV+ +   +H ++V+
Sbjct: 53  IGEGSTGIVCLA------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           +       E   ++ E++  G+L + + +   V L       +     + LA+LH   + 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH--AQG 161
Query: 206 VIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
           VI+RD K+ +ILL  D   KLSDFG    ++KD P+         ++GT  + APE +  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKXLVGTPYWMAPEVISR 215
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  D++S G++++E++ G        P Q  + L +   P L ++ K+  ++   L
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 321 EGQYSETGARKAAA 334
           E         +A A
Sbjct: 276 ERMLVRDPQERATA 289

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+              Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 29  IGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +       +       +     + L FLH  +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ-- 137
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
           VI+R+ K+ NILL  D + KL+DFG  A+  PE   +  ST V GT  + APE V     
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 194
Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPMLNDARKLGRI 315
               D++S G++ +E++ G        P R   L+     P L +  KL  I
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 115/298 (38%), Gaps = 61/298 (20%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           F     +G GGFG V K       +  +  +   +K +     +  RE    V  L +L 
Sbjct: 13  FKEIELIGSGGFGQVFKA------KHRIDGKTYVIKRVKYNNEKAERE----VKALAKLD 62
Query: 140 HPHLVKLIG------YCCEEEHR----------LLVYEYMPRGSLENQLFRRYSVSLPWS 183
           H ++V   G      Y  E   +           +  E+  +G+LE  + +R    L   
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA----KDGPEGD 239
             +++     KG+ ++H   K +I RD K SNI L      K+ DFGL      DG    
Sbjct: 123 LALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
                 R  GT  Y +PE + +       D+Y+ G++L ELL                  
Sbjct: 179 -----XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH----------------- 216
Query: 300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
                + + A +  +      +G  S+   +K   L  + LS +P+ RP  S +++TL
Sbjct: 217 -----VCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQL 138
           +++ +++GEG +G V   +        L    VA+K +   E     +  L E+  L + 
Sbjct: 23  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGLA 197
           RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL 
Sbjct: 77  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAAP 256
           ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y AP
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 257 EYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           E ++     T   D++S G +L E+LS R
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 72  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 127
Query: 141 PHLVKLIGYCCEEEHRLLV-YEYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 188 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 103/240 (42%), Gaps = 24/240 (10%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
           ++   +F     LG+G FG V    +  K    L A  V  K++ L+          + I
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARV--KETGDLYAVKVLKKDVILQDDDVECTMTEKRI 76
Query: 134 FLGQLRHPHLVKLIGYCCEE--EHRLLVYEYMPRGSL--ENQLFRRYSVSLPWSTRMKI- 188
                 HP L +L  +CC +  +    V E++  G L    Q  RR+        R +  
Sbjct: 77  LSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFY 129
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A      L FLHD  K +IYRD K  N+LLD +   KL+DFG+ K+G     T  +    
Sbjct: 130 AAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFC 185
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
           GT  Y APE +         D ++ GV+L E+L G    +    + E  L E    +LND
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFE---AILND 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 85
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 145
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 146 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 97
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 158 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 121/304 (39%), Gaps = 61/304 (20%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAVK +D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + + L            RMK     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G+         G   YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPE 182
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
                       DV+S GV+L  L+SG      S P   Q+L E    +L    ++   M
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKELRERVLRGKYRIPFYM 236
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT---------------LEPLK 361
               E             L  + L   P +R T+  ++K                +EPL 
Sbjct: 237 STDCEN------------LLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284
Query: 362 DFDD 365
           D+ D
Sbjct: 285 DYKD 288

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 69  TLAEL---KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN-LDLEGLQG 124
            LAE+   K T   F     LG+G FG V+     +K    + A  V  K+ L+ EG++ 
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVE- 59
Query: 125 HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
             +   E+     LRHP+++++  Y  + +   L+ E+ PRG L  +L +        S 
Sbjct: 60  -HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 118
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
                L  A  L + H  E+ VI+RD K  N+L+      K++DFG +   P      + 
Sbjct: 119 TFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LR 169
Query: 245 TRVM-GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
            R M GT  Y  PE +         D++  GV+  E L G    D
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAVK +D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + + L            RMK     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 182
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRKSVD 288
                       DV+S GV+L  L+SG    D
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 86  LGEGGFGAVHKG--FIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQL-RH 140
           LG G FG V +   F  DK       + VAVK L  EG     HR  ++E+  L  +  H
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 92
Query: 141 PHLVKLIGYCCEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTR-------------- 185
            ++V L+G C +    L+V  E+   G+L   L  + +  +P+                 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           +  +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D     
Sbjct: 153 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
                  + APE +     T  SDV+SFGV+L E+ S
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L  
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLA 79
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 140 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 118/284 (41%), Gaps = 37/284 (13%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL 135
           T + F     LG+G FG V+     ++    + A  V  K   LE      +   EV   
Sbjct: 10  TLEDFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQ 66
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
             LRHP++++L GY  +     L+ EY P G++  +L ++ S      T   I    A  
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYIT-ELANA 124
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG-DDTHVSTRVMGTQGYA 254
           L++ H   K VI+RD K  N+LL S+   K++DFG +   P    DT     + GT  Y 
Sbjct: 125 LSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-----LCGTLDYL 177
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ---REQSLVEWARPMLNDARK 311
            PE +         D++S GV+  E L G    +    Q   R  S VE+  P       
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP------- 230
Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                       +   GAR    L  + L H   QR T++ V++
Sbjct: 231 -----------DFVTEGARD---LISRLLKHNASQRLTLAEVLE 260

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTE 131
           + +  +     LG+G FG V      DK+      Q  AVK +    ++   +    L E
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVI--LCKDKI----TGQECAVKVISKRQVKQKTDKESLLRE 82
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           V  L QL HP+++KL  +  ++ +  LV E    G L +++  R   S   + R  I   
Sbjct: 83  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQ 140
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRV- 247
              G+ ++H  +  +++RD K  N+LL+S   D   ++ DFGL+        TH      
Sbjct: 141 VLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKK 190
Query: 248 ----MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
               +GT  Y APE V+ G      DV+S GV+L  LLSG
Sbjct: 191 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G+G +G V  G          + + VAVK     E     RE  TE+     +RH +++
Sbjct: 45  IGKGRYGEVWMG--------KWRGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENIL 94
Query: 145 KLIGYCCE----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
             I    +         L+ +Y   GSL + L    S +L   + +K+A  +  GL  LH
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 201 DA-----EKPVI-YRDFKASNILLDSDYTAKLSDFGLA----KDGPEGDDTHVSTRVMGT 250
                   KP I +RD K+ NIL+  + T  ++D GLA     D  E  D   +TRV GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV-DIPPNTRV-GT 209
Query: 251 QGYAAPEY----VMTGHLTS--MSDVYSFGVVLLELLSGRKSVDKSRPQREQ----SLVE 300
           + Y  PE     +   H  S  M+D+YSFG++L E+   R+ V     +  Q     LV 
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVP 267
Query: 301 WARPMLNDARKLGRI--MDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
            + P   D R++  I  + P    ++ S+   R+   L  +C +H P  R T   V KTL
Sbjct: 268 -SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 358 EPLKDFDD 365
             + +  D
Sbjct: 327 AKMSESQD 334

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 122/304 (40%), Gaps = 61/304 (20%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAV+ +D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + + L            RMK     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPE 182
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
                       DV+S GV+L  L+SG      S P   Q+L E    +L    ++   M
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKELRERVLRGKYRIPFYM 236
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT---------------LEPLK 361
               E             L  + L   P +R T+  ++K                +EPL 
Sbjct: 237 STDCEN------------LLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284
Query: 362 DFDD 365
           D+ D
Sbjct: 285 DYKD 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 122/304 (40%), Gaps = 61/304 (20%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAV+ +D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + + L            RMK     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 182
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
                       DV+S GV+L  L+SG      S P   Q+L E    +L    ++   M
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKELRERVLRGKYRIPFYM 236
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT---------------LEPLK 361
               E             L  + L   P +R T+  ++K                +EPL 
Sbjct: 237 STDCEN------------LLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284
Query: 362 DFDD 365
           D+ D
Sbjct: 285 DYKD 288

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLTEV 132
           T  +F     +G G F  V++          L   PVA+K +   DL   +   + + E+
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAAC------LLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIAL 190
             L QL HP+++K      E+    +V E    G L   +  F++    +P  T  K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
                L  +H   + V++RD K +N+ + +    KL D GL +       T  +  ++GT
Sbjct: 144 QLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGT 199
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLEL 280
             Y +PE +        SD++S G +L E+
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 69  TLAEL---KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN-LDLEGLQG 124
            LAE+   K T   F     LG+G FG V+     +K    + A  V  K+ L+ EG++ 
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVE- 58
Query: 125 HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
             +   E+     LRHP+++++  Y  + +   L+ E+ PRG L  +L +        S 
Sbjct: 59  -HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS 244
                L  A  L + H  E+ VI+RD K  N+L+      K++DFG +   P      + 
Sbjct: 118 TFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LR 168
Query: 245 TRVM-GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD 288
            R M GT  Y  PE +         D++  GV+  E L G    D
Sbjct: 169 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAVK +D   L     ++   EV  +  L HP++
Sbjct: 23  IGKGNFAKVKLA------RHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   LV EY   G + + L            RMK     AK       + 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 128
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD D   K++DFG + +   G+         G+  YAAPE
Sbjct: 129 YCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPE 183
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSG 283
                       DV+S GV+L  L+SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA++ +   E     +  L E+  L +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIRKISPFEHQTYCQRTLREIKILLR 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L  
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVR-------VAIKKISPFEHQTYCQRTLREIKILLA 79
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y A
Sbjct: 140 KYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 81  SSSNF-----LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIF 134
           SSS F     LG G +  V+KG              VA+K + L+  +G     + E+  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTT------GVYVALKEVKLDSEEGTPSTAIREISL 56
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYM----------------PRGSLENQLFRRYSV 178
           + +L+H ++V+L      E    LV+E+M                PRG LE  L + +  
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELNLVKYFQW 115
Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
            L             +GLAF H  E  +++RD K  N+L++     KL DFGLA+     
Sbjct: 116 QL------------LQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161
Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
            +T  S  V  T  Y AP+ +M     S S D++S G +L E+++G+
Sbjct: 162 VNTFSSEVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 121/265 (45%), Gaps = 36/265 (13%)
Query: 83  SNFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH 140
           +NF+  GEG  G V    I  +   G Q   VAVK +DL   Q       EV+ +    H
Sbjct: 48  ANFIKIGEGSTGIV---CIATEKHTGKQ---VAVKKMDLRKQQRRELLFNEVVIMRDYHH 101
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAK 194
            ++V +       +   +V E++  G+L +         +   TRM       + L   +
Sbjct: 102 DNVVDMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLSVLR 152
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGT 250
            L++LH+  + VI+RD K+ +ILL SD   KLSDFG    ++K+ P+         ++GT
Sbjct: 153 ALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKXLVGT 204
Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWARPMLNDA 309
             + APE +      +  D++S G++++E++ G        P Q  + + +   P + D 
Sbjct: 205 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDL 264
Query: 310 RKLGRIMDPRLEGQYSETGARKAAA 334
            K+  ++   L+       +++A A
Sbjct: 265 HKVSSVLRGFLDLMLVREPSQRATA 289

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K    +K    L     A K ++ +  +   +++ E+  L    HP++VK
Sbjct: 27  LGDGAFGKVYKA--KNKETGAL----AAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G    +    ++ E+ P G++ + +       L       +     + L FLH   K 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS--KR 137
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           +I+RD KA N+L+  +   +L+DFG++    +      S   +GT  + APE VM   + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 195
Query: 266 SM-----SDVYSFGVVLLEL 280
                  +D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K    +K    L     A K ++ +  +   +++ E+  L    HP++VK
Sbjct: 19  LGDGAFGKVYKA--KNKETGAL----AAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G    +    ++ E+ P G++ + +       L       +     + L FLH   K 
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS--KR 129
Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           +I+RD KA N+L+  +   +L+DFG++    +      S   +GT  + APE VM   + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 187
Query: 266 SM-----SDVYSFGVVLLEL 280
                  +D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T      + T+ Y A
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 80  FSSSNFLGEGGFGAVHKGFID-DKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQ 137
           +++ +++GEG +G V   + + +K+R       VA+K +   E     +  L E+  L +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVR-------VAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL-GAAKGL 196
            RH +++ +           +   Y+ +  +E  L++        +  +   L    +GL
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 142
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQGYAA 255
            ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T      + T+ Y A
Sbjct: 143 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 256 PEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           PE ++     T   D++S G +L E+LS R
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS 220
           E+  +G+LE  + +R    L     +++     KG+ ++H   K +I+RD K SNI L  
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLIHRDLKPSNIFLVD 171
Query: 221 DYTAKLSDFGLA----KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVV 276
               K+ DFGL      DG         TR  GT  Y +PE + +       D+Y+ G++
Sbjct: 172 TKQVKIGDFGLVTSLKNDGKR-------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 224
Query: 277 LLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALA 336
           L ELL                       + + A +  +      +G  S+   +K   L 
Sbjct: 225 LAELLH----------------------VCDTAFETSKFFTDLRDGIISDIFDKKEKTLL 262
Query: 337 YQCLSHRPKQRPTMSTVVKTL 357
            + LS +P+ RP  S +++TL
Sbjct: 263 QKLLSKKPEDRPNTSEILRTL 283

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 38/229 (16%)
Query: 80  FSSSNFLGEGGFGAVH--KGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLG 136
           F     LG GGFG V   K  +DD           A+K + L   +  RE  + EV  L 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDD--------CNYAIKRIRLPNRELAREKVMREVKALA 58
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL--ENQLFRRYSVSLPW------------ 182
           +L HP +V+      E+     +    P+  L  + QL R+ ++   W            
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK-DWMNGRCTIEERER 117
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL--AKDGPEGDD 240
           S  + I L  A+ + FLH   K +++RD K SNI    D   K+ DFGL  A D  E + 
Sbjct: 118 SVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 241 THVS--------TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
           T ++        T  +GT+ Y +PE +     +   D++S G++L ELL
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 109/239 (45%), Gaps = 31/239 (12%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQA-----QPVAVKNLDLEGLQGHREW 128
           +V    F+    LG+G FG V     D K    L A     + V +++ D+E        
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVM--LADRKGTEELYAIKILKKDVVIQDDDVECT------ 66
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           + E   L  L  P  +  +  C +   RL  V EY+  G L   + +      P +    
Sbjct: 67  MVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY- 125
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGDDTHV 243
            A   + GL FLH  ++ +IYRD K  N++LDS+   K++DFG+ K    DG       V
Sbjct: 126 -AAEISIGLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG-------V 175
Query: 244 STR-VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD-KSRPQREQSLVE 300
           +TR   GT  Y APE +         D +++GV+L E+L+G+   D +   +  QS++E
Sbjct: 176 TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTE 131
           + +  +     LG+G FG V      DK+      Q  AVK +    ++   +    L E
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVI--LCKDKI----TGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           V  L QL HP++ KL  +  ++ +  LV E    G L +++  R   S   + R  I   
Sbjct: 77  VQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQ 134
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRV- 247
              G+ + H  +  +++RD K  N+LL+S   D   ++ DFGL+        TH      
Sbjct: 135 VLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKK 184
Query: 248 ----MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
               +GT  Y APE V+ G      DV+S GV+L  LLSG
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRP----GLQAQPVAVKNLDLEGLQGHREWL 129
           KV  ++F     LG G +G V   F+  K+       L A  V  K   ++  +      
Sbjct: 50  KVGIENFELLKVLGTGAYGKV---FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           TE   L  +R    +  + Y  + E +L L+ +Y+  G L   L +R   +      ++I
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQI 163
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
            +G    LA  H  +  +IYRD K  NILLDS+    L+DFGL+K+    D+T  +    
Sbjct: 164 YVGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFC 221
Query: 249 GTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSG 283
           GT  Y AP+ V    +GH  ++ D +S GV++ ELL+G
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTG 258

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 13  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 123
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 118/257 (45%), Gaps = 46/257 (17%)
Query: 50  TTLSE---DLSISLAGSNLHVF---TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL 103
           TTL +   D++ S +GS L +    T+A   V  +S      +G+G FG V +G      
Sbjct: 14  TTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQES------IGKGRFGEVWRG------ 61
Query: 104 RPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHLVKLIGYCCEEE----HRL 157
               + + VAVK   +   +  R W    E+     LRH +++  I    ++        
Sbjct: 62  --KWRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116
Query: 158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH-----DAEKPVI-YRDF 211
           LV +Y   GSL + L  RY+V++     +K+AL  A GLA LH        KP I +RD 
Sbjct: 117 LVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173
Query: 212 KASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEY----VMTGHLT 265
           K+ NIL+  + T  ++D GLA       DT        +GT+ Y APE     +   H  
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233
Query: 266 SM--SDVYSFGVVLLEL 280
           S   +D+Y+ G+V  E+
Sbjct: 234 SFKRADIYAMGLVFWEI 250

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 13/230 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK-SRPQREQSLVEWARPMLNDARKL 312
            +   DV+S G+VL  +L+G    D+ S   +E S  +  +  LN  +K+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKI 233

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 118/257 (45%), Gaps = 46/257 (17%)
Query: 50  TTLSE---DLSISLAGSNLHVF---TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKL 103
           TTL +   D++ S +GS L +    T+A   V  +S      +G+G FG V +G      
Sbjct: 1   TTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQES------IGKGRFGEVWRG------ 48
Query: 104 RPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHLVKLIGYCCEEE----HRL 157
               + + VAVK   +   +  R W    E+     LRH +++  I    ++        
Sbjct: 49  --KWRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 103
Query: 158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH-----DAEKPVI-YRDF 211
           LV +Y   GSL + L  RY+V++     +K+AL  A GLA LH        KP I +RD 
Sbjct: 104 LVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 160
Query: 212 KASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEY----VMTGHLT 265
           K+ NIL+  + T  ++D GLA       DT        +GT+ Y APE     +   H  
Sbjct: 161 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 220
Query: 266 SM--SDVYSFGVVLLEL 280
           S   +D+Y+ G+V  E+
Sbjct: 221 SFKRADIYAMGLVFWEI 237

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+  ++DK + G Q    AVK + LE  +       E++    L  P +V 
Sbjct: 82  LGRGSFGEVHR--MEDK-QTGFQC---AVKKVRLEVFRAE-----ELMACAGLTSPRIVP 130
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G   E     +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLVKEQGC-LPEDRALYYLGQALEGLEYLHS--RR 186
Query: 206 VIYRDFKASNILLDSDYT-AKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           +++ D KA N+LL SD + A L DFG    L  DG  G D      + GT+ + APE V+
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKDLLTGDYIPGTETHMAPEVVL 245
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
                +  DV+S   ++L +L+G
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG +G V            +  + VAVK +D++  +        E+     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHL 143
           FLG+GGF    +  I D     + A  +  K+L L+  Q  RE ++ E+     L H H+
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 79
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G+  + +   +V E   R SL     RR +++ P +     +I LG      +LH 
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHR 135
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               VI+RD K  N+ L+ D   K+ DFGLA    E D     T + GT  Y APE +  
Sbjct: 136 NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKT-LCGTPNYIAPEVLSK 191
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
              +   DV+S G ++  LL G+   + S
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHL 143
           FLG+GGF    +  I D     + A  +  K+L L+  Q  RE ++ E+     L H H+
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 101
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G+  + +   +V E   R SL     RR +++ P +     +I LG      +LH 
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHR 157
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
               VI+RD K  N+ L+ D   K+ DFGLA K   +G+   V   + GT  Y APE + 
Sbjct: 158 NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 212
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
               +   DV+S G ++  LL G+   + S
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHL 143
           FLG+GGF    +  I D     + A  +  K+L L+  Q  RE ++ E+     L H H+
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 83
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G+  + +   +V E   R SL     RR +++ P +     +I LG      +LH 
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHR 139
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               VI+RD K  N+ L+ D   K+ DFGLA    E D     T + GT  Y APE +  
Sbjct: 140 NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKT-LCGTPNYIAPEVLSK 195
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
              +   DV+S G ++  LL G+   + S
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHL 143
           FLG+GGF    +  I D     + A  +  K+L L+  Q  RE ++ E+     L H H+
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 103
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G+  + +   +V E   R SL     RR +++ P +     +I LG      +LH 
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHR 159
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
               VI+RD K  N+ L+ D   K+ DFGLA K   +G+   V   + GT  Y APE + 
Sbjct: 160 NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 214
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
               +   DV+S G ++  LL G+   + S
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHL 143
           FLG+GGF    +  I D     + A  +  K+L L+  Q  RE ++ E+     L H H+
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 79
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G+  + +   +V E   R SL     RR +++ P +     +I LG      +LH 
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHR 135
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               VI+RD K  N+ L+ D   K+ DFGLA    E D     T + GT  Y APE +  
Sbjct: 136 NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKT-LCGTPNYIAPEVLSK 191
Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
              +   DV+S G ++  LL G+   + S
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHL 143
           FLG+GGF    +  I D     + A  +  K+L L+  Q  RE ++ E+     L H H+
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHV 77
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G+  + +   +V E   R SL     RR +++ P +     +I LG      +LH 
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHR 133
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
               VI+RD K  N+ L+ D   K+ DFGLA K   +G+   V   + GT  Y APE + 
Sbjct: 134 NR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 188
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
               +   DV+S G ++  LL G+   + S
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           +   + LG G F  V     +DK    L A     K   LEG +G  E   E+  L +++
Sbjct: 20  YDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKKA-LEGKEGSME--NEIAVLHKIK 74
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++V L        H  L+ + +  G L +++  +   +   ++R+   +  A  + +L
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYL 132
Query: 200 HDAEKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           HD    +++RD K  N+L   LD D    +SDFGL+K     D   V +   GT GY AP
Sbjct: 133 HDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAP 187
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E +     +   D +S GV+   LL G
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           +   + LG G F  V     +DK    L A     K   LEG +G  E   E+  L +++
Sbjct: 20  YDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEA-LEGKEGSME--NEIAVLHKIK 74
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++V L        H  L+ + +  G L +++  +   +   ++R+   +  A  + +L
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYL 132
Query: 200 HDAEKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           HD    +++RD K  N+L   LD D    +SDFGL+K    G    V +   GT GY AP
Sbjct: 133 HDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAP 187
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E +     +   D +S GV+   LL G
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           +   + LG G F  V     +DK    L A     K   LEG +G  E   E+  L +++
Sbjct: 20  YDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEA-LEGKEGSME--NEIAVLHKIK 74
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++V L        H  L+ + +  G L +++  +   +   ++R+   +  A  + +L
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYL 132
Query: 200 HDAEKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           HD    +++RD K  N+L   LD D    +SDFGL+K    G    V +   GT GY AP
Sbjct: 133 HDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAP 187
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E +     +   D +S GV+   LL G
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 125 HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV-SLPWS 183
           H E   E+  L  L HP+++KL     ++++  LV E+   G L  Q+  R+       +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGDD 240
             MK  L    G+ +LH  +  +++RD K  NILL++       K+ DFGL+    +  D
Sbjct: 150 NIMKQILS---GICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--D 202
Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             +  R +GT  Y APE V+        DV+S GV++  LL G
Sbjct: 203 YKLRDR-LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---REWLTEV 132
           + + + +   +GEG +G V K       R     + VA+K   LE        +  + E+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMK------CRNKDTGRIVAIKKF-LESDDDKMVKKIAMREI 75
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
             L QLRH +LV L+  C +++   LV+E++    L++     +   L +    K     
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDD--LELFPNGLDYQVVQKYLFQI 133
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GP-EGDDTHVSTRVMG 249
             G+ F H     +I+RD K  NIL+      KL DFG A+    P E  D  V+TR   
Sbjct: 134 INGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR--- 188
Query: 250 TQGYAAPEYVMTGHLT--SMSDVYSFGVVLLELLSG 283
              Y APE ++ G +      DV++ G ++ E+  G
Sbjct: 189 --WYRAPE-LLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V      DKL    +A  + +K   +         L EV  L QL HP+++K
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALGAAKGLAFLHDAEK 204
           L  +  ++ +  LV E    G L +++  R   S +  +  MK  L    G  +LH  + 
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLH--KH 123
Query: 205 PVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            +++RD K  N+LL+S   D   K+ DFGL+     G         +GT  Y APE V+ 
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTAYYIAPE-VLR 179
Query: 262 GHLTSMSDVYSFGVVLLELLSG 283
                  DV+S GV+L  LL G
Sbjct: 180 KKYDEKCDVWSCGVILYILLCG 201

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           +   + LG G F  V     +DK    L A     K   LEG +G  E   E+  L +++
Sbjct: 20  YDFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEA-LEGKEGSME--NEIAVLHKIK 74
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++V L        H  L+ + +  G L +++  +   +   ++R+   +  A  + +L
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYL 132
Query: 200 HDAEKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           HD    +++RD K  N+L   LD D    +SDFGL+K     D   V +   GT GY AP
Sbjct: 133 HDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAP 187
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E +     +   D +S GV+   LL G
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 21/219 (9%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV 132
           L++  + +     +G G FG V    +  K    + A  +  K   ++       W  E 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQ--LVRHKASQKVYAMKLLSKFEMIKRSDSAFFW-EER 126
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW----STRMKI 188
             +     P +V+L     ++++  +V EYMP G L N L   Y V   W    +  + +
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVL 185
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           AL A   +  +H        RD K  N+LLD     KL+DFG      E    H  T V 
Sbjct: 186 ALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV- 236
Query: 249 GTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSG 283
           GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+  + DK + G Q    AVK + LE  +     + E++    L  P +V 
Sbjct: 80  LGRGSFGEVHR--MKDK-QTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 128
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G   E     +  E +  GSL  QL ++    LP    +     A +GL +LH   + 
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLHT--RR 184
Query: 206 VIYRDFKASNILLDSDYT-AKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           +++ D KA N+LL SD + A L DFG    L  DG  G        + GT+ + APE VM
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTGDYIPGTETHMAPEVVM 243
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
                +  D++S   ++L +L+G
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEVIF 134
           + +     +GEG +G V K    D        Q VA+K   LE        +  L E+  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRD------TGQIVAIKKF-LESEDDPVIKKIALREIRM 55
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           L QL+HP+LV L+     +    LV+EY     L      RY   +P      I     +
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSITWQTLQ 113
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGP-EGDDTHVSTRVMGTQ 251
            + F H      I+RD K  NIL+      KL DFG A+   GP +  D  V+TR     
Sbjct: 114 AVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR----- 166
Query: 252 GYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSG 283
            Y +PE ++         DV++ G V  ELLSG
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V      DKL    +A  + +K   +         L EV  L QL HP+++K
Sbjct: 29  LGSGAYGEVL--LCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALGAAKGLAFLHDAEK 204
           L  +  ++ +  LV E    G L +++  R   S +  +  MK  L    G  +LH  + 
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLH--KH 140
Query: 205 PVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            +++RD K  N+LL+S   D   K+ DFGL+     G         +GT  Y APE V+ 
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTAYYIAPE-VLR 196
Query: 262 GHLTSMSDVYSFGVVLLELLSG 283
                  DV+S GV+L  LL G
Sbjct: 197 KKYDEKCDVWSCGVILYILLCG 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VA+K +D   L     ++   EV  +  L HP++
Sbjct: 20  IGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   L+ EY   G + + L            RMK     +K       + 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIVSAVQ 125
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G          G+  YAAPE
Sbjct: 126 YCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPE 180
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSG 283
                       DV+S GV+L  L+SG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 68/151 (45%), Gaps = 6/151 (3%)
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           + L  ++HP LV L       +    V +Y+  G L   L R      P +      + +
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 150
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           A  L +LH     ++YRD K  NILLDS     L+DFGL K+  E + T  ++   GT  
Sbjct: 151 A--LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLV 144
           LGEG  G V            +  + VAVK +D++      E + + I + + L H ++V
Sbjct: 14  LGEGAAGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++     +  P + R    L A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TSMS-DVYSFGVVLLELLSGRKSVDK 289
            +   DV+S G+VL  +L+G    D+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 4/93 (4%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGDDTHVSTRVMGTQG 252
           +GL ++H A   V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ 
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 253 YAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGR 284
           Y APE ++     T   D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VA+K +D   L     ++   EV  +  L HP++
Sbjct: 23  IGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GLA 197
           VKL      E+   L+ EY   G + + L            RMK     +K       + 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIVSAVQ 128
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           + H  +K +++RD KA N+LLD+D   K++DFG + +   G          G   YAAPE
Sbjct: 129 YCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPE 183
Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSG 283
                       DV+S GV+L  L+SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 118/298 (39%), Gaps = 51/298 (17%)
Query: 80  FSSSNFL---GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIF 134
           F   NFL    E   G + KG          Q   + VK L +     +  R++  E   
Sbjct: 9   FKQLNFLTKLNENHSGELWKG--------RWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 135 LGQLRHPHLVKLIGYC--CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           L    HP+++ ++G C      H  L+  +MP GSL N L    +  +  S  +K AL  
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS--DFGLAKDGPEGDDTHVSTRVMGT 250
           A+G+AFLH  E  +      + ++++D D TA++S  D   +   P           M  
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYA 171
Query: 251 QGYAAPEYVMTGHLTS---MSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
             + APE +      +    +D++SF V+L EL++           RE            
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-----------REVPFA-------- 212
Query: 308 DARKLGRIMDPRLEGQYSETG---ARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
           D   +   M   LEG         +   + L   C++  P +RP    +V  LE ++D
Sbjct: 213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HPH++ LI          LV++ M +G L + L  +  V+L       I     + ++FL
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFL 216
Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H     +++RD K  NILLD +   +LSDFG +     G+       + GT GY APE +
Sbjct: 217 H--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEIL 271
Query: 260 MTGHLTSMS------DVYSFGVVLLELLSG 283
                 +        D+++ GV+L  LL+G
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LG GGFG V +    D        + VA+K    E    +RE W  E+  + +L HP++V
Sbjct: 23  LGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 145 KL------IGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRMKIALGAAKGLA 197
                   +      +  LL  EY   G L   L +      L       +    +  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 198 FLHDAEKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           +LH  E  +I+RD K  NI+L         K+ D G AK+  +G+   + T  +GT  Y 
Sbjct: 137 YLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYL 191
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE +     T   D +SFG +  E ++G
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G FG V +G          + + VAVK   +   +  R W    E+     LRH ++
Sbjct: 12  IGKGRFGEVWRG--------KWRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENI 60
Query: 144 VKLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I    ++        LV +Y   GSL + L  RY+V++     +K+AL  A GLA L
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHL 117
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQ 251
           H        KP I +RD K+ NIL+  + T  ++D GLA       DT        +GT+
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 252 GYAAPEY----VMTGHLTSM--SDVYSFGVVLLEL 280
            Y APE     +   H  S   +D+Y+ G+V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LG GGFG V +    D        + VA+K    E    +RE W  E+  + +L HP++V
Sbjct: 22  LGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 145 KL------IGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRMKIALGAAKGLA 197
                   +      +  LL  EY   G L   L +      L       +    +  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 198 FLHDAEKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           +LH  E  +I+RD K  NI+L         K+ D G AK+  +G+   + T  +GT  Y 
Sbjct: 136 YLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYL 190
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE +     T   D +SFG +  E ++G
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G FG V +G          + + VAVK   +   +  R W    E+     LRH ++
Sbjct: 11  IGKGRFGEVWRG--------KWRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENI 59
Query: 144 VKLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I    ++        LV +Y   GSL + L  RY+V++     +K+AL  A GLA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHL 116
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQ 251
           H        KP I +RD K+ NIL+  + T  ++D GLA       DT        +GT+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 252 GYAAPEY----VMTGHLTSM--SDVYSFGVVLLEL 280
            Y APE     +   H  S   +D+Y+ G+V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 86  LGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           LG+G FG V     KG  D+     +  + V +++ D+E        + E   L     P
Sbjct: 349 LGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECT------MVEKRVLALPGKP 401
Query: 142 HLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
             +  +  C +   RL  V EY+  G L   + +      P +     A   A GL FL 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQ 459
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
              K +IYRD K  N++LDS+   K++DFG+ K+     D   +    GT  Y APE + 
Sbjct: 460 S--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEIIA 515
Query: 261 TGHLTSMSDVYSFGVVLLELLSGR 284
                   D ++FGV+L E+L+G+
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G F  V         R  L  + VAVK +D   L     ++   EV     L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           VKL      E+   LV EY   G + + L   +        R K        + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVA-HGRXKEKEARAKFR-QIVSAVQYCH--Q 131
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           K +++RD KA N+LLD+D   K++DFG + +   G+         G   YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKK 188
Query: 264 LTSMS-DVYSFGVVLLELLSGRKSVD 288
                 DV+S GV+L  L+SG    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 84  NFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           NF+  GEG  G V    +          + VAVK +DL   Q       EV+ +   +H 
Sbjct: 33  NFIKIGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 86
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKG 195
           ++V++       +   +V E++  G+L + +           TRM       + L   + 
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQA 137
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L+ LH   + VI+RD K+ +ILL  D   KLSDFG         +      ++GT  + A
Sbjct: 138 LSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMA 193
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPMLNDARKLGR 314
           PE +         D++S G++++E++ G        P +   ++ +   P L +  K+  
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS- 252
Query: 315 IMDPRLEGQYSETGARKAA--ALAYQCLSH 342
              P L+G       R  A  A A + L H
Sbjct: 253 ---PSLKGFLDRLLVRDPAQRATAAELLKH 279

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+  ++DK + G Q    AVK + LE  +       E++    L  P +V 
Sbjct: 101 LGRGSFGEVHR--MEDK-QTGFQC---AVKKVRLEVFRAE-----ELMACAGLTSPRIVP 149
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G   E     +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSL-GQLVKEQGC-LPEDRALYYLGQALEGLEYLHS--RR 205
Query: 206 VIYRDFKASNILLDSDYT-AKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           +++ D KA N+LL SD + A L DFG    L  DG  G        + GT+ + APE V+
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKSLLTGDYIPGTETHMAPEVVL 264
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
                +  DV+S   ++L +L+G
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G FG V +G          + + VAVK   +   +  R W    E+     LRH ++
Sbjct: 17  IGKGRFGEVWRG--------KWRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENI 65
Query: 144 VKLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I    ++        LV +Y   GSL + L  RY+V++     +K+AL  A GLA L
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHL 122
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQ 251
           H        KP I +RD K+ NIL+  + T  ++D GLA       DT        +GT+
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 252 GYAAPEY----VMTGHLTSM--SDVYSFGVVLLEL 280
            Y APE     +   H  S   +D+Y+ G+V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G FG V +G          + + VAVK   +   +  R W    E+     LRH ++
Sbjct: 14  IGKGRFGEVWRG--------KWRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENI 62
Query: 144 VKLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I    ++        LV +Y   GSL + L  RY+V++     +K+AL  A GLA L
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAHL 119
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQ 251
           H        KP I +RD K+ NIL+  + T  ++D GLA       DT        +GT+
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 252 GYAAPEY----VMTGHLTSM--SDVYSFGVVLLEL 280
            Y APE     +   H  S   +D+Y+ G+V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH+  + DK + G Q    AVK + LE  +     + E++    L  P +V 
Sbjct: 66  VGRGSFGEVHR--MKDK-QTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G   E     +  E +  GSL  QL ++    LP    +     A +GL +LH   + 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLHT--RR 170
Query: 206 VIYRDFKASNILLDSDYT-AKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           +++ D KA N+LL SD + A L DFG    L  DG  G        + GT+ + APE VM
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTGDYIPGTETHMAPEVVM 229
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
                +  D++S   ++L +L+G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 42/274 (15%)
Query: 84  NFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           NF+  GEG  G V    +          + VAVK +DL   Q       EV+ +   +H 
Sbjct: 28  NFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 81
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKG 195
           ++V++       +   +V E++  G+L + +           TRM       + L   + 
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQA 132
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQ 251
           L+ LH   + VI+RD K+ +ILL  D   KLSDFG    ++K+ P          ++GT 
Sbjct: 133 LSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTP 184
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPMLNDAR 310
            + APE +         D++S G++++E++ G        P +   ++ +   P L +  
Sbjct: 185 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 244
Query: 311 KLGRIMDPRLEGQYSETGARKAA--ALAYQCLSH 342
           K+     P L+G       R  A  A A + L H
Sbjct: 245 KVS----PSLKGFLDRLLVRDPAQRATAAELLKH 274

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 84  NFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           NF+  GEG  G V    +          + VAVK +DL   Q       EV+ +   +H 
Sbjct: 155 NFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 208
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKG 195
           ++V++       +   +V E++  G+L + +           TRM       + L   + 
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQA 259
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L+ LH   + VI+RD K+ +ILL  D   KLSDFG         +      ++GT  + A
Sbjct: 260 LSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMA 315
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPMLNDARKLGR 314
           PE +         D++S G++++E++ G        P +   ++ +   P L +  K+  
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS- 374
Query: 315 IMDPRLEGQYSETGARKAA--ALAYQCLSH 342
              P L+G       R  A  A A + L H
Sbjct: 375 ---PSLKGFLDRLLVRDPAQRATAAELLKH 401

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 84  NFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           NF+  GEG  G V    +          + VAVK +DL   Q       EV+ +   +H 
Sbjct: 35  NFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 88
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKG 195
           ++V++       +   +V E++  G+L + +           TRM       + L   + 
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQA 139
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L+ LH   + VI+RD K+ +ILL  D   KLSDFG         +      ++GT  + A
Sbjct: 140 LSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMA 195
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPMLNDARKLGR 314
           PE +         D++S G++++E++ G        P +   ++ +   P L +  K+  
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS- 254
Query: 315 IMDPRLEGQYSETGARKAA--ALAYQCLSH 342
              P L+G       R  A  A A + L H
Sbjct: 255 ---PSLKGFLDRLLVRDPAQRATAAELLKH 281

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH+  + DK + G Q    AVK + LE  +     + E++    L  P +V 
Sbjct: 82  VGRGSFGEVHR--MKDK-QTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 130
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G   E     +  E +  GSL  QL ++    LP    +     A +GL +LH   + 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLHT--RR 186
Query: 206 VIYRDFKASNILLDSDYT-AKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           +++ D KA N+LL SD + A L DFG    L  DG  G        + GT+ + APE VM
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTGDYIPGTETHMAPEVVM 245
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
                +  D++S   ++L +L+G
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 42/274 (15%)
Query: 84  NFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           NF+  GEG  G V    +          + VAVK +DL   Q       EV+ +   +H 
Sbjct: 24  NFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKG 195
           ++V++       +   +V E++  G+L + +           TRM       + L   + 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQA 128
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQ 251
           L+ LH   + VI+RD K+ +ILL  D   KLSDFG    ++K+ P          ++GT 
Sbjct: 129 LSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTP 180
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPMLNDAR 310
            + APE +         D++S G++++E++ G        P +   ++ +   P L +  
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 240
Query: 311 KLGRIMDPRLEGQYSETGARKAA--ALAYQCLSH 342
           K+     P L+G       R  A  A A + L H
Sbjct: 241 KVS----PSLKGFLDRLLVRDPAQRATAAELLKH 270

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   + D +LR     Q VAVK L    + L   R    E+  L  L+H ++
Sbjct: 36  VGSGAYGSVCSAY-DARLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         E+   + +   +    L N +    S +L       +     +GL +
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KSQALSDEHVQFLVYQLLRGLKY 146
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+TR      Y APE 
Sbjct: 147 IHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEI 199
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 43/279 (15%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +GEG FG   K  +      G Q     +K +++  +  +   E   EV  L  ++HP++
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQ---YVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-------ENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           V+      E     +V +Y   G L       +  LF+   + L W  ++ +AL      
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQICLALK----- 139
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
              H  ++ +++RD K+ NI L  D T +L DFG+A+         ++   +GT  Y +P
Sbjct: 140 ---HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARACIGTPYYLSP 194
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E        + SD+++ G VL EL + + + +             A  M N   K+    
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFE-------------AGSMKNLVLKIISGS 241
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            P +   YS        +L  Q     P+ RP+++++++
Sbjct: 242 FPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           ++    F+    LG+G FG V     KG  D+     +  + V +++ D+E        +
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECT------M 68
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
            E   L     P  +  +  C +   RL  V EY+  G L   + +      P +     
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-- 126
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A   A GL FL    K +IYRD K  N++LDS+   K++DFG+ K+     D   +    
Sbjct: 127 AAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKXFC 182
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           GT  Y APE +         D ++FGV+L E+L+G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 84  NFL--GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP 141
           NF+  GEG  G V    +          + VAVK +DL   Q       EV+ +   +H 
Sbjct: 78  NFIKIGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE 131
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IALGAAKG 195
           ++V++       +   +V E++  G+L + +           TRM       + L   + 
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQA 182
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           L+ LH   + VI+RD K+ +ILL  D   KLSDFG         +      ++GT  + A
Sbjct: 183 LSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMA 238
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV-EWARPMLNDARKLGR 314
           PE +         D++S G++++E++ G        P +   ++ +   P L +  K+  
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV-- 296
Query: 315 IMDPRLEGQYSETGARKAA--ALAYQCLSH 342
              P L+G       R  A  A A + L H
Sbjct: 297 --SPSLKGFLDRLLVRDPAQRATAAELLKH 324

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 185
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR------KSVDK--------SRPQRE 295
           + Y APE +      TS  DV+S G VL ELL G+        VD+          P RE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 296 Q------SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
           Q      +  E+A P +  A    ++  PR   +        A AL  + L + P  R T
Sbjct: 246 QIREMNPNYTEFAFPQIK-AHPWTKVFRPRTPPE--------AIALCSRLLEYTPTARLT 296

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           + +L++  + +     +G G FG V    +  K    + A  +  K   ++       W 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW- 117
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW----STR 185
            E   +     P +V+L     ++ +  +V EYMP G L N L   Y V   W    +  
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 176
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDT 241
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    DT
Sbjct: 177 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 242 HVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSG 283
            V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 229 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 75  VTTQSFSSSNF-----LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKN-LDLEGLQGHREW 128
           + T+ F+  +F     LG+G FG V+     +K    + A  V  K+ ++ EG++   + 
Sbjct: 15  ILTRHFTIDDFEIGRPLGKGKFGNVY--LAREKKSHFIVALKVLFKSQIEKEGVE--HQL 70
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
             E+     L HP++++L  Y  +     L+ EY PRG L  +L +  S +        I
Sbjct: 71  RREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQRTATI 128
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
               A  L + H   K VI+RD K  N+LL      K++DFG +   P      +  + M
Sbjct: 129 MEELADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS-----LRRKTM 181
Query: 249 -GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            GT  Y  PE +         D++  GV+  ELL G
Sbjct: 182 CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           + S +  LG G FG VHK    ++   GL+   +A K +   G++   E   E+  + QL
Sbjct: 90  TVSKTEILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
            H +L++L      +   +LV EY+  G L +++    S +L     +       +G+  
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRH 202
Query: 199 LHDAEKPVIYRDFKASNIL-LDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           +H  +  +++ D K  NIL ++ D    K+ DFGLA+     +   V+    GT  + AP
Sbjct: 203 MH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAP 257
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E V    ++  +D++S GV+   LLSG
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           + +L++  + +     +G G FG V    +  K    + A  +  K   ++       W 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW- 122
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW----STR 185
            E   +     P +V+L     ++ +  +V EYMP G L N L   Y V   W    +  
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDT 241
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    DT
Sbjct: 182 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 242 HVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSG 283
            V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 234 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 57/302 (18%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLENQLFRRYS---VSLPWSTRMKIA 189
            H ++V+L       G   +E +  LV +Y+P  +   ++ R YS    +LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVM 248
               + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXI 183
Query: 249 GTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR------KSVDK--------SRPQ 293
            ++ Y APE +      TS  DV+S G VL ELL G+        VD+          P 
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 294 REQ------SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
           REQ      +  E+A P +  A    ++  PR   +        A AL  + L + P  R
Sbjct: 244 REQIREMNPNYTEFAFPQIK-AHPWTKVFRPRTPPE--------AIALCSRLLEYTPTAR 294
Query: 348 PT 349
            T
Sbjct: 295 LT 296

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL 129
           + +L++  + +     +G G FG V    +  K    + A  +  K   ++       W 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW- 122
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW----STR 185
            E   +     P +V+L     ++ +  +V EYMP G L N L   Y V   W    +  
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDT 241
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    DT
Sbjct: 182 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 242 HVSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSG 283
            V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 234 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWL 129
           + +T   FS    +G GGFG V+        R     +  A+K LD + +   QG    L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 236
Query: 130 TEVIFLGQLRH---PHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
            E I L  +     P +V  + Y      +L  + + M  G L   L  ++ V      R
Sbjct: 237 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMR 294
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              A     GL  +H+  + V+YRD K +NILLD     ++SD GLA D  +    H S 
Sbjct: 295 F-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS- 349
Query: 246 RVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSG 283
             +GT GY APE +  G    S +D +S G +L +LL G
Sbjct: 350 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWL 129
           + +T   FS    +G GGFG V+        R     +  A+K LD + +   QG    L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 130 TEVIFLGQLRH---PHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
            E I L  +     P +V  + Y      +L  + + M  G L   L  ++ V      R
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMR 295
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              A     GL  +H+  + V+YRD K +NILLD     ++SD GLA D  +    H S 
Sbjct: 296 F-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS- 350
Query: 246 RVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSG 283
             +GT GY APE +  G    S +D +S G +L +LL G
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWL 129
           + +T   FS    +G GGFG V+        R     +  A+K LD + +   QG    L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 130 TEVIFLGQLRH---PHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
            E I L  +     P +V  + Y      +L  + + M  G L   L  ++ V      R
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMR 295
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              A     GL  +H+  + V+YRD K +NILLD     ++SD GLA D  +    H S 
Sbjct: 296 F-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS- 350
Query: 246 RVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSG 283
             +GT GY APE +  G    S +D +S G +L +LL G
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   + D +LR     Q VAVK L    + L   R    E+  L  L+H ++
Sbjct: 28  VGSGAYGSVCSAY-DARLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 144 VKLIGYCC------EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           + L+          +     LV   M  G+  N + +  ++S      +   L   +GL 
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQL--LRGLK 137
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+TR      Y APE
Sbjct: 138 YIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPE 190
Query: 258 YVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            ++   H     D++S G ++ ELL G+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWL 129
           + +T   FS    +G GGFG V+        R     +  A+K LD + +   QG    L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 130 TEVIFLGQLRH---PHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
            E I L  +     P +V  + Y      +L  + + M  G L   L  ++ V      R
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMR 295
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
              A     GL  +H+  + V+YRD K +NILLD     ++SD GLA D  +    H S 
Sbjct: 296 F-YAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS- 350
Query: 246 RVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSG 283
             +GT GY APE +  G    S +D +S G +L +LL G
Sbjct: 351 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 104
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 219
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 98
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 159 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 213
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 89
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 149
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 150 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 204
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 104
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 219
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 78
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 138
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 139 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 193
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 82
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 143 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 197
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   + D +LR     Q VAVK L    + L   R    E+  L  L+H ++
Sbjct: 36  VGSGAYGSVCSAY-DARLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 144 VKLI-----GYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           + L+         E+   + LV   M  G+  N + +  ++S      +   L   +GL 
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQL--LRGLK 145
Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V+TR      Y APE
Sbjct: 146 YIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPE 198
Query: 258 YVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            ++   H     D++S G ++ ELL G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 83
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 143
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 144 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 198
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 75
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 135
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 136 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 190
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 106
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 167 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 221
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 82
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 143 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 197
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G F  V +          L  Q  A K ++ + L    H++   E      L+HP++
Sbjct: 30  LGKGAFSVVRRCV------KVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           V+L     EE H  L+++ +  G L E+ + R Y      S  ++  L A      LH  
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHCH 138
Query: 203 EKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           +  V++RD K  N+LL S       KL+DFGLA +  EG+         GT GY +PE +
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQ-QAWFGFAGTPGYLSPEVL 196
Query: 260 MTGHLTSMSDVYSFGVVLLELLSG 283
                    D+++ GV+L  LL G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 185
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 185
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 71
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 132 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 186
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 108
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 169 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 223
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 185
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 74
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 134
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 135 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 189
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 149
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 209
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 210 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 264
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 37/250 (14%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGH-REWLTEVIFL 135
           Q +     +GEG +G V K      L+ G   + VA+K + ++ G +G     + EV  L
Sbjct: 11  QQYECVAEIGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 136 GQLR---HPHLVKLIGYCC----EEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
             L    HP++V+L   C     + E +L LV+E++ +  L   L +     +P  T   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           +     +GL FLH     V++RD K  NIL+ S    KL+DFGLA+           T V
Sbjct: 125 MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSV 179
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
           + T  Y APE ++     +  D++S G +  E+             R + L   +    +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF------------RRKPLFRGS----S 223
Query: 308 DARKLGRIMD 317
           D  +LG+I+D
Sbjct: 224 DVDQLGKILD 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 139 RHPHLVKL------IGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L       G   +E +  LV +Y+P       + + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 185
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 41/299 (13%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG-LQAQPVAVKNLDLEGLQGHREWLTEV 132
           K+  +    +  LG+G F  + KG   +    G L    V +K LD    + HR + +E 
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNY-SES 58
Query: 133 IF-----LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRM 186
            F     + +L H HLV   G C   +  +LV E++  GSL+  L + +  +++ W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           ++A   A  + FL   E  +I+ +  A NILL  +   K  +    K    G    V  +
Sbjct: 117 EVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 247 VMGTQ--GYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR 303
            +  +   +  PE +    +L   +D +SFG  L E+ SG                   +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-----------------K 217
Query: 304 PM--LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           P+  L+  RKL    D     Q     A + A L   C+ + P  RP+   +++ L  L
Sbjct: 218 PLSALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+K             +  A+K + LE    G+      + E+  L +L+H 
Sbjct: 10  IGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHS 60
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++VKL      ++  +LV+E++ +     +L       L   T     L    G+A+ HD
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM- 260
             + V++RD K  N+L++ +   K++DFGLA+    G      T  + T  Y AP+ +M 
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
           +   ++  D++S G +  E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 37/250 (14%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGH-REWLTEVIFL 135
           Q +     +GEG +G V K      L+ G   + VA+K + ++ G +G     + EV  L
Sbjct: 11  QQYECVAEIGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 136 GQLR---HPHLVKLIGYCC----EEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
             L    HP++V+L   C     + E +L LV+E++ +  L   L +     +P  T   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           +     +GL FLH     V++RD K  NIL+ S    KL+DFGLA+           T V
Sbjct: 125 MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSV 179
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
           + T  Y APE ++     +  D++S G +  E+        + +P    S         +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-------RRKPLFRGS---------S 223
Query: 308 DARKLGRIMD 317
           D  +LG+I+D
Sbjct: 224 DVDQLGKILD 233

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 70
Query: 139 RHPHLVKL--IGYCCEEEHRL----LVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
            H ++V+L    Y   E+  +    LV +Y+P       + + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+    +   + +
Sbjct: 131 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICS 185
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +      TS  DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVS 244
           +++   A + L F H  +  +I+RD K +NIL+ +    K+ DFG+A+     G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             V+GT  Y +PE      + + SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+K             +  A+K + LE    G+      + E+  L +L+H 
Sbjct: 10  IGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHS 60
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++VKL      ++  +LV+E++ +     +L       L   T     L    G+A+ HD
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM- 260
             + V++RD K  N+L++ +   K++DFGLA+    G      T  + T  Y AP+ +M 
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
           +   ++  D++S G +  E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHL 143
           LGE G G   + +   K+R       +AVK +   G   +  R  +   + L     P++
Sbjct: 30  LGEMGSGTCGQVW---KMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+  G         +  E M  G+   +L +R    +P     K+ +   K L +L +  
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
             VI+RD K SNILLD     KL DFG++  G   DD     R  G   Y APE +    
Sbjct: 145 G-VIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDD-KAKDRSAGCAAYMAPERIDPPD 200
Query: 264 LTS-----MSDVYSFGVVLLELLSGR 284
            T       +DV+S G+ L+EL +G+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GLQGHREWLTEVIFLGQLRHP 141
           +GEG +G V+K             +  A+K + LE    G+      + E+  L +L+H 
Sbjct: 10  IGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHS 60
Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++VKL      ++  +LV+E++ +     +L       L   T     L    G+A+ HD
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM- 260
             + V++RD K  N+L++ +   K++DFGLA+    G      T  + T  Y AP+ +M 
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
           +   ++  D++S G +  E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 37/250 (14%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGH-REWLTEVIFL 135
           Q +     +GEG +G V K      L+ G   + VA+K + ++ G +G     + EV  L
Sbjct: 11  QQYECVAEIGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 136 GQLR---HPHLVKLIGYCC----EEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
             L    HP++V+L   C     + E +L LV+E++ +  L   L +     +P  T   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
           +     +GL FLH     V++RD K  NIL+ S    KL+DFGLA+           T V
Sbjct: 125 MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSV 179
Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
           + T  Y APE ++     +  D++S G +  E+        + +P    S         +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-------RRKPLFRGS---------S 223
Query: 308 DARKLGRIMD 317
           D  +LG+I+D
Sbjct: 224 DVDQLGKILD 233

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMK 187
           L EV  L  L HP+++KL  +  ++ +  LV E    G L +++  R   + +  +  +K
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVS 244
             L    G+ +LH  +  +++RD K  N+LL+S   D   K+ DFGL+      ++    
Sbjct: 144 QVLS---GVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKM 195
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
              +GT  Y APE V+        DV+S GV+L  LL+G
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 37  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 90
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLV-YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
           + +L HP  VKL  +C +++ +L     Y   G L   + R+        TR   A    
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 147
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQG 252
             L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 204
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EYMP G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +  +    L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EYMP G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
           T+ +     LG+G F  V +     K+  G +   + +    L   + H++   E     
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCV---KVLAGQEYAAMIINTKKLSA-RDHQKLEREARICR 65
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKG 195
            L+HP++V+L     EE H  L+++ +  G L E+ + R Y      S  ++  L A   
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-- 123
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
              LH  +  V++R+ K  N+LL S       KL+DFGLA +  EG+         GT G
Sbjct: 124 ---LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQ-QAWFGFAGTPG 178
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y +PE +         D+++ GV+L  LL G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 35  IGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 145
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 146 IHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 198
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +  +    L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 50/235 (21%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIF 134
           F     LG+G FG V K       R  L ++  A+K +       H E      L+EV+ 
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI------RHTEEKLSTILSEVML 55
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLV---------------YEYMPRGSLENQLFRRYSVS 179
           L  L H ++V+   Y    E R  V                EY   G+L + L    +++
Sbjct: 56  LASLNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLN 112
Query: 180 LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
                  ++     + L+++H   + +I+RD K  NI +D     K+ DFGLAK+     
Sbjct: 113 QQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 240 D------------THVSTRVMGTQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELL 281
           D            +   T  +GT  Y A E +  TGH     D+YS G++  E++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 147
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEI 200
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 41/299 (13%)
Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPG-LQAQPVAVKNLDLEGLQGHREWLTEV 132
           K+  +    +  LG+G F  + KG   +    G L    V +K LD    + HR + +E 
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNY-SES 58
Query: 133 IF-----LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFR-RYSVSLPWSTRM 186
            F     + +L H HLV   G C   +  +LV E++  GSL+  L + +  +++ W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           ++A   A  + FL   E  +I+ +  A NILL  +   K  +    K    G    V  +
Sbjct: 117 EVAKQLAWAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 247 VMGTQ--GYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR 303
            +  +   +  PE +    +L   +D +SFG  L E+ SG                   +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-----------------K 217
Query: 304 PM--LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           P+  L+  RKL    D     Q     A + A L   C+ + P  RP+   +++ L  L
Sbjct: 218 PLSALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEV-I 133
           T +       +G G +G+V+K       +P    Q +AVK +      +  ++ L ++ +
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMV----HKPS--GQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-----LPWSTRMKI 188
            +     P++V+  G    E    +  E M   S     F +Y  S     +P     KI
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELM---STSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
            L   K L  L +  K +I+RD K SNILLD     KL DFG++    +  D+   TR  
Sbjct: 131 TLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDA 186
Query: 249 GTQGYAAPEYVMTGH----LTSMSDVYSFGVVLLELLSGR 284
           G + Y APE +            SDV+S G+ L EL +GR
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 147
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEI 200
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 147
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEI 200
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 147
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 200
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 142
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 143 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 195
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 145
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 146 IHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 198
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVS 244
           +++   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             V+GT  Y +PE      + + SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVS 244
           +++   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             V+GT  Y +PE      + + SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVS 244
           +++   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             V+GT  Y +PE      + + SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVS 244
           +++   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             V+GT  Y +PE      + + SDVYS G VL E+L+G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 145
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 146 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 198
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 29  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 83  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 139
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 140 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 192
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 142
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 143 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 195
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 142
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 143 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 195
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 27  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 137
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 138 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 190
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      ++ V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 200
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +     +  SD+++ G ++ +L++G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 145
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 146 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 198
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 152
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 153 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 205
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 152
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 153 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 205
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 116/273 (42%), Gaps = 53/273 (19%)
Query: 52  LSEDLSISLAGSNLHVFTLAELKVTTQS---------FSSSNFLGEGGFGAVHKGF---- 98
           L+ +  I+L+ S   VF   +L V  QS         +  S  LG G  G V   F    
Sbjct: 100 LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT 159
Query: 99  -------IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC 151
                  I  K +  + +   A   L++E         TE+  L +L HP ++K+  +  
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVE---------TEIEILKKLNHPCIIKIKNFFD 210
Query: 152 EEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPV 206
            E++  +V E M  G L      N+  +  +  L +  +M +A+       +LH  E  +
Sbjct: 211 AEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV------QYLH--ENGI 260
Query: 207 IYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--- 260
           I+RD K  N+LL S   D   K++DFG +K   E   T +   + GT  Y APE ++   
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVG 317
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           T       D +S GV+L   LSG     + R Q
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 152
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 153 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 205
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +    S  L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGL +   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 26  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 136
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 137 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 189
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 53  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 163
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 164 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEI 216
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 28  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 81
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 82  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 138
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 139 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 191
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 27  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 137
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 138 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 190
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G +G V +G            + VAVK   +   +  + W   TE+     LRH ++
Sbjct: 16  VGKGRYGEVWRGL--------WHGESVAVK---IFSSRDEQSWFRETEIYNTVLLRHDNI 64
Query: 144 VKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I       +      L+  Y   GSL + L R+   +L     +++A+ AA GLA L
Sbjct: 65  LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLEPHLALRLAVSAACGLAHL 121
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRVMGT 250
           H        KP I +RDFK+ N+L+ S+    ++D GLA     G +  D   + RV GT
Sbjct: 122 HVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GT 180
Query: 251 QGYAAPEY----VMTGHLTS--MSDVYSFGVVLLEL 280
           + Y APE     + T    S   +D+++FG+VL E+
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 116/273 (42%), Gaps = 53/273 (19%)
Query: 52  LSEDLSISLAGSNLHVFTLAELKVTTQS---------FSSSNFLGEGGFGAVHKGF---- 98
           L+ +  I+L+ S   VF   +L V  QS         +  S  LG G  G V   F    
Sbjct: 114 LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT 173
Query: 99  -------IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC 151
                  I  K +  + +   A   L++E         TE+  L +L HP ++K+  +  
Sbjct: 174 CKKVAIRIISKRKFAIGSAREADPALNVE---------TEIEILKKLNHPCIIKIKNFFD 224
Query: 152 EEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPV 206
            E++  +V E M  G L      N+  +  +  L +  +M +A+       +LH  E  +
Sbjct: 225 AEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV------QYLH--ENGI 274
Query: 207 IYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--- 260
           I+RD K  N+LL S   D   K++DFG +K   E   T +   + GT  Y APE ++   
Sbjct: 275 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVG 331
Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           T       D +S GV+L   LSG     + R Q
Sbjct: 332 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 364

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVS 244
           +++   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +
Sbjct: 136 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 245 TRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             V+GT  Y +PE      + + SDVYS G VL E+L+G
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 142
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 143 IHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 195
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 211
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 36  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 146
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y APE 
Sbjct: 147 IHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 199
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWL-TEVIFLGQLRHPHL 143
           +G G +G   K      +R     + +  K LD   + +  ++ L +EV  L +L+HP++
Sbjct: 14  IGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 144 VKLIGYCCEEEHRLL--VYEYMPRGSLENQLF-----RRY---SVSLPWSTRMKIALGAA 193
           V+      +  +  L  V EY   G L + +      R+Y      L   T++ +AL   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
              +   D    V++RD K +N+ LD     KL DFGLA+      DT  +   +GT  Y
Sbjct: 128 HRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYY 182
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +PE +        SD++S G +L EL +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 165 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 217
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 104/229 (45%), Gaps = 53/229 (23%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL------DLEGLQGHREWLTE 131
           +++ S   +G G +G+V    ID +       + VA+K L      ++   + +RE    
Sbjct: 24  KTYVSPTHVGSGAYGSVCSA-IDKR-----SGEKVAIKKLSRPFQSEIFAKRAYRE---- 73
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW-STRMKIAL 190
           ++ L  ++H +++ L+              + P  SL N  F  + + +P+  T ++  +
Sbjct: 74  LLLLKHMQHENVIGLLDV------------FTPASSLRN--FYDFYLVMPFMQTDLQKIM 119
Query: 191 GAA--------------KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
           G                KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+   
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 237 EGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
                +V TR      Y APE +++  H     D++S G ++ E+L+G+
Sbjct: 178 AEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 82
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 140
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      ++ V GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 197
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWL-TEVIFLGQLRHPHL 143
           +G G +G   K      +R     + +  K LD   + +  ++ L +EV  L +L+HP++
Sbjct: 14  IGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 144 VKLIGYCCEEEHRLL--VYEYMPRGSLENQLF-----RRY---SVSLPWSTRMKIALGAA 193
           V+      +  +  L  V EY   G L + +      R+Y      L   T++ +AL   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
              +   D    V++RD K +N+ LD     KL DFGLA+      DT  +   +GT  Y
Sbjct: 128 HRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGTPYY 182
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +PE +        SD++S G +L EL +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 10  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 121
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 122 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 178
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLG 136
           +++   + LGEG +  V+KG      +  L    VA+K + LE  +G     + EV  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK 55
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLE-----NQLFRRYSVSLPWSTRMKIALG 191
            L+H ++V L      E+   LV+EY+ +   +       +   ++V L           
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL-------FLFQ 108
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
             +GLA+ H   + V++RD K  N+L++     KL+DFGLA+       T+ +  V  T 
Sbjct: 109 LLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TL 164
Query: 252 GYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            Y  P+ ++ +   ++  D++  G +  E+ +GR
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ DFGLA+     DD    T  + T+ Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE--MTGXVATRWYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 144
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      ++ V GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 201
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 107/229 (46%), Gaps = 53/229 (23%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL------DLEGLQGHREWLTE 131
           +++ S   +G G +G+V    ID +       + VA+K L      ++   + +RE    
Sbjct: 42  KTYVSPTHVGSGAYGSVCSA-IDKR-----SGEKVAIKKLSRPFQSEIFAKRAYRE---- 91
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW-STRMKIAL 190
           ++ L  ++H +++ L+              + P  SL N  F  + + +P+  T ++  +
Sbjct: 92  LLLLKHMQHENVIGLLDV------------FTPASSLRN--FYDFYLVMPFMQTDLQKIM 137
Query: 191 GAA--------------KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
           G                KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+   
Sbjct: 138 GMEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA- 194
Query: 237 EGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
              D  ++  V+ T+ Y APE +++  H     D++S G ++ E+L+G+
Sbjct: 195 ---DAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 7   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 118
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 175
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 9   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 120
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 121 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 177
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 47/91 (51%), Gaps = 2/91 (2%)
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D           
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            + APE +     T  SDV+SFGV+L E+ S
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 8   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 119
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 176
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT---- 130
           + T  +     +G G +G V+K       R       VA+K++ +    G    L     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 131 -EVIFLGQLR---HPHLVKLIGYCC-----EEEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
            EV  L +L    HP++V+L+  C       E    LV+E++ +  L   L +     LP
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
             T   +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+        
Sbjct: 119 AETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQ 173
Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
              T V+ T  Y APE ++     +  D++S G +  E+ 
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 47/91 (51%), Gaps = 2/91 (2%)
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D           
Sbjct: 207 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            + APE +     T  SDV+SFGV+L E+ S
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQY 198
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI-----F 134
           +     +G+G F  V +    +        Q  AVK +D+          TE +      
Sbjct: 26  YELCEVIGKGAFSVVRRCINRE------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIA 189
              L+HPH+V+L+     +    +V+E+M    L  ++ +R      +S       M+  
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
           L A   L + HD    +I+RD K  N+LL S   +   KL DFG+A     G+   V+  
Sbjct: 140 LEA---LRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGG 192
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +GT  + APE V         DV+  GV+L  LLSG
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 47/91 (51%), Gaps = 2/91 (2%)
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D           
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            + APE +     T  SDV+SFGV+L E+ S
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 14  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 67
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 125
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 182
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 47/91 (51%), Gaps = 2/91 (2%)
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D           
Sbjct: 209 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            + APE +     T  SDV+SFGV+L E+ S
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 198
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 198
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 82
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 140
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 197
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 144
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 201
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 19/232 (8%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           + L   NL+   +A     T  +     LG+G F  V +     K  P    Q  A K +
Sbjct: 11  VDLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCV---KKTP---TQEYAAKII 64
Query: 118 DLEGLQG--HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFR 174
           + + L    H++   E      L+HP++V+L     EE    LV++ +  G L E+ + R
Sbjct: 65  NTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR 124
Query: 175 RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY---TAKLSDFGL 231
            Y      S  +   L +       H  +  +++RD K  N+LL S       KL+DFGL
Sbjct: 125 EYYSEADASHCIHQILESVN-----HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGL 179
Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           A +  +G+         GT GY +PE +         D+++ GV+L  LL G
Sbjct: 180 AIE-VQGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLG 136
           F     LG G FG V    +   +  G      A+K LD + +   +E    L E   L 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
            +  P LVKL     +  +  +V EY P G + + L R    S P   R   A       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-YAAQIVLTF 154
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGY 253
            +LH  +  +IYRD K  N+++D     K++DFGLAK         V  R   + GT  Y
Sbjct: 155 EYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGTPEY 204
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            APE +++       D ++ GV++ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 46/237 (19%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQ 137
           +   + +G G +G V + +  DKL    + + VA+K +    E L   +  L E+  L +
Sbjct: 55  YEIRHLIGTGSYGHVCEAY--DKL----EKRVVAIKKILRVFEDLIDCKRILREIAILNR 108
Query: 138 LRHPHLVKLIGYC----CEEEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALG 191
           L H H+VK++        E+   L V   +     + +LFR   Y   L   T +   L 
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFK-KLFRTPVYLTELHIKTLLYNLLV 167
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEG----------- 238
              G+ ++H A   +++RD K +N L++ D + K+ DFGLA+  D PE            
Sbjct: 168 ---GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 239 DDTHVST---------RVMG---TQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELLS 282
           DD ++ T         ++ G   T+ Y APE + +  + T   DV+S G +  ELL+
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ D+GLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQL 138
           F     LG G F  V     ++K    L     AVK +  + L+G    +  E+  L ++
Sbjct: 24  FEFKETLGTGAFSEV--VLAEEKATGKL----FAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKGLA 197
           +H ++V L        H  LV + +  G L +++  + +      ST ++  L A   + 
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA---VY 134
Query: 198 FLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           +LH     +++RD K  N+L    D +    +SDFGL+K   +GD   V +   GT GY 
Sbjct: 135 YLH--RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYV 189
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE +     +   D +S GV+   LL G
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLT 130
           + T  +     +G G +G V+K       R       VA+K++ +    EGL      + 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPIST--VR 52
Query: 131 EVIFLGQLR---HPHLVKLIGYCC-----EEEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182
           EV  L +L    HP++V+L+  C       E    LV+E++ +  L   L +     LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
            T   +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 166
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
               V+ T  Y APE ++     +  D++S G +  E+ 
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 35  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 88
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 146
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 203
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 113 AVKNLDLEG--------LQGHREW-LTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYEY 162
           AVK +D+ G        +Q  RE  L EV  L ++  HP++++L           LV++ 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           M +G L + L  +  V+L      KI     + +  LH     +++RD K  NILLD D 
Sbjct: 106 MKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM 161
Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH------LTSMSDVYSFGVV 276
             KL+DFG +     G+       V GT  Y APE +               D++S GV+
Sbjct: 162 NIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 277 LLELLSG 283
           +  LL+G
Sbjct: 219 MYTLLAG 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT-EVIF 134
           + F     LGEG F  V         R    ++  A+K L+   +  +    ++T E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 200
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
           + +L HP  VKL     ++E       Y   G L   + R+        TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGY 253
            L +LH   K +I+RD K  NILL+ D   +++DFG AK   PE      +  V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQY 198
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            +PE +        SD+++ G ++ +L++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V+TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 113 AVKNLDLEG--------LQGHREW-LTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYEY 162
           AVK +D+ G        +Q  RE  L EV  L ++  HP++++L           LV++ 
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           M +G L + L  +  V+L      KI     + +  LH     +++RD K  NILLD D 
Sbjct: 93  MKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM 148
Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH------LTSMSDVYSFGVV 276
             KL+DFG +     G+       V GT  Y APE +               D++S GV+
Sbjct: 149 NIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 205
Query: 277 LLELLSG 283
           +  LL+G
Sbjct: 206 MYTLLAG 212

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 113 AVKNLDLEG--------LQGHREW-LTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYEY 162
           AVK +D+ G        +Q  RE  L EV  L ++  HP++++L           LV++ 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           M +G L + L  +  V+L      KI     + +  LH     +++RD K  NILLD D 
Sbjct: 106 MKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM 161
Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH------LTSMSDVYSFGVV 276
             KL+DFG +     G+       V GT  Y APE +               D++S GV+
Sbjct: 162 NIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 277 LLELLSG 283
           +  LL+G
Sbjct: 219 MYTLLAG 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLT 130
           + T  +     +G G +G V+K       R       VA+K++ +    EGL      + 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPIST--VR 52
Query: 131 EVIFLGQLR---HPHLVKLIGYCC-----EEEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182
           EV  L +L    HP++V+L+  C       E    LV+E++ +  L   L +     LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
            T   +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 166
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
               V+ T  Y APE ++     +  D++S G +  E+ 
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 121/306 (39%), Gaps = 43/306 (14%)
Query: 64  NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           +L    L+ L+     F     +G G +G V+KG      R     Q  A+K +D+ G +
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE 63
Query: 124 GHREWLTEVIFLGQL-RHPHLVKLIGYCCE------EEHRLLVYEYMPRGSLENQLFRRY 176
              E   E+  L +   H ++    G   +      ++   LV E+   GS+ + +    
Sbjct: 64  -EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 177 SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
             +L       I     +GL+ LH  +  VI+RD K  N+LL  +   KL DFG++    
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL- 179
Query: 237 EGDDTHVSTR--VMGTQGYAAPEYVMTGH-----LTSMSDVYSFGVVLLELLSGRKSVDK 289
              D  V  R   +GT  + APE +             SD++S G+  +E+  G   +  
Sbjct: 180 ---DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
Query: 290 SRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
             P R   L+              R   PRL+   S+  ++K  +    CL     QRP 
Sbjct: 237 MHPMRALFLIP-------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPA 280
Query: 350 MSTVVK 355
              ++K
Sbjct: 281 TEQLMK 286

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWL-TEVIFLGQLRHPHL 143
           +G G +G   K      +R     + +  K LD   + +  ++ L +EV  L +L+HP++
Sbjct: 14  IGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 144 VKLIGYCCEEEHRLL--VYEYMPRGSLENQLF-----RRY---SVSLPWSTRMKIALGAA 193
           V+      +  +  L  V EY   G L + +      R+Y      L   T++ +AL   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
              +   D    V++RD K +N+ LD     KL DFGLA+     +D   +   +GT  Y
Sbjct: 128 HRRS---DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYY 182
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            +PE +        SD++S G +L EL +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G F  V +  +         A+ +  K L     Q       E     +L+HP++V+
Sbjct: 37  LGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 92
Query: 146 LIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L     EE    LV++ +  G L E+ + R +      S  ++  L   + +A+ H    
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESIAYCH--SN 147
Query: 205 PVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            +++R+ K  N+LL S       KL+DFGLA    E +D+       GT GY +PE +  
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 262 GHLTSMSDVYSFGVVLLELLSG 283
              +   D+++ GV+L  LL G
Sbjct: 205 DPYSKPVDIWACGVILYILLVG 226

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 167
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 168 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 217
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLT 130
           + T  +     +G G +G V+K       R       VA+K++ +    EGL      + 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPIST--VR 52
Query: 131 EVIFLGQLR---HPHLVKLIGYCC-----EEEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182
           EV  L +L    HP++V+L+  C       E    LV+E++ +  L   L +     LP 
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
            T   +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+         
Sbjct: 112 ETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 166
Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELL 281
               V+ T  Y APE ++     +  D++S G +  E+ 
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/309 (22%), Positives = 128/309 (41%), Gaps = 51/309 (16%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHRE 127
           L E  +  +       +G+G FG V+ G    +         VA++ +D+E       + 
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKA 75
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           +  EV+   Q RH ++V  +G C    H L +   + +G     + R   + L  +   +
Sbjct: 76  FKREVMAYRQTRHENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ 134
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL------AKDGPEGDDT 241
           IA    KG+ +LH   K ++++D K+ N+  D+     ++DFGL       + G   D  
Sbjct: 135 IAQEIVKGMGYLH--AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKL 191
Query: 242 HVSTRVMGTQGYAAPEYVMTGH---------LTSMSDVYSFGVVLLELLSGRKSVDKSRP 292
            +     G   + APE +              +  SDV++ G +  E L  R+   K++P
Sbjct: 192 RIQN---GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQP 247
Query: 293 QREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETG-ARKAAALAYQCLSHRPKQRPTMS 351
                 + W         ++G  M P L    S+ G  ++ + +   C +   ++RPT +
Sbjct: 248 AEA---IIW---------QMGTGMKPNL----SQIGMGKEISDILLFCWAFEQEERPTFT 291
Query: 352 TVVKTLEPL 360
            ++  LE L
Sbjct: 292 KLMDMLEKL 300

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 139
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 140 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 189
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R    S P   R   
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARF-Y 132
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 133 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 182
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 183 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQ 251
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T+
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 252 GYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRK 285
            Y APE +++ H  T   D++S G +  E+L+ R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 50/235 (21%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIF 134
           F     LG+G FG V K       R  L ++  A+K +       H E      L+EV+ 
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI------RHTEEKLSTILSEVML 55
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLV---------------YEYMPRGSLENQLFRRYSVS 179
           L  L H ++V+   Y    E R  V                EY    +L + L    +++
Sbjct: 56  LASLNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLN 112
Query: 180 LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
                  ++     + L+++H   + +I+RD K  NI +D     K+ DFGLAK+     
Sbjct: 113 QQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 240 D------------THVSTRVMGTQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELL 281
           D            +   T  +GT  Y A E +  TGH     D+YS G++  E++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLG 136
           F     LG G FG V    +   +  G      A+K LD + +   +E    L E   L 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
            +  P LVKL     +  +  +V EY P G + + L R    S P   R   A       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-YAAQIVLTF 154
Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGY 253
            +LH  +  +IYRD K  N+++D     +++DFGLAK         V  R   + GT  Y
Sbjct: 155 EYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTPEY 204
Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            APE +++       D ++ GV++ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLG 136
           ++   + +G G +G V+  +  +        + VA+K ++   E L   +  L E+  L 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKN------ANKNVAIKKVNRMFEDLIDCKRILREITILN 82
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYE--YMPRGSLENQLFRRYSVSLPWSTR--MKIALGA 192
           +L+  ++++L      E+  LL ++  Y+     ++ L + +   +  + +    I    
Sbjct: 83  RLKSDYIIRLHDLIIPED--LLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNL 140
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS-------- 244
             G  F+H  E  +I+RD K +N LL+ D + K+ DFGLA+      D H+         
Sbjct: 141 LLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 245 ---------------TRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKS 286
                          T  + T+ Y APE ++   + T+  D++S G +  ELL+  KS
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 36/242 (14%)
Query: 77  TQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLD-----LEGLQGHRE 127
           +  F   + LGEG +G V    HK             + VA+K ++     L  L+    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKP----------TGEIVAIKKIEPFDKPLFALRT--- 56
Query: 128 WLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
            L E+  L   +H +++ +      +        Y+ +  ++  L R  S  +     ++
Sbjct: 57  -LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 188 IAL-GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVS 244
             +    + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+  D    D++  +
Sbjct: 116 YFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 245 ------TRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQS 297
                 T  + T+ Y APE ++T    S + DV+S G +L EL   R+ +   R  R Q 
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQL 232
Query: 298 LV 299
           L+
Sbjct: 233 LL 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 28/238 (11%)
Query: 77  TQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTE 131
           +  F   + LGEG +G V    HK             + VA+K ++  +        L E
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKP----------TGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL- 190
           +  L   +H +++ +      +        Y+ +  ++  L R  S  +     ++  + 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVS---- 244
              + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+  D    D++  +    
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 245 --TRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
             T  + T+ Y APE ++T    S + DV+S G +L EL   R+ +   R  R Q L+
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQ 251
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T+
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 252 GYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRK 285
            Y APE +++ H  T   D++S G +  E+L+ R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 124/302 (41%), Gaps = 44/302 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G +G V +G          Q + VAVK   +   +  + W   TE+     LRH ++
Sbjct: 45  VGKGRYGEVWRG--------SWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENI 93
Query: 144 VKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I       H      L+  Y   GSL + L      +L   + ++I L  A GLA L
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHL 150
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRVMGT 250
           H        KP I +RD K+ NIL+  +    ++D GLA          D   + RV GT
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 209
Query: 251 QGYAAPEY----VMTGHLTSMS--DVYSFGVVLLEL---LSGRKSVDKSRPQREQSLVEW 301
           + Y APE     +      S    D+++FG+VL E+   +     V+  +P     +   
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN- 268
Query: 302 ARPMLNDARKLGRI--MDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             P   D RK+  +    P +  ++ S+      A L  +C    P  R T   + KTL 
Sbjct: 269 -DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 327
Query: 359 PL 360
            +
Sbjct: 328 KI 329

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 124/302 (41%), Gaps = 44/302 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G +G V +G          Q + VAVK   +   +  + W   TE+     LRH ++
Sbjct: 16  VGKGRYGEVWRG--------SWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENI 64
Query: 144 VKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I       H      L+  Y   GSL + L      +L   + ++I L  A GLA L
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRVMGT 250
           H        KP I +RD K+ NIL+  +    ++D GLA          D   + RV GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180
Query: 251 QGYAAPEY----VMTGHLTSMS--DVYSFGVVLLEL---LSGRKSVDKSRPQREQSLVEW 301
           + Y APE     +      S    D+++FG+VL E+   +     V+  +P     +   
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN- 239
Query: 302 ARPMLNDARKLGRI--MDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             P   D RK+  +    P +  ++ S+      A L  +C    P  R T   + KTL 
Sbjct: 240 -DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 359 PL 360
            +
Sbjct: 299 KI 300

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+  FGLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ--AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG+G F  V +         GL+  A+ +  K L     Q       E     +L+HP++
Sbjct: 14  LGKGAFSVVRRCV---HKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNI 67
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           V+L     EE    LV++ +  G L E+ + R +      S  ++  L   + +A+ H  
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESIAYCH-- 122
Query: 203 EKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
              +++R+ K  N+LL S       KL+DFGLA    E +D+       GT GY +PE +
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVL 179
Query: 260 MTGHLTSMSDVYSFGVVLLELLSG 283
                +   D+++ GV+L  LL G
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVG 203

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  LH  ++ +IYRD K  N+LLD D   ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D ++ GV L E+++ R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 44/302 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G +G V +G          Q + VAVK   +   +  + W   TE+     LRH ++
Sbjct: 16  VGKGRYGEVWRG--------SWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENI 64
Query: 144 VKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I       H      L+  Y   GSL + L      +L   + ++I L  A GLA L
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGD---DTHVSTRVMGT 250
           H        KP I +RD K+ NIL+  +    ++D GLA    +     D   + RV GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180
Query: 251 QGYAAPEY----VMTGHLTSMS--DVYSFGVVLLEL---LSGRKSVDKSRPQREQSLVEW 301
           + Y APE     +      S    D+++FG+VL E+   +     V+  +P     +   
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN- 239
Query: 302 ARPMLNDARKLGRI--MDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             P   D RK+  +    P +  ++ S+      A L  +C    P  R T   + KTL 
Sbjct: 240 -DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 359 PL 360
            +
Sbjct: 299 KI 300

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  LH  ++ +IYRD K  N+LLD D   ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D ++ GV L E+++ R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ--AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG+G F  V +         GL+  A+ +  K L     Q       E     +L+HP++
Sbjct: 13  LGKGAFSVVRRCV---HKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNI 66
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           V+L     EE    LV++ +  G L E+ + R +      S  ++  L   + +A+ H  
Sbjct: 67  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESIAYCH-- 121
Query: 203 EKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
              +++R+ K  N+LL S       KL+DFGLA    E +D+       GT GY +PE +
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVL 178
Query: 260 MTGHLTSMSDVYSFGVVLLELLSG 283
                +   D+++ GV+L  LL G
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVG 202

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  LH  ++ +IYRD K  N+LLD D   ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D ++ GV L E+++ R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           GL  LH  ++ +IYRD K  N+LLD D   ++SD GLA +   G     +    GT G+ 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFM 356
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           APE ++        D ++ GV L E+++ R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G F  V +  +         A+ +  K L     Q       E     +L+HP++V+
Sbjct: 14  LGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 69
Query: 146 LIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L     EE    LV++ +  G L E+ + R +      S  ++  L   + +A+ H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESIAYCH--SN 124
Query: 205 PVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            +++R+ K  N+LL S       KL+DFGLA    E +D+       GT GY +PE +  
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 262 GHLTSMSDVYSFGVVLLELLSG 283
              +   D+++ GV+L  LL G
Sbjct: 182 DPYSKPVDIWACGVILYILLVG 203

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DF LA+   +    +V+TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---- 125
           +AEL      ++   F+  G +GAV  G +D       +  PVA+K +      G     
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAG-VDS------EGIPVAIKRVFNTVSDGRTVNI 66
Query: 126 -------REWLTEVIFLGQLRHPHLVKLIGYCCEEE----HRLLVYEYMPRGSLENQLFR 174
                  +  L E+  L    HP+++ L       E    H+L +   + R  L   +  
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126
Query: 175 RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK- 233
           +  V  P   +         GL  LH+A   V++RD    NILL  +    + DF LA+ 
Sbjct: 127 QRIVISPQHIQY-FMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSV 287
           D  + + TH  T     + Y APE VM     T + D++S G V+ E+ + RK++
Sbjct: 184 DTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 53/232 (22%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---REWLTEVIFLGQLR-HP 141
           LG+G +G V K  ID +       + VAVK +  +  Q     +    E++ L +L  H 
Sbjct: 17  LGKGAYGIVWKS-IDRR-----TGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 142 HLVKLIGYCCEEEHR--LLVYEYMP-------RGSLENQLFRRYSVSLPWSTRMKIALGA 192
           ++V L+     +  R   LV++YM        R ++   + ++Y           +    
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-----------VVYQL 118
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-----------------DG 235
            K + +LH     +++RD K SNILL+++   K++DFGL++                 + 
Sbjct: 119 IKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 236 PEG--DDTHVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            E   DD  + T  + T+ Y APE ++ +   T   D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH---- 125
           +AEL      ++   F+  G +GAV  G +D       +  PVA+K +      G     
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAG-VDS------EGIPVAIKRVFNTVSDGRTVNI 66
Query: 126 -------REWLTEVIFLGQLRHPHLVKLIGYCCEEE----HRLLVYEYMPRGSLENQLFR 174
                  +  L E+  L    HP+++ L       E    H+L +   + R  L   +  
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126
Query: 175 RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK- 233
           +  V  P   +         GL  LH+A   V++RD    NILL  +    + DF LA+ 
Sbjct: 127 QRIVISPQHIQY-FMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSV 287
           D  + + TH  T     + Y APE VM     T + D++S G V+ E+ + RK++
Sbjct: 184 DTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWST 184
           TE+  L +L HP ++K+  +   E++  +V E M  G L      N+  +  +  L +  
Sbjct: 70  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 127
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDT 241
           +M +A+       +LH  E  +I+RD K  N+LL S   D   K++DFG +K   E   T
Sbjct: 128 QMLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 176
Query: 242 HVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
            +   + GT  Y APE ++   T       D +S GV+L   LSG     + R Q
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 231

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 2/91 (2%)
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            A+G+ FL  + +  I+RD  A NILL  +   K+ DFGLA+D  +  D           
Sbjct: 208 VARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
            + APE +     ++ SDV+S+GV+L E+ S
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 15/146 (10%)
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           P LVKL     +  +  +V EY P G + + L R    S P   R   A        +LH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP-HARF-YAAQIVLTFEYLH 159
Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAAPE 257
             +  +IYRD K  N+L+D     K++DFG AK         V  R   + GT  Y APE
Sbjct: 160 SLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSG 283
            +++       D ++ GV++ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWST 184
           TE+  L +L HP ++K+  +   E++  +V E M  G L      N+  +  +  L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDT 241
           +M +A+       +LH  E  +I+RD K  N+LL S   D   K++DFG +K   E   T
Sbjct: 122 QMLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 170
Query: 242 HVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
            +   + GT  Y APE ++   T       D +S GV+L   LSG     + R Q
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWST 184
           TE+  L +L HP ++K+  +   E++  +V E M  G L      N+  +  +  L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDT 241
           +M +A+       +LH  E  +I+RD K  N+LL S   D   K++DFG +K   E   T
Sbjct: 122 QMLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 170
Query: 242 HVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
            +   + GT  Y APE ++   T       D +S GV+L   LSG     + R Q
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 72/163 (44%), Gaps = 10/163 (6%)
Query: 126 REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR 185
           R    E+  +  L HP LV L     +EE   +V + +  G L   L  + +V     T 
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETV 117
Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
                     L +L +    +I+RD K  NILLD      ++DF +A   P   +T ++T
Sbjct: 118 KLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT 173
Query: 246 RVMGTQGYAAPEYVMTGHLTSMS---DVYSFGVVLLELLSGRK 285
            + GT+ Y APE   +      S   D +S GV   ELL GR+
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWST 184
           TE+  L +L HP ++K+  +   E++  +V E M  G L      N+  +  +  L +  
Sbjct: 63  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 120
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDT 241
           +M +A+       +LH  E  +I+RD K  N+LL S   D   K++DFG +K   E   T
Sbjct: 121 QMLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 169
Query: 242 HVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
            +   + GT  Y APE ++   T       D +S GV+L   LSG     + R Q
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 224

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP++VKL     ++ H  LV E +  G L  ++ ++   S   ++ +   L +A  ++ +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHM 122
Query: 200 HDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           HD    V++RD K  N+L    + +   K+ DFG A+  P  D+  + T    T  YAAP
Sbjct: 123 HDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAP 178
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGR---KSVDKSRPQREQSLVEWARPMLNDARKLG 313
           E +         D++S GV+L  +LSG+   +S D+S      S VE  + +     K G
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--TSAVEIMKKI-----KKG 231
Query: 314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
              D   EG+  +  +++A  L    L+  P +R  MS
Sbjct: 232 ---DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWST 184
           TE+  L +L HP ++K+  +   E++  +V E M  G L      N+  +  +  L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 121
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDT 241
           +M +A+       +LH  E  +I+RD K  N+LL S   D   K++DFG +K   E   T
Sbjct: 122 QMLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 170
Query: 242 HVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
            +   + GT  Y APE ++   T       D +S GV+L   LSG     + R Q
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY P G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + GL+   VAVK L    + +   +    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLI-----GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +       L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKY 140
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V+TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPEI 193
Query: 259 VMTG-HLTSMSDVYSFGVVLLELLSGR 284
           ++   H     D++S G ++ ELL+GR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R      P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R      P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R      P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG+G +G V+ G  + +++R       +A+K +     +  +    E+     L+H ++V
Sbjct: 30  LGKGTYGIVYAGRDLSNQVR-------IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY------SVSLPWSTRMKIALGAAKGLAF 198
           + +G   E     +  E +P GSL   L  ++        ++ + T+  +     +GL +
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKY 137
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           LHD +  +++RD K  N+L+++ Y+   K+SDFG +K    G +    T   GT  Y AP
Sbjct: 138 LHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKR-LAGINPCTET-FTGTLQYMAP 192
Query: 257 EYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
           E +  G       +D++S G  ++E+ +G+
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G F  V+KG +D +    +    +  + L     Q  +E   E   L  L+HP++V+
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVR 89
Query: 146 LI--------GYCCEEEHRLLVYEYMPRGSLENQLFR----RYSVSLPWSTRMKIALGAA 193
                     G  C     +LV E    G+L+  L R    +  V   W  ++       
Sbjct: 90  FYDSWESTVKGKKC----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------L 139
Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           KGL FLH    P+I+RD K  NI +     + K+ D GLA           +  V+GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPE 195
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLE 279
           + APE     +  S+ DVY+FG   LE
Sbjct: 196 FXAPEXYEEKYDESV-DVYAFGXCXLE 221

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+P G + + L R      P   R   
Sbjct: 82  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARF-Y 139
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 140 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 189
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY P G + + L R      P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P L KL     +  +  +V EY P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P L KL     +  +  +V EY P G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 28/238 (11%)
Query: 77  TQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTE 131
           +  F   + LGEG +G V    HK             + VA+K ++  +        L E
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKP----------TGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL- 190
           +  L   +H +++ +      +        Y+ +  ++  L R  S  +     ++  + 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVS---- 244
              + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+  D    D++  +    
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 245 --TRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
                + T+ Y APE ++T    S + DV+S G +L EL   R+ +   R  R Q L+
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 39/278 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQLRHPHLV 144
           LG G FG VH   + ++   GL+     +K ++ +  Q   E +  E+  L  L HP+++
Sbjct: 30  LGSGAFGDVH---LVEERSSGLER---VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLF----RRYSVSLPWSTR-MKIALGAAKGLAFL 199
           K+     +  +  +V E    G L  ++     R  ++S  +    MK  + A   LA+ 
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYF 140
Query: 200 HDAEKPVIYRDFKASNILLDSDYT---AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           H   + V+++D K  NIL          K+ DFGLA+      D H ST   GT  Y AP
Sbjct: 141 HS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEH-STNAAGTALYMAP 195
Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E V    +T   D++S GVV+  LL+G      +  +  Q    +  P  N A +  R +
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--NYAVEC-RPL 251
Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
            P            +A  L  Q L+  P++RP+ + V+
Sbjct: 252 TP------------QAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVI 133
           Q +     +GEG +G V K       +     + VA+K + L    EG+      L E+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSA--LREIC 53
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA---- 189
            L +L+H ++V+L      ++   LV+E+       +Q  ++Y  S       +I     
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
               KGL F H   + V++RD K  N+L++ +   KL+DFGLA+    G      +  + 
Sbjct: 108 FQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVV 163
Query: 250 TQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSV 287
           T  Y  P+ +    L S S D++S G +  EL +  + +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+      +         A K +             E+  +  LRHP LV 
Sbjct: 59  LGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     ++   +++YE+M  G L  ++   ++  +     ++      KGL  +H  E  
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH--ENN 169
Query: 206 VIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
            ++ D K  NI+  +  +   KL DFGL           V+T   GT  +AAPE      
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 226
Query: 264 LTSMSDVYSFGVVLLELLSG 283
           +   +D++S GV+   LLSG
Sbjct: 227 VGYYTDMWSVGVLSYILLSG 246

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 113/296 (38%), Gaps = 47/296 (15%)
Query: 80  FSSSNFL---GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIF 134
           F   NFL    E   G + KG          Q   + VK L +     +  R++  E   
Sbjct: 9   FKQLNFLTKLNENHSGELWKG--------RWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 135 LGQLRHPHLVKLIGYC--CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           L    HP+++ ++G C      H  L+  + P GSL N L    +  +  S  +K AL  
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDX 120
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG--- 249
           A+G AFLH  E  +      + ++ +D D TA++S            D   S +  G   
Sbjct: 121 ARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARIS----------XADVKFSFQSPGRXY 170
Query: 250 TQGYAAPEYVMTGHLTS---MSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML 306
              + APE +      +    +D +SF V+L EL++           RE    +     L
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVT-----------REVPFAD-----L 214
Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
           ++     ++    L        +   + L   C +  P +RP    +V  LE  +D
Sbjct: 215 SNXEIGXKVALEGLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G F  V +     K+  G   Q  A K ++ + L    H++   E      L+HP++
Sbjct: 12  LGKGAFSVVRRCM---KIPTG---QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           V+L     EE    LV++ +  G L E+ + R Y      S  ++  L +       H  
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN-----HCH 120
Query: 203 EKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
              +++RD K  N+LL S       KL+DFGLA +  +GD         GT GY +PE +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYLSPEVL 178
Query: 260 MTGHLTSMSDVYSFGVVLLELLSG 283
                    D+++ GV+L  LL G
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVG 202

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 115/280 (41%), Gaps = 45/280 (16%)
Query: 85  FLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR---- 139
            LG+GGFG V  G  + D+L+  ++  P   + L    L        EV  L ++     
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRN-RVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP +++L+ +   +E  +LV E   R      LF   +   P               A  
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 200 HDAEKPVIYRDFKASNILLD-SDYTAKLSDFG---LAKDGPEGDDTHVSTRVMGTQGYAA 255
           H   + V++RD K  NIL+D     AKL DFG   L  D P  D         GT+ Y+ 
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-------FDGTRVYSP 206
Query: 256 PEYVMTGHLTSM-SDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
           PE++      ++ + V+S G++L +++ G         +R+Q ++E              
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPF-----ERDQEILE-------------- 247
Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
                 E  +    +    AL  +CL+ +P  RP++  ++
Sbjct: 248 -----AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG+G +G V+ G  + +++R       +A+K +     +  +    E+     L+H ++V
Sbjct: 16  LGKGTYGIVYAGRDLSNQVR-------IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS------VSLPWSTRMKIALGAAKGLAF 198
           + +G   E     +  E +P GSL   L  ++        ++ + T+  +     +GL +
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKY 123
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           LHD +  +++RD K  N+L+++ Y+   K+SDFG +K    G +    T   GT  Y AP
Sbjct: 124 LHDNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKR-LAGINPCTET-FTGTLQYMAP 178
Query: 257 EYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
           E +  G       +D++S G  ++E+ +G+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+         + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++     +  D++S G ++ EL+ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 40/275 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G +G V      +K+R     Q +AVK +   +   +  R  +   I +  +  P  
Sbjct: 15  LGRGAYGVV------EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----SLPWSTRMKIALGAAKGLAFL 199
           V   G    E    +  E M   SL+   F +  +    ++P     KIA+   K L  L
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H ++  VI+RD K SN+L+++    K+ DFG++  G   DD        G + Y APE +
Sbjct: 126 H-SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDIDA-GCKPYMAPERI 181
Query: 260 -----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
                  G+ +  SD++S G+ ++EL   R   D            W  P     ++L +
Sbjct: 182 NPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SWGTPF----QQLKQ 225
Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
           +++       ++  + +      QCL    K+RPT
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 260

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+      +         A K +             E+  +  LRHP LV 
Sbjct: 165 LGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     ++   +++YE+M  G L  ++   ++  +     ++      KGL  +H  E  
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH--ENN 275
Query: 206 VIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
            ++ D K  NI+  +  +   KL DFGL           V+T   GT  +AAPE      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 332
Query: 264 LTSMSDVYSFGVVLLELLSG 283
           +   +D++S GV+   LLSG
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 40/275 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G +G V      +K+R     Q +AVK +   +   +  R  +   I +  +  P  
Sbjct: 59  LGRGAYGVV------EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV----SLPWSTRMKIALGAAKGLAFL 199
           V   G    E    +  E M   SL+   F +  +    ++P     KIA+   K L  L
Sbjct: 113 VTFYGALFREGDVWICMELM-DTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H ++  VI+RD K SN+L+++    K+ DFG++       D+   T   G + Y APE +
Sbjct: 170 H-SKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDSVAKTIDAGCKPYMAPERI 225
Query: 260 -----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
                  G+ +  SD++S G+ ++EL   R   D            W  P     ++L +
Sbjct: 226 NPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SWGTPF----QQLKQ 269
Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
           +++       ++  + +      QCL    K+RPT
Sbjct: 270 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 304

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
           T  +     +G+G F  V +     KL  G +     +    L   + H++   E     
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCV---KLCTGHEYAAKIINTKKLSA-RDHQKLEREARICR 58
Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKG 195
            L+H ++V+L     EE    LV++ +  G L E+ + R Y      S  ++  L A   
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-- 116
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
              LH  +  V++RD K  N+LL S       KL+DFGLA +  +GD         GT G
Sbjct: 117 ---LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPG 171
Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y +PE +         D+++ GV+L  LL G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           ++++   +G G FG V +  +       +++  VA+K +    LQ  R    E+  +  +
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKL-------VESDEVAIKKV----LQDKRFKNRELQIMRIV 89
Query: 139 RHPHLVKLIGYCC------EEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMKIALG 191
           +HP++V L  +        +E    LV EY+P      ++ + +   ++P          
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD      KL DFG AK    G+    +   + +
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICS 204
Query: 251 QGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           + Y APE +    + T+  D++S G V+ EL+ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 167
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK       T     + 
Sbjct: 168 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LC 220
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G F  V +     K+  G   Q  A K ++ + L    H++   E      L+HP++
Sbjct: 12  LGKGAFSVVRRCM---KIPTG---QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSL-ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           V+L     EE    LV++ +  G L E+ + R Y      S  ++  L +       H  
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN-----HCH 120
Query: 203 EKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
              +++RD K  N+LL S       KL+DFGLA +  +GD         GT GY +PE +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYLSPEVL 178
Query: 260 MTGHLTSMSDVYSFGVVLLELLSG 283
                    D+++ GV+L  LL G
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVG 202

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++  V+ T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVV-TRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+         + T  + T+ Y 
Sbjct: 136 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART---ASTNFMMTPYVVTRYYR 190
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ EL+ G
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 133
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 134 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTW 183
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 86  LGEGGFGAVHKG--------FIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ 137
           LG G FG VH+         F+   +          VKN              E+  + Q
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN--------------EISIMNQ 104
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L HP L+ L     ++   +L+ E++  G L +++       +  +  +     A +GL 
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLK 163
Query: 198 FLHDAEKPVIYRDFKASNILLDSDY--TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
            +H  E  +++ D K  NI+ ++    + K+ DFGLA      +   V+T    T  +AA
Sbjct: 164 HMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAA 218
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           PE V    +   +D+++ GV+   LLSG
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 21/127 (16%)
Query: 165 RGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA 224
           R SLE+   R + V L       I +  A+ + FLH   K +++RD K SNI    D   
Sbjct: 155 RCSLED---REHGVCL------HIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVV 203
Query: 225 KLSDFGL--AKDGPEGDDTHVSTRV--------MGTQGYAAPEYVMTGHLTSMSDVYSFG 274
           K+ DFGL  A D  E + T ++           +GT+ Y +PE +   + +   D++S G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 275 VVLLELL 281
           ++L ELL
Sbjct: 264 LILFELL 270

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P L KL     +  +  +V EY P G + + L R      P   R   
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARF-Y 147
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     K++DFG AK         V  R  
Sbjct: 148 AAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTW 197
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR 139
           F      G+G FG V  G      +       VA+K +  +    +RE L  +  L  L 
Sbjct: 25  FQVERMAGQGTFGTVQLG------KEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 140 HPHLVKLIGY---CCEEEHRLL----VYEYMPRG--SLENQLFRRYSVSLPWSTRMKIAL 190
           HP++V+L  Y     E + R +    V EY+P          +RR     P   ++    
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILL-DSDYTAKLSDFGLAK--DGPEGDDTHVSTRV 247
              + +  LH     V +RD K  N+L+ ++D T KL DFG AK     E +  ++ +R 
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 248 MGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSG 283
                Y APE +    H T+  D++S G +  E++ G
Sbjct: 197 -----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+++D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 92/235 (39%), Gaps = 50/235 (21%)
Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIF 134
           F     LG+G FG V K       R  L ++  A+K +       H E      L+EV  
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI------RHTEEKLSTILSEVXL 55
Query: 135 LGQLRHPHLVKLIGYCCEEEHRLLV---------------YEYMPRGSLENQLFRRYSVS 179
           L  L H ++V+   Y    E R  V                EY    +L + L    +++
Sbjct: 56  LASLNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLN 112
Query: 180 LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
                  ++     + L+++H   + +I+R+ K  NI +D     K+ DFGLAK+     
Sbjct: 113 QQRDEYWRLFRQILEALSYIH--SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 240 D------------THVSTRVMGTQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELL 281
           D            +   T  +GT  Y A E +  TGH     D YS G++  E +
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIFLGQLRHPH 142
            +G G +G V+  +  +        + VA+K ++   E L   +  L E+  L +L+  +
Sbjct: 33  LIGRGSYGYVYLAYDKN------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 143 LVKLIGYCCEEEHRLLVYE--YMPRGSLENQLFRRYSVSLPWSTR--MKIALGAAKGLAF 198
           +++L      ++  LL ++  Y+     ++ L + +   +  +      I      G  F
Sbjct: 87  IIRLYDLIIPDD--LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS-------------- 244
           +H  E  +I+RD K +N LL+ D + K+ DFGLA+      DT++               
Sbjct: 145 IH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 245 ------TRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKS 286
                 T  + T+ Y APE ++   + T   D++S G +  ELL+  +S
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    + P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVI 133
           Q +     +GEG +G V K       +     + VA+K + L    EG+      L E+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSA--LREIC 53
Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA---- 189
            L +L+H ++V+L      ++   LV+E+       +Q  ++Y  S       +I     
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG 249
               KGL F H   + V++RD K  N+L++ +   KL++FGLA+    G      +  + 
Sbjct: 108 FQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVV 163
Query: 250 TQGYAAPEYVMTGHLTSMS-DVYSFGVVLLEL 280
           T  Y  P+ +    L S S D++S G +  EL
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/306 (21%), Positives = 124/306 (40%), Gaps = 48/306 (15%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           + L   NL+  +++   V  + +S    +G GG   V +   + K       Q  A+K +
Sbjct: 11  VDLGTENLYFQSMS---VKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYV 60
Query: 118 DLEGL--QGHREWLTEVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQL 172
           +LE    Q    +  E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N  
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSW 117
Query: 173 FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
            ++     PW  R        + +  +H  +  +++ D K +N L+  D   KL DFG+A
Sbjct: 118 LKKKKSIDPWE-RKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELL 281
                   + V    +GT  Y  PE +               ++  SDV+S G +L  + 
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 282 SGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLS 341
            G+    +               ++N   KL  I+DP  E ++ +   +    +   CL 
Sbjct: 234 YGKTPFQQ---------------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 278
Query: 342 HRPKQR 347
             PKQR
Sbjct: 279 RDPKQR 284

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 137 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 191
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + +    + T+ Y 
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMVPFVVTRYYR 194
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE ++        D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ ++ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL------DLEGLQGHREWLTEVIFLGQLR 139
           +G G +GAV    +D     G     VA+K L      +L   + +RE    +  L  +R
Sbjct: 33  VGSGAYGAVCSA-VD-----GRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82
Query: 140 HPHLVKLIGYCCEEE------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK-IALGA 192
           H +++ L+     +E         LV  +M  G+   +L +   +      R++ +    
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG---EDRIQFLVYQM 137
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
            KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+      D+ +   V+ T+ 
Sbjct: 138 LKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMXGXVV-TRW 190
Query: 253 YAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGR 284
           Y APE ++     T   D++S G ++ E+++G+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 26/220 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQ-AQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEGGF  V        L  GL      A+K +     Q   E   E        HP+++
Sbjct: 37  LGEGGFSYV-------DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 145 KLIGYCCEE----EHRLLVYEYMPRGSLENQLFRRYSVS--LPWSTRMKIALGAAKGLAF 198
           +L+ YC  E        L+  +  RG+L N++ R       L     + + LG  +GL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP---EGDDTHVSTRVMGTQ---- 251
           +H   K   +RD K +NILL  +    L D G         EG    ++ +    Q    
Sbjct: 150 IH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 252 GYAAPE-YVMTGH--LTSMSDVYSFGVVLLELLSGRKSVD 288
            Y APE + +  H  +   +DV+S G VL  ++ G    D
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCE--EEHRLLVYEYMPRGS-LENQLFRRYSVSLPWSTRMK 187
           E+  L +L HP++VKL+    +  E+H  +V+E + +G  +E    +  S       R  
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED---QARFY 142
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 KG+ +LH   + +I+RD K SN+L+  D   K++DFG++ +  +G D  +S  V
Sbjct: 143 FQ-DLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTV 198
Query: 248 MGTQGYAAPE------YVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  + APE       + +G      DV++ GV L   + G+
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQ 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R      P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R      P   R   
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF-Y 141
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 142 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 191
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R      P   R   
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF-Y 167
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 168 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 217
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G    +   V+ T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-TRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R      P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGA 192
           L+HPH+V+L+     +    +V+E+M    L  ++ +R      +S       M+  L A
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGDDTHVSTRVMG 249
              L + HD    +I+RD K   +LL S   +   KL  FG+A     G+   V+   +G
Sbjct: 145 ---LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVG 197
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           T  + APE V         DV+  GV+L  LLSG
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R      P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/309 (21%), Positives = 125/309 (40%), Gaps = 48/309 (15%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           + L   NL+  +++   V  + +S    +G GG   V +   + K       Q  A+K +
Sbjct: 11  VDLGTENLYFQSMS---VKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYV 60
Query: 118 DLEGL--QGHREWLTEVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQL 172
           +LE    Q    +  E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N  
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSW 117
Query: 173 FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
            ++     PW  R        + +  +H  +  +++ D K +N L+  D   KL DFG+A
Sbjct: 118 LKKKKSIDPWE-RKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELL 281
                     V    +GT  Y  PE +               ++  SDV+S G +L  + 
Sbjct: 174 NQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 282 SGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLS 341
            G+    +               ++N   KL  I+DP  E ++ +   +    +   CL 
Sbjct: 234 YGKTPFQQ---------------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 278
Query: 342 HRPKQRPTM 350
             PKQR ++
Sbjct: 279 RDPKQRISI 287

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGA 192
           L+HPH+V+L+     +    +V+E+M    L  ++ +R      +S       M+  L A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGDDTHVSTRVMG 249
              L + HD    +I+RD K   +LL S   +   KL  FG+A     G+   V+   +G
Sbjct: 143 ---LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVG 195
Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           T  + APE V         DV+  GV+L  LLSG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 28/236 (11%)
Query: 58  ISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL 117
           + L   NL+  ++ E       +     LG G F  V K       R     +  A K +
Sbjct: 11  VDLGTENLYFQSMVE-----DHYEMGEELGSGQFAIVRK------CRQKGTGKEYAAKFI 59
Query: 118 DLEGLQGHREWLT------EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ 171
               L   R  ++      EV  L ++RHP+++ L      +   +L+ E +  G L + 
Sbjct: 60  KKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF 119
Query: 172 LFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLS 227
           L  + S++   +T+    +    G+ +LH   K + + D K  NI LLD +      KL 
Sbjct: 120 LAEKESLTEDEATQFLKQI--LDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLI 175
Query: 228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           DFG+A     G++      + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 176 DFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 143 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 197
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L ++RHP+++ L      +   +L+ E +  G L + L  + S++   +T+    +
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFG+A     G++      
Sbjct: 125 --LDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KN 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L ++RHP+++ L      +   +L+ E +  G L + L  + S++   +T+    +
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFG+A     G++      
Sbjct: 118 --LDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KN 170
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 128/302 (42%), Gaps = 59/302 (19%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG GG G V     +D        + VA+K + L   Q  +  L E+  + +L H ++VK
Sbjct: 19  LGCGGNGLVFSAVDNDC------DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 146 L--------------IGYCCEEEHRLLVYEYM--------PRGSLENQLFRRYSVSLPWS 183
           +              +G   E     +V EYM         +G L  +  R +   L   
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL--- 129
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAK--DGPEGDD 240
                     +GL ++H A   V++RD K +N+ +++ D   K+ DFGLA+  D      
Sbjct: 130 ---------LRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 241 THVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
            H+S  ++ T+ Y +P  +++  + T   D+++ G +  E+L+G+     +    +  L+
Sbjct: 179 GHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 300 EWARPMLN--DARKLGRIMDPRLEGQYSETG----------ARKAAALAYQCLSHRPKQR 347
             + P+++  D ++L  ++   +    +E            +R+A     Q L+  P  R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 348 PT 349
            T
Sbjct: 298 LT 299

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 63/307 (20%)
Query: 82  SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-H 140
           S   LG G  G V         +   Q +PVAVK + ++        L E+  L +   H
Sbjct: 19  SEKILGYGSSGTV-------VFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDH 68
Query: 141 PHLVKLIGYCCEEEHRLL----------VYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           P++++   YC E   R L          + + +   ++ ++  +      P S   +IA 
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA- 125
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAK-----------LSDFGLAKDGPE 237
               G+A LH  +  +I+RD K  NIL+   S +TA            +SDFGL K    
Sbjct: 126 ---SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 238 GDDTHVST--RVMGTQGYAAPEYVMTGH-------LTSMSDVYSFGVVLLELLSGRKSVD 288
           G  +  +      GT G+ APE +   +       LT   D++S G V   +LS  K   
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 289 KSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP 348
             +  RE +++             G      ++  +  +   +A  L  Q + H P +RP
Sbjct: 241 GDKYSRESNIIR------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 349 TMSTVVK 355
           T   V++
Sbjct: 289 TAMKVLR 295

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 66/148 (44%), Gaps = 5/148 (3%)
Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           G+L+ PH+V +  +  E + +L V   +  G       RR     P +    +A+    G
Sbjct: 89  GRLQEPHVVPIHDFG-EIDGQLYVDXRLINGVDLAAXLRRQG---PLAPPRAVAIVRQIG 144
Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
            A          +RD K  NIL+ +D  A L DFG+A    +   T +   V GT  Y A
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXA 203
Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           PE     H T  +D+Y+   VL E L+G
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTG 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L Q+ HP+++ L          +L+ E +  G L + L ++ S+S   +T     +
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFGLA +  +G +      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---N 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT  Y AP  +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 45/291 (15%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 59
Query: 131 EVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMK 187
           E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N   ++     PW  R  
Sbjct: 60  EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE-RKS 115
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 + +  +H  +  +++ D K +N L+  D   KL DFG+A        + V    
Sbjct: 116 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 248 MGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
           +GT  Y  PE +               ++  SDV+S G +L  +  G+    +       
Sbjct: 173 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------- 225
Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
                   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR
Sbjct: 226 --------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 268

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 45/291 (15%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 103
Query: 131 EVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMK 187
           E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N   ++     PW  R  
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE-RKS 159
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 + +  +H  +  +++ D K +N L+  D   KL DFG+A        + V    
Sbjct: 160 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 248 MGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
           +GT  Y  PE +               ++  SDV+S G +L  +  G+    +       
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------- 269
Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
                   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR
Sbjct: 270 --------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 77/164 (46%), Gaps = 19/164 (11%)
Query: 125 HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL---ENQLF---RRYSV 178
           + ++  E+  +  +++ + +   G     +   ++YEYM   S+   +   F   + Y+ 
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
            +P      I        +++H+ EK + +RD K SNIL+D +   KLSDFG +      
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGES------ 199
Query: 239 DDTHVSTRVMGTQG---YAAPEYVM--TGHLTSMSDVYSFGVVL 277
            +  V  ++ G++G   +  PE+    + +  +  D++S G+ L
Sbjct: 200 -EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G    +   V+ T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-TRYYR 192
Query: 255 APEYVMTGHLTSMSDVYSFGVVLLE------LLSGRKSVDKSRPQREQ 296
           APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIA 189
           E+  L +++H ++V L        H  LV + +  G L +++  R        S  ++  
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           L A K   +LH  E  +++RD K  N+L    + +    ++DFGL+K    G    + + 
Sbjct: 116 LSAVK---YLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMST 166
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             GT GY APE +     +   D +S GV+   LL G
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 123 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 174
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 216
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 45/294 (15%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 55
Query: 131 EVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMK 187
           E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N   ++     PW  R  
Sbjct: 56  EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE-RKS 111
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 + +  +H  +  +++ D K +N L+  D   KL DFG+A        + V    
Sbjct: 112 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 248 MGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
           +GT  Y  PE +               ++  SDV+S G +L  +  G+    +       
Sbjct: 169 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------- 221
Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
                   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR ++
Sbjct: 222 --------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 19/202 (9%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG          +R  L  + VAVK ++  G         E+I    LRHP++V+
Sbjct: 28  IGSGNFGVARL------MRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVR 80
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
                    H  ++ EY   G L  ++      S   +      L    G+++ H  +  
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--LSGVSYCHSMQ-- 136
Query: 206 VIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVMTG 262
           + +RD K  N LLD       K+ DFG +K        H   +  +GT  Y APE ++  
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----LHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 263 HLT-SMSDVYSFGVVLLELLSG 283
                ++DV+S GV L  +L G
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVG 214

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 123 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 174
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 216
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKI 188
           TE+  L +L HP+++KL           LV E +  G L +++  + Y      +  +K 
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVST 245
            L A   +A+LH  E  +++RD K  N+L  +   D   K++DFGL+K     +   +  
Sbjct: 157 ILEA---VAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMK 208
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            V GT GY APE +         D++S G++   LL G
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 45/294 (15%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 56
Query: 131 EVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMK 187
           E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N   ++     PW  R  
Sbjct: 57  EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE-RKS 112
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 + +  +H  +  +++ D K +N L+  D   KL DFG+A        + V    
Sbjct: 113 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 248 MGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
           +GT  Y  PE +               ++  SDV+S G +L  +  G+    +       
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------- 222
Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
                   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR ++
Sbjct: 223 --------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 25/176 (14%)
Query: 179 SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
           ++P     KIA+   K L  LH ++  VI+RD K SN+L+++    K  DFG++  G   
Sbjct: 132 TIPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKXCDFGIS--GYLV 188
Query: 239 DDTHVSTRVMGTQGYAAPEYV-----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
           DD        G + Y APE +       G+ +  SD++S G+  +EL   R   D     
Sbjct: 189 DDVAKDIDA-GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYDS---- 242
Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
                  W  P     ++L ++++       ++  + +      QCL    K+RPT
Sbjct: 243 -------WGTPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 287

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GLQGHREWLTEVIFLGQLRHP 141
           LGEG +G V+K  ID      +  + VA+K + LE    G+ G    + EV  L +L+H 
Sbjct: 42  LGEGTYGEVYKA-IDT-----VTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHR 93
Query: 142 HLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAF 198
           ++++L        HRL L++EY      EN L +    +   S R+          G+ F
Sbjct: 94  NIIELKS-VIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 199 LHDAEKPVIYRDFKASNILL---DSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            H   +  ++RD K  N+LL   D+  T   K+ DFGLA+    G      T  + T  Y
Sbjct: 148 CHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWY 203
Query: 254 AAPEYVM-TGHLTSMSDVYSFGVVLLELL 281
             PE ++ + H ++  D++S   +  E+L
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 59/303 (19%)
Query: 82  SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-H 140
           S   LG G  G V         +   Q +PVAVK + ++        L E+  L +   H
Sbjct: 37  SEKILGYGSSGTV-------VFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDH 86
Query: 141 PHLVKLIGYCCEEEHRLL----------VYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           P++++   YC E   R L          + + +   ++ ++  +      P S   +IA 
Sbjct: 87  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA- 143
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAK-----------LSDFGLAKDGPE 237
               G+A LH  +  +I+RD K  NIL+   S +TA            +SDFGL K    
Sbjct: 144 ---SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 238 GDDTHVST--RVMGTQGYAAPEYVMTG---HLTSMSDVYSFGVVLLELLSGRKSVDKSRP 292
           G            GT G+ APE +       LT   D++S G V   +LS  K     + 
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 258
Query: 293 QREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMST 352
            RE +++             G      ++  +  +   +A  L  Q + H P +RPT   
Sbjct: 259 SRESNIIR------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 306
Query: 353 VVK 355
           V++
Sbjct: 307 VLR 309

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 59/303 (19%)
Query: 82  SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-H 140
           S   LG G  G V         +   Q +PVAVK + ++        L E+  L +   H
Sbjct: 37  SEKILGYGSSGTV-------VFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDH 86
Query: 141 PHLVKLIGYCCEEEHRLL----------VYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           P++++   YC E   R L          + + +   ++ ++  +      P S   +IA 
Sbjct: 87  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA- 143
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAK-----------LSDFGLAKDGPE 237
               G+A LH  +  +I+RD K  NIL+   S +TA            +SDFGL K    
Sbjct: 144 ---SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 238 GDDTHVST--RVMGTQGYAAPEYVMTG---HLTSMSDVYSFGVVLLELLSGRKSVDKSRP 292
           G            GT G+ APE +       LT   D++S G V   +LS  K     + 
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 258
Query: 293 QREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMST 352
            RE +++             G      ++  +  +   +A  L  Q + H P +RPT   
Sbjct: 259 SRESNIIR------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 306
Query: 353 VVK 355
           V++
Sbjct: 307 VLR 309

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   L  +  P LVKL     +  +  +V EY+  G + + L R    S P   R   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARF-Y 146
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR-- 246
           A        +LH  +  +IYRD K  N+L+D     +++DFG AK         V  R  
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTW 196
Query: 247 -VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            + GT    APE +++       D ++ GV++ E+ +G
Sbjct: 197 XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 45/291 (15%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 103
Query: 131 EVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMK 187
           E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N   ++     PW  R  
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE-RKS 159
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 + +  +H  +  +++ D K +N L+  D   KL DFG+A        + V    
Sbjct: 160 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 248 MGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
           +GT  Y  PE +               ++  SDV+S G +L  +  G+    +       
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------- 269
Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR 347
                   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR
Sbjct: 270 --------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIA 189
           EV  L +++HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVST 245
           L    G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G++     
Sbjct: 124 LN---GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175
Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
            + GT  + APE V    L   +D++S GV+   LLSG                  A P 
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPF 217
Query: 306 LNDARK--LGRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           L D ++  L  +  ++   E +Y    +  A     + L   PK+R T+
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 120/307 (39%), Gaps = 63/307 (20%)
Query: 82  SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-H 140
           S   LG G  G V         +   Q +PVAVK + ++        L E+  L +   H
Sbjct: 19  SEKILGYGSSGTV-------VFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDH 68
Query: 141 PHLVKLIGYCCEEEHRLL----------VYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           P++++   YC E   R L          + + +   ++ ++  +      P S   +IA 
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA- 125
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAK-----------LSDFGLAKDGPE 237
               G+A LH  +  +I+RD K  NIL+   S +TA            +SDFGL K    
Sbjct: 126 ---SGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 238 GDDTHVST--RVMGTQGYAAPEYVMTGH-------LTSMSDVYSFGVVLLELLSGRKSVD 288
           G            GT G+ APE +   +       LT   D++S G V   +LS  K   
Sbjct: 181 GQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 289 KSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP 348
             +  RE +++             G      ++  +  +   +A  L  Q + H P +RP
Sbjct: 241 GDKYSRESNIIR------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 349 TMSTVVK 355
           T   V++
Sbjct: 289 TAMKVLR 295

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++V+
Sbjct: 26  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 78
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--IALGAAKGLAFLHDAE 203
                    H  +V EY   G    +LF R   +  +S             G+++ H  +
Sbjct: 79  FKEVILTPTHLAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 204 KPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVM 260
             V +RD K  N LLD       K+ DFG +K        H   +  +GT  Y APE ++
Sbjct: 135 --VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----LHSQPKSTVGTPAYIAPEVLL 188
Query: 261 TGHLT-SMSDVYSFGVVLLELLSG 283
                  ++DV+S GV L  +L G
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 103
Query: 131 EVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEYMPRGSLE-NQLFRRYSVSLPWSTRMK 187
           E+ +L +L+     +++L  Y   +++   +Y  M  G+++ N   ++     PW  R  
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE-RKS 159
Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                 + +  +H  +  +++ D K +N L+  D   KL DFG+A        + V    
Sbjct: 160 YWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 248 MGTQGYAAPEYV-----------MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ 296
           +G   Y  PE +               ++  SDV+S G +L  +  G+    +       
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------- 269
Query: 297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
                   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR ++
Sbjct: 270 --------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 103/265 (38%), Gaps = 52/265 (19%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAV-----------HKGFIDDKLRPGLQAQPVAVKNLD 118
           + E+++  + F     +G G FG V           +   I +K     +A+    +   
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 119 LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178
              + G  +W+T + +  Q              +E H  LV +Y   G L   L  ++  
Sbjct: 126 DVLVNGDCQWITALHYAFQ--------------DENHLYLVMDYYVGGDLLT-LLSKFED 170
Query: 179 SLP------WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
            LP      +   M +A+ +   L ++H        RD K  N+LLD +   +L+DFG  
Sbjct: 171 KLPEDMARFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSC 222
Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSV 287
               + D T  S+  +GT  Y +PE +       G      D +S GV + E+L G    
Sbjct: 223 LKMND-DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET-- 279
Query: 288 DKSRPQREQSLVEWARPMLNDARKL 312
               P   +SLVE    ++N   + 
Sbjct: 280 ----PFYAESLVETYGKIMNHEERF 300

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 178 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 234 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSXECQHL 267
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 268 IRWCLALRPSDRPTFEEI 285

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 178 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 234 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSSECQHL 267
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 268 IRWCLALRPSDRPTFEEI 285

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPV------AVKNLDLEGLQGHREWLTEVIFLGQLR 139
           L EGGF  V+            +AQ V      A+K L     + +R  + EV F+ +L 
Sbjct: 36  LAEGGFAFVY------------EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 140 -HPHLVKLIGYCC---EE----EHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIAL 190
            HP++V+         EE    +   L+   + +G L   L +  S   L   T +KI  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
              + +  +H  + P+I+RD K  N+LL +  T KL DFG A
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 177 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 233 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSXECQHL 266
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 267 IRWCLALRPSDRPTFEEI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 178 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 234 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSXECQHL 267
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 268 IRWCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 177 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 233 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSSECQHL 266
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 267 IRWCLALRPSDRPTFEEI 284

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEE----HRLLVYEYMPRGSLENQLFR-RYSVSLPWS 183
           + E   L +L H ++VKL  +  EEE    H++L+ E+ P GSL   L     +  LP S
Sbjct: 55  MREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYTAKLSDFGLAKDGPEGD 239
             + +      G+   H  E  +++R+ K  NI+     D     KL+DFG A++  E D
Sbjct: 113 EFLIVLRDVVGGMN--HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDD 169
Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLT--------SMSDVYSFGVVLLELLSG 283
           +  VS  + GT+ Y  P+      L         +  D++S GV      +G
Sbjct: 170 EQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++V+
Sbjct: 27  IGAGNFGVARL------MRDKQANELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--IALGAAKGLAFLHDAE 203
                    H  +V EY   G    +LF R   +  +S             G+++ H  +
Sbjct: 80  FKEVILTPTHLAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 204 KPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVM 260
             V +RD K  N LLD       K++DFG +K        H   +  +GT  Y APE ++
Sbjct: 136 --VAHRDLKLENTLLDGSPAPRLKIADFGYSK----ASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 261 TGHLT-SMSDVYSFGVVLLELLSG 283
                  ++DV+S GV L  +L G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 103/265 (38%), Gaps = 52/265 (19%)
Query: 70  LAELKVTTQSFSSSNFLGEGGFGAV-----------HKGFIDDKLRPGLQAQPVAVKNLD 118
           + E+++  + F     +G G FG V           +   I +K     +A+    +   
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 119 LEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV 178
              + G  +W+T + +  Q              +E H  LV +Y   G L   L  ++  
Sbjct: 142 DVLVNGDCQWITALHYAFQ--------------DENHLYLVMDYYVGGDLLT-LLSKFED 186
Query: 179 SLP------WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
            LP      +   M +A+ +   L ++H        RD K  N+LLD +   +L+DFG  
Sbjct: 187 KLPEDMARFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSC 238
Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSV 287
               + D T  S+  +GT  Y +PE +       G      D +S GV + E+L G    
Sbjct: 239 LKMND-DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET-- 295
Query: 288 DKSRPQREQSLVEWARPMLNDARKL 312
               P   +SLVE    ++N   + 
Sbjct: 296 ----PFYAESLVETYGKIMNHEERF 316

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 178 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 234 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSSECQHL 267
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 268 IRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 78/318 (24%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 177 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ--YSETGARKAAAL 335
            +++ G                    P  +D   +G        GQ  + +  + +   L
Sbjct: 233 YDMVCGDI------------------PFEHDEEIIG--------GQVFFRQRVSSECQHL 266
Query: 336 AYQCLSHRPKQRPTMSTV 353
              CL+ RP  RPT   +
Sbjct: 267 IRWCLALRPSDRPTFEEI 284

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++V+
Sbjct: 27  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIAANVKREIINHRSLRHPNIVR 79
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--IALGAAKGLAFLHDAE 203
                    H  +V EY   G    +LF R   +  +S             G+++ H  +
Sbjct: 80  FKEVILTPTHLAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 204 KPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVM 260
             V +RD K  N LLD       K+ DFG +K        H   +  +GT  Y APE ++
Sbjct: 136 --VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----LHSQPKSTVGTPAYIAPEVLL 189
Query: 261 TGHLT-SMSDVYSFGVVLLELLSG 283
                  ++DV+S GV L  +L G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 22/136 (16%)
Query: 157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRM-------KIALGAAKGLAFLHDAEKPVIYR 209
           +L+ EY   G +       +S+ LP    M       ++     +G+ +LH  +  +++ 
Sbjct: 105 ILILEYAAGGEI-------FSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHL 155
Query: 210 DFKASNILLDSDY---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTS 266
           D K  NILL S Y     K+ DFG+++      +      +MGT  Y APE +    +T+
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITT 212
Query: 267 MSDVYSFGVVLLELLS 282
            +D+++ G++   LL+
Sbjct: 213 ATDMWNIGIIAYMLLT 228

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L Q+ H +++ L          +L+ E +  G L + L ++ S+S   +T     +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFGLA +  +G +      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L Q+ H +++ L          +L+ E +  G L + L ++ S+S   +T     +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFGLA +  +G +      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L Q+ H +++ L          +L+ E +  G L + L ++ S+S   +T     +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFGLA +  +G +      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 60/300 (20%)
Query: 39  ISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAV---- 94
           I   D  N S     +++   L  +      + ++++  + F     +G G FG V    
Sbjct: 35  ICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVK 94
Query: 95  ----HKGF---IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLI 147
                K F   I +K     +A+    +      + G  +W+T + +  Q          
Sbjct: 95  LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ---------- 144
Query: 148 GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP------WSTRMKIALGAAKGLAFLHD 201
               ++ +  LV +Y   G L   L  ++   LP      +   M IA+ +   L ++H 
Sbjct: 145 ----DDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH- 198
Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVMGTQGYAAPE 257
                  RD K  NIL+D +   +L+DFG    L +DG     T  S+  +GT  Y +PE
Sbjct: 199 -------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPDYISPE 246
Query: 258 YVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            +       G      D +S GV + E+L G        P   +SLVE    ++N   + 
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKIMNHKERF 300

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L Q+ H +++ L          +L+ E +  G L + L ++ S+S   +T     +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFGLA +  +G +      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           EV  L Q+ H +++ L          +L+ E +  G L + L ++ S+S   +T     +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGDDTHVSTR 246
               G+ +LH   K + + D K  NI LLD +      KL DFGLA +  +G +      
Sbjct: 125 --LDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           + GT  + APE V    L   +D++S GV+   LLSG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 71/291 (24%)
Query: 85  FLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------EVIFLGQ 137
            LG GGFG+V+ G  + D L       PVA+K+++ + +    E         EV+ L +
Sbjct: 15  LLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 138 LR--HPHLVKLIGYCCEEEHRLLVYEYM-----------PRGSLENQLFRRYSVSLPWST 184
           +      +++L+ +    +  +L+ E M            RG+L+ +L R    S  W  
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR----SFFWQV 123
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHV 243
                L A +     H     V++RD K  NIL+D +    KL DFG    G    DT V
Sbjct: 124 -----LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-V 169
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            T   GT+ Y+ PE++        S  V+S G++L +++ G                   
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI----------------- 212
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            P  +D   +      R +  + +  + +   L   CL+ RP  RPT   +
Sbjct: 213 -PFEHDEEII------RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           I L   +HP+++ L     + +H  LV E M  G L +++ R+   S   ++ +   +G 
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG- 131
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKLSDFGLAKDGPEGDDTHVSTRVM 248
            K + +LH   + V++RD K SNIL   +       ++ DFG AK     ++  + T   
Sbjct: 132 -KTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY 187
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            T  + APE +         D++S G++L  +L+G
Sbjct: 188 -TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 24/172 (13%)
Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEE----HRLLVYEYMPRGSLENQLFR-RYSVSLPWS 183
           + E   L +L H ++VKL  +  EEE    H++L+ E+ P GSL   L     +  LP S
Sbjct: 55  MREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYTAKLSDFGLAKDGPEGD 239
             + +      G+   H  E  +++R+ K  NI+     D     KL+DFG A+   E +
Sbjct: 113 EFLIVLRDVVGGMN--HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELE 167
Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLT--------SMSDVYSFGVVLLELLSG 283
           D      + GT+ Y  P+      L         +  D++S GV      +G
Sbjct: 168 DDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           I L   +HP+++ L     + +H  LV E M  G L +++ R+   S   ++ +   +G 
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG- 131
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKLSDFGLAKDGPEGDDTHVSTRVM 248
            K + +LH   + V++RD K SNIL   +       ++ DFG AK     ++  + T   
Sbjct: 132 -KTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY 187
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            T  + APE +         D++S G++L  +L+G
Sbjct: 188 -TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 39/235 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQLRH 140
           +G+G FG V K       R     Q VA+K + +E     +E      L E+  L  L+H
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKH 76
Query: 141 PHLVKLIGYC---------CEEEHRLLVYEYMPR---GSLENQLFRRYSVSLPWSTRMKI 188
            ++V LI  C         C+     LV+++      G L N L     V    S   ++
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRV 130
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGDDTHVST 245
                 GL ++H     +++RD KA+N+L+  D   KL+DFGLA+               
Sbjct: 131 MQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 246 RVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           RV+ T  Y  PE ++         D++  G ++ E+ +    +  +  Q + +L+
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 39/235 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQLRH 140
           +G+G FG V K       R     Q VA+K + +E     +E      L E+  L  L+H
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKH 76
Query: 141 PHLVKLIGYC---------CEEEHRLLVYEYMPR---GSLENQLFRRYSVSLPWSTRMKI 188
            ++V LI  C         C+     LV+++      G L N L     V    S   ++
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASI-YLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRV 130
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGDDTHVST 245
                 GL ++H     +++RD KA+N+L+  D   KL+DFGLA+               
Sbjct: 131 MQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 246 RVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           RV+ T  Y  PE ++         D++  G ++ E+ +    +  +  Q + +L+
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 75/293 (25%)
Query: 85  FLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------EVIFLGQ 137
            LG GGFG+V+ G  + D L       PVA+K+++ + +    E         EV+ L +
Sbjct: 11  LLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 138 LR--HPHLVKLIGYCCEEEHRLLVYE-----------YMPRGSLENQLFRRYSVSLPWST 184
           +      +++L+ +    +  +L+ E              RG+L+ +L R    S  W  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR----SFFWQV 119
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHV 243
                L A +     H     V++RD K  NIL+D +    KL DFG    G    DT V
Sbjct: 120 -----LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-V 165
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            T   GT+ Y+ PE++        S  V+S G++L +++ G                   
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI----------------- 208
Query: 303 RPMLNDARKLGRIMDPRLEGQ--YSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            P  +D   +G        GQ  + +  + +   L   CL+ RP  RPT   +
Sbjct: 209 -PFEHDEEIIG--------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 127/316 (40%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R    S  W       L A +     H     V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELAR----SFFWQV-----LEAVR-----HCHNCGVLHRDIKDENILID 176
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 177 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 233 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSSECQHLIR 268
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 269 WCLALRPSDRPTFEEI 284

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 58
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 59  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 164
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 165 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 221 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSXECQHLIR 256
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 257 WCLALRPSDRPTFEEI 272

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 5   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 57
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 58  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 163
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 164 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 220 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSSECQHLIR 255
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 256 WCLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 58
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 59  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 164
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 165 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 221 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSSECQHLIR 256
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 257 WCLALRPSDRPTFEEI 272

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++V+
Sbjct: 27  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--IALGAAKGLAFLHDAE 203
                    H  +V EY   G    +LF R   +  +S             G+++ H  +
Sbjct: 80  FKEVILTPTHLAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 204 KPVIYRDFKASNILLDSDYTA--KLSDFGLAKDG---PEGDDTHVSTRVMGTQGYAAPEY 258
             V +RD K  N LLD       K+  FG +K      +  DT      +GT  Y APE 
Sbjct: 136 --VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT------VGTPAYIAPEV 187
Query: 259 VMTGHLT-SMSDVYSFGVVLLELLSG 283
           ++       ++DV+S GV L  +L G
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 39/235 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQLRH 140
           +G+G FG V K       R     Q VA+K + +E     +E      L E+  L  L+H
Sbjct: 25  IGQGTFGEVFKA------RHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKH 75
Query: 141 PHLVKLIGYC---------CEEEHRLLVYEYMPR---GSLENQLFRRYSVSLPWSTRMKI 188
            ++V LI  C         C+     LV+++      G L N L     V    S   ++
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRV 129
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGDDTHVST 245
                 GL ++H     +++RD KA+N+L+  D   KL+DFGLA+               
Sbjct: 130 MQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 246 RVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           RV+ T  Y  PE ++         D++  G ++ E+ +    +  +  Q + +L+
Sbjct: 188 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 5   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 57
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 58  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 163
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 164 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 220 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSXECQHLIR 255
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 256 WCLALRPSDRPTFEEI 271

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 39/235 (16%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQLRH 140
           +G+G FG V K       R     Q VA+K + +E     +E      L E+  L  L+H
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKH 76
Query: 141 PHLVKLIGYC---------CEEEHRLLVYEYMPR---GSLENQLFRRYSVSLPWSTRMKI 188
            ++V LI  C         C+     LV+++      G L N L     V    S   ++
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRV 130
Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGDDTHVST 245
                 GL ++H     +++RD KA+N+L+  D   KL+DFGLA+               
Sbjct: 131 MQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 246 RVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
           RV+ T  Y  PE ++         D++  G ++ E+ +    +  +  Q + +L+
Sbjct: 189 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 38  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 90
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 91  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 150
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 151 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 196
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 197 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 252
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 253 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSXECQHLIR 288
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 289 WCLALRPSDRPTFEEI 304

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 33  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 85
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 86  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 191
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 192 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 248 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSXECQHLIR 283
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 284 WCLALRPSDRPTFEEI 299

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 33  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 85
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 86  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 191
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 192 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 248 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSSECQHLIR 283
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 284 WCLALRPSDRPTFEEI 299

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 58
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 59  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 164
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 165 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 221 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSXECQHLIR 256
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 257 WCLALRPXDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 74/316 (23%)
Query: 63  SNLHVFTLA---ELKVTTQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD 118
           ++LH   LA   E +     +     LG GGFG+V+ G  + D L       PVA+K+++
Sbjct: 25  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 77
Query: 119 LEGLQGHREWLT------EVIFLGQLR--HPHLVKLIGYCCEEEHRLLVYE--------- 161
            + +    E         EV+ L ++      +++L+ +    +  +L+ E         
Sbjct: 78  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 137
Query: 162 --YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD 219
                RG+L+ +L R +   +  + R              H     V++RD K  NIL+D
Sbjct: 138 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 183
Query: 220 SDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVL 277
            +    KL DFG    G    DT V T   GT+ Y+ PE++        S  V+S G++L
Sbjct: 184 LNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 278 LELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY 337
            +++ G                    P  +D   +      R +  + +  + +   L  
Sbjct: 240 YDMVCGDI------------------PFEHDEEII------RGQVFFRQRVSSECQHLIR 275
Query: 338 QCLSHRPKQRPTMSTV 353
            CL+ RP  RPT   +
Sbjct: 276 WCLALRPSDRPTFEEI 291

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
           I L   +HP+++ L     + ++  +V E M  G L +++ R+   S   ++ +   +  
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI-- 125
Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKLSDFGLAKDGPEGDDTHVSTRVM 248
            K + +LH   + V++RD K SNIL   +     + ++ DFG AK     ++  + T   
Sbjct: 126 TKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLMTPCY 182
Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            T  + APE +      +  D++S GV+L  +L+G
Sbjct: 183 -TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 19/140 (13%)
Query: 158 LVYEYMPRGSLENQLF-RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI 216
           LV+E M  GS+ + +  RR+   L  S    +    A  L FLH+  K + +RD K  NI
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 217 LLDSDYT---AKLSDFGLAKD-GPEGDDTHVSTRVM----GTQGYAAPEYV-----MTGH 263
           L +        K+ DFGL       GD + +ST  +    G+  Y APE V         
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 264 LTSMSDVYSFGVVLLELLSG 283
                D++S GV+L  LLSG
Sbjct: 203 YDKRCDLWSLGVILYILLSG 222

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++V+
Sbjct: 27  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK--IALGAAKGLAFLHDAE 203
                    H  +V EY   G    +LF R   +  +S             G+++ H  +
Sbjct: 80  FKEVILTPTHLAIVMEYASGG----ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 204 KPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTR-VMGTQGYAAPEYVM 260
             V +RD K  N LLD       K+  FG +K        H   +  +GT  Y APE ++
Sbjct: 136 --VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSV----LHSQPKSTVGTPAYIAPEVLL 189
Query: 261 TGHLT-SMSDVYSFGVVLLELLSG 283
                  ++DV+S GV L  +L G
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 71/296 (23%)
Query: 80  FSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------EV 132
           +     LG GGFG+V+ G  + D L       PVA+K+++ + +    E         EV
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 133 IFLGQLR--HPHLVKLIGYCCEEEHRLLVYE-----------YMPRGSLENQLFRRYSVS 179
           + L ++      +++L+ +    +  +L+ E              RG+L+ +L R    S
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR----S 114
Query: 180 LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEG 238
             W       L A +     H     V++RD K  NIL+D +    KL DFG    G   
Sbjct: 115 FFWQV-----LEAVR-----HCHNXGVLHRDIKDENILIDLNRGELKLIDFG---SGALL 161
Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQS 297
            DT V T   GT+ Y+ PE++        S  V+S G++L +++ G              
Sbjct: 162 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------ 208
Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
                 P  +D   +      R +  + +  + +   L   CL+ RP  RPT   +
Sbjct: 209 ------PFEHDEEII------RGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 35/232 (15%)
Query: 75  VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEV 132
           V +  +   + LGEG FG V +  ID K   G       VKN+D   E  +   + L  +
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVEC-IDHKA-GGRHVAVKIVKNVDRYCEAARSEIQVLEHL 68
Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--MKIAL 190
                      V+++ +     H  +V+E +    L    F + +  LP+      K+A 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNIL-LDSDYTA------------------KLSDFGL 231
              K + FLH  +  + + D K  NIL + SDYT                   K+ DFG 
Sbjct: 126 QICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           A      DD H ST V  T+ Y APE ++    +   DV+S G +L+E   G
Sbjct: 184 AT----YDDEHHSTLV-STRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 82  SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-H 140
           +S  LGEG +  V        L+ G   +  AVK ++ +          EV  L Q + +
Sbjct: 17  TSELLGEGAYAKVQGAV---SLQNG---KEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
            ++++LI +  ++    LV+E +  GS+   + ++   +   ++R+   + AA  L FLH
Sbjct: 71  KNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFLH 128
Query: 201 DAEKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGDD-----THVSTRVMGTQG 252
              K + +RD K  NIL +S       K+ DF L       +      T   T   G+  
Sbjct: 129 T--KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 253 YAAPEYV--MTGHLT---SMSDVYSFGVVLLELLSG 283
           Y APE V   T   T      D++S GVVL  +LSG
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------ 130
           +Q +S+ + LG G FG V      +K       + V VK +  E +     W+       
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEK------NKEVVVKFIKKEKVL-EDCWIEDPKLGK 75
Query: 131 ---EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRG-SLENQLFRRYSVSLPWSTRM 186
              E+  L ++ H +++K++     +    LV E    G  L   + R   +  P ++ +
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
              L +A G   L D    +I+RD K  NI++  D+T KL DFG A     G    +   
Sbjct: 136 FRQLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYT 188
Query: 247 VMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELL 281
             GT  Y APE +M   +     +++S GV L  L+
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 71/291 (24%)
Query: 85  FLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------EVIFLGQ 137
            LG GGFG+V+ G  + D L       PVA+K+++ + +    E         EV+ L +
Sbjct: 15  LLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 138 LR--HPHLVKLIGYCCEEEHRLLVYE-----------YMPRGSLENQLFRRYSVSLPWST 184
           +      +++L+ +    +  +L+ E              RG+L+ +L R    S  W  
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR----SFFWQV 123
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHV 243
                L A +     H     V++RD K  NIL+D +    KL DFG    G    DT V
Sbjct: 124 -----LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-V 169
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            T   GT+ Y+ PE++        S  V+S G++L +++ G                   
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI----------------- 212
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            P  +D   +      R +  + +  + +   L   CL+ RP  RPT   +
Sbjct: 213 -PFEHDEEII------RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 71/291 (24%)
Query: 85  FLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------EVIFLGQ 137
            LG GGFG+V+ G  + D L       PVA+K+++ + +    E         EV+ L +
Sbjct: 14  LLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 138 LR--HPHLVKLIGYCCEEEHRLLVYE-----------YMPRGSLENQLFRRYSVSLPWST 184
           +      +++L+ +    +  +L+ E              RG+L+ +L R    S  W  
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR----SFFWQV 122
Query: 185 RMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHV 243
                L A +     H     V++RD K  NIL+D +    KL DFG    G    DT V
Sbjct: 123 -----LEAVR-----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-V 168
Query: 244 STRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
            T   GT+ Y+ PE++        S  V+S G++L +++ G                   
Sbjct: 169 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI----------------- 211
Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            P  +D   +      R +  + +  + +   L   CL+ RP  RPT   +
Sbjct: 212 -PFEHDEEII------RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 255
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	455
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-154
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-53
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-45
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-41
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-39
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-38
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  537 bits (1387), Expect = 0.0
 Identities = 110/318 (34%), Positives = 180/318 (56%), Gaps = 25/318 (7%)

Query: 54  EDLSISLAGSNLHVFTLAELKVTTQSFSS------SNFLGEGGFGAVHKGFIDDKLRPGL 107
           E+ S+ ++ +  H F+  ELK  T +F         N +GEGGFG V+KG++++      
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------ 54

Query: 108 QAQPVAVKNL----DLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYM 163
               VAVK L    D+   +  +++  E+  + + +H +LV+L+G+  + +   LVY YM
Sbjct: 55  --TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 164 PRGSLENQLF-RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
           P GSL ++L     +  L W  R KIA GAA G+ FLH  E   I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 170

Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
           TAK+SDFGLA+   +   T +++R++GT  Y APE  + G +T  SD+YSFGVVLLE+++
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229

Query: 283 GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSH 342
           G  +VD+ R    Q L++    + ++ + +   +D ++      T      ++A QCL  
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286

Query: 343 RPKQRPTMSTVVKTLEPL 360
           +  +RP +  V + L+ +
Sbjct: 287 KKNKRPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  512 bits (1321), Expect = 0.0
 Identities = 122/316 (38%), Positives = 178/316 (56%), Gaps = 12/316 (3%)

Query: 45  SNPSSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLR 104
           S  +++      S  L     +   L +L+  T +F     +G G FG V+KG + D   
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-- 63

Query: 105 PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMP 164
                  VA+K    E  QG  E+ TE+  L   RHPHLV LIG+C E    +L+Y+YM 
Sbjct: 64  -----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 165 RGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY 222
            G+L+  L+     ++S+ W  R++I +GAA+GL +LH   + +I+RD K+ NILLD ++
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENF 176

Query: 223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS 282
             K++DFG++K G E D TH+ST V GT GY  PEY + G LT  SDVYSFGVVL E+L 
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

Query: 283 GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSH 342
            R ++ +S P+   +L EWA    N+  +L +I+DP L  +      RK    A +CL+ 
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295

Query: 343 RPKQRPTMSTVVKTLE 358
             + RP+M  V+  LE
Sbjct: 296 SSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  438 bits (1130), Expect = e-154
 Identities = 122/301 (40%), Positives = 178/301 (59%), Gaps = 15/301 (4%)

Query: 64  NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
            L  F+L EL+V + +FS+ N LG GGFG V+KG + D          VAVK L  E  Q
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERTQ 68

Query: 124 GH-REWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS--VSL 180
           G   ++ TEV  +    H +L++L G+C     RLLVY YM  GS+ + L  R      L
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 181 PWSTRMKIALGAAKGLAFLH-DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
            W  R +IALG+A+GLA+LH   +  +I+RD KA+NILLD ++ A + DFGLAK     D
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS-- 297
            THV+T V GT G+ APEY+ TG  +  +DV+ +GV+LLEL++G+++ D +R   +    
Sbjct: 189 -THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
           L++W + +L + +KL  ++D  L+G Y +    +   +A  C    P +RP MS VV+ L
Sbjct: 248 LLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 358 E 358
           E
Sbjct: 307 E 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  268 bits (688), Expect = 2e-87
 Identities = 75/322 (23%), Positives = 126/322 (39%), Gaps = 38/322 (11%)

Query: 68  FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE 127
                L   +           G FG V K  + +        + VAVK   +   Q  + 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPI---QDKQS 62

Query: 128 WL--TEVIFLGQLRHPHLVKLIGYCCE----EEHRLLVYEYMPRGSLENQLFRRYSVSLP 181
           W    EV  L  ++H ++++ IG        +    L+  +  +GSL + L       + 
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVS 119

Query: 182 WSTRMKIALGAAKGLAFLH-------DAEKP-VIYRDFKASNILLDSDYTAKLSDFGLAK 233
           W+    IA   A+GLA+LH       D  KP + +RD K+ N+LL ++ TA ++DFGLA 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTS-----MSDVYSFGVVLLELLSGRKSVD 288
               G     +   +GT+ Y APE +              D+Y+ G+VL EL S   + D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 289 KSRPQREQSLVE--WARPMLNDARKL--GRIMDPRLEGQY-SETGARKAAALAYQCLSHR 343
               +      E     P L D +++   +   P L   +    G         +C  H 
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 344 PKQRPTMSTVVKTLEPLKDFDD 365
            + R +   V + +  ++   +
Sbjct: 300 AEARLSAGCVGERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  215 bits (549), Expect = 1e-66
 Identities = 66/328 (20%), Positives = 117/328 (35%), Gaps = 49/328 (14%)

Query: 68  FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE 127
              +E  +   +      +G G +GAV+KG         L  +PVAVK          + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS--------LDERPVAVKVFSF---ANRQN 51

Query: 128 WLTE--VIFLGQLRHPHLVKLIGYCCE-----EEHRLLVYEYMPRGSLENQLFRRYSVSL 180
           ++ E  +  +  + H ++ + I              LLV EY P GSL   L      + 
Sbjct: 52  FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TS 108

Query: 181 PWSTRMKIALGAAKGLAFLHD-------AEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
            W +  ++A    +GLA+LH         +  + +RD  + N+L+ +D T  +SDFGL+ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 234 ------DGPEGDDTHVSTRVMGTQGYAAPEYVM-------TGHLTSMSDVYSFGVVLLEL 280
                     G++ + +   +GT  Y APE +                D+Y+ G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 281 LSGRKSVDKSRPQREQSL----VEWARPMLNDARKLGRIMDPRLE----GQYSETGARKA 332
                 +       E  +         P   D + L      R +     + +    R  
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 333 AALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                 C     + R T     + +  L
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAEL 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  199 bits (508), Expect = 1e-60
 Identities = 81/280 (28%), Positives = 135/280 (48%), Gaps = 33/280 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G G FG VH+               VAVK L  +        E+L EV  + +LRHP++
Sbjct: 45  IGAGSFGTVHRAE--------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDA 202
           V  +G   +  +  +V EY+ RGSL   L +  +   L    R+ +A   AKG+ +LH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
             P+++R+ K+ N+L+D  YT K+ DFGL++   +      S    GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG--RIMDPRL 320
                SDVYSFGV+L EL + ++      P    +  +    +    ++L   R ++P++
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQ------PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                       AA+   C ++ P +RP+ +T++  L PL
Sbjct: 269 ------------AAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (505), Expect = 1e-60
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 44/287 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           L E   G + KG          Q   + VK L +        R++  E   L    HP++
Sbjct: 18  LNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 144 VKLIGYCCE--EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           + ++G C      H  L+  +MP GSL N L    +  +  S  +K AL  A+G+AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            E  +      + ++++D D TA++S   +         +  S   M    + APE  + 
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE-ALQ 181

Query: 262 G----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG--RI 315
                     +D++SF V+L EL++         P  + S +E    +  +  +      
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREV------PFADLSNMEIGMKVALEGLRPTIPPG 235

Query: 316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
           + P +            + L   C++  P +RP    +V  LE ++D
Sbjct: 236 ISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  195 bits (497), Expect = 5e-59
 Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 42/291 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG   K       R     + + +K L     +  R +L EV  +  L HP+++K
Sbjct: 18  LGKGCFGQAIKV----THRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            IG   +++    + EY+  G+L   + +      PWS R+  A   A G+A+LH     
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLR-GIIKSMDSQYPWSQRVSFAKDIASGMAYLH--SMN 128

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAK------------DGPEGDDTHVSTRVMGTQGY 253
           +I+RD  + N L+  +    ++DFGLA+               +  D      V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV---EWARPMLNDAR 310
            APE +         DV+SFG+VL E++    +     P+     +    +         
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247

Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
                  P                +  +C    P++RP+   +   LE L+
Sbjct: 248 -----CPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  193 bits (492), Expect = 1e-58
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 52/294 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-------REWLTEVIFLGQL 138
           +G+GGFG VHKG    +L        VA+K+L L   +G        +E+  EV  +  L
Sbjct: 27  IGKGGFGLVHKG----RLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
            HP++VKL G         +V E++P G L ++L    +  + WS ++++ L  A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 199 LHDAEKPVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           + +   P+++RD ++ NI L S        AK++DFGL++        H  + ++G   +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192

Query: 254 AAPEYVMTG---HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML---N 307
            APE  +       T  +D YSF ++L  +L+G        P  E S  +     +    
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFINMIREE 245

Query: 308 DAR-KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             R  +     PRL              +   C S  PK+RP  S +VK L  L
Sbjct: 246 GLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (491), Expect = 3e-58
 Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 41/282 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG V K           +A+ VA+K ++ E  +  + ++ E+  L ++ HP++VK
Sbjct: 16  VGRGAFGVVCKAK--------WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLF-RRYSVSLPWSTRMKIALGAAKGLAFLHDAE- 203
           L G C       LV EY   GSL N L           +  M   L  ++G+A+LH  + 
Sbjct: 66  LYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 204 KPVIYRDFKASNILLDSDYT-AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
           K +I+RD K  N+LL +  T  K+ DFG A D          T   G+  + APE     
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGS 178

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM--LNDAR-KLGRIMDPR 319
           + +   DV+S+G++L E+++ RK      P  E     +       N  R  L + +   
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRK------PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232

Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
           +             +L  +C S  P QRP+M  +VK +  L 
Sbjct: 233 I------------ESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (482), Expect = 2e-57
 Identities = 77/290 (26%), Positives = 121/290 (41%), Gaps = 48/290 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH----REWLTEVIFLGQLRHP 141
           +G GGFG V++ F             VAVK    +  +           E      L+HP
Sbjct: 15  IGIGGFGKVYRAFWIG--------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           +++ L G C +E +  LV E+   G L   L  +    +P    +  A+  A+G+ +LHD
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD 123

Query: 202 -AEKPVIYRDFKASNILLD--------SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
            A  P+I+RD K+SNIL+         S+   K++DFGLA+   E   T   +   G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYA 179

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
           + APE +     +  SDV+S+GV+L ELL+G        P R    +  A  +  +   L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGIDGLAVAYGVAMNKLAL 233

Query: 313 GRI--MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                                 A L   C +  P  RP+ + ++  L  +
Sbjct: 234 PIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (476), Expect = 1e-55
 Identities = 73/302 (24%), Positives = 119/302 (39%), Gaps = 40/302 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL--TEVIFLGQLRHPHL 143
           +G+G +G V  G          + + VAVK            W   TE+     +RH ++
Sbjct: 45  IGKGRYGEVWMGK--------WRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENI 93

Query: 144 VKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I    +         L+ +Y   GSL + L      +L   + +K+A  +  GL  L
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHL 150

Query: 200 HD------AEKPVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGDDTHVSTRVMGTQ 251
           H        +  + +RD K+ NIL+  + T  ++D GLA        +        +GT+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 252 GYAAPEYVMTGHL-------TSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWAR 303
            Y  PE V+   L         M+D+YSFG++L E+     S       Q     +  + 
Sbjct: 211 RYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

Query: 304 PMLNDARKLGRIMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           P   D R++  I   R        S+   R+   L  +C +H P  R T   V KTL  +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 361 KD 362
            +
Sbjct: 330 SE 331

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (471), Expect = 2e-55
 Identities = 72/301 (23%), Positives = 116/301 (38%), Gaps = 42/301 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV-IF-LGQLRHPHL 143
           +G+G +G V +G          Q + VAVK       +  + W  E  ++    LRH ++
Sbjct: 16  VGKGRYGEVWRGS--------WQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENI 64

Query: 144 VKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I       H      L+  Y   GSL + L      +L   + ++I L  A GLA L
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHL 121

Query: 200 HDAEK------PVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGDDTHVSTRVMGTQ 251
           H           + +RD K+ NIL+  +    ++D GLA             +   +GT+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 252 GYAAPEYVMTGHL-------TSMSDVYSFGVVLLELLSGRKSVDKSRPQRE--QSLVEWA 302
            Y APE V+   +           D+++FG+VL E+     S       +     +V   
Sbjct: 182 RYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP-N 239

Query: 303 RPMLNDARKLGRIMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP 359
            P   D RK+  +   R       +S+      A L  +C    P  R T   + KTL  
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

Query: 360 L 360
           +
Sbjct: 300 I 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 9e-55
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 30/280 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G G FG V+KG    K         VAVK L++        + +  EV  L + RH ++
Sbjct: 32  IGSGSFGTVYKG----KWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +G         +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 83  LLFMG-YSTAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLH--A 138

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE---YVM 260
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
           +   +  SDVY+FG+VL EL++G+       P    +  +    M+   R        ++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVG--RGSLSPDLSKV 250

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                    ++   L  +CL  +  +RP+   ++  +E L
Sbjct: 251 ----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  183 bits (466), Expect = 3e-54
 Identities = 76/302 (25%), Positives = 117/302 (38%), Gaps = 40/302 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE--VIFLGQLRHPHL 143
           +G+G FG V +G          + + VAVK       +  R W  E  +     LRH ++
Sbjct: 50  IGKGRFGEVWRGK--------WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 98

Query: 144 VKLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +  I    ++        LV +Y   GSL + L R    ++     +K+AL  A GLA L
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 155

Query: 200 H-----DAEKPVI-YRDFKASNILLDSDYTAKLSDFGLA--KDGPEGDDTHVSTRVMGTQ 251
           H        KP I +RD K+ NIL+  + T  ++D GLA   D             +GT+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 252 GYAAPEYVMTGHL-------TSMSDVYSFGVVLLELLSGRKSVDKSRP-QREQSLVEWAR 303
            Y APE V+   +          +D+Y+ G+V  E+             Q     +  + 
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274

Query: 304 PMLNDARKLGRIMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           P + + RK+      R        S    R  A +  +C       R T   + KTL  L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

Query: 361 KD 362
             
Sbjct: 335 SQ 336

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (458), Expect = 3e-53
 Identities = 61/300 (20%), Positives = 115/300 (38%), Gaps = 63/300 (21%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPHL 143
           +G+G FG V+ G    +         VA++ +D+E       + +  EV+   Q RH ++
Sbjct: 41  IGKGRFGQVYHG----RWH-----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V  +G C    H  ++       +L + + R   + L  +   +IA    KG+ +LH   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH--A 148

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           K ++++D K+ N+  D +    ++DFGL         G          G   + APE + 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 261 TGHLTSM---------SDVYSFGVVLLELLSGRKSVDKSRPQREQSL--VEWA-----RP 304
                +          SDV++ G +  EL +         P + Q    + W      +P
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW------PFKTQPAEAIIWQMGTGMKP 261

Query: 305 MLNDA---RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
            L+     +++  I+                      C +   ++RPT + ++  LE L 
Sbjct: 262 NLSQIGMGKEISDILL--------------------FCWAFEQEERPTFTKLMDMLEKLP 301

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  165 bits (421), Expect = 3e-47
 Identities = 78/283 (27%), Positives = 121/283 (42%), Gaps = 38/283 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V  G    +LR       VAVK+  +        ++L E   L Q  HP++V
Sbjct: 122 IGRGNFGEVFSG----RLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +LIG C +++   +V E +  G     L R     L   T +++   AA G+ +L    K
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE--SK 232

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY-----AAPEYV 259
             I+RD  A N L+      K+SDFG++++  +G          G          APE +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTAPEAL 287

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
             G  +S SDV+SFG++L E  S G        P    S  +  R  +      G  +  
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGA------SPYPNLSNQQ-TREFVEK----GGRLPC 336

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
                  E        L  QC ++ P QRP+ ST+ + L+ ++
Sbjct: 337 ------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  160 bits (407), Expect = 9e-46
 Identities = 83/290 (28%), Positives = 122/290 (42%), Gaps = 34/290 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG+V     D           VAVK L   G    R++  E+  L  L    +VK
Sbjct: 31  LGKGNFGSVELCRYDP--LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 146 LIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
             G       +   LV EY+P G L + L +R+   L  S  +  +    KG+ +L    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG--S 145

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPEY 258
           +  ++RD  A NIL++S+   K++DFGLAK  P   D +V        G     + APE 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPES 201

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL---GR 314
           +     +  SDV+SFGVVL EL +   KS   S         E   P L+   +L   G+
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261

Query: 315 IMDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            + P         +          L   C +  P+ RP+ S +   L+ L
Sbjct: 262 RL-PAPPACPAEVHE---------LMKLCWAPSPQDRPSFSALGPQLDML 301

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (404), Expect = 1e-45
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 35/291 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V     D         + VAVK+L    G     +   E+  L  L H ++V
Sbjct: 29  LGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 145 KLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           K  G C E+      L+ E++P GSL+  L  +    +    ++K A+   KG+ +L   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--G 143

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPE 257
            +  ++RD  A N+L++S++  K+ DFGL K      + +               + APE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAPE 199

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL---G 313
            +M       SDV+SFGV L ELL+             +       +  +         G
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259

Query: 314 RIMDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           + + P         Y          L  +C   +P  R +   +++  E L
Sbjct: 260 KRL-PCPPNCPDEVYQ---------LMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  159 bits (405), Expect = 2e-45
 Identities = 88/293 (30%), Positives = 124/293 (42%), Gaps = 37/293 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V     D         + VAVK L    G Q    W  E+  L  L H H++
Sbjct: 39  LGEGHFGKVSLYCYD--PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 145 KLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           K  G C +       LV EY+P GSL + L  R+S+ L     +  A    +G+A+LH  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLA--QLLLFAQQICEGMAYLH-- 151

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPE 257
            +  I+RD  A N+LLD+D   K+ DFGLAK  PEG + +     +   G     + APE
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAPE 207

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL---G 313
            +        SDV+SFGV L ELL+    S        E   +   +  +    +L   G
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

Query: 314 RIMDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
             + PR +      Y          L   C       RPT   ++  L+ + +
Sbjct: 268 ERL-PRPDKCPAEVYH---------LMKNCWETEASFRPTFENLIPILKTVHE 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  158 bits (402), Expect = 3e-45
 Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 31/291 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG+V     D         + VAVK L     +  R++  E+  L  L+H ++VK
Sbjct: 18  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 146 LIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
             G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG--T 132

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG---YAAPEYVM 260
           K  I+RD    NIL++++   K+ DFGL K  P+  +          +    + APE + 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIFWYAPESLT 190

Query: 261 TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDV+SFGVVL EL +  +       +  + +    +  +     +  +     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL----- 245

Query: 321 EGQYSETGARKAA---------ALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                +   R             +  +C ++   QRP+   +   ++ ++D
Sbjct: 246 -----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  158 bits (401), Expect = 7e-45
 Identities = 68/293 (23%), Positives = 122/293 (41%), Gaps = 35/293 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG+V     D         + VAVK L     +  R++  E+  L  L+H ++VK
Sbjct: 49  LGKGNFGSVEMCRYD--PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 146 LIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
             G C     R   L+ EY+P GSL + L +++   +     ++      KG+ +L    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GT 163

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG-----YAAPEY 258
           K  I+RD    NIL++++   K+ DFGL K  P+  + +         G     + APE 
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPES 219

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +     +  SDV+SFGVVL EL +  +       +  + +    +  +     +  +   
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL--- 276

Query: 319 RLEGQYSETGARKAA---------ALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                  +   R             +  +C ++   QRP+   +   ++ ++D
Sbjct: 277 -------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (383), Expect = 8e-43
 Identities = 82/285 (28%), Positives = 128/285 (44%), Gaps = 40/285 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    +         VAVK +  EG     E+  E   + +L HP LVK
Sbjct: 16  LGSGQFGVVKLGKWKGQY-------DVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
             G C +E    +V EY+  G L N L R +   L  S  +++     +G+AFL      
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQ 124

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD  A N L+D D   K+SDFG+ +     DD +     +GT+    ++APE     
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYF 180

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD--PR 319
             +S SDV++FG+++ E+ S G+       P    +  E     ++   +L R       
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGK------MPYDLYTNSE-VVLKVSQGHRLYRPHLASDT 233

Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
           +   Y          + Y C    P++RPT   ++ ++EPL++ D
Sbjct: 234 I---YQ---------IMYSCWHELPEKRPTFQQLLSSIEPLREKD 266

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  152 bits (387), Expect = 9e-43
 Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 41/283 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG V+KG             PVA+K L +    + ++E L E   +  + +PH+ 
Sbjct: 23  LGSGAFGTVYKGLW--IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L+G  C      L+ + MP G L + + R +  ++     +   +  AKG+ +L   ++
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL--EDR 136

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST------RVMGTQGYAAPEY 258
            +++RD  A N+L+ +    K++DFGLAK     +  + +       + M      A E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ALES 190

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
           ++    T  SDV+S+GV + EL++ G       +P       E    +L    +L +   
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGS------KPYDGIPASE-ISSILEKGERLPQPPI 243

Query: 318 --PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
               +   Y          +  +C       RP    ++    
Sbjct: 244 CTIDV---YM---------IMRKCWMIDADSRPKFRELIIEFS 274

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  150 bits (382), Expect = 2e-42
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 36/280 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG+V +G      R   +   VA+K L          E + E   + QL +P++V
Sbjct: 18  LGCGNFGSVRQG----VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +LIG  C+ E  +LV E    G L   L       +P S   ++    + G+ +L   EK
Sbjct: 74  RLIG-VCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL--EEK 129

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMT 261
             ++RD  A N+LL + + AK+SDFGL+K     D  + +      +    + APE +  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINF 187

Query: 262 GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD--P 318
              +S SDV+S+GV + E LS G+      +P ++    E     +   +++    +  P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQ------KPYKKMKGPE-VMAFIEQGKRMECPPECPP 240

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            L   Y+         L   C  ++ + RP   TV + + 
Sbjct: 241 EL---YA---------LMSDCWIYKWEDRPDFLTVEQRMR 268

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (380), Expect = 3e-42
 Identities = 66/290 (22%), Positives = 106/290 (36%), Gaps = 39/290 (13%)

Query: 86  LGEGGFGAVHKG-FIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG+G F  + KG   +      L    V +K LD         +      + +L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
              G C   +  +LV E++  GSL+  L ++    +    ++++A   A  + FL   E 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL--EEN 132

Query: 205 PVIYRDFKASNILLDSDYT--------AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            +I+ +  A NILL  +           KLSD G++      D        +       P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------PP 186

Query: 257 EYVMTG-HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
           E +    +L   +D +SFG  L E+ S G K      P               D  +L  
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDK------PLSALDSQR-KLQFYEDRHQLPA 239

Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
                L    +         L   C+ + P  RP+   +++ L  L   D
Sbjct: 240 PKAAEL---AN---------LINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  148 bits (377), Expect = 5e-42
 Identities = 83/281 (29%), Positives = 129/281 (45%), Gaps = 40/281 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+  +K         VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 16  IGSGQFGLVHLGYWLNK-------DKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV E+M  G L + L R         T + + L   +G+A+L   E  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 124

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
           VI+RD  A N L+  +   K+SDFG+ +     DD +  T   GT+    +A+PE     
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFS 180

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL- 320
             +S SDV+SFGV++ E+ S G+       P   +S  E     ++   +L +   PRL 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGK------IPYENRSNSE-VVEDISTGFRLYK---PRLA 230

Query: 321 -EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               Y          +   C   RP+ RP  S +++ L  +
Sbjct: 231 STHVYQ---------IMNHCWRERPEDRPAFSRLLRQLAEI 262

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (377), Expect = 9e-42
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 38/281 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG G FG V KG      +     + VAVK L  +        E L E   + QL +P++
Sbjct: 25  LGSGNFGTVKKG----YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V++IG  CE E  +LV E    G L   L  + +  +     +++    + G+ +L   E
Sbjct: 81  VRMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EE 135

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVM 260
              ++RD  A N+LL + + AK+SDFGL+K     ++ + +      +    + APE + 
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPECIN 193

Query: 261 TGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-- 317
               +S SDV+SFGV++ E  S G+      +P R     E    ML    ++G      
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQ------KPYRGMKGSE-VTAMLEKGERMGCPAGCP 246

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             +   Y          L   C ++  + RP  + V   L 
Sbjct: 247 REM---YD---------LMNLCWTYDVENRPGFAAVELRLR 275

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  148 bits (376), Expect = 1e-41
 Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 40/285 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    +         VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYGKWRGQY-------DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L R           +++     + + +L    K 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQ 140

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            ++RD  A N L++     K+SDFGL++     DD +  T  +G++    ++ PE +M  
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYS 196

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD--PR 319
             +S SD+++FGV++ E+ S G+       P    +  E     +    +L R      +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSE-TAEHIAQGLRLYRPHLASEK 249

Query: 320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
           +   Y+         + Y C   +  +RPT   ++  +  + D +
Sbjct: 250 V---YT---------IMYSCWHEKADERPTFKILLSNILDVMDEE 282

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  148 bits (377), Expect = 1e-41
 Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 40/286 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D      +    AVK+L  +  +    ++LTE I +    HP+++
Sbjct: 33  IGRGHFGCVYHGTLLD---NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 145 KLIGYCCEEEH-RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N + R  + +      +   L  AKG+ +L  A 
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL--AS 146

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA------APE 257
           K  ++RD  A N +LD  +T K++DFGLA+D  + +       V    G        A E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMALE 202

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
            + T   T+ SDV+SFGV+L EL++ G        P  + +  +    +     +  R++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFD----ITVYLLQGRRLL 252

Query: 317 DPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            P    +  Y          +  +C   + + RP+ S +V  +  +
Sbjct: 253 QPEYCPDPLYE---------VMLKCWHPKAEMRPSFSELVSRISAI 289

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  152 bits (385), Expect = 2e-41
 Identities = 75/277 (27%), Positives = 116/277 (41%), Gaps = 32/277 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +           VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTT-------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD +A+NIL+  +   K++DFGLA+   + + T         + + APE  + G  T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFT 359

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL--EGQ 323
             SDV+SFG++L EL +  +      P       E     +    ++     P    E  
Sbjct: 360 IKSDVWSFGILLTELTTKGR-----VPYPGMVNRE-VLDQVERGYRMPC---PPECPESL 410

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           +          L  QC    P++RPT   +   LE  
Sbjct: 411 HD---------LMCQCWRKEPEERPTFEYLQAFLEDY 438

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (377), Expect = 2e-41
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 40/285 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G  G V  G +     PG +  PVA+K L      +  R++L+E   +GQ  HP+++
Sbjct: 57  IGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L G        ++V EYM  GSL+  L R +         + +  G   G+ +L  ++ 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SDL 170

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEY 258
             ++RD  A N+L+DS+   K+SDFGL++   +  D   +     T G      + APE 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEA 225

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
           +     +S SDV+SFGVV+ E+L+ G       RP    +  +     + +  +L   M 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGE------RPYWNMTNRD-VISSVEEGYRLPAPMG 278

Query: 318 --PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
               L   +          L   C      QRP  S +V  L+ L
Sbjct: 279 CPHAL---HQ---------LMLDCWHKDRAQRPRFSQIVSVLDAL 311

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  149 bits (377), Expect = 3e-41
 Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 35/283 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG +  K   G +  PVA+K L   G   +   ++L E   +GQ  H ++
Sbjct: 52  IGAGEFGEVYKGML--KTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           ++L G   + +  +++ EYM  G+L+  L R           + +  G A G+ +L  A 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL--AN 165

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVM 260
              ++RD  A NIL++S+   K+SDFGL++   +  +   +T   G +    + APE + 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEAIS 223

Query: 261 TGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-- 317
               TS SDV+SFG+V+ E+++ G       RP  E S  E     +ND  +L   MD  
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGE------RPYWELSNHE-VMKAINDGFRLPTPMDCP 276

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             +   Y          L  QC      +RP  + +V  L+ L
Sbjct: 277 SAI---YQ---------LMMQCWQQERARRPKFADIVSILDKL 307

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (373), Expect = 3e-41
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL---DLEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G         +V E  P GSL ++L R++       T  + A+  A+G+ +L   
Sbjct: 83  LIRLYG-VVLTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 138

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYV 259
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V       +    + APE +
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196

Query: 260 MTGHLTSMSDVYSFGVVLLELLS-GRK 285
            T   +  SD + FGV L E+ + G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  152 bits (385), Expect = 3e-41
 Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 32/278 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  E      E+L E   + +++HP+LV+
Sbjct: 228 LGGGQYGEVYEGVWKKY------SLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 338

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+R+  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-PRL--EG 322
             SDV++FGV+L E+ +         P     L +    +L         M+ P    E 
Sbjct: 398 IKSDVWAFGVLLWEIATYGM-----SPYPGIDLSQ-VYELLEK----DYRMERPEGCPEK 447

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            Y          L   C    P  RP+ + + +  E +
Sbjct: 448 VYE---------LMRACWQWNPSDRPSFAEIHQAFETM 476

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  147 bits (373), Expect = 3e-41
 Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 43/293 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V++G   +      +   VAVK       L    ++++E + +  L HPH+V
Sbjct: 20  LGEGFFGEVYEGVYTN---HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KLIG   EEE   ++ E  P G L + L  R   SL   T +  +L   K +A+L     
Sbjct: 77  KLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYL--ESI 132

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST------RVMGTQGYAAPEY 258
             ++RD    NIL+ S    KL DFGL++   E +D + ++      + M      +PE 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWM------SPES 185

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
           +     T+ SDV+ F V + E+LS G+      +P       +    +L    +L +   
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGK------QPFFWLENKD-VIGVLEKGDRLPKPDL 238

Query: 318 --PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIA 368
             P L   Y+         L  +C  + P  RP  + +V +L  +   + DIA
Sbjct: 239 CPPVL---YT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  147 bits (374), Expect = 6e-41
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 52/304 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LGEG FG V      + L P      VAVK L        +++  E   L  L+H H+V+
Sbjct: 49  LGEGAFGKVFLAECHN-LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-------------MKIALGA 192
             G C E    L+V+EYM  G L   L      +   +               + +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV----- 247
           A G+ +L  A    ++RD    N L+      K+ DFG+++D    D   V  R      
Sbjct: 168 AAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 248 -MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM 305
            M       PE ++    T+ SDV+SFGVVL E+ + G+      +P  + S  E     
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTE----A 269

Query: 306 LNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
           ++   + GR ++ PR      Y+         +   C    P+QR ++  V   L+ L  
Sbjct: 270 IDCITQ-GRELERPRACPPEVYA---------IMRGCWQREPQQRHSIKDVHARLQALAQ 319

Query: 363 FDDD 366
               
Sbjct: 320 APPV 323

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  145 bits (369), Expect = 9e-41
 Identities = 83/282 (29%), Positives = 125/282 (44%), Gaps = 42/282 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G+ +           VAVK+L  +G      +L E   + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGH-------TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      +E   ++ EYM  GSL + L     + L  +  + +A   A+G+AF+   E+ 
Sbjct: 73  LYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMTG 262
            I+RD +A+NIL+    + K++DFGLA+   + + T       G +    + APE +  G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYG 185

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-PRL 320
             T  SDV+SFG++L E+++ GR       P    +  E     L      G  M  P  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR------IPYPGMTNPE-VIQNLER----GYRMVRPDN 234

Query: 321 --EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             E  Y          L   C   RP+ RPT   +   LE  
Sbjct: 235 CPEELYQ---------LMRLCWKERPEDRPTFDYLRSVLEDF 267

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  146 bits (370), Expect = 1e-40
 Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 56/290 (19%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  E      E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA----------- 254
            I+RD  A N L+  ++  K++DFGL+             R+M    Y            
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIKW 178

Query: 255 -APEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            APE +     +  SDV++FGV+L E+ + G        P     L +    +     K 
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQ----VYELLEKD 228

Query: 313 GRIMDPRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            R+  P    E  Y          L   C    P  RP+ + + +  E +
Sbjct: 229 YRMERPEGCPEKVYE---------LMRACWQWNPSDRPSFAEIHQAFETM 269

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  147 bits (374), Expect = 2e-40
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 40/286 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G G FG V+ G + D      +    AVK+L  +  +    ++LTE I +    HP+++
Sbjct: 97  IGRGHFGCVYHGTLLD---NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 145 KLIGYCCEEEH-RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            L+G C   E   L+V  YM  G L N + R  + +      +   L  AKG+ FL  A 
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL--AS 210

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG------TQGYAAPE 257
           K  ++RD  A N +LD  +T K++DFGLA+D  + +   V  +              A E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
            + T   T+ SDV+SFGV+L EL++ G        P  + +  +     L   R+L +  
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFD-ITVYLLQGRRLLQPE 319

Query: 317 D--PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                L   Y          +  +C   + + RP+ S +V  +  +
Sbjct: 320 YCPDPL---YE---------VMLKCWHPKAEMRPSFSELVSRISAI 353

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (374), Expect = 2e-40
 Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 36/283 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHL 143
           +G G FG V  G +     P  +   VA+K L   G   +  R++L E   +GQ  HP++
Sbjct: 53  VGAGEFGEVCSGRL---KLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           ++L G   + +  ++V EYM  GSL++ L R++         + +  G A G+ +L  ++
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL--SD 165

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVM 260
              ++RD  A NIL++S+   K+SDFGL +   +  +   +TR  G +    + +PE + 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIA 223

Query: 261 TGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-- 317
               TS SDV+S+G+VL E++S G       RP  E S  +     +++  +L   MD  
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGE------RPYWEMSNQD-VIKAVDEGYRLPPPMDCP 276

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             L   Y          L   C       RP    +V  L+ L
Sbjct: 277 AAL---YQ---------LMLDCWQKDRNNRPKFEQIVSILDKL 307

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  146 bits (370), Expect = 2e-40
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 8/202 (3%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG VHKG    +        PV +K + D  G Q  +     ++ +G L H H+V
Sbjct: 21  LGSGVFGTVHKGVWIPEGESI--KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L+G  C      LV +Y+P GSL + + R++  +L     +   +  AKG+ +L   E 
Sbjct: 79  RLLG-LCPGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL--EEH 134

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            +++R+  A N+LL S    +++DFG+A   P  D   + +       + A E +  G  
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 265 TSMSDVYSFGVVLLELLS-GRK 285
           T  SDV+S+GV + EL++ G +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAE 216

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  145 bits (368), Expect = 2e-40
 Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 60/296 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +G+G FG V+ G   D           A+K+L  +  +Q    +L E + +  L HP+++
Sbjct: 29  IGKGHFGVVYHGEYID---QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 145 KLIGYCCEEE-HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
            LIG     E    ++  YM  G L   + R    +      +   L  A+G+ +L  AE
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL--AE 142

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMG------TQGYAAPE 257
           +  ++RD  A N +LD  +T K++DFGLA+D  + +   V            T    A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI-- 315
            + T   T+ SDV+SFGV+L ELL+                              G    
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT-----------------------------RGAPPY 229

Query: 316 --MDPRLEGQYSETGARKAA---------ALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             +DP     +   G R             +  QC    P  RPT   +V  +E +
Sbjct: 230 RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (380), Expect = 3e-40
 Identities = 75/277 (27%), Positives = 116/277 (41%), Gaps = 32/277 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +           VA+K L   G      +L E   + +LRH  LV+
Sbjct: 275 LGQGCFGEVWMGTWNGTT-------RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 327 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 383

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD +A+NIL+  +   K++DFGLA+   + + T         + + APE  + G  T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFT 442

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL--EGQ 323
             SDV+SFG++L EL +  +      P       E     +    ++     P    E  
Sbjct: 443 IKSDVWSFGILLTELTTKGR-----VPYPGMVNRE-VLDQVERGYRMPC---PPECPESL 493

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           +          L  QC    P++RPT   +   LE  
Sbjct: 494 HD---------LMCQCWRKEPEERPTFEYLQAFLEDY 521

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (367), Expect = 4e-40
 Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 50/302 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHL 143
           LGEG FG+V +G +         +  VAVK + L+    +   E+L+E   +    HP++
Sbjct: 42  LGEGEFGSVMEGNLKQ---EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 144 VKLIGYCCEEE-----HRLLVYEYMPRGSLENQLFRR----YSVSLPWSTRMKIALGAAK 194
           ++L+G C E         +++  +M  G L   L           +P  T +K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV------M 248
           G+ +L  + +  ++RD  A N +L  D T  ++DFGL+K    GD              +
Sbjct: 159 GMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLN 307
                 A E +     TS SDV++FGV + E+ + G        P       E    M +
Sbjct: 217 ------AIESLADRVYTSKSDVWAFGVTMWEIATRGMT------PYPGVQNHE----MYD 260

Query: 308 DARKLGRIMDPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDD 365
                 R+  P   L+  Y          + Y C    P  RPT S +   LE L +   
Sbjct: 261 YLLHGHRLKQPEDCLDELYE---------IMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

Query: 366 DI 367
           D+
Sbjct: 312 DV 313

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  145 bits (367), Expect = 5e-40
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG V+KG    +        PVA+K L +    + ++E L E   +  + +PH+ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +L+G  C      L+ + MP G L + + R +  ++     +   +  AKG+ +L   ++
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL--EDR 136

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST------RVMGTQGYAAPEY 258
            +++RD  A N+L+ +    K++DFGLAK     +  + +       + M      A E 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ALES 190

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRK 285
           ++    T  SDV+S+GV + EL++ G K
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (374), Expect = 7e-40
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 48/288 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +        + +L E   + QLRH +LV+
Sbjct: 201 IGKGEFGDVMLGD--------YRGNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQ 250

Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN 308

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV----MGTQGYAAPEYVM 260
             ++RD  A N+L+  D  AK+SDFGL K+      T  + ++           APE + 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWT------APEALR 359

Query: 261 TGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR 319
               ++ SDV+SFG++L E+ S GR       P     L +    ++    K  ++  P 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKD----VVPRVEKGYKMDAPD 409

Query: 320 L--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDD 365
                 Y          +   C       RPT   + + LE ++  + 
Sbjct: 410 GCPPAVYD---------VMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  144 bits (366), Expect = 7e-40
 Identities = 71/321 (22%), Positives = 136/321 (42%), Gaps = 56/321 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG+G FG V++G     +        VA+K + +   ++   E+L E   + +    H+V
Sbjct: 33  LGQGSFGMVYEGVAKG-VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTR------MKIALGAAKGL 196
           +L+G   + +  L++ E M RG L++ L   R    + P          +++A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV------MGT 250
           A+L       ++RD  A N ++  D+T K+ DFG+ +D  E D      +       M  
Sbjct: 152 AYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDA 309
               +PE +  G  T+ SDV+SFGVVL E+ +   +      P +  S  +     + + 
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQ-VLRFVME- 255

Query: 310 RKLGRIMD------PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF 363
              G ++D        L   +          L   C  + PK RP+   ++ +++  ++ 
Sbjct: 256 ---GGLLDKPDNCPDML---FE---------LMRMCWQYNPKMRPSFLEIISSIK--EEM 298

Query: 364 DDDIAIGTFVFTVPTESSNND 384
           +      +F ++   +    +
Sbjct: 299 EPGFREVSFYYSEENKLPEPE 319

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (363), Expect = 8e-40
 Identities = 79/289 (27%), Positives = 122/289 (42%), Gaps = 50/289 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +        + +L E   + QLRH +LV+
Sbjct: 29  IGKGEFGDVMLGD--------YRGNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQ 78

Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN 136

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV----MGTQGYAAPEYVM 260
             ++RD  A N+L+  D  AK+SDFGL K+      T  + ++           APE + 
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWT------APEALR 187

Query: 261 TGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-P 318
               ++ SDV+SFG++L E+ S GR       P     L +   P +      G  MD P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKD-VVPRVEK----GYKMDAP 236

Query: 319 RL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDD 365
                  Y          +   C       RP+   + + LE +K  + 
Sbjct: 237 DGCPPAVYE---------VMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (374), Expect = 8e-40
 Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 42/282 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V     +           VAVK +   G      +L E   +  L+H  LVK
Sbjct: 196 LGAGQFGEVWMATYNKH-------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 247

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      +E   ++ E+M +GSL + L        P    +  +   A+G+AF+   ++ 
Sbjct: 248 LHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 304

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG---YAAPEYVMTG 262
            I+RD +A+NIL+ +    K++DFGLA+   + + T       G +    + APE +  G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFG 360

Query: 263 HLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-PRL 320
             T  SDV+SFG++L+E+++ GR       P    S  E     L      G  M  P  
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGR------IPYPGMSNPE-VIRALER----GYRMPRPEN 409

Query: 321 --EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             E  Y+         +  +C  +RP++RPT   +   L+  
Sbjct: 410 CPEELYN---------IMMRCWKNRPEERPTFEYIQSVLDDF 442

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  143 bits (364), Expect = 1e-39
 Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 53/301 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LGEG FG V      + L P      VAVK L    L   +++  E   L  L+H H+VK
Sbjct: 23  LGEGAFGKVFLAECYN-LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MKIALG 191
             G C + +  ++V+EYM  G L   L      ++                   + IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV---- 247
            A G+ +L  A +  ++RD    N L+ ++   K+ DFG+++D    D   V        
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 248 --MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARP 304
             M       PE +M    T+ SDV+SFGV+L E+ + G+      +P  + S  E    
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTE---- 243

Query: 305 MLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
           ++    + GR+++ PR+  +  Y          +   C    P+QR  +  + K L  L 
Sbjct: 244 VIECITQ-GRVLERPRVCPKEVYD---------VMLGCWQREPQQRLNIKEIYKILHALG 293

Query: 362 D 362
            
Sbjct: 294 K 294

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  143 bits (364), Expect = 2e-39
 Identities = 76/316 (24%), Positives = 121/316 (38%), Gaps = 44/316 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG V++G +   +        VAVK L ++   Q   ++L E + + +  H ++V
Sbjct: 38  LGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRR-----YSVSLPWSTRMKIALGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L           SL     + +A   A G  +L
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 200 HDAEKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY--- 253
              E   I+RD  A N LL        AK+ DFG+A+D              G       
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPV 209

Query: 254 --AAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR 310
               PE  M G  TS +D +SFGV+L E+ S G        P   +S  E     +    
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEFVTSGG 262

Query: 311 KLGRIMD--PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIA 368
           ++    +    +   Y          +  QC  H+P+ RP  + +++ +E      D I 
Sbjct: 263 RMDPPKNCPGPV---YR---------IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310

Query: 369 IGTFVFTVPTESSNND 384
               +   P       
Sbjct: 311 TALPIEYGPLVEEEEK 326

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  141 bits (359), Expect = 3e-39
 Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 43/285 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +GEG FG VH+G     + P   A  VA+K   +        ++L E + + Q  HPH+V
Sbjct: 23  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KLIG    E    ++ E    G L + L +    SL  ++ +  A   +  LA+L    K
Sbjct: 80  KLIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYL--ESK 135

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG------YAAPEY 258
             ++RD  A N+L+ S+   KL DFGL++   +                     + APE 
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 188

Query: 259 VMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
           +     TS SDV+ FGV + E+L  G       +P +     +     + +  +L    +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGV------KPFQGVKNND-VIGRIENGERLPMPPN 241

Query: 318 --PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             P L   YS         L  +C ++ P +RP  + +   L  +
Sbjct: 242 CPPTL---YS---------LMTKCWAYDPSRRPRFTELKAQLSTI 274

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  148 bits (374), Expect = 5e-39
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 36/280 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG+V +G      R   +   VA+K L          E + E   + QL +P++V
Sbjct: 344 LGCGNFGSVRQG----VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           +LIG  C+ E  +LV E    G L   L       +P S   ++    + G+ +L   EK
Sbjct: 400 RLIG-VCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL--EEK 455

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ---GYAAPEYVMT 261
             ++R+  A N+LL + + AK+SDFGL+K     D  + +      +    + APE +  
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINF 513

Query: 262 GHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD--P 318
              +S SDV+S+GV + E LS G+      +P ++    E     +   +++    +  P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQ------KPYKKMKGPE-VMAFIEQGKRMECPPECPP 566

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            L   Y+         L   C  ++ + RP   TV + + 
Sbjct: 567 EL---YA---------LMSDCWIYKWEDRPDFLTVEQRMR 594

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  142 bits (361), Expect = 9e-39
 Identities = 76/316 (24%), Positives = 121/316 (38%), Gaps = 44/316 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LG G FG V++G +   +        VAVK L ++   Q   ++L E + + +  H ++V
Sbjct: 79  LGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRR-----YSVSLPWSTRMKIALGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L           SL     + +A   A G  +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 200 HDAEKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY--- 253
              E   I+RD  A N LL        AK+ DFG+A+D              G       
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPV 250

Query: 254 --AAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR 310
               PE  M G  TS +D +SFGV+L E+ S G        P   +S  E     +    
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEFVTSGG 303

Query: 311 KLGRIMD--PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIA 368
           ++    +    +   Y          +  QC  H+P+ RP  + +++ +E      D I 
Sbjct: 304 RMDPPKNCPGPV---YR---------IMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351

Query: 369 IGTFVFTVPTESSNND 384
               +   P       
Sbjct: 352 TALPIEYGPLVEEEEK 367

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  141 bits (358), Expect = 9e-39
 Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 51/296 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL--DLEGLQGHREWLTEVIFLGQLRHPHL 143
           LG+G FG+V +  +            VAVK L  D+       E+L E   + +  HPH+
Sbjct: 31  LGKGEFGSVREAQLKQ---EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 144 VKLIGYCCEEEHR------LLVYEYMPRGSLENQL----FRRYSVSLPWSTRMKIALGAA 193
            KL+G       +      +++  +M  G L   L          +LP  T ++  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV------ 247
            G+ +L  + +  I+RD  A N +L  D T  ++DFGL++    GD              
Sbjct: 148 CGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPML 306
           +      A E +     T  SDV++FGV + E+++ G+       P       E    + 
Sbjct: 206 L------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQT------PYAGIENAE----IY 249

Query: 307 NDARKLGRIMDPRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           N      R+  P    E  Y          L YQC S  PKQRP+ + +   LE +
Sbjct: 250 NYLIGGNRLKQPPECMEEVYD---------LMYQCWSADPKQRPSFTCLRMELENI 296

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (355), Expect = 1e-38
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 54/302 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGE  FG V+KG +     PG Q Q VA+K L D        E+  E +   +L+HP++V
Sbjct: 17  LGEDRFGKVYKGHLFG-PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MKIAL 190
            L+G   +++   +++ Y   G L   L  R   S   ST               + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST----- 245
             A G+ +L  +   V+++D    N+L+      K+SD GL ++    D   +       
Sbjct: 136 QIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193

Query: 246 -RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWAR 303
            R M      APE +M G  +  SD++S+GVVL E+ S G       +P    S  +   
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSNQD-VV 240

Query: 304 PMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
            M+ +     +++  P       Y+         L  +C +  P +RP    +   L   
Sbjct: 241 EMIRN----RQVLPCPDDCPAWVYA---------LMIECWNEFPSRRPRFKDIHSRLRAW 287

Query: 361 KD 362
            +
Sbjct: 288 GN 289

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (366), Expect = 8e-38
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 31/279 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +GEG FG VH+G     + P   A  VA+K   +        ++L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KLIG    E    ++ E    G L + L +    SL  ++ +  A   +  LA+L    K
Sbjct: 455 KLIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYL--ESK 510

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   E    + +++      + APE +     
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 265 TSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD--PRLE 321
           TS SDV+ FGV + E+L  G       +P +     +     + +  +L    +  P L 
Sbjct: 570 TSASDVWMFGVCMWEILMHGV------KPFQGVKNND-VIGRIENGERLPMPPNCPPTL- 621

Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             YS         L  +C ++ P +RP  + +   L  +
Sbjct: 622 --YS---------LMTKCWAYDPSRRPRFTELKAQLSTI 649

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  137 bits (346), Expect = 6e-37
 Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 63/302 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPHL 143
           +GEG FG V K     +++        A+K + +      HR++  E+  L +L  HP++
Sbjct: 33  IGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTR-------------MKIA 189
           + L+G C    +  L  EY P G+L + L   R   + P                 +  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST---- 245
              A+G+ +L  ++K  I+RD  A NIL+  +Y AK++DFGL++      + +V      
Sbjct: 149 ADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMGR 202

Query: 246 ---RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW 301
              R M      A E +     T+ SDV+S+GV+L E++S G        P    +  E 
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGMTCAE- 249

Query: 302 ARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
               L +    G  ++ P    +  Y          L  QC   +P +RP+ + ++ +L 
Sbjct: 250 ----LYEKLPQGYRLEKPLNCDDEVYD---------LMRQCWREKPYERPSFAQILVSLN 296

Query: 359 PL 360
            +
Sbjct: 297 RM 298

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (338), Expect = 1e-35
 Identities = 72/308 (23%), Positives = 120/308 (38%), Gaps = 62/308 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           +GEG FG V +      L P      VAVK L +        ++  E   + +  +P++V
Sbjct: 55  IGEGAFGRVFQARAPG-LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR------------------- 185
           KL+G C   +   L++EYM  G L   L      ++   +                    
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 186 ---MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
              + IA   A G+A+L  +E+  ++RD    N L+  +   K++DFGL+++    D   
Sbjct: 174 AEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231

Query: 243 VSTRV------MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
                      M       PE +     T+ SDV+++GVVL E+ S G       +P   
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGL------QPYYG 279

Query: 296 QSLVEWARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMST 352
            +  E     + D    G I+  P       Y+         L   C S  P  RP+  +
Sbjct: 280 MAHEE-VIYYVRD----GNILACPENCPLELYN---------LMRLCWSKLPADRPSFCS 325

Query: 353 VVKTLEPL 360
           + + L+ +
Sbjct: 326 IHRILQRM 333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (336), Expect = 1e-35
 Identities = 86/308 (27%), Positives = 124/308 (40%), Gaps = 62/308 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG FG V K      L+       VAVK L +       R+ L+E   L Q+ HPH++
Sbjct: 31  LGEGEFGKVVKATAFH-LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRR----------------------YSVSLPW 182
           KL G C ++   LL+ EY   GSL   L                            +L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
              +  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL++D  E D   
Sbjct: 150 GDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 243 VST------RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
             +      + M      A E +     T+ SDV+SFGV+L E+++ G        P   
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------PYPG 255

Query: 296 QSLVEWARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMST 352
                     L +  K G  M+ P    E  Y          L  QC    P +RP  + 
Sbjct: 256 IPPER-----LFNLLKTGHRMERPDNCSEEMYR---------LMLQCWKQEPDKRPVFAD 301

Query: 353 VVKTLEPL 360
           + K LE +
Sbjct: 302 ISKDLEKM 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (336), Expect = 1e-35
 Identities = 83/302 (27%), Positives = 115/302 (38%), Gaps = 54/302 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPHL 143
           LG G FG V +      L     A  VAVK L     L      ++E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEATAYG-LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR----------------YSVSLPWSTRMK 187
           V L+G C      L++ EY   G L N L R+                  ++L     + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST-- 245
            +   AKG+AFL  A K  I+RD  A NILL      K+ DFGLA+D     +  V    
Sbjct: 150 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 246 ----RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW 301
               + M      APE +     T  SDV+S+G+ L EL S   S     P   +     
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY--- 258

Query: 302 ARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
              M+ +    G  M  P       Y          +   C    P +RPT   +V+ +E
Sbjct: 259 --KMIKE----GFRMLSPEHAPAEMYD---------IMKTCWDADPLKRPTFKQIVQLIE 303

Query: 359 PL 360
             
Sbjct: 304 KQ 305

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (333), Expect = 2e-35
 Identities = 65/291 (22%), Positives = 109/291 (37%), Gaps = 55/291 (18%)

Query: 84  NFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH 142
             +G GGFG V K     D        +   +K +     +  RE    V  L +L H +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDG-------KTYVIKRVKYNNEKAERE----VKALAKLDHVN 65

Query: 143 LVKLIGYCCEEEHRL----------------LVYEYMPRGSLENQLFRRYSVSLPWSTRM 186
           +V   G     ++                  +  E+  +G+LE  + +R    L     +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           ++     KG+ ++H   K +I RD K SNI L      K+ DFGL        +    TR
Sbjct: 126 ELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTR 180

Query: 247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML 306
             GT  Y +PE + +       D+Y+ G++L ELL                         
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDTAF 222

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL 357
             ++    + D  +   +     +K   L  + LS +P+ RP  S +++TL
Sbjct: 223 ETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  133 bits (336), Expect = 2e-35
 Identities = 78/305 (25%), Positives = 116/305 (38%), Gaps = 64/305 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPHL 143
           LG G FG V +      L        VAVK L            ++E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEATAFG-LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTR----------MKIALG 191
           V L+G C      L++ EY   G L N L    R   + P              +  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST------ 245
            A+G+AFL  A K  I+RD  A N+LL + + AK+ DFGLA+D     +  V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

Query: 246 RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-------GRKSVDKSRPQREQSL 298
           + M      APE +     T  SDV+S+G++L E+ S       G     K         
Sbjct: 231 KWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--------F 276

Query: 299 VEWARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            +    ++ D    G  M  P    +  YS         +   C +  P  RPT   +  
Sbjct: 277 YK----LVKD----GYQMAQPAFAPKNIYS---------IMQACWALEPTHRPTFQQICS 319

Query: 356 TLEPL 360
            L+  
Sbjct: 320 FLQEQ 324

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  131 bits (332), Expect = 8e-35
 Identities = 75/302 (24%), Positives = 123/302 (40%), Gaps = 55/302 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPH 142
           LGEG FG V         +    +A  VAVK L D    +   + ++E+  +  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--------------YSVSLPWSTRMKI 188
           ++ L+G C ++    ++ EY  +G+L   L  R                  + +   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST--- 245
               A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D    +T   
Sbjct: 163 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220

Query: 246 ---RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW 301
              + M      APE +     T  SDV+SFGV++ E+ + G        P     + E 
Sbjct: 221 LPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGIPVEE- 267

Query: 302 ARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
               L    K G  MD P       Y          +   C    P QRPT   +V+ L+
Sbjct: 268 ----LFKLLKEGHRMDKPANCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLD 314

Query: 359 PL 360
            +
Sbjct: 315 RI 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (328), Expect = 9e-35
 Identities = 59/272 (21%), Positives = 101/272 (37%), Gaps = 37/272 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWL-TEVIFLGQLRHPHL 143
           +G G F  V+KG   +          VA   L    L +  R+    E   L  L+HP++
Sbjct: 34  IGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 144 VKLIGYC---CEEEHRLLVY-EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           V+         + +  +++  E M  G+L     +R+   +             KGL FL
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFK-VMKIKVLRSWCRQILKGLQFL 145

Query: 200 HDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           H    P+I+RD K  NI +     + K+ D GLA        +     V+GT  + APE 
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGTPEFMAPEM 201

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI-MD 317
               +     DVY+FG+ +LE+ +         P  E            +A ++ R    
Sbjct: 202 YEEKY-DESVDVYAFGMCMLEMATSE------YPYSE----------CQNAAQIYRRVTS 244

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
                 + +    +   +   C+     +R +
Sbjct: 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (329), Expect = 4e-34
 Identities = 75/302 (24%), Positives = 123/302 (40%), Gaps = 55/302 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPH 142
           LGEG FG V         +    +A  VAVK L D    +   + ++E+  +  + +H +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--------------YSVSLPWSTRMKI 188
           ++ L+G C ++    ++ EY  +G+L   L  R                  + +   +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST--- 245
               A+G+ +L  A +  I+RD  A N+L+  +   K++DFGLA+D    D    +T   
Sbjct: 209 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266

Query: 246 ---RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW 301
              + M      APE +     T  SDV+SFGV++ E+ + G        P     + E 
Sbjct: 267 LPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGIPVEE- 313

Query: 302 ARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
               L    K G  MD P       Y          +   C    P QRPT   +V+ L+
Sbjct: 314 ----LFKLLKEGHRMDKPANCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLD 360

Query: 359 PL 360
            +
Sbjct: 361 RI 362

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  128 bits (325), Expect = 9e-34
 Identities = 74/308 (24%), Positives = 113/308 (36%), Gaps = 61/308 (19%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPHL 143
           LG G FG V        +     +  VAVK L +          ++E+  + QL  H ++
Sbjct: 53  LGSGAFGKVMNATAYG-ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTR----------------- 185
           V L+G C       L++EY   G L N L  +R   S                       
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 186 ---MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
              +  A   AKG+ FL    K  ++RD  A N+L+      K+ DFGLA+D     +  
Sbjct: 172 EDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 243 VST------RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE 295
           V        + M      APE +  G  T  SDV+S+G++L E+ S G        P   
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGV------NPYPG 277

Query: 296 QSLVEWARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMST 352
             +      ++ +    G  MD P    E  Y          +   C +   ++RP+   
Sbjct: 278 IPVDANFYKLIQN----GFKMDQPFYATEEIYI---------IMQSCWAFDSRKRPSFPN 324

Query: 353 VVKTLEPL 360
           +   L   
Sbjct: 325 LTSFLGCQ 332

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (323), Expect = 9e-34
 Identities = 80/302 (26%), Positives = 114/302 (37%), Gaps = 55/302 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPHL 143
           LG G FG V +      +      + VAVK L +      HR  ++E+  L  +  H ++
Sbjct: 35  LGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 144 VKLIGYCC-EEEHRLLVYEYMPRGSL--------------ENQLFRRYSVSLPWSTRMKI 188
           V L+G C       +++ E+   G+L              +      Y   L     +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST--- 245
           +   AKG+ FL  A +  I+RD  A NILL      K+ DFGLA+D  +  D        
Sbjct: 154 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 246 ---RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW 301
              + M      APE +     T  SDV+SFGV+L E+ S G        P     + E 
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKIDEE 259

Query: 302 ARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
               L +    G  M  P       Y              C    P QRPT S +V+ L 
Sbjct: 260 FCRRLKE----GTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLG 306

Query: 359 PL 360
            L
Sbjct: 307 NL 308

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  127 bits (321), Expect = 9e-34
 Identities = 69/296 (23%), Positives = 112/296 (37%), Gaps = 53/296 (17%)

Query: 85  FLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPH 142
            LG GGFG V +     D           A+K + L   +  RE  + EV  L +L HP 
Sbjct: 12  CLGRGGFGVVFEAKNKVDD-------CNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 143 LVKLIGYCCEEE---------HRLLVY---EYMPRGSLENQLFRRYSVSLP-WSTRMKIA 189
           +V+      E+           ++ +Y   +   + +L++ +  R ++     S  + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK----------DGPEGD 239
           L  A+ + FLH   K +++RD K SNI    D   K+ DFGL                  
Sbjct: 125 LQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV 299
                T  +GT+ Y +PE +     +   D++S G++L ELL             +   V
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--------YPFSTQMERV 234

Query: 300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                 L D R   +   P L  Q           +    LS  P +RP    +++
Sbjct: 235 R----TLTDVRN-LKF--PPLFTQKYP----CEYVMVQDMLSPSPMERPEAINIIE 279

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  129 bits (325), Expect = 1e-33
 Identities = 83/333 (24%), Positives = 132/333 (39%), Gaps = 58/333 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPH 142
           LGEG FG V         +    +   VAVK L      +   + ++E+  +  + +H +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR--------------MKI 188
           ++ L+G C ++    ++ EY  +G+L   L  R    L +S                +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST--- 245
           A   A+G+ +L  A K  I+RD  A N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 197 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254

Query: 246 ---RVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW 301
              + M      APE +     T  SDV+SFGV+L E+ + G        P     + E 
Sbjct: 255 LPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVPVEE- 301

Query: 302 ARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
               L    K G  MD P       Y          +   C    P QRPT   +V+ L+
Sbjct: 302 ----LFKLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLD 348

Query: 359 PLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDL 391
            +     +  +G   +       + D    E+L
Sbjct: 349 RIVALTSNQEMG---YYHHHHHHDYDIPTTENL 378

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (316), Expect = 5e-33
 Identities = 64/298 (21%), Positives = 113/298 (37%), Gaps = 56/298 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V K       R  L ++  A+K +     +     L+EV+ L  L H ++V+
Sbjct: 14  LGQGAFGQVVKA------RNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 146 LIGYCCEEEHRL-------------LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
                 E  + +             +  EY   G+L   L    +++       ++    
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY-DLIHSENLNQQRDEYWRLFRQI 125

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK-------------DGPEGD 239
            + L+++H   + +I+RD K  NI +D     K+ DFGLAK                 G 
Sbjct: 126 LEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 240 DTHVSTRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
             ++++ + GT  Y A E V+  TGH     D+YS G++  E++                
Sbjct: 184 SDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGME 233

Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            V     +L   R +     P  +    +        +    + H P +RP   T++ 
Sbjct: 234 RVN----ILKKLRSVSIEFPPDFDDNKMKV----EKKIIRLLIDHDPNKRPGARTLLN 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (317), Expect = 6e-33
 Identities = 66/288 (22%), Positives = 100/288 (34%), Gaps = 45/288 (15%)

Query: 78  QSFSSSNF-----LGEGGFGAVHKGF--IDDKLRPGLQAQPVAVK--NLDLEGLQGHREW 128
           +SF   +F     LG G +G V K     D +L         AVK       G +     
Sbjct: 52  ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL--------YAVKRSMSPFRGPKDRARK 103

Query: 129 LTEVIFLGQL-RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           L EV    ++ +HP  V+L     E     L  E     SL+      +  SLP +    
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWG 161

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                   LA LH   + +++ D K +NI L      KL DFGL  +        V    
Sbjct: 162 YLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---Q 216

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
            G   Y APE +   +  + +DV+S G+ +LE+    +          Q L +       
Sbjct: 217 EGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELPHGGEGW--QQLRQ------- 266

Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                   + P      S     +  ++    L   PK R T   ++ 
Sbjct: 267 ------GYLPPEFTAGLSS----ELRSVLVMMLEPDPKLRATAEALLA 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (317), Expect = 6e-33
 Identities = 63/306 (20%), Positives = 105/306 (34%), Gaps = 39/306 (12%)

Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
            + +  + +     LGEGGF  V                  A+K +     Q   E   E
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLV------EGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTR-- 185
                   HP++++L+ YC  E        L+  +  RG+L N++ R        +    
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
           + + LG  +GL  +H   K   +RD K +NILL  +    L D G         +     
Sbjct: 137 LWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 246 RVM-------GTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE 295
             +        T  Y APE         +   +DV+S G VL  ++ G        P   
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDM 248

Query: 296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                      + A  +   +      ++S         L    ++  P QRP +  ++ 
Sbjct: 249 VFQ-----KGDSVALAVQNQLSIPQSPRHSS----ALWQLLNSMMTVDPHQRPHIPLLLS 299

Query: 356 TLEPLK 361
            LE L+
Sbjct: 300 QLEALQ 305

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  124 bits (313), Expect = 2e-32
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 33/275 (12%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHP 141
           +G G F  V++   + D         PVA+K + +  L   +     + E+  L QL HP
Sbjct: 40  IGRGQFSEVYRAACLLDG-------VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAAKGLAFL 199
           +++K      E+    +V E    G L   +  F++    +P  T  K  +     L  +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H   + V++RD K +N+ + +    KL D GL +       T   + V GT  Y +PE +
Sbjct: 153 HS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERI 208

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR-IMDP 318
                   SD++S G +L E+ + +       P            + +  +K+ +    P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQ------SPFYGD-----KMNLYSLCKKIEQCDYPP 257

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
                YSE    +   L   C++  P++RP ++ V
Sbjct: 258 LPSDHYSE----ELRQLVNMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 3e-31
 Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 31/271 (11%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLTEVIFLGQLRHPH 142
           +GEG FG        +D        +   +K +++  +      E   EV  L  ++HP+
Sbjct: 32  IGEGSFGKAILVKSTEDG-------RQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +V+      E     +V +Y   G L  ++  +  V       +   +     L  +HD 
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD- 143

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
            + +++RD K+ NI L  D T +L DFG+A+             + GT  Y +PE     
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPEICENK 200

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
              + SD+++ G VL EL + +            S+      +++ +        P +  
Sbjct: 201 PYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVLKIISGSF-------PPVSL 247

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            YS        +L  Q     P+ RP+++++
Sbjct: 248 HYSY----DLRSLVSQLFKRNPRDRPSVNSI 274

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 4e-31
 Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 33/271 (12%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV 144
            LG+G +G V+ G     L        +A+K +     +  +    E+     L+H ++V
Sbjct: 29  VLGKGTYGIVYAGR---DLSNQ---VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAE 203
           + +G   E     +  E +P GSL   L  ++  +     T         +GL +LHD  
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 140

Query: 204 KPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV--- 259
             +++RD K  N+L+++     K+SDFG +K     +    +    GT  Y APE +   
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKG 198

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD-P 318
             G+    +D++S G  ++E+ +G+       P  E  L E    M     K+G     P
Sbjct: 199 PRGY-GKAADIWSLGCTIIEMATGK------PPFYE--LGEPQAAMF----KVGMFKVHP 245

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
            +    S     +A A   +C    P +R  
Sbjct: 246 EIPESMSA----EAKAFILKCFEPDPDKRAC 272

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (303), Expect = 7e-31
 Identities = 66/289 (22%), Positives = 103/289 (35%), Gaps = 46/289 (15%)

Query: 71  AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT 130
            E +      +    +G G FG VH+                AVK + LE  +       
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQ------TGFQCAVKKVRLEVFRVE----- 99

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E++    L  P +V L G   E     +  E +  GSL  QL ++    LP    +    
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMG-CLPEDRALYYLG 157

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAK---DGPEGDDTHVSTR 246
            A +GL +LH   + +++ D KA N+LL SD   A L DFG A        G        
Sbjct: 158 QALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 247 VMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM 305
           + GT+ + APE VM      +  D++S   ++L +L+G        P        W +  
Sbjct: 216 IPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGC------HP--------WTQ-- 258

Query: 306 LNDARKLGRIMD-----PRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
                   +I         +    +       A    + L   P  R +
Sbjct: 259 YFRGPLCLKIASEPPPIREIPPSCAPL----TAQAIQEGLRKEPVHRAS 303

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (309), Expect = 3e-30
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 25/205 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           +  GG G ++     D+    +  +PV +K L   G    +   + E  FL ++ HP +V
Sbjct: 88  IAHGGLGWIYLAL--DRN---VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 145 KLIGYCCEEEHRL-----LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           ++  +    +        +V EY+   SL+    ++    LP +  +   L     L++L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           H     ++Y D K  NI+L  +   KL D G        +       + GT G+ APE +
Sbjct: 199 HSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVS---RINSFGY---LYGTPGFQAPE-I 248

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGR 284
           +    T  +D+Y+ G  L  L    
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDL 273

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (294), Expect = 5e-30
 Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 36/280 (12%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPH 142
           +G G +G   K     D        + +  K LD   +     +  ++EV  L +L+HP+
Sbjct: 14  IGTGSYGRCQKIRRKSDG-------KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 143 LVKLIGYCCEEEHRLL--VYEYMPRGSLENQL--FRRYSVSLPWSTRMKIALGAAKGLAF 198
           +V+      +  +  L  V EY   G L + +    +    L     +++       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 199 LHD---AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
            H        V++RD K +N+ LD     KL DFGLA+      DT  +   +GT  Y +
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMS 184

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           PE +        SD++S G +L EL +         P    S  E A  +       G+ 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIRE-----GKF 233

Query: 316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              R+  +YS+    +   +  + L+ +   RP++  +++
Sbjct: 234 --RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 267

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  118 bits (297), Expect = 7e-30
 Identities = 71/368 (19%), Positives = 134/368 (36%), Gaps = 67/368 (18%)

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE         +  
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 56

Query: 131 EVIFLGQLRHP--HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           E+ +L +L+     +++L  Y   +++  +V E      L + L ++   S+    R   
Sbjct: 57  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSY 113

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
                + +  +H     +++ D K +N L+      KL DFG+A        + V    +
Sbjct: 114 WKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 170

Query: 249 GTQGYAAPEYVM-----------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
           GT  Y  PE +               ++  SDV+S G +L  +  G+       P     
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP----- 219

Query: 298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM------- 350
              + + ++N   KL  I+DP  E ++ +   +    +   CL   PKQR ++       
Sbjct: 220 ---FQQ-IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275

Query: 351 -----------------STVVKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKE 393
                              +   L  L   +   +I     T+    S  + +N+   K 
Sbjct: 276 YVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKT 335

Query: 394 CEAKKETK 401
            E K+  K
Sbjct: 336 FEKKRGKK 343

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  116 bits (292), Expect = 1e-29
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 86  LGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEGLQGHREWLT----EVIFLGQLRH 140
           LG GG   V+    D  L         VA+K + +   +   E L     EV    QL H
Sbjct: 19  LGGGGMSTVYLAE-DTILNIK------VAIKAIFIP-PREKEETLKRFEREVHNSSQLSH 70

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
            ++V +I    E++   LV EY+   +L   +       L   T +        G+   H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAH 128

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           D    +++RD K  NIL+DS+ T K+ DFG+AK   E   T  +  V+GT  Y +PE   
Sbjct: 129 DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAK 185

Query: 261 TGHLTSMSDVYSFGVVLLELLSGR 284
                  +D+YS G+VL E+L G 
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (293), Expect = 1e-29
 Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 18/204 (8%)

Query: 86  LGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEGLQGHREWLT----EVIFLGQLRH 140
           +G GG G V++   D    R       VA+K +    L     + T    E    G+L+ 
Sbjct: 42  VGRGGMGDVYEAE-DTVRERI------VALKLMSET-LSSDPVFRTRMQREARTAGRLQE 93

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           PH+V +  +   +    +    +    L   L R+    L     + I       L   H
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAH 151

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
            A     +RD K  NIL+ +D  A L DFG+A    +   T +    +GT  Y APE   
Sbjct: 152 AAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFS 208

Query: 261 TGHLTSMSDVYSFGVVLLELLSGR 284
             H T  +D+Y+   VL E L+G 
Sbjct: 209 ESHATYRADIYALTCVLYECLTGS 232

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (296), Expect = 2e-29
 Identities = 77/429 (17%), Positives = 146/429 (34%), Gaps = 59/429 (13%)

Query: 18  QEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTT 77
                   P+ +  K+++  +     + +P   T  +D + S A   +         V  
Sbjct: 4   HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECI--------SVKG 55

Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFL 135
           + +S    +G GG   V +   + K       Q  A+K ++LE    Q    +  E+ +L
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 136 GQLRHP--HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            +L+     +++L  Y   +++  +V E      L + L ++ S  +    R        
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNML 165

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           + +  +H  +  +++ D K +N L+      KL DFG+A        + V    +G   Y
Sbjct: 166 EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222

Query: 254 AAPEYVM-----------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
             PE +               ++  SDV+S G +L  +  G+    +             
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----------- 271

Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
               N   KL  I+DP  E ++ +   +    +   CL   PKQR ++       E L  
Sbjct: 272 ----NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP------ELLAH 321

Query: 363 --FDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVNG 420
                       +    TE           L    +  +  K    H    + HN   + 
Sbjct: 322 PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 381

Query: 421 RRRHMRSPR 429
                R  +
Sbjct: 382 TFEKKRGKK 390

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (289), Expect = 4e-29
 Identities = 61/297 (20%), Positives = 114/297 (38%), Gaps = 49/297 (16%)

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--REWLT 130
           + V  + +S    +G GG   V +   + K       Q  A+K ++LE         +  
Sbjct: 23  MSVKGRIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRN 75

Query: 131 EVIFLGQLRHP--HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           E+ +L +L+     +++L  Y   +++  +V E      L + L ++   S+    R   
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSY 132

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
                + +  +H     +++ D K +N L+      KL DFG+A        + V    +
Sbjct: 133 WKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189

Query: 249 GTQGYAAPEYVM-----------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS 297
           GT  Y  PE +               ++  SDV+S G +L  +  G+             
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------- 236

Query: 298 LVEWARP---MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
                 P   ++N   KL  I+DP  E ++ +   +    +   CL   PKQR ++ 
Sbjct: 237 -----TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (287), Expect = 2e-28
 Identities = 41/229 (17%), Positives = 83/229 (36%), Gaps = 48/229 (20%)

Query: 86  LGEGGFG----AVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT----------- 130
           L +G F                      +  A+K  +   L+  R++             
Sbjct: 39  LNQGKFNKIILCEKDN------------KFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 131 ------EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
                 E+  +  +++ + +   G     +   ++YEYM   S+       + +   ++ 
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 185 RMKIALGA------AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 238
            + I +            +++H  EK + +RD K SNIL+D +   KLSDFG ++     
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-- 203

Query: 239 DDTHVSTRVMGTQGYAAPEYVMTGHLT---SMSDVYSFGVVLLELLSGR 284
            D  +     GT  +  PE   +   +   +  D++S G+ L  +    
Sbjct: 204 -DKKIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  111 bits (280), Expect = 4e-28
 Identities = 59/309 (19%), Positives = 100/309 (32%), Gaps = 69/309 (22%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGF-IDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVI 133
           T  F     +G G FG+V K     D           A+K     L G    +  L EV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDG-------CIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 134 FLGQL-RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQL--FRRYSVSLPWSTRMKIAL 190
               L +H H+V+      E++H L+  EY   GSL + +    R       +    + L
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSD-------------------YTAKLSDFGL 231
              +GL ++H     +++ D K SNI +                         K+ D G 
Sbjct: 123 QVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGRKSVDK 289
                      V     G   + A E +     HL   +D+++  + ++           
Sbjct: 181 VT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA------ 227

Query: 290 SRPQREQSLVEWARPMLNDARKLGRIMD---PRLEGQYSETGARKAAALAYQCLSHRPKQ 346
                         P+  +  +   I     PR+    S+        L    +   P++
Sbjct: 228 -------------EPLPRNGDQWHEIRQGRLPRIPQVLSQEFTE----LLKVMIHPDPER 270

Query: 347 RPTMSTVVK 355
           RP+   +VK
Sbjct: 271 RPSAMALVK 279

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (278), Expect = 2e-27
 Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 48/298 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLV 144
           L EGGF  V++       +     +  A+K L     + +R  + EV F+ +L  HP++V
Sbjct: 36  LAEGGFAFVYEA------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 145 KLIGYCCEEEHR-------LLVYEYMPRGSLENQLFRRYSV-SLPWSTRMKIALGAAKGL 196
           +        +          L+   + +G L   L +  S   L   T +KI     + +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRVM----- 248
             +H  + P+I+RD K  N+LL +  T KL DFG A      P+   +     ++     
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 249 --GTQGYAAPEYV-MTGHL--TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR 303
              T  Y  PE + +  +       D+++ G +L  L   +   +     R  +      
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN------ 263

Query: 304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
                    G+   P  + QY+        +L    L   P++R +++ VV  L+ + 
Sbjct: 264 ---------GKYSIPPHDTQYTV-----FHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (279), Expect = 2e-27
 Identities = 39/227 (17%), Positives = 69/227 (30%), Gaps = 17/227 (7%)

Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTE 131
           E ++ ++     + LGEG F  V++      L      Q   +K                
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEA-TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLE---NQLFRRYSVSLPWSTRMKI 188
           +  L        +K       +   +LV E    G+L    N         +P    +  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA-----------KLSDFGLAKDGPE 237
           A+     +  +HD E  +I+ D K  N +L + +              L D G + D   
Sbjct: 178 AMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
                + T    T G+   E +         D +     +  +L G 
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (278), Expect = 2e-27
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 48/295 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLV 144
           LG G  G V K       +P      +A K + LE       + + E+  L +   P++V
Sbjct: 41  LGAGNGGVVFKV----SHKPSGL--VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
              G    +    +  E+M  GSL+  L  + +  +P     K+++   KGL +L +  K
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++    +  D+  ++ V GT+ Y +PE +   H 
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHY 207

Query: 265 TSMSDVYSFGVVLLELLSGR--------------------------KSVDKSRPQREQSL 298
           +  SD++S G+ L+E+  GR                              ++  +     
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 299 VEWARPMLNDARKLGRIMD---PRL-EGQYSETGARKAAALAYQCLSHRPKQRPT 349
              +RP +     L  I++   P+L  G +S     +      +CL   P +R  
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL----EFQDFVNKCLIKNPAERAD 318

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  109 bits (275), Expect = 4e-27
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LG+G    V +G      R        A+K  +        +  + E   L +L H ++V
Sbjct: 17  LGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 145 KLIGYCCEEE----HRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKGLAFL 199
           KL  +  EEE    H++L+ E+ P GSL   L     +  LP S  + +      G+  L
Sbjct: 71  KL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 200 HDAEKPVIYRDFKASNILL----DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
              E  +++R+ K  NI+     D     KL+DFG A++    DD    +   GT+ Y  
Sbjct: 129 R--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLH 183

Query: 256 PEYVMTGHLTSMS--------DVYSFGVVLLELLSGR 284
           P+      L            D++S GV      +G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (273), Expect = 6e-27
 Identities = 68/276 (24%), Positives = 109/276 (39%), Gaps = 42/276 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEV-IFLGQLRHPHL 143
           LG G +G V K     +  P    Q +AVK +      Q  +  L ++ I +  +  P  
Sbjct: 15  LGRGAYGVVEKM----RHVPS--GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRM--KIALGAAKGLAFLHD 201
           V   G    E    +  E M   SL+    +           +  KIA+   K L  LH 
Sbjct: 69  VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               VI+RD K SN+L+++    K+ DFG++       D        G + Y APE +  
Sbjct: 128 KLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINP 183

Query: 262 GHL----TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
                  +  SD++S G+ ++EL   R       P        W  P     ++L ++++
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRF------P-----YDSWGTPF----QQLKQVVE 228

Query: 318 ---PRL-EGQYSETGARKAAALAYQCLSHRPKQRPT 349
              P+L   ++S     +      QCL    K+RPT
Sbjct: 229 EPSPQLPADKFSA----EFVDFTSQCLKKNSKERPT 260

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  108 bits (271), Expect = 1e-26
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 22/209 (10%)

Query: 86  LGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEGLQGHREWLT----EVIFLGQLRH 140
           LG GG   VH    D +  R       VAVK L  + L     +      E      L H
Sbjct: 20  LGFGGMSEVHLA-RDLRDHRD------VAVKVLRAD-LARDPSFYLRFRREAQNAAALNH 71

Query: 141 PHLVKLIGYCCEEEHRL----LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           P +V +      E        +V EY+   +L + +       +     +++   A + L
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQAL 129

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST-RVMGTQGYAA 255
            F H     +I+RD K +NI++ +    K+ DFG+A+   +  ++   T  V+GT  Y +
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           PE      + + SDVYS G VL E+L+G 
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  109 bits (273), Expect = 2e-26
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LG+G    V +G      R        A+K  +        +  + E   L +L H ++V
Sbjct: 17  LGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 145 KLIGYCCEEE----HRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKGLAFL 199
           KL  +  EEE    H++L+ E+ P GSL   L     +  LP S  + +      G+  L
Sbjct: 71  KL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 200 HDAEKPVIYRDFKASNILL----DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
              E  +++R+ K  NI+     D     KL+DFG A++    DD    +   GT+ Y  
Sbjct: 129 R--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLH 183

Query: 256 PEYVMTGHLTSMS--------DVYSFGVVLLELLSGR 284
           P+      L            D++S GV      +G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (268), Expect = 3e-26
 Identities = 72/280 (25%), Positives = 105/280 (37%), Gaps = 45/280 (16%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQLRHP 141
           FLG+GGF    +             +  A K +    L       +   E+     L H 
Sbjct: 22  FLGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           H+V   G+  + +   +V E   R SL     RR +++ P   R         G  +LH 
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLGCQYLH- 132

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               VI+RD K  N+ L+ D   K+ DFGLA    E D       + GT  Y APE V++
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGTPNYIAPE-VLS 188

Query: 262 GHLTS-MSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               S   DV+S G ++  LL G+       P     L E             RI     
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYL----------RI----K 228

Query: 321 EGQYSE-----TGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           + +YS        A     L  + L   P  RPT++ ++ 
Sbjct: 229 KNEYSIPKHINPVAAS---LIQKMLQTDPTARPTINELLN 265

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  108 bits (272), Expect = 5e-26
 Identities = 65/314 (20%), Positives = 111/314 (35%), Gaps = 49/314 (15%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVI 133
            V   SF   + LG G  G +    + D        + VAVK +  E          EV 
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVYRGMFDN-------RDVAVKRILPECFSFADR---EVQ 69

Query: 134 FLGQL-RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
            L +   HP++++      + + + +  E     +L+ +   +   +      + +    
Sbjct: 70  LLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ-EYVEQKDFAHLGLEPITLLQQT 127

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILL-----DSDYTAKLSDFGLAK--DGPEGDDTHVST 245
             GLA LH     +++RD K  NIL+          A +SDFGL K         +  S 
Sbjct: 128 TSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 246 RVMGTQGYAAPEYV---MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
              GT+G+ APE +      + T   D++S G V   ++S         P  +       
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSL----- 234

Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV--------- 353
           +   N       +     E          A  L  + ++  P++RP+   V         
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVI----ARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

Query: 354 VKTLEPLKDFDDDI 367
            K L+  +D  D I
Sbjct: 291 EKQLQFFQDVSDRI 304

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  110 bits (275), Expect = 5e-26
 Identities = 58/212 (27%), Positives = 84/212 (39%), Gaps = 26/212 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LG GGFG V +         G   + VA+K    E    +RE W  E+  + +L HP++V
Sbjct: 22  LGTGGFGYVLRWI---HQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 145 KLIGYCCEEEHR--------LLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKG 195
                   +  +        LL  EY   G L   L +      L       +    +  
Sbjct: 76  SA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 196 LAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           L +LH  E  +I+RD K  NI+L         K+ D G AK+         +  V GT  
Sbjct: 134 LRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQ 188

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           Y APE +     T   D +SFG +  E ++G 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (270), Expect = 6e-26
 Identities = 45/315 (14%), Positives = 90/315 (28%), Gaps = 80/315 (25%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-------HREWLTEVIFLGQ- 137
           LG+    A  +   D +       +   V                   E L   +  G  
Sbjct: 86  LGQEDPYAYLEA-TDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 138 -----------------LRHPHLVKLIGYCCEEEHRLLVYEY--MPR-----GSLENQLF 173
                            ++ P   K+I    +E    ++  +   PR      +    L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 174 RRYSV--SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL 231
              S   SL    R+++ L   + LA LH     +++   +  +I+LD      L+ F  
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVM----------TGHLTSMSDVYSFGVVLLELL 281
                +G     S      +G+A PE                +T   D ++ G+ +  + 
Sbjct: 258 LV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 282 SGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLS 341
                     P  + + +  +  +    + +     P+              AL    L 
Sbjct: 312 CAD------LPNTDDAALGGSEWIFRSCKNI-----PQP-----------VRALLEGFLR 349

Query: 342 HRPKQRPTMSTVVKT 356
           +  + R      ++T
Sbjct: 350 YPKEDRLLPLQAMET 364

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  106 bits (267), Expect = 7e-26
 Identities = 72/280 (25%), Positives = 105/280 (37%), Gaps = 45/280 (16%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQLRHP 141
           FLG+GGF    +             +  A K +    L       +   E+     L H 
Sbjct: 48  FLGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
           H+V   G+  + +   +V E   R SL     RR +++ P   R         G  +LH 
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLGCQYLH- 158

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
               VI+RD K  N+ L+ D   K+ DFGLA    E D       + GT  Y APE V++
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGTPNYIAPE-VLS 214

Query: 262 GHLTS-MSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               S   DV+S G ++  LL G+       P     L E             RI     
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKP------PFETSCLKE----TYL------RI----K 254

Query: 321 EGQYSE-----TGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           + +YS        A     L  + L   P  RPT++ ++ 
Sbjct: 255 KNEYSIPKHINPVAAS---LIQKMLQTDPTARPTINELLN 291

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (266), Expect = 7e-26
 Identities = 48/242 (19%), Positives = 92/242 (38%), Gaps = 32/242 (13%)

Query: 125 HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP-WS 183
                 ++  +      + V  +     + +  +  +   + +L++ + RR S+      
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164

Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--------- 234
             + I +  A+ + FLH   K +++RD K SNI    D   K+ DFGL            
Sbjct: 165 VCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222

Query: 235 -GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ 293
                      T  +GT+ Y +PE +   + +   D++S G++L ELL           Q
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS------TQ 276

Query: 294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            E+  +      + D R   +   P L  Q       +   +    LS  P +RP  + +
Sbjct: 277 MERVRI------ITDVRN-LKF--PLLFTQKYP----QEHMMVQDMLSPSPTERPEATDI 323

Query: 354 VK 355
           ++
Sbjct: 324 IE 325

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  106 bits (265), Expect = 2e-25
 Identities = 41/380 (10%), Positives = 79/380 (20%), Gaps = 74/380 (19%)

Query: 16  SIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSI---SLAGSNLHVFTLAE 72
           S   +    + +     +    +     +   ++T   ++      SL         L E
Sbjct: 9   SFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE 68

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---L 129
                        L  G    V      D  R     +  A+K   +       E     
Sbjct: 69  P------------LRVGDRSVVFLVR--DVERL----EDFALKVFTMGAENSRSELERLH 110

Query: 130 TEVIFLGQLRHPHLVKLIGYC--------------------------CEEEHRLLVYEYM 163
                  +L      +                                   + LL+    
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170

Query: 164 PRGSLEN--QLFRRYSVS---LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL 218
               LE          V            +     +  A L    K +++  F   N+ +
Sbjct: 171 -SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFI 227

Query: 219 DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL--TSMSDVYSFGVV 276
             D    L D                        YA  E++       T   + +  G+ 
Sbjct: 228 MPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282

Query: 277 LLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALA 336
           +  +           P    +            R  G      L              L 
Sbjct: 283 IYRVWCLF------LPFGLVTPGIKGSWKRPSLRVPGT---DSLAFGSCTPLPDFVKTLI 333

Query: 337 YQCLSHRPKQRPTMSTVVKT 356
            + L+   ++R      ++T
Sbjct: 334 GRFLNFDRRRRLLPLEAMET 353

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  103 bits (258), Expect = 9e-25
 Identities = 65/276 (23%), Positives = 106/276 (38%), Gaps = 43/276 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEV-IFLGQLRHPHL 143
           +G G  G V K     + R       +AVK +   G  + ++  L ++ + L     P++
Sbjct: 33  MGSGTCGQVWKM----RFRKT--GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+  G         +  E M   + +  L +R    +P     K+ +   K L +L +  
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
             VI+RD K SNILLD     KL DFG++       D     R  G   Y APE +    
Sbjct: 145 G-VIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 264 L-----TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD- 317
                    +DV+S G+ L+EL +G+      +   E                L +++  
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---------------LTKVLQE 245

Query: 318 --PRLEG--QYSETGARKAAALAYQCLSHRPKQRPT 349
             P L G   +S        +    CL+   ++RP 
Sbjct: 246 EPPLLPGHMGFSG----DFQSFVKDCLTKDHRKRPK 277

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (254), Expect = 1e-24
 Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 19/203 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQLRHPH 142
           LG+G FG V+        R       +A+K L    L+      +   EV     LRHP+
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +++L GY  +     L+ EY P G++  +L  +                 A  L++ H  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH-- 126

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM-GTQGYAAPEYVMT 261
            K VI+RD K  N+LL S    K++DFG +   P           + GT  Y  PE +  
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTLDYLPPEMIEG 181

Query: 262 GHLTSMSDVYSFGVVLLELLSGR 284
                  D++S GV+  E L G+
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGK 204

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  105 bits (263), Expect = 1e-24
 Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 33/225 (14%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW- 128
            +    F     LG GGFG V     K     KL         A K L+ + L+  + + 
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKA--TGKL--------YACKKLNKKRLKKRKGYQ 230

Query: 129 --LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWS-T 184
             + E   L ++    +V L  Y  E +  L LV   M  G +   ++     +  +   
Sbjct: 231 GAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289

Query: 185 RMK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD 239
           R       I  G    L  LH  ++ +IYRD K  N+LLD D   ++SD GLA +   G 
Sbjct: 290 RAIFYTAQIVSG----LEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
                    GT G+ APE ++        D ++ GV L E+++ R
Sbjct: 344 TK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (257), Expect = 2e-24
 Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 36/275 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEV-IFLGQLRHPHL 143
           +G G +G+V+K       +P    Q +AVK +      +  ++ L ++ + +     P++
Sbjct: 30  IGRGAYGSVNKM----VHKPS--GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLEN---QLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           V+  G    E    +  E M   S +     ++      +P     KI L   K L  L 
Sbjct: 84  VQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
           +  K +I+RD K SNILLD     KL DFG++    +  D+   TR  G + Y APE + 
Sbjct: 143 ENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERID 198

Query: 261 TGHL----TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ--SLVEWARPMLNDARKLGR 314
                      SDV+S G+ L EL +GR    K     +Q   +V+   P L+++     
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE---- 254

Query: 315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
                 E ++S             CL+    +RP 
Sbjct: 255 ------EREFSP----SFINFVNLCLTKDESKRPK 279

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (258), Expect = 2e-24
 Identities = 38/317 (11%), Positives = 86/317 (27%), Gaps = 81/317 (25%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---------------------- 122
            LG+    A  +         G   +   V                              
Sbjct: 80  VLGQEDPYAYLEAT---DQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 123 ------QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE--HRLLVYEYM--PRGSLENQL 172
                 + H  ++     +   +   ++++     +     R  +Y  M     +    L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 173 FRRYSV--SLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG 230
               S   SL    R+++ L   + LA LH     +++   +  +I+LD      L+ F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----------GHLTSMSDVYSFGVVLLE 279
                 +G           ++G+  PE                 +T   D ++ G+V+  
Sbjct: 252 HLV--RDGAR----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 280 LLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQC 339
           +           P  + + +  +  +    + +             +       AL    
Sbjct: 306 IWCAD------LPITKDAALGGSEWIFRSCKNI------------PQP----VRALLEGF 343

Query: 340 LSHRPKQRPTMSTVVKT 356
           L +  + R      ++T
Sbjct: 344 LRYPKEDRLLPLQAMET 360

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (259), Expect = 3e-24
 Identities = 74/387 (19%), Positives = 124/387 (32%), Gaps = 76/387 (19%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL- 138
             S   LG G  G V         +   Q +PVAVK + ++          E+  L +  
Sbjct: 17  VVSEKILGYGSSGTV-------VFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESD 66

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALGAA 193
            HP++++       +    +  E     +L        +             + +    A
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDS-------------DYTAKLSDFGLAK---DGPE 237
            G+A LH     +I+RD K  NIL+ +             +    +SDFGL K    G  
Sbjct: 126 SGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 238 GDDTHVSTRVMGTQGYAAPE-------YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS 290
              T+++    GT G+ APE             LT   D++S G V   +LS        
Sbjct: 184 SFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK-----GK 237

Query: 291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
            P          +         G      ++  +  +   +A  L  Q + H P +RPT 
Sbjct: 238 HPF-------GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290

Query: 351 STV---------VKTLEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLK-ECEAKKET 400
             V          K LE L    D +           E  N D  +   +K +  +    
Sbjct: 291 MKVLRHPLFWPKSKKLEFLLKVSDRL-----------EIENRDPPSALLMKFDAGSDFVI 339

Query: 401 KKEKGNHRQNHKLHNDIVNGRRRHMRS 427
                  + +    +++   R+ H   
Sbjct: 340 PSGDWTVKFDKTFMDNLERYRKYHSSK 366

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (261), Expect = 3e-24
 Identities = 67/224 (29%), Positives = 95/224 (42%), Gaps = 34/224 (15%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW- 128
            VT  +F     LG+GGFG V     +     K+         A K L+ + ++  +   
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRA--TGKM--------YACKKLEKKRIKKRKGEA 229

Query: 129 --LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
             L E   L ++    +V L  Y  E +  L LV   M  G L+  ++       P   R
Sbjct: 230 MALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EAR 287

Query: 186 MK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD 240
                  I  G    L  LH   + ++YRD K  NILLD     ++SD GLA   PEG  
Sbjct: 288 AVFYAAEICCG----LEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341

Query: 241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
                RV GT GY APE V     T   D ++ G +L E+++G+
Sbjct: 342 IK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  100 bits (252), Expect = 3e-24
 Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 16/204 (7%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQLRHP 141
            LG+G F  V++               VA+K +D + +           EV    QL+HP
Sbjct: 18  LLGKGSFAGVYRA------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
            +++L  Y  +  +  LV E    G +   L  R         R  +      G+ +LH 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH- 129

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM- 260
               +++RD   SN+LL  +   K++DFGLA    +       T + GT  Y +PE    
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHEKHYT-LCGTPNYISPEIATR 186

Query: 261 TGHLTSMSDVYSFGVVLLELLSGR 284
           + H    SDV+S G +   LL GR
Sbjct: 187 SAH-GLESDVWSLGCMFYTLLIGR 209

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (253), Expect = 4e-24
 Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 47/273 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHLV 144
           +G+G FG V KG ID++ +     + VA+K +DLE  +   E +  E+  L Q   P++ 
Sbjct: 30  IGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 145 KLIGYCCEEEHRL-LVYEYMPRGS----LENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           K  G    ++ +L ++ EY+  GS    LE        ++        I     KGL +L
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYL 135

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAAP 256
           H   +  I+RD KA+N+LL      KL+DFG+A     G  T    +    +GT  + AP
Sbjct: 136 H--SEKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAP 188

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +      S +D++S G+  +EL  G     +  P +   L+    P            
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------ 236

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
            P LEG YS+   ++       CL+  P  RPT
Sbjct: 237 -PTLEGNYSKP-LKEFVE---ACLNKEPSFRPT 264

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (252), Expect = 5e-24
 Identities = 70/280 (25%), Positives = 114/280 (40%), Gaps = 37/280 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQLRHPHLV 144
           +G G    V         +     + VA+K ++LE  Q   + L  E+  + Q  HP++V
Sbjct: 23  IGSGATAVVQAA-YCAPKK-----EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK---IAL---GAAKGLAF 198
                   ++   LV + +  GS+ + +    +     S  +    IA       +GL +
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTR--VMGTQGYAA 255
           LH  +   I+RD KA NILL  D + +++DFG+ A     GD T    R   +GT  + A
Sbjct: 137 LH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194

Query: 256 PEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR 314
           PE +         +D++SFG+  +EL +G     K  P +   L     P          
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---------- 244

Query: 315 IMDPRLEGQYSETGARKAAALAY-----QCLSHRPKQRPT 349
              P LE    +    K    ++      CL   P++RPT
Sbjct: 245 ---PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 99.6 bits (249), Expect = 8e-24
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 19/203 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR---EWLTEVIFLGQLRHPH 142
           LG+G FG V+        R       +A+K L    L+      +   E+     LRHP+
Sbjct: 22  LGKGKFGNVYLA------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           ++++  Y  + +   L+ E+ PRG L  +L +         +   +    A  L + H  
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEE-LADALHYCH-- 131

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM-GTQGYAAPEYVMT 261
           E+ VI+RD K  N+L+      K++DFG +   P      +  R M GT  Y  PE +  
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-----SLRRRTMCGTLDYLPPEMIEG 186

Query: 262 GHLTSMSDVYSFGVVLLELLSGR 284
                  D++  GV+  E L G 
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGM 209

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
            + ++    +G+G  G V+              Q VA++ ++L+        + E++ + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVAT------GQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IAL 190
           + ++P++V  +      +   +V EY+  GSL +         +   T M       +  
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD---------VVTETCMDEGQIAAVCR 123

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
              + L FLH     VI+RD K+ NILL  D + KL+DFG         +    + ++GT
Sbjct: 124 ECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGT 179

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
             + APE V         D++S G++ +E++ G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 99.6 bits (248), Expect = 4e-23
 Identities = 43/208 (20%), Positives = 75/208 (36%), Gaps = 19/208 (9%)

Query: 87  GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLV 144
           G      V+      K       + V V+ ++LE            E+       HP++V
Sbjct: 36  GFEDLMTVNLAR--YKPT----GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
                   +    +V  +M  GS ++ +   +   +       I  G  K L ++H    
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HM 147

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGDDTHVSTRVM-GTQGYAAPEYV 259
             ++R  KAS+IL+  D    LS       +   G      H   +       + +PE V
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-V 206

Query: 260 MTGHL---TSMSDVYSFGVVLLELLSGR 284
           +  +L    + SD+YS G+   EL +G 
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGH 234

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 29/215 (13%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
                S   +GEG  G V               + VAVK +DL   Q       EV+ + 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHS------GRQVAVKMMDLRKQQRRELLFNEVVIMR 97

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK------IAL 190
             +H ++V++       E   ++ E++  G+L +         +    R+       +  
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD---------IVSQVRLNEEQIATVCE 148

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR--VM 248
              + LA+LH   + VI+RD K+ +ILL  D   KLSDFG      +     V  R  ++
Sbjct: 149 AVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKD-VPKRKSLV 202

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           GT  + APE +      +  D++S G++++E++ G
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 22/206 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K   + +          A K ++ +  +   +++ E+  L    HP++VK
Sbjct: 27  LGDGAFGKVYKA-KNKETG-----ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G    +    ++ E+ P G+++  +       L       +     + L FLH   K 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH--SKR 137

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAAPEYVMTG 262
           +I+RD KA N+L+  +   +L+DFG++       +     +    +GT  + APE VM  
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 263 HLTSMS-----DVYSFGVVLLELLSG 283
            +         D++S G+ L+E+   
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQI 218

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 31/214 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT----EVIFLGQLRHP 141
           LGEG +G V +                AVK L  + L+           E+  L +LRH 
Sbjct: 13  LGEGSYGKVKEV------LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 142 HLVKLIG-YCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK----- 194
           ++++L+     EE+ ++ +V EY   G  E  +            R  +           
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLD-SVPE----KRFPVCQAHGYFCQLI 119

Query: 195 -GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            GL +LH   + ++++D K  N+LL +  T K+S  G+A+               G+  +
Sbjct: 120 DGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 254 AAPEYVMTGHLT---SMSDVYSFGVVLLELLSGR 284
             PE +  G  T      D++S GV L  + +G 
Sbjct: 178 QPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 65/259 (25%), Positives = 106/259 (40%), Gaps = 37/259 (14%)

Query: 48  SSTTLSEDLSISLAGSNLHVFTLAELKVTTQSFSSSNF---------LGEGGFGAVHKGF 98
               L+ +  I+L+ S   VF   +L V  QS               LG G  G V   F
Sbjct: 96  KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155

Query: 99  IDDKLRPGLQAQPVAVKNLDLEGLQGHREW--------LTEVIFLGQLRHPHLVKLIGYC 150
             ++       + VA++ +                    TE+  L +L HP ++K+  + 
Sbjct: 156 --ERKT----CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209

Query: 151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRD 210
            + E   +V E M  G L +++       L  +T           + +LH+    +I+RD
Sbjct: 210 -DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRD 264

Query: 211 FKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSM 267
            K  N+LL S   D   K++DFG +K    G+ + + T   GT  Y APE +++      
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGY 321

Query: 268 S---DVYSFGVVLLELLSG 283
           +   D +S GV+L   LSG
Sbjct: 322 NRAVDCWSLGVILFICLSG 340

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 23/219 (10%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVH--KGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW--- 128
           K   + F     LGEG F  V   +     +          A+K L+   +    +    
Sbjct: 26  KKRPEDFKFGKILGEGSFSTVVLARELATSRE--------YAIKILEKRHIIKENKVPYV 77

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
             E   + +L HP  VKL  +  +++ +L     Y   G L   + +  S      TR  
Sbjct: 78  TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFY 135

Query: 188 IA-LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
            A + +A  L +LH   K +I+RD K  NILL+ D   +++DFG AK          +  
Sbjct: 136 TAEIVSA--LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191

Query: 247 VMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
            +GT  Y +PE +         SD+++ G ++ +L++G 
Sbjct: 192 FVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 68/229 (29%), Positives = 95/229 (41%), Gaps = 43/229 (18%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHR 126
            +T   FS    +G GGFG V           K+         A+K LD   ++  QG  
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKAD--TGKM--------YAMKCLDKKRIKMKQGET 234

Query: 127 EWLTEVIFLGQL---RHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPW 182
             L E I L  +     P +V +  Y      +L  + + M  G L   L +    S   
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA- 292

Query: 183 STRMK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
              M+     I LG    L  +H   + V+YRD K +NILLD     ++SD GLA D  +
Sbjct: 293 --DMRFYAAEIILG----LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 238 GDDTHVSTRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGR 284
               H    V GT GY APE +     +  S +D +S G +L +LL G 
Sbjct: 345 -KKPH--ASV-GTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGH 388

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
            + F     LGEG +G+V+K     K   G   Q VA+K + +E     +E + E+  + 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAI--HK-ETG---QIVAIKQVPVE--SDLQEIIKEISIMQ 79

Query: 137 QLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           Q   PH+VK  G   +     +V EY   GS+ + + R  + +L       I     KGL
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGL 138

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGY 253
            +LH      I+RD KA NILL+++  AKL+DFG+A     G  T    +   V+GT  +
Sbjct: 139 EYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFW 191

Query: 254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            APE +       ++D++S G+  +E+  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 40/275 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLGQLRHPH 142
           LG+G FG V      DK+      Q  AVK +    ++   +    L EV  L QL HP+
Sbjct: 34  LGKGSFGEVILCK--DKI----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALGAAKGLAFLHD 201
           ++KL  +  ++ +  LV E    G L +++  R   S +  +  ++  L     + ++H 
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG---ITYMH- 143

Query: 202 AEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
            +  +++RD K  N+LL+S   D   ++ DFGL+      + +      +GT  Y APE 
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE- 198

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM-- 316
           V+ G      DV+S GV+L  LLSG        P              N+   L ++   
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGC------PPF-------NGA---NEYDILKKVEKG 242

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
               E    +  +  A  L  + L++ P  R +  
Sbjct: 243 KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR 277

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 92.6 bits (231), Expect = 4e-21
 Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 27/221 (12%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW--LTE 131
           K     F     LG+G FG V   F+  K+      Q  A+K L    L+         E
Sbjct: 20  KADPSQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76

Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK--- 187
              L ++ HP +VKL  Y  + E +L L+ +++  G L  +L +    +      +K   
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYL 132

Query: 188 --IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
             +AL     L  LH     +IYRD K  NILLD +   KL+DFGL+K+  + +      
Sbjct: 133 AELALA----LDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---A 183

Query: 246 RVM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
               GT  Y APE V   GH T  +D +SFGV++ E+L+G 
Sbjct: 184 YSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 78/277 (28%), Positives = 112/277 (40%), Gaps = 34/277 (12%)

Query: 18  QEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTT 77
           +E E+     + V      Q  + +D  + S +  S    + ++ +        + +VT 
Sbjct: 94  EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK------PKHRVTM 147

Query: 78  QSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
             F     LG+G FG V     K     +          A+K L  E +    E    LT
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA--TGRY--------YAMKILKKEVIVAKDEVAHTLT 197

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI- 188
           E   L   RHP L  L  Y  +   RL  V EY   G L   L R    S     R +  
Sbjct: 198 ENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFY 253

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
                  L +LH +EK V+YRD K  N++LD D   K++DFGL K+G +   T    +  
Sbjct: 254 GAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTF 309

Query: 249 -GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
            GT  Y APE +         D +  GVV+ E++ GR
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.3 bits (227), Expect = 7e-21
 Identities = 43/299 (14%), Positives = 85/299 (28%), Gaps = 56/299 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
            G        +   D  L      + VA+  +D +G+      +E L+  + L ++  P 
Sbjct: 39  HGGVPPLQFWQAL-DTALD-----RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           + +++         L+V E++  GSL+                ++     A      H A
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA 148

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
              V       S + +  D    L+                                   
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA----- 179

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
                 D+   G  L  LL  R       P  E  +     P   D    G+ ++P    
Sbjct: 180 --NPQDDIRGIGASLYALLVNR------WPLPEAGVRSGLAPAERDTA--GQPIEPA--- 226

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFVFTVPTESS 381
                   + +A+A + +      R   ST++  ++      D   +   +   P  ++
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSAA 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 92.2 bits (230), Expect = 7e-21
 Identities = 67/235 (28%), Positives = 100/235 (42%), Gaps = 29/235 (12%)

Query: 62  GSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG 121
           GS+         K+  + F     LG+GG+G V   F   K+      +  A+K L    
Sbjct: 1   GSSETSVNRGPEKIRPECFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAM 57

Query: 122 L---QGHREW-LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRY 176
           +            E   L +++HP +V LI Y  +   +L L+ EY+  G L  QL R  
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREG 116

Query: 177 SVSLPWSTRMK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL 231
                           I++     L  LH  +K +IYRD K  NI+L+     KL+DFGL
Sbjct: 117 IFMED---TACFYLAEISMA----LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167

Query: 232 AKDGPEGDDTHVSTRVM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
            K+          T    GT  Y APE +M +GH     D +S G ++ ++L+G 
Sbjct: 168 CKESIHDGTV---THTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.0 bits (234), Expect = 7e-21
 Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 39/274 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG G +G V      DK+         A+K +    +    + + L EV  L  L HP++
Sbjct: 45  LGSGAYGEVLLCR--DKV----THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALGAAKGLAFLHDA 202
           +KL  +  ++ +  LV E    G L +++  R   + +  +  +K  L     + +LH  
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG---VTYLH-- 153

Query: 203 EKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           +  +++RD K  N+LL+S   D   K+ DFGL+      ++       +GT  Y APE V
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPE-V 209

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM--D 317
           +        DV+S GV+L  LL+G                   +    D   L ++    
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPF-------------GGQ---TDQEILRKVEKGK 253

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
              +    +  +  A  L  Q L    ++R +  
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.7 bits (226), Expect = 9e-21
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 28/209 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E +  E+     L H ++V
Sbjct: 15  LGEGAYGEVQLA------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK-------GLA 197
           K  G+  E   + L  EY   G    +LF            M     A +       G+ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGG----ELFD-RIEP---DIGMPEPD-AQRFFHQLMAGVV 119

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           +LH     + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE
Sbjct: 120 YLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 258 YVMTGHL--TSMSDVYSFGVVLLELLSGR 284
            ++          DV+S G+VL  +L+G 
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-TEVIFLGQLRHPHLV 144
           LG G FG VH     ++           +K ++ +  Q   E +  E+  L  L HP+++
Sbjct: 30  LGSGAFGDVHLVE--ERS----SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAKGLAFL 199
           K+     +  +  +V E    G L  ++    +     S       MK  + A   LA+ 
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYF 140

Query: 200 HDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           H   + V+++D K  NIL          K+ DFGLA+          ST   GT  Y AP
Sbjct: 141 H--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAP 195

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E V    +T   D++S GVV+  LL+G
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 69/226 (30%), Positives = 92/226 (40%), Gaps = 39/226 (17%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW- 128
           KVT   F     LG+G FG V     K     +          A+K L  E +    E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKA--TGRY--------YAMKILRKEVIIAKDEVA 50

Query: 129 --LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
             +TE   L   RHP L  L  Y  +   RL  V EY   G L   L R    +     R
Sbjct: 51  HTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---R 106

Query: 186 MK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD 240
            +     I       L +LH   + V+YRD K  N++LD D   K++DFGL K+G     
Sbjct: 107 ARFYGAEIVSA----LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 241 THVSTRVM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           T    +   GT  Y APE +    +     D +  GVV+ E++ GR
Sbjct: 161 T---MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 26/215 (12%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVI 133
            + FS    +G G FGAV+    D +       + VA+K +   G Q + +W   + EV 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFA-RDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVR 106

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
           FL +LRHP+ ++  G    E    LV EY   GS  + L   +   L       +  GA 
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA-SDLLEVHKKPLQEVEIAAVTHGAL 164

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR--VMGTQ 251
           +GLA+LH     +I+RD KA NILL      KL DFG A        + ++     +GT 
Sbjct: 165 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTP 214

Query: 252 GYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSG 283
            + APE ++    G      DV+S G+  +EL   
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 66/231 (28%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNL---------DLE 120
           K+  + F     LG+G FG V     K    ++          A+K L         D+E
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKK--TNQF--------FAIKALKKDVVLMDDDVE 62

Query: 121 GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVS 179
                +      +      HP L  +     + +  L  V EY+  G L   +   +   
Sbjct: 63  CTMVEKR-----VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD 116

Query: 180 LPWSTRMK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 234
           L    R       I LG    L FLH   K ++YRD K  NILLD D   K++DFG+ K+
Sbjct: 117 LS---RATFYAAEIILG----LQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167

Query: 235 GPEGDDTHVSTRVM-GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
              GD     T    GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 168 NMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 62/285 (21%), Positives = 105/285 (36%), Gaps = 50/285 (17%)

Query: 86  LGEGGFGAVHKGF------------ID-DKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV 132
           LG G +G V                I   +   G  +          E +        E+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY------NEI 97

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALG 191
             L  L HP+++KL     ++++  LV E+   G L  Q+  R+       +  MK  L 
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
               + +LH  +  +++RD K  NILL++       K+ DFGL+         +     +
Sbjct: 158 G---ICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRL 209

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
           GT  Y APE V+        DV+S GV++  LL G        P          +   ND
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG------YPPF-------GGQ---ND 252

Query: 309 ARKLGRIM--DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
              + ++       +    +  + +A  L    L++   +R T  
Sbjct: 253 QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 46/231 (19%)

Query: 86  LGEGGFGAVHKGF-----------IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT---- 130
           +G+G +G V   +           +  K +   QA                         
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 131 -----EVIFLGQLRHPHLVKL--IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 183
                E+  L +L HP++VKL  +     E+H  +V+E + +G     +       +P  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG----PVM-----EVPTL 131

Query: 184 TRMKIALGAAK-------GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
             +     A         G+ +LH   + +I+RD K SN+L+  D   K++DFG++ +  
Sbjct: 132 KPLSEDQ-ARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-F 187

Query: 237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLT---SMSDVYSFGVVLLELLSGR 284
           +G D  +S  V GT  + APE +            DV++ GV L   + G+
Sbjct: 188 KGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 28/212 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQLRH 140
           +G+G F  V +    ++       Q  AVK +D+                E      L+H
Sbjct: 32  IGKGPFSVVRRCI--NRE----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAKG 195
           PH+V+L+     +    +V+E+M    L  ++ +R      +S       M+  L A   
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA--- 142

Query: 196 LAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           L + H  +  +I+RD K   +LL S       KL  FG+A    E        RV GT  
Sbjct: 143 LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV-GTPH 198

Query: 253 YAAPEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
           + APE V+         DV+  GV+L  LLSG
Sbjct: 199 FMAPE-VVKREPYGKPVDVWGCGVILFILLSG 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 30/210 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT-EVIFLGQLRHPHLV 144
           LGEG +G V            +  + VAVK +D++      E +  E+     L H ++V
Sbjct: 15  LGEGAYGEVQLA------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK-------GLA 197
           K  G+  E   + L  EY   G    +LF            M     A +       G+ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGG----ELFD-RIEP---DIGMPEPD-AQRFFHQLMAGVV 119

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGDDTHVSTRVMGTQGYAAP 256
           +LH     + +RD K  N+LLD     K+SDFGL         +  ++    GT  Y AP
Sbjct: 120 YLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176

Query: 257 EYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
           E ++          DV+S G+VL  +L+G 
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.5 bits (225), Expect = 1e-19
 Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 39/274 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G FG V K    D++      Q  AVK ++    +       L EV  L +L HP++
Sbjct: 30  LGKGSFGEVLKCK--DRI----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAKGLAFLHDA 202
           +KL     +     +V E    G L +++ +R   S   + R +K        + ++H  
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMH-- 138

Query: 203 EKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV 259
           +  +++RD K  NILL+S   D   K+ DFGL+               +GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPE-V 194

Query: 260 MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM--D 317
           + G      DV+S GV+L  LLSG      + P        + +   N+   L R+    
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG------TPPF-------YGK---NEYDILKRVETGK 238

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
              +     T +  A  L  + L+  P  R T +
Sbjct: 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
             E+  +  L HP LV L  Y  ++E  + +V + +  G L   L +        + ++ 
Sbjct: 63  FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLF 120

Query: 188 IA-LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           I  L  A  L +L    + +I+RD K  NILLD      ++DF +A   P        T 
Sbjct: 121 ICELVMA--LDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TT 173

Query: 247 VMGTQGYAAPEYVM----TGHLTSMSDVYSFGVVLLELLSGR 284
           + GT+ Y APE        G+ +   D +S GV   ELL GR
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 27/206 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V       K          A K +    ++    +  E+  +  L HP++++
Sbjct: 17  IGRGSWGEVKIA--VQKG----TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAKGLAFLH 200
           L     +     LV E    G    +LF R      +        MK  L A   +A+ H
Sbjct: 71  LYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSA---VAYCH 123

Query: 201 DAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
                V +RD K  N L  +   D   KL DFGLA          +    +GT  Y +P+
Sbjct: 124 K--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQ 178

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSG 283
            V+ G      D +S GV++  LL G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 40/215 (18%)

Query: 86  LGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTE-VIFLGQ 137
           +G+G FG V    HK   ++           AVK L  + +   +E    ++E  + L  
Sbjct: 46  IGKGSFGKVLLARHKA--EEVF--------YAVKVLQKKAILKKKEEKHIMSERNVLLKN 95

Query: 138 LRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK-----IALG 191
           ++HP LV L  +  +   +L  V +Y+  G L   L R      P   R +     IA  
Sbjct: 96  VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA 151

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM-GT 250
               L +LH     ++YRD K  NILLDS     L+DFGL K+  E + T   T    GT
Sbjct: 152 ----LGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGT 202

Query: 251 QGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
             Y APE +    +     D +  G VL E+L G 
Sbjct: 203 PEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 29/213 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLV 144
           +G G +G V+KG    K       Q  A+K +D+ G     E   E+  L +   H ++ 
Sbjct: 32  VGNGTYGQVYKG-RHVKTG-----QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 145 KLIG-----YCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
              G          + +L LV E+   GS+ + +      +L       I     +GL+ 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR---VMGTQGYAA 255
           LH  +  VI+RD K  N+LL  +   KL DFG++             R    +GT  + A
Sbjct: 145 LH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPYWMA 197

Query: 256 PEYVMTGHLT-----SMSDVYSFGVVLLELLSG 283
           PE +             SD++S G+  +E+  G
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 66/232 (28%), Positives = 98/232 (42%), Gaps = 50/232 (21%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNL---------DLE 120
           ++    F+    LG+G FG V     KG   D+L         AVK L         D+E
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKG--TDEL--------YAVKILKKDVVIQDDDVE 65

Query: 121 GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVS 179
                +      +     + P L +L   C +   RL  V EY+  G L   + +     
Sbjct: 66  CTMVEKR-----VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 119

Query: 180 LPWSTRMK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 234
            P           IA+G    L FL    K +IYRD K  N++LDS+   K++DFG+ K+
Sbjct: 120 EP---HAVFYAAEIAIG----LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170

Query: 235 GPEGDDTHVSTRVM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
                 T   T+   GT  Y APE +    +     D ++FGV+L E+L+G+
Sbjct: 171 NIWDGVT---TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 65/232 (28%), Positives = 91/232 (39%), Gaps = 50/232 (21%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNL---------DLE 120
           ++   +F     LG+G FG V     K      L         AVK L         D+E
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKE--TGDL--------YAVKVLKKDVILQDDDVE 68

Query: 121 GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVS 179
                +      I      HP L +L   C +   RL  V E++  G L   + +     
Sbjct: 69  CTMTEKR-----ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122

Query: 180 LPWSTRMK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 234
                R +     I       L FLH  +K +IYRD K  N+LLD +   KL+DFG+ K+
Sbjct: 123 EA---RARFYAAEIISA----LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173

Query: 235 GPEGDDTHVSTRVM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
           G     T   T    GT  Y APE +    +     D ++ GV+L E+L G 
Sbjct: 174 GICNGVT---TATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 21/203 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G F  V       +L      +  A+K +             E+  L +++H ++V 
Sbjct: 17  LGSGAFSEVFLVK--QRL----TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           L        H  LV + +  G L +++  R  Y+     S  ++  L A   + +LH+  
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA-SLVIQQVLSA---VKYLHE-- 124

Query: 204 KPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM 260
             +++RD K  N+L  +   +    ++DFGL+K    G    + +   GT GY APE + 
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLA 180

Query: 261 TGHLTSMSDVYSFGVVLLELLSG 283
               +   D +S GV+   LL G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 61/250 (24%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQLRH 140
           +G+G +G V      +           A+K ++   ++           TEV  + +L H
Sbjct: 34  IGQGSYGVVRVAI--ENQT----RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG--------- 191
           P++ +L     +E++  LV E    G L ++L      S        +            
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 192 ----------------------AAK-------GLAFLHDAEKPVIYRDFKASNILLDSDY 222
                                  +         L +LH   + + +RD K  N L  ++ 
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNK 205

Query: 223 TA--KLSDFGLAK---DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS---DVYSFG 274
           +   KL DFGL+K       G+   ++T+  GT  + APE V+     S     D +S G
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNESYGPKCDAWSAG 263

Query: 275 VVLLELLSGR 284
           V+L  LL G 
Sbjct: 264 VLLHLLLMGA 273

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 46/230 (20%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNL---------DLE 120
            +  Q F     +G G +  V     K    D++         A+K +         D++
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLLVRLKK--TDRI--------YAMKVVKKELVNDDEDID 54

Query: 121 GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVS 179
            +Q  +      +F     HP LV L   C + E RL  V EY+  G L   + R+  + 
Sbjct: 55  WVQTEKH-----VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 108

Query: 180 LPWSTRM---KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 236
                R    +I+L     L +LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G 
Sbjct: 109 EEH-ARFYSAEISLA----LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161

Query: 237 EGDDTHVSTRVM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
              DT   T    GT  Y APE +    +     D ++ GV++ E+++GR
Sbjct: 162 RPGDT---TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLV 144
           LGEG    V      + +     +Q  AVK ++ +          EV  L Q + H +++
Sbjct: 21  LGEGAHARVQTCI--NLI----TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS-LPWSTRMKIALGAAKGLAFLHDAE 203
           +LI +  EE+   LV+E M  GS+ + + +R   + L  S  ++    A   L FLH+  
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA---LDFLHN-- 129

Query: 204 KPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDD-THVSTRVM----GTQGYAA 255
           K + +RD K  NIL    +     K+ DF L        D + +ST  +    G+  Y A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 256 PEYVMTGHLTSMS------DVYSFGVVLLELLSG 283
           PE V+       S      D++S GV+L  LLSG
Sbjct: 190 PE-VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 33/216 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK--------NLDLEGLQGHREWL-TEVIFLG 136
           LG G    V +     K       +  AVK        +   E +Q  RE    EV  L 
Sbjct: 25  LGRGVSSVVRRCI--HKP----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 137 QL-RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAK 194
           ++  HP++++L           LV++ M +G L + L  + ++S   + + M+  L    
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV-- 136

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
            +  LH     +++RD K  NILLD D   KL+DFG +     G+         GT  Y 
Sbjct: 137 -ICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVC-GTPSYL 190

Query: 255 APEYVMTGHLTSMS-------DVYSFGVVLLELLSG 283
           APE ++   +           D++S GV++  LL+G
Sbjct: 191 APE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE--WLTEVIFLGQLRHPHL 143
           LG+G FG V K    D++      Q  AVK ++    +       L EV  L +L HP++
Sbjct: 30  LGKGSFGEVLKCK--DRI----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAKGLAF 198
           +KL     +     +V E    G    +LF        +S       +K        + +
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSG---ITY 136

Query: 199 LHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           +H     +++RD K  NILL+S   D   K+ DFGL+               +GT  Y A
Sbjct: 137 MHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIA 191

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           PE V+ G      DV+S GV+L  LLSG
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.3 bits (212), Expect = 8e-19
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL---TEVIFLGQLRHPH 142
           LG G FG V  G         L    VAVK L+ + ++          E+  L   RHPH
Sbjct: 19  LGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GL 196
           ++KL           +V EY+  G L + + +          R++              +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEMEARRLFQQILSAV 124

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            + H     V++RD K  N+LLD+   AK++DFGL+    +G+    S    G+  YAAP
Sbjct: 125 DYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 179

Query: 257 EYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
           E V++G L      D++S GV+L  LL G 
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 29/225 (12%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW----L 129
           KV  ++F     LG G +G V   F+  K+      +  A+K L    +    +      
Sbjct: 50  KVGIENFELLKVLGTGAYGKV---FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106

Query: 130 TE-VIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
           TE  +     + P LV L  Y  + E +L L+ +Y+  G L   L +R   +      ++
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQ 162

Query: 188 -----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
                I L     L  LH  +  +IYRD K  NILLDS+    L+DFGL+K+    +   
Sbjct: 163 IYVGEIVLA----LEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 243 VSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGR 284
                 GT  Y AP+ V    +GH     D +S GV++ ELL+G 
Sbjct: 217 AYDFC-GTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 85.7 bits (213), Expect = 9e-19
 Identities = 62/210 (29%), Positives = 87/210 (41%), Gaps = 27/210 (12%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQL 138
             +GEG +G V K       R     Q VA+K                  L E+  L QL
Sbjct: 9   GKIGEGSYGVVFKC------RNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           +HP+LV L+     +    LV+EY    ++ ++L  RY   +P      I     + + F
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTH-VSTRVMGTQGYAA 255
            H      I+RD K  NIL+      KL DFG A+   GP       V+TR      Y +
Sbjct: 118 CHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRS 170

Query: 256 PEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
           PE ++         DV++ G V  ELLSG 
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 22/160 (13%)

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMK---- 187
           +F     HP LV L   C + E RL  V EY+  G L   + R+  +        +    
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSA 160

Query: 188 -IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
            I+L     L +LH  E+ +IYRD K  N+LLDS+   KL+D+G+ K+G    DT   T 
Sbjct: 161 EISLA----LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TS 211

Query: 247 VM-GTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
              GT  Y APE +    +     D ++ GV++ E+++GR
Sbjct: 212 TFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 56/256 (21%), Positives = 95/256 (37%), Gaps = 36/256 (14%)

Query: 48  SSTTLSEDLSIS--LAGSNLHVFTLAELKVTTQSFSSSNFLGEGGFGAV----HKGFIDD 101
            ++ L++D  ++  L  +   V  L E+++    F     +G G F  V     K     
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---- 84

Query: 102 KLRPGLQAQPVAVKNLDLEGLQGHRE---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRL- 157
                   Q  A+K ++   +    E   +  E   L       + +L  +  ++E+ L 
Sbjct: 85  ------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLY 137

Query: 158 LVYEYMPRGSLENQLFRRYSVSLPWS-TRMKIA-LGAAKGLAFLHDAEKPVIYRDFKASN 215
           LV EY   G L   L  ++   +P    R  +A +  A  +  +H      ++RD K  N
Sbjct: 138 LVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMA--IDSVH--RLGYVHRDIKPDN 192

Query: 216 ILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVY---- 271
           ILLD     +L+DFG                V GT  Y +PE +        +  Y    
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPEC 251

Query: 272 ---SFGVVLLELLSGR 284
              + GV   E+  G+
Sbjct: 252 DWWALGVFAYEMFYGQ 267

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.4 bits (216), Expect = 2e-18
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 42/228 (18%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNL---------DLE 120
           ++    F+    LG+G FG V     KG   D+L         AVK L         D+E
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG--TDEL--------YAVKILKKDVVIQDDDVE 386

Query: 121 GLQGHREWLTEVIFLGQLRHPHLVKLIGYCC--EEEHRLLVYEYMPRGSLENQLFRRYSV 178
                +      +     + P L +L  + C    +    V EY+  G L   + +    
Sbjct: 387 CTMVEKR-----VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439

Query: 179 SLPWSTRMKI-ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
             P        A   A GL FL    K +IYRD K  N++LDS+   K++DFG+ K+   
Sbjct: 440 KEP---HAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494

Query: 238 GDDTHVSTRVM-GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
              T   T+   GT  Y APE +         D ++FGV+L E+L+G+
Sbjct: 495 DGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 42/288 (14%)

Query: 18  QEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAELKVTT 77
           +E+ +A           S   ++     N +    +E+L     G    +   A  K   
Sbjct: 34  REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93

Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL-------- 129
           Q +   + +G G    V +     +          AVK +++   +   E L        
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCV--HRA----TGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 130 TEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YS----VSLPW 182
            E   L Q+  HPH++ LI          LV++ M +G L + L  +   S     S+  
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-- 205

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
              M+  L A   ++FLH     +++RD K  NILLD +   +LSDFG +          
Sbjct: 206 ---MRSLLEA---VSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255

Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMS-------DVYSFGVVLLELLSG 283
           +     GT GY APE ++   +           D+++ GV+L  LL+G
Sbjct: 256 LRELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 86  LGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEGLQGHRE--WLTEVIFLGQLRHPH 142
           +G+G F  V       KL R  L  + VA+K +D   L          EV  +  L HP+
Sbjct: 23  IGKGNFAKV-------KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GL 196
           +VKL      E+   L+ EY   G    ++F  Y V+     RMK     +K       +
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGG----EVFD-YLVA---HGRMKEKEARSKFRQIVSAV 127

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            + H  +K +++RD KA N+LLD+D   K++DFG + +        +     G   YAAP
Sbjct: 128 QYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAP 182

Query: 257 EYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
           E +  G        DV+S GV+L  L+SG 
Sbjct: 183 E-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 42/219 (19%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW--------LTEVIFLGQ 137
           LG G  G V   F  ++       + VA+K +                    TE+  L +
Sbjct: 18  LGSGACGEVKLAF--ERKT----CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFR-RYSVSLPWSTRMKIALG 191
           L HP ++K+  +  + E   +V E M  G L      N+  +                L 
Sbjct: 72  LNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL 125

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A   + +LH+    +I+RD K  N+LL S   D   K++DFG +K    G+ + + T   
Sbjct: 126 A---VQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLC- 177

Query: 249 GTQGYAAPEYVMTGHL----TSMSDVYSFGVVLLELLSG 283
           GT  Y APE V+            D +S GV+L   LSG
Sbjct: 178 GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 43/219 (19%)

Query: 86  LGEGGFG----AVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--------EVI 133
           LG G FG    AV K           + + V VK +  E +                E+ 
Sbjct: 32  LGSGAFGFVWTAVDK----------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            L ++ H +++K++     +    LV E    G     LF  +    P   R+   L + 
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFA-FIDRHP---RLDEPLASY 134

Query: 194 K------GLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
                   + +L    K +I+RD K  NI++  D+T KL DFG A     G   +     
Sbjct: 135 IFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-- 190

Query: 248 MGTQGYAAPEYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
            GT  Y APE V+ G+       +++S GV L  L+   
Sbjct: 191 -GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 28/219 (12%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
                 F     LG G FG V        ++        A+K LD + +   ++    L 
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVML------VKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRM--- 186
           E   L  +  P LVKL  +  ++   L +V EY+  G + + L R    S P   R    
Sbjct: 91  EKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAA 148

Query: 187 KIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 246
           +I L       +LH     +IYRD K  N+L+D     +++DFG AK       T     
Sbjct: 149 QIVLT----FEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 197

Query: 247 VMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
           + GT    APE +++ G+     D ++ GV++ E+ +G 
Sbjct: 198 LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGY 235

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 31/226 (13%)

Query: 72  ELKVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE 127
           +L++  + +     +G G FG V    HK     K+         A+K L    +    +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS--TRKV--------YAMKLLSKFEMIKRSD 112

Query: 128 ---WLTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWS 183
              +  E   +     P +V+L  Y  +++  L +V EYMP G L N +   Y V   W+
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWA 170

Query: 184 TRMKIA-LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
            R   A +  A  L  +H      I+RD K  N+LLD     KL+DFG      +     
Sbjct: 171 -RFYTAEVVLA--LDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 243 VSTRVMGTQGYAAPEYVMT----GHLTSMSDVYSFGVVLLELLSGR 284
             T V GT  Y +PE + +    G+     D +S GV L E+L G 
Sbjct: 226 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.0 bits (206), Expect = 9e-18
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQLRH 140
           +GEG +G V K       R     + VA+K           +      + E+  L QLRH
Sbjct: 33  VGEGSYGMVMKC------RNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRH 83

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
            +LV L+  C +++   LV+E++   ++       +   L +    K       G+ F H
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TIL-DDLELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTH-VSTRVMGTQGYAAPE 257
                +I+RD K  NIL+      KL DFG A+    P       V+TR      Y APE
Sbjct: 142 S--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE 194

Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGR 284
            ++       + DV++ G ++ E+  G 
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.9 bits (210), Expect = 9e-18
 Identities = 59/284 (20%), Positives = 98/284 (34%), Gaps = 29/284 (10%)

Query: 14  CFSIQEEEKACKPKKAVKKQSSIQRISFVDLSNPSSTTLSEDLSISLAGSNLHVFTLAEL 73
             +   + K C+P   V      ++       +     +    ++S    N       + 
Sbjct: 84  AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143

Query: 74  KVTTQSFSSSNF---------LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG 124
                     +          LG G FG VH+    ++          A K +       
Sbjct: 144 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV--TERA----TGNNFAAKFVMTPHESD 197

Query: 125 HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWST 184
                 E+  +  LRHP LV L     ++   +++YE+M  G    +LF + +      +
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMS 253

Query: 185 RMKIALGA---AKGLAFLHDAEKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGD 239
             +         KGL  +H  E   ++ D K  NI+  +      KL DFGL        
Sbjct: 254 EDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311

Query: 240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
              V     GT  +AAPE      +   +D++S GV+   LLSG
Sbjct: 312 SVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.0 bits (206), Expect = 9e-18
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 42/226 (18%)

Query: 74  KVTTQSFSSSNFLGEGGFGAV----HKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW- 128
           K + Q F     LG G FG V     +   + +          A+K L  E +   ++  
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRH--NGRY--------YAMKVLKKEIVVRLKQVE 51

Query: 129 --LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTR 185
               E + L  + HP ++++     ++  ++ ++ +Y+  G L + L +      P    
Sbjct: 52  HTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---V 107

Query: 186 MK-----IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD 240
            K     + L     L +LH   K +IYRD K  NILLD +   K++DFG AK      D
Sbjct: 108 AKFYAAEVCLA----LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPD 158

Query: 241 THVSTRVM-GTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
               T  + GT  Y APE V T  +  S+ D +SFG+++ E+L+G 
Sbjct: 159 V---TYTLCGTPDYIAPEVVSTKPYNKSI-DWWSFGILIYEMLAGY 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 82.6 bits (205), Expect = 9e-18
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-----REWLTEVIFLGQL 138
             LG G +  V+KG              VA+K + L+  +G      RE    +  + +L
Sbjct: 11  EKLGNGTYATVYKG------LNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKEL 60

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           +H ++V+L      E    LV+E+M    +  ++++        L  +          +G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGDDTHVSTRVMGTQGY 253
           LAF H+    +++RD K  N+L++     KL DFGLA     P    +     V+ T  Y
Sbjct: 121 LAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWY 174

Query: 254 AAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
            AP+ V+ G    ++  D++S G +L E+++G+
Sbjct: 175 RAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 26/215 (12%)

Query: 78  QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-----REWLTEV 132
           +++   + LGEG +  V+KG      +  L    VA+K + LE  +G      RE    V
Sbjct: 2   ETYIKLDKLGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIRE----V 51

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
             L  L+H ++V L      E+   LV+EY+ +  L+ Q        +            
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLK-QYLDDCGNIINMHNVKLFLFQL 109

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGDDTHVSTRVMGT 250
            +GLA+ H   + V++RD K  N+L++     KL+DFGLA  K  P     +    V+ T
Sbjct: 110 LRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-T 163

Query: 251 QGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
             Y  P+ ++     S   D++  G +  E+ +GR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT---EVIFLGQLRHPH 142
           LG G FG V  G      +  L    VAVK L+ + ++          E+  L   RHPH
Sbjct: 24  LGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GL 196
           ++KL           +V EY+  G L + + +          R+              G+
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--------GRLDEKESRRLFQQILSGV 129

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            + H     V++RD K  N+LLD+   AK++DFGL+    +G+    S    G+  YAAP
Sbjct: 130 DYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 184

Query: 257 EYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
           E V++G L      D++S GV+L  LL G 
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 52/231 (22%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
             S++ +  +G G FG V++     KL      + VA+K +    LQ  R    E+  + 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQA----KLCDS--GELVAIKKV----LQDKRFKNRELQIMR 102

Query: 137 QLRHPHLVKLIGYCCEEEHRL------LVYEYMPRGSLEN--QLFRRYSVSLPWSTRMKI 188
           +L H ++V+L  +      +       LV +Y+P    E   ++ R YS       R K 
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYS-------RAKQ 151

Query: 189 ALGAA----------KGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPE 237
            L             + LA++H     + +RD K  N+LLD D    KL DFG AK    
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209

Query: 238 GDD-TH-VSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
           G+     + +R      Y APE ++ G    TS  DV+S G VL ELL G+
Sbjct: 210 GEPNVSYICSRY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 71/290 (24%), Positives = 111/290 (38%), Gaps = 58/290 (20%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLV 144
           LGEG F    K     K       Q  AVK +        ++   E+  L     HP++V
Sbjct: 19  LGEGSFSICRKCV--HKK----SNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIV 69

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAKGLAFL 199
           KL     ++ H  LV E +  G    +LF R      +S       M+  + A   ++ +
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVSA---VSHM 122

Query: 200 HDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           HD    V++RD K  N+L    + +   K+ DFG A+  P  +   + T    T  YAAP
Sbjct: 123 HD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAP 178

Query: 257 EYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           E ++  +    S D++S GV+L  +LSG+       P         +            I
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCTSAVEI 224

Query: 316 MDPRLEGQY----------SETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           M    +G +          S+     A  L    L+  P +R  MS +  
Sbjct: 225 MKKIKKGDFSFEGEAWKNVSQE----AKDLIQGLLTVDPNKRLKMSGLRY 270

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+    +K       +    K ++            E+  + QL HP L+ 
Sbjct: 59  LGSGAFGVVHRCV--EKA----TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 146 LIGYCCEEEHRLLVYEYMPRGSL-------ENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           L     ++   +L+ E++  G L       + ++     ++      M+ A     GL  
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKH 164

Query: 199 LHDAEKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           +H  E  +++ D K  NI+ ++    + K+ DFGLA    + +   +      T  +AAP
Sbjct: 165 MH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAP 219

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E V    +   +D+++ GV+   LLSG
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 25/209 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW------LTEVIFLGQLR 139
           LG G F  V K     K   G +    A K +    L   R          EV  L ++R
Sbjct: 13  LGSGQFAIVRKCR--QK-GTGKE---YAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAKGLAF 198
           HP+++ L      +   +L+ E +  G L + L  + S++   +T+ +K  L    G+ +
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHY 123

Query: 199 LHDAEKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           LH   K + + D K  NI+L      +   KL DFG+A     G++      + GT  + 
Sbjct: 124 LH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFV 178

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE V    L   +D++S GV+   LLSG
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           + S +  LG G FG VHK   ++          +A K +   G++   E   E+  + QL
Sbjct: 90  TVSKTEILGGGRFGQVHKC--EETA----TGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSL------ENQLFR-RYSVSLPWSTRMKIALG 191
            H +L++L      +   +LV EY+  G L      E+       ++       MK    
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE 198

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMG 249
              G+  +H  +  +++ D K  NIL  +      K+ DFGLA+     +   V     G
Sbjct: 199 ---GIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFG 250

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           T  + APE V    ++  +D++S GV+   LLSG
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQL 138
           +FLGEG F  V+K       R     Q VA+K + L      ++      L E+  L +L
Sbjct: 16  DFLGEGQFATVYKA------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
            HP+++ L+     + +  LV+++M    LE  + +  S+ L  S      L   +GL +
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEY 127

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGDDTHVSTRVMGTQGYAAP 256
           LH     +++RD K +N+LLD +   KL+DFGLAK    P    TH   +V+ T+ Y AP
Sbjct: 128 LHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRAP 181

Query: 257 EYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
           E +    +  +  D+++ G +L ELL   
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 30/209 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G F  V +     K          A K ++ + L     ++   E     +L+HP++
Sbjct: 14  LGKGAFSVVRRCV--HKT----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YS----VSLPWSTRMKIALGAAKGLA 197
           V+L     EE    LV++ +  G L   +  R  YS            ++  L +   +A
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IA 119

Query: 198 FLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           + H     +++R+ K  N+LL S       KL+DFGLA +  + +  H      GT GY 
Sbjct: 120 YCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFA-GTPGYL 174

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           +PE +     +   D+++ GV+L  LL G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.0 bits (201), Expect = 3e-17
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL----EGLQGHREWLTEVIFLGQLR 139
             +GEG +G V K       +     + VA+K + L    EG+      L E+  L +L+
Sbjct: 8   EKIGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELK 59

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           H ++V+L      ++   LV+E+  +  L+ + F   +  L             KGL F 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 200 HDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPE 257
           H   + V++RD K  N+L++ +   KL++FGLA+    P    +     V+ T  Y  P+
Sbjct: 118 HS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPD 171

Query: 258 YVMTGHLTSMS-DVYSFGVVLLELLSGRK 285
            +    L S S D++S G +  EL +  +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 33/209 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +    +     K          AVK +D        E     I L   +HP+++ 
Sbjct: 30  IGVGSYSVCKRCI--HKA----TNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIIT 80

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YS----VSLPWSTRMKIALGAAKGLAFL 199
           L     + ++  +V E M  G L +++ R+  +S     ++     +         + +L
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKT---VEYL 132

Query: 200 HDAEKPVIYRDFKASNILLDSD----YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           H   + V++RD K SNIL   +     + ++ DFG AK     ++  + T    T  + A
Sbjct: 133 HA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPC-YTANFVA 188

Query: 256 PEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
           PE V+       + D++S GV+L  +L+G
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTG 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 50/233 (21%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLG 136
              F      G+G FG V  G    K +       VA+K +  +    +RE L  +  L 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLG----KEKST--GMSVAIKKVIQDPRFRNRE-LQIMQDLA 74

Query: 137 QLRHPHLVKLI------GYCCEEEHRL-LVYEYMP-------------RGSLENQLFRRY 176
            L HP++V+L       G     +  L +V EY+P             + +    L + +
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 177 SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDG 235
              L             + +  LH     V +RD K  N+L++ +D T KL DFG AK  
Sbjct: 135 LFQL------------IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 236 PEGDD-TH-VSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
              +     + +R      Y APE ++ G  H T+  D++S G +  E++ G 
Sbjct: 183 SPSEPNVAYICSRY-----YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 26/225 (11%)

Query: 72  ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---W 128
           ++++  + F     +G G FG V        ++     +  A+K L+   +    E   +
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAV------VKLKNADKVFAMKILNKWEMLKRAETACF 121

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWS-TRM 186
             E   L       +  L  Y  ++++ L LV +Y   G L   L  ++   LP    R 
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARF 179

Query: 187 KIA-LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVST 245
            +A +  A  +  +H  +   ++RD K  NIL+D +   +L+DFG      E      S 
Sbjct: 180 YLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 246 RVMGTQGYAAPEYVMT------GHLTSMSDVYSFGVVLLELLSGR 284
            V GT  Y +PE +         +     D +S GV + E+L G 
Sbjct: 236 AV-GTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 53/222 (23%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG V +     KL        VA+K +    LQ  R    E+  +  ++HP++V 
Sbjct: 48  IGNGSFGVVFQA----KLVES---DEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVD 96

Query: 146 LIGYCCEEEHRL------LVYEYMPRGSLEN--QLFRRYSVSLPWSTRMKIALGAA---- 193
           L  +      +       LV EY+P    E   +  R Y+       ++K  +       
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYA-------KLKQTMPMLLIKL 145

Query: 194 ------KGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDD-TH-VS 244
                 + LA++H     + +RD K  N+LLD      KL DFG AK    G+     + 
Sbjct: 146 YMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203

Query: 245 TRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
           +R      Y APE ++ G  + T+  D++S G V+ EL+ G+
Sbjct: 204 SRY-----YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G F  V +     K          A K ++ + L     ++   E     +L+HP++
Sbjct: 37  LGKGAFSVVRRCV--HKT----TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YS----VSLPWSTRMKIALGAAKGLA 197
           V+L     EE    LV++ +  G L   +  R  YS            ++  L +   +A
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IA 142

Query: 198 FLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           + H     +++R+ K  N+LL S       KL+DFGLA    E +D+       GT GY 
Sbjct: 143 YCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYL 197

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           +PE +     +   D+++ GV+L  LL G
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G +G V+K     K + G   +  A+K ++  G+        E+  L +L+HP+++ 
Sbjct: 29  VGRGTYGHVYKA----KRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVIS 82

Query: 146 LIGYCCE-EEHRL-LVYEYMPR------GSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L        + ++ L+++Y                  +  V LP      +      G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTA----KLSDFGLAK--DGPEGDDTHVSTRVMGTQ 251
           +LH     V++RD K +NIL+  +       K++D G A+  + P      +   V+ T 
Sbjct: 143 YLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199

Query: 252 GYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
            Y APE ++ G  H T   D+++ G +  ELL+  
Sbjct: 200 WYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 25/209 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW------LTEVIFLGQLR 139
           LG G F  V K    +K          A K +     +  R          EV  L Q+ 
Sbjct: 20  LGSGQFAIVKKC--REKS----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAKGLAF 198
           H +++ L          +L+ E +  G L + L ++ S+S   +T  +K  L    G+ +
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130

Query: 199 LHDAEKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           LH   K + + D K  NI+L          KL DFGLA +  +G +      + GT  + 
Sbjct: 131 LH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE V    L   +D++S GV+   LLSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 38/213 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWL---TEVIFLGQLRHPH 142
           LGEG FG V               Q VA+K +  + L+     +    E+ +L  LRHPH
Sbjct: 17  LGEGSFGKVKLA------THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 143 LVKLIGYCCEEEHRLLVYEY---------MPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
           ++KL          ++V EY         + +  +     RR+        +  I     
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF-------FQQIIC---- 119

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
             + + H     +++RD K  N+LLD +   K++DFGL+    +G+    S    G+  Y
Sbjct: 120 -AIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173

Query: 254 AAPEYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
           AAPE V+ G L      DV+S G+VL  +L GR
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.9 bits (198), Expect = 7e-17
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQL 138
             +GEG +G V+K     +   G   +  A+K + LE      E      + E+  L +L
Sbjct: 8   EKIGEGTYGVVYKA----QNNYG---ETFALKKIRLEK---EDEGIPSTTIREISILKEL 57

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           +H ++VKL      ++  +LV+E++ +  L+ +L       L   T     L    G+A+
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK-KLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAP 256
            HD  + V++RD K  N+L++ +   K++DFGLA+    P    TH    ++ T  Y AP
Sbjct: 116 CHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAP 169

Query: 257 EYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
           + V+ G    ++  D++S G +  E+++G 
Sbjct: 170 D-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 79.9 bits (198), Expect = 8e-17
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 28/210 (13%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQL 138
             +GEG +G V+K     K   G   + VA+K + L+      E      + E+  L +L
Sbjct: 27  EKVGEGTYGVVYKA----KDSQG---RIVALKRIRLDA---EDEGIPSTAIREISLLKEL 76

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
            HP++V LI     E    LV+E+M +  L+ ++       L  S          +G+A 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLK-KVLDENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAP 256
            H     +++RD K  N+L++SD   KL+DFGLA+    P    TH    V+ T  Y AP
Sbjct: 135 CHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAP 188

Query: 257 EYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
           + V+ G    ++  D++S G +  E+++G+
Sbjct: 189 D-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 54/212 (25%), Positives = 81/212 (38%), Gaps = 37/212 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           +G G FG           R  L  + VAVK ++          RE    +I    LRHP+
Sbjct: 28  IGSGNFGVARLM------RDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPN 77

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK------GL 196
           +V+         H  ++ EY   G    +L+     +   + R               G+
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGG----ELYE-RICN---AGRFSEDEARFFFQQLLSGV 129

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           ++ H     + +RD K  N LLD       K+ DFG +K           + V GT  Y 
Sbjct: 130 SYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYI 184

Query: 255 APEYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
           APE V+        ++DV+S GV L  +L G 
Sbjct: 185 APE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW------LTEVIFLGQLR 139
           LG G F  V K    +K          A K +     +  R          EV  L Q+ 
Sbjct: 20  LGSGQFAIVKKC--REKS----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAKGLAF 198
           HP+++ L          +L+ E +  G L + L ++ S+S   +T  +K  L    G+ +
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130

Query: 199 LHDAEKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           LH   K + + D K  NI+L          KL DFGLA +  +G +      + GT  + 
Sbjct: 131 LH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE V    L   +D++S GV+   LLSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 57/196 (29%), Positives = 74/196 (37%), Gaps = 25/196 (12%)

Query: 169 ENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD 228
           E      Y   L     +  +   AKG+ FL  A +  I+RD  A NILL      K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICD 236

Query: 229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV 287
           FGLA+D  +  D            + APE +     T  SDV+SFGV+L E+ S G    
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 293

Query: 288 DKSRPQREQSLVEWARPMLNDARKLGRIMD-PRL--EGQYSETGARKAAALAYQCLSHRP 344
               P     + E     L +    G  M  P       Y              C    P
Sbjct: 294 ---SPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQ---------TMLDCWHGEP 337

Query: 345 KQRPTMSTVVKTLEPL 360
            QRPT S +V+ L  L
Sbjct: 338 SQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEVIFLGQL-RHPHL 143
           LG G FG V +       +     + VAVK L +      HR  ++E+  L  +  H ++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTA-TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 144 VKLIGYCCEEEHRLLV-YEYMPRGSLENQLFRRYSVSLPWSTR 185
           V L+G C +    L+V  E+   G+L   L  + +  +P+ T+
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 55/225 (24%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT------EVIFLGQL 138
           LG GGFG+V+ G  + D         PVA+K+++ + +    E         EV+ L ++
Sbjct: 51  LGSGGFGSVYSGIRVSDN-------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 139 RH--PHLVKLIGYCCEEEHRLLVYEY-----------MPRGSLENQLFRRYSVSLPWSTR 185
                 +++L+ +    +  +L+ E              RG+L+ +L R +   +     
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV----- 158

Query: 186 MKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLA---KDGPEGDDT 241
                   + +   H+    V++RD K  NIL+D +    KL DFG     KD       
Sbjct: 159 -------LEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------ 203

Query: 242 HVSTRVMGTQGYAAPEYVMTGHL--TSMSDVYSFGVVLLELLSGR 284
             +    GT+ Y+ PE++   H      + V+S G++L +++ G 
Sbjct: 204 VYTDFD-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 37/211 (17%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+    +        +    K + ++G         E+  L   RH +++ 
Sbjct: 13  LGRGEFGIVHRCV--ETS----SKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRR-------YS----VSLPWSTRMKIALGAAK 194
           L       E  ++++E++        +F R        +    VS      +       +
Sbjct: 66  LHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSY-----VHQVC---E 113

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
            L FLH     + + D +  NI+  +  ++  K+ +FG A+    GD+  +   +     
Sbjct: 114 ALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPE 168

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y APE      +++ +D++S G ++  LLSG
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 45/221 (20%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLD------LEGLQGHREWLTEVIFLGQL 138
           LG+GGFG V  G  + D+         VA+K +          L        EV  L ++
Sbjct: 39  LGKGGFGTVFAGHRLTDR-------LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 139 R----HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAK 194
                HP +++L+ +   +E  +LV E          LF  Y         +        
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFD-YITE---KGPLGEGPSRCF 144

Query: 195 ------GLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLA---KDGPEGDDTHVS 244
                  +   H   + V++RD K  NIL+D     AKL DFG      D P        
Sbjct: 145 FGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFD- 199

Query: 245 TRVMGTQGYAAPEYVMTGHLT-SMSDVYSFGVVLLELLSGR 284
               GT+ Y+ PE++         + V+S G++L +++ G 
Sbjct: 200 ----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 56/211 (26%), Positives = 83/211 (39%), Gaps = 35/211 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV-IFLGQLRHPHLV 144
           LG G  G V + F     R G   Q  A+K L             EV         PH+V
Sbjct: 37  LGLGVNGKVLECF---HRRTG---QKCALKLLYDSPKAR-----QEVDHHWQASGGPHIV 85

Query: 145 KLIGYCCEEEHR----LLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAKG 195
            ++       H     L++ E M  G L +++  R   +   + R     M+    A   
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAAEIMRDIGTA--- 140

Query: 196 LAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQG 252
           + FLH     + +RD K  N+L    + D   KL+DFG AK+  +     + T    T  
Sbjct: 141 IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPY 194

Query: 253 YAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           Y APE +         D++S GV++  LL G
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW------LTEVIFLGQLR 139
           LG G F  V K    +K          A K +     +  R          EV  L +++
Sbjct: 19  LGSGQFAVVKKCR--EKS----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-MKIALGAAKGLAF 198
           HP+++ L      +   +L+ E +  G L + L  + S++   +T  +K  L     + +
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYY 129

Query: 199 LHDAEKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
           LH     + + D K  NI+L          K+ DFGLA     G++      + GT  + 
Sbjct: 130 LH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSG 283
           APE V    L   +D++S GV+   LLSG
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 31/210 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG+G F  V +         G   Q  A   ++ + L    H++   E      L+HP++
Sbjct: 19  LGKGAFSVVRRC--VKV-LAG---QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YS----VSLPWSTRMKIALGAAKGLA 197
           V+L     EE H  L+++ +  G L   +  R  YS            ++  L A   + 
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VL 124

Query: 198 FLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYA 254
             H  +  V++R+ K  N+LL S       KL+DFGLA +  EG+         GT GY 
Sbjct: 125 HCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFA-GTPGYL 180

Query: 255 APEYVMTGHL-TSMSDVYSFGVVLLELLSG 283
           +PE V+         D+++ GV+L  LL G
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVILYILLVG 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 30/207 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G    V++     K      A  V  K +D + ++      TE+  L +L HP+++K
Sbjct: 61  LGRGATSIVYRC--KQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIK 112

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRR--YS----VSLPWSTRMKIALGAAKGLAFL 199
           L           LV E +  G L +++  +  YS            +K  L A   +A+L
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYL 164

Query: 200 HDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           H  E  +++RD K  N+L      D   K++DFGL+K         +   V GT GY AP
Sbjct: 165 H--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAP 219

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E +         D++S G++   LL G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 47/207 (22%), Positives = 81/207 (39%), Gaps = 23/207 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRH-PH 142
           LG G F  V +     K       Q  A K L           E L E+  L   +  P 
Sbjct: 37  LGRGKFAVVRQCI--SKS----TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLP---WSTRMKIALGAAKGLAFL 199
           ++ L          +L+ EY   G + +      +  +        +K  L    G+ +L
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYL 147

Query: 200 HDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           H  +  +++ D K  NILL         K+ DFG+++      +      +MGT  Y AP
Sbjct: 148 H--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAP 202

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSG 283
           E +    +T+ +D+++ G++   LL+ 
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTH 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----LTEVIFLGQL 138
             +G G +G V+K       R       VA+K++ +    G         + EV  L +L
Sbjct: 15  AEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 139 R---HPHLVKLI----GYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
               HP++V+L+        + E ++ LV+E++ +  L   L +     LP  T   +  
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMG 249
              +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+    +   T     V+ 
Sbjct: 128 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV- 181

Query: 250 TQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           T  Y APE ++     +  D++S G +  E+   +
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQLRH 140
           +G+G FG V K       R     Q VA+K + +E     +E      L E+  L  L+H
Sbjct: 25  IGQGTFGEVFKA------RHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKH 75

Query: 141 PHLVKLIGYCCEEEHRL--------LVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIA 189
            ++V LI  C  +            LV+++      G L N       V    S   ++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVM 130

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA------KDGPEGDDTHV 243
                GL ++H     +++RD KA+N+L+  D   KL+DFGLA      K+      T+ 
Sbjct: 131 QMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN- 187

Query: 244 STRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGR 284
             RV+ T  Y  PE ++         D++  G ++ E+ +  
Sbjct: 188 --RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 42/225 (18%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIF 134
            + + +   +G G  G V     D  L      + VA+K L    +     +    E++ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAA-YDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVL 114

Query: 135 LGQLRHPHLVKLI-----GYCCEEEHRL-LVYEYMP-------RGSLENQLFRRYSVSLP 181
           +  + H +++ L+         EE   + LV E M        +  L+++        + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174

Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT 241
                        G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+        
Sbjct: 175 ------------CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220

Query: 242 --HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
             +V TR      Y APE ++        D++S G ++ E++  +
Sbjct: 221 TPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 33/217 (15%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-------LTEVIFLG 136
             +GEG +G V K    D    G   + VA+K + ++               + EV  L 
Sbjct: 17  AEIGEGAYGKVFKAR--DLKNGG---RFVALKRVRVQ-----TGEEGMPLSTIREVAVLR 66

Query: 137 QLR---HPHLVKLI----GYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
            L    HP++V+L         + E +L LV+E++ +  L   L +     +P  T   +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRV 247
                +GL FLH     V++RD K  NIL+ S    KL+DFGLA+    +   T     V
Sbjct: 126 MFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VV 180

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           + T  Y APE ++     +  D++S G +  E+   +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 36/212 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEV-IFLGQLRHPHL 143
           LG G  G V + F  +K       +  A+K L D    +       EV +     + PH+
Sbjct: 70  LGLGINGKVLQIF--NKR----TQEKFALKMLQDCPKAR------REVELHWRASQCPHI 117

Query: 144 VKLIGYC----CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAK 194
           V+++          +  L+V E +  G L +++  R   +   + R     MK    A  
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEA-- 173

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            + +LH     + +RD K  N+L  S   +   KL+DFG AK+    +   ++T    T 
Sbjct: 174 -IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTP 227

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            Y APE +         D++S GV++  LL G
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 55/237 (23%), Positives = 86/237 (36%), Gaps = 71/237 (29%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW-----------LTEVI 133
           F+  G +GAV  G   D      +  PVA+K +      G               L E+ 
Sbjct: 29  FISSGSYGAVCAGV--DS-----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 134 FLGQLRHPHLVKL----IGYCCEEEHRL-LVYEYM----------PRGSLEN-------- 170
            L    HP+++ L    + +     H+L LV E M           R  +          
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 171 QLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG 230
            +                      GL  LH+A   V++RD    NILL  +    + DF 
Sbjct: 142 HILL--------------------GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFN 179

Query: 231 LAKDGPEGDDT--HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
           LA++     +   +V+ R      Y APE VM     T + D++S G V+ E+ + +
Sbjct: 180 LAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 51/232 (21%), Positives = 91/232 (39%), Gaps = 54/232 (23%)

Query: 76  TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVI 133
             + + +   +G G  G V     D  L      + VA+K L    +     +    E++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAA-YDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 134 FLGQLRHPHLVKLI-----GYCCEEEHRL-LVYEYMP-------RGSLEN--------QL 172
            +  + H +++ L+         EE   + +V E M        +  L++        Q+
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136

Query: 173 FRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA 232
                                 G+  LH A   +I+RD K SNI++ SD T K+ DFGLA
Sbjct: 137 LC--------------------GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 174

Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
                   + + T  + T+ Y APE ++        D++S G ++ E++ G 
Sbjct: 175 ---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 67/254 (26%)

Query: 64  NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ 123
           N+H F L         +     LG GG G V    +D+        + VA+K + L   Q
Sbjct: 3   NIHGFDL------GSRYMDLKPLGCGGNGLVFSA-VDNDCD-----KRVAIKKIVLTDPQ 50

Query: 124 GHREWLTEVIFLGQLRHPHLVKLI-------------GYCCEEEHRL-LVYEYMP----- 164
             +  L E+  + +L H ++VK+                   E + + +V EYM      
Sbjct: 51  SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110

Query: 165 ---RGSLEN--------QLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKA 213
              +G L          QL R                    GL ++H A   V++RD K 
Sbjct: 111 VLEQGPLLEEHARLFMYQLLR--------------------GLKYIHSAN--VLHRDLKP 148

Query: 214 SNILLDS-DYTAKLSDFGLAK-DGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDV 270
           +N+ +++ D   K+ DFGLA+   P        +  + T+ Y +P  +++  + T   D+
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208

Query: 271 YSFGVVLLELLSGR 284
           ++ G +  E+L+G+
Sbjct: 209 WAAGCIFAEMLTGK 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 39/218 (17%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-----WLTEVIFLGQL 138
             LGEG +G V+K          +  + VA+K + LE      E      + EV  L +L
Sbjct: 40  TKLGEGTYGEVYKA------IDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKEL 90

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           +H ++++L           L++EY     +  ++       +  +              G
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK------NPDVSMRVIKSFLYQLING 144

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTA-----KLSDFGLAKD--GPEGDDTHVSTRVM 248
           + F H   +  ++RD K  N+LL     +     K+ DFGLA+    P    TH    ++
Sbjct: 145 VNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII 199

Query: 249 GTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGR 284
            T  Y  PE ++ G  H ++  D++S   +  E+L   
Sbjct: 200 -TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 57/232 (24%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEGLQGHREWLTEVIF 134
            +++ S   +G G +G+V    ID +       + VA+K L    +     +    E++ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSA-IDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELLL 76

Query: 135 LGQLRHPHLVKLI-----GYCCEEEHRL-LVYEYMP-------RGSLEN--------QLF 173
           L  ++H +++ L+            +   LV  +M                      Q+ 
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML 136

Query: 174 RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK 233
           +                    GL ++H A   V++RD K  N+ ++ D   K+ DFGLA+
Sbjct: 137 K--------------------GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
                   +V TR      Y APE +++  H     D++S G ++ E+L+G+
Sbjct: 175 HADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 52/232 (22%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFL 135
              +++ +++GEG +G V     D+  +       VA+K +   E     +  L E+  L
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSA-YDNLNK-----VRVAIKKISPFEHQTYCQRTLREIKIL 79

Query: 136 GQLRHPHLVKLIG----YCCEEEHRL-LVYEYMP--------RGSLEN--------QLFR 174
            + RH +++ +         E+   + +V + M            L N        Q+ R
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 139

Query: 175 RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK- 233
                               GL ++H A   V++RD K SN+LL++    K+ DFGLA+ 
Sbjct: 140 --------------------GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

Query: 234 DGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
             P+ D T   T  + T+ Y APE ++     T   D++S G +L E+LS R
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 55/234 (23%), Positives = 86/234 (36%), Gaps = 67/234 (28%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD-LEGLQGHREWLTEVIFLGQLRHPHLV 144
           LGEG +G V               + VA+K ++  +        L E+  L   +H +++
Sbjct: 19  LGEGAYGVVCSA-THKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72

Query: 145 KLI----GYCCEEEHRL-LVYEYMP--------RGSLEN--------QLFRRYSVSLPWS 183
            +         E  + + ++ E M            L +        Q  R         
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR--------- 123

Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA----KDGPEGD 239
                       +  LH +   VI+RD K SN+L++S+   K+ DFGLA    +   +  
Sbjct: 124 -----------AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 240 DTHVSTRVM----GTQGYAAPEYVMTGHLTSMS-----DVYSFGVVLLELLSGR 284
           +       M     T+ Y APE VM   LTS       DV+S G +L EL   R
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPE-VM---LTSAKYSRAMDVWSCGCILAELFLRR 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 57/261 (21%), Positives = 102/261 (39%), Gaps = 72/261 (27%)

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV 132
           L+ +++ +S    LG G FG V + F  +        +  A+K +  +    +RE    +
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIES------GKRFALKKVLQDPRYKNRE----L 51

Query: 133 IFLGQLRHPHLVKL--IGYCCEEEHRL--------------------------------- 157
             +  L H +++KL    Y   +E                                    
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 158 ---LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG------AAKGLAFLHDAEKPVIY 208
              ++ EY+P  +L +++ + +  S      + + L         + + F+H     + +
Sbjct: 112 YLNVIMEYVP-DTL-HKVLKSFIRS---GRSIPMNLISIYIYQLFRAVGFIHSLG--ICH 164

Query: 209 RDFKASNILLDS-DYTAKLSDFGLAKDGPEGDD-TH-VSTRVMGTQGYAAPEYVMTG--H 263
           RD K  N+L++S D T KL DFG AK     +     + +R      Y APE +M G   
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATE 218

Query: 264 LTSMSDVYSFGVVLLELLSGR 284
            T   D++S G V  EL+ G+
Sbjct: 219 YTPSIDLWSIGCVFGELILGK 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V+TR      Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195

Query: 254 AAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
            APE ++   H     D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 139 KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 254 AAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR 284
            APE ++     T   D++S G ++ E+++G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 40/213 (18%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLV 144
           LG G +  V +    +        + V VK L        ++   E+  L  LR  P+++
Sbjct: 44  LGRGKYSEVFEAI--NITN----NEKVVVKILKPVK---KKKIKREIKILENLRGGPNII 94

Query: 145 KLIGYCCEEEHR--LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA------LGAAKGL 196
            L     +   R   LV+E+     + N  F++   +L   T   I       L   K L
Sbjct: 95  TLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTL---TDYDIRFYMYEIL---KAL 143

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGDD-TH-VSTRVMGTQGY 253
            + H     +++RD K  N+++D ++   +L D+GLA+    G +    V++R      +
Sbjct: 144 DYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----F 196

Query: 254 AAPEYVMTGHLTSMS-DVYSFGVVLLELLSGRK 285
             PE ++   +   S D++S G +L  ++  ++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 36/208 (17%), Positives = 65/208 (31%), Gaps = 65/208 (31%)

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRL-----LVYEYMP---------RGSLEN------ 170
           E+  L +L+  ++++L      ++        +V E               L        
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134

Query: 171 --QLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD 228
              L                      G  F+H++   +I+RD K +N LL+ D + K+ D
Sbjct: 135 LYNLLL--------------------GENFIHESG--IIHRDLKPANCLLNQDCSVKVCD 172

Query: 229 FGLA----KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH------------LTSMS---- 268
           FGLA     +        +             +  +T H            L   +    
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232

Query: 269 -DVYSFGVVLLELLSGRKSVDKSRPQRE 295
            D++S G +  ELL+  +S       R 
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRF 260

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 39/218 (17%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKN--LDLEGLQGHREWLTEVIFLGQLRHPH 142
           +GEG FG + +G  + +        Q VA+K      +  Q   E+ T  +  G      
Sbjct: 18  IGEGSFGVIFEGTNLLNN-------QQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TG 67

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +  +  +  E  H +LV + +   SLE  L           T    A      +  +H  
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 123

Query: 203 EKPVIYRDFKASNILLDSDYTAK-----LSDFGLAK---DGPEGDDTHVSTR----VMGT 250
           EK ++YRD K  N L+    +       + DFG+ K   D       H+  R    + GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIPYREKKNLSGT 181

Query: 251 QGYAAPEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
             Y +    +  HL    S   D+ + G V +  L G 
Sbjct: 182 ARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 22/111 (19%)

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGDDTHVSTRVMGT 250
           K + +LH     +++RD K SNILL+++   K++DFGL+    +     +    +    T
Sbjct: 120 KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 251 QGYAAPEYVMTGH------------LTSMS-----DVYSFGVVLLELLSGR 284
           + +   + ++T +            L S       D++S G +L E+L G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 50/213 (23%), Positives = 80/213 (37%), Gaps = 31/213 (14%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH-PHL 143
           +G G FG ++ G  I       ++ + V  K+  L           E      ++    +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---------IESKIYKMMQGGVGI 67

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
             +     E ++ ++V E +   SLE  LF   S      T + +A      + ++H   
Sbjct: 68  PTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--S 123

Query: 204 KPVIYRDFKASNILLDSDYTAK---LSDFGLAKD-GPEGDDTHVSTR----VMGTQGYAA 255
           K  I+RD K  N L+          + DFGLAK         H+  R    + GT  YA+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 256 PEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
               +  HL    S   D+ S G VL+    G 
Sbjct: 184 ----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 35/216 (16%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK---NLDLEGLQGHREWLTEVIFLGQLRH 140
           + +G+G FG V K + D   +     + VA+K   N      Q       EV  L  +  
Sbjct: 60  SLIGKGSFGQVVKAY-DRVEQ-----EWVAIKIIKNKKAFLNQA----QIEVRLLELMNK 109

Query: 141 P------HLVKLIGYCCEEEHRLLVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIALG 191
                  ++V L  +     H  LV+E +       L N  FR  S++L   TR K A  
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL---TR-KFAQQ 165

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMG 249
               L FL   E  +I+ D K  NILL +   +  K+ DFG +    +    ++ +R   
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-- 223

Query: 250 TQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
              Y +PE V+ G    ++ D++S G +L+E+ +G 
Sbjct: 224 ---YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 45/224 (20%), Positives = 83/224 (37%), Gaps = 43/224 (19%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK---NLDLEGLQGHREWLTEVIFLGQLR--- 139
           LG G F  V     D           VA+K      +           E+  L ++    
Sbjct: 27  LGWGHFSTVWLAK-DMVNN-----THVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76

Query: 140 --------HPHLVKLIGY----CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMK 187
                     H++KL+ +         H ++V+E +   +L   + +     +P     +
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLD------SDYTAKLSDFGLAKDGPEGDDT 241
           I+     GL ++H     +I+ D K  N+L++      +    K++D G A    E    
Sbjct: 136 ISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 242 HVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
            + TR      Y +PE V+ G       D++S   ++ EL++G 
Sbjct: 195 SIQTRE-----YRSPE-VLLGAPWGCGADIWSTACLIFELITGD 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 53/259 (20%), Positives = 85/259 (32%), Gaps = 78/259 (30%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G V +   D   +     + VA+K      E L   +  L E+  L +L H H+
Sbjct: 61  IGTGSYGHVCEA-YDKLEK-----RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 144 VKL----IGYCCEEEHRL-LVYEYMP---------RGSLEN--------QLFRRYSVSLP 181
           VK+    I    E+   L +V E               L           L         
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV------- 167

Query: 182 WSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA--------- 232
                        G+ ++H A   +++RD K +N L++ D + K+ DFGLA         
Sbjct: 168 -------------GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH------------LTSMS-----DVYSFGV 275
                         ++        +  +TGH            L   +     DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 276 VLLELLSGRKSVDKSRPQR 294
           +  ELL+  K        R
Sbjct: 273 IFAELLNMIKENVAYHADR 291

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 42/228 (18%), Positives = 75/228 (32%), Gaps = 41/228 (17%)

Query: 86  LGEGGFGAVHKGF--IDDKLRPGLQAQPVAVK------NLDLEGLQGHREWLTEVIF--- 134
                 G +++           G Q Q  ++K       L  E     R      +    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 135 -LGQLRHPHLVKLIGYCCEE-EHRLLVYEYMPRGSLENQLFRRYSV-SLPWSTRMKIALG 191
            L       +   +G+   + ++R LV   + R SL+           L   + +++A  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHVLSERSVLQVACR 167

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK--LSDFGLAK---DGPEGDDTHVSTR 246
               L FLH  E   ++ +  A NI +D +  ++  L+ +G A            HV+  
Sbjct: 168 LLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP----SGKHVAYV 221

Query: 247 ------VMGTQGYAAPEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
                   G   + +    M  H     S   D+ S G  +L+ L G 
Sbjct: 222 EGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 39/218 (17%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVIFLGQLRHPH 142
           +G G FG +  G  +          + VA+K   +     Q H E+              
Sbjct: 17  IGCGNFGELRLGKNLYTN-------EYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---DG 66

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           + ++  +    ++  +V E +   SLE  LF     +    T + IA+     + ++H  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLISRMEYVH-- 122

Query: 203 EKPVIYRDFKASNILLDSDYTAK-----LSDFGLAK---DGPEGDDTHVSTR----VMGT 250
            K +IYRD K  N L+            + DF LAK   D       H+  R    + GT
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--KHIPYREHKSLTGT 180

Query: 251 QGYAAPEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
             Y +    +  HL    S   D+ + G + +  L G 
Sbjct: 181 ARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 50/212 (23%), Positives = 81/212 (38%), Gaps = 57/212 (26%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNL-DLEGLQGHREWLTEV-IFLGQLRHPHL 143
           LG G  G V + F  +K       +  A+K L D    +       EV +     + PH+
Sbjct: 26  LGLGINGKVLQIF--NKR----TQEKFALKMLQDCPKAR------REVELHWRASQCPHI 73

Query: 144 VKLIGYC----CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR-----MKIALGAAK 194
           V+++          +  L+V E +  G L +++  R   +   + R     MK    A  
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEA-- 129

Query: 195 GLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
            + +LH     + +RD K  N+L  S   +   KL+DFG A    E           G +
Sbjct: 130 -IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---------TTG-E 173

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG 283
            Y               D++S GV++  LL G
Sbjct: 174 KYDKS-----------CDMWSLGVIMYILLCG 194

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 31/213 (14%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHL 143
           +G G FG ++ G  I       ++ + V  K+  L           E      L+    +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL---------YESKIYRILQGGTGI 65

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
             +  +  E ++ +LV + +   SLE  LF   S  L   T + +A      + F+H   
Sbjct: 66  PNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVH--S 121

Query: 204 KPVIYRDFKASNILLDSDYTAK---LSDFGLAKD-GPEGDDTHVSTR----VMGTQGYAA 255
           K  ++RD K  N L+     A    + DFGLAK         H+  R    + GT  YA+
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

Query: 256 PEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
               +  HL    S   D+ S G VL+  L G 
Sbjct: 182 ----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK---NLDLEGLQGHREWLTEVIFLGQLRH- 140
            +G+G FG V K + D K+      Q VA+K   N      + HR+   E+  L  LR  
Sbjct: 104 VIGKGSFGQVVKAY-DHKVH-----QHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153

Query: 141 -----PHLVKLIGYCCEEEHRLLVYEYMP---RGSLENQLFRRYSVSLPWSTRMKIALGA 192
                 +++ ++       H  + +E +       ++   F+ +S+ L    R K A   
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL---VR-KFAHSI 209

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGDDTHVSTRVMGT 250
            + L  LH     +I+ D K  NILL     +  K+ DFG +    +   T++ +R    
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264

Query: 251 QGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSGR 284
             Y APE V+ G    M  D++S G +L ELL+G 
Sbjct: 265 --YRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 42/225 (18%), Positives = 88/225 (39%), Gaps = 35/225 (15%)

Query: 86  LGEGGFGAVHKGFID------DKLRPGLQAQPVAVKNLDLEG-----LQGHREWLTEVIF 134
           +G+GGFG ++   ++            ++ +P     L  E           +   + I 
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI-QKWIR 101

Query: 135 LGQLRHPHLVKLIGY----CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
             +L++  + K  G        + +R ++ +      L+  ++   +      T ++++L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFSRKTVLQLSL 159

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK--LSDFGLAKD-GPEGDDTHVSTR- 246
                L ++H  E   ++ D KASN+LL+     +  L D+GLA    PEG     +   
Sbjct: 160 RILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 247 ---VMGTQGYAAPEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
                GT  + +    +  H   + S   D+   G  +++ L+G 
Sbjct: 218 KRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 32/180 (17%), Positives = 55/180 (30%), Gaps = 56/180 (31%)

Query: 154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKA 213
            H  +V+E +    L   + +     LP     KI     +GL +LH  +  +I+ D K 
Sbjct: 118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKP 175

Query: 214 SNILL-------------------------------------------------DSDYTA 224
            NILL                                                       
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235

Query: 225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR 284
           K++D G A    +     + TR      Y + E ++     + +D++S   +  EL +G 
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 43/232 (18%), Positives = 85/232 (36%), Gaps = 52/232 (22%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLV- 144
           +G GGFG ++         P  + +  A   + +E  Q +    +E+ F  ++     + 
Sbjct: 45  IGSGGFGLIYLA------FPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIK 97

Query: 145 --------------KLIGY----CCEEEHRLLVYEYMPRGSLENQLF---RRYSVSLPWS 183
                            G          +R +V E +    L+ ++      +  S    
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISGQNGTFKKS---- 151

Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK--LSDFGLAKD-GPEGDD 240
           T +++ +     L ++H  E   ++ D KA+N+LL      +  L+D+GL+    P G+ 
Sbjct: 152 TVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

Query: 241 THVSTRV----MGTQGYAAPEYVMTGHL-TSMS---DVYSFGVVLLELLSGR 284
                       GT  + +    +  H   ++S   DV   G  +L  L G+
Sbjct: 210 KQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.1 bits (116), Expect = 1e-06
 Identities = 39/201 (19%), Positives = 62/201 (30%), Gaps = 53/201 (26%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH--------REW 128
           T+       +GEG FG V +   D          PVA+K + +EG             E 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHT--------PVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 129 LTEVIFLGQL---------RHPHLVKLIG-YCCEE---EHRLLVYEYM----------PR 165
           L E+I   +L         R    + L   +C +       L  +++           P 
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 166 GSLENQLF-------------RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK 212
              ++QLF             +  +     +T   I       LA    + +   +RD  
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR-FEHRDLH 189

Query: 213 ASNILLDSDYTAKLSDFGLAK 233
             N+LL      KL      K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 54/233 (23%), Positives = 85/233 (36%), Gaps = 57/233 (24%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK---NLDLEGLQGHREWLTEVIFLGQLRHP 141
            LGEG FG V +    D  R       VA+K   N+             E+  L +++  
Sbjct: 26  NLGEGTFGKVVECL--DHARGK---SQVALKIIRNVGKYREAA----RLEINVLKKIKEK 76

Query: 142 ------HLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIAL 190
                   V +  +     H  + +E +   +      EN  F+ Y +      R  +A 
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPH---VR-HMAY 130

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILL-DSDYTA------------------KLSDFGL 231
                L FLH+ +  + + D K  NIL  +S++                    +++DFG 
Sbjct: 131 QLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
           A    E   T V+TR      Y  PE V+     +   DV+S G +L E   G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 66/233 (28%), Positives = 91/233 (39%), Gaps = 57/233 (24%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK---NLDLEGLQGHREWLTEVIFLGQLRHP 141
            LGEG FG V +   D K       + VAVK   N+D    +      +E+  L  L   
Sbjct: 21  TLGEGAFGKVVECI-DHKA----GGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTT 71

Query: 142 ------HLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIAL 190
                   V+++ +     H  +V+E +   S      EN  F  + +      R K+A 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDH---IR-KMAY 125

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILL-DSDYTA------------------KLSDFGL 231
              K + FLH  +  + + D K  NIL   SDYT                   K+ DFG 
Sbjct: 126 QICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
           A    E   T VSTR      Y APE V+     S   DV+S G +L+E   G
Sbjct: 184 ATYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 53/238 (22%), Positives = 86/238 (36%), Gaps = 63/238 (26%)

Query: 85  FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK---NLDLEGLQGHREWLTEVIFLGQLRH- 140
            +G+G FG V         +     +  AVK   N+             E   L ++++ 
Sbjct: 42  KMGDGTFGRVLLCQ-HIDNK-----KYYAVKVVRNIKKYTRSA----KIEADILKKIQND 91

Query: 141 ----PHLVKLIGYCCEEEHRLLVYEYMPRGSL-----ENQLFRRYSVSLPWSTRMKIALG 191
                ++VK  G     +H  L++E +   SL      N  +  + +      +    + 
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIED---IK-LYCIE 145

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILL-DSDYTA------------------------KL 226
             K L +L      + + D K  NILL D  +                          KL
Sbjct: 146 ILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMS-DVYSFGVVLLELLSG 283
            DFG A    +   + ++TR      Y APE V+      +S D++SFG VL EL +G
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCVLAELYTG 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 3e-04
 Identities = 43/327 (13%), Positives = 87/327 (26%), Gaps = 116/327 (35%)

Query: 64  NLHVFTLAELKVTTQSFSSSNFLGEGGFGAV-----HKGFIDDKLRPGLQAQPVAVKNLD 118
           NL    L    +TT+    ++FL       +           D+++  L  + +  +  D
Sbjct: 263 NLSCKIL----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQD 317

Query: 119 L--EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE-HRLLVYEYMP--------RGS 167
           L  E L  +               P  + +I     +       ++++           S
Sbjct: 318 LPREVLTTN---------------PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362

Query: 168 LENQ---LFRRY---------SVSLP-------WS------TRMKIALGAAKGLA----- 197
           L       +R+          S  +P       W         + +       L      
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

Query: 198 ----FLHDAEKPVIYRDFKAS--------NILLDSDYTAKLSDFGLAKDGPEGDD---TH 242
                +       IY + K            ++D  Y    +        P  D    +H
Sbjct: 423 ESTISIPS-----IYLELKVKLENEYALHRSIVDH-YNIPKTFDSDDLIPPYLDQYFYSH 476

Query: 243 VSTRVMGTQGYAAPEYVMTGHLTS--MSDVYS-FGVVLLEL--LSGRKSVDKSRPQREQS 297
           +        G+         HL +    +  + F +V L+   L  +   D +      S
Sbjct: 477 I--------GH---------HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519

Query: 298 LVEWARPMLNDARKLGRIM---DPRLE 321
           ++      L   +     +   DP+ E
Sbjct: 520 IL----NTLQQLKFYKPYICDNDPKYE 542

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	455
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.62
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.24
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.02
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.8
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.35
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.33
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.31
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.12
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.11
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.85
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.5
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.45
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.94
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.95
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.19
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.75

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-59  Score=450.85  Aligned_cols=265  Identities=27%  Similarity=0.413  Sum_probs=217.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|.+.+. ....++..||||+++.......++|.+|+.+|++++|||||+++|+|.+++..
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSC-C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCc-ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            46788899999999999999976542 22345788999999876666778899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          157 LLVYEYMPRGSLENQLFRR-----------YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      +||||||++|+|.++|...           ....+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+|
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEE
Confidence            9999999999999999753           2357999999999999999999999966  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      |+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||.......   +...   
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~---  242 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC---  242 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH---
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---
Confidence            999999986544433333334679999999999999999999999999999999998 999998754321   1111   


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      +...           .....+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       243 i~~~-----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          243 ITQG-----------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcC-----------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1000           011235567788999999999999999999999999987764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.5e-59  Score=453.02  Aligned_cols=266  Identities=27%  Similarity=0.406  Sum_probs=212.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|.+... .+..++..||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSS-CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCc-ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45678889999999999999987542 23446789999999877667778899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          157 LLVYEYMPRGSLENQLFRRY-------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                      |||||||++|+|.++|....             ...+++.+++.|+.||+.||+|||+.+  ||||||||+||||+.++.
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCc
Confidence            99999999999999987542             246899999999999999999999966  999999999999999999


Q ss_pred             eEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 012832          224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~  302 (455)
                      +||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||........   +.. 
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~-  272 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDC-  272 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHH-
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHH-
Confidence            99999999987655444444455789999999999999999999999999999999998 9999986543221   111 


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        +..       -    .....+..++.++.+||.+||+.||++|||+.+|+++|+.+..
T Consensus       273 --i~~-------g----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          273 --ITQ-------G----RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             --HHH-------T----CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --HHc-------C----CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence              100       0    1112345667889999999999999999999999999988754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-58  Score=441.89  Aligned_cols=264  Identities=25%  Similarity=0.429  Sum_probs=208.1

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ++..+++.+.+.||+|+||+||+|.+.         ..||||+++..  .....+.|.+|+.+|++++|||||+++|++.
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~  102 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH---------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT  102 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS---------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC---------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345678889999999999999999642         24999998643  2344577999999999999999999999875


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                       ++.++||||||+||+|.++|... ...+++..++.|+.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+
T Consensus       103 -~~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          103 -KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             -CCeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccC
Confidence             45689999999999999998754 357999999999999999999999966  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |+..............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||............      .. 
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~------~~-  251 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM------VG-  251 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HH-
T ss_pred             ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH------Hh-
Confidence            987654443333455789999999999964   45899999999999999999999999865432111100      00 


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          .....+.+ ...+..++.++.+|+.+||+.+|++|||+.+|+++|+.++.
T Consensus       252 ----~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          252 ----RGYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ----TTCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ----cCCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                01111211 23455677889999999999999999999999999987754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-58  Score=451.86  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=208.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++....  ....+.+.+|+.+|+.|+|||||++++++.+++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   96 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKS------TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG   96 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEE------TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEEeEEEecCCCeEEEEEEE------CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence            36899999999999999999954      3467899999986543  334567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .+|||||||+||+|.++|..+....+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+.
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEccccccee
Confidence            9999999999999999998776677899999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .....  ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+......      ...+...      
T Consensus       175 ~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~------  240 (350)
T 4b9d_A          175 LNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLKIISG------  240 (350)
T ss_dssp             CCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHT------
T ss_pred             ecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcC------
Confidence            54321  123346899999999999999999999999999999999999999986543211      1111110      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          .. ...+..++.++.+||.+||+.||++|||+.|+++|-+
T Consensus       241 ----~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  279 (350)
T 4b9d_A          241 ----SF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF  279 (350)
T ss_dssp             ----CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             ----CC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence                00 1223455678999999999999999999999998843

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-58  Score=447.32  Aligned_cols=264  Identities=27%  Similarity=0.401  Sum_probs=214.5

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++.+.+.||+|+||.||+|.+... .+..+++.||||+++... ....++|.+|+.+|++++|||||+++|+|..++..
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~-~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCC-ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            4466778899999999999987432 223457889999986543 23457799999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      +||||||++|+|.++|..+.              ...+++..++.|+.||+.||+|||+.+  ||||||||+||||+.++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCC
Confidence            99999999999999996532              246899999999999999999999966  99999999999999999


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~  301 (455)
                      .+||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||+||||+| |..||.+.....   +...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999987654433333445689999999999999999999999999999999998 899998754321   1111


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..             . ......+..++.++.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       260 i~-------------~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          260 IR-------------N-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HH-------------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HH-------------c-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            10             0 0112345567788999999999999999999999999997653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.2e-58  Score=448.23  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=214.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ..|.+.+.||+|+||.||+|...      .+++.||||+++.......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVR------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEEC------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46999999999999999999643      468899999997666555667889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      ||||||+||+|.+++..   ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+....
T Consensus       148 ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            99999999999998865   36999999999999999999999977  99999999999999999999999999987654


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.........+      .       ....
T Consensus       223 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~-------~~~~  287 (346)
T 4fih_A          223 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------R-------DNLP  287 (346)
T ss_dssp             SSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-------HSSC
T ss_pred             CCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-------cCCC
Confidence            322  234578999999999999999999999999999999999999999865432211111      0       1111


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      +.  ......++.++.+||.+||+.||++|||+.|+++|-+.
T Consensus       288 ~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~  327 (346)
T 4fih_A          288 PR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL  327 (346)
T ss_dssp             CC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             CC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            11  12234567889999999999999999999999998554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-58  Score=441.04  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=211.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||+||+|..      ..+++.||||+++...   ....+.+.+|+.+|+.|+|||||++++++.++
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~------~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  104 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARE------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD  104 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEecccCeEEEEEEE------CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            46799999999999999999954      4468899999986432   23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +.+|||||||+||+|.++|.+.  ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            9999999999999999999765  57999999999999999999999976  9999999999999999999999999999


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............+||+.|||||++.+..|+.++|||||||++|||++|.+||...+....      ...+...     
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~-----  249 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------FAKIIKL-----  249 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHT-----
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcC-----
Confidence            77554443344557999999999999999999999999999999999999999976543211      1111111     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV  354 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell  354 (455)
                         .    ..++...+.++.+||.+||+.||++|||+.|++
T Consensus       250 ---~----~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 ---E----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---C----CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---C----CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               1    123444567899999999999999999999863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-57  Score=430.49  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe----CC
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE----EE  154 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~  154 (455)
                      .+.+.||+|+||.||+|...      .++..||+|++....  ....+.|.+|+.+|+.|+|||||++++++..    +.
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             EeeeEEecCcCcEEEEEEEC------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            56678999999999999654      357899999986432  3345678999999999999999999999865    35


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~  233 (455)
                      .+|||||||+||+|.+++.+.  ..+++..+..++.||+.||+|||+++.+||||||||+||||+. ++.+||+|||+|+
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            689999999999999999765  5799999999999999999999997767999999999999985 7999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....    .....+||+.|||||++.+ .|+.++|||||||++|||+||++||........  +..   .+        
T Consensus       181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~---~i--------  242 (290)
T 3fpq_A          181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR---RV--------  242 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH---HH--------
T ss_pred             eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH---HH--------
Confidence            64322    2344789999999998865 699999999999999999999999975432111  111   00        


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        .....+..++...+.++.+||.+||+.||++|||+.++++|-+
T Consensus       243 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          243 --TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             --TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             --HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence              0111111223334567899999999999999999999999854

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.7e-57  Score=450.33  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=214.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +.|.+.+.||+|+||.||+|..      ..+++.||||+++.......+.+.+|+.+|+.++|||||++++++..++.+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATV------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEE------CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            4699999999999999999954      3468899999997766555667889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      ||||||+||+|.+++..   ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+....
T Consensus       225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999998865   36999999999999999999999977  99999999999999999999999999987654


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.........+.             ....
T Consensus       300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------------~~~~  364 (423)
T 4fie_A          300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------------DNLP  364 (423)
T ss_dssp             SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------HSCC
T ss_pred             CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------------cCCC
Confidence            322  2345789999999999999999999999999999999999999997654322111110             1111


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      +.+  .....++.++.+||.+||..||++|||+.|+++|-+.
T Consensus       365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~  404 (423)
T 4fie_A          365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL  404 (423)
T ss_dssp             CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence            111  1233456789999999999999999999999998554

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.2e-57  Score=439.26  Aligned_cols=254  Identities=24%  Similarity=0.276  Sum_probs=208.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+.|.+.+.||+|+||.||+|..      ..+++.||||+++.+...     .+|+.+|+.++|||||++++++.+++.+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~------~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKD------KQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEE------CCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45688889999999999999954      446889999999754332     4699999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCCccCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDG  235 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGla~~~  235 (455)
                      |||||||+||+|.++|...  ..+++..+..++.||+.||+|||+++  ||||||||+||||+.+| .+||+|||+|+..
T Consensus       126 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            9999999999999999765  57999999999999999999999976  99999999999999987 6999999999876


Q ss_pred             CCCCCcc---ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          236 PEGDDTH---VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       236 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......   .....+||+.|||||++.+..|+.++|||||||++|||++|++||...........+.      ..    
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~----  271 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SE----  271 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HS----
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cC----
Confidence            5432211   1233689999999999999999999999999999999999999998754432211111      10    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                           +.....++..++.++.+||.+||+.||++|||+.|++++|...
T Consensus       272 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          272 -----PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -----CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                 0011123456678899999999999999999999999987654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.2e-56  Score=421.40  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=195.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|++.+.||+|+||.||+|.      +..+++.||||+++...   ......+.+|+.+|+.++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAY------HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEE------CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEE------ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            689999999999999999995      34568899999986432   233466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..||||||| +|+|.+++.++  ..+++..+..++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 78999998765  57999999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....   .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.......   +   ...+...     
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~---~~~i~~~-----  227 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---L---FKNISNG-----  227 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHT-----
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHcC-----
Confidence            54332   2334789999999999998876 579999999999999999999997643211   1   1111110     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                             ...++...+.++.+|+.+||+.||++|||+.|+++|-+.
T Consensus       228 -------~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          228 -------VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence                   112334456789999999999999999999999998543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.9e-57  Score=442.31  Aligned_cols=274  Identities=27%  Similarity=0.365  Sum_probs=223.8

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCC-CCcccE
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRH-PHLVKL  146 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~nIv~~  146 (455)
                      ....+++..++|.+.+.||+|+||.||+|.+... .....++.||||.+..... ...+.|.+|+.+|.++.| ||||++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCC-CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4456777788999999999999999999987542 2344567899999875433 345678999999999975 899999


Q ss_pred             EEEEEeC-CeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEecc
Q 012832          147 IGYCCEE-EHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF  211 (455)
Q Consensus       147 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDl  211 (455)
                      +|+|... ..++||||||++|+|.++|....              ...+++..++.++.|||.||+|||+.+  ||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence            9999765 56899999999999999997532              245899999999999999999999966  999999


Q ss_pred             CCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCC
Q 012832          212 KASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKS  290 (455)
Q Consensus       212 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~  290 (455)
                      ||+||||+.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997765544444455789999999999999999999999999999999998 99999865


Q ss_pred             CccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .....  +..    .+..          ......+..++.++.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       292 ~~~~~--~~~----~i~~----------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          292 KIDEE--FCR----RLKE----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCSHH--HHH----HHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHH--HHH----HHHc----------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            43211  111    1111          0112234556788999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-56  Score=430.68  Aligned_cols=255  Identities=26%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|++.+.||+|+||.||+|....   +..+++.||||+++....  .....+.+|+.+|+.++|||||++++++.+++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKIS---GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECS---STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEcc---CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            4679999999999999999996432   234678999999864321  22345778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      .+|||||||+||+|.++|.+.  ..+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+|+.
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            999999999999999999765  57999999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......  .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+......      .+...      
T Consensus       176 ~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~------  241 (304)
T 3ubd_A          176 SIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT------MILKA------  241 (304)
T ss_dssp             -----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC------
T ss_pred             ccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH------HHHcC------
Confidence            543322  2334789999999999999999999999999999999999999998654321111      11110      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                            ...++..++.++.+|+.+||+.||++|||     ++|+++|-+
T Consensus       242 ------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~  284 (304)
T 3ubd_A          242 ------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF  284 (304)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence                  11234456678999999999999999998     578988844

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-54  Score=418.07  Aligned_cols=272  Identities=25%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC---
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE---  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---  154 (455)
                      .+|.+.+.||+|+||.||+|.+        +++.||||+++..... ...+..|+..+..++|||||+++++|..++   
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--------~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~   73 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--------CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence            4577889999999999999965        3578999998754322 122234666667889999999999998764   


Q ss_pred             -eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeEEeccCCCCEEEcCCCceEEc
Q 012832          155 -HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA------EKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       155 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                       .+|||||||++|+|.++|...   .+++..+..++.|++.||+|||+.      .++||||||||+||||+.++.+||+
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence             579999999999999999764   689999999999999999999975      2359999999999999999999999


Q ss_pred             cCCCccCCCCCCCcc--ceeccccCCCCcCccccccC------CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          228 DFGLAKDGPEGDDTH--VSTRVMGTQGYAAPEYVMTG------HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       228 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      |||+|+.........  .....+||+.|||||++.+.      .++.++|||||||+||||+||.+||......... ..
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~  229 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YY  229 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-ch
Confidence            999998654433221  12346799999999999764      3678999999999999999999887543221100 00


Q ss_pred             Hhh--hhhhHh--hhhhcccCCCcccCCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          300 EWA--RPMLND--ARKLGRIMDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       300 ~~~--~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .+.  .+....  .......+++.++..+ +..++..+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000  000000  0011122233333221 23567789999999999999999999999999987754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.3e-54  Score=412.39  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=188.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC--
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE--  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  154 (455)
                      ++|++.+.||+|+||.||+|..      ..+++.||||+++.... ...+.+.+|+.+|+.|+|||||++++++.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKN------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEE------TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEE------CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            3589999999999999999954      34678999999875443 34467889999999999999999999987654  


Q ss_pred             ----------eEEEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          155 ----------HRLLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       155 ----------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                                .+|||||||+||+|.+++..... ...++..++.++.||+.||+|||+.+  ||||||||+||||+.++.
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCc
Confidence                      37999999999999999976532 23456678899999999999999976  999999999999999999


Q ss_pred             eEEccCCCccCCCCCCCcc----------ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCcc
Q 012832          224 AKLSDFGLAKDGPEGDDTH----------VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ  293 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~  293 (455)
                      +||+|||+|+.........          ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||....  
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--  231 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--  231 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence            9999999998765432211          1233679999999999999999999999999999999996   664311  


Q ss_pred             chhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         ......    ..   .   .+..++ ......+..+.+|+.+||+.||++|||+.++++|-
T Consensus       232 ---~~~~~~----~~---~---~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~  281 (299)
T 4g31_A          232 ---ERVRTL----TD---V---RNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA  281 (299)
T ss_dssp             ---HHHHHH----HH---H---HTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ---HHHHHH----HH---H---hcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence               001000    00   0   010111 01123345678899999999999999999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-52  Score=415.63  Aligned_cols=272  Identities=21%  Similarity=0.297  Sum_probs=206.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||+++...  ....+.+++|+.+|+.|+|||||++++++... 
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~------~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARR------RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEE------CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            36799999999999999999954      4468899999986432  33446788999999999999999999987643 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           +.+|||||||+ |+|.+++...  ..+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEee
Confidence                 57899999995 6899988654  57999999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCC--ccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          229 FGLAKDGPEGDD--THVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       229 fGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      ||+|+.......  .......+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+.......+......
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999987543221  1223457899999999998875 5699999999999999999999999876544333222211000


Q ss_pred             h--Hh--------hhhhcccCCCcccC---CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          306 L--ND--------ARKLGRIMDPRLEG---QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       306 ~--~~--------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .  ..        .......+.+....   ......+.++.+||.+||..||++|||+.|+++|-+.
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  348 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL  348 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence            0  00        00000000000000   0112345688999999999999999999999999543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-50  Score=401.27  Aligned_cols=271  Identities=23%  Similarity=0.266  Sum_probs=202.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      ..+.|.+.+.||+|+||.||+|....   +..+++.||||.+....  ....+.+|+.+|+.+ +||||+++++++...+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQL---QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEB---TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcc---cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            45789999999999999999996532   12357889999885443  345678899999988 5999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-CceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL~DfGla~  233 (455)
                      ++|||||||+||+|.+++.     .+++..+..++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999999872     5899999999999999999999977  9999999999999876 799999999997


Q ss_pred             CCCCCCCc--------------------------cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCC
Q 012832          234 DGPEGDDT--------------------------HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKS  286 (455)
Q Consensus       234 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p  286 (455)
                      ........                          ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            54332110                          112235799999999999875 589999999999999999999999


Q ss_pred             CCCCCccch-hhHHHhh-h--hhhHhhhhhc---------------------ccCC---Cc---------ccCCCCHHHH
Q 012832          287 VDKSRPQRE-QSLVEWA-R--PMLNDARKLG---------------------RIMD---PR---------LEGQYSETGA  329 (455)
Q Consensus       287 ~~~~~~~~~-~~~~~~~-~--~~~~~~~~~~---------------------~~~~---~~---------~~~~~~~~~~  329 (455)
                      |........ ...+... .  ..........                     ...+   +.         .........+
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            965432211 1111000 0  0000000000                     0000   00         0001122345


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          330 RKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       330 ~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .++.+|+.+||+.||++|||++|+++|-+
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~  355 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPF  355 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence            78899999999999999999999999854

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.5e-51  Score=424.48  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=206.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHH---HHHHHHHhcCCCCCcccEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREW---LTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~nIv~~~~  148 (455)
                      +..++|.+.++||+|+||.||+|..      +.+++.||||+++....   .....+   ..++.+++.++|||||++++
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~------~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~  259 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRK------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY  259 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             CchHHeEEEEEEecccCeEEEEEEE------CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence            3457899999999999999999954      44688999999864321   122223   34467778889999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      ++.+.+.+|||||||+||+|.++|.+.  ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|
T Consensus       260 ~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~D  335 (689)
T 3v5w_A          260 AFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISD  335 (689)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecc
Confidence            999999999999999999999999775  57999999999999999999999976  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      ||+|+......    ....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||..........+..   ....
T Consensus       336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~  408 (689)
T 3v5w_A          336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLT  408 (689)
T ss_dssp             CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHH
T ss_pred             cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcC
Confidence            99998764432    234689999999999974 579999999999999999999999997543222111111   1111


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                                  ....++...+.++.+||.+||+.||++|++     +++|++|-+
T Consensus       409 ------------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          409 ------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence                        012234556788999999999999999998     799999843

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6e-51  Score=426.37  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=213.6

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ++|.+.+.||+|+||.||+|..      +.+++.||||++........+.+.+|+.+|+.|+|||||++++++.+...+|
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~------~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTE------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEE------CCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            6799999999999999999954      4468899999997766666777899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC--CceEEccCCCccCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD--YTAKLSDFGLAKDG  235 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~--~~~kL~DfGla~~~  235 (455)
                      ||||||+||+|.++|... ...+++..+..++.||+.||+|||+++  |+||||||+|||++.+  +.+||+|||+|+..
T Consensus       231 iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999988644 347899999999999999999999977  9999999999999854  89999999999976


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ....   .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.........+      ..        
T Consensus       308 ~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~~--------  370 (573)
T 3uto_A          308 DPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KS--------  370 (573)
T ss_dssp             CTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HT--------
T ss_pred             cCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------Hh--------
Confidence            5432   234468999999999999999999999999999999999999999865432211111      00        


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .+..+........+.++.+||.+||+.||++|||+.|+++|-+
T Consensus       371 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence            0111122222345678999999999999999999999999954

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-49  Score=387.87  Aligned_cols=286  Identities=41%  Similarity=0.704  Sum_probs=239.2

Q ss_pred             cchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEE
Q 012832           68 FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLI  147 (455)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~  147 (455)
                      +++.++...+++|.+.+.||+|+||.||+|...       ++..||||++..........+.+|+.+++.++||||++++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~  101 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI  101 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            344455567889999999999999999999632       3678999998776666677899999999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      +++...+..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+|
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             EECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEE
T ss_pred             EEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999886543  235899999999999999999999976  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |+|||++................||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|....
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999998654433333334467999999999999999999999999999999999999999877665555555554332


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      . ....+...+++.+........+..+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus       260 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          260 H-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             H-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             c-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            1 12234455566666677888999999999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.4e-48  Score=371.29  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=213.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMD------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEB------TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEE------CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            46899999999999999999953      346789999998776666677789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999988764   6899999999999999999999976  9999999999999999999999999998665


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccC
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM  316 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (455)
                      .....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.      ..        
T Consensus       168 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~--------  231 (297)
T 3fxz_A          168 PEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TN--------  231 (297)
T ss_dssp             STTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HH--------
T ss_pred             Ccccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------
Confidence            43322  334679999999999999999999999999999999999999997654322111110      00        


Q ss_pred             CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                       .......+...+..+.+|+.+||+.||++|||+.++++|.+
T Consensus       232 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          232 -GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             -CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             -CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence             00111223455678999999999999999999999999844

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.8e-48  Score=376.28  Aligned_cols=289  Identities=42%  Similarity=0.700  Sum_probs=234.4

Q ss_pred             CCCcccchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCC
Q 012832           63 SNLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHP  141 (455)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~  141 (455)
                      ..+..+++.++....++|.+.+.||+|+||.||+|..       .++..||||++...... ....+.+|+.+++.++||
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~   87 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-------ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR   87 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-------SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEe-------cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence            3456788999999999999999999999999999942       13678999998654322 223578999999999999


Q ss_pred             CcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEE
Q 012832          142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILL  218 (455)
Q Consensus       142 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill  218 (455)
                      ||+++++++......++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+. ..+|+||||||+|||+
T Consensus        88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            99999999999999999999999999999987653  23589999999999999999999996 0139999999999999


Q ss_pred             cCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCC--ccchh
Q 012832          219 DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSR--PQREQ  296 (455)
Q Consensus       219 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~--~~~~~  296 (455)
                      +.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||+...  .....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV  246 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred             CCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence            99999999999999876443322 2334569999999999999899999999999999999999999996321  11122


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ....|...... ........+..+...++...+..+.+++.+||+.+|.+|||+.+++++|+..
T Consensus       247 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          247 MLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             BHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            23333332222 2234445566666778888999999999999999999999999999999764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-47  Score=375.87  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=210.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|..      ..+++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARH------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEE------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            457899999999999999999954      346789999998654  234456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             CEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999999999998765  56899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT-SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......   ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.........+      ...    
T Consensus       163 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~----  229 (328)
T 3fe3_A          163 EFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LRG----  229 (328)
T ss_dssp             GGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC----
T ss_pred             ecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC----
Confidence            6544322   3346799999999999988765 7899999999999999999999875432111111      100    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                              ...++...+.++.+|+.+||..||.+|||+.++++|.+.
T Consensus       230 --------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~  268 (328)
T 3fe3_A          230 --------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI  268 (328)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred             --------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence                    011233456778999999999999999999999998554

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.6e-47  Score=373.53  Aligned_cols=254  Identities=28%  Similarity=0.343  Sum_probs=211.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+|+.++||||+++++++..
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREK------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEEC------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            3568999999999999999999543      467899999986542   2345668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..++||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccch
Confidence            99999999999999999988765  57899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      +........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||.........      ..+...    
T Consensus       153 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~----  220 (337)
T 1o6l_A          153 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILME----  220 (337)
T ss_dssp             BCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHC----
T ss_pred             hhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH------HHHHcC----
Confidence            864333221  33468999999999999999999999999999999999999999764322111      111110    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~  359 (455)
                              ...++...+.++.+|+.+||+.+|++||     ++.++++|-+.
T Consensus       221 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          221 --------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence                    1123445567899999999999999999     99999998543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-47  Score=378.51  Aligned_cols=268  Identities=24%  Similarity=0.364  Sum_probs=217.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCC-CCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+.||+|+||.||+|...... .....+..||||++.... ......+.+|+.+|+.+ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            34578999999999999999999764321 123456789999987543 33456789999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nil  217 (455)
                      ..+..|+||||+++|+|.+++....              ...+++..++.++.||+.||+|||+.+  |+||||||+|||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl  235 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL  235 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence            9999999999999999999997653              235789999999999999999999976  999999999999


Q ss_pred             EcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchh
Q 012832          218 LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQ  296 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~  296 (455)
                      |+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999999986654433222333568899999999999999999999999999999999 99999865432211


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..+.             .    ......+..++.++.+|+.+||+.+|.+|||+.+++++|+.+.
T Consensus       316 ~~~~-------------~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          316 KLLK-------------E----GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHH-------------T----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHh-------------c----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110             0    0112234456678999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=370.94  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=214.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||+|....      ++..||+|.+..........+.+|+.+++.++||||+++++++.....
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRE------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECC------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            35689999999999999999996543      578899998876666677889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            99999999999999998764 457999999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCcc------------ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          236 PEGDDTH------------VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       236 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      .......            ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+......... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-R  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-H
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-h
Confidence            4332211            01135799999999999999999999999999999999999999876433221110000 0


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ..              .....+..++..+.+|+.+||+.+|++|||+.++++.|+.++.
T Consensus       238 ~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          238 GF--------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HH--------------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cc--------------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            00              0011233445678999999999999999999999999887753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.2e-47  Score=370.79  Aligned_cols=264  Identities=30%  Similarity=0.475  Sum_probs=207.0

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      +.+..++|.+.+.||+|+||.||+|..        .+..||||++....  ......+.+|+.+|+.++||||+++++++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE--------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE--------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            345567899999999999999999954        35679999986543  23346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      ......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+.+|+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            99999999999999999999887542 12389999999999999999999996656999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..        
T Consensus       184 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~--------  253 (309)
T 3p86_A          184 GLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF--------  253 (309)
T ss_dssp             C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH--------
T ss_pred             CCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence            99975433221  12336799999999999999999999999999999999999999986543221111100        


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                              ......++..++.++.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       254 --------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          254 --------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             --------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             --------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                    011123345566789999999999999999999999999987754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-46  Score=361.25  Aligned_cols=287  Identities=36%  Similarity=0.621  Sum_probs=227.9

Q ss_pred             cCCCCcccchHHHHHhcCCCCCc------ccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc----chhhHHHHHH
Q 012832           61 AGSNLHVFTLAELKVTTQSFSSS------NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----GLQGHREWLT  130 (455)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~~~~~~------~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~  130 (455)
                      .+...+.|++.++...+++|...      +.||+|+||.||+|..        .+..||||++...    .......+.+
T Consensus         8 ~~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~   79 (307)
T 2nru_A            8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--------NNTTVAVKKLAAMVDITTEELKQQFDQ   79 (307)
T ss_dssp             ---CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--------SSCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred             CCCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--------CCceEEEEEEecccCcchHHHHHHHHH
Confidence            34456778889999899888877      8999999999999953        3568999988542    2334567889


Q ss_pred             HHHHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEe
Q 012832          131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYR  209 (455)
Q Consensus       131 E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHr  209 (455)
                      |+.+++.++||||+++++++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+  |+||
T Consensus        80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~  157 (307)
T 2nru_A           80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHR  157 (307)
T ss_dssp             HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecC
Confidence            9999999999999999999999999999999999999999887432 356899999999999999999999976  9999


Q ss_pred             ccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCC
Q 012832          210 DFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       210 Dlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~  289 (455)
                      ||||+|||++.++.++|+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|.+||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999987654433333344679999999998865 588999999999999999999999986


Q ss_pred             CCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          290 SRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ........  .+..........+...++..+ ...+...+..+.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus       237 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          237 HREPQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TBSSSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             CcchHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            54322111  111111111111222333333 2356778889999999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-46  Score=373.51  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=209.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh------hHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ------GHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .+.|.+.+.||+|+||.||+|..      ..++..||+|++......      ....+.+|+.+|+.++||||+++++++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~------~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~   84 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCRE------KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY   84 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEE------CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence            46799999999999999999954      346789999998654322      346788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----ceEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKL  226 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----~~kL  226 (455)
                      ......++||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++    .+||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEE
Confidence            9999999999999999999998654  57999999999999999999999976  99999999999998876    7999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+      .
T Consensus       161 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i------~  231 (361)
T 2yab_A          161 IDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------T  231 (361)
T ss_dssp             CCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H
T ss_pred             EecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H
Confidence            99999987654322   23467999999999999999999999999999999999999999765332111110      0


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .    .    ...+...+....+..+.+||.+||..||++|||+.++++|.+.
T Consensus       232 ~----~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  276 (361)
T 2yab_A          232 A----V----SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (361)
T ss_dssp             T----T----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             h----c----CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence            0    0    0001111112345678999999999999999999999998543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-47  Score=377.74  Aligned_cols=275  Identities=27%  Similarity=0.367  Sum_probs=220.9

Q ss_pred             cchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCccc
Q 012832           68 FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVK  145 (455)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~  145 (455)
                      +....+.+..++|.+.+.||+|+||.||+|.+... .+..+++.||||++.... ....+.+.+|+.+|..+ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34566677889999999999999999999976432 245577899999997543 33446789999999999 7999999


Q ss_pred             EEEEEEeCCe-EEEEEEecCCCChHHHHhhcCC-----------------------------------------------
Q 012832          146 LIGYCCEEEH-RLLVYEYMPRGSLENQLFRRYS-----------------------------------------------  177 (455)
Q Consensus       146 ~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  177 (455)
                      +++++...+. .++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 8999999999999999976432                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          178 -----------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       178 -----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                                       ..+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             12889999999999999999999976  99999999999999999999999999987654443


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |..||.........  ...    ...          .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~----------~  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKE----------G  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHH----------T
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHc----------C
Confidence            333444678999999999999999999999999999999998 99999765432111  110    000          0


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .....+..++.++.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            111223345678999999999999999999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=374.62  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=205.4

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++...   .......+..|..+|..+ +||||+++++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVK------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEc------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            45678999999999999999999653      35789999998653   223445678899999988 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+..||||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEcccc
Confidence            9999999999999999999998765  57999999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.........      ..+...  
T Consensus       170 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~--  239 (353)
T 3txo_A          170 MCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAILND--  239 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHC--
T ss_pred             ceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH------HHHHcC--
Confidence            9986443322  234468999999999999989999999999999999999999999865432111      111110  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM------STVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~------~ell~~L~  358 (455)
                                ...++...+.++.+|+.+||..+|.+||++      .++++|-+
T Consensus       240 ----------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          240 ----------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence                      112334456779999999999999999998      88998854

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-47  Score=371.82  Aligned_cols=276  Identities=25%  Similarity=0.354  Sum_probs=209.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...        ++.||||++..... .......|+.+|+.++||||+++++++....
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT   91 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cchhhchhhheecccCceEEEEEEEC--------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence            45678999999999999999999543        57899999875443 2344566899999999999999999998754


Q ss_pred             ----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CCCeEEeccCCCCEEEcCCC
Q 012832          155 ----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA--------EKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       155 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------~~~iiHrDlkp~Nill~~~~  222 (455)
                          ..++||||+++|+|.+++...   .+++..++.++.|++.||+|||+.        ..+|+||||||+|||++.++
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence                479999999999999998764   589999999999999999999986        11399999999999999999


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC-----CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-----HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS  297 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~  297 (455)
                      .+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            9999999999765543332223346799999999999863     45678899999999999999999998654332222


Q ss_pred             HHHhhh--hhhHhh--hhhcccCCCcccCCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          298 LVEWAR--PMLNDA--RKLGRIMDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       298 ~~~~~~--~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ......  +.....  ........+.+...+ ....+.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            211110  000000  001111122222111 23456789999999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-46  Score=360.34  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=209.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||+|++...   .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDT------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEET------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEEC------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            4578999999999999999999543      35788999988543   23344678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..++||||++|++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999999998765  47899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ...          .
T Consensus       159 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~----------~  225 (294)
T 4eqm_A          159 KALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKH----------I  225 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHH----------H
T ss_pred             ccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH----------h
Confidence            876443222 123367999999999999999999999999999999999999999865432110  000          0


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-TMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-t~~ell~~L~~~~~  362 (455)
                      . ...+..........+..+.+++.+||+.+|.+|| +++++.+.|..+..
T Consensus       226 ~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          226 Q-DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             S-SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             h-ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            0 0011111223344567899999999999999998 89999998877654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=368.12  Aligned_cols=264  Identities=28%  Similarity=0.424  Sum_probs=212.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|.+...   ...+..||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVP---GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCT---TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecC---CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            457899999999999999999976532   223556999998754 3344567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999988654 357999999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.            
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------------  268 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------------  268 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------------
Confidence            65432221 1223457889999999999999999999999999999999 999997654321111110            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                       .    ......+..++..+.+|+.+||..+|++|||+.++++.|+.+..
T Consensus       269 -~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          269 -E----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -c----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             0    11122344566789999999999999999999999999987754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.6e-46  Score=363.46  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=209.6

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  159 (455)
                      |...+.||+|+||.||+|...      .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREK------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEEC------CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            667789999999999999653      35789999999766666677889999999999999999999999999999999


Q ss_pred             EEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCC
Q 012832          160 YEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGD  239 (455)
Q Consensus       160 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~  239 (455)
                      |||+++|+|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus       121 ~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             ECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence            999999999998754   46899999999999999999999976  9999999999999999999999999998654432


Q ss_pred             CccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          240 DTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...          +.....+.
T Consensus       196 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~~----------~~~~~~~~  260 (321)
T 2c30_A          196 PK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKR----------LRDSPPPK  260 (321)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----------HHHSSCCC
T ss_pred             cc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----------HhcCCCCC
Confidence            21  2346799999999999999999999999999999999999999976543211   110          00111111


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      +  ......+..+.+|+.+||+.+|++|||+.+++++.+..
T Consensus       261 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          261 L--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             C--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             c--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            1  11234567799999999999999999999999986554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.3e-47  Score=366.25  Aligned_cols=270  Identities=29%  Similarity=0.418  Sum_probs=219.3

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .+.+..++|.+.+.||+|+||.||+|..... .....+..||||++.... ....+.+.+|+.+|+.++||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETG-GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEecc-CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            3445678899999999999999999976432 123456889999987543 34456788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYS----------------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIY  208 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiH  208 (455)
                      ...+..++||||+++|+|.+++.....                      ..+++..++.++.||+.||+|||+.+  |+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH  173 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH  173 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence            999999999999999999999976532                      24889999999999999999999976  999


Q ss_pred             eccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCC
Q 012832          209 RDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSV  287 (455)
Q Consensus       209 rDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~  287 (455)
                      |||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986654433222333567889999999999999999999999999999999 99999


Q ss_pred             CCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          288 DKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ...........+.             .    ......+..++..+.+|+.+||+.+|++|||+.+++++|+.+.
T Consensus       254 ~~~~~~~~~~~~~-------------~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          254 PGIPPERLFNLLK-------------T----GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TTCCGGGHHHHHH-------------T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHhh-------------c----CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            8654432211111             0    0111233455678999999999999999999999999987763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-46  Score=370.89  Aligned_cols=255  Identities=27%  Similarity=0.384  Sum_probs=208.8

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGY  149 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~  149 (455)
                      .+..++|.+.+.||+|+||.||+|...      .+++.||||+++...   ......+..|..+|..+ +||||++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFK------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            456789999999999999999999653      357899999986542   23445677899999876 89999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +...+..|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        87 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           87 FQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEC
Confidence            99999999999999999999998765  46899999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      |+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||.........   .   .+... 
T Consensus       163 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~---~i~~~-  233 (345)
T 1xjd_A          163 GMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---H---SIRMD-  233 (345)
T ss_dssp             TTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHHHC-
T ss_pred             hhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---H---HHHhC-
Confidence            999864332221  34478999999999999999999999999999999999999999765432111   1   11100 


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS-TVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~-ell~~L~  358 (455)
                             .    ..++...+.++.+|+.+||..+|++||++. ++++|-+
T Consensus       234 -------~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          234 -------N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             -------C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             -------C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence                   1    123344567899999999999999999998 8887743

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=377.30  Aligned_cols=267  Identities=26%  Similarity=0.373  Sum_probs=213.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|.+... .+..++..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccC-CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            457899999999999999999976532 23446788999998643 3344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC---ceEE
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYS-----VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY---TAKL  226 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~---~~kL  226 (455)
                      ..++||||+++|+|.+++.....     ..+++..++.++.||+.||+|||+.+  |+||||||+||||+.++   .+||
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999999976532     45899999999999999999999976  99999999999998544   5999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.     
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-----  300 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-----  300 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence            99999974322222222333568999999999999999999999999999999998 999998654321111110     


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                              .    ......+..++..+.+|+.+||+.+|.+|||+.+|+++|+.+..
T Consensus       301 --------~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          301 --------S----GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             --------T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------c----CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                    0    00112234556789999999999999999999999999988754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-46  Score=366.78  Aligned_cols=264  Identities=18%  Similarity=0.197  Sum_probs=210.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|..      ..+++.||||++.....  ...+.+|+.+++.+ +||||+++++++....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   78 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKN------LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK   78 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEE------TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred             EcCCeEEEEEeeccCCceEEEEEE------CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence            357899999999999999999954      34578999999864432  23577899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc-----eEEccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT-----AKLSDF  229 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~-----~kL~Df  229 (455)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.     +||+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999999999 99999988754 457999999999999999999999976  999999999999998887     999999


Q ss_pred             CCccCCCCCCCcc-----ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh
Q 012832          230 GLAKDGPEGDDTH-----VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       230 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      |+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||...............  
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i--  232 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI--  232 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH--
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH--
Confidence            9998654332211     123467999999999999999999999999999999999999999876433322222111  


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                       .......    .   ........+ ++.+|+..||+.+|.+||++.+|++.|+.+..
T Consensus       233 -~~~~~~~----~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          233 -GDTKRAT----P---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             -HHHHHHS----C---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -HhhhccC----C---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence             0000000    0   000112234 89999999999999999999999999876644

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-46  Score=362.94  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=209.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++....   ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   78 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSR------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   78 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence            467999999999999999999543      357899999986432   23446678899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcce
Confidence            9999999999999999998764  57899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||........      ...+...     
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~-----  218 (318)
T 1fot_A          155 YVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNA-----  218 (318)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHC-----
T ss_pred             ecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC-----
Confidence            65432     2236799999999999999999999999999999999999999976432211      1111110     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~  359 (455)
                             ...++...+.++.+|+.+||..+|++||     +++++++|-+.
T Consensus       219 -------~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          219 -------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence                   0123344567899999999999999999     89999998543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-46  Score=371.83  Aligned_cols=289  Identities=16%  Similarity=0.167  Sum_probs=215.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH-----------HHHHHHHHHHhcCCCCCcc
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-----------REWLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv  144 (455)
                      ..++|.+.+.||+|+||.||+|.+... .....++.||||++........           ..+..|+..+..++||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCS-SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCc-cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            456899999999999999999976542 2233568999999865432111           2244577788889999999


Q ss_pred             cEEEEEEeC----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-
Q 012832          145 KLIGYCCEE----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-  219 (455)
Q Consensus       145 ~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-  219 (455)
                      ++++++...    ...+|||||+ |++|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+||||+ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence            999998765    4589999999 99999988764 457999999999999999999999976  99999999999999 


Q ss_pred             -CCCceEEccCCCccCCCCCCCcc-----ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCcc
Q 012832          220 -SDYTAKLSDFGLAKDGPEGDDTH-----VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ  293 (455)
Q Consensus       220 -~~~~~kL~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~  293 (455)
                       .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999997654322111     112356999999999999999999999999999999999999999753222


Q ss_pred             chhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCCCccccccee
Q 012832          294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGTFV  373 (455)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~~~~~~~~~~  373 (455)
                      .  ........  .....+..++++++.   ...++.++.+|+..||..+|.+||++.+|++.|+.+...........+.
T Consensus       268 ~--~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  340 (364)
T 3op5_A          268 P--KYVRDSKI--RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD  340 (364)
T ss_dssp             H--HHHHHHHH--HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred             H--HHHHHHHH--HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence            1  11111110  111112222222221   1234578999999999999999999999999988776544444444555


Q ss_pred             eee
Q 012832          374 FTV  376 (455)
Q Consensus       374 ~~~  376 (455)
                      |..
T Consensus       341 w~~  343 (364)
T 3op5_A          341 LSV  343 (364)
T ss_dssp             C--
T ss_pred             eEe
Confidence            543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=374.18  Aligned_cols=272  Identities=24%  Similarity=0.362  Sum_probs=220.3

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCC-CCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      .+..++|.+.+.||+|+||.||+|....... ....+..||||++.... ......+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            4556789999999999999999997643211 22455789999986543 33446788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      ...+..++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+.+  |+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence            99999999999999999999998753              245899999999999999999999976  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccch
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE  295 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~  295 (455)
                      ||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987654433333334568899999999999999999999999999999999 9999976543211


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                         ....          ..    ......+..++.++.+|+.+||+.+|++|||+.+++++|+.+....
T Consensus       303 ---~~~~----------~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          303 ---FKLL----------KE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             ---HHHH----------HT----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ---HHHH----------Hc----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence               1110          00    1111223445678999999999999999999999999998876433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-46  Score=367.98  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=207.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            468999999999999999999644      3578899999865432 223567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeecccee
Confidence            99999999999999988543  56999999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+..           
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~-----------  223 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-----------  223 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT-----------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc-----------
Confidence            43333223344689999999999987775 7789999999999999999999976543211 1111110           


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                         ...........+..+.+|+.+||..||++|||+.+++++.+..
T Consensus       224 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          224 ---KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             ---TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             ---ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence               0001111234567789999999999999999999999986543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=368.26  Aligned_cols=272  Identities=25%  Similarity=0.378  Sum_probs=218.7

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      ..+.+..++|.+.+.||+|+||.||+|..... ....++..||||++.... ......+.+|+.+++.++||||++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCc-CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34456678999999999999999999976532 122456889999987543 3345678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeE
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRY----------------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVI  207 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ii  207 (455)
                      +...+..++||||+++|+|.+++....                      ...+++..++.++.||+.||+|||+.+  |+
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv  196 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV  196 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            999999999999999999999997642                      156899999999999999999999976  99


Q ss_pred             EeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCC
Q 012832          208 YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKS  286 (455)
Q Consensus       208 HrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p  286 (455)
                      ||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999975433222222333568999999999999999999999999999999999 9999


Q ss_pred             CCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          287 VDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      |.......   .....   .          .. .....+..++..+.+|+.+||+.+|++|||+.+++++|+.+..
T Consensus       277 ~~~~~~~~---~~~~~---~----------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          277 YYGMAHEE---VIYYV---R----------DG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTSCHHH---HHHHH---H----------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCChHH---HHHHH---h----------CC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            97653221   11100   0          00 0112344556789999999999999999999999999988754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.4e-46  Score=377.54  Aligned_cols=257  Identities=23%  Similarity=0.301  Sum_probs=208.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|..      ..+++.||+|++....  ......+.+|+.+|+.++||||+++++++.+.
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~------~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVK------VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEE------TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEE------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence            356799999999999999999954      3467899999986543  23446688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc---CCCceEEccCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD---SDYTAKLSDFG  230 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~---~~~~~kL~DfG  230 (455)
                      +..++||||+.||+|.+.+...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++   .++.+||+|||
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            9999999999999999988765  56999999999999999999999976  99999999999998   46789999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+      ...  
T Consensus       159 ~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~--  228 (444)
T 3soa_A          159 LAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI------KAG--  228 (444)
T ss_dssp             SCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHT--
T ss_pred             eeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HhC--
Confidence            99876543222  23467999999999999999999999999999999999999999765322111111      000  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            ...+........+.++.+|+.+||+.||++|||+.++++|.+
T Consensus       229 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          229 ------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             ------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             ------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence                  011111222345678999999999999999999999999854

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.4e-46  Score=366.87  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=209.2

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+..|..+|..+ +||||+++++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERK------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEET------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            45678999999999999999999543      357899999986542   23446678899999988 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+..|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCC
Confidence            9999999999999999999998765  46899999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|.+||........      ...+...  
T Consensus       167 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~--  236 (353)
T 2i0e_A          167 MCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEH--  236 (353)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC--
T ss_pred             cccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHHHhC--
Confidence            9986433222  23346899999999999999999999999999999999999999976533211      1111110  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                                ...++...+.++.+|+.+||..+|.+||+     +.++++|.+
T Consensus       237 ----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          237 ----------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence                      11234456678999999999999999995     688988844

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=369.86  Aligned_cols=254  Identities=25%  Similarity=0.331  Sum_probs=209.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+|+.++||||+++++++..
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   86 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKN------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD   86 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3468999999999999999999643      357889999986432   2345678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....|+||||+.||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a  162 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIA  162 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEecccee
Confidence            99999999999999999988754  57999999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ........   ....+||+.|+|||++.+   ..++.++|||||||++|||++|..||................   .  
T Consensus       163 ~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~--  234 (384)
T 4fr4_A          163 AMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---T--  234 (384)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---H--
T ss_pred             eeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---h--
Confidence            87643322   334689999999999964   458999999999999999999999997654332222221110   0  


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHhc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-MSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-~~ell~~L  357 (455)
                                ....++...+.++.+||.+||+.+|.+||+ ++++++|.
T Consensus       235 ----------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp  273 (384)
T 4fr4_A          235 ----------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP  273 (384)
T ss_dssp             ----------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred             ----------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence                      011234455678999999999999999998 78888764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=364.55  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=207.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch------hhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL------QGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .+.|.+.+.||+|+||.||+|...      .++..||+|++.....      .....+.+|+.+|+.++||||+++++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREK------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEET------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEEC------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            356899999999999999999543      3578999999865432      1356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----ceEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKL  226 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----~~kL  226 (455)
                      ......++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++    .+||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999999999998654  57899999999999999999999976  99999999999998877    8999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.      
T Consensus       160 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------  230 (326)
T 2y0a_A          160 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------  230 (326)
T ss_dssp             CCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------
T ss_pred             EECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------
Confidence            99999987643322   233679999999999999999999999999999999999999997653321111100      


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ..    ...+...+....+..+.+|+.+||..||++|||+.++++|.+
T Consensus       231 ----~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          231 ----AV----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             ----HT----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             ----hc----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                00    001111111234567899999999999999999999999854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5e-46  Score=372.54  Aligned_cols=260  Identities=25%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||+|++.....   .....+..|..+|..+ +||||+++++++
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLK------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            34578999999999999999999654      3578899999865432   2224467899999876 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+.++|||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999988765  57999999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchh--hHHHhh-hhhhH
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ--SLVEWA-RPMLN  307 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~--~~~~~~-~~~~~  307 (455)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.........  ...... ..+..
T Consensus       199 la~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          199 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             eeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            9986433222  234478999999999999999999999999999999999999999754221110  000100 01110


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHhcc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM------STVVKTLE  358 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~------~ell~~L~  358 (455)
                                .  ...++...+.++.+||.+||+.||.+||++      .++++|-+
T Consensus       277 ----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          277 ----------K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             ----------C--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             ----------c--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence                      0  112344566789999999999999999985      78998854

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.4e-47  Score=378.96  Aligned_cols=263  Identities=27%  Similarity=0.404  Sum_probs=212.5

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +.+..++|.+.+.||+|+||.||+|.+..      ++..||||++.... ......+.+|+.+|+.++||||+++++++.
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEec------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34456788999999999999999996643      46789999986442 233356789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCC
Confidence            999999999999999999998754 346899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...........+.          
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~----------  329 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------  329 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH----------
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------
Confidence            986433211111112346778999999999999999999999999999998 999998654321111110          


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                             .......+..++..+.+||.+||+.+|++|||+.++++.|+.+.
T Consensus       330 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          330 -------KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                   00111234456778999999999999999999999999987764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.1e-46  Score=365.90  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=209.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+|+.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  113 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHK------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEEC------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            467999999999999999999643      357899999986432   23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccce
Confidence            9999999999999999999765  46899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....     ....+||+.|+|||++.+..++.++|||||||++|||++|.+||........      ...+...     
T Consensus       190 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~-----  253 (350)
T 1rdq_E          190 RVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVSG-----  253 (350)
T ss_dssp             ECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC-----
T ss_pred             eccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------HHHHHcC-----
Confidence            65432     2236799999999999999999999999999999999999999976533211      1111110     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~~  359 (455)
                             ...++...+.++.+|+.+||+.||.+||+     +.++++|-+.
T Consensus       254 -------~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f  297 (350)
T 1rdq_E          254 -------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence                   11233445678999999999999999998     9999998543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=365.32  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=209.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|.+.... .....+.+|+.+|+.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVET------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEEC------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            468999999999999999999643      357899999987543 3445678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC--CCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS--DYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~--~~~~kL~DfGla~~  234 (455)
                      ++||||++||+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.  ++.+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            9999999999999988653 347899999999999999999999976  999999999999987  78999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...........      +...      
T Consensus       154 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------i~~~------  218 (321)
T 1tki_A          154 LKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNA------  218 (321)
T ss_dssp             CCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHT------
T ss_pred             CCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------HHcC------
Confidence            654322   3346799999999999988899999999999999999999999976543211111      1100      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        ...+........+.++.+|+.+||..||.+|||+.++++|.+.
T Consensus       219 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~  261 (321)
T 1tki_A          219 --EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             --CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             --CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence              0000000012345778999999999999999999999998653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=369.70  Aligned_cols=271  Identities=24%  Similarity=0.339  Sum_probs=216.4

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +.+..++|.+.+.||+|+||.||+|..... .....+..||||++.... ......+.+|+.+|..+ +||||+++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGI-SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESC-SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeecc-ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            455678899999999999999999976432 123456789999986442 23346788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEe
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYS---------------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYR  209 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHr  209 (455)
                      ...+..++||||+++|+|.+++.....                     ..+++..++.++.||+.||+|||+.+  |+||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~  196 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR  196 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence            999999999999999999999976532                     23789999999999999999999976  9999


Q ss_pred             ccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCC
Q 012832          210 DFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVD  288 (455)
Q Consensus       210 Dlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~  288 (455)
                      ||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986654433333344668899999999999999999999999999999998 999997


Q ss_pred             CCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          289 KSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .......  .....    .          .......+..++.++.+|+.+||..+|.+|||+.+++++|+.+..
T Consensus       277 ~~~~~~~--~~~~~----~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          277 GIPVDAN--FYKLI----Q----------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TCCCSHH--HHHHH----H----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCcHHH--HHHHH----h----------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            6543211  11100    0          011122334456789999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.8e-47  Score=363.61  Aligned_cols=279  Identities=24%  Similarity=0.355  Sum_probs=212.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      +..++|++.+.||+|+||.||+|.+..  .+..+++.||||++........+.+.+|+.+|+.++||||+++++++... 
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECT--TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEec--ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345789999999999999999997543  23456889999999876666667889999999999999999999998653 


Q ss_pred             -CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          154 -EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       154 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                       ...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence             5689999999999999998765 345899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh---hHh
Q 012832          233 KDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM---LND  308 (455)
Q Consensus       233 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~---~~~  308 (455)
                      ......... .......||..|+|||++.+..++.++|||||||++|+|++|..||......    ........   ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMI  237 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchh
Confidence            876443221 1122345788899999999999999999999999999999999998643111    00000000   000


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .......+........+..++.++.+|+.+||+.+|++|||+.++++.|+.+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            000000111111223345667889999999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.2e-46  Score=353.74  Aligned_cols=260  Identities=28%  Similarity=0.419  Sum_probs=212.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...+       +..||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY   76 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             echhheeeeeeeccCCCceEEEEEecC-------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            456789999999999999999996543       45699999875433 3466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             ceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcccee
Confidence            999999999999999998764 346899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.             
T Consensus       154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------------  219 (268)
T 3sxs_A          154 VLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------------  219 (268)
T ss_dssp             CCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------------
T ss_pred             cchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-------------
Confidence            6543322 1223456778999999999899999999999999999999 999997654321111110             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      ..    .....+...+..+.+++.+||+.+|.+|||+.+++++|+.++..
T Consensus       220 ~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          220 QG----HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TT----CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             cC----CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            00    01112233456789999999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-46  Score=365.14  Aligned_cols=264  Identities=24%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|.+...  ......+||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCC--CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            356799999999999999999976442  12234457899875432 344577899999999999999999999998754


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                       .++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeE
Confidence             78999999999999988764 357899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.             
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------------  233 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------------  233 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------------
Confidence            554433333334567889999999999999999999999999999999 999998754432211111             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          .......+..++.++.+|+.+||+.+|.+|||+.+++++|+.+..
T Consensus       234 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          234 ----KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ----cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                011112344456789999999999999999999999999887643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.3e-46  Score=382.07  Aligned_cols=255  Identities=29%  Similarity=0.351  Sum_probs=202.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+.||+|+||.||+|..      ..+++.||||++....   ......+.+|+.+|+.++||||+++++++.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKE------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEE------cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            4557899999999999999999954      3467899999986532   233456778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ..+..+|||||+++|+|.+++...  ..+++..+..++.||+.||+|||+ .+  ||||||||+||||+.++.+||+|||
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCC
Confidence            999999999999999999988765  478999999999999999999997 67  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+      ...  
T Consensus       295 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~--  364 (446)
T 4ejn_A          295 LCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME--  364 (446)
T ss_dssp             CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC--
T ss_pred             CceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhC--
Confidence            99864433222  33478999999999999999999999999999999999999999765432111111      000  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEP  359 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~  359 (455)
                                ...++...+.++.+|+.+||+.||.+||     ++.++++|.+.
T Consensus       365 ----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          365 ----------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             ----------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence                      1123344567899999999999999999     99999998543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-46  Score=370.16  Aligned_cols=257  Identities=20%  Similarity=0.292  Sum_probs=211.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++..........+.+|+.+|+.++||||+++++++......
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            467999999999999999999643      35789999998766555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC--CCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS--DYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~--~~~~kL~DfGla~~  234 (455)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.  ++.+||+|||++..
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999999999999988643 347899999999999999999999976  999999999999974  57899999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..   .+.    ..  
T Consensus       201 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~---~i~----~~--  265 (387)
T 1kob_A          201 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQ---NVK----RC--  265 (387)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HHH----HC--
T ss_pred             cCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HH---HHH----hC--
Confidence            654322   2335799999999999999999999999999999999999999986533211   11   000    00  


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        ...+........+.++.+|+.+||..||++|||+.++++|.+.
T Consensus       266 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          266 --DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             --CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             --CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence              1111222233456789999999999999999999999998543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.5e-46  Score=367.22  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=208.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHK------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES  101 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCeEEeeEEecCCCeEEEEEEEC------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            467999999999999999999643      357899999986543  234467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC---CceEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~---~~~kL~DfGl  231 (455)
                      ..++||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.+   +.+||+|||+
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            999999999999999988654  56899999999999999999999976  9999999999999764   4599999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +........   .....||+.|+|||++.+..++.++|||||||++|+|++|.+||........   ..   .+...   
T Consensus       178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~---~i~~~---  245 (362)
T 2bdw_A          178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YA---QIKAG---  245 (362)
T ss_dssp             CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHT---
T ss_pred             ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhC---
Confidence            987654322   2336799999999999999999999999999999999999999976532211   11   00000   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ...+........+.++.+|+.+||..||++|||+.++++|.+
T Consensus       246 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          246 -----AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             -----CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             -----CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence                 001111112345678999999999999999999999999854

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-46  Score=367.91  Aligned_cols=257  Identities=25%  Similarity=0.338  Sum_probs=206.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-----hhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      .+.|.+.+.||+|+||.||+|...      .+++.||||++.....     ...+.+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   96 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINR------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS   96 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEEC------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            457999999999999999999543      3578999999854321     23567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc---eEE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT---AKL  226 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~---~kL  226 (455)
                      ..+..|+||||++||+|.+.+....  ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.   +||
T Consensus        97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEE
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEE
Confidence            9999999999999999998886542  346899999999999999999999976  999999999999986554   999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....    .+..   .+.
T Consensus       175 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~---~i~  245 (351)
T 3c0i_A          175 GGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE---GII  245 (351)
T ss_dssp             CCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH---HHH
T ss_pred             ecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH---HHH
Confidence            99999987654322  13346799999999999999999999999999999999999999976321    1111   000


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..    .....+..    ....+.++.+|+.+||..||++|||+.++++|.+
T Consensus       246 ~~----~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  289 (351)
T 3c0i_A          246 KG----KYKMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNHPW  289 (351)
T ss_dssp             HT----CCCCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cC----CCCCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence            00    00000000    1123567899999999999999999999999844

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=356.74  Aligned_cols=270  Identities=20%  Similarity=0.278  Sum_probs=212.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  154 (455)
                      .++|.+.+.||+|+||.||+|....      +++.||||++.... ......+.+|+.+|+.++||||+++++++.... 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            4679999999999999999996543      57899999986543 334567789999999999999999999998765 


Q ss_pred             -eEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE----cCCCceEEcc
Q 012832          155 -HRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYTAKLSD  228 (455)
Q Consensus       155 -~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill----~~~~~~kL~D  228 (455)
                       ..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEcc
Confidence             7899999999999999987643 234999999999999999999999976  9999999999999    7888899999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccc--------cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      ||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|..||............ 
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-  235 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV-  235 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH-
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH-
Confidence            999987654332   22357999999999986        567899999999999999999999999754332211111 


Q ss_pred             hhhhhhHhhh-----hhcccC--------CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          301 WARPMLNDAR-----KLGRIM--------DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       301 ~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                       ...+.....     .+....        .......++...+..+.+|+.+||+.||++|||+.|++++...
T Consensus       236 -~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          236 -MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             -HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             -HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence             111111000     000000        0111224567888999999999999999999999999999653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.7e-46  Score=361.85  Aligned_cols=269  Identities=28%  Similarity=0.377  Sum_probs=218.7

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      .+..++|.+.+.||+|+||.||+|.+... .....+..||||++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeec-cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            44567899999999999999999975431 2345678999999875433 3456788999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYS----------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASN  215 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~N  215 (455)
                      ..+..++||||+++|+|.+++.....                ..+++..++.++.|++.||+|||+.+  |+||||||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~N  175 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN  175 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccce
Confidence            99999999999999999999976532                24899999999999999999999976  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccc
Q 012832          216 ILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQR  294 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~  294 (455)
                      ||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987665443333344568899999999999999999999999999999998 999997654321


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .  ....    ...      .    .....+...+..+.+|+.+||..+|.+|||+.+++++|+.+.
T Consensus       256 ~--~~~~----~~~------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          256 K--FYKM----IKE------G----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             H--HHHH----HHH------T----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHH----hcc------C----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            1  1110    000      0    111123345678999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.4e-46  Score=369.07  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=202.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+|.+.+.||+|+||.||+|....   ....+..||||+++... ....+.+.+|+.+|+.++||||+++++++....
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKL---PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBC---TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEec---CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            45689999999999999999996542   12357789999987542 344567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999988654 457899999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   .....          
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i----------  263 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV----------  263 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH----------
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----------
Confidence            64432211 1122346788999999999999999999999999999998 999997653321   11100          


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          ........+..++..+.+|+.+||+.+|++||++.++++.|+.+..
T Consensus       264 ----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          264 ----DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ----HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                0011112234556789999999999999999999999999987754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-45  Score=363.91  Aligned_cols=280  Identities=24%  Similarity=0.279  Sum_probs=214.6

Q ss_pred             CCcccchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC----
Q 012832           64 NLHVFTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR----  139 (455)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----  139 (455)
                      ....+++.+.....++|.+.+.||+|+||.||+|....      +++.||||++... ......+..|+.+++.+.    
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~   93 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID------NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDI   93 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCST
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC------CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCC
Confidence            34445556666778999999999999999999996533      5788999998642 234456678999999886    


Q ss_pred             -CCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE
Q 012832          140 -HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL  218 (455)
Q Consensus       140 -h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill  218 (455)
                       ||||+++++++...+..++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||+
T Consensus        94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll  170 (360)
T 3llt_A           94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILL  170 (360)
T ss_dssp             TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEE
Confidence             999999999999999999999999 999999998776667999999999999999999999976  9999999999999


Q ss_pred             cC-------------------------CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhH
Q 012832          219 DS-------------------------DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSF  273 (455)
Q Consensus       219 ~~-------------------------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  273 (455)
                      +.                         ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence            75                         7899999999998644322     23579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccchhhHHHhhh-h----hhHhhhh--hcccC-CCcccCCCC--------------------
Q 012832          274 GVVLLELLSGRKSVDKSRPQREQSLVEWAR-P----MLNDARK--LGRIM-DPRLEGQYS--------------------  325 (455)
Q Consensus       274 G~il~ell~G~~p~~~~~~~~~~~~~~~~~-~----~~~~~~~--~~~~~-~~~~~~~~~--------------------  325 (455)
                      ||++|+|++|..||...........+.... +    .......  ..... ...+...++                    
T Consensus       246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  325 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK  325 (360)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred             HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence            999999999999998755432222221110 0    0000000  00000 000000000                    


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       326 ~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ......+.+|+.+||+.||++|||+.++++|-+
T Consensus       326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             cchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence            011256789999999999999999999998743

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-45  Score=353.62  Aligned_cols=257  Identities=29%  Similarity=0.534  Sum_probs=206.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-------HHHHHHHHHHHhcCCCCCcccEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-------HREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      ..++|.+.+.||+|+||.||+|....      +++.||||++.......       .+.+.+|+.+++.++||||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVK------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG   90 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETT------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhccceehhccccCCceeEEEEEEcC------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence            45789999999999999999996543      57889999985433211       156889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc-----
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT-----  223 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~-----  223 (455)
                      ++....  ++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+.+|+||||||+|||++.++.     
T Consensus        91 ~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           91 LMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             eecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence            986554  7999999999999888654 45799999999999999999999996656999999999999988776     


Q ss_pred             eEEccCCCccCCCCCCCccceeccccCCCCcCccccc--cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM--TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      +||+|||+++.....     .....||+.|+|||++.  ...++.++|||||||++|+|++|..||..............
T Consensus       168 ~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          168 AKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             EEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             EEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence            999999999854332     33467999999999984  45578999999999999999999999976543221111110


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                                    ........++..++..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       243 --------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 --------------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --------------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --------------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                          001122233455667899999999999999999999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.5e-46  Score=362.72  Aligned_cols=269  Identities=26%  Similarity=0.412  Sum_probs=199.2

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      ++.+..++|.+.+.||+|+||.||+|.....   ......||||++...  .....+.+.+|+.+++.++||||++++++
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQE---DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEccc---CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            3445678899999999999999999965432   112247999998654  33445778999999999999999999999


Q ss_pred             EEeCCeE------EEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          150 CCEEEHR------LLVYEYMPRGSLENQLFRRY----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       150 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                      +......      ++||||+++|+|.+++....    ...+++..++.++.|++.||+|||+.+  |+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~  171 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA  171 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc
Confidence            9877655      99999999999999886542    225899999999999999999999976  99999999999999


Q ss_pred             CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhH
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSL  298 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~  298 (455)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  251 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY  251 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            999999999999987654433333334567889999999999999999999999999999999 9999987543321111


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      +.      .           ......+..++.++.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       252 ~~------~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          252 LI------G-----------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HH------T-----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hh------c-----------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            10      0           00112234456789999999999999999999999999887654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.4e-46  Score=378.16  Aligned_cols=255  Identities=28%  Similarity=0.421  Sum_probs=211.0

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .+..++|.+.+.||+|+||.||+|.+.        +..||||+++...  ..+.+.+|+.+|+.++||||+++++++...
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            345678899999999999999999643        4689999987543  456789999999999999999999998776


Q ss_pred             C-eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          154 E-HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       154 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      . ..++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            5 7999999999999999998775556899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +......     ....+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.           
T Consensus       337 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----------  400 (450)
T 1k9a_A          337 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----------  400 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-----------
T ss_pred             ccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------
Confidence            8543321     12357899999999999999999999999999999998 999998654322111110           


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        .    ......+..++..+.+||.+||..+|++|||+.++++.|+.+..
T Consensus       401 --~----~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          401 --K----GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             --T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --c----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              0    11122345667889999999999999999999999999887643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-45  Score=362.81  Aligned_cols=259  Identities=25%  Similarity=0.345  Sum_probs=207.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|..++..+ +||||+++++++..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   81 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLK------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT   81 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence            467999999999999999999653      357899999986542   23345678899999887 79999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999999988765  46899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchh--hHHHhhhhhhHhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ--SLVEWARPMLNDAR  310 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~--~~~~~~~~~~~~~~  310 (455)
                      +.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.........  .........+.   
T Consensus       158 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~---  232 (345)
T 3a8x_A          158 KEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---  232 (345)
T ss_dssp             BCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH---
T ss_pred             ccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH---
Confidence            86433222  133468999999999999999999999999999999999999999753221100  00000000000   


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM------STVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~------~ell~~L~  358 (455)
                            ..  ...++...+.++.+|+.+||..||.+||++      .++++|-+
T Consensus       233 ------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~  278 (345)
T 3a8x_A          233 ------EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  278 (345)
T ss_dssp             ------HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred             ------cC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence                  00  112344556789999999999999999995      78888854

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-45  Score=356.77  Aligned_cols=270  Identities=22%  Similarity=0.293  Sum_probs=204.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|...       .++.||+|++.....  .....+.+|+.+|+.++||||+++++++...
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            3578999999999999999999642       267899999865432  2346688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCce
Confidence            99999999996 5888877654 356899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh----hhH
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP----MLN  307 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~----~~~  307 (455)
                      ........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ..    .+.
T Consensus       168 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          168 AFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            65432221  233578999999999876 56899999999999999999999999875543322211100 00    000


Q ss_pred             hhhh---h----cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 DARK---L----GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ~~~~---~----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....   .    ................+.++.+|+.+||+.||++|||+.++++|-+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  303 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY  303 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence            0000   0    0000000000112234567899999999999999999999999844

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.5e-46  Score=363.42  Aligned_cols=264  Identities=25%  Similarity=0.377  Sum_probs=207.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|.+...  .......||+|.+.... ......+.+|+.+++.++||||+++++++. ..
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPE--GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCT--TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCC--CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            346799999999999999999976542  12233458888874332 222345678999999999999999999885 56


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccc
Confidence            689999999999999988654 347888999999999999999999977  99999999999999999999999999997


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............||..|+|||++.+..++.++|||||||++|+|++ |..||...........+..            
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------  232 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK------------  232 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT------------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc------------
Confidence            765544444455678899999999999999999999999999999999 9999987543322111110            


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                           ......+..++.++.+|+.+||..+|.+|||+.+++++|+.+..
T Consensus       233 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          233 -----GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -----TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -----CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 00111233345568899999999999999999999999987643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-46  Score=352.53  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=210.7

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...+       +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             eChhhceeeheecCCCccEEEEEEecC-------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345789999999999999999996543       4579999987543 23467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             ceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccc
Confidence            999999999999999988654 356899999999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+             .
T Consensus       156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-------------~  221 (269)
T 4hcu_A          156 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------S  221 (269)
T ss_dssp             BCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------------H
T ss_pred             cccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------------h
Confidence            543211 11222457888999999999999999999999999999999 99999765432111100             0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..    .....+...+..+.+|+.+||+.+|++|||+.+++++|+.+.
T Consensus       222 ~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          222 TG----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             TT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC----ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            00    111223344677999999999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.4e-46  Score=374.12  Aligned_cols=264  Identities=22%  Similarity=0.279  Sum_probs=211.8

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKL  146 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~  146 (455)
                      +.++....++|.+.+.||+|+||.||+|...      .+++.||+|++.....   .....+.+|+.+++.++||||+++
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l  134 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL  134 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCE
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEEC------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            4455667789999999999999999999654      3578999999864221   222347789999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          147 IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                      ++++.+...+||||||++||+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||
T Consensus       135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL  209 (410)
T 3v8s_A          135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKL  209 (410)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEE
Confidence            99999999999999999999999988653   6899999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH----LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      +|||+++........ .....+||+.|+|||++.+..    ++.++|||||||++|||++|.+||..........     
T Consensus       210 ~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-----  283 (410)
T 3v8s_A          210 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-----  283 (410)
T ss_dssp             CCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----
T ss_pred             eccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH-----
Confidence            999999876543221 223468999999999998765    7899999999999999999999998654321111     


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhccc
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLEP  359 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~~  359 (455)
                       .+......+        ........+.++.+||.+||..+|.+  ||++++|++|.+.
T Consensus       284 -~i~~~~~~~--------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          284 -KIMNHKNSL--------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             -HHHTHHHHC--------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             -HHHhccccc--------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence             111110000        00111234578999999999999988  9999999999654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-45  Score=359.70  Aligned_cols=257  Identities=25%  Similarity=0.310  Sum_probs=201.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ..++|.+.+.||+|+||.||+|....   +..+++.||+|++....    ......+.+|+.+|+.++||||+++++++.
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVT---GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECS---STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEec---cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            45789999999999999999996532   13467899999986542    223455778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCc
Confidence            999999999999999999998765  46889999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........   .   ..+...   
T Consensus       168 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~---~~i~~~---  236 (327)
T 3a62_A          168 CKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---I---DKILKC---  236 (327)
T ss_dssp             C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HHHHHT---
T ss_pred             ccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---H---HHHHhC---
Confidence            976433221  12346799999999999999999999999999999999999999976533211   1   111110   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEP  359 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~  359 (455)
                               ...++...+.++.+|+.+||..+|.+||     ++.++++|.+.
T Consensus       237 ---------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          237 ---------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence                     1122344567899999999999999999     88899998543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=357.04  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=198.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--------------------------hHHHHH
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--------------------------GHREWL  129 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~  129 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++......                          ..+.+.
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNE------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEET------TTTEEEEEEEEECC-------------------------------CHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEEC------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            4578999999999999999999643      35789999998643211                          124578


Q ss_pred             HHHHHHhcCCCCCcccEEEEEEe--CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeE
Q 012832          130 TEVIFLGQLRHPHLVKLIGYCCE--EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVI  207 (455)
Q Consensus       130 ~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ii  207 (455)
                      +|+.+|+.++||||+++++++..  ....++||||+++++|.+++.   ...+++..+..++.||+.||+|||+.+  |+
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--iv  159 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK--II  159 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            99999999999999999999987  568999999999999987543   247999999999999999999999976  99


Q ss_pred             EeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCC---CCccCchhhHHHHHHHHHhCC
Q 012832          208 YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH---LTSMSDVYSFGVVLLELLSGR  284 (455)
Q Consensus       208 HrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~G~  284 (455)
                      ||||||+|||++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|.
T Consensus       160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            999999999999999999999999987644322  233467999999999998765   377899999999999999999


Q ss_pred             CCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          285 KSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       285 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .||.......      ....+..      .    ..........+.++.+|+.+||+.||++|||+.++++|-
T Consensus       238 ~pf~~~~~~~------~~~~~~~------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          238 CPFMDERIMC------LHSKIKS------Q----ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             CSSCCSSHHH------HHHHHHH------C----CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             CCCCCccHHH------HHHHHhc------c----cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            9997643211      1100000      0    001111223457799999999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.9e-46  Score=377.31  Aligned_cols=268  Identities=20%  Similarity=0.246  Sum_probs=213.6

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCccc
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVK  145 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~  145 (455)
                      .+.++.+..++|.+.+.||+|+||.||+|....      +++.||+|++.....   .....+.+|+.++..++||||++
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcC------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            345566778899999999999999999996543      578899999864322   12233778999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      +++++.+.+.+|||||||+||+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+|
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEE
Confidence            999999999999999999999999998753 357999999999999999999999976  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      |+|||+++........ .....+||+.|+|||++.     ...++.++|||||||++|||++|.+||..........   
T Consensus       216 L~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---  291 (437)
T 4aw2_A          216 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---  291 (437)
T ss_dssp             ECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---
T ss_pred             EcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---
Confidence            9999999866543322 233468999999999997     4568999999999999999999999998654322111   


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHhccc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ--RPTMSTVVKTLEP  359 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPt~~ell~~L~~  359 (455)
                         .+......   ..-+.    .....+.++.+||.+||..+|++  ||+++++++|-+.
T Consensus       292 ---~i~~~~~~---~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          292 ---KIMNHKER---FQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             ---HHHTHHHH---CCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             ---hhhhcccc---ccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence               11111000   00011    11234578999999999988888  9999999999544

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.8e-46  Score=365.32  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=207.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+|+.++||||+++++++...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHY------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            468999999999999999999643      357899999986432   12235688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+ +|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             CEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999999999 78999988765  57999999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||+.......                 
T Consensus       157 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------  216 (336)
T 3h4j_B          157 IMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------  216 (336)
T ss_dssp             TTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------
T ss_pred             eccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------
Confidence            6544322   234679999999999988776 6899999999999999999999976432110                 


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ...+.. ....++...+.++.+|+.+||..||.+|||+.++++|.+.
T Consensus       217 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          217 FKKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             BCCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred             HHHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence            000110 1112344556789999999999999999999999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.4e-46  Score=354.03  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|.+.+.||+|+||.||+|.....   ...+..||+|.+.... ....+.+.+|+.+++.++||||+++++++ .+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence            4567899999999999999999976432   2345679999986533 33456788999999999999999999997 45


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence            6789999999999999988754 357899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.            
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------------  231 (281)
T 1mp8_A          165 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------------  231 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------------
T ss_pred             ccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------------
Confidence            76443221 1223457889999999999999999999999999999996 999998654322111110            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                       .    ......+..++..+.+|+.+||+.+|++|||+.+++++|+.+.
T Consensus       232 -~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          232 -N----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -c----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0    0011234456678999999999999999999999999987653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-45  Score=354.40  Aligned_cols=268  Identities=17%  Similarity=0.159  Sum_probs=212.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  153 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++....  ....+.+|+.+++.+ +|+||+++++++...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNL------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEET------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             ccccceEEEEEEeecCCEEEEEEEEC------CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            34578999999999999999999543      357899999885432  234567899999999 699999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc-----eEEcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT-----AKLSD  228 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~-----~kL~D  228 (455)
                      ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.     +||+|
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            9999999999 99999998754 346999999999999999999999966  999999999999987765     99999


Q ss_pred             CCCccCCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          229 FGLAKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       229 fGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      ||++.........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            9999865443221     11234679999999999999999999999999999999999999998754433222222111


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                      .   ....   ..    .......++.++.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus       235 ~---~~~~---~~----~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          235 E---KKQS---TP----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             H---HHHH---SC----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             h---hccC---cc----HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            0   0000   00    00112234578999999999999999999999999998775433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.5e-46  Score=382.43  Aligned_cols=262  Identities=23%  Similarity=0.373  Sum_probs=217.5

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +.+...+|.+.+.||+|+||.||+|.+..      ++..||||++.... .....+.+|+.+|+.++||||++++++|..
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  287 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR  287 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGG------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcC------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34456778899999999999999996543      46789999987543 346778999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....+|||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus       288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccc
Confidence            999999999999999999998765667999999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.           
T Consensus       366 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-----------  433 (495)
T 1opk_A          366 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------  433 (495)
T ss_dssp             ECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----------
T ss_pred             eeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------
Confidence            87643221 11222456789999999999999999999999999999999 999998754322111110           


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                            .......+..++..+.+||.+||+.+|++|||+.+|++.|+.+.
T Consensus       434 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          434 ------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                  11122334556788999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.4e-46  Score=380.05  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=215.1

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      ..+.+..++|.+.+.||+|+||.||+|.+.+       +..||||+++... ...+.+.+|+.+|+.++||||+++++++
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~  252 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV  252 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECC-------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            4455667889999999999999999997643       4679999987543 3467899999999999999999999998


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      . .+..++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus       253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCC
Confidence            6 667899999999999999997654457889999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      +++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+       .. 
T Consensus       330 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~-  400 (454)
T 1qcf_A          330 LARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ER-  400 (454)
T ss_dssp             GGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HH-
T ss_pred             CceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------Hc-
Confidence            9986543211 11122446788999999999999999999999999999999 99999865432111110       00 


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                               ......+..++.++.+||.+||..+|++|||+.+|++.|+.+...
T Consensus       401 ---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          401 ---------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                     011122445678899999999999999999999999999887543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-45  Score=366.64  Aligned_cols=271  Identities=23%  Similarity=0.316  Sum_probs=196.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCC-CCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+.+|+.+. ||||+++++++..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~   80 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDR------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA   80 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEET------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEEC------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence            4578999999999999999999543      35789999988532  3345566789999999998 9999999999976


Q ss_pred             CC--eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          153 EE--HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       153 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      .+  ..|+|||||+ |+|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus        81 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           81 DNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             TTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCc
Confidence            54  6899999996 689988865   36899999999999999999999977  9999999999999999999999999


Q ss_pred             CccCCCCCC-------------------CccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCC
Q 012832          231 LAKDGPEGD-------------------DTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKS  290 (455)
Q Consensus       231 la~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~  290 (455)
                      +++......                   .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            997643211                   1112234689999999999986 67899999999999999999999999876


Q ss_pred             CccchhhHHHhhh-----------------hhhHhhhhhcccCCCcccCC------------CCHHHHHHHHHHHHHHhc
Q 012832          291 RPQREQSLVEWAR-----------------PMLNDARKLGRIMDPRLEGQ------------YSETGARKAAALAYQCLS  341 (455)
Q Consensus       291 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~cl~  341 (455)
                      ........+....                 ..+.................            ....++.++.+|+.+||.
T Consensus       235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            5433222211000                 00000000000000000000            011345678999999999


Q ss_pred             cCCCCCCCHHHHHHhcc
Q 012832          342 HRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       342 ~~P~~RPt~~ell~~L~  358 (455)
                      .||++|||+.++++|.+
T Consensus       315 ~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          315 FNPNKRISANDALKHPF  331 (388)
T ss_dssp             SSGGGSCCHHHHTTSTT
T ss_pred             cCcccCCCHHHHhCCHH
Confidence            99999999999999943

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.1e-45  Score=356.01  Aligned_cols=271  Identities=23%  Similarity=0.323  Sum_probs=193.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++..... .....+.+|+.+|+.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLN------KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEEC------SSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEE------CCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            46799999999999999999953      34678999999865432 233667899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRY----SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      .++||||++ |+|.+++....    ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999996 69999887542    245889999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-h----hh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-R----PM  305 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~----~~  305 (455)
                      +.........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... .    ..
T Consensus       155 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          155 ARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             CEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             ceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            9865432221  233579999999999976 46899999999999999999999999876443222111100 0    00


Q ss_pred             hHhhhhhcccCCCcc------------cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          306 LNDARKLGRIMDPRL------------EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      +........ ..+.+            ........+.++.+|+.+||+.||++|||+.++++|-+.
T Consensus       233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f  297 (317)
T 2pmi_A          233 WPSVTKLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF  297 (317)
T ss_dssp             CGGGGGCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhhhhhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence            000000000 00000            001112345689999999999999999999999998543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=363.50  Aligned_cols=257  Identities=24%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCC--CCcccEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRH--PHLVKLIGYC  150 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~  150 (455)
                      +..++|.+.+.||+|+||.||+|...       .++.||||++....  ......+.+|+.+|..++|  +||+++++++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            34577999999999999999999542       36789999986443  3344678899999999986  9999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ......+||||+ .+++|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++ ++.+||+|||
T Consensus        79 ~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           79 ITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             ECSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             eeCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecc
Confidence            999999999995 588999998764  57899999999999999999999976  99999999999997 6789999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCcccccc-----------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      +++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||.......     
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----  227 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----  227 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----
Confidence            9987655433333345679999999999865           678999999999999999999999997532210     


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                                ..+..++++.....++...+.++.+|+.+||+.||.+|||+.++++|.+.
T Consensus       228 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          228 ----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             ----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ----------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence                      01111122233334444556789999999999999999999999998654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-45  Score=364.36  Aligned_cols=260  Identities=21%  Similarity=0.295  Sum_probs=198.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||+|..      ..+++.||||++..... ....+.+|+.+++.++||||+++++++.....
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRD------KLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTH   90 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEE------TTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEE------CCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence            356899999999999999999954      34678999999864432 33567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc--eEEccCCCcc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT--AKLSDFGLAK  233 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~--~kL~DfGla~  233 (455)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.  +||+|||+++
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            99999999999999988765  46999999999999999999999977  999999999999987665  9999999997


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCcc-CchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSM-SDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......   .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........  ......       
T Consensus       167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~-------  234 (361)
T 3uc3_A          167 SSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRI-------  234 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHH-------
T ss_pred             cccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHH-------
Confidence            5332221   233579999999999988887665 899999999999999999997654322111  111111       


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         .............+.++.+|+.+||..+|++|||+.++++|-+...
T Consensus       235 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          235 ---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             ---HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             ---hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence               0111111111234577899999999999999999999999966543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.6e-46  Score=355.54  Aligned_cols=261  Identities=24%  Similarity=0.382  Sum_probs=218.1

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +.+..++|.+.+.||+|+||.||+|....      ++..||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGG------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecC------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            34567889999999999999999996543      57889999987543 345678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....++||||+++++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccc
Confidence            999999999999999999998766677999999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.           
T Consensus       159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-----------  226 (288)
T 3kfa_A          159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------  226 (288)
T ss_dssp             GTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----------
T ss_pred             eeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----------
Confidence            87654332 22333567889999999999999999999999999999999 999998654332111111           


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                            .......+..++..+.+|+.+||..+|.+|||+.++++.|+.+
T Consensus       227 ------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          227 ------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                  0111223345567899999999999999999999999998765

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=360.19  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=205.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|.....  ......+||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCT--TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCC--CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            357899999999999999999976542  1223345688877533 3345677899999999999999999999998655


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                       .++||+|+.+|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence             78999999999999988764 357899999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.             
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------------  233 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------------  233 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence            654433333334567889999999999999999999999999999999 999998764432211111             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          .......+..++.++.+|+.+||..+|.+|||+.++++.|+.+..
T Consensus       234 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          234 ----KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ----cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                011112244456789999999999999999999999999987754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-45  Score=367.08  Aligned_cols=275  Identities=19%  Similarity=0.239  Sum_probs=208.8

Q ss_pred             hcCCCCCccccccc--CCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           76 TTQSFSSSNFLGEG--GFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        76 ~~~~~~~~~~LG~G--~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ..++|.+.+.||+|  +||.||+|...      .+++.||||++....  ......+.+|+.+|+.++||||+++++++.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYK------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEc------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            35789999999999  99999999654      357899999986543  334466788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..++||||+++|+|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccccc
Confidence            9999999999999999999998776677999999999999999999999977  99999999999999999999999999


Q ss_pred             ccCCCCCCCc-----cceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-hh
Q 012832          232 AKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-AR  303 (455)
Q Consensus       232 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-~~  303 (455)
                      +.........     .......||+.|+|||++.+  ..++.++|||||||++|||++|..||.............. ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            8643222110     11222479999999999987  5799999999999999999999999976543322111000 00


Q ss_pred             h-hhHhh----hh-------------hcccC---------CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          304 P-MLNDA----RK-------------LGRIM---------DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       304 ~-~~~~~----~~-------------~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      + .....    ..             ....+         .......++...+.++.+|+.+||+.||++|||+.++++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0 00000    00             00000         0000112334456789999999999999999999999998


Q ss_pred             cc
Q 012832          357 LE  358 (455)
Q Consensus       357 L~  358 (455)
                      .+
T Consensus       335 p~  336 (389)
T 3gni_B          335 SF  336 (389)
T ss_dssp             GG
T ss_pred             HH
Confidence            43

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=365.32  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEEe
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      .+.||+|+||.||+|...      .++..||+|++........+.+.+|+.+|+.++||||+++++++...+..+|||||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEET------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEECC-----CEEEEEET------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEecCcCEEEEEEEEc------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            578999999999999643      35789999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE--cCCCceEEccCCCccCCCCCCC
Q 012832          163 MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL--DSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       163 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill--~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      +++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus       168 ~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999999988654 346899999999999999999999976  9999999999999  5678999999999987654332


Q ss_pred             ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcc
Q 012832          241 THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL  320 (455)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (455)
                         .....||+.|+|||++.+..++.++|||||||++|||++|..||..........      .+...        ...+
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~~~--------~~~~  307 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN------NILAC--------RWDL  307 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHT--------CCCS
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhc--------cCCC
Confidence               223569999999999998899999999999999999999999998654321111      11110        0001


Q ss_pred             cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ........+.++.+|+.+||+.+|.+|||+.++++|.+
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence            11112234578999999999999999999999999843

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=351.64  Aligned_cols=272  Identities=24%  Similarity=0.285  Sum_probs=203.4

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-----hhHHHHHHHHHHHhcC---CCCCcccE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----QGHREWLTEVIFLGQL---RHPHLVKL  146 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~nIv~~  146 (455)
                      ...++|.+.+.||+|+||.||+|..      ..+++.||||++.....     .....+.+|+.+++.+   +||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARD------PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEEC------TTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEE------CCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            3467999999999999999999953      44678999999864321     1123456677776666   49999999


Q ss_pred             EEEEEeCC-----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          147 IGYCCEEE-----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       147 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      ++++....     ..++||||+. |+|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC
Confidence            99998765     5899999995 69999998776566999999999999999999999977  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      +.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+..
T Consensus       157 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999986543322   2346799999999999999999999999999999999999999987543322111110


Q ss_pred             hhhhhHhhhhhccc-------CCCc---ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          302 ARPMLNDARKLGRI-------MDPR---LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       302 ~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ...... ...+...       +.+.   .........+..+.+|+.+||+.||++|||+.++++|-+.
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~  300 (308)
T 3g33_A          234 LIGLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL  300 (308)
T ss_dssp             HHCCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred             HhCCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence            000000 0000000       0000   0000112345788999999999999999999999998543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.1e-45  Score=350.35  Aligned_cols=268  Identities=21%  Similarity=0.259  Sum_probs=203.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+++.++||||+++++++.....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEEC------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            57899999999999999999653      357889999986443  2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999965 666665543 467999999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh-------hH
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM-------LN  307 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~-------~~  307 (455)
                      .....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .+.......       +.
T Consensus       152 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCT
T ss_pred             CCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhh
Confidence            43222  123357899999999998765 89999999999999999998887543322111 111100000       00


Q ss_pred             hhhhhcccC------CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 DARKLGRIM------DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .........      ............+.++.+|+.+||+.||++|||+.++++|-+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence            000000000      000011123345678899999999999999999999999854

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-45  Score=369.79  Aligned_cols=257  Identities=22%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             cCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHH-hcCCCCCcccEEEEEEe--
Q 012832           77 TQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL-GQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        77 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~--  152 (455)
                      .++|.+. +.||+|+||.||+|...      .+++.||||++...     ..+.+|+.++ +..+||||+++++++..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNK------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEEC------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3566665 78999999999999643      35789999998532     3456788877 45579999999999875  


Q ss_pred             --CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEc
Q 012832          153 --EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLS  227 (455)
Q Consensus       153 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~  227 (455)
                        ...+|||||||+||+|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEE
Confidence              567899999999999999998765567999999999999999999999976  999999999999987   7899999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhh-HHHhhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS-LVEWARPML  306 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~-~~~~~~~~~  306 (455)
                      |||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .....   .
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~  280 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---R  280 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---H
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---H
Confidence            999998654322   1234679999999999999999999999999999999999999997654322110 00000   0


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                           ...   ..+.......++.++.+||.+||..||++|||+.++++|.+..
T Consensus       281 -----~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          281 -----MGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             -----HTC---CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             -----cCc---ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence                 000   0111111234567899999999999999999999999996654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-45  Score=359.46  Aligned_cols=272  Identities=24%  Similarity=0.400  Sum_probs=217.6

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      .++.+..++|.+.+.||+|+||.||+|..... .....+..||||.+.... ......+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCc-cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            44556778999999999999999999975421 112356789999986443 2344568899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRY--------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      +......++||||+++|+|.+++....        ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence            999999999999999999999987532        145789999999999999999999976  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~  300 (455)
                      +.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........   ..
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LR  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HH
Confidence            9999999999986543322222233567899999999999999999999999999999999 8999976533211   11


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ..   .          ... ....+..++..+.+|+.+||+.+|.+|||+.+++++|+.+..
T Consensus       252 ~~---~----------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FV---M----------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HH---H----------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH---H----------cCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            00   0          000 112234556789999999999999999999999999987644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-45  Score=349.72  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=208.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|.+.        +..||||++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            3467999999999999999999652        5679999987543  34456789999999999999999999999877


Q ss_pred             --CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          154 --EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       154 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                        ...++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+.+|+||||||+|||++.++.++|+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~  159 (271)
T 3kmu_A           80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV  159 (271)
T ss_dssp             TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred             CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence              788999999999999999987655579999999999999999999998666699999999999999999999998888


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCc---cCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTS---MSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      +.....       ....||+.|+|||++.+..++.   ++|||||||++|||++|..||............         
T Consensus       160 ~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------  223 (271)
T 3kmu_A          160 KFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV---------  223 (271)
T ss_dssp             CCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH---------
T ss_pred             eeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH---------
Confidence            764322       1246899999999998765544   799999999999999999999765432111000         


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         .    ........+..++.++.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       224 ---~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 ---A----LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ---H----HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ---H----hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence               0    011122334456678999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.5e-46  Score=363.32  Aligned_cols=269  Identities=25%  Similarity=0.363  Sum_probs=215.6

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +.+..++|.+.+.||+|+||.||+|..... ........||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTC-SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCC-CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445678899999999999999999976542 112344689999986543 23456788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL  218 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill  218 (455)
                      ...+..++||||+++|+|.+++....            ...+++..++.++.|++.||+|||+.+  |+||||||+|||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL  197 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEE
Confidence            99999999999999999999987542            346899999999999999999999976  9999999999999


Q ss_pred             cCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhh
Q 012832          219 DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQS  297 (455)
Q Consensus       219 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~  297 (455)
                      +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......... 
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-  276 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-  276 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence            9999999999999986544333322334568889999999999999999999999999999998 99999765432111 


Q ss_pred             HHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                       ..    ....          ......+...+..+.+|+.+||+.+|.+|||+.+++++|+.+
T Consensus       277 -~~----~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 -YK----LVKD----------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -HH----HHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HH----HHhc----------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             11    0000          011112333467899999999999999999999999998765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-45  Score=349.64  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=197.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch----hhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL----QGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ..++|.+.+.||+|+||.||+|...        +..||||++.....    ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL   76 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4568999999999999999999642        56899999865432    23467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC-CeEEeccCCCCEEEcC--------CC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK-PVIYRDFKASNILLDS--------DY  222 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~iiHrDlkp~Nill~~--------~~  222 (455)
                      ..+..++||||+++++|.+++..   ..+++..++.++.|++.||+|||+.+. +|+||||||+|||++.        ++
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             cCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence            99999999999999999998753   478999999999999999999999653 2899999999999986        77


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      .++|+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........    
T Consensus       154 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----  225 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG----  225 (271)
T ss_dssp             CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----
T ss_pred             ceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh----
Confidence            89999999998654332    1235799999999999999999999999999999999999999976532211100    


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                                  ..........+..++..+.+++.+||+.+|.+|||+.+++++|+.+
T Consensus       226 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 ------------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                        0011122233455667899999999999999999999999998653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-45  Score=359.11  Aligned_cols=274  Identities=27%  Similarity=0.365  Sum_probs=219.2

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcC-CCCCcccE
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL-RHPHLVKL  146 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~  146 (455)
                      ....+.+..++|.+.+.||+|+||.||+|..... ....+++.||||++..... .....+.+|+.++..+ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3455666778999999999999999999975431 2345678999999875433 3446788999999999 69999999


Q ss_pred             EEEEEeCC-eEEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEecc
Q 012832          147 IGYCCEEE-HRLLVYEYMPRGSLENQLFRRYS--------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF  211 (455)
Q Consensus       147 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDl  211 (455)
                      ++++...+ ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||+.+  |+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence            99987754 48999999999999999976532              12789999999999999999999976  999999


Q ss_pred             CCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCC
Q 012832          212 KASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKS  290 (455)
Q Consensus       212 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~  290 (455)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655443333344678999999999999999999999999999999998 99999765


Q ss_pred             CccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .....  ....    +..      ..    ....+...+..+.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus       255 ~~~~~--~~~~----~~~------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDEE--FCRR----LKE------GT----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSHH--HHHH----HHH------TC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHH--HHHH----hcc------Cc----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            43211  1110    000      00    11123344577999999999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=372.58  Aligned_cols=267  Identities=20%  Similarity=0.217  Sum_probs=212.1

Q ss_pred             cchHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcc
Q 012832           68 FTLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv  144 (455)
                      +.+.++.+..++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|..+|..++||||+
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv  124 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT  124 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCee
Confidence            345666777899999999999999999999653      3678999999864322   2223477899999999999999


Q ss_pred             cEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      ++++++.+.+.+||||||++||+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+
T Consensus       125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCE
T ss_pred             eEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCE
Confidence            9999999999999999999999999998764 347999999999999999999999976  9999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCccccc-------cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhh
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS  297 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~  297 (455)
                      ||+|||+++........ .....+||+.|+|||++.       +..++.++|||||||++|||++|.+||..........
T Consensus       202 kL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          202 RLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             EECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999876543321 123368999999999997       3568999999999999999999999997654321111


Q ss_pred             HHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCC---CCHHHHHHhcc
Q 012832          298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR---PTMSTVVKTLE  358 (455)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R---Pt~~ell~~L~  358 (455)
                            .+......   ..-+    .++...+.++.+||.+||. +|.+|   |+++++++|-+
T Consensus       281 ------~i~~~~~~---~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf  330 (412)
T 2vd5_A          281 ------KIVHYKEH---LSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF  330 (412)
T ss_dssp             ------HHHTHHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred             ------HHHhcccC---cCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence                  11111000   0001    1123456789999999999 99998   69999999854

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.4e-45  Score=347.76  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=206.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|....      ++..||+|++....   ......+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence            45789999999999999999996543      57789999985432   2234668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....++||||+++|+|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEecccc
Confidence            99999999999999999988765  46899999999999999999999966  999999999999999999999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.          . 
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------~-  221 (279)
T 3fdn_A          157 VHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------R-  221 (279)
T ss_dssp             SCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----------H-
T ss_pred             ccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH----------h-
Confidence            7554322    233579999999999999999999999999999999999999998653321111110          0 


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                             ....++...+..+.+|+.+||+.+|++|||+.++++|.+
T Consensus       222 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          222 -------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             -------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence                   111233445678899999999999999999999999854

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-45  Score=360.05  Aligned_cols=270  Identities=23%  Similarity=0.357  Sum_probs=215.7

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCC-CCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKL-RPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      .+..++|.+.+.||+|+||.||+|...... .....+..||||++.... ......+.+|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            345678999999999999999999765321 122457789999987543 33456788999999999 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYS--------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNI  216 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Ni  216 (455)
                      ...+..++||||+++|+|.+++.....              ..+++..++.++.||+.||+|||+.+  |+||||||+||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI  188 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV  188 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceE
Confidence            999999999999999999999976532              24889999999999999999999976  99999999999


Q ss_pred             EEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccch
Q 012832          217 LLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQRE  295 (455)
Q Consensus       217 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~  295 (455)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            999999999999999987654433222333567889999999998889999999999999999999 9999976532211


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                         ....    .      ..    .....+..++.++.+|+.+||..+|.+|||+.+++++|+.+..
T Consensus       269 ---~~~~----~------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          269 ---FKLL----K------EG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ---HHHH----H------HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHH----h------cC----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               1100    0      00    0112234456789999999999999999999999999987754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-45  Score=353.58  Aligned_cols=259  Identities=23%  Similarity=0.398  Sum_probs=208.2

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .+..++|.+.+.||+|+||.||+|...+       +..||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETT-------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcC-------CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            3456789999999999999999996543       45799999875433 346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccc
Confidence            9999999999999999988653 346999999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+             
T Consensus       169 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------------  234 (283)
T 3gen_A          169 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------  234 (283)
T ss_dssp             GBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------------
T ss_pred             cccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------------
Confidence            65432111 1122457888999999999999999999999999999998 99999865432111111             


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ...    .....+...+..+.+|+.+||+.+|.+|||+.+++++|+.+.
T Consensus       235 ~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          235 AQG----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             HTT----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcc----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            011    111223334577899999999999999999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-45  Score=354.42  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=207.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCC-CCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|....... ....+..||+|++........+.+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            45689999999999999999997543211 11223579999997766667788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc--------eEE
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT--------AKL  226 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~--------~kL  226 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999998764 334899999999999999999999977  999999999999998887        999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCC-CCCCCCCccchhhHHHhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGR-KSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~-~p~~~~~~~~~~~~~~~~~~  304 (455)
                      +|||++......      ....||+.|+|||++.+ ..++.++|||||||++|+|++|. +||.........   ..   
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~~---  230 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---QF---  230 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HH---
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH---HH---
Confidence            999999765321      23568999999999987 67999999999999999999954 555443221111   00   


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                       ...        ..    ..+...+.++.+|+.+||+.+|++|||+.+++++|+.+..
T Consensus       231 -~~~--------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 -YED--------RH----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -HHT--------TC----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -hhc--------cC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             000        01    1122224568899999999999999999999999988865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-45  Score=360.81  Aligned_cols=282  Identities=27%  Similarity=0.341  Sum_probs=217.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE--eC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC--EE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~  153 (455)
                      ..++|.+.+.||+|+||.||+|.+..  .+..++..||||++........+.+.+|+.+++.++||||+++++++.  ..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDP--LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECT--TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEecc--CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            34689999999999999999997543  234568899999998776666778899999999999999999999987  45


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence            67899999999999999987642 46899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ..... ......+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~  253 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERD-VPALSRL  253 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccc-cccHHHH
Confidence            765433221 12235688899999999999999999999999999999999999864321100000 00000 0000011


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                      ...+........+..++..+.+|+.+||+.+|.+|||+.+++++|+.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1111112222345566788999999999999999999999999998875533

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.1e-45  Score=364.57  Aligned_cols=252  Identities=26%  Similarity=0.334  Sum_probs=198.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHH-HhcCCCCCcccEEEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIF-LGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~  151 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+..|..+ ++.++||||+++++++.
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHK------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEET------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEc------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            4578999999999999999999653      3578899999865432   233456677776 57789999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcc
Confidence            999999999999999999988765  46889999999999999999999977  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.......      ....+...   
T Consensus       186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~---  254 (373)
T 2r5t_A          186 CKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNK---  254 (373)
T ss_dssp             CGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHS---
T ss_pred             ccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhc---
Confidence            986433221  2344789999999999999999999999999999999999999997643211      11111110   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH----HHHHHhc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM----STVVKTL  357 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~----~ell~~L  357 (455)
                               ...++...+..+.+|+.+||+.||.+||++    .++++|.
T Consensus       255 ---------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~  295 (373)
T 2r5t_A          255 ---------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV  295 (373)
T ss_dssp             ---------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred             ---------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence                     112234456789999999999999999987    4676664

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.7e-45  Score=350.12  Aligned_cols=263  Identities=27%  Similarity=0.471  Sum_probs=198.1

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      .+..++|.+.+.||+|+||.||+|...         ..||||++....  ....+.+.+|+.+|+.++||||+++++++ 
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            345678999999999999999999532         249999986543  34456788999999999999999999965 


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      .....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEcccee
Confidence            556789999999999999988644 457899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      +................||+.|+|||++.   +..++.++|||||||++|+|++|..||........  .....    ..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~~  240 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMV----GR  240 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHH----HH
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHh----cc
Confidence            98654433332334467999999999986   56788899999999999999999999976543211  11110    00


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                           ....+. .......++..+.+|+.+||..+|.+|||+.++++.|+.+.
T Consensus       241 -----~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          241 -----GSLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -----TSCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----cccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                 011111 11233456688999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-45  Score=355.45  Aligned_cols=270  Identities=26%  Similarity=0.409  Sum_probs=205.4

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      .++.+..++|.+.+.||+|+||.||+|.....   ..++..||+|.+....  ......+.+|+.+++.++||||+++++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQE---DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECT---TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEecc---CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            33445678899999999999999999976542   3356789999987543  334467889999999999999999999


Q ss_pred             EEEeCC-----eEEEEEEecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          149 YCCEEE-----HRLLVYEYMPRGSLENQLFRR----YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       149 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                      ++....     ..++||||+++|+|.+++...    ....+++..++.++.||+.||.|||+.+  |+||||||+|||++
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~  181 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR  181 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence            997765     359999999999999988542    2357899999999999999999999976  99999999999999


Q ss_pred             CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhH
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSL  298 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~  298 (455)
                      .++.+||+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            999999999999987654332222333567889999999999999999999999999999999 9999976543221111


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      +.             ..    .....+..++..+.+|+.+||..+|.+|||+.+++++|+.+..
T Consensus       262 ~~-------------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          262 LL-------------HG----HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HH-------------TT----CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH-------------cC----CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            10             00    0112234456789999999999999999999999999987643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.6e-45  Score=380.32  Aligned_cols=259  Identities=29%  Similarity=0.407  Sum_probs=214.1

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+|+.++||||+++++++.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            45678999999999999999999653      357899999986432   234466789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..||||||++||+|.+++.......+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEeccc
Confidence            9999999999999999999987765556999999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ++.......   ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+.  ..+..    
T Consensus       333 a~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--~~i~~----  403 (576)
T 2acx_A          333 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKE----  403 (576)
T ss_dssp             CEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--HHHHH----
T ss_pred             ceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--HHhhc----
Confidence            987654322   234689999999999999899999999999999999999999998654321111111  00000    


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                              ....++...+.++.+||.+||..||.+||     ++.++++|-+
T Consensus       404 --------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          404 --------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             --------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence                    11223445567899999999999999999     7899999854

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.9e-45  Score=353.95  Aligned_cols=275  Identities=26%  Similarity=0.378  Sum_probs=211.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      ...|.+.+.||+|+||.||+|.+..  .+..+++.||||++.... ......+.+|+.+|+.++||||+++++++...  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT--TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcc--ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            4568999999999999999997543  235578899999987443 23456788999999999999999999999876  


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence            6689999999999999998654 356899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh--Hhhh
Q 012832          234 DGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML--NDAR  310 (455)
Q Consensus       234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~--~~~~  310 (455)
                      ........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+.....    .......+..  ....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence            76544321 122335688899999999999999999999999999999999998743210    0000000000  0000


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .+...+........+..++..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            00011111112233455678899999999999999999999999998765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8e-45  Score=348.94  Aligned_cols=267  Identities=23%  Similarity=0.301  Sum_probs=201.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|...       +++.||+|++.....  .....+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57899999999999999999642       367899999865432  223667899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            999999996 4999887653 357899999999999999999999976  999999999999999999999999999764


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh----hhHhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP----MLNDA  309 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~----~~~~~  309 (455)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+... ..    .+...
T Consensus       151 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             Ccccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence            32211  12335789999999999764 5899999999999999999999999865432211111000 00    00000


Q ss_pred             hhhcccCCCcc-------cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          310 RKLGRIMDPRL-------EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .... ..++.+       ...+....+.++.+|+.+||+.||++|||+.++++|-+
T Consensus       229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          229 TELP-KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             GGST-TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             hccc-ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            0000 001111       11122345678899999999999999999999999854

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.4e-45  Score=371.54  Aligned_cols=253  Identities=26%  Similarity=0.344  Sum_probs=208.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+.+|+.++||||+++++++..
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHE------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEET------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3578999999999999999999543      4678999999864422   234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..++||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a  163 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS  163 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccch
Confidence            99999999999999999988653  57999999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........   .   .+.     
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~---~i~-----  229 (476)
T 2y94_A          164 NMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF---K---KIC-----  229 (476)
T ss_dssp             EECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH---H---HHH-----
T ss_pred             hhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH---H---HHh-----
Confidence            87644322   234679999999999988765 78999999999999999999999865432111   1   110     


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                           +..  ...+...+.++.+|+.+||..||.+|||+.++++|-+.
T Consensus       230 -----~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~  270 (476)
T 2y94_A          230 -----DGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF  270 (476)
T ss_dssp             -----TTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             -----cCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence                 000  01233345678999999999999999999999998543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-45  Score=375.12  Aligned_cols=262  Identities=29%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      .+.+..++|.+.+.||+|+||.||+|.+..       +..||||++.... ...+.+.+|+.+|+.++||||+++++++.
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECC-------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            344566788999999999999999997643       3469999987544 33567899999999999999999999986


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      . +..++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCcc
Confidence            5 67899999999999999997654567899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+           
T Consensus       327 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----------  394 (452)
T 1fmk_A          327 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----------  394 (452)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----------
T ss_pred             ceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------
Confidence            9865432211 1223457889999999999999999999999999999999 99999765432111100           


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        ..    ......+..++..+.+||.+||+.+|++|||+.+|++.|+.+..
T Consensus       395 --~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          395 --ER----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             --HT----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --Hc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence              00    01112345567889999999999999999999999999987754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.5e-45  Score=356.77  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=197.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.+.. 
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNK------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEET------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhcCceeeEecCCCCeEEEEEEEc------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            357899999999999999999653      3578999999865433 34577899999999999999999999986543 


Q ss_pred             --------------------------------------------------------eEEEEEEecCCCChHHHHhhcCC-
Q 012832          155 --------------------------------------------------------HRLLVYEYMPRGSLENQLFRRYS-  177 (455)
Q Consensus       155 --------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-  177 (455)
                                                                              ..++||||+++|+|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    38999999999999999876532 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc----------cceecc
Q 012832          178 VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT----------HVSTRV  247 (455)
Q Consensus       178 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~----------~~~~~~  247 (455)
                      ...++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++.........          ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            23456678999999999999999976  999999999999999999999999999876543211          112335


Q ss_pred             ccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHH
Q 012832          248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSET  327 (455)
Q Consensus       248 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (455)
                      .||+.|+|||++.+..++.++|||||||++|||++|..|+..     ......       .   ..   .... ......
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~-------~---~~---~~~~-~~~~~~  297 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIIT-------D---VR---NLKF-PLLFTQ  297 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHH-------H---HH---TTCC-CHHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHH-------H---hh---ccCC-Cccccc
Confidence            799999999999999999999999999999999998766421     000000       0   00   0000 011233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          328 GARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       328 ~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .+.++.+|+.+||+.+|++|||+.++++|-
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIENA  327 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence            456778999999999999999999999984

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.4e-45  Score=366.06  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=200.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCC--CCCcccEEEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLR--HPHLVKLIGYCC  151 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~  151 (455)
                      ...+|.+.+.||+|+||.||+|...       .++.||||++....  ......+.+|+.+|+.++  ||||+++++++.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcC-------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            3456999999999999999999532       26789999986543  344567889999999997  599999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..+|||| +.+++|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+ ++.+||+|||+
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~  200 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGI  200 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCc
Confidence            9999999999 4588999998765  47888999999999999999999976  99999999999995 57999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCcccccc-----------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      ++..............+||+.|+|||++.+           ..++.++|||||||++|||++|..||.......     .
T Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~  275 (390)
T 2zmd_A          201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S  275 (390)
T ss_dssp             SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H
T ss_pred             cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H
Confidence            987654433323344679999999999865           368899999999999999999999997542210     0


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                                .+..++++.....++...+.++.+|+.+||..||++|||+.++++|.+.
T Consensus       276 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~  324 (390)
T 2zmd_A          276 ----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  324 (390)
T ss_dssp             ----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence                      0111122222223334445788999999999999999999999998543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.2e-44  Score=343.59  Aligned_cols=254  Identities=22%  Similarity=0.274  Sum_probs=207.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|....      ++..||+|++..........+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKG------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCC------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            4679999999999999999996543      5678999998766566677889999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCCCcc
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAK  233 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfGla~  233 (455)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||+   +.++.++|+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            9999999999999988765  56899999999999999999999977  9999999999999   788999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .......   .....||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+.      ..     
T Consensus       158 ~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~-----  222 (277)
T 3f3z_A          158 RFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR------EG-----  222 (277)
T ss_dssp             ECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-----
T ss_pred             eccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hC-----
Confidence            6544322   2335799999999988654 8999999999999999999999997654321111100      00     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         ............+..+.+|+.+||+.+|.+|||+.++++|-+
T Consensus       223 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  264 (277)
T 3f3z_A          223 ---TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW  264 (277)
T ss_dssp             ---CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             ---CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence               000000000124578899999999999999999999998743

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.4e-45  Score=371.34  Aligned_cols=272  Identities=23%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+.+|+.++||||+++++++... 
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            478999999999999999999543      35789999988542  334456788999999999999999999998543 


Q ss_pred             ----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          154 ----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       154 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                          ..+|+||||+ +|+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+||
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             cccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeeccc
Confidence                5689999998 67999888653  57999999999999999999999977  999999999999999999999999


Q ss_pred             CCccCCCCCCCc-------------------------cceeccccCCCCcCcccc-ccCCCCccCchhhHHHHHHHHHh-
Q 012832          230 GLAKDGPEGDDT-------------------------HVSTRVMGTQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELLS-  282 (455)
Q Consensus       230 Gla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~-  282 (455)
                      |+++........                         ...+..+||++|+|||++ .+..|+.++|||||||++|||++ 
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            999875432111                         122346799999999986 45679999999999999999999 


Q ss_pred             ----------CCCCCCCCCccch-----------------hhHHHhhhhhhH-------------hhhhhcccCCCccc-
Q 012832          283 ----------GRKSVDKSRPQRE-----------------QSLVEWARPMLN-------------DARKLGRIMDPRLE-  321 (455)
Q Consensus       283 ----------G~~p~~~~~~~~~-----------------~~~~~~~~~~~~-------------~~~~~~~~~~~~~~-  321 (455)
                                |+++|.+......                 ..........+.             ........+..... 
T Consensus       281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (458)
T 3rp9_A          281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT  360 (458)
T ss_dssp             STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred             ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence                      6677765432100                 000000000000             00000000000000 


Q ss_pred             --CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          322 --GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       322 --~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        .......+.++.+|+.+||..||++|||+.|+++|-+.
T Consensus       361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f  400 (458)
T 3rp9_A          361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF  400 (458)
T ss_dssp             CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence              01122346789999999999999999999999999543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=354.83  Aligned_cols=250  Identities=24%  Similarity=0.240  Sum_probs=196.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||+||+|....      +++.||||++....  ......+..|+..+..+ +||||+++++++..
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKE------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECC------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            34679999999999999999996543      57899999875432  23334455566555555 89999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceee
Confidence            99999999999 77999888765 457999999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.....     ...            
T Consensus       205 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~------------  263 (311)
T 3p1a_A          205 VELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQ------------  263 (311)
T ss_dssp             EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHH------------
T ss_pred             eecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHH------------
Confidence            86544322   233569999999998876 799999999999999999999766643210     000            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        +........++...+.++.+|+.+||+.+|++|||+.+++++.+
T Consensus       264 --~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          264 --LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             --HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             --HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence              00111111122234578999999999999999999999999854

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-45  Score=357.44  Aligned_cols=256  Identities=24%  Similarity=0.351  Sum_probs=196.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+++.++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDL------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEEC------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            578999999999999999999543      357899999986543   23345688999999999999999999998765


Q ss_pred             Ce----EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          154 EH----RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       154 ~~----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      ..    .|+||||++|++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCC
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeec
Confidence            43    49999999999999998765  47899999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........  .    ....
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~----~~~~  234 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--Q----HVRE  234 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H----HHHC
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--H----HhcC
Confidence            999865443221 12233579999999999999999999999999999999999999997654321110  0    0000


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                              ............+.++.+|+.+||+.||.+||+..+++.+
T Consensus       235 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          235 --------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             --------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence                    0000001122345778999999999999999988777765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.7e-44  Score=344.06  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=207.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|++....  ......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHK------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEc------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence            578999999999999999999654      357889999986543  234466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc---eEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT---AKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~---~kL~DfGl  231 (455)
                      ..++||||+++++|.+.+...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.   +||+|||+
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            999999999999999888765  56899999999999999999999976  999999999999976655   99999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.      ..   
T Consensus       155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~---  222 (284)
T 3kk8_A          155 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------AG---  222 (284)
T ss_dssp             CEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT---
T ss_pred             eEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH------hc---
Confidence            976544322   233579999999999999999999999999999999999999997653321111110      00   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ............+.++.+|+.+||+.+|++|||+.++++|.+
T Consensus       223 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (284)
T 3kk8_A          223 -----AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  264 (284)
T ss_dssp             -----CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred             -----cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence                 001111112344677999999999999999999999999843

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-44  Score=370.79  Aligned_cols=267  Identities=21%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++...  .......+.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYD------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEE------TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEE------CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            57899999999999999999954      335788999998643  334456788999999999999999999999654 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           ...||||||+++ +|.+.+.    ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEE
Confidence                 357999999965 5666663    34899999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-h----
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-R----  303 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~----  303 (455)
                      ||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.........+... .    
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          208 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998654322   233468999999999999999999999999999999999999999876533222111100 0    


Q ss_pred             ----hhhHhhhhhc----ccCCCcccCCC-----------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          304 ----PMLNDARKLG----RIMDPRLEGQY-----------SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       304 ----~~~~~~~~~~----~~~~~~~~~~~-----------~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          ..........    ......+...+           ....+.++.+|+.+||..||++|||+.|+++|-+.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence                0000000000    00000000001           11226789999999999999999999999999554

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.5e-45  Score=360.33  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=204.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++......    ..+|+++|..+ +||||+++++++.+...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHK------ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            467999999999999999999543      35789999998654332    34688888877 79999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC----CceEEccCCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD----YTAKLSDFGL  231 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~----~~~kL~DfGl  231 (455)
                      .|+||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||+..+    +.+||+|||+
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            99999999999999988764  57899999999999999999999976  9999999999998543    3599999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +.........  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+....   ..    
T Consensus       167 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~----  237 (342)
T 2qr7_A          167 AKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---GS----  237 (342)
T ss_dssp             CEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---HH----
T ss_pred             cccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---cc----
Confidence            9865443221  23467999999999998888999999999999999999999999764322222211111   00    


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          ....+...+....+.++.+|+.+||..||++|||+.++++|.+.
T Consensus       238 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          238 ----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             ----CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             ----CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence                01112223344567789999999999999999999999998554

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.6e-45  Score=355.49  Aligned_cols=254  Identities=26%  Similarity=0.323  Sum_probs=182.4

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      .+.||+|+||.||+|...      .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEET------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEEC------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            478999999999999653      35789999998643   3456678999999997 9999999999999999999999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC---ceEEccCCCccCCCCC
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEG  238 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~---~~kL~DfGla~~~~~~  238 (455)
                      |+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++   .+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999998765  57999999999999999999999976  99999999999997665   8999999999865443


Q ss_pred             CCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchh-hHHHhhhhhhHhhhhhcccCC
Q 012832          239 DDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ-SLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ...  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........+..        ..
T Consensus       163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--------~~  232 (325)
T 3kn6_A          163 NQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--------GD  232 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--------TC
T ss_pred             CCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--------CC
Confidence            221  23467899999999999999999999999999999999999999764332110 01111100000        00


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..+........+.++.+|+.+||..||.+|||+.++++|-+.
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~  274 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL  274 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence            011111112346789999999999999999999999988543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=354.89  Aligned_cols=265  Identities=25%  Similarity=0.416  Sum_probs=206.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ...+|.+.+.||+|+||.||+|.....  ....+..||||.+.... ......+.+|+.+++.++||||+++++++....
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecC--CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            456788899999999999999976542  22345679999987543 234456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999988754 457899999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||.......   .....          
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~----------  263 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAI----------  263 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----------
Confidence            54432211 1222456889999999999999999999999999999998 999997643221   11100          


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ..    ......+..++..+.+|+.+||+.+|++||++.+++++|+.+..
T Consensus       264 ~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          264 ND----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             HT----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HC----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00    01112234456789999999999999999999999999887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.2e-45  Score=358.76  Aligned_cols=256  Identities=23%  Similarity=0.291  Sum_probs=194.0

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||+|....      +++.||||++....  ..+.+.+|+.+|+.++||||+++++++.....
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKG------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECC------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            45789999999999999999996543      56789999986442  34567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEccCCCc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLA  232 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~DfGla  232 (455)
                      .++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.   ++.+||+|||++
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999999999988654  56899999999999999999999976  999999999999975   889999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ...   .+...    
T Consensus       199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i~~~----  266 (349)
T 2w4o_A          199 KIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RILNC----  266 (349)
T ss_dssp             -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HHHTT----
T ss_pred             cccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HHHhC----
Confidence            8654322   12336799999999999999999999999999999999999999975433210  110   00000    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          ............+.++.+|+.+||..||++|||+.++++|-+.
T Consensus       267 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  309 (349)
T 2w4o_A          267 ----EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV  309 (349)
T ss_dssp             ----CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             ----CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                0111122234456789999999999999999999999998543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.4e-45  Score=358.06  Aligned_cols=271  Identities=19%  Similarity=0.206  Sum_probs=201.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-----------hHHHHHHHHHHHhcCCCCCcc
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-----------GHREWLTEVIFLGQLRHPHLV  144 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv  144 (455)
                      ..++|.+.+.||+|+||.||+|.....   ...+..||||++......           ....+.+|+.++..++||||+
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNK---PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSS---CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCC---CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            346899999999999999999976431   235788999998654321           113366788999999999999


Q ss_pred             cEEEEEEe----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC
Q 012832          145 KLIGYCCE----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS  220 (455)
Q Consensus       145 ~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~  220 (455)
                      ++++++..    ....++||||+ +++|.+++....  .+++..++.++.||+.||+|||+.+  |+||||||+|||++.
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGY  186 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEES
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEcc
Confidence            99999988    67899999999 999999887653  7899999999999999999999976  999999999999988


Q ss_pred             CC--ceEEccCCCccCCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCcc
Q 012832          221 DY--TAKLSDFGLAKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ  293 (455)
Q Consensus       221 ~~--~~kL~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~  293 (455)
                      ++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            77  9999999999765432111     1113357999999999999999999999999999999999999999643211


Q ss_pred             chhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ... ..........   .+...+....   ....++.++.+|+.+||..+|++|||+.+|++.|+.+.
T Consensus       267 ~~~-~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          267 PVA-VQTAKTNLLD---ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHH-HHHHHHHHHH---TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cHH-HHHHHHhhcc---cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111 1110000000   0000000000   01134568999999999999999999999999998763

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=349.27  Aligned_cols=269  Identities=25%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++.....  .....+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNR------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEeeEEeecCCeEEEEEEeC------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence            67999999999999999999653      3578999998854432  334667899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            99999999999998876543  56899999999999999999999977  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh-------hh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP-------ML  306 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~-------~~  306 (455)
                      ......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... ..       ..
T Consensus       153 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          153 TGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence            433221  233579999999999976 56899999999999999999999999876543322222111 00       00


Q ss_pred             HhhhhhcccCCCcccCC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          307 NDARKLGRIMDPRLEGQ-----YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...........+.....     .....+..+.+|+.+||+.||++|||+.++++|-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  287 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY  287 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence            00000000000000000     01234567899999999999999999999999843

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.3e-45  Score=350.01  Aligned_cols=262  Identities=25%  Similarity=0.385  Sum_probs=199.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhc--CCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ--LRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|..        +++.||||++....   ...+..|.+++..  ++||||+++++++...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--------QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--------TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--------CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            457899999999999999999954        35789999986542   3445566666665  7899999999987543


Q ss_pred             ----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCeEEeccCCCCEEEcCC
Q 012832          154 ----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH--------DAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       154 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~iiHrDlkp~Nill~~~  221 (455)
                          ...++||||+++|+|.+++..   ..+++..++.++.|++.||+|||        +.+  |+||||||+|||++.+
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN  149 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC
Confidence                458999999999999999854   47899999999999999999999        755  9999999999999999


Q ss_pred             CceEEccCCCccCCCCCCCcc--ceeccccCCCCcCccccccC------CCCccCchhhHHHHHHHHHhC----------
Q 012832          222 YTAKLSDFGLAKDGPEGDDTH--VSTRVMGTQGYAAPEYVMTG------HLTSMSDVYSFGVVLLELLSG----------  283 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~G----------  283 (455)
                      +.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999999997543332211  11234799999999999876      455789999999999999999          


Q ss_pred             CCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCccc-CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          284 RKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE-GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       284 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..||....+...... . .....     ......+.+. ..++...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       230 ~~pf~~~~~~~~~~~-~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFE-D-MRKVV-----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCHH-H-HHHHH-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcchh-h-hhHHH-----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            788765432211110 0 00000     0001111111 112345778999999999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-45  Score=358.75  Aligned_cols=263  Identities=22%  Similarity=0.235  Sum_probs=202.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-----chhhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-----GLQGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      ....++|.+.+.||+|+||.||+|...      .++..||+|++...     .......+.+|+.+++.++||||+++++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIEN------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhheeecceeeecCCeEEEEEEEC------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            345678999999999999999999643      35788999998643     2344567889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcC--------------------------------------CCCCCHHHHHHHHH
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRY--------------------------------------SVSLPWSTRMKIAL  190 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~  190 (455)
                      ++.+.+..++||||+++|+|.+++....                                      ...+++..++.++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            9999999999999999999999884210                                      11235677888999


Q ss_pred             HHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC--ceEEccCCCccCCCCCCC--ccceeccccCCCCcCcccccc--CCC
Q 012832          191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDY--TAKLSDFGLAKDGPEGDD--THVSTRVMGTQGYAAPEYVMT--GHL  264 (455)
Q Consensus       191 ~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~--~~kL~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~  264 (455)
                      ||+.||+|||+.+  |+||||||+|||++.++  .+||+|||++........  ........||+.|+|||++.+  ..+
T Consensus       176 qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          176 QIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            9999999999976  99999999999998766  899999999975432211  112234679999999999975  678


Q ss_pred             CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCC
Q 012832          265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRP  344 (455)
Q Consensus       265 ~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P  344 (455)
                      +.++|||||||++|+|++|..||...........      ....        ...+........+..+.+|+.+||+.+|
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ------VLNK--------KLCFENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC--------CCCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHH------HHhc--------ccccCCcccccCCHHHHHHHHHHcCCCh
Confidence            9999999999999999999999976543211111      1100        0011111122346789999999999999


Q ss_pred             CCCCCHHHHHHhcc
Q 012832          345 KQRPTMSTVVKTLE  358 (455)
Q Consensus       345 ~~RPt~~ell~~L~  358 (455)
                      .+|||+.++++|.+
T Consensus       320 ~~Rps~~~~l~hp~  333 (345)
T 3hko_A          320 DERFDAMRALQHPW  333 (345)
T ss_dssp             TTSCCHHHHHHSHH
T ss_pred             hHCCCHHHHhcChh
Confidence            99999999999843

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-45  Score=348.56  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=210.0

Q ss_pred             hcCCCCCcc-cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSN-FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~-~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.. .||+|+||.||+|.+..    ...+..||||++.... ....+.+.+|+.+++.++||||+++++++ ..
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRM----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             cHHHhhhhhccccccCceeEEEeEecc----CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            345677776 99999999999997543    2246789999987643 34457788999999999999999999999 56


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECccccee
Confidence            6789999999999999988643 456899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          234 DGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-----------  227 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----------  227 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-----------
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-----------
Confidence            76443221 11222457899999999998889999999999999999998 999997654321111110           


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                        .    .....++..++.++.+|+.+||..+|++||++.+++++|+.+.
T Consensus       228 --~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          228 --Q----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             --T----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --c----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              0    0112234456788999999999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-44  Score=345.98  Aligned_cols=263  Identities=27%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|.+.+.||+|+||.||+|.+...   ...+..||+|.+... .....+.+.+|+.+++.++||||+++++++.. 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECT---TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCC---CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            3467899999999999999999976542   234567999998754 33445778899999999999999999999764 


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCc
Confidence            4578999999999999998764 356899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.       .    
T Consensus       162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-------~----  229 (281)
T 3cc6_A          162 YIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------K----  229 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-------H----
T ss_pred             cccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-------c----
Confidence            76443221 1223457889999999999999999999999999999998 999997654322111111       0    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        .    .....+..++..+.+|+.+||..+|++|||+.+++++|+.+..
T Consensus       230 --~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          230 --G----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             --T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence              0    0111233456779999999999999999999999999987643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.9e-45  Score=354.15  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=207.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh------hHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ------GHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||||++......      ....+.+|+.+++.++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREK------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY   84 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEEC------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            457999999999999999999643      35789999998654321      356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----ceEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKL  226 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----~~kL  226 (455)
                      ......++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++    .++|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEE
Confidence            9999999999999999999998654  57899999999999999999999976  99999999999999887    7999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+       
T Consensus       161 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-------  230 (321)
T 2a2a_A          161 IDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-------  230 (321)
T ss_dssp             CCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------
T ss_pred             ccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------
Confidence            99999987654322   23357999999999999999999999999999999999999999765322111100       


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         ....    ..+...+....+..+.+|+.+||..+|++|||+.++++|.+
T Consensus       231 ---~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          231 ---TSVS----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             ---HTTC----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             ---Hhcc----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence               0000    00110111233567899999999999999999999999843

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-44  Score=348.08  Aligned_cols=261  Identities=28%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             HhcCCCCCcc-cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           75 VTTQSFSSSN-FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~-~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+ .||+|+||.||+|.+..    ...+..||||++....  ......+.+|+.+++.++||||+++++++ 
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEEC----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ecchhhhhccCccccccCeeeEeeeecC----CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            3456788888 99999999999996643    2357889999986543  23356788999999999999999999999 


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCc
Confidence            667789999999999999998764  56899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          232 AKDGPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       232 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      +.......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---------  234 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---------  234 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---------
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---------
Confidence            98765433221 1222456789999999998889999999999999999999 999998654321111110         


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                          .    ......+..++..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       235 ----~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          235 ----K----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ----T----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----c----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                0    0111234456678999999999999999999999999987663

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-44  Score=350.96  Aligned_cols=269  Identities=23%  Similarity=0.249  Sum_probs=201.4

Q ss_pred             cCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           77 TQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      .+.|.+. +.||+|+||.||+|..      ..+++.||||++..........+.+|+.+|.++ +||||+++++++...+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCIN------LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEEC------SSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ceeEEecCceecCCceEEEEEEEE------cCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3567774 7899999999999953      346789999999766555567889999999885 7999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc---eEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT---AKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~---~kL~DfGl  231 (455)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.   +||+|||+
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999999999765  46899999999999999999999976  999999999999988765   99999999


Q ss_pred             ccCCCCCCCc-----cceeccccCCCCcCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          232 AKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMT-----GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       232 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      +.........     ......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            9765432211     11223569999999999975     5588999999999999999999999976543221100000


Q ss_pred             -----hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          302 -----ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       302 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                           ...........    ...+........+..+.+|+.+||..||++|||+.++++|.+.
T Consensus       241 ~~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          241 ACPACQNMLFESIQEG----KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             CCHHHHHHHHHHHHHC----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             cchhHHHHHHHHHhcc----CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence                 00000000000    0000000001245678999999999999999999999998543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.6e-45  Score=353.53  Aligned_cols=275  Identities=30%  Similarity=0.430  Sum_probs=212.1

Q ss_pred             CCC-CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           78 QSF-SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        78 ~~~-~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      ++| .+.+.||+|+||.||+|.+..  .+..+++.||||++.... ......+.+|+.+|+.++||||+++++++...  
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDP--TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECS--CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEcc--CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            344 899999999999999986643  335578899999987553 23456788999999999999999999999874  


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++|+|.+++...   .+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccc
Confidence            6789999999999999988654   5899999999999999999999977  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ........ .......||..|+|||++.+..++.++|||||||++|+|++|..||...... ......+...... ...+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMT-VLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHH-HHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchh-HHHH
Confidence            76544321 1223356888999999999999999999999999999999999999643111 0000000000000 0011


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ...+........+..++.++.+|+.+||+.+|++|||+.++++.|+.+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111122223345566788999999999999999999999999987764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.5e-44  Score=348.13  Aligned_cols=254  Identities=21%  Similarity=0.315  Sum_probs=206.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++..........+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQR------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccceeeeeccCCCCceEEEEEEC------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            467999999999999999999543      35789999998765444456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCCCcc
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLAK  233 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfGla~  233 (455)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||+   +.++.++|+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999999999988765  46899999999999999999999976  9999999999999   778999999999997


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..   .+...     
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~i~~~-----  222 (304)
T 2jam_A          158 MEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FE---KIKEG-----  222 (304)
T ss_dssp             CCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH---HHHHC-----
T ss_pred             ecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHcC-----
Confidence            643321    2235799999999999999999999999999999999999999976432211   11   00000     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         ...+........+..+.+|+.+||..+|++|||+.++++|.+
T Consensus       223 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          223 ---YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             ---CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ---CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence               001122233455678999999999999999999999998844

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.1e-45  Score=356.17  Aligned_cols=267  Identities=26%  Similarity=0.386  Sum_probs=207.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|.+... .+..++..||||.+... .......+.+|+.+++.++||||+++++++....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCC-CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            457899999999999999999975431 13446788999998643 3344567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEE
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYS-----VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKL  226 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL  226 (455)
                      ..++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.   +..++|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999976532     45889999999999999999999976  999999999999984   456999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   .....   
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~---  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV---  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH---
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHH---
Confidence            99999875433222222233568999999999999999999999999999999998 999997653221   11110   


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .       .    ......+..++..+.+|+.+||..+|.+|||+.+++++|+.+..
T Consensus       259 ~-------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 T-------S----GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             H-------T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             h-------c----CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            0       0    00112234456789999999999999999999999999987754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-44  Score=356.57  Aligned_cols=251  Identities=29%  Similarity=0.396  Sum_probs=204.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +.|.+.+.||+|+||.||+|...      .++..||||++....   ......+.+|+.+|+.++||||+++++++....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDV------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEc------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            45889999999999999999543      357899999986442   233466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+. |+|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999996 6888877544 357899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ....      ....||+.|+|||++.   +..++.++|||||||++|||++|.+||.........      .....    
T Consensus       204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~----  267 (348)
T 1u5q_A          204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ----  267 (348)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH----
T ss_pred             cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh----
Confidence            5432      2357999999999985   567899999999999999999999999765322111      00000    


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                         ...+.   ..+...+..+.+|+.+||+.+|++|||+.+++++.+..
T Consensus       268 ---~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          268 ---NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             ---SCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             ---cCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence               00111   11234457789999999999999999999999986544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=345.34  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=187.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+.+++.++||||+++++++...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESI------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEc------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            467999999999999999999543      3578899999864322   2346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            9999999999999999988754 357899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........                
T Consensus       161 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------  222 (278)
T 3cok_A          161 QLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------  222 (278)
T ss_dssp             ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred             eccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------
Confidence            65432221  223579999999999999899999999999999999999999997653221100                


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .+....  ...+...+.++.+|+.+||..+|++|||+.++++|.+
T Consensus       223 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          223 KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             -CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence            000010  1223445678899999999999999999999998844

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.6e-44  Score=372.71  Aligned_cols=259  Identities=23%  Similarity=0.357  Sum_probs=211.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+.+|+.++||||+++++++..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  256 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMK------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET  256 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEC------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence            3478999999999999999999653      3578999999864422   334678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+|+||||++||+|.+++....  ...+++..+..++.||+.||+|||+.+  |+||||||+||||+.+|.+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecc
Confidence            999999999999999999887643  356999999999999999999999977  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +++........  ....+||+.|+|||++.+..++.++|||||||++|||++|.+||..........  .....+...  
T Consensus       335 la~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~~--  408 (543)
T 3c4z_A          335 LAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLEQ--  408 (543)
T ss_dssp             TCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHHC--
T ss_pred             eeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhhc--
Confidence            99876543221  233589999999999999999999999999999999999999997653221111  111111110  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~L~  358 (455)
                                ...++...+..+.+|+.+||..+|.+||++     .++++|-+
T Consensus       409 ----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf  451 (543)
T 3c4z_A          409 ----------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL  451 (543)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred             ----------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence                      112344566789999999999999999964     78888743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=358.18  Aligned_cols=246  Identities=24%  Similarity=0.291  Sum_probs=203.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||||++.....        .....+.+|+.+|+.++||||+++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~   96 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDK------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD   96 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEET------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred             ccceEEEeEEEecCCEEEEEEEEC------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            467999999999999999999543      3578999999865421        12234667999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          149 YCCEEEHRLLVYEYMPRG-SLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      ++...+..++||||+.+| +|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~  172 (335)
T 3dls_A           97 IFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLI  172 (335)
T ss_dssp             EEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEEC
T ss_pred             EEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEe
Confidence            999999999999999776 999988654  56999999999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      |||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......             
T Consensus       173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------  236 (335)
T 3dls_A          173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------  236 (335)
T ss_dssp             CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------
T ss_pred             ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------
Confidence            9999987654322   233679999999999988876 88999999999999999999999642110             


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                               .....  ..+...+.++.+|+.+||+.+|++|||+.+++++.+.
T Consensus       237 ---------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          237 ---------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             ---------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             ---------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                     00000  1122345779999999999999999999999999654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=351.25  Aligned_cols=272  Identities=24%  Similarity=0.370  Sum_probs=204.1

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC--CCCCcccEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL--RHPHLVKLIG  148 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~  148 (455)
                      .......++|.+.+.||+|+||.||+|...        +..||||++....   ...+..|.+++..+  +||||+++++
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~   98 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA   98 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence            334455678999999999999999999542        5789999985432   23445566666554  8999999999


Q ss_pred             EEEeC----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeEEeccCCCCEEE
Q 012832          149 YCCEE----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA------EKPVIYRDFKASNILL  218 (455)
Q Consensus       149 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~iiHrDlkp~Nill  218 (455)
                      ++...    ...++||||+++|+|.+++...   .+++..++.++.|++.||+|||+.      ..+|+||||||+|||+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A           99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             EEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             EEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence            99887    7899999999999999998654   689999999999999999999986      1149999999999999


Q ss_pred             cCCCceEEccCCCccCCCCCCCcc--ceeccccCCCCcCccccccCCCCcc------CchhhHHHHHHHHHhC-------
Q 012832          219 DSDYTAKLSDFGLAKDGPEGDDTH--VSTRVMGTQGYAAPEYVMTGHLTSM------SDVYSFGVVLLELLSG-------  283 (455)
Q Consensus       219 ~~~~~~kL~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~ell~G-------  283 (455)
                      +.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997654432211  1123579999999999988776665      9999999999999999       


Q ss_pred             ---CCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          284 ---RKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       284 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         ..||....+..... ..     ..... ......+.+...+ ...++.++.+|+.+||+.||.+|||+.+++++|+.
T Consensus       256 ~~~~~p~~~~~~~~~~~-~~-----~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSY-ED-----MREIV-CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCCCTTTTTSCSSCCH-HH-----HHHHH-TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCch-hh-----hHHHH-hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence               56664432211110 00     00000 0111122222111 23678899999999999999999999999999988


Q ss_pred             ccCC
Q 012832          360 LKDF  363 (455)
Q Consensus       360 ~~~~  363 (455)
                      +...
T Consensus       329 l~~~  332 (337)
T 3mdy_A          329 MSES  332 (337)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            7543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9e-45  Score=355.50  Aligned_cols=272  Identities=19%  Similarity=0.247  Sum_probs=197.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ...++|.+.+.||+|+||.||+|...      .+++.||||++......  ....+.+|+.+|+.++||||+++++++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDT------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEET------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEEC------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            34578999999999999999999543      35789999998654332  23557789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE-----cCCCceEEc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL-----DSDYTAKLS  227 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill-----~~~~~~kL~  227 (455)
                      ....++||||++ |+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||+     +.++.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999996 5999988765  46899999999999999999999976  9999999999999     455669999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh-
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM-  305 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~-  305 (455)
                      |||++........  ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+...... 
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999976533221  12335789999999999875 4899999999999999999999999865432211111100000 


Q ss_pred             ----hHhhhhh-------cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          306 ----LNDARKL-------GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       306 ----~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          +......       .......+...+....+.++.+|+.+||+.||++|||+.++++|-+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence                0000000       00000000000112245788999999999999999999999998543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.6e-44  Score=344.01  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=207.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ecceEEEEEeecCCCcEEEEEEEC------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence            467999999999999999999643      357889999986543 2345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999999999987543  56899999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+...          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~----------  224 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----------  224 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT----------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc----------
Confidence            43322222334679999999999987665 7789999999999999999999976543211 11111100          


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ..........+..+.+|+.+||+.+|++|||+.+++++.+
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          225 ----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             ----CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ----ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence                0000112344677899999999999999999999998854

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-44  Score=356.52  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+.+|+.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDG------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEET------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEEC------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            578999999999999999999543      35789999998543  2334567889999999999999999999997653


Q ss_pred             ------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          155 ------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       155 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                            ..|+||||+ +++|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEe
Confidence                  459999999 8899998865   36899999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--h-
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--P-  304 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~-  304 (455)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.........+....  + 
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999875432     233679999999999987 679999999999999999999999998765432221111000  0 


Q ss_pred             --hh---------HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          305 --ML---------NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       305 --~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        .+         .....+.......+ .......+..+.+|+.+||..||++|||+.++++|-.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence              00         00001111111111 1223345678999999999999999999999999843

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-44  Score=347.30  Aligned_cols=261  Identities=21%  Similarity=0.237  Sum_probs=201.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+.+++.++||||+++++++..
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDT------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI  105 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEET------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEc------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence            3578999999999999999999643      3578899999865432   234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            99999999999999999998765  46899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......   ....    .+.     
T Consensus       182 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~~~-----  248 (309)
T 2h34_A          182 SATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGA----HIN-----  248 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHH----HHH-----
T ss_pred             ccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHH----Hhc-----
Confidence            765443221 123357999999999999999999999999999999999999999764321   0000    000     


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-TMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-t~~ell~~L~~~~~  362 (455)
                       ...  ......+..++.++.+|+.+||..+|++|| +++++++.|+....
T Consensus       249 -~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          249 -QAI--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             -SCC--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             -cCC--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence             000  011122344567789999999999999999 99999999877644

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.6e-44  Score=382.64  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=210.0

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcC-CCCCcccEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQL-RHPHLVKLIGY  149 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~  149 (455)
                      .+..++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+..|..+|..+ +||||+.++++
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERK------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEES------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEEC------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            345678999999999999999999643      357889999986432   23345678899999988 69999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +...+.+||||||++||+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+||
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCC
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeec
Confidence            99999999999999999999999765  46999999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      |+++........  ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||........      ...+.   
T Consensus       487 Gla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~---  555 (674)
T 3pfq_A          487 GMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM---  555 (674)
T ss_dssp             TTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH---
T ss_pred             ceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHH---
Confidence            999864433222  3447899999999999999999999999999999999999999986543211      11111   


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM-----STVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~-----~ell~~L~  358 (455)
                             ..  ...++...+.++.+||.+||+.||++||++     .+|++|-.
T Consensus       556 -------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f  600 (674)
T 3pfq_A          556 -------EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  600 (674)
T ss_dssp             -------SS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred             -------hC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence                   11  113445567889999999999999999998     88888743

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.1e-44  Score=342.05  Aligned_cols=253  Identities=22%  Similarity=0.339  Sum_probs=202.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe---
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE---  152 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  152 (455)
                      ..|.+.+.||+|+||.||+|....      ++..||+|.+....  ......+.+|+.+|+.++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecC------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            447888899999999999996543      57789999886442  3345678899999999999999999999875   


Q ss_pred             -CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-CCCceEEccCC
Q 012832          153 -EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-SDYTAKLSDFG  230 (455)
Q Consensus       153 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-~~~~~kL~DfG  230 (455)
                       ....++||||+++|+|.+++...  ..+++..++.++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             35689999999999999999765  568999999999999999999998665699999999999998 78999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++.......    .....||+.|+|||++. +.++.++|||||||++|+|++|..||........  ....         
T Consensus       178 ~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~---------  241 (290)
T 1t4h_A          178 LATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR---------  241 (290)
T ss_dssp             GGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH---------
T ss_pred             Ccccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHH---------
Confidence            997544322    23357999999999886 4599999999999999999999999976432211  1100         


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          +........++...+.++.+|+.+||+.+|.+|||+.++++|.+
T Consensus       242 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          242 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             ----HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ----HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence                00011111122333467899999999999999999999999854

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=343.83  Aligned_cols=256  Identities=20%  Similarity=0.256  Sum_probs=204.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcCCCCCcccEEEEEE-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQLRHPHLVKLIGYCC-  151 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-  151 (455)
                      .++|.+.+.||+|+||.||+|..      ..++..||+|++....    ......+.+|+.+++.++||||+++++++. 
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLD------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN   77 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEB------TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccceeEeeEEecCCCeEEEEEEE------CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            46899999999999999999954      3457899999986543    234567889999999999999999999984 


Q ss_pred             -eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          152 -EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       152 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                       .....++||||++++ |.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||
T Consensus        78 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             C---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccc
Confidence             445789999999765 877777666678999999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ++................||+.|+|||++.+..  ++.++|||||||++|+|++|..||........   ..   .+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~i~~~  228 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---FE---NIGKG  228 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHHC
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HH---HHhcC
Confidence            998765433333334467999999999997654  37799999999999999999999986432111   10   00000


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                                  ...++..++..+.+|+.+||..||.+|||+.++++|.+.
T Consensus       229 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          229 ------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             ------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             ------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                        011233456778999999999999999999999998543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.4e-44  Score=346.60  Aligned_cols=262  Identities=22%  Similarity=0.333  Sum_probs=199.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||||++...   .......+.+|+.+++.++||||+++++++...
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEET------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceEEEEeecCCCCceEEEEEEc------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            457999999999999999999643      35789999998642   334456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            9999999999999999988642  3467899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....   .       
T Consensus       183 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~-------  249 (310)
T 2wqm_A          183 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---K-------  249 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH---H-------
T ss_pred             eeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH---H-------
Confidence            986543221  1223579999999999999999999999999999999999999997543211 11111   0       


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      +..   ...........+.++.+|+.+||..||++|||+.++++.|+.+..
T Consensus       250 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          250 IEQ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             HHT---TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhc---ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            000   011111123456789999999999999999999999999987754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=355.17  Aligned_cols=266  Identities=24%  Similarity=0.298  Sum_probs=207.7

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  152 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++..........+.+|+.+++.++||||+++++++..  
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGL------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEET------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEec------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            34678999999999999999999543      3578999999876666667788999999999999999999999873  


Q ss_pred             --CCeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          153 --EEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       153 --~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                        ....++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEe
Confidence              34789999999999999988753  3467899999999999999999999976  99999999999999999999999


Q ss_pred             CCCccCCCCCCCcc-------ceeccccCCCCcCccccccCC---CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH
Q 012832          229 FGLAKDGPEGDDTH-------VSTRVMGTQGYAAPEYVMTGH---LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL  298 (455)
Q Consensus       229 fGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~  298 (455)
                      ||++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||........ ..
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~  256 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV  256 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh
Confidence            99987643211100       011245799999999987654   68899999999999999999999953110000 00


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      ...          ...    ..........+..+.+|+.+||+.+|.+|||+.+++++|+.+...
T Consensus       257 ~~~----------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          257 ALA----------VQN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHH----------HHC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hHH----------hhc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            000          000    111112234567899999999999999999999999999887543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=353.06  Aligned_cols=270  Identities=22%  Similarity=0.304  Sum_probs=198.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhH-HHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||++........ ..+.+|+.+|+.++||||+++++++......
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            57899999999999999999643      3578899999865432211 2345799999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||++ |+|.+++... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999996 6999888754 457899999999999999999999976  9999999999999999999999999998654


Q ss_pred             CCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh--------hhH
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP--------MLN  307 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~--------~~~  307 (455)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....        ...
T Consensus       152 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          152 IPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            3222  1233578999999999876 5689999999999999999999999987654322221111000        000


Q ss_pred             hhhhhcccCCCcccC----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          308 DARKLGRIMDPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..........+....    ......+.++.+|+.+||+.||++|||+.++++|-+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  285 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF  285 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence            000000000000000    0112345678999999999999999999999998554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.9e-44  Score=344.22  Aligned_cols=253  Identities=25%  Similarity=0.323  Sum_probs=208.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|....      +++.||+|++....   ......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            4679999999999999999996543      56789999986442   23456688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCce
Confidence            9999999999999999988665  47899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........  .    ..       
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~----~~-------  228 (294)
T 2rku_A          164 KVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--R----IK-------  228 (294)
T ss_dssp             ECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H----HH-------
T ss_pred             ecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----Hh-------
Confidence            65433221  233579999999999998889999999999999999999999997653221100  0    00       


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         ..  ...++...+..+.+|+.+||+.+|++|||+.+++++.+.
T Consensus       229 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          229 ---KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             ---TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             ---hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence               00  011233455778999999999999999999999998543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.8e-45  Score=344.07  Aligned_cols=258  Identities=27%  Similarity=0.440  Sum_probs=210.2

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|.+.+.||+|+||.||+|...+       +..||+|++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   76 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   76 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EchhheeeeeEecCCCceeEEEEEecC-------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345789999999999999999996542       46799999875433 3467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             CeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccc
Confidence            999999999999999988754 356899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...   +       .
T Consensus       154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~---i-------~  219 (267)
T 3t9t_A          154 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VED---I-------S  219 (267)
T ss_dssp             BCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---H-------H
T ss_pred             cccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHH---H-------h
Confidence            533211 11122457889999999999999999999999999999999 8999976532211   110   0       0


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..    .....+...+..+.+|+.+||..+|++|||+.+++++|+.+.
T Consensus       220 ~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          220 TG----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             TT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC----CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00    111123344678899999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.4e-45  Score=346.45  Aligned_cols=260  Identities=29%  Similarity=0.442  Sum_probs=210.3

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +.+..++|.+.+.||+|+||.||+|...+       +..||||.+.... .....+.+|+.+|+.++||||+++++++. 
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcC-------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            34556789999999999999999996532       4579999986543 34567889999999999999999999876 


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..++||||+++++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccc
Confidence            456899999999999999987553347899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   ....          
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----------  222 (279)
T 1qpc_A          157 RLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQN----------  222 (279)
T ss_dssp             EECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----------
T ss_pred             ccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHH----------
Confidence            876443211 1223457889999999998899999999999999999999 999997653321   1110          


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      +...    .....+..++..+.+|+.+||..+|++|||+.++++.|+.+.
T Consensus       223 ~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          223 LERG----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             HHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhcc----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            0000    111223445678999999999999999999999999988764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.4e-44  Score=342.82  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=208.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|....      ++..||||++....   ......+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQ------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcC------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            45689999999999999999996533      56789999985432   2234678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      ....++||||+++|+|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~  161 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWS  161 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEeccccc
Confidence            99999999999999999998765  46899999999999999999999976  999999999999999999999999998


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      .......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........      .+.      
T Consensus       162 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~------  225 (284)
T 2vgo_A          162 VHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIV------  225 (284)
T ss_dssp             EECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH------
T ss_pred             ccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHh------
Confidence            7654322    223579999999999999999999999999999999999999997643221110      000      


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ..  ...++...+..+.+|+.+||..+|.+|||+.++++|.+
T Consensus       226 ----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~  265 (284)
T 2vgo_A          226 ----NV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW  265 (284)
T ss_dssp             ----TT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred             ----cc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence                00  11233445678899999999999999999999999844

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-44  Score=343.18  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=201.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .++..||+|++.... ......+.+|+.+|+.++||||+++++++.....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEER------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhheeecceeccCCCeEEEEEEEc------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            467999999999999999999643      357889999986543 2345778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFG  230 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfG  230 (455)
                      .++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.+  |+||||||+|||+   +.++.+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            99999999999999988653  2467999999999999999999999976  9999999999999   456889999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++........   .....||+.|+|||++. ..++.++|||||||++|+|++|..||.............+         
T Consensus       173 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~---------  239 (285)
T 3is5_A          173 LAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY---------  239 (285)
T ss_dssp             CCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred             cceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc---------
Confidence            9986543321   23367999999999875 5689999999999999999999999986543221111110         


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ..+.... .....+.++.+|+.+||+.||++|||+.++++|-+
T Consensus       240 -----~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          240 -----KEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             -----CCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             -----CCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence                 0011110 01113567889999999999999999999998743

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.4e-44  Score=351.50  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=208.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...+      +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4679999999999999999996543      57789999986432   23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++++|.+++...  ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCce
Confidence            9999999999999999988765  57899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........      .+...     
T Consensus       190 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~-----  256 (335)
T 2owb_A          190 KVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKN-----  256 (335)
T ss_dssp             ECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHT-----
T ss_pred             ecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcC-----
Confidence            65433221  233679999999999999899999999999999999999999997643211100      00000     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         .    ..++...+..+.+|+.+||+.||++|||+.+++++.+
T Consensus       257 ---~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          257 ---E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             ---C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             ---C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence               0    1123344567899999999999999999999999844

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-44  Score=352.96  Aligned_cols=261  Identities=20%  Similarity=0.283  Sum_probs=208.1

Q ss_pred             HHhcCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCC-CCCcccEEEE
Q 012832           74 KVTTQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLR-HPHLVKLIGY  149 (455)
Q Consensus        74 ~~~~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~  149 (455)
                      ....+.|.+. +.||+|+||.||+|...      .+++.||||++....  ......+.+|+.++..+. ||||++++++
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISK------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEEC------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4445667777 89999999999999653      357899999986533  233567889999999995 6999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEE
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKL  226 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL  226 (455)
                      +......++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.   ++.+||
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEE
Confidence            999999999999999999999887665678999999999999999999999976  999999999999987   789999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.      
T Consensus       176 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------  246 (327)
T 3lm5_A          176 VDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS------  246 (327)
T ss_dssp             CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------
T ss_pred             eeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH------
Confidence            99999987643322   233579999999999999999999999999999999999999997654321111110      


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                          .    .............+..+.+|+.+||+.+|.+|||+.++++|.+.
T Consensus       247 ----~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          247 ----Q----VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             ----H----TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             ----h----cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence                0    01111222234456789999999999999999999999998543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-44  Score=359.28  Aligned_cols=269  Identities=23%  Similarity=0.324  Sum_probs=207.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||+|++.... ......+.+|+.+|+.++||||+++++++...+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHK------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             ccccceeeeeecCCCCeEEEEEEEC------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            3568999999999999999999654      357899999987553 334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+. +  |+||||||+|||++.++.++|+|||++.
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            999999999999999998765  4689999999999999999999984 6  9999999999999999999999999986


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh----------
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR----------  303 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~----------  303 (455)
                      .....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||................          
T Consensus       181 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          181 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             ccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            43221    1223579999999999999999999999999999999999999998654322111100000          


Q ss_pred             ----------------hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          304 ----------------PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       304 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                      +..........+.............+.++.+|+.+||+.||++|||+.++++|.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                            0000000000000001111112234678999999999999999999999999854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.5e-45  Score=348.02  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=201.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      +..++|.+.+.||+|+||.||+|..        .+..||||++....  ..+.+.+|+.+++.++||||+++++++... 
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3457899999999999999999954        25689999986543  456788999999999999999999987654 


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccc
Confidence            47899999999999999997654344889999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......     ....+++.|+|||++.+..++.++|||||||++|+|++ |..||........   ...          +
T Consensus       166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----------~  227 (278)
T 1byg_A          166 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----------V  227 (278)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH----------H
T ss_pred             cccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----------H
Confidence            654321     22468899999999999999999999999999999998 9999976533211   110          0


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          ........+..++..+.+++.+||+.+|++|||+.++++.|+.++.
T Consensus       228 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          228 ----EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ----TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                0111122344556789999999999999999999999999887643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.3e-44  Score=368.51  Aligned_cols=255  Identities=26%  Similarity=0.337  Sum_probs=205.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+|+.++||||+++++++....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDR------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEET------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcceEEeEEEeecCCEEEEEEEEC------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            467999999999999999999543      357899999985432  234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc---CCCceEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD---SDYTAKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~---~~~~~kL~DfGl  231 (455)
                      ..++||||+.+|+|.+.+...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++   .++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            999999999999999988765  47899999999999999999999977  99999999999995   456799999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +........   ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+.      ..   
T Consensus       171 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~---  237 (486)
T 3mwu_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE------TG---  237 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT---
T ss_pred             CeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC---
Confidence            986543321   233579999999999875 59999999999999999999999997654321111110      00   


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                           ............+.++.+|+.+||..+|.+|||+.++++|.+.
T Consensus       238 -----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~  280 (486)
T 3mwu_A          238 -----KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI  280 (486)
T ss_dssp             -----CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred             -----CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence                 0001111123456789999999999999999999999998543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=358.55  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=198.7

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-CCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-EEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~  156 (455)
                      .|.+.+.||+|+||.||+|.+.+.   ......||||.+... .......+.+|+.+++.++||||+++++++.. ++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET---TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC---CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            466788999999999999976432   223457999998643 33455778999999999999999999998754 4578


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999988653 456889999999999999999999976  9999999999999999999999999998654


Q ss_pred             CCCCc--cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          237 EGDDT--HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       237 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+.      .    . 
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------~----~-  312 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------Q----G-  312 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------T----T-
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------c----C-
Confidence            33211  11233567889999999999999999999999999999999 788887654332111111      0    0 


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        .    ....+..++..+.+++.+||..+|++|||+.+++++|+.+..
T Consensus       313 --~----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          313 --R----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             --C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              0    111234456789999999999999999999999999987754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.9e-44  Score=363.96  Aligned_cols=271  Identities=22%  Similarity=0.309  Sum_probs=198.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+.+|+.++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDK------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEEC------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            578999999999999999999643      35789999998643  334456788999999999999999999998776 


Q ss_pred             ----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          154 ----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       154 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                          ...|+||||++ |+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+||
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccC
Confidence                57899999995 6999988653  57999999999999999999999977  999999999999999999999999


Q ss_pred             CCccCCCCCCCc--------------------cceeccccCCCCcCcccc-ccCCCCccCchhhHHHHHHHHHhCCCC--
Q 012832          230 GLAKDGPEGDDT--------------------HVSTRVMGTQGYAAPEYV-MTGHLTSMSDVYSFGVVLLELLSGRKS--  286 (455)
Q Consensus       230 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~p--  286 (455)
                      |+++........                    ...+..+||++|+|||++ .+..++.++|||||||++|||++|..|  
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999876443221                    112457899999999986 556699999999999999999985444  


Q ss_pred             ---------CCCCCccc--------------hhhHHHhhhhhhH-------------hhhhhcccCCCcccC---CCCHH
Q 012832          287 ---------VDKSRPQR--------------EQSLVEWARPMLN-------------DARKLGRIMDPRLEG---QYSET  327 (455)
Q Consensus       287 ---------~~~~~~~~--------------~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~---~~~~~  327 (455)
                               |.+.....              ....+......+.             ........+......   .....
T Consensus       254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (432)
T 3n9x_A          254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS  333 (432)
T ss_dssp             SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred             cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence                     43322100              0000000000000             000000000000000   00123


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          328 GARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       328 ~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .+.++.+|+.+||..||++|||+.++++|.+
T Consensus       334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  364 (432)
T 3n9x_A          334 ISDDGINLLESMLKFNPNKRITIDQALDHPY  364 (432)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence            4678999999999999999999999999944

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8e-45  Score=378.56  Aligned_cols=262  Identities=28%  Similarity=0.398  Sum_probs=213.1

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      .+.+..++|.+.+.||+|+||.||+|.+..       +..||||+++... ...+.+.+|+.+|+.++||||+++++++.
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            344566788999999999999999997643       3469999987544 33567899999999999999999999986


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      . ...+|||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccccc
Confidence            5 67899999999999999997654557899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||........   ....        
T Consensus       410 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i--------  477 (535)
T 2h8h_A          410 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV--------  477 (535)
T ss_dssp             TTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHH--------
T ss_pred             ceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH--------
Confidence            986543211 11122457889999999999999999999999999999999 9999976543211   1100        


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        ..    ......+..++..+.+||.+||+.+|++|||+.+|++.|+.+..
T Consensus       478 --~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          478 --ER----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --Hc----CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence              00    01112344567789999999999999999999999999987754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-44  Score=352.59  Aligned_cols=269  Identities=23%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....  .....+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            467999999999999999999654      3578899998754332  33455789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            99999999999888876543  356999999999999999999999976  99999999999999999999999999976


Q ss_pred             CCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-h-------hh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-R-------PM  305 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~-------~~  305 (455)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+... .       ..
T Consensus       174 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          174 LAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            543322  12335799999999999875 6899999999999999999999999876433221111100 0       00


Q ss_pred             hHhhhhhcccCCCcccCC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          306 LNDARKLGRIMDPRLEGQ-----YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      +...........+.+...     .....+..+.+|+.+||+.||++|||+.++++|-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            011001111111111111     1123467899999999999999999999999884

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.5e-45  Score=356.41  Aligned_cols=262  Identities=24%  Similarity=0.308  Sum_probs=192.7

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEe
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCE  152 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~  152 (455)
                      .+...+|.+.+.||+|+||.||+|...      .+++.||||++..........+.+|+.++..+. ||||+++++++..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDV------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEET------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             eccCceEEEEEEEccCCceEEEEEEEC------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            345568999999999999999999653      357889999987666666678899999999996 9999999999853


Q ss_pred             --------CCeEEEEEEecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          153 --------EEHRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       153 --------~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                              ....++||||+. |+|.+++... ....+++..++.++.||+.||+|||+.+.+|+||||||+||||+.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence                    345899999994 7999888652 345699999999999999999999986656999999999999999999


Q ss_pred             eEEccCCCccCCCCCCCcc----------ceeccccCCCCcCcccc---ccCCCCccCchhhHHHHHHHHHhCCCCCCCC
Q 012832          224 AKLSDFGLAKDGPEGDDTH----------VSTRVMGTQGYAAPEYV---MTGHLTSMSDVYSFGVVLLELLSGRKSVDKS  290 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~G~~p~~~~  290 (455)
                      +||+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            9999999998765432211          01135699999999998   5667899999999999999999999999753


Q ss_pred             CccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ....                    +.............+..+.+|+.+||+.+|.+|||+.+++++|+.+..
T Consensus       257 ~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          257 AKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2210                    001111111122233557899999999999999999999999987754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5e-44  Score=344.73  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=205.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEE-eCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCC-EEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~  154 (455)
                      ..+|.+.+.||+|+||.||+|...+.   ......||+|.+... .......+.+|+.+++.++||||+++++++. .+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecC---CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            35688899999999999999976432   223456899988643 3344567889999999999999999999865 456


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccccccc
Confidence            789999999999999988653 456899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCc--cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          235 GPEGDDT--HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       235 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      .......  .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+.           
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-----------  246 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-----------  246 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-----------
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-----------
Confidence            5443211  11233568889999999999999999999999999999999 666776543322111110           


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        ..    .....+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       247 --~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          247 --QG----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             --TT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cC----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              00    0111233445779999999999999999999999999887654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=377.96  Aligned_cols=259  Identities=27%  Similarity=0.378  Sum_probs=205.1

Q ss_pred             CCCCCcc-cccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSN-FLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~-~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      +++.+.+ .||+|+||.||+|.+...    ..+..||||+++... ....+.+.+|+.+|+.++||||+++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECS----SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecC----CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            3444444 799999999999976542    245679999997543 3456789999999999999999999999876 56


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .+|||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++..
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            89999999999999988654 457999999999999999999999976  999999999999999999999999999876


Q ss_pred             CCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          236 PEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       236 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.             
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------------  553 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------------  553 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence            4432211 1122346789999999999999999999999999999998 999998754432111110             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                          .......+..++.++.+||.+||..+|++||++.+|++.|+.+.
T Consensus       554 ----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          554 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                00112234556788999999999999999999999999987653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6e-44  Score=345.13  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=209.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .+.|.+.+.||+|+||.||+|...      .+++.||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDN------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEEC------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            456899999999999999999543      357899999986543 3445778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999999998854   46899999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+             ...
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~  234 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------------PKN  234 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHS
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-------------hcC
Confidence            43321  123357999999999999999999999999999999999999999765332111100             001


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ..+    .++..++..+.+|+.+||..+|.+|||+.+++++.+..
T Consensus       235 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          235 NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             CCC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence            111    22334456789999999999999999999999986543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-44  Score=345.39  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=205.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe---
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE---  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  152 (455)
                      ...+|.+.+.||+|+||.||+|...      .+++.||+|.+....    ..+.+|+.+++.++||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEc------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            3467999999999999999999654      357899999986543    245689999999999999999998864   


Q ss_pred             -------------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc
Q 012832          153 -------------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD  219 (455)
Q Consensus       153 -------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~  219 (455)
                                   ....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~  156 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV  156 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc
Confidence                         345899999999999999998765678999999999999999999999976  99999999999999


Q ss_pred             CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          220 SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       220 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      .++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..|+...     ... 
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~-  227 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKF-  227 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHH-
T ss_pred             CCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHH-
Confidence            999999999999987654322   22356999999999999999999999999999999999999887321     000 


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                            ...      +...    .++...+..+.+|+.+||..+|.+|||+.+++++|+.++.
T Consensus       228 ------~~~------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          228 ------FTD------LRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             ------HHH------HHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ------HHH------hhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                  000      0011    1223345678999999999999999999999999987754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-44  Score=351.63  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=206.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccc--cEEEEecccc-chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQ--PVAVKNLDLE-GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      .++|.+.+.||+|+||.||+|....      ++.  .||+|.+... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKK------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEE------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEcc------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            4689999999999999999996543      344  4599987643 233445688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL  218 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill  218 (455)
                      .+..++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+.+  |+||||||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~  175 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV  175 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEE
Confidence            999999999999999999987542              247899999999999999999999976  9999999999999


Q ss_pred             cCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhh
Q 012832          219 DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQS  297 (455)
Q Consensus       219 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~  297 (455)
                      +.++.+||+|||++.......   ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---  249 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---  249 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---
T ss_pred             cCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---
Confidence            999999999999997533211   1222457889999999998889999999999999999998 999997654321   


Q ss_pred             HHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          298 LVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      ...          .+..    ......+..++..+.+|+.+||..+|.+|||+.+++++|..+...
T Consensus       250 ~~~----------~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          250 LYE----------KLPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HHH----------HGGG----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHH----------Hhhc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            111          0000    111123345567899999999999999999999999999877543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=350.25  Aligned_cols=274  Identities=25%  Similarity=0.287  Sum_probs=200.7

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-----HHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-----HREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      ...++|.+.+.||+|+||.||+|..      ..+++.||||++.......     ...+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARD------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA   80 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEEC------SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEE------CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            3457899999999999999999953      3457899999986533211     2457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +......++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           81 FGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             ECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999965 888877653 356889999999999999999999977  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh--hhh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR--PML  306 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~--~~~  306 (455)
                      |++........  ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+....  +..
T Consensus       157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99987643322  12346799999999999764 58999999999999999999999998754322111110000  000


Q ss_pred             ---HhhhhhcccCCCcccCC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          307 ---NDARKLGRIMDPRLEGQ-----YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       307 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                         .................     .....+.++.+|+.+||..||++|||+.++++|.+.-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence               00000000000000000     1133457899999999999999999999999996543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-44  Score=342.44  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=206.3

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE-
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR-  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-  156 (455)
                      .|.+.+.||+|+||.||+|.+.+.   ...+..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ---AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS---SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecC---CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            466679999999999999976542   2345579999986433 34456788999999999999999999999876655 


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999988653 467899999999999999999999977  9999999999999999999999999998654


Q ss_pred             CCCC--ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCC-CCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          237 EGDD--THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR-KSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       237 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....  ........||+.|+|||.+.+..++.++|||||||++|+|++|. +||...........+.             
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------------  242 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------------  242 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------------
Confidence            3221  11122356889999999999999999999999999999999954 5555433322111111             


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .    ......+..++..+.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       243 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          243 Q----GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c----CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0    00112234456789999999999999999999999999887643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.9e-44  Score=368.83  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=201.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .+.|.+.+.||+|+||.||+|..      ..++..||||++....  ......+.+|+.+|+.++||||+++++++....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  109 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRD------KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR  109 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEE------TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             hcCeEEeeEEecCCCEEEEEEEE------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            45699999999999999999954      3357889999986442  233467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~DfGl  231 (455)
                      ..++|||||++|+|.+.+...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            999999999999999988765  56899999999999999999999976  999999999999976   45599999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      +........   ....+||+.|+|||++. ..++.++|||||||++|+|++|.+||...........+.      .    
T Consensus       186 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~----  251 (494)
T 3lij_A          186 SAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------K----  251 (494)
T ss_dssp             CEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H----
T ss_pred             CeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h----
Confidence            987643321   23367999999999886 569999999999999999999999998754321111111      0    


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...    .+........+..+.+|+.+||+.+|.+|||+.++++|.+
T Consensus       252 ~~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          252 GKY----TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             TCC----CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             CCC----CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence            000    0111111234577899999999999999999999999844

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.5e-44  Score=343.07  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=203.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch------hhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL------QGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++.....      .....+.+|+.+++.++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQK------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF   77 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEc------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee
Confidence            356899999999999999999654      3578999998864322      1356788999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----ceEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKL  226 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----~~kL  226 (455)
                      ......++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++    .++|
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEE
Confidence            9999999999999999999998764  47899999999999999999999976  99999999999998876    8999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.      
T Consensus       154 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------  224 (283)
T 3bhy_A          154 IDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS------  224 (283)
T ss_dssp             CCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------
T ss_pred             EecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH------
Confidence            99999986543321   233569999999999999999999999999999999999999997654321111000      


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          ..    ............+..+.+|+.+||..+|++|||+.++++|.
T Consensus       225 ----~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          225 ----AV----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             ----TT----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred             ----hc----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence                00    00011111123356789999999999999999999999973

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=351.55  Aligned_cols=260  Identities=26%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGY  149 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~  149 (455)
                      .++....++|.+.+.||+|+||.||+|....      +++.||||++.... .....+.+|+.+++.+ +||||++++++
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECC------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            3344567889999999999999999996533      57889999986543 2346788999999998 79999999999


Q ss_pred             EEe------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          150 CCE------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       150 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                      +..      ....++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCC
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCC
Confidence            987      468899999999999999998765567999999999999999999999976  999999999999999999


Q ss_pred             eEEccCCCccCCCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH
Q 012832          224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL  298 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~  298 (455)
                      +||+|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........
T Consensus       168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            99999999986543211  123357999999999987     56789999999999999999999999976543211110


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      +      .       ....+.   .....++..+.+|+.+||..+|.+|||+.++++|.
T Consensus       246 ~------~-------~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          246 I------P-------RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             H------H-------HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             h------h-------cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence            0      0       000111   11233457899999999999999999999999884

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=345.53  Aligned_cols=255  Identities=30%  Similarity=0.479  Sum_probs=198.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...        ++.||||.+...  ...+.+.+|+.+|+.++||||+++++++.  +..
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   74 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPV   74 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence            467889999999999999999643        467999998643  34567889999999999999999999876  447


Q ss_pred             EEEEEecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCC-CCeEEeccCCCCEEEcCCCc-eEEccCCCcc
Q 012832          157 LLVYEYMPRGSLENQLFRRYS-VSLPWSTRMKIALGAAKGLAFLHDAE-KPVIYRDFKASNILLDSDYT-AKLSDFGLAK  233 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~-~~iiHrDlkp~Nill~~~~~-~kL~DfGla~  233 (455)
                      ++||||+++|+|.+++..... ..++...++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            999999999999999875432 24788899999999999999999832 34999999999999988876 7999999997


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +.+.         ..
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~---------~~  218 (307)
T 2eva_A          155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---------VH  218 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH---------HH
T ss_pred             ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH---------Hh
Confidence            65332     12346999999999999999999999999999999999999999754322111  1110         00


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDF  363 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~  363 (455)
                      ....    ......++..+.+|+.+||+.+|++|||+.+++++|+.+...
T Consensus       219 ~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          219 NGTR----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             TTCC----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             cCCC----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            0011    122334567789999999999999999999999998877543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-44  Score=342.81  Aligned_cols=265  Identities=20%  Similarity=0.224  Sum_probs=207.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEE-EeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYC-CEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....  ...+.+|+.+++.++|++++..+.++ .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDI------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEc------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            578999999999999999999543      3578999999865432  24578899999999988766666554 66778


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCCCc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLA  232 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfGla  232 (455)
                      .++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             eEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            89999999 99999988643 357999999999999999999999976  9999999999999   47889999999999


Q ss_pred             cCCCCCCCcc-----ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hhhh
Q 012832          233 KDGPEGDDTH-----VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RPML  306 (455)
Q Consensus       233 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~~~  306 (455)
                      ..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            8655433211     123467999999999999999999999999999999999999999875433222222111 0000


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                      ..       ..+    .....++.++.+|+.+||+.+|++|||+.++++.|+.+....
T Consensus       236 ~~-------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          236 ST-------PIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HS-------CHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CC-------chH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            00       000    011234577999999999999999999999999998775433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-44  Score=347.70  Aligned_cols=270  Identities=24%  Similarity=0.358  Sum_probs=191.0

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +.+..++|.+.+.||+|+||.||+|...      .+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCA------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEEC------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            3456789999999999999999999543      357789999986543 233466789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRR------YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      ..+..++||||+++++|.+++...      ....+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEE
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEE
Confidence            999999999999999999988642      2356899999999999999999999976  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCc---cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          226 LSDFGLAKDGPEGDDT---HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       226 L~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      |+|||++.........   .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. 
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-  240 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-  240 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-
Confidence            9999998765433211   11233579999999999876 568999999999999999999999998754432111100 


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           .  ...................+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus       241 -----~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          241 -----Q--NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             -----T--SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             -----c--cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence                 0  0000000000011122334567899999999999999999999999843

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.4e-44  Score=344.28  Aligned_cols=264  Identities=20%  Similarity=0.228  Sum_probs=203.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEE-EeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYC-CEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.....  ...+.+|+.+++.++|++++..++.+ ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEc------CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            3578999999999999999999643      3578999998654322  23467899999999988777666655 6677


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCCC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGL  231 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfGl  231 (455)
                      ..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            889999999 99999988643 357999999999999999999999977  9999999999999   7889999999999


Q ss_pred             ccCCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hhh
Q 012832          232 AKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RPM  305 (455)
Q Consensus       232 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~~  305 (455)
                      +.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ...
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            9865443221     1123467999999999999999999999999999999999999999875443322222111 000


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ...       .    .......++.++.+|+.+||+.+|++|||+.++++.|+.+..
T Consensus       235 ~~~-------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          235 MST-------P----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHS-------C----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccc-------h----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            000       0    000112235679999999999999999999999999887754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.2e-44  Score=338.88  Aligned_cols=253  Identities=26%  Similarity=0.357  Sum_probs=200.2

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQ------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS   81 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEEC------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            45678999999999999999999653      357899999986432   233467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      ..+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeeccc
Confidence            999999999999999999998765  46899999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      +........   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........   ..   .+...  
T Consensus       158 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---~~~~~--  226 (276)
T 2h6d_A          158 SNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FK---KIRGG--  226 (276)
T ss_dssp             GGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHC--
T ss_pred             ccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH---HhhcC--
Confidence            987644321   223579999999999987765 6899999999999999999999976432111   11   00000  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                                ...++...+..+.+++.+||+.+|.+|||+.++++|-+
T Consensus       227 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          227 ----------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             ----------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence                      01123334577899999999999999999999999844

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-44  Score=370.45  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=208.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++....   ......+.+|+.+|+.++||||+++++++...
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   98 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKD------KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK   98 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCceEEeeEEecCCCEEEEEEEE------CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            46799999999999999999954      3467899999985432   34567789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFG  230 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfG  230 (455)
                      ...++||||+.+|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            9999999999999999988664  57899999999999999999999977  9999999999999   567899999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+.      ..  
T Consensus       175 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~--  242 (484)
T 3nyv_A          175 LSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE------KG--  242 (484)
T ss_dssp             HHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC--
T ss_pred             eeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------cC--
Confidence            9986544322   233579999999999876 69999999999999999999999998754322111111      00  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                            ...+........+.++.+|+.+||+.+|.+|||+.++++|.+.
T Consensus       243 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          243 ------KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             ------CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             ------CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence                  0001111123456789999999999999999999999998543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=343.08  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+.|....+||+|+||.||+|...      .++..||||.+..........+.+|+.+++.++||||+++++++...+..
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDL------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEET------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEEC------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            345666679999999999999643      35788999998766555667789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL~DfGla~~  234 (455)
                      ++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++. ++.++|+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccc
Confidence            99999999999999987653 235678889999999999999999976  999999999999987 89999999999986


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......  ......||+.|+|||++.+..  ++.++|||||||++|+|++|..||......... ...       . .  
T Consensus       173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-------~-~--  239 (295)
T 2clq_A          173 LAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK-------V-G--  239 (295)
T ss_dssp             SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH-------H-H--
T ss_pred             cCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh-------h-c--
Confidence            543221  123357999999999997654  889999999999999999999999643221110 000       0 0  


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....    ...++...+.++.+|+.+||+.+|++|||+.+++++-+
T Consensus       240 ~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~  281 (295)
T 2clq_A          240 MFKV----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF  281 (295)
T ss_dssp             HHCC----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred             cccc----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            0011    12234455678999999999999999999999998743

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.3e-44  Score=368.29  Aligned_cols=256  Identities=24%  Similarity=0.296  Sum_probs=204.3

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-------------hhHHHHHHHHHHHhcCCCCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-------------QGHREWLTEVIFLGQLRHPH  142 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~n  142 (455)
                      ..++|.+.+.||+|+||.||+|...      .++..||||++.....             ...+.+.+|+.+|+.++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEK------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEET------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEEC------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            3578999999999999999999643      3578899999864321             23467889999999999999


Q ss_pred             cccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC
Q 012832          143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       143 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~  222 (455)
                      |+++++++......++|||||+||+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCC
Confidence            999999999999999999999999999988765  56999999999999999999999976  99999999999998775


Q ss_pred             ---ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          223 ---TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       223 ---~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                         .+||+|||++........   .....||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.........+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  259 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV  259 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence               699999999987654322   23367999999999987 46999999999999999999999999875432211111


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .      ..        ...+........+.++.+|+.+||..+|.+|||+.++++|.+.
T Consensus       260 ~------~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          260 E------KG--------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             H------HC--------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             H------cC--------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence            1      00        0000000012345779999999999999999999999998543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=357.71  Aligned_cols=283  Identities=17%  Similarity=0.202  Sum_probs=211.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCC--CCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCccc---------
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLR--PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK---------  145 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------  145 (455)
                      .++|.+.+.||+|+||.||+|.......  ....++.||||++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999997643110  0113789999998644     35678999999999999887         


Q ss_pred             ------EEEEEEe-CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE
Q 012832          146 ------LIGYCCE-EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL  218 (455)
Q Consensus       146 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill  218 (455)
                            +++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE
Confidence                  6777776 67899999999 999999998754567999999999999999999999976  9999999999999


Q ss_pred             cCCC--ceEEccCCCccCCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCC
Q 012832          219 DSDY--TAKLSDFGLAKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSR  291 (455)
Q Consensus       219 ~~~~--~~kL~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~  291 (455)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9988  9999999999865432211     11133579999999999999999999999999999999999999997653


Q ss_pred             ccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCCCcccccc
Q 012832          292 PQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDIAIGT  371 (455)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~~~~~~~~  371 (455)
                      ... ...........   .....+....   ......+.++.+|+.+||..+|++|||+.++++.|+.+..........+
T Consensus       273 ~~~-~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  345 (352)
T 2jii_A          273 PNT-EDIMKQKQKFV---DKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP  345 (352)
T ss_dssp             TCH-HHHHHHHHHHH---HSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             cCH-HHHHHHHHhcc---CChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence            221 11111111110   1111111111   0112335789999999999999999999999999987765443333334


Q ss_pred             eee
Q 012832          372 FVF  374 (455)
Q Consensus       372 ~~~  374 (455)
                      +.|
T Consensus       346 ~dw  348 (352)
T 2jii_A          346 IGL  348 (352)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=360.36  Aligned_cols=274  Identities=20%  Similarity=0.274  Sum_probs=213.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.... ......+.+|+.+|+.++||||+++++++....
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHK------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEEC------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence            3567999999999999999999654      357899999986543 234566789999999999999999999998765


Q ss_pred             --eEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE----cCCCceEEc
Q 012832          155 --HRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYTAKLS  227 (455)
Q Consensus       155 --~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill----~~~~~~kL~  227 (455)
                        ..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEe
Confidence              7899999999999999887543 234999999999999999999999976  9999999999999    778889999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCcccccc--------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT--------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      |||+++.......   .....||+.|+|||++.+        ..++.++|||||||++|||++|..||............
T Consensus       159 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  235 (396)
T 4eut_A          159 DFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (396)
T ss_dssp             CGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred             cCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence            9999987544321   233679999999999875        56788999999999999999999999754322111111


Q ss_pred             HhhhhhhHhh-h----hhcccC--------CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          300 EWARPMLNDA-R----KLGRIM--------DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       300 ~~~~~~~~~~-~----~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        ...+.... .    ......        .......++...+..+.+++.+||+.||++||++.++++.+..+..
T Consensus       236 --~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          236 --MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             --HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             --HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence              11111100 0    000000        0111234567788999999999999999999999999999877654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8e-44  Score=361.26  Aligned_cols=269  Identities=20%  Similarity=0.255  Sum_probs=206.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC------CCCCcccEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL------RHPHLVKLIGY  149 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~~~  149 (455)
                      ...+|.+.+.||+|+||.||+|...      .+++.||||++.... .....+.+|+.+++.+      +|+||++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDH------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEET------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEEC------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            4567999999999999999999643      357899999986532 3345566788777766      57799999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc--eEEc
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT--AKLS  227 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~--~kL~  227 (455)
                      +......++||||+. ++|.+++.......+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.  +||+
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEEC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEe
Confidence            999999999999994 69999998776667999999999999999999999976  999999999999999887  9999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh----
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR----  303 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~----  303 (455)
                      |||++......     ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.........+....    
T Consensus       245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999764432     223579999999999999999999999999999999999999998765432221111000    


Q ss_pred             -hhhHhhhhhcccCCCc------------------------------------ccCCCCHHHHHHHHHHHHHHhccCCCC
Q 012832          304 -PMLNDARKLGRIMDPR------------------------------------LEGQYSETGARKAAALAYQCLSHRPKQ  346 (455)
Q Consensus       304 -~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~li~~cl~~~P~~  346 (455)
                       .++.........++..                                    +...+....+..+.+||.+||+.||++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence             0000000000000000                                    000011122567899999999999999


Q ss_pred             CCCHHHHHHhccc
Q 012832          347 RPTMSTVVKTLEP  359 (455)
Q Consensus       347 RPt~~ell~~L~~  359 (455)
                      |||+.|+++|-+.
T Consensus       400 Rpta~e~L~Hpw~  412 (429)
T 3kvw_A          400 RMTPGQALRHPWL  412 (429)
T ss_dssp             SCCHHHHHTSTTT
T ss_pred             CCCHHHHhCChhh
Confidence            9999999999654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=352.91  Aligned_cols=261  Identities=17%  Similarity=0.169  Sum_probs=205.6

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC---CCCcccEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR---HPHLVKLIG  148 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~  148 (455)
                      ++.+..++|.+.+.||+|+||.||+|...+. .+...++.||||++....   ..++..|+.++..++   |+||+.+++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3445678899999999999999999964331 234568899999987543   345667777777776   999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-----
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRR---YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-----  220 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-----  220 (455)
                      ++...+..+|||||+++|+|.+++...   ....+++..++.++.||+.||+|||+.+  ||||||||+||||+.     
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCc
Confidence            999999999999999999999999753   2457999999999999999999999966  999999999999998     


Q ss_pred             ------CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccc
Q 012832          221 ------DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR  294 (455)
Q Consensus       221 ------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~  294 (455)
                            ++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999975433222333445789999999999999999999999999999999999999985432110


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCC-CCHHHHHHhcccc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQR-PTMSTVVKTLEPL  360 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R-Pt~~ell~~L~~~  360 (455)
                      .                   .....+.. +  ..+..+.+++..||..+|.+| |++.++.+.|+.+
T Consensus       293 ~-------------------~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 C-------------------KPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             E-------------------EECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             e-------------------eechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            0                   00111111 1  124667889999999999998 6788887777655

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-44  Score=354.36  Aligned_cols=263  Identities=27%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      ..++|.+.+.||+|+||.||+|....   ...+++.||||++....    ......+.+|+.+|+.+ +||||+++++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKIS---GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECS---STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcc---cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            44789999999999999999997532   13467899999986432    12334566799999999 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ......++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999999999765  46899999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      +++....... ......+||+.|+|||++.+.  .++.++|||||||++|||++|..||..........  ........ 
T Consensus       205 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~-  280 (355)
T 1vzo_A          205 LSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILK-  280 (355)
T ss_dssp             EEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHH-
T ss_pred             CCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhc-
Confidence            9986543222 123346799999999999863  47899999999999999999999997543322111  11111110 


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLEPL  360 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~~~  360 (455)
                                 ....++...+..+.+|+.+||..||.+||     ++.++++|+...
T Consensus       281 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          281 -----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             -----------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence                       01123445567889999999999999999     999999996543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.2e-44  Score=342.62  Aligned_cols=259  Identities=20%  Similarity=0.285  Sum_probs=206.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  152 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEEC------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            468999999999999999999653      357899999986543  3345678899999999999999999998864  


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCC---CCeEEeccCCCCEEEcCCCceEEc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAE---KPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~---~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      ....++||||+++++|.+++....  ...+++..++.++.|++.||+|||+.+   .+|+||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            568999999999999999987542  345899999999999999999999854   239999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .+..
T Consensus       159 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~i~~  230 (279)
T 2w5a_A          159 DFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG---KIRE  230 (279)
T ss_dssp             CCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH
T ss_pred             cCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH---HHhh
Confidence            9999986543221  1223579999999999999999999999999999999999999998653211   111   0000


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                             ..    ...++..++.++.+|+.+||+.+|.+|||+.+++++++..
T Consensus       231 -------~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          231 -------GK----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             -------TC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             -------cc----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                   00    1122344567899999999999999999999999987654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.7e-44  Score=376.84  Aligned_cols=251  Identities=28%  Similarity=0.392  Sum_probs=201.5

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      +.||+|+||.||+|.+..    ...++.||||+++....  ....++.+|+.+|+.++||||+++++++. .+..+||||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEEC----SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcC----CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEE
Confidence            479999999999997654    23567899999875432  34578999999999999999999999986 456899999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~  241 (455)
                      |+++|+|.+++...  ..+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++........
T Consensus       450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999654  57899999999999999999999976  999999999999999999999999999866443321


Q ss_pred             -cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          242 -HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       242 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                       .......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.                 ..
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-----------------~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----------------KG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----------------TT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------------cC
Confidence             12223457889999999999999999999999999999998 999998754322111111                 01


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .....+..++.++.+||.+||+.+|++|||+.+|++.|+.+
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11223455678899999999999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=342.85  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=203.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||.+....  ....+.+|+.+++.++||||+++++++.....
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            4578999999999999999999654      357899999986543  34668899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++...
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999999988643 457899999999999999999999977  999999999999999999999999999765


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||............             ...
T Consensus       176 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~  240 (314)
T 3com_A          176 TDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------------PTN  240 (314)
T ss_dssp             BTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHS
T ss_pred             hhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------hcC
Confidence            43221  123357999999999999999999999999999999999999999765432111000             000


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..+.  ...+...+..+.+|+.+||..+|.+|||+.++++|.+
T Consensus       241 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          241 PPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             CCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             CCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            0111  1123345678999999999999999999999998743

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=351.27  Aligned_cols=277  Identities=23%  Similarity=0.349  Sum_probs=213.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC-
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  154 (455)
                      ..++|.+.+.||+|+||.||+|.+..  .+..+++.||||++........+.+.+|+.+++.++||||+++++++...+ 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECT--TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEecc--ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            45678999999999999999997532  234568899999998766666678999999999999999999999986554 


Q ss_pred             -eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          155 -HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       155 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                       ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchh
Confidence             689999999999999998764 346899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh---hHhh
Q 012832          234 DGPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM---LNDA  309 (455)
Q Consensus       234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~---~~~~  309 (455)
                      ........ .......||..|+|||++.+..++.++|||||||++|+|++|..||.....    .........   ....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhH
Confidence            76543321 112224578889999999998899999999999999999999999863210    000000000   0000


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..+...+........+..++.++.+|+.+||..+|++|||+.++++.|+.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0000011111111234556788999999999999999999999999987764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.3e-44  Score=341.38  Aligned_cols=249  Identities=20%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+..+..+ +||||+++++++...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKR------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED   83 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred             cchhhhhhhhcCCCceEEEEEEEc------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            467999999999999999999653      35789999998653  233456788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-----------
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRY--SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-----------  220 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-----------  220 (455)
                      +..++||||+++++|.+++....  ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.           
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccc
Confidence            99999999999999999987643  256899999999999999999999976  999999999999984           


Q ss_pred             --------CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCC
Q 012832          221 --------DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSR  291 (455)
Q Consensus       221 --------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~  291 (455)
                              ...++|+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             ccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                    4479999999998764422      24599999999999876 56789999999999999999998764321


Q ss_pred             ccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          292 PQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .     ...           +.....    ..++...+..+.+|+.+||+.||++|||+.++++|.+.
T Consensus       236 ~-----~~~-----------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  283 (289)
T 1x8b_A          236 Q-----WHE-----------IRQGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL  283 (289)
T ss_dssp             H-----HHH-----------HHTTCC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred             H-----HHH-----------HHcCCC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence            1     000           000011    12233456789999999999999999999999998543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-44  Score=355.74  Aligned_cols=269  Identities=23%  Similarity=0.285  Sum_probs=201.2

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-  152 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-  152 (455)
                      ....++|.+.+.||+|+||.||+|...      .+++.||||++..+...    ..+|+.+|+.++||||+++++++.. 
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~------~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDI------ESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEET------TTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEEC------CCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeec
Confidence            456788999999999999999999643      35789999988644222    2369999999999999999999844 


Q ss_pred             -------------------------------------CCeEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHH
Q 012832          153 -------------------------------------EEHRLLVYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAA  193 (455)
Q Consensus       153 -------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~  193 (455)
                                                           ....++||||++ |+|.+.+..  .....+++..+..++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 334889999996 588877764  3356799999999999999


Q ss_pred             HHHHHhhhCCCCeEEeccCCCCEEEc-CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchh
Q 012832          194 KGLAFLHDAEKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVY  271 (455)
Q Consensus       194 ~~L~~LH~~~~~iiHrDlkp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  271 (455)
                      .||+|||+.+  |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999966  99999999999997 688999999999986544332   2235789999999998775 489999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCccchhhHHH-hhh-hhhHhhhh----hc-----ccCCCcccCCCCHHHHHHHHHHHHHHh
Q 012832          272 SFGVVLLELLSGRKSVDKSRPQREQSLVE-WAR-PMLNDARK----LG-----RIMDPRLEGQYSETGARKAAALAYQCL  340 (455)
Q Consensus       272 slG~il~ell~G~~p~~~~~~~~~~~~~~-~~~-~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl  340 (455)
                      ||||++|||++|.+||.+.........+. ... +.......    ..     ......+...++...+.++.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            99999999999999998764432221111 000 00000000    00     001111111234446678999999999


Q ss_pred             ccCCCCCCCHHHHHHhcc
Q 012832          341 SHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       341 ~~~P~~RPt~~ell~~L~  358 (455)
                      ..+|.+|||+.++++|-+
T Consensus       307 ~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             CSSGGGSCCHHHHHTSGG
T ss_pred             cCChhhCCCHHHHhcCHH
Confidence            999999999999999843

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.7e-44  Score=356.87  Aligned_cols=268  Identities=19%  Similarity=0.213  Sum_probs=207.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC--------CCCcccEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR--------HPHLVKLI  147 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~~~  147 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++... ......+.+|+.+|+.++        |+||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDI------QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEec------CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            3578999999999999999999543      35789999998643 334566788999999885        78899999


Q ss_pred             EEEE----eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCC
Q 012832          148 GYCC----EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       148 ~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~  222 (455)
                      +++.    .....++||||+ +++|.+.+.......+++..+..++.||+.||+|||+. +  |+||||||+||||+.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccc
Confidence            9987    456789999999 67887777766556799999999999999999999996 6  99999999999998775


Q ss_pred             -------------------------------------------------ceEEccCCCccCCCCCCCccceeccccCCCC
Q 012832          223 -------------------------------------------------TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY  253 (455)
Q Consensus       223 -------------------------------------------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y  253 (455)
                                                                       .+||+|||++......     .....||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence                                                             7999999999865432     2235799999


Q ss_pred             cCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh-----------hhcccCCC----
Q 012832          254 AAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR-----------KLGRIMDP----  318 (455)
Q Consensus       254 ~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~----  318 (455)
                      +|||++.+..++.++|||||||++|||++|..||.................+.....           .....+..    
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            999999999999999999999999999999999986543322111111110000000           00000000    


Q ss_pred             ------c---------ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          319 ------R---------LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       319 ------~---------~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            .         -...++...+..+.+|+.+||+.||++|||+.++++|-+
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence                  0         001245677889999999999999999999999999854

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.6e-44  Score=342.88  Aligned_cols=264  Identities=26%  Similarity=0.377  Sum_probs=202.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|.+...   ......||||++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECT---TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccC---CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            356899999999999999999975432   123457999998654   23445678899999999999999999999876


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .. .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccc
Confidence            55 89999999999999988764 246899999999999999999999976  999999999999999999999999999


Q ss_pred             cCCCCCCCcc-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          233 KDGPEGDDTH-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       233 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      .......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||........   ...   .     
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~---~-----  237 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHK---I-----  237 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---H-----
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HHH---H-----
Confidence            8765443221 1223567889999999998889999999999999999999 9999976543211   110   0     


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                           .........+..++.++.+++.+||..+|.+|||+.+++++|+.+..
T Consensus       238 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          238 -----DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 00011112234556789999999999999999999999999887643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.5e-43  Score=349.15  Aligned_cols=266  Identities=21%  Similarity=0.288  Sum_probs=195.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDA------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEEC------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            478999999999999999999543      35788999998643  2344566889999999999999999999997665


Q ss_pred             ------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          155 ------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       155 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                            ..++||||++ |+|.+.+.    ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEE
Confidence                  7899999996 57888774    35889999999999999999999976  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-------
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-------  301 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-------  301 (455)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.-       
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998654321   12336799999999999999999999999999999999999999987543221111100       


Q ss_pred             --hh---hhhHh-hhhhcc--------cCCCccc---CCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          302 --AR---PMLND-ARKLGR--------IMDPRLE---GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       302 --~~---~~~~~-~~~~~~--------~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ..   +.... ......        .+.....   .......+.++.+|+.+||..||++|||+.++++|-+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence              00   00000 000000        0000000   0011234678999999999999999999999999954

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.4e-44  Score=360.50  Aligned_cols=257  Identities=25%  Similarity=0.321  Sum_probs=194.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcCCCCCcccE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQLRHPHLVKL  146 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~  146 (455)
                      ...++|.+.+.||+|+||.||+|...      .+++.||||++.....        .....+.+|+.+|+.++||||+++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  205 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFER------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI  205 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEEC------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence            34578999999999999999999654      3578999999864321        112247789999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC---Cc
Q 012832          147 IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YT  223 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~---~~  223 (455)
                      ++++. .+..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.+   +.
T Consensus       206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          206 KNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             CEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCC
T ss_pred             EEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcce
Confidence            99975 55689999999999999887643  57999999999999999999999976  9999999999999754   45


Q ss_pred             eEEccCCCccCCCCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      +||+|||+++......   .....+||+.|+|||++.+   ..++.++|||||||++|+|++|.+||........  +..
T Consensus       281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~  355 (419)
T 3i6u_A          281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  355 (419)
T ss_dssp             EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH
T ss_pred             EEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH
Confidence            9999999998764332   2334679999999999853   5688999999999999999999999976433211  111


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...       ..    ............+..+.+|+.+||+.+|++|||+.++++|-+
T Consensus       356 ~i~-------~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          356 QIT-------SG----KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             HHH-------TT----CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHh-------cC----CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence            000       00    000000001123567899999999999999999999999854

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-43  Score=351.15  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=205.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcC-CCCCcc
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQL-RHPHLV  144 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv  144 (455)
                      ....++|.+.+.||+|+||.||+|...      .+++.||||++.....        ...+.+.+|+.+++.+ +||||+
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv  163 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHR------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII  163 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEEC------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            334567999999999999999999653      3578999998864321        1235577899999999 799999


Q ss_pred             cEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCce
Q 012832          145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTA  224 (455)
Q Consensus       145 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~  224 (455)
                      ++++++......++||||++|++|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+
T Consensus       164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             CEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred             EEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999998765  57899999999999999999999976  9999999999999999999


Q ss_pred             EEccCCCccCCCCCCCccceeccccCCCCcCcccccc------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhH
Q 012832          225 KLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSL  298 (455)
Q Consensus       225 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~  298 (455)
                      +|+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||...........
T Consensus       240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  316 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM  316 (365)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999987654322   233679999999999864      3588899999999999999999999976432211111


Q ss_pred             HHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          299 VEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      +      ...      ...  .........+..+.+|+.+||+.+|++|||+.++++|-+
T Consensus       317 i------~~~------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          317 I------MEG------QYQ--FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             H------HHT------CCC--CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             H------HhC------CCC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            0      000      000  000000123467899999999999999999999999854

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.5e-45  Score=362.37  Aligned_cols=244  Identities=16%  Similarity=0.166  Sum_probs=191.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHH---HHHhcCCCCCcccEE---
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEV---IFLGQLRHPHLVKLI---  147 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~~~---  147 (455)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++...   .....+.+.+|+   .+|+.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATD------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEE------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            46789999999999999999954      335789999998632   334557788999   555566799999998   


Q ss_pred             ----EEEEeCC-----------------eEEEEEEecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhh
Q 012832          148 ----GYCCEEE-----------------HRLLVYEYMPRGSLENQLFRRYS-----VSLPWSTRMKIALGAAKGLAFLHD  201 (455)
Q Consensus       148 ----~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~  201 (455)
                          +++...+                 ..||||||+ +|+|.+++.....     ..+++..++.++.||+.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                6666553                 278999999 6899999976421     123347888899999999999999


Q ss_pred             CCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC-----------CCCccCch
Q 012832          202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-----------HLTSMSDV  270 (455)
Q Consensus       202 ~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv  270 (455)
                      .+  |+||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||
T Consensus       225 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            77  99999999999999999999999999986332     2334678 999999999887           89999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 012832          271 YSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM  350 (455)
Q Consensus       271 wslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~  350 (455)
                      |||||++|||++|+.||..........                .+..      ....++.++.+|+.+||+.||++|||+
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSE----------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSG----------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchh----------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            999999999999999997543221110                0000      012345778999999999999999999


Q ss_pred             HHHHHhc
Q 012832          351 STVVKTL  357 (455)
Q Consensus       351 ~ell~~L  357 (455)
                      .++++|.
T Consensus       355 ~e~l~hp  361 (377)
T 3byv_A          355 LQAMETP  361 (377)
T ss_dssp             HHHHTSH
T ss_pred             HHHhhCh
Confidence            9999873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-43  Score=348.98  Aligned_cols=271  Identities=23%  Similarity=0.315  Sum_probs=205.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      ..+|.+.+.||+|+||.||+|...      .++..||||++.... ......+.+|+.+|+.++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDN------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEEC------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            468999999999999999999543      357889999986433 33446788999999999999999999998765  


Q ss_pred             ---CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          154 ---EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       154 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                         ...++||||+. |+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCc
Confidence               36899999995 6999988653   6899999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCc-cceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh-hh
Q 012832          231 LAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP-ML  306 (455)
Q Consensus       231 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~-~~  306 (455)
                      ++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... .. ..
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99865433221 11233579999999998754 45899999999999999999999999876544332222110 00 00


Q ss_pred             Hh--------hhh-hcccCCCcc--cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 ND--------ARK-LGRIMDPRL--EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~--------~~~-~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..        ... .........  ...+....+.++.+|+.+||..||++|||+.++++|-+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  317 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  317 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence            00        000 000000000  001112345678999999999999999999999998554

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.5e-44  Score=354.15  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=188.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++...  .......+.+|+.+|+.++||||+++++++... 
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDT------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEET------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEEC------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            478999999999999999999543      35789999998643  334456788999999999999999999998654 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           ...++||||+ +++|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEee
Confidence                 5679999999 7899988754   46999999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-h-hh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-R-PM  305 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~-~~  305 (455)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.........+... . +.
T Consensus       176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     233679999999999987 67899999999999999999999999876543222211100 0 00


Q ss_pred             hH--------hhhhhcccCCCcccC---CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          306 LN--------DARKLGRIMDPRLEG---QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       306 ~~--------~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..        ........+......   ......+..+.+|+.+||..||++|||+.++++|.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~  315 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  315 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence            00        000000000000000   0112235678999999999999999999999998543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.2e-44  Score=345.12  Aligned_cols=256  Identities=21%  Similarity=0.358  Sum_probs=202.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..++|.+.+.||+|+||.||+|....      ++..||+|++..........+.+|+.+++.++||||+++++++...+.
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETT------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEcC------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            35689999999999999999996543      578899999877666667888999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999987654 357899999999999999999999976  999999999999999999999999987532


Q ss_pred             CCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ....  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||.........  ..    ...   
T Consensus       168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~---  236 (302)
T 2j7t_A          168 LKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LK----IAK---  236 (302)
T ss_dssp             HHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HH----HHH---
T ss_pred             cccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HH----Hhc---
Confidence            1100  0112256999999999983     567899999999999999999999999765432111  00    000   


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          ...+  ....+..++..+.+|+.+||..+|++|||+.++++|.
T Consensus       237 ----~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  277 (302)
T 2j7t_A          237 ----SDPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP  277 (302)
T ss_dssp             ----SCCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred             ----cCCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence                0000  1112344567899999999999999999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.9e-43  Score=346.77  Aligned_cols=273  Identities=22%  Similarity=0.272  Sum_probs=203.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....  .....+.+|+.+|+.++||||+++++++... 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHR------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEET------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             ccceeEEEEEecCCCcEEEEEEEC------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            467999999999999999999653      3578999998854432  2245678999999999999999999998773 


Q ss_pred             -------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          154 -------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       154 -------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                             +..++||||++ |+|.+.+... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             -------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEE
T ss_pred             cccccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEE
Confidence                   46899999996 5787777544 356999999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCC--ccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          227 SDFGLAKDGPEGDD--THVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       227 ~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      +|||++........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+....
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999986543221  112234678999999999876 458999999999999999999999998765432222221110


Q ss_pred             hh-----hHhhhh--hcccCCCccc--CCCCHH-----HHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          304 PM-----LNDARK--LGRIMDPRLE--GQYSET-----GARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       304 ~~-----~~~~~~--~~~~~~~~~~--~~~~~~-----~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..     +.....  ....+.....  ......     .+..+.+|+.+||+.||++|||+.++++|-+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  315 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  315 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence            00     000000  0000000000  000000     13568899999999999999999999999554

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.1e-44  Score=342.00  Aligned_cols=257  Identities=24%  Similarity=0.282  Sum_probs=190.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++.....  .....+..+...++.++||||+++++++..
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHV------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEec------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            45678999999999999999999643      3578999999865422  222334455566888999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      .+..++||||++ |+|.+++...  ....+++..++.++.|++.||+|||+. +  |+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeec
Confidence            999999999996 5888777542  346799999999999999999999995 6  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCcccc----ccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYV----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||........ .....    
T Consensus       155 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----  226 (290)
T 3fme_A          155 GISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQV----  226 (290)
T ss_dssp             ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHH----
T ss_pred             CCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHH----
Confidence            99986544322   2224699999999996    556789999999999999999999999975332111 00000    


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .          ............+.++.+|+.+||+.+|++|||+.++++|.+
T Consensus       227 ~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~  269 (290)
T 3fme_A          227 V----------EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF  269 (290)
T ss_dssp             H----------HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             h----------ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence            0          001111112345678999999999999999999999998743

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.5e-43  Score=337.90  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=206.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---------hhhHHHHHHHHHHHhcCC-CCCcccE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---------LQGHREWLTEVIFLGQLR-HPHLVKL  146 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~~  146 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....         ....+.+.+|+.+++.+. ||||+++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHK------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhccceeeeecCCCceEEEEEEEc------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            578999999999999999999653      357899999986442         122356789999999996 9999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          147 IGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                      ++++......++||||+++++|.+++...  ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++|
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEE
Confidence            99999999999999999999999998765  57899999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccc------cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM------TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      +|||++........   .....||+.|+|||++.      ...++.++|||||||++|+|++|..||..........   
T Consensus       166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---  239 (298)
T 1phk_A          166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR---  239 (298)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---
T ss_pred             ecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH---
Confidence            99999986544322   23357999999999985      4568899999999999999999999997643221111   


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         .+...        ............+..+.+|+.+||..+|.+|||+.++++|-+
T Consensus       240 ---~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          240 ---MIMSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             ---HHHHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             ---HHhcC--------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence               00000        001111122345678999999999999999999999998744

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.3e-43  Score=343.92  Aligned_cols=263  Identities=18%  Similarity=0.243  Sum_probs=202.7

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEe--C
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCE--E  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....   ...+.+|+.+|+.++ ||||+++++++..  .
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINI------TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEecccCCeEEEEEEEC------CCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            467999999999999999999643      357899999986433   456789999999997 9999999999988  5


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCCc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLA  232 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGla  232 (455)
                      ...++||||+.+++|.+++.     .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++ .+||+|||++
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            67899999999999998773     3888999999999999999999977  99999999999999776 8999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh-----hh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP-----ML  306 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~-----~~  306 (455)
                      ........   .....||..|+|||++.+ ..++.++|||||||++|+|++|..||......... +......     ..
T Consensus       179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~  254 (330)
T 3nsz_A          179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLY  254 (330)
T ss_dssp             EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHH
T ss_pred             eEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhh
Confidence            86544332   223579999999999977 67899999999999999999999999544322111 1111000     00


Q ss_pred             HhhhhhcccCC----------------CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          307 NDARKLGRIMD----------------PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       307 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..........+                ...........+.++.+|+.+||+.||++|||+.++++|-+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            00000000000                011111223356789999999999999999999999998543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-43  Score=361.25  Aligned_cols=264  Identities=21%  Similarity=0.247  Sum_probs=207.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC-CCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH-PHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....  ...+..|+.+++.|+| ++|+.+..++.....
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI------QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET------TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC------CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            578999999999999999999643      3578999998764432  2347789999999986 566677777788889


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE---cCCCceEEccCCCc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL---DSDYTAKLSDFGLA  232 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill---~~~~~~kL~DfGla  232 (455)
                      .+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+  ||||||||+||||   +.++.+||+|||++
T Consensus        78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99999999 99999988643 457999999999999999999999976  9999999999999   68899999999999


Q ss_pred             cCCCCCCCcc-----ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          233 KDGPEGDDTH-----VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       233 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      +.........     ......||+.|+|||++.+..++.++|||||||+||||++|..||.................   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---  230 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---  230 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH---
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh---
Confidence            8765433211     12246799999999999999999999999999999999999999987654332222221110   


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      .  .....+     ..+...++.++.+|+..||+.+|++||++.+|++.|+.+..
T Consensus       231 ~--~~~~~~-----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          231 K--KVATSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             H--HHHSCH-----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             c--cccccH-----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            0  000000     00112335789999999999999999999999998876643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=347.89  Aligned_cols=274  Identities=23%  Similarity=0.374  Sum_probs=197.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHH--HhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIF--LGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||.||+|..        .++.||||++.....   ..+..|.++  +..++||||+++++.+..
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~   78 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--------DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDER   78 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--------TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--------CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccc
Confidence            3457899999999999999999954        357899999865432   334444444  455899999999986543


Q ss_pred             -----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-------CCCeEEeccCCCCEEEcC
Q 012832          153 -----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-------EKPVIYRDFKASNILLDS  220 (455)
Q Consensus       153 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~iiHrDlkp~Nill~~  220 (455)
                           ....++||||+++|+|.+++...   ..++..++.++.||+.||+|||+.       ..+|+||||||+||||+.
T Consensus        79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           79 VTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN  155 (336)
T ss_dssp             ECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred             cccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence                 23578999999999999998654   458899999999999999999986       114999999999999999


Q ss_pred             CCceEEccCCCccCCCCCCC------ccceeccccCCCCcCcccccc-------CCCCccCchhhHHHHHHHHHhCCCCC
Q 012832          221 DYTAKLSDFGLAKDGPEGDD------THVSTRVMGTQGYAAPEYVMT-------GHLTSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~G~~p~  287 (455)
                      ++.+||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            99999999999986543221      111223579999999999986       35667899999999999999997776


Q ss_pred             CCCCccch-hhHHH---hhhhhhHhhh--hhcccCCCcccCCC--CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          288 DKSRPQRE-QSLVE---WARPMLNDAR--KLGRIMDPRLEGQY--SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       288 ~~~~~~~~-~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ........ .....   ...+......  .......+.+...+  ...++..+.+|+.+||+.||++|||+.++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            43222111 11000   0000000000  00111122222221  23467789999999999999999999999999887


Q ss_pred             ccC
Q 012832          360 LKD  362 (455)
Q Consensus       360 ~~~  362 (455)
                      +..
T Consensus       316 ll~  318 (336)
T 3g2f_A          316 LMM  318 (336)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.6e-43  Score=341.81  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=208.1

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCC------CcccEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP------HLVKLIGY  149 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~~~  149 (455)
                      ..++|.+.+.||+|+||.||+|...     ...++.||||++.... .....+.+|+.+++.++|+      +|++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDH-----KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEET-----TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEec-----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            4578999999999999999999642     2356889999986432 3446678899999888765      49999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---------
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---------  220 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---------  220 (455)
                      +...+..++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||++.         
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCC
Confidence            99999999999999 899999998775567899999999999999999999976  999999999999987         


Q ss_pred             ----------CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCC
Q 012832          221 ----------DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS  290 (455)
Q Consensus       221 ----------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~  290 (455)
                                ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      6689999999998654322     2357999999999999999999999999999999999999999876


Q ss_pred             CccchhhHHHhhhh-----hhHhhhh--------------------hcccCCCc-ccCCCCHHHHHHHHHHHHHHhccCC
Q 012832          291 RPQREQSLVEWARP-----MLNDARK--------------------LGRIMDPR-LEGQYSETGARKAAALAYQCLSHRP  344 (455)
Q Consensus       291 ~~~~~~~~~~~~~~-----~~~~~~~--------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P  344 (455)
                      ........+.....     +......                    ......+. -........+.++.+|+.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            54322222111100     0000000                    00000000 0011234567889999999999999


Q ss_pred             CCCCCHHHHHHhc
Q 012832          345 KQRPTMSTVVKTL  357 (455)
Q Consensus       345 ~~RPt~~ell~~L  357 (455)
                      .+|||+.++++|-
T Consensus       318 ~~Rpt~~ell~hp  330 (339)
T 1z57_A          318 AKRITLREALKHP  330 (339)
T ss_dssp             TTSCCHHHHTTSG
T ss_pred             ccccCHHHHhcCH
Confidence            9999999999883

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-42  Score=347.74  Aligned_cols=273  Identities=22%  Similarity=0.241  Sum_probs=207.1

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CC-----CcccEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HP-----HLVKLI  147 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~~  147 (455)
                      ....++|.+.+.||+|+||.||+|...      .+++.||||++.... .....+..|+.++..++ |+     +|++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDR------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEET------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEc------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            344678999999999999999999643      357889999987432 33456677888888775 44     499999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc--CCCceE
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAK  225 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~--~~~~~k  225 (455)
                      +++...+..++||||+. |+|.+++.......+++..+..++.|++.||.|||++..+||||||||+||||+  .++.+|
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            99999999999999995 699999987655679999999999999999999996556699999999999995  478899


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh-
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP-  304 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~-  304 (455)
                      |+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|.+||...........+..... 
T Consensus       202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999876432     2236799999999999999999999999999999999999999987654322211111000 


Q ss_pred             ----hhHhh---hh-hcccCCCcc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 012832          305 ----MLNDA---RK-LGRIMDPRL-------------------------------------EGQYSETGARKAAALAYQC  339 (455)
Q Consensus       305 ----~~~~~---~~-~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~li~~c  339 (455)
                          .....   .. +..+.+..+                                     ..........++.+||.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence                00000   00 000000000                                     0011223346789999999


Q ss_pred             hccCCCCCCCHHHHHHhccc
Q 012832          340 LSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       340 l~~~P~~RPt~~ell~~L~~  359 (455)
                      |+.||++|||+.++++|-+.
T Consensus       357 L~~dP~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQHSFF  376 (382)
T ss_dssp             TCSCTTTSCCHHHHTTSGGG
T ss_pred             cCCChhhCCCHHHHhcCccc
Confidence            99999999999999998543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=354.93  Aligned_cols=275  Identities=22%  Similarity=0.291  Sum_probs=187.5

Q ss_pred             CCCCC-cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--CC
Q 012832           78 QSFSS-SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--EE  154 (455)
Q Consensus        78 ~~~~~-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~  154 (455)
                      +.|.+ .+.||+|+||.||+|...+    ...+..||||++.....  ...+.+|+.+|+.++||||+++++++..  ..
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~----~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKD----GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESS----SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEcc----CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            34655 5689999999999997543    23578899999865432  2467899999999999999999999965  67


Q ss_pred             eEEEEEEecCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE----cCCCc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRY-------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL----DSDYT  223 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill----~~~~~  223 (455)
                      ..+|||||+. |+|.+++....       ...+++..++.++.||+.||+|||+.+  |+||||||+||||    +.++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence            8999999995 58888775321       235899999999999999999999977  9999999999999    67789


Q ss_pred             eEEccCCCccCCCCCCCc-cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccc-------
Q 012832          224 AKLSDFGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR-------  294 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~-------  294 (455)
                      +||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.......       
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999875432111 122346799999999999874 58999999999999999999999997654310       


Q ss_pred             hhhHHHhhhhh-------hHh-------hhhhcccCCCcccC--------CCCHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 012832          295 EQSLVEWARPM-------LND-------ARKLGRIMDPRLEG--------QYSETGARKAAALAYQCLSHRPKQRPTMST  352 (455)
Q Consensus       295 ~~~~~~~~~~~-------~~~-------~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~RPt~~e  352 (455)
                      ...+......+       +..       ......+.......        ......+..+.+||.+||..||.+|||+.+
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            00000000000       000       00000000000000        000011457889999999999999999999


Q ss_pred             HHHhccccc
Q 012832          353 VVKTLEPLK  361 (455)
Q Consensus       353 ll~~L~~~~  361 (455)
                      +++|-+...
T Consensus       331 ~L~hp~f~~  339 (405)
T 3rgf_A          331 AMQDPYFLE  339 (405)
T ss_dssp             HHTSGGGTS
T ss_pred             HhcChhhcc
Confidence            999976543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.6e-43  Score=345.22  Aligned_cols=270  Identities=27%  Similarity=0.389  Sum_probs=208.3

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhc--CCCCCcccEE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ--LRHPHLVKLI  147 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~  147 (455)
                      +.......++|.+.+.||+|+||.||+|..        .++.||||++...   ....+.+|++++..  ++||||++++
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~  102 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI  102 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE--------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence            333455678899999999999999999954        3678999998643   34567788888877  7899999999


Q ss_pred             EEEEeCC----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCeEEeccCCCC
Q 012832          148 GYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH--------DAEKPVIYRDFKASN  215 (455)
Q Consensus       148 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~iiHrDlkp~N  215 (455)
                      +++....    ..++||||+++|+|.+++...   .+++..++.++.|++.||+|||        +.+  |+||||||+|
T Consensus       103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~N  177 (342)
T 1b6c_B          103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKN  177 (342)
T ss_dssp             EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGG
T ss_pred             eeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHH
Confidence            9998876    789999999999999999653   6899999999999999999999        655  9999999999


Q ss_pred             EEEcCCCceEEccCCCccCCCCCCCcc--ceeccccCCCCcCccccccCC------CCccCchhhHHHHHHHHHhC----
Q 012832          216 ILLDSDYTAKLSDFGLAKDGPEGDDTH--VSTRVMGTQGYAAPEYVMTGH------LTSMSDVYSFGVVLLELLSG----  283 (455)
Q Consensus       216 ill~~~~~~kL~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ell~G----  283 (455)
                      |||+.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999997654332211  123357999999999997653      34689999999999999999    


Q ss_pred             ------CCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCC-CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          284 ------RKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ-YSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       284 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                            ..||......... ...+...      .......+.+... ....++..+.+|+.+||+.+|++|||+.+++++
T Consensus       258 ~~~~~~~~p~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPS-VEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCC-HHHHHHH------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccccccCccccCcCccc-HHHHHHH------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                  6777654321110 1111100      0011112222211 134667889999999999999999999999999


Q ss_pred             cccccC
Q 012832          357 LEPLKD  362 (455)
Q Consensus       357 L~~~~~  362 (455)
                      |+.+..
T Consensus       331 L~~i~~  336 (342)
T 1b6c_B          331 LSQLSQ  336 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            987754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.5e-43  Score=344.61  Aligned_cols=270  Identities=22%  Similarity=0.263  Sum_probs=202.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE--  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.... ......+.+|+.+++.++||||+++++++...  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHK------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccceEEeeEEcCCCCeEEEEEEEC------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            578999999999999999999653      357899999986433 33446678999999999999999999988664  


Q ss_pred             ---CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          154 ---EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       154 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                         ...++||||+. |+|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCT
T ss_pred             CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecc
Confidence               67899999995 699988865   36899999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCcc--------ceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          231 LAKDGPEGDDTH--------VSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       231 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      ++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            998654322110        1123578999999998765 6789999999999999999999999987643221111110


Q ss_pred             hhhh---------------hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          302 ARPM---------------LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       302 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ....               ......+.......+ .......+.++.+|+.+||..||++|||+.++++|.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            0000               000000000000000 01112456788999999999999999999999998543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4e-43  Score=348.04  Aligned_cols=277  Identities=23%  Similarity=0.314  Sum_probs=202.3

Q ss_pred             chHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-----------hhHHHHHHHHHHHhc
Q 012832           69 TLAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-----------QGHREWLTEVIFLGQ  137 (455)
Q Consensus        69 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~  137 (455)
                      .+.++....++|.+.+.||+|+||.||+|...       .+..||||++.....           ...+.+.+|+.+|+.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC-------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence            46677888899999999999999999999532       277899998854221           223678899999999


Q ss_pred             CCCCCcccEEEEEEeC-----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccC
Q 012832          138 LRHPHLVKLIGYCCEE-----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK  212 (455)
Q Consensus       138 l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlk  212 (455)
                      ++||||+++++++...     ...++||||++ |+|.+++... ...+++..+..++.||+.||+|||+.+  |+|||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk  161 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLH  161 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCC
Confidence            9999999999998543     36899999996 6888877643 457899999999999999999999976  9999999


Q ss_pred             CCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCC
Q 012832          213 ASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSR  291 (455)
Q Consensus       213 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~  291 (455)
                      |+|||++.++.+||+|||++........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999975433221   233579999999999877 678999999999999999999999998754


Q ss_pred             ccchhhHHH-hhh-hhhH---------hhhhhcccCCC---cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          292 PQREQSLVE-WAR-PMLN---------DARKLGRIMDP---RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       292 ~~~~~~~~~-~~~-~~~~---------~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .......+. ... +...         ...........   ..........+..+.+|+.+||+.+|.+|||+.++++|.
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence            322211111 000 0000         00000000000   000011223456789999999999999999999999985


Q ss_pred             cc
Q 012832          358 EP  359 (455)
Q Consensus       358 ~~  359 (455)
                      +.
T Consensus       319 ~f  320 (362)
T 3pg1_A          319 YF  320 (362)
T ss_dssp             GG
T ss_pred             hh
Confidence            43

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.8e-43  Score=354.01  Aligned_cols=267  Identities=25%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC---
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE---  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---  153 (455)
                      ..+|.+.+.||+|+||.||+|....      +++.||||++.....    .+.+|+.+|+.++||||+++++++...   
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECC------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            3468999999999999999996543      578999998854322    234699999999999999999988542   


Q ss_pred             ---CeEEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC-CceEEc
Q 012832          154 ---EHRLLVYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLS  227 (455)
Q Consensus       154 ---~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~-~~~kL~  227 (455)
                         ..+++||||+++ +|.+.+..  .....+++..+..++.||+.||+|||+.+  |+||||||+||||+.+ +.+||+
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEec
Confidence               246799999965 67666543  23467999999999999999999999976  9999999999999965 678999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hh-hh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WA-RP  304 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~-~~  304 (455)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+. .. .+
T Consensus       200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999986544322   2235799999999999765 79999999999999999999999998754322211111 00 00


Q ss_pred             hhHhhhhh----cccCCCcc-----cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          305 MLNDARKL----GRIMDPRL-----EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       305 ~~~~~~~~----~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ........    ..+.-+.+     ...++...+.++.+|+.+||..||.+|||+.++++|.+.
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence            00000000    00000111     111233456789999999999999999999999998543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-43  Score=343.09  Aligned_cols=262  Identities=23%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCC--CCCccc
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLR--HPHLVK  145 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~  145 (455)
                      +..+.+..++|.+.+.||+|+||.||+|...       .++.||||++....  ......+.+|+.++..++  |+||++
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcC-------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            3344556778999999999999999999532       26789999986442  344567889999999997  599999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       146 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      +++++......++|||+ .+++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||+++ +.+|
T Consensus        93 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           93 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             EEEEEECSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEE
T ss_pred             EEEEeecCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEE
Confidence            99999999999999995 588999998765  57899999999999999999999976  999999999999964 8999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCcccccc-----------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccc
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-----------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR  294 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~  294 (455)
                      |+|||++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||.......
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  246 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence            999999987654333222334679999999999875           468889999999999999999999997543211


Q ss_pred             hhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .               .+....++.....++...+.++.+|+.+||+.+|++|||+.+++++.+.
T Consensus       247 ~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          247 S---------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             H---------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             H---------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            0               0011112222223344446789999999999999999999999998543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.6e-43  Score=371.30  Aligned_cols=266  Identities=26%  Similarity=0.367  Sum_probs=210.8

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEE
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGY  149 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~  149 (455)
                      .+..+..++|.+.+.||+|+||.||+|.+...   ...+..||||.+.... ....+.+.+|+.+|+.++||||++++++
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSP---ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCS---SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecC---CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34455667899999999999999999976542   2245689999986533 3344678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +. ++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEec
Confidence            84 56689999999999999988754 356899999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||........   ....   .. 
T Consensus       536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i---~~-  607 (656)
T 2j0j_A          536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI---EN-  607 (656)
T ss_dssp             CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH---HH-
T ss_pred             CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH---Hc-
Confidence            999876443221 1223567889999999999999999999999999999997 9999986543211   1110   00 


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                            .    .....+..++..+.+|+.+||..+|++|||+.++++.|+.+.
T Consensus       608 ------~----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          608 ------G----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ------T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------C----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                  0    011234456678999999999999999999999999987653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-43  Score=353.61  Aligned_cols=256  Identities=13%  Similarity=0.023  Sum_probs=185.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHH---HHHhcCCCCCcccEE---
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEV---IFLGQLRHPHLVKLI---  147 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~~~---  147 (455)
                      ..+|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+   .+|+. +||||++++   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~  133 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDV------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRL  133 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CB
T ss_pred             ceeeeeeeeccCCCCEEEEEEEEC------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeE
Confidence            345889999999999999999653      3578999999876432   3345566774   55555 799988755   


Q ss_pred             ----EEEEeC-----------------CeEEEEEEecCCCChHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHhh
Q 012832          148 ----GYCCEE-----------------EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTR------MKIALGAAKGLAFLH  200 (455)
Q Consensus       148 ----~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~L~~LH  200 (455)
                          +++...                 ...||||||++ |+|.+++.... ..+++..+      +.++.||+.||+|||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence                455433                 33799999997 89999997642 23455566      788899999999999


Q ss_pred             hCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc--CCCCccCchhhHHHHHH
Q 012832          201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLL  278 (455)
Q Consensus       201 ~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~  278 (455)
                      +.+  |+||||||+||||+.++.+||+|||+++.....     .....||+.|+|||++.+  ..++.++|||||||++|
T Consensus       212 ~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          212 SKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             HTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             HCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence            977  999999999999999999999999999865421     113567899999999987  67999999999999999


Q ss_pred             HHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          279 ELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       279 ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ||++|+.||....+.......   .      ..........+........+..+.+|+.+||+.||++|||+.++++|-
T Consensus       285 elltg~~Pf~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGSWK---R------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTCCC---B------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             HHHhCCCCCCCcCcccccchh---h------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            999999999865432111000   0      000000111111122235578899999999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3e-43  Score=346.79  Aligned_cols=267  Identities=18%  Similarity=0.245  Sum_probs=206.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-----------------HHHHHHHHHHHhcC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-----------------HREWLTEVIFLGQL  138 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l  138 (455)
                      ..++|.+.+.||+|+||.||+|..        +++.||||++.......                 ...+.+|+.+++.+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            357899999999999999999964        46899999986443221                 16788999999999


Q ss_pred             CCCCcccEEEEEEeCCeEEEEEEecCCCChHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEecc
Q 012832          139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQ------LFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDF  211 (455)
Q Consensus       139 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDl  211 (455)
                      +||||+++++++...+..++||||+++|+|.++      +.......+++..++.++.|++.||+|||+ .+  |+||||
T Consensus       101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl  178 (348)
T 2pml_X          101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDV  178 (348)
T ss_dssp             CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCC
T ss_pred             CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCC
Confidence            999999999999999999999999999999998      555445789999999999999999999998 77  999999


Q ss_pred             CCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCc-cCchhhHHHHHHHHHhCCCCCCC
Q 012832          212 KASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTS-MSDVYSFGVVLLELLSGRKSVDK  289 (455)
Q Consensus       212 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~ell~G~~p~~~  289 (455)
                      ||+|||++.++.++|+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999865432    23346799999999999887 6666 99999999999999999999986


Q ss_pred             CCccchhhHHHhhhhh-hHhhhhhcccCCC---cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          290 SRPQREQSLVEWARPM-LNDARKLGRIMDP---RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       290 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....  .......... ............+   ..........+.++.+|+.+||+.+|.+|||+.++++|-+
T Consensus       255 ~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          255 KISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             SSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            5431  1111111000 0000000000000   0000011345678999999999999999999999999843

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-42  Score=343.35  Aligned_cols=276  Identities=22%  Similarity=0.269  Sum_probs=192.5

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      .....++|.+.+.||+|+||.||+|...      .++..||||++.... .....+.+++..+..++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEK------STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEET------TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEEC------CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            4456789999999999999999999653      357899999885432 223345678888899999999999999876


Q ss_pred             CCe-------EEEEEEecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CC
Q 012832          153 EEH-------RLLVYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DY  222 (455)
Q Consensus       153 ~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~  222 (455)
                      ...       .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||.+..+|+||||||+||||+. ++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            443       7899999965 56554443  2346788999999999999999999933344999999999999997 89


Q ss_pred             ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          223 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       223 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      .+||+|||++........   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            999999999987654332   22357899999999987654 89999999999999999999999987543322211110


Q ss_pred             h-h----hhhHhhhhhc---ccCC------CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          302 A-R----PMLNDARKLG---RIMD------PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       302 ~-~----~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      . .    ..+.......   ....      ...........+.++.+|+.+||+.||.+|||+.++++|.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            0 0    0000000000   0000      000011222356789999999999999999999999998543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.3e-43  Score=348.86  Aligned_cols=269  Identities=19%  Similarity=0.222  Sum_probs=204.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-----------CCCcc
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-----------HPHLV  144 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv  144 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.... .....+.+|+.+++.++           |+||+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDM------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEec------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            3578999999999999999999543      357899999987432 33456778999988876           89999


Q ss_pred             cEEEEEEeCC----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEc
Q 012832          145 KLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLD  219 (455)
Q Consensus       145 ~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~  219 (455)
                      ++++++....    ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+. +  |+||||||+||||+
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~  166 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME  166 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEe
Confidence            9999987654    789999999 89999999876666799999999999999999999996 6  99999999999994


Q ss_pred             ------CCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCcc
Q 012832          220 ------SDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQ  293 (455)
Q Consensus       220 ------~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~  293 (455)
                            ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence                  4458999999999865432     22357999999999999999999999999999999999999999865422


Q ss_pred             chhhHHHhhhhhhHhhh---------------------hhcccCCC---------cccCCCCHHHHHHHHHHHHHHhccC
Q 012832          294 REQSLVEWARPMLNDAR---------------------KLGRIMDP---------RLEGQYSETGARKAAALAYQCLSHR  343 (455)
Q Consensus       294 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~  343 (455)
                      ...........+.....                     ....+...         .....++...+.++.+||.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            11110110000000000                     00000000         0011356778899999999999999


Q ss_pred             CCCCCCHHHHHHhccc
Q 012832          344 PKQRPTMSTVVKTLEP  359 (455)
Q Consensus       344 P~~RPt~~ell~~L~~  359 (455)
                      |++|||+.++++|-+.
T Consensus       322 P~~Rpt~~ell~hp~f  337 (373)
T 1q8y_A          322 PRKRADAGGLVNHPWL  337 (373)
T ss_dssp             TTTCBCHHHHHTCGGG
T ss_pred             ccccCCHHHHhhChhh
Confidence            9999999999998554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=340.82  Aligned_cols=270  Identities=24%  Similarity=0.328  Sum_probs=198.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEE-----
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCC-----  151 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-----  151 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++........+.+.+|+.+++.++||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            468999999999999999999654      357899999987766666778899999999999999999999873     


Q ss_pred             ---------eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-CC
Q 012832          152 ---------EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-SD  221 (455)
Q Consensus       152 ---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-~~  221 (455)
                               .....++||||++ |+|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++ .+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTED  157 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTT
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCC
Confidence                     3467899999996 699998854   46899999999999999999999976  99999999999997 56


Q ss_pred             CceEEccCCCccCCCCCCC-ccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          222 YTAKLSDFGLAKDGPEGDD-THVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      +.+||+|||++........ ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7999999999986543211 111233568999999998865 67899999999999999999999999876532221111


Q ss_pred             Hhhhhhh--HhhhhhcccC---------CCcc-cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          300 EWARPML--NDARKLGRIM---------DPRL-EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       300 ~~~~~~~--~~~~~~~~~~---------~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....+..  .....+...+         .+.. ........+.++.+|+.+||+.||++|||+.++++|.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            1000000  0000000000         0000 00112234678999999999999999999999999843

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.4e-43  Score=341.61  Aligned_cols=254  Identities=27%  Similarity=0.347  Sum_probs=197.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------hhHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------QGHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....        .....+.+|+.+|+.++||||+++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   82 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFER------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN   82 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEEc------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence            467999999999999999999653      3578999999864321        12234778999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc---eE
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT---AK  225 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~---~k  225 (455)
                      ++.... .++||||+++++|.+++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.   +|
T Consensus        83 ~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           83 FFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             EEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEE
T ss_pred             EEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEE
Confidence            987655 89999999999999988653  57899999999999999999999976  999999999999987654   99


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~  302 (455)
                      |+|||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  +....
T Consensus       158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~  232 (322)
T 2ycf_A          158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI  232 (322)
T ss_dssp             ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH
T ss_pred             EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH
Confidence            99999998754321   123357999999999974   46689999999999999999999999976433211  11100


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .   ..    .....+.    .....+..+.+|+.+||..||++|||+.++++|-
T Consensus       233 ~---~~----~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          233 T---SG----KYNFIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             H---HT----CCCCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             H---hC----ccccCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence            0   00    0000000    0122356789999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=343.22  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=202.9

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLI  147 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~  147 (455)
                      ..++.+..++|.+.+.||+|+||.||+|...         ..||+|++.....  .....+.+|+.+++.++||||++++
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWH---------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEES---------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEc---------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            3444566789999999999999999999643         2599999865322  2234567899999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      +++......++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+|||++ ++.++|+
T Consensus        96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           96 GACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             EEEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEEC
T ss_pred             EEEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEe
Confidence            9999999999999999999999988653 357899999999999999999999976  99999999999998 6799999


Q ss_pred             cCCCccCCCCCCC---ccceeccccCCCCcCcccccc---------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccch
Q 012832          228 DFGLAKDGPEGDD---THVSTRVMGTQGYAAPEYVMT---------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE  295 (455)
Q Consensus       228 DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~  295 (455)
                      |||++........   ........||+.|+|||++.+         ..++.++|||||||++|+|++|..||........
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999875432111   111223569999999999864         4578899999999999999999999976543211


Q ss_pred             hhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          296 QSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                      ...+             .....+..   ....++.++.+|+.+||..+|++|||+.++++.|+.+....
T Consensus       252 ~~~~-------------~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          252 IWQM-------------GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHHH-------------HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HHHh-------------ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            1000             00111111   11234466889999999999999999999999999886543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.4e-42  Score=332.83  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe----
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE----  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----  152 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++... ......+.+|+.+++.++||||+++++++..    
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNA------LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEc------CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            457899999999999999999643      35789999998643 3445678899999999999999999998865    


Q ss_pred             ---------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          153 ---------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       153 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                               ....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSC
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCC
Confidence                     35689999999999999998754 356788899999999999999999976  999999999999999999


Q ss_pred             eEEccCCCccCCCCCCC------------ccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCC
Q 012832          224 AKLSDFGLAKDGPEGDD------------THVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKS  290 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~  290 (455)
                      +||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999986543210            1112335799999999999764 68999999999999999998   44321


Q ss_pred             CccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        ...   ....    ....    .....++..++...+..+.+|+.+||+.||.+|||+.++++|.+.
T Consensus       232 --~~~---~~~~----~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          232 --MER---VNIL----KKLR----SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             --HHH---HHHH----HHHH----STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             --hhH---HHHH----Hhcc----ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence              000   1111    0000    012223344555667789999999999999999999999998543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-42  Score=346.52  Aligned_cols=265  Identities=21%  Similarity=0.299  Sum_probs=199.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+++.++||||+++++++...+
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDK------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccEEEEeEEecCCCeEEEEEEEC------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            578999999999999999999543      357899999986532  233467889999999999999999999998776


Q ss_pred             eE------EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          155 HR------LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       155 ~~------~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      ..      ++||||+. ++|.+++.    ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECS
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEe
Confidence            54      99999996 68887663    35899999999999999999999976  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-hhhh-
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPM-  305 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-~~~~-  305 (455)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.- .... 
T Consensus       188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            9999865432     233579999999999987 6799999999999999999999999987543222111100 0000 


Q ss_pred             ---h-----HhhhhhcccCCCcccC---CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          306 ---L-----NDARKLGRIMDPRLEG---QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       306 ---~-----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         .     .........+......   ......+..+.+|+.+||+.||++|||+.++++|-+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  327 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  327 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence               0     0000000000000000   1122346789999999999999999999999999543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.3e-42  Score=336.17  Aligned_cols=271  Identities=24%  Similarity=0.314  Sum_probs=204.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcC---CCCCcccEEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQL---RHPHLVKLIGYC  150 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~  150 (455)
                      ..++|.+.+.||+|+||.||+|....     ..++.||+|++......  ....+.+|+.+++.+   +||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLK-----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT-----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecC-----CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            45789999999999999999996532     24678999998643221  122455677666655   899999999998


Q ss_pred             E-----eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceE
Q 012832          151 C-----EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       151 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                      .     .....++||||++ |+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEE
Confidence            7     4567899999996 69999998766667999999999999999999999976  99999999999999999999


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+......
T Consensus       161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999998654321   223367999999999999999999999999999999999999999875432211111000000


Q ss_pred             hHhhhhhcc-------cC---CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 LNDARKLGR-------IM---DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ~~~~~~~~~-------~~---~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      . ....+..       .+   .......+....+..+.+|+.+||..+|.+|||+.++++|-+
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          238 P-GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             C-CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             C-CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            0 0000000       00   000011233445678899999999999999999999998843

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.3e-43  Score=349.66  Aligned_cols=265  Identities=22%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE--  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  154 (455)
                      ..+|.+.+.||+|+||.||+|....      ++ .||+|++......    ..+|+.+|+.++||||+++++++....  
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVE------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETT------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECC------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            4579999999999999999996543      23 4888877433221    236999999999999999999986544  


Q ss_pred             ----eEEEEEEecCCCChHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-CCCceEEc
Q 012832          155 ----HRLLVYEYMPRGSLENQLF--RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-SDYTAKLS  227 (455)
Q Consensus       155 ----~~~lv~e~~~~g~L~~~l~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-~~~~~kL~  227 (455)
                          ..++||||++++ |...+.  ......+++..+..++.||+.||+|||+.+  |+||||||+||||+ .++.+||+
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEe
Confidence                378999999764 444333  223467999999999999999999999976  99999999999999 79999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH-hhh-h
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE-WAR-P  304 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~-~~~-~  304 (455)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+. ... +
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999987544322   2235789999999998765 58999999999999999999999998765332221111 000 0


Q ss_pred             hhHhhhhh-cccCCC--------cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          305 MLNDARKL-GRIMDP--------RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       305 ~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ........ ......        .+...++...+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence            00000000 001111        1111123345678999999999999999999999999843

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.9e-42  Score=337.83  Aligned_cols=269  Identities=21%  Similarity=0.260  Sum_probs=205.6

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC------cccEEEE
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH------LVKLIGY  149 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~  149 (455)
                      ..++|.+.+.||+|+||.||+|.....     .+..||||++... ......+.+|+.+++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR-----GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC-----CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            357899999999999999999965331     2368999998643 234466778999999887665      8999999


Q ss_pred             EEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEE-----------
Q 012832          150 CCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILL-----------  218 (455)
Q Consensus       150 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill-----------  218 (455)
                      +......++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||+           
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccc
Confidence            99999999999999 778888887765567999999999999999999999976  9999999999999           


Q ss_pred             --------cCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCC
Q 012832          219 --------DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKS  290 (455)
Q Consensus       219 --------~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~  290 (455)
                              +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    567899999999998644322     2357999999999999999999999999999999999999999865


Q ss_pred             CccchhhHHHhhh-h----hhHhhhh--------------------hcccCCCc-ccCCCCHHHHHHHHHHHHHHhccCC
Q 012832          291 RPQREQSLVEWAR-P----MLNDARK--------------------LGRIMDPR-LEGQYSETGARKAAALAYQCLSHRP  344 (455)
Q Consensus       291 ~~~~~~~~~~~~~-~----~~~~~~~--------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P  344 (455)
                      ........+.... +    +......                    ......+. .........+.++.+|+.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            4332211111100 0    0000000                    00000000 0001223446789999999999999


Q ss_pred             CCCCCHHHHHHhcc
Q 012832          345 KQRPTMSTVVKTLE  358 (455)
Q Consensus       345 ~~RPt~~ell~~L~  358 (455)
                      ++|||+.++++|-+
T Consensus       323 ~~Rpt~~e~l~hp~  336 (355)
T 2eu9_A          323 AQRITLAEALLHPF  336 (355)
T ss_dssp             TTSCCHHHHTTSGG
T ss_pred             hhCcCHHHHhcChh
Confidence            99999999998844

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.6e-42  Score=331.10  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=203.7

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDR------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEc------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence            3568999999999999999999643      357889999985432  23457788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC---CceEEccCC
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD---YTAKLSDFG  230 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~---~~~kL~DfG  230 (455)
                      ...++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             CeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccC
Confidence            9999999999999999988765  46899999999999999999999976  9999999999999754   479999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR  310 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  310 (455)
                      ++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||........   ..   .+...  
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---~~~~~--  237 (287)
T 2wei_A          170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK---RVETG--  237 (287)
T ss_dssp             GGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHC--
T ss_pred             cceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHcC--
Confidence            9986543321   223568999999998875 489999999999999999999999976543211   11   00000  


Q ss_pred             hhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          ...  .........+.++.+|+.+||..+|++|||+.+++++.
T Consensus       238 ----~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  278 (287)
T 2wei_A          238 ----KYA--FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (287)
T ss_dssp             ----CCC--CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             ----CCC--CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence                000  00001123457789999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.8e-42  Score=337.15  Aligned_cols=260  Identities=25%  Similarity=0.322  Sum_probs=183.8

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHH-HHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVI-FLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||.||+|...      .+++.||||++.... ......+..|+. +++.++||||+++++++..
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHK------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEET------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEc------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            45678999999999999999999653      357899999986543 233345556665 7788899999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFR---RYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      .+..++||||++ |+|.+++..   .....+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A           93 EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEcc
Confidence            999999999996 488777653   2346789999999999999999999996 6  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccc----ccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV----MTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      ||++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||.......     ...  
T Consensus       170 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~--  239 (327)
T 3aln_A          170 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL--  239 (327)
T ss_dssp             CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------
T ss_pred             CCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH--
Confidence            999986543321   2234799999999998    45678999999999999999999999997542210     000  


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ........+.+.......++..+.+|+.+||..+|++|||+.+++++.+
T Consensus       240 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  288 (327)
T 3aln_A          240 -----TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF  288 (327)
T ss_dssp             -----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             -----HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence                 0000111111222222345678999999999999999999999998743

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-42  Score=340.72  Aligned_cols=258  Identities=23%  Similarity=0.260  Sum_probs=177.9

Q ss_pred             hcCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--
Q 012832           76 TTQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        76 ~~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  152 (455)
                      ..++|.+. ++||+|+||.||+|...      .+++.||||++.... .   ........++.+.||||+++++++..  
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHR------RTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEEC------CCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            35788885 47999999999999654      357899999985432 1   11223334567789999999999876  


Q ss_pred             --CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEc
Q 012832          153 --EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLS  227 (455)
Q Consensus       153 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~  227 (455)
                        ....++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEe
Confidence              455899999999999999998776668999999999999999999999976  999999999999976   4569999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............  ...  
T Consensus       174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~--  245 (336)
T 3fhr_A          174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RRI--  245 (336)
T ss_dssp             CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hhh--
Confidence            999998654322    223578999999999988889999999999999999999999997543221100000  000  


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                            ......+.......++.++.+|+.+||+.+|.+|||+.++++|.+.
T Consensus       246 ------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  291 (336)
T 3fhr_A          246 ------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI  291 (336)
T ss_dssp             -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             ------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence                  0000111111223456789999999999999999999999998543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=338.89  Aligned_cols=263  Identities=21%  Similarity=0.309  Sum_probs=200.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++....  ......+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDK------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEEC------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            468999999999999999999643      357899999986432  233467889999999999999999999997765


Q ss_pred             e------EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          155 H------RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       155 ~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      .      .++||||+. ++|.+++.    ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEee
Confidence            4      499999996 68887653    35899999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-----
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-----  302 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-----  302 (455)
                      ||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...     
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     223579999999999877 67899999999999999999999999875432211111000     


Q ss_pred             ----hhhh-----HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          303 ----RPML-----NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       303 ----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                          ....     .....+.......+ .......+.++.+|+.+||..||++|||+.++++|-+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                0000     00000000011111 1223455778999999999999999999999999854

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=334.77  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=194.4

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh------hHHHHHHHHHHHhcC----CCCCc
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ------GHREWLTEVIFLGQL----RHPHL  143 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nI  143 (455)
                      ....++|.+.+.||+|+||.||+|..      ..+++.||||++......      ....+.+|+.++..+    +||||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i  100 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHR------LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV  100 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEEC------TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEE------ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence            34567899999999999999999953      335789999998654321      223345788888888    89999


Q ss_pred             ccEEEEEEeCCeEEEEEEe-cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-CC
Q 012832          144 VKLIGYCCEEEHRLLVYEY-MPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-SD  221 (455)
Q Consensus       144 v~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-~~  221 (455)
                      +++++++...+..++|||| +.+++|.+++...  ..+++..++.++.||+.||+|||+.+  |+||||||+|||++ .+
T Consensus       101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRR  176 (312)
T ss_dssp             CCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTT
T ss_pred             eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCC
Confidence            9999999999999999999 7899999999765  46899999999999999999999976  99999999999999 78


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT-SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE  300 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~  300 (455)
                      +.++|+|||++.......    .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||....     ..  
T Consensus       177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~--  245 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI--  245 (312)
T ss_dssp             TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH--
T ss_pred             CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH--
Confidence            999999999998765432    2335699999999999877664 58999999999999999999996421     00  


Q ss_pred             hhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                           ...            ...++...+..+.+|+.+||+.+|++|||+.+++++.+.
T Consensus       246 -----~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          246 -----LEA------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             -----HHT------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             -----hhh------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                 000            011234456778999999999999999999999998543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-42  Score=339.18  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh------hHHHHHHHHHHHhcCC--CCC
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ------GHREWLTEVIFLGQLR--HPH  142 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~n  142 (455)
                      .+.....++|.+.+.||+|+||.||+|...      .+++.||||++......      ....+.+|+.+++.++  |+|
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRV------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEET------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEEC------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            334456788999999999999999999643      35789999998654321      2234567999999996  599


Q ss_pred             cccEEEEEEeCCeEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-C
Q 012832          143 LVKLIGYCCEEEHRLLVYEYMPR-GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-S  220 (455)
Q Consensus       143 Iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-~  220 (455)
                      |+++++++...+..++||||+.+ ++|.+++...  ..+++..++.++.||+.||+|||+.+  |+||||||+|||++ .
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN  185 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCC
Confidence            99999999999999999999976 8999998765  57899999999999999999999976  99999999999999 7


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV  299 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~  299 (455)
                      ++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.....     . 
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-  255 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-  255 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-
T ss_pred             CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-
Confidence            8999999999998764322    223579999999999987765 6889999999999999999999964210     0 


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                            ...            ...++...+.++.+|+.+||+.+|++|||+.+++++.+
T Consensus       256 ------~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          256 ------IRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             ------HHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             ------hcc------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence                  000            00122334577899999999999999999999999854

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-41  Score=343.41  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=189.3

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  156 (455)
                      +.|.+.+.||+|+||+||.+.       ..+++.||||++..+.   ...+.+|+.+|..+ +||||+++++++......
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-------~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-------SFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-------ESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-------EECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            345667889999999998652       2347899999986432   34567899999876 899999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC----------
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVS-----LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD----------  221 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~----------  221 (455)
                      +||||||. |+|.+++.......     .++..++.++.||+.||+|||+.+  |+||||||+||||+.+          
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccC
Confidence            99999995 69999987643211     133456789999999999999976  9999999999999654          


Q ss_pred             ---CceEEccCCCccCCCCCCCcc--ceeccccCCCCcCcccccc-------CCCCccCchhhHHHHHHHHHh-CCCCCC
Q 012832          222 ---YTAKLSDFGLAKDGPEGDDTH--VSTRVMGTQGYAAPEYVMT-------GHLTSMSDVYSFGVVLLELLS-GRKSVD  288 (455)
Q Consensus       222 ---~~~kL~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-G~~p~~  288 (455)
                         +.+||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               489999999998765432211  1233579999999999976       568999999999999999999 999997


Q ss_pred             CCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          289 KSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ...... ....       ..     ....+..........+.++.+|+.+||+.||.+|||+.++++|.+.
T Consensus       242 ~~~~~~-~~i~-------~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          242 DKYSRE-SNII-------RG-----IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             STTTHH-HHHH-------HT-----CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             CchhhH-HHHh-------cC-----CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            543211 1110       00     0001111222345678899999999999999999999999998543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=330.07  Aligned_cols=256  Identities=23%  Similarity=0.346  Sum_probs=183.1

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hh-HHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QG-HREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ...++|.+.+.||+|+||.||+|....      +++.||||++..... .. .+.+..+..+++.++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRK------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETT------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhccccccceeeecCCeeEEEEEEec------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            345789999999999999999996543      577999999865432 22 2334455567888899999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA-EKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      .+..++||||+ ++.+..++ ......+++..++.++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCcEEEEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCC
Confidence            99999999999 55555444 33356799999999999999999999983 6  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +........   .....||+.|+|||++.     +..++.++|||||||++|+|++|..||.......  ....   ...
T Consensus       172 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~  243 (318)
T 2dyl_A          172 SGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLT---KVL  243 (318)
T ss_dssp             C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH---HHH
T ss_pred             chhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHH---HHh
Confidence            976543221   22357999999999994     4568899999999999999999999997543211  1111   111


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ..       ..+.+.  .....+.++.+|+.+||..+|.+|||+.++++|.
T Consensus       244 ~~-------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          244 QE-------EPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             HS-------CCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             cc-------CCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence            00       011111  1123457789999999999999999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=343.08  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=189.5

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  153 (455)
                      +...+|.+.+.||+|+||+||...       ..+++.||||++......   .+.+|+.+|+.+ +||||+++++++.+.
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~-------~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~   90 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRG-------MFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR   90 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEE-------ESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred             EccEEEecCCeeecCcCEEEEEEE-------EeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            345679999999999999965431       234678999998654322   245799999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-----CCceEEcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-----DYTAKLSD  228 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-----~~~~kL~D  228 (455)
                      ...|||||||. |+|.+++.... ..+....++.++.||+.||+|||+.+  |+||||||+||||+.     ...+||+|
T Consensus        91 ~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           91 QFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             TEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             CEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99999999995 69999887553 34555677899999999999999977  999999999999943     34688999


Q ss_pred             CCCccCCCCCCCc-cceeccccCCCCcCccccc---cCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhh
Q 012832          229 FGLAKDGPEGDDT-HVSTRVMGTQGYAAPEYVM---TGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       229 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      ||+++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||...........     
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-----  241 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-----  241 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-----
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-----
Confidence            9999876543211 1223467999999999997   4567889999999999999999 9999964322110000     


Q ss_pred             hhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                              .......  ........+..+.+|+.+||+.||.+|||+.++++|.+
T Consensus       242 --------~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~  286 (432)
T 3p23_A          242 --------LGACSLD--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF  286 (432)
T ss_dssp             --------TTCCCCT--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred             --------hccCCcc--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence                    0000000  01112345667899999999999999999999999844

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.7e-41  Score=352.39  Aligned_cols=264  Identities=24%  Similarity=0.319  Sum_probs=201.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEe---
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE---  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---  152 (455)
                      .++|.+.+.||+|+||.||+|.      +..++..||||++... .......+.+|+.+|+.++||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~------~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWI------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCC------CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEE------ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            4789999999999999999983      4456889999998654 33445678899999999999999999998755   


Q ss_pred             ---CCeEEEEEEecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc---eE
Q 012832          153 ---EEHRLLVYEYMPRGSLENQLFRRY-SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT---AK  225 (455)
Q Consensus       153 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~---~k  225 (455)
                         .+..++||||++||+|.+++.... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.   ++
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEE
Confidence               667899999999999999987643 236889999999999999999999976  999999999999987664   99


Q ss_pred             EccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          226 LSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       226 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|....
T Consensus       165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i  236 (676)
T 3qa8_A          165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKV  236 (676)
T ss_dssp             ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTC
T ss_pred             Ecccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhh
Confidence            999999987654332   2336799999999999999999999999999999999999999975421     11221111


Q ss_pred             hHhhhh---hcccC--------CCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          306 LNDARK---LGRIM--------DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       306 ~~~~~~---~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                      ......   .....        .......+....+..+.+|+.+||..||++|||+.++++|
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h  298 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV  298 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence            100000   00000        0011233556688999999999999999999999886655

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.9e-39  Score=313.19  Aligned_cols=232  Identities=22%  Similarity=0.281  Sum_probs=182.2

Q ss_pred             cCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHH-hcCCCCCcccEEEEEEe--
Q 012832           77 TQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFL-GQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        77 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~--  152 (455)
                      .++|.+. +.||+|+||.||+|...      .+++.||||++...     ..+.+|+.++ +.++||||+++++++..  
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNK------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEc------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            3567776 78999999999999643      35789999998532     3456788887 66689999999999877  


Q ss_pred             --CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEc
Q 012832          153 --EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLS  227 (455)
Q Consensus       153 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~  227 (455)
                        ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.   ++.++|+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEe
Confidence              677899999999999999998876667999999999999999999999977  999999999999998   7899999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |||++....                        +..++.++|||||||++|+|++|..||..........          
T Consensus       163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----------  208 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------  208 (299)
T ss_dssp             CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C----------
T ss_pred             ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH----------
Confidence            999986432                        2346789999999999999999999997543211000          


Q ss_pred             hhhhhcccCCCcccCCCC----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          308 DARKLGRIMDPRLEGQYS----ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        .....+...  ...++    ..++.++.+|+.+||+.+|.+|||+.++++|.+.
T Consensus       209 --~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~  260 (299)
T 3m2w_A          209 --GMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  260 (299)
T ss_dssp             --CSCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             --HHHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence              000000000  00111    2346789999999999999999999999998543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-39  Score=312.67  Aligned_cols=234  Identities=15%  Similarity=0.113  Sum_probs=185.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.+|+.++..++||||+++++++..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDT------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEET------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEec------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            4578999999999999999999653      3578999999975432   334678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..|+||||++|++|.+++...    .....+..++.|++.||+|||+.+  |+||||||+||||+.++.+||+++|  
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--
Confidence            99999999999999999988432    355678899999999999999977  9999999999999999999998543  


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                                          |++|       ++.++|||||||++|||++|+.||............             
T Consensus       175 --------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------  214 (286)
T 3uqc_A          175 --------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------  214 (286)
T ss_dssp             --------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------
T ss_pred             --------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------
Confidence                                3332       688999999999999999999999875432110000             


Q ss_pred             cccCCC--cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccCCC
Q 012832          313 GRIMDP--RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD  364 (455)
Q Consensus       313 ~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~~~  364 (455)
                      ......  .........++.++.+|+.+||+.||++| |+.++++.|+.+....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            000000  00011223456789999999999999999 9999999998775433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.3e-40  Score=350.06  Aligned_cols=241  Identities=24%  Similarity=0.377  Sum_probs=191.4

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|.+.+.||+|+||.||+|.+..     .+++.||||++.... ......+.+|+.+|..++||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRN-----VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGG-----GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcC-----CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            345789999999999999999996542     146789999886433 34456688999999999999999999999877


Q ss_pred             Ce-----EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 EH-----RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                      +.     .||||||++|++|.+++..    .+++..++.++.||+.||.|||+.+  ||||||||+||||+.+ .+||+|
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEe
Confidence            65     7999999999999986643    6899999999999999999999977  9999999999999885 899999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      ||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.......              
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            9999876442      235799999999998765 4889999999999999999999886421100              


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHHhcc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS-TVVKTLE  358 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~-ell~~L~  358 (455)
                            +    .........+..+.+|+.+||+.+|++||+.. ++...|.
T Consensus       284 ------~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          284 ------L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ------C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ------c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                  0    00001112346788999999999999999654 4444443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-40  Score=333.96  Aligned_cols=244  Identities=17%  Similarity=0.178  Sum_probs=182.8

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCC-CCc--------
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRH-PHL--------  143 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~nI--------  143 (455)
                      ....|...++||+|+||.||+|.+..      +++.||||++.....   ...+.+.+|+.+++.+.| +|+        
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~  149 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR  149 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred             CceeEEEecccccCCCEEEEEEEecC------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence            34557888999999999999996543      577999999874332   224678899999999987 221        


Q ss_pred             -cc------------EEEEEEe-----CCeEEEEEEecCCCChHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 012832          144 -VK------------LIGYCCE-----EEHRLLVYEYMPRGSLENQLF-----RRYSVSLPWSTRMKIALGAAKGLAFLH  200 (455)
Q Consensus       144 -v~------------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH  200 (455)
                       +.            +..++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||+|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  228 (413)
T 3dzo_A          150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  228 (413)
T ss_dssp             BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence             11            1111111     22467888877 789998884     222345778899999999999999999


Q ss_pred             hCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCcccc----------ccCCCCccCch
Q 012832          201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYV----------MTGHLTSMSDV  270 (455)
Q Consensus       201 ~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv  270 (455)
                      +.+  ||||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||
T Consensus       229 ~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          229 HYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             HTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             hCC--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence            976  999999999999999999999999998864332     334678 999999999          45558889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 012832          271 YSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM  350 (455)
Q Consensus       271 wslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~  350 (455)
                      |||||++|||++|+.||..........                .++..      ....+.++.+|+.+||+.+|++|||+
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh------cccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999999999999997643221100                01110      11234779999999999999999999


Q ss_pred             HHHHHh
Q 012832          351 STVVKT  356 (455)
Q Consensus       351 ~ell~~  356 (455)
                      .+++++
T Consensus       359 ~~~l~~  364 (413)
T 3dzo_A          359 LQAMET  364 (413)
T ss_dssp             HHHTTS
T ss_pred             HHHHhC
Confidence            999876

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.1e-38  Score=310.99  Aligned_cols=246  Identities=18%  Similarity=0.223  Sum_probs=187.4

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--------hhhHHHHHHHHHHHhcCC--------
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--------LQGHREWLTEVIFLGQLR--------  139 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~--------  139 (455)
                      ..++|.+.+.||+|+||.||+|..        +++.||||++....        ......+.+|+.+|+.++        
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             ccccchheeeecccCceEEEEEEe--------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            356789999999999999999964        35789999986542        223366788888888875        


Q ss_pred             -CCCcccEEEEEE------------------------------eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHH
Q 012832          140 -HPHLVKLIGYCC------------------------------EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI  188 (455)
Q Consensus       140 -h~nIv~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i  188 (455)
                       ||||+++++++.                              .....||||||+++|++.+.+..   ..+++..+..+
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i  166 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI  166 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence             888888887754                              26789999999999977666643   46899999999


Q ss_pred             HHHHHHHHHHhh-hCCCCeEEeccCCCCEEEcCCC--------------------ceEEccCCCccCCCCCCCccceecc
Q 012832          189 ALGAAKGLAFLH-DAEKPVIYRDFKASNILLDSDY--------------------TAKLSDFGLAKDGPEGDDTHVSTRV  247 (455)
Q Consensus       189 ~~~i~~~L~~LH-~~~~~iiHrDlkp~Nill~~~~--------------------~~kL~DfGla~~~~~~~~~~~~~~~  247 (455)
                      +.||+.||+||| +.+  |+||||||+||||+.++                    .+||+|||+|+.....       ..
T Consensus       167 ~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~  237 (336)
T 2vuw_A          167 LHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IV  237 (336)
T ss_dssp             HHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EE
T ss_pred             HHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cE
Confidence            999999999999 877  99999999999999887                    8999999999865431       24


Q ss_pred             ccCCCCcCccccccCCCCccCchhhHHHH-HHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCH
Q 012832          248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVV-LLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSE  326 (455)
Q Consensus       248 ~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (455)
                      +||+.|+|||++.+.. +.++||||||++ .++++.|..||...         .|.......... ..............
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLK-QMTFKTKCNTPAMK  306 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHH-TCCCSSCCCSHHHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhh-hhccCcccchhhhh
Confidence            7999999999998766 889999998777 77788899888421         111111111000 00111111122345


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCHHHHH-Hhc
Q 012832          327 TGARKAAALAYQCLSHRPKQRPTMSTVV-KTL  357 (455)
Q Consensus       327 ~~~~~~~~li~~cl~~~P~~RPt~~ell-~~L  357 (455)
                      ..+.++.+|+.+||+.+     |+.+++ +|-
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp  333 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQHS  333 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence            67889999999999976     999999 874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3e-33  Score=292.39  Aligned_cols=185  Identities=18%  Similarity=0.098  Sum_probs=129.5

Q ss_pred             ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----------hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           86 LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----------LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        86 LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      ++.|++|.+..+      +....|+.||+|++....          ....++|.+|+++|+++ .|+||+++++++.++.
T Consensus       242 ~~~~~~~~h~~~------rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRS------RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CC------EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCccccccc------ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            566666655543      234568899999985431          23346689999999999 5999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..||||||++|++|.++|...  ..++..   .|+.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|+.
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999999764  455543   58899999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCC
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS  286 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p  286 (455)
                      ......  .....+||+.|||||++.+ .+..++|+||+|+++++|.+|..+
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            654332  2344789999999999875 467789999999998887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3e-29  Score=260.71  Aligned_cols=185  Identities=17%  Similarity=0.206  Sum_probs=143.6

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--------hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--------LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ...+.||+|+||.||+|..        .+..+|+|......        ....+.+.+|+.+|+.++||||+++..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEEC--------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            4467899999999999932        35678888753221        1123457899999999999999966666667


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..||||||++|++|.+++..          +..++.|++.||+|||+.+  |+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccC
Confidence            7888999999999999998854          5689999999999999976  999999999999998  9999999999


Q ss_pred             cCCCCCCCcc-----ceeccccCCCCcCcccccc--CCCCccCchhhHHHHHHHHHhCCCCC
Q 012832          233 KDGPEGDDTH-----VSTRVMGTQGYAAPEYVMT--GHLTSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       233 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~p~  287 (455)
                      +.........     .....+||+.|||||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9765432211     1234689999999999987  56888899999999999888877765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.9e-25  Score=212.08  Aligned_cols=153  Identities=14%  Similarity=0.095  Sum_probs=119.7

Q ss_pred             HHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch------------------hhHHHHHHHH
Q 012832           71 AELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL------------------QGHREWLTEV  132 (455)
Q Consensus        71 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~  132 (455)
                      ..+......|.+.+.||+|+||.||+|.. .      +++.||||++.....                  .....+.+|+
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~  155 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-E------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF  155 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEE-T------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEe-C------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHH
Confidence            33444456677889999999999999965 2      477899999864321                  1345688999


Q ss_pred             HHHhcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccC
Q 012832          133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK  212 (455)
Q Consensus       133 ~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlk  212 (455)
                      .+|+.++  | +++++++.. +..++||||++||+|.+ +.      .  .....++.|++.||.|||+.+  |+|||||
T Consensus       156 ~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~g--iiHrDlk  220 (282)
T 1zar_A          156 RALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRG--IVHGDLS  220 (282)
T ss_dssp             HHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             HHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCC--CEeCCCC
Confidence            9999999  4 566555433 45699999999999987 41      1  235579999999999999977  9999999


Q ss_pred             CCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCcccccc
Q 012832          213 ASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT  261 (455)
Q Consensus       213 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  261 (455)
                      |+||||+ ++.+||+|||+|+.               +..|+|||++..
T Consensus       221 p~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          221 QYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             HHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9999999 99999999999863               445789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=2.8e-21  Score=182.07  Aligned_cols=137  Identities=18%  Similarity=0.107  Sum_probs=104.6

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCccccc--EEEEeccccchh------------------------hHHHHHHHHH
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQP--VAVKNLDLEGLQ------------------------GHREWLTEVI  133 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  133 (455)
                      |.+.+.||+|+||.||+|...      .++..  ||||++......                        ....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            678899999999999999652      23667  999986433111                        1135778999


Q ss_pred             HHhcCCCCCc--ccEEEEEEeCCeEEEEEEecCC-C----ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCC
Q 012832          134 FLGQLRHPHL--VKLIGYCCEEEHRLLVYEYMPR-G----SLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH-DAEKP  205 (455)
Q Consensus       134 ~l~~l~h~nI--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~  205 (455)
                      +|..+.|++|  +.++++    ...+|||||+.+ |    +|.++...     .++..+..++.|++.||.||| +.+  
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--
Confidence            9999988864  444442    246899999942 3    67665432     235577889999999999999 866  


Q ss_pred             eEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          206 VIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       206 iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ||||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1.2e-17  Score=164.10  Aligned_cols=138  Identities=14%  Similarity=0.111  Sum_probs=98.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--------------hhHHH--------HHHHHHHH
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--------------QGHRE--------WLTEVIFL  135 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l  135 (455)
                      .-|.+.+.||.|+||.||+|...       .|+.||||+++....              .....        ..+|...|
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEecCEeeeCCceEEEEEECC-------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            34899999999999999999532       378899998643210              00111        23567777


Q ss_pred             hcCCCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCC
Q 012832          136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASN  215 (455)
Q Consensus       136 ~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~N  215 (455)
                      .++.+.++.-..-+...  ..+|||||++|++|..+.      ..  .....++.|++.+|.|||.++  ||||||||.|
T Consensus       168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~--~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~N  235 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS------SV--PDPASLYADLIALILRLAKHG--LIHGDFNEFN  235 (397)
T ss_dssp             HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC------CC--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTS
T ss_pred             HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhc------cc--HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHH
Confidence            77765544322112222  237999999998886532      11  234578899999999999977  9999999999


Q ss_pred             EEEcCCC----------ceEEccCCCccC
Q 012832          216 ILLDSDY----------TAKLSDFGLAKD  234 (455)
Q Consensus       216 ill~~~~----------~~kL~DfGla~~  234 (455)
                      |||+.++          .+.|+||+-+..
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEEeCCCCcccccccccceEEEEeCCccc
Confidence            9998776          389999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=3.8e-13  Score=126.27  Aligned_cols=143  Identities=13%  Similarity=0.005  Sum_probs=111.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  154 (455)
                      ....|.+...+|.|+++.||++..        .+..+++|+...........+.+|+.+|+.+. +..++++++++...+
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~--------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HhccceeEeeccCCCCCeEEEEEC--------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            345788889999999999998731        24689999986432222345778999999885 677889999999989


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC-------------------------------
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE-------------------------------  203 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------  203 (455)
                      ..|+||||++|.+|.+.+.       +......++.+++.+|..||+..                               
T Consensus        84 ~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999999887531       11234578889999999999810                               


Q ss_pred             --------------------------CCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          204 --------------------------KPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       204 --------------------------~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                                                ..++|+|++|.|||++++..+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                      238999999999999876667799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1.1e-11  Score=115.61  Aligned_cols=136  Identities=16%  Similarity=0.039  Sum_probs=97.1

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC--cccEEEEEEeCCeE
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH--LVKLIGYCCEEEHR  156 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~  156 (455)
                      ++.+..+.+.|.++.||++...       .+..+++|.....   ....+..|+.+++.+.+.+  +++++++....+..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~-------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             CCceEecccCCCCceEEEEecC-------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            4444444456667999987421       2467999987543   1234667888888886444  56689988888889


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE---------------------------------  203 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------  203 (455)
                      ++||||++|.+|.  ..     ..   ....++.+++..|..||+..                                 
T Consensus        91 ~~v~e~i~G~~l~--~~-----~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS-----HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEEECCSSEETT--TS-----CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEecCCcccC--cC-----cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999999998884  21     11   12356777788888888642                                 


Q ss_pred             -----------------------CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 -----------------------KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 -----------------------~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                                             ..++|+|++|.|||+++++.+.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                   1299999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=8.3e-11  Score=115.57  Aligned_cols=143  Identities=15%  Similarity=0.191  Sum_probs=105.1

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecc--ccc-hhhHHHHHHHHHHHhcCC--CCCcccEEEEEEeC--
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD--LEG-LQGHREWLTEVIFLGQLR--HPHLVKLIGYCCEE--  153 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~--  153 (455)
                      ...+.|+.|.++.||+....        +..+++|+..  ... ......+.+|+.+++.|.  +..+++++.++.+.  
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~  112 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV  112 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred             ceEEEcCCcccceEEEEEEC--------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence            34677999999999987432        3578899875  322 122345778999999887  45678899888766  


Q ss_pred             -CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------------------------------
Q 012832          154 -EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA------------------------------  202 (455)
Q Consensus       154 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------  202 (455)
                       +..|+||||++|..+.+..    ...++......++.+++..|+.||..                              
T Consensus       113 ~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          113 IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence             3479999999988775421    13467788888999999999999973                              


Q ss_pred             --------------------------CCCeEEeccCCCCEEEcCCCc--eEEccCCCccCC
Q 012832          203 --------------------------EKPVIYRDFKASNILLDSDYT--AKLSDFGLAKDG  235 (455)
Q Consensus       203 --------------------------~~~iiHrDlkp~Nill~~~~~--~kL~DfGla~~~  235 (455)
                                                ...++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                      134899999999999987653  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=5e-11  Score=114.39  Aligned_cols=182  Identities=19%  Similarity=0.198  Sum_probs=121.4

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCC--cccEEEEEEeCC---eE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPH--LVKLIGYCCEEE---HR  156 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~---~~  156 (455)
                      .+.++.|.+..||+.           +..+++|+....  .....+.+|+.+|+.+. +..  ++.++.......   ..
T Consensus        25 i~~~~~G~~n~v~~v-----------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI-----------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEES-----------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             eEecCCCCcceEEEE-----------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            456899999999975           246899986432  33456788999998874 333  445555543333   34


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE---------------------------------  203 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------  203 (455)
                      |+||++++|.+|.+...    ..++..+...++.+++..|+.||+..                                 
T Consensus        92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            89999999988875433    24667777788888888888888511                                 


Q ss_pred             -----------------------CCeEEeccCCCCEEEcC--CCceEEccCCCccCCCCCCCccceeccccCCCC---cC
Q 012832          204 -----------------------KPVIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY---AA  255 (455)
Q Consensus       204 -----------------------~~iiHrDlkp~Nill~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y---~a  255 (455)
                                             ..++|+|++|.|||++.  +..+.|+||+.+.......+      ......+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccC
Confidence                                   23799999999999988  56688999999875432110      0011111   22


Q ss_pred             cccccc-----CCC---------CccCchhhHHHHHHHHHhCCCCC
Q 012832          256 PEYVMT-----GHL---------TSMSDVYSFGVVLLELLSGRKSV  287 (455)
Q Consensus       256 PE~~~~-----~~~---------~~~~DvwslG~il~ell~G~~p~  287 (455)
                      |+....     +..         ....+.|++|.++|.+.+|.++|
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222210     000         11258999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=1e-07  Score=91.27  Aligned_cols=136  Identities=18%  Similarity=0.128  Sum_probs=93.9

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCC---CcccEEEEEE-eCCeEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHP---HLVKLIGYCC-EEEHRLL  158 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~~~l  158 (455)
                      ...++.|....||+.           +..+++|+..  .......+..|+.+|+.|.+.   .++.++.++. ..+..++
T Consensus        24 v~~l~~G~~n~v~~v-----------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eeecCCCcceeEEEE-----------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            456888998999986           3578899843  223345678999999998742   3667777764 3456789


Q ss_pred             EEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------------------------------------
Q 012832          159 VYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA------------------------------------  202 (455)
Q Consensus       159 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------  202 (455)
                      ||||++|.+|.+....    .++......++.+++..|+.||+.                                    
T Consensus        91 v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           91 GYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            9999999888763221    234444445555555555555532                                    


Q ss_pred             ----------------------CCCeEEeccCCCCEEEcC---CCc-eEEccCCCccCC
Q 012832          203 ----------------------EKPVIYRDFKASNILLDS---DYT-AKLSDFGLAKDG  235 (455)
Q Consensus       203 ----------------------~~~iiHrDlkp~Nill~~---~~~-~kL~DfGla~~~  235 (455)
                                            ...++|+|+.|.|||++.   ++. +.|+||+.+...
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                  123699999999999987   355 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.62  E-value=3.2e-07  Score=85.85  Aligned_cols=134  Identities=17%  Similarity=0.081  Sum_probs=94.8

Q ss_pred             ccccCCe-eEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEEEec
Q 012832           86 LGEGGFG-AVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVYEYM  163 (455)
Q Consensus        86 LG~G~fG-~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~  163 (455)
                      +..|..| .||+...      ...+..+++|+-...   ....+..|...|+.+. +--+.++++++.+.+..++|||++
T Consensus        32 ~~~G~S~~~v~rl~~------~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYG------KPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEEC------CTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEe------cCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            4445554 6887532      223567899985432   3455778999988875 334778999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------------
Q 012832          164 PRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE----------------------------------------  203 (455)
Q Consensus       164 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  203 (455)
                      +|.++.+.....      ......++.+++..|.-||...                                        
T Consensus       103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            998887755321      1233455666667777777410                                        


Q ss_pred             ----------------CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 ----------------KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 ----------------~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                                      ..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                            0278999999999999887778999998854

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=4.4e-07  Score=88.69  Aligned_cols=87  Identities=3%  Similarity=-0.145  Sum_probs=54.2

Q ss_pred             cccc-cccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCC-C--CCcccEEEEEEeC--
Q 012832           83 SNFL-GEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLR-H--PHLVKLIGYCCEE--  153 (455)
Q Consensus        83 ~~~L-G~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~--  153 (455)
                      .+.| +.|....+|+............+..+++|......   ......+..|+.+|+.|. +  -.+++++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999987432000000014678899765332   101234567888888775 3  3567888877654  


Q ss_pred             -CeEEEEEEecCCCChH
Q 012832          154 -EHRLLVYEYMPRGSLE  169 (455)
Q Consensus       154 -~~~~lv~e~~~~g~L~  169 (455)
                       +..++||||++|..|.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=5.7e-06  Score=79.90  Aligned_cols=31  Identities=16%  Similarity=0.175  Sum_probs=27.5

Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4599999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.24  E-value=2.8e-06  Score=84.29  Aligned_cols=76  Identities=13%  Similarity=0.090  Sum_probs=48.3

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-------hhHHHHHHHHHHHhcCCC--C-CcccEEEEEEe
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-------QGHREWLTEVIFLGQLRH--P-HLVKLIGYCCE  152 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~~~~~~~~  152 (455)
                      .+.||.|.++.||++....      .+..|+||.......       .....+..|+++|+.+..  + .+++++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECC------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            5679999999999985322      246799997542211       122345678888887742  3 34566644  3


Q ss_pred             CCeEEEEEEecCCC
Q 012832          153 EEHRLLVYEYMPRG  166 (455)
Q Consensus       153 ~~~~~lv~e~~~~g  166 (455)
                      .+..++||||++|.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            45568999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.02  E-value=2.5e-05  Score=74.69  Aligned_cols=76  Identities=17%  Similarity=0.087  Sum_probs=58.6

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC---CCCcccEEEEEEeCCeEEE
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR---HPHLVKLIGYCCEEEHRLL  158 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~l  158 (455)
                      ..+.|+.|.+..+|+...        .+..+++|+....   ....+..|+..|+.|.   ...+++++.++...+..++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l  108 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL  108 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred             eeEEeCCccceeeeEEEE--------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence            346799999999998732        2457889986532   2456778988888875   3568899999888888999


Q ss_pred             EEEecCCCCh
Q 012832          159 VYEYMPRGSL  168 (455)
Q Consensus       159 v~e~~~~g~L  168 (455)
                      ||||++|..+
T Consensus       109 vme~l~G~~~  118 (312)
T 3jr1_A          109 LLEALNKSKN  118 (312)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeccCCCC
Confidence            9999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.80  E-value=4.9e-05  Score=71.72  Aligned_cols=81  Identities=16%  Similarity=0.149  Sum_probs=55.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC---CCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH---PHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~  153 (455)
                      .........+|.|..+.||+....|       |+.|++|+...........+..|+..|+.|.-   --+++++++.  .
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~D-------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~   84 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELAD-------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D   84 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETT-------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECC-------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C
Confidence            3455567789999999999986554       57899998654433333456789998888752   2345565542  2


Q ss_pred             CeEEEEEEecCCCCh
Q 012832          154 EHRLLVYEYMPRGSL  168 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L  168 (455)
                        .++||||++++..
T Consensus        85 --~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 --RTLAMEWVDERPP   97 (288)
T ss_dssp             --TEEEEECCCCCCC
T ss_pred             --ceEEEEeecccCC
Confidence              3789999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.74  E-value=0.00012  Score=72.95  Aligned_cols=31  Identities=16%  Similarity=0.325  Sum_probs=27.2

Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      ..++|+|++|.|||++.++ +.|+||+.+...
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            4499999999999998876 999999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=8.5e-05  Score=70.52  Aligned_cols=74  Identities=7%  Similarity=0.055  Sum_probs=45.7

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEE
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLL  158 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~l  158 (455)
                      |.-.+.|+.|....+|+.            ..+++|+....... ......|+.+++.+...++ ++++++  ..+..++
T Consensus        20 ~~~i~~l~gG~tN~~~~~------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~   84 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM   84 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred             ccceeEcCCcccccccee------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence            333678999999999986            35888876532111 1112357777777653333 466654  3444579


Q ss_pred             EEEec-CCCCh
Q 012832          159 VYEYM-PRGSL  168 (455)
Q Consensus       159 v~e~~-~~g~L  168 (455)
                      |+||+ +|.+|
T Consensus        85 v~e~i~~g~~l   95 (301)
T 3dxq_A           85 VTRYIAGAQTM   95 (301)
T ss_dssp             EEECCTTCEEC
T ss_pred             EEeecCCCccC
Confidence            99999 66555

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.35  E-value=0.00053  Score=67.27  Aligned_cols=147  Identities=19%  Similarity=0.179  Sum_probs=81.2

Q ss_pred             cccccccCCeeEEEEEEcCCCC-CCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      .+.|..|-...+|+....+... ....+..+++|+... .......+.+|..+++.|. +.-.+++++++.  +  .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence            3567778889999875432110 112346799998532 1223455668999988886 333366766553  2  3999


Q ss_pred             EecCCCChHHH----------Hhh------cC----CCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 012832          161 EYMPRGSLENQ----------LFR------RY----SVSLP--WSTRMKIALGAAK-------------------GLAFL  199 (455)
Q Consensus       161 e~~~~g~L~~~----------l~~------~~----~~~l~--~~~~~~i~~~i~~-------------------~L~~L  199 (455)
                      ||++|.+|...          +.+      ..    .....  +.++..+..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988655310          100      00    11111  3344444433321                   22333


Q ss_pred             ----hhC--CCCeEEeccCCCCEEEcCC----CceEEccCCCccC
Q 012832          200 ----HDA--EKPVIYRDFKASNILLDSD----YTAKLSDFGLAKD  234 (455)
Q Consensus       200 ----H~~--~~~iiHrDlkp~Nill~~~----~~~kL~DfGla~~  234 (455)
                          ...  ...++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                222  2238999999999999876    7899999998753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00064  Score=64.87  Aligned_cols=141  Identities=12%  Similarity=0.097  Sum_probs=75.0

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC--cccEEEE------EEeCCe
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH--LVKLIGY------CCEEEH  155 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~~~~  155 (455)
                      +.|+.|....+|+....        +..+++|+.....  ....+..|+.++..|...+  +++++..      ....+.
T Consensus        28 ~~i~~G~~n~~~~v~~~--------~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT--------KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEECC---EEEEEEEES--------SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             eccCCCcccceEEEEeC--------CccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            45777888999987432        2368899876421  1123445666666654212  2333321      223466


Q ss_pred             EEEEEEecCCCChHH--------------HHhhc---CCCC----CC---HHHHHH------------HHHHHHHHHHHh
Q 012832          156 RLLVYEYMPRGSLEN--------------QLFRR---YSVS----LP---WSTRMK------------IALGAAKGLAFL  199 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~--------------~l~~~---~~~~----l~---~~~~~~------------i~~~i~~~L~~L  199 (455)
                      .++||+|++|..+..              .+...   ....    ..   |...+.            +...+...++++
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            789999998865421              01111   0111    00   111000            001133445555


Q ss_pred             hhC-----CCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          200 HDA-----EKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       200 H~~-----~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ...     ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            421     23489999999999998876668999997753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.33  E-value=0.00057  Score=68.34  Aligned_cols=80  Identities=18%  Similarity=0.180  Sum_probs=50.1

Q ss_pred             cccccccCCeeEEEEEEcCCCCC-CcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRP-GLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~  160 (455)
                      .+.|+.|....||++...+.... ...+..+++|+.....  ....+..|+.+++.|...++ +++++.+.  +  .+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            45688888999999865321100 1124678999873311  12455678888888863344 66776543  2  3899


Q ss_pred             EecCCCCh
Q 012832          161 EYMPRGSL  168 (455)
Q Consensus       161 e~~~~g~L  168 (455)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.31  E-value=0.00072  Score=64.97  Aligned_cols=33  Identities=33%  Similarity=0.373  Sum_probs=28.0

Q ss_pred             CCeEEeccCCCCEEEcCC----CceEEccCCCccCCC
Q 012832          204 KPVIYRDFKASNILLDSD----YTAKLSDFGLAKDGP  236 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~----~~~kL~DfGla~~~~  236 (455)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            349999999999999874    689999999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.19  E-value=0.0014  Score=65.98  Aligned_cols=75  Identities=11%  Similarity=-0.032  Sum_probs=45.8

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeEEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e  161 (455)
                      .+.|+.|-...+|+....+      .+..+++|+....... .-+...|+.++..|...++ +++++++  .+  .+|||
T Consensus       113 i~~lsgG~tN~~y~v~~~~------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e  181 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEE  181 (458)
T ss_dssp             EEEECC--CEEEEEEEETT------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCeEeEEEEEEECC------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEE
Confidence            4568888889999885432      2357889876432111 1111468888888875555 5677766  22  35999


Q ss_pred             ecCCCCh
Q 012832          162 YMPRGSL  168 (455)
Q Consensus       162 ~~~~g~L  168 (455)
                      |++|.+|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.12  E-value=0.0022  Score=61.30  Aligned_cols=76  Identities=14%  Similarity=0.040  Sum_probs=46.1

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC--cccEEEE-----EEeCCeE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH--LVKLIGY-----CCEEEHR  156 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~-----~~~~~~~  156 (455)
                      ..|+ |....||+....       .+..+++|...... .....+..|..++..|...+  +++++..     ....+..
T Consensus        32 ~~l~-g~~n~~y~v~~~-------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~  102 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY  102 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred             Eeec-CcccceEEEEcC-------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence            4577 888899986321       24579999875321 12345566777777664222  3444432     2235567


Q ss_pred             EEEEEecCCCCh
Q 012832          157 LLVYEYMPRGSL  168 (455)
Q Consensus       157 ~lv~e~~~~g~L  168 (455)
                      ++||+|++|..+
T Consensus       103 ~~l~~~i~G~~~  114 (328)
T 1zyl_A          103 FAVFPSVGGRQF  114 (328)
T ss_dssp             EEEEECCCCEEC
T ss_pred             EEEEEecCCCCC
Confidence            899999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.11  E-value=0.0024  Score=56.88  Aligned_cols=98  Identities=15%  Similarity=0.087  Sum_probs=63.7

Q ss_pred             ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceec
Q 012832          167 SLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR  246 (455)
Q Consensus       167 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~  246 (455)
                      +|.+.|... +.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.             
T Consensus        34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc-------------
Confidence            788877654 6799999999999999999877621111 11334557999999999998764 2111             


Q ss_pred             cccCCCCcCccccccCCCCccCchhhHHHHHHHHHh
Q 012832          247 VMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS  282 (455)
Q Consensus       247 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  282 (455)
                       .....+.+||... ...+.+.=|||||+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1233466888653 334567889999999999876

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.85  E-value=0.0016  Score=63.60  Aligned_cols=81  Identities=7%  Similarity=-0.040  Sum_probs=43.4

Q ss_pred             cccccccCCeeEEEEEEcCCC--CCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCC-cccEEEEEEeCCeEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKL--RPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPH-LVKLIGYCCEEEHRLLV  159 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv  159 (455)
                      ...|+.|..-.+|+....+..  .....+..+++|+....... ..+...|..+++.+...+ ++++++..  .  .++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            456788888899987542200  00011257888876432211 112246777777775333 45676544  2  3789


Q ss_pred             EEecCCCCh
Q 012832          160 YEYMPRGSL  168 (455)
Q Consensus       160 ~e~~~~g~L  168 (455)
                      |||++|.+|
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.45  E-value=0.019  Score=55.18  Aligned_cols=31  Identities=16%  Similarity=0.216  Sum_probs=27.3

Q ss_pred             CeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       205 ~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++|+|+.+.|||++.++.+.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            4899999999999998888999999877643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.94  E-value=0.028  Score=55.78  Aligned_cols=81  Identities=10%  Similarity=-0.040  Sum_probs=47.3

Q ss_pred             cccccccCCeeEEEEEEcCCCC-CCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLR-PGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      .+.|..|-...+|+....+... ....+..+++++..... ...-+..+|..+++.+. +.-.+++++.+  .  .++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            4567788889999986542100 01125678999864321 11112246788887775 33345666533  2  27899


Q ss_pred             EecCCCCh
Q 012832          161 EYMPRGSL  168 (455)
Q Consensus       161 e~~~~g~L  168 (455)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.95  E-value=0.32  Score=47.71  Aligned_cols=29  Identities=28%  Similarity=0.314  Sum_probs=24.6

Q ss_pred             eEEeccCCCCEEE------cCCCceEEccCCCccC
Q 012832          206 VIYRDFKASNILL------DSDYTAKLSDFGLAKD  234 (455)
Q Consensus       206 iiHrDlkp~Nill------~~~~~~kL~DfGla~~  234 (455)
                      ++|+|+.+.|||+      +.+..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.19  E-value=1.6  Score=38.69  Aligned_cols=85  Identities=8%  Similarity=0.048  Sum_probs=61.2

Q ss_pred             CCCCcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCeEEeccCCCCEE
Q 012832          139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA-FLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       139 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~iiHrDlkp~Nil  217 (455)
                      .||++  -..+-..++.+.+.++.-+++.=...+     ..++...+++++..|+.... +++.    -+|--|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEE
Confidence            57887  334446677777777765444323334     25788899999999887776 5553    578889999999


Q ss_pred             EcCCCceEEccCCCccC
Q 012832          218 LDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~  234 (455)
                      ++.++.+++.-.|+-..
T Consensus       117 f~~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES  133 (219)
T ss_dssp             ECTTCCEEESCCEETTT
T ss_pred             EeCCCcEEEEEcCCccc
Confidence            99999999987776543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.75  E-value=1.2  Score=39.41  Aligned_cols=115  Identities=9%  Similarity=0.087  Sum_probs=78.4

Q ss_pred             CCCCcccEEEEEEeCCeEEEEEEecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEE
Q 012832          139 RHPHLVKLIGYCCEEEHRLLVYEYMPRG-SLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       139 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nil  217 (455)
                      .||+++.. .+-..++.+.+.++.-+.+ ++.. +     ..++....++++..|+....+++.    -+|--|.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEE
Confidence            58888877 5666667666666554322 2222 2     357788999999999888766653    468889999999


Q ss_pred             EcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 012832          218 LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVD  288 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~  288 (455)
                      ++.++.+++.-.|+-...++..                        ++...=+-.+=|++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l~P~~------------------------~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVDPLP------------------------VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTBSCCC------------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCCCCCC------------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998877654332211                        1111112367788889999888774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	455
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-72
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-64
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-63
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 4e-72
 Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 30/281 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G FG V+KG              VAVK L++     Q  + +  EV  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           +  +GY        +V ++    SL + L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-- 261
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
               +  SDVY+FG+VL EL++G+       P    +  +    M+         + P L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGR-----GYLSPDL 231

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
             +      +    L  +CL  +  +RP    ++ ++E L 
Sbjct: 232 S-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 8e-65
 Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 28/277 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG VH G+  +K         VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 13  IGSGQFGLVHLGYWLNK-------DKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C E+    LV+E+M  G L     R         T + + L   +G+A+L   E  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EAC 121

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           VI+RD  A N L+  +   K+SDFG+ +   + D    ST       +A+PE       +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
           S SDV+SFGV++ E+ S  K   ++R   E         ++ D     R+  PRL     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAST-- 229

Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                    +   C   RP+ RP  S +++ L  + +
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 2e-64
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 28/275 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G+ +           VAVK+L  +G      +L E   + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGH-------TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L      +E   ++ EYM  GSL + L     + L  +  + +A   A+G+AF+   E+ 
Sbjct: 73  LYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD +A+NIL+    + K++DFGLA+   + ++            + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV+SFG++L E+++  +         E              + L R           
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------------IQNLERGYRMVRPDNCP 236

Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E    +   L   C   RP+ RPT   +   LE  
Sbjct: 237 E----ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (521), Expect = 2e-63
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 35/306 (11%)

Query: 68  FTLAELKVTTQSFSSS---------NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD 118
           FT  +     + F+             +G G FG V  G +     PG +   VA+K L 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKL---PGKREIFVAIKTLK 63

Query: 119 LEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYS 177
                +  R++L+E   +GQ  HP+++ L G   +    +++ E+M  GSL++ L +   
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 178 VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 237
                   + +  G A G+ +L D     ++RD  A NIL++S+   K+SDFGL++   +
Sbjct: 124 QF-TVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 238 GDDTHVSTRV---MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQR 294
                  T          + APE +     TS SDV+S+G+V+ E++S  +     RP  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYW 235

Query: 295 EQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVV 354
           + +  +    +  D R                        L   C       RP    +V
Sbjct: 236 DMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 355 KTLEPL 360
            TL+ +
Sbjct: 285 NTLDKM 290

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-63
 Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 28/273 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG V  G    +         VA+K +  EG     E++ E   +  L H  LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQ-------YDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L G C ++    ++ EYM  G L N L             +++     + + +L    K 
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES--KQ 120

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD  A N L++     K+SDFGL++   + D+   S        ++ PE +M    +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
           S SD+++FGV++ E+ S  K   +     E               +  R+  P L  +  
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQGLRLYRPHLASE-- 228

Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                K   + Y C   +  +RPT   ++  + 
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-62
 Identities = 68/296 (22%), Positives = 126/296 (42%), Gaps = 23/296 (7%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEV 132
           ++     +    +G G FG V+KG    K   G +  PVA+K L     +  R ++L E 
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGM--LKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 133 IFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGA 192
             +GQ  H ++++L G   + +  +++ EYM  G+  ++  R           + +  G 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGI 119

Query: 193 AKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD-THVSTRVMGTQ 251
           A G+ +L       ++RD  A NIL++S+   K+SDFGL++   +  + T+ ++      
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK 311
            + APE +     TS SDV+SFG+V+ E+++  +         E                
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------- 221

Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFDDDI 367
           + + ++                 L  QC      +RP  + +V  L+ L    D +
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 34/277 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G FG V  G          +   VAVK +  +     + +L E   + QLRH +LV+
Sbjct: 15  IGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64

Query: 146 LIGYCCEEEHRL-LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           L+G   EE+  L +V EYM +GSL + L  R    L     +K +L   + + +L     
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GN 122

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+  D  AK+SDFGL K+     DT           + APE +     
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKF 177

Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
           ++ SDV+SFG++L E+ S  +      P     L +    +    +              
Sbjct: 178 STKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYK-------MDAPDGC 225

Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
                     +   C       RP+   + + LE +K
Sbjct: 226 PP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-62
 Identities = 71/301 (23%), Positives = 116/301 (38%), Gaps = 38/301 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQLRHPHLV 144
           +G+G FG V +G            + VAVK       +   RE   E+     LRH +++
Sbjct: 11  IGKGRFGEVWRGKWRG--------EEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 60

Query: 145 KLIGYCCEEE----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
             I    ++        LV +Y   GSL + L R    ++     +K+AL  A GLA LH
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLH 117

Query: 201 ------DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT--HVSTRVMGTQG 252
                   +  + +RD K+ NIL+  + T  ++D GLA       DT        +GT+ 
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 253 YAAPEYVMT------GHLTSMSDVYSFGVVLLELLSGRK----SVDKSRPQREQSLVEWA 302
           Y APE +              +D+Y+ G+V  E+           D   P  +    + +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGA-RKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
              +       + + P +  ++    A R  A +  +C       R T   + KTL  L 
Sbjct: 238 VEEMRKVV-CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 362 D 362
            
Sbjct: 297 Q 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-61
 Identities = 78/291 (26%), Positives = 112/291 (38%), Gaps = 36/291 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQL-RHPHL 143
           LG G FG V +      L     A  VAVK L        RE  ++E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEA-TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY----------------SVSLPWSTRMK 187
           V L+G C      L++ EY   G L N L R+                  ++L     + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 188 IALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 247
            +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D     +  V    
Sbjct: 150 FSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 248 MGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN 307
                + APE +     T  SDV+S+G+ L EL S   S     P   +           
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----------- 256

Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                 +++         E    +   +   C    P +RPT   +V+ +E
Sbjct: 257 ----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (508), Expect = 2e-61
 Identities = 70/314 (22%), Positives = 119/314 (37%), Gaps = 42/314 (13%)

Query: 70  LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EW 128
           L  L+    +      +GEG FG V +      L P      VAVK L  E     + ++
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQA-RAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--------- 179
             E   + +  +P++VKL+G C   +   L++EYM  G L   L      +         
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 180 -------------LPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL 226
                        L  + ++ IA   A G+A+L   E+  ++RD    N L+  +   K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKI 181

Query: 227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKS 286
           +DFGL+++    D             +  PE +     T+ SDV+++GVVL E+ S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 287 VDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQ 346
                   E                +  + D  +     E    +   L   C S  P  
Sbjct: 242 PYYGMAHEEV---------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPAD 285

Query: 347 RPTMSTVVKTLEPL 360
           RP+  ++ + L+ +
Sbjct: 286 RPSFCSIHRILQRM 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 3e-61
 Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 26/282 (9%)

Query: 83  SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQLRHP 141
           +  +G G FG V+ G + D      +    AVK+L+     G   ++LTE I +    HP
Sbjct: 32  NEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88

Query: 142 HLVKLIGYCCEEE-HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +++ L+G C   E   L+V  YM  G L     R  + +      +   L  AKG+ FL 
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 201 DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGDDTHVSTRVMGTQGYAAPEY 258
              K  ++RD  A N +LD  +T K++DFGLA+D    E D  H  T       + A E 
Sbjct: 148 S--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           + T   T+ SDV+SFGV+L EL++         P  + +  +    +L       R++ P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQG----RRLLQP 256

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                  E        +  +C   + + RP+ S +V  +  +
Sbjct: 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (504), Expect = 6e-61
 Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 29/285 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 25  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 77

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L   +K 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 135

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            I+RD  A N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV++FGV+L E+ +   S                     D  ++  +++     +  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKDYRMERP 238

Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL---KDFDDDI 367
           E    K   L   C    P  RP+ + + +  E +       D++
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 7e-61
 Identities = 67/296 (22%), Positives = 109/296 (36%), Gaps = 41/296 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQL-RHPHL 143
           LG G FG V        +     +  VAVK L  +     RE  ++E+  + QL  H ++
Sbjct: 45  LGSGAFGKVMNA-TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR---------------------YSVSLPW 182
           V L+G C       L++EY   G L N L  +                         L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 183 STRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH 242
              +  A   AKG+ FL    K  ++RD  A N+L+      K+ DFGLA+D     +  
Sbjct: 164 EDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221

Query: 243 VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA 302
           V         + APE +  G  T  SDV+S+G++L E+ S   +     P          
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------ 275

Query: 303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
                      +++    +         +   +   C +   ++RP+   +   L 
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-60
 Identities = 66/310 (21%), Positives = 123/310 (39%), Gaps = 40/310 (12%)

Query: 73  LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTE 131
           +++    F   + LG G  G V K               +A K + LE     R   + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPS------GLVMARKLIHLEIKPAIRNQIIRE 54

Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
           +  L +   P++V   G    +    +  E+M  GSL+  L +     +P     K+++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
             KGL +L + +  +++RD K SNIL++S    KL DFG++    +     ++   +GT+
Sbjct: 113 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRK-------------------------- 285
            Y +PE +   H +  SD++S G+ L+E+  GR                           
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 286 SVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPK 345
              ++  +   S    +RP +     L  I++       S   + +      +CL   P 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 346 QRPTMSTVVK 355
           +R  +  ++ 
Sbjct: 288 ERADLKQLMV 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 7e-60
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 27/290 (9%)

Query: 72  ELKVTTQSFSSSNF-LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WL 129
           +L +   +   ++  LG G FG+V +G      R   +   VA+K L     +   E  +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQG----VYRMRKKQIDVAIKVLKQGTEKADTEEMM 57

Query: 130 TEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIA 189
            E   + QL +P++V+LIG  C+ E  +LV E    G L   L  +    +P S   ++ 
Sbjct: 58  REAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELL 115

Query: 190 LGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVM 248
              + G+ +L +  K  ++RD  A N+LL + + AK+SDFGL+K  G +       +   
Sbjct: 116 HQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
               + APE +     +S SDV+S+GV + E LS  +     +P ++    E    +   
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG 228

Query: 309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
            R            +       +  AL   C  ++ + RP   TV + + 
Sbjct: 229 KR-------MECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 28/277 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           LG G FG V KG+   K       + VAVK L  E        E L E   + QL +P++
Sbjct: 15  LGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V++IG  CE E  +LV E    G L   L +     +     +++    + G+ +L +  
Sbjct: 71  VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE-- 125

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTH-VSTRVMGTQGYAAPEYVMTG 262
              ++RD  A N+LL + + AK+SDFGL+K     ++ +   T       + APE +   
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
             +S SDV+SFGV++ E  S  +     +P R     E    +    R            
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGER-------MGCPA 233

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP 359
                   +   L   C ++  + RP  + V   L  
Sbjct: 234 GCPR----EMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-59
 Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 28/275 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V  G  +           VA+K L   G      +L E   + +LRH  LV+
Sbjct: 25  LGQGCFGEVWMGTWNGT-------TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++      
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MN 133

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
            ++RD +A+NIL+  +   K++DFGLA+   + ++            + APE  + G  T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
             SDV+SFG++L EL +  +        RE               ++ R        +  
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREV------------LDQVERGYRMPCPPECP 240

Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
           E        L  QC    P++RPT   +   LE  
Sbjct: 241 E----SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-58
 Identities = 68/329 (20%), Positives = 128/329 (38%), Gaps = 26/329 (7%)

Query: 71  AELKVTTQS-FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREW 128
           A L++  ++ F     LG G FG V+KG             PVA+K L      + ++E 
Sbjct: 1   ALLRILKETEFKKIKVLGSGAFGTVYKGL--WIPEGEKVKIPVAIKELREATSPKANKEI 58

Query: 129 LTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           L E   +  + +PH+ +L+   C      L+ + MP G L + +             +  
Sbjct: 59  LDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNW 116

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
            +  AKG+ +L D  + +++RD  A N+L+ +    K++DFGLAK     +  + +    
Sbjct: 117 CVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
               + A E ++    T  SDV+S+GV + EL++         P  E             
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------- 221

Query: 309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL-KDFDDDI 367
              +  I++                 +  +C       RP    ++     + +D    +
Sbjct: 222 ---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278

Query: 368 AI-GTFVFTVPTESSNNDKNNNEDLKECE 395
            I G     +P+ + +N      D ++ +
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMDEEDMD 307

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-57
 Identities = 69/299 (23%), Positives = 124/299 (41%), Gaps = 41/299 (13%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL 138
               + +GEG FG V K     +++        A+K +        HR++  E+  L +L
Sbjct: 12  IKFQDVIGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 139 -RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSV--------------SLPWS 183
             HP+++ L+G C    +  L  EY P G+L + L +   +              +L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 184 TRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV 243
             +  A   A+G+ +L   +K  I+RD  A NIL+  +Y AK++DFGL++          
Sbjct: 128 QLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183

Query: 244 STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR 303
            T       + A E +     T+ SDV+S+GV+L E++S   +     P    +  E   
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYE 237

Query: 304 PMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
            +    R               +    +   L  QC   +P +RP+ + ++ +L  + +
Sbjct: 238 KLPQGYR-------LEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 26/280 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPH 142
           LG+G FG V +G  D    P  +   VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           L++L G         +V E  P GSL ++L +         T  + A+  A+G+ +L   
Sbjct: 73  LIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE-- 128

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHV-STRVMGTQGYAAPEYVMT 261
            K  I+RD  A N+LL +    K+ DFGL +  P+ DD +V          + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +  SD + FGV L E+ +  +      P    +  +    +  +  +L R       
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPR------- 236

Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
               E   +    +  QC +H+P+ RPT   +   L   +
Sbjct: 237 ---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-57
 Identities = 58/277 (20%), Positives = 101/277 (36%), Gaps = 35/277 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G F  V+KG   +          VA   L    L     + +  E   L  L+HP++
Sbjct: 17  IGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 144 VKLIGYCCE----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           V+           ++  +LV E M  G+L+  L R     +             KGL FL
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFL 128

Query: 200 HDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           H    P+I+RD K  NI +     + K+ D GLA           +  V+GT  + APE 
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPE- 183

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP 318
           +         DVY+FG+ +LE+ +      + +   +                  R+   
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSG 228

Query: 319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                + +    +   +   C+     +R ++  ++ 
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 31/275 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG+G FG V+K    +       +   A K +D +  +   +++ E+  L    HP++VK
Sbjct: 20  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L+     E +  ++ E+   G+++  +       L  S    +       L +LH  +  
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH--DNK 130

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT---- 261
           +I+RD KA NIL   D   KL+DFG++               +GT  + APE VM     
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSK 188

Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRL 320
                  +DV+S G+ L+E+           P  E + +     +               
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAK-----SEPPTLAQ 237

Query: 321 EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             ++S            +CL      R T S +++
Sbjct: 238 PSRWSS----NFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 25/278 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           +GEG FG VH+G       P      VA+K          RE +L E + + Q  HPH+V
Sbjct: 15  IGEGQFGDVHQGIYMSPENPA---LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           KLIG    E    ++ E    G L     +    SL  ++ +  A   +  LA+L    K
Sbjct: 72  KLIG-VITENPVWIIMELCTLGELR-SFLQVRKYSLDLASLILYAYQLSTALAYLE--SK 127

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
             ++RD  A N+L+ S+   KL DFGL++   +    + +++      + APE +     
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRF 186

Query: 265 TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQY 324
           TS SDV+ FGV + E+L         +P +     +    + N  R         +    
Sbjct: 187 TSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER-------LPMPPNC 234

Query: 325 SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
                    +L  +C ++ P +RP  + +   L  + +
Sbjct: 235 PP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 8e-56
 Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 34/279 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G +G   K     +   G   + +  K LD   +     +  ++EV  L +L+HP++
Sbjct: 12  IGTGSYGRCQKIR---RKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 144 VKLIGYCCEEEHRLL--VYEYMPRGSLENQLFR--RYSVSLPWSTRMKIALGAAKGLAFL 199
           V+      +  +  L  V EY   G L + + +  +    L     +++       L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 200 H---DAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           H   D    V++RD K +N+ LD     KL DFGLA+      DT  +   +GT  Y +P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSP 183

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +        SD++S G +L EL +         P    S  E A  +           
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGKF------ 231

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             R+  +YS+    +   +  + L+ +   RP++  +++
Sbjct: 232 -RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 8e-56
 Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 27/272 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LGEG +G V               + VAVK +D++      E    E+     L H ++V
Sbjct: 13  LGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
           K  G+  E   + L  EY   G L +++       +P     +       G+ +LH    
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH--GI 122

Query: 205 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 265 TSM-SDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
            +   DV+S G+VL  +L+G    D+     +           +D ++    ++P  +  
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKKTYLNPWKK-- 231

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                     AL ++ L   P  R T+  + K
Sbjct: 232 IDS----APLALLHKILVENPSARITIPDIKK 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (469), Expect = 2e-55
 Identities = 75/285 (26%), Positives = 114/285 (40%), Gaps = 38/285 (13%)

Query: 77  TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVI 133
            + FS    +G G FGAV+       +R     + VA+K +   G Q + +W   + EV 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
           FL +LRHP+ ++  G    E    LV EY    + +     +    L       +  GA 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGAL 125

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
           +GLA+LH     +I+RD KA NILL      KL DFG A           +   +GT  +
Sbjct: 126 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYW 177

Query: 254 AAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
            APE ++    G      DV+S G+  +EL   +       P    + +     +  +  
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNES 231

Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                      G +SE            CL   P+ RPT   ++K
Sbjct: 232 ------PALQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 6e-55
 Identities = 68/286 (23%), Positives = 126/286 (44%), Gaps = 28/286 (9%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHR-EWLTEVIFLGQLRHPHLV 144
           LG+G FG V++G +   +        VA+K ++       R E+L E   + +    H+V
Sbjct: 28  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRY--------SVSLPWSTRMKIALGAAKGL 196
           +L+G   + +  L++ E M RG L++ L                  S  +++A   A G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
           A+L+      ++RD  A N ++  D+T K+ DFG+ +D  E D      + +    + +P
Sbjct: 147 AYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIM 316
           E +  G  T+ SDV+SFGVVL E+ +  +                    L++ + L  +M
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSNEQVLRFVM 249

Query: 317 DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD 362
           +  L     +        L   C  + PK RP+   ++ +++   +
Sbjct: 250 EGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-53
 Identities = 68/273 (24%), Positives = 107/273 (39%), Gaps = 35/273 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLD---LEGLQGHREWLTEVIFLGQLRHPH 142
           LG+G FG V+    + + +       +A+K L    LE      +   EV     LRHP+
Sbjct: 14  LGKGKFGNVYLA-REKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           +++L GY  +     L+ EY P G++  +L +                  A  L++ H  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH-- 123

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
            K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEGR 179

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
                 D++S GV+  E L G+       P    +  E  + +          +      
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVTE---- 229

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                    A  L  + L H P QRP +  V++
Sbjct: 230 --------GARDLISRLLKHNPSQRPMLREVLE 254

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 76/292 (26%), Positives = 113/292 (38%), Gaps = 35/292 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-HREWLTEVIFLGQ-LRHPHL 143
           LG G FG V +      +      + VAVK L        HR  ++E+  L     H ++
Sbjct: 21  LGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 144 VKLIGYCCEEEHRL-LVYEYMPRGSLENQLFRR--------------YSVSLPWSTRMKI 188
           V L+G C +    L ++ E+   G+L   L  +              Y   L     +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  D        
Sbjct: 140 SFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
               + APE +     T  SDV+SFGV+L E+ S   S     P     + E     L +
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKE 252

Query: 309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
             ++          +  +    +       C    P QRPT S +V+ L  L
Sbjct: 253 GTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 2e-52
 Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 28/270 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G+G  G V+       +  G   Q VA++ ++L+        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            +      +   +V EY+  GSL + +               +     + L FLH     
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH--SNQ 136

Query: 206 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLT 265
           VI+RD K+ NILL  D + KL+DFG         +    + ++GT  + APE V      
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 266 SMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYS 325
              D++S G++ +E++ G        P R   L+                 +   E Q  
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---------------ATNGTPELQNP 239

Query: 326 ETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
           E  +        +CL    ++R +   +++
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-51
 Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 35/292 (11%)

Query: 86  LGEGGFGAVHKGF-IDDKLRPGLQAQPVAVKNLDLEGLQGH-REWLTEVIFLGQL-RHPH 142
           LGEG FG V     I        +   VAVK L  +  +    + ++E+  +  + +H +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVS--------------LPWSTRMKI 188
           ++ L+G C ++    ++ EY  +G+L   L  R                  L     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
           A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    D    +T   
Sbjct: 141 AYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198

Query: 249 GTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND 308
               + APE +     T  SDV+SFGV+L E+ +   S     P  E             
Sbjct: 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------------- 245

Query: 309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
              L +++              +   +   C    P QRPT   +V+ L+ +
Sbjct: 246 ---LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 3e-49
 Identities = 59/291 (20%), Positives = 102/291 (35%), Gaps = 31/291 (10%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLT 130
           K   + F     LGEG F  V       +L      +  A+K L+   +           
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLAR---ELATS---REYAIKILEKRHIIKENKVPYVTR 57

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E   + +L HP  VKL     ++E       Y   G L   + +    S   +       
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTA 115

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
                L +LH   K +I+RD K  NILL+ D   +++DFG AK          +   +GT
Sbjct: 116 EIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
             Y +PE +        SD+++ G ++ +L++G        P R  +     + ++    
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIK--- 224

Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK 361
                ++     ++      KA  L  + L     +R     +        
Sbjct: 225 -----LEYDFPEKFFP----KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (416), Expect = 3e-47
 Identities = 62/272 (22%), Positives = 97/272 (35%), Gaps = 28/272 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+     +   G      A K +             E+  +  LRHP LV 
Sbjct: 34  LGTGAFGVVHRVT---ERATG---NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     ++   +++YE+M  G L  ++   ++  +     ++      KGL  +H  E  
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH--ENN 144

Query: 206 VIYRDFKASNILLDSDY--TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
            ++ D K  NI+  +      KL DFGL       D         GT  +AAPE      
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
           +   +D++S GV+   LLSG                      L + +     MD      
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------TLRNVKSCDWNMDDSAFSG 251

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            SE           + L   P  R T+   ++
Sbjct: 252 ISE----DGKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (413), Expect = 7e-47
 Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 28/272 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+  ++         +    K ++            E+  + QL HP L+ 
Sbjct: 37  LGSGAFGVVHRC-VEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L     ++   +L+ E++  G L +++       +  +  +     A +GL  +H  E  
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHS 147

Query: 206 VIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           +++ D K  NI+ ++    + K+ DFGLA      +          T  +AAPE V    
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREP 204

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
           +   +D+++ GV+   LLSG        P   +  +E     L + ++     D      
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLE----TLQNVKRCDWEFDEDAFSS 254

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            S     +A       L   P++R T+   ++
Sbjct: 255 VSP----EAKDFIKNLLQKEPRKRLTVHDALE 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 33/282 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG---HREWLTEVIFLGQLRHPH 142
           LG GG   VH    D +L      + VAVK L  +  +    +  +  E      L HP 
Sbjct: 15  LGFGGMSEVHLA-RDLRLH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 143 LVKLIGYCCEEEHRL----LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           +V +      E        +V EY+   +L + +       +     +++   A + L F
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 126

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGYAAPE 257
            H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +  V+GT  Y +PE
Sbjct: 127 SH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
                 + + SDVYS G VL E+L+G        P    S V  A   + +        D
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE--------D 230

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRP-TMSTVVKTLE 358
           P       E  +    A+  + L+  P+ R  T + +   L 
Sbjct: 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 43/286 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---------QGHREWLTEVIFLG 136
           LG G    V +  I          +  AVK +D+ G          +     L EV  L 
Sbjct: 11  LGRGVSSVVRRC-IHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 137 QLR-HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           ++  HP++++L           LV++ M +G L + L  +  V+L      KI     + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEV 122

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           +  LH  +  +++RD K  NILLD D   KL+DFG +    + D       V GT  Y A
Sbjct: 123 ICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLA 177

Query: 256 PEYVMTGHL------TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA 309
           PE +               D++S GV++  LL+G        P   +  +   R +++  
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMIMSGN 231

Query: 310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            + G               +     L  + L  +P++R T    + 
Sbjct: 232 YQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 69/283 (24%), Positives = 107/283 (37%), Gaps = 34/283 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE----WLTEVIFLGQLRHP 141
           LG+G FG V       K       Q  A+K L  + +    +     + + +      HP
Sbjct: 10  LGKGSFGKVFLA-EFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD 201
            L  +      +E+   V EY+  G L   +   +      S     A     GL FLH 
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH- 120

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
             K ++YRD K  NILLD D   K++DFG+ K+   GD         GT  Y APE ++ 
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLG 177

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
                  D +SFGV+L E+L G+       P   Q   E    +  D     R ++    
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRWLEKE-- 229

Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKDFD 364
                     A  L  +     P++R  +   ++     ++ +
Sbjct: 230 ----------AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 67/278 (24%), Positives = 103/278 (37%), Gaps = 36/278 (12%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVI--- 133
           FS    +G GGFG V+      K   G   +  A+K LD + +   QG    L E I   
Sbjct: 6   FSVHRIIGRGGFGEVYGCR---KADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 134 FLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAA 193
            +     P +V +       +    + + M  G L   L +        +     A    
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEII 117

Query: 194 KGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGY 253
            GL  +H   + V+YRD K +NILLD     ++SD GLA D  +          +GT GY
Sbjct: 118 LGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 171

Query: 254 AAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL 312
            APE +  G    S +D +S G +L +LL G     + + + +  +              
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------- 223

Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
              M   L   +S     +  +L    L     +R   
Sbjct: 224 ---MAVELPDSFSP----ELRSLLEGLLQRDVNRRLGC 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 31/274 (11%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPHLV 144
           LG G F  V     D + +     + VA+K +  + L+G       E+  L +++HP++V
Sbjct: 17  LGTGAFSEVILA-EDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            L        H  L+ + +  G L +++  +           ++       + +LH  + 
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH--DL 126

Query: 205 PVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
            +++RD K  N+L    D D    +SDFGL+K     D   V +   GT GY APE +  
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 262 GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLE 321
              +   D +S GV+   LL G        P  +++  +    +L    +        + 
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSPYWDDI- 236

Query: 322 GQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                  +  A       +   P++R T    ++
Sbjct: 237 -------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 1e-42
 Identities = 52/272 (19%), Positives = 105/272 (38%), Gaps = 29/272 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G FG VH+  ++   +     +    K + ++G         E+  L   RH +++ 
Sbjct: 13  LGRGEFGIVHRC-VETSSK-----KTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
           L       E  ++++E++    +  ++    +  L     +       + L FLH     
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH--SHN 122

Query: 206 VIYRDFKASNILLDSD--YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           + + D +  NI+  +    T K+ +FG A+    GD+  +   +     Y APE      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV 179

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
           +++ +D++S G ++  LLSG        P   ++  +    ++N         D     +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTF----DEEAFKE 229

Query: 324 YSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
            S     +A     + L    K R T S  ++
Sbjct: 230 ISI----EAMDFVDRLLVKERKSRMTASEALQ 257

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 55/281 (19%), Positives = 92/281 (32%), Gaps = 29/281 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           +G G FG ++ G  D         + VA+K   ++    H +   E      ++    + 
Sbjct: 15  IGSGSFGDIYLG-TDIAAG-----EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKP 205
            I +C  E    ++   +   SLE  LF   S      T + +A      + ++H   K 
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKN 123

Query: 206 VIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGDDT-----HVSTRVMGTQGYAAPE 257
            I+RD K  N L           + DFGLAK   +           +  + GT  YA+  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
             +    +   D+ S G VL+    G       +   ++   E                 
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM------STPI 237

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE 358
             L   Y      + A     C S R   +P  S + +   
Sbjct: 238 EVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 62/282 (21%), Positives = 101/282 (35%), Gaps = 41/282 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW------LTEVIFLGQLR 139
           LG G F  V K     +   G      A K +     +  R          EV  L +++
Sbjct: 18  LGSGQFAVVKKCR---EKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 140 HPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFL 199
           HP+++ L      +   +L+ E +  G L + L  + S  L      +       G+ +L
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYL 129

Query: 200 HDAEKPVIYRDFKASNILLDSD----YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAA 255
           H     + + D K  NI+L          K+ DFGLA     G++      + GT  + A
Sbjct: 130 H--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVA 184

Query: 256 PEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           PE V    L   +D++S GV+   LLSG                            L  +
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGA----------------SPFLGDTKQETLANV 228

Query: 316 M--DPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              +   E +Y    +  A     + L   PK+R T+   ++
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-42
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 28/288 (9%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-----HREWLTEVIFLGQL 138
           +FLGEG F  V+K   D         Q VA+K + L          +R  L E+  L +L
Sbjct: 4   DFLGEGQFATVYKA-RDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 139 RHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
            HP+++ L+     + +  LV+++M        + +  S+ L  S      L   +GL +
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           LH  +  +++RD K +N+LLD +   KL+DFGLAK    G      T  + T+ Y APE 
Sbjct: 116 LH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPEL 171

Query: 259 VMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV----------EWARPMLN 307
           +    +     D+++ G +L ELL     +       + + +          +W      
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                 +                    L        P  R T +  +K
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 8e-41
 Identities = 75/344 (21%), Positives = 133/344 (38%), Gaps = 32/344 (9%)

Query: 84  NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE-WLTEVIFLGQLRHPH 142
           +++GEG +G V     D+  +       VA+K +     Q + +  L E+  L + RH +
Sbjct: 14  SYIGEGAYGMVCSA-YDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRR-YSVSLPWSTRMKIALGAAKGLAFLHD 201
           ++ +           +   Y+    +   L++   +  L             +GL ++H 
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH- 126

Query: 202 AEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGDDTHVSTRVMGTQGYAAPEYVM 260
               V++RD K SN+LL++    K+ DFGLA+   P+ D T   T  + T+ Y APE ++
Sbjct: 127 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 261 TGHLTSMS-DVYSFGVVLLELLSGR-------------KSVDKSRPQREQSLVEWARPML 306
                + S D++S G +L E+LS R               +       ++ L        
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK--TLEPLKDFD 364
            +        +     +       KA  L  + L+  P +R  +   +    LE   D  
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD-P 304

Query: 365 DDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKETKKEKGNHR 408
            D  I    F    E  +  K   E LKE    +ET + +  +R
Sbjct: 305 SDEPIAEAPFKFDMELDDLPK---EKLKEL-IFEETARFQPGYR 344

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-40
 Identities = 61/289 (21%), Positives = 115/289 (39%), Gaps = 23/289 (7%)

Query: 80  FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVIFLGQ 137
           F     +GEG +G V+K    +KL      + VA+K   LD E        + E+  L +
Sbjct: 4   FQKVEKIGEGTYGVVYKAR--NKLT----GEVVALKKIRLDTETEGVPSTAIREISLLKE 57

Query: 138 LRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           L HP++VKL+     E    LV+E++ +  L+  +       +P            +GLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
           F H     V++RD K  N+L++++   KL+DFGLA+          +  V+     A   
Sbjct: 117 FCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEI 173

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +   + ++  D++S G +  E+++ R          +   +       ++    G    
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 318 PRLEGQYSETGARK-----------AAALAYQCLSHRPKQRPTMSTVVK 355
           P  +  + +   +              +L  Q L + P +R +    + 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 68/278 (24%), Positives = 111/278 (39%), Gaps = 41/278 (14%)

Query: 80  FSSSNF-----LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE---WLTE 131
           +S  +F     LG G FG VH          G   +  A+K L  E +   ++      E
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIR---SRHNG---RYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 132 VIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALG 191
            + L  + HP ++++ G   + +   ++ +Y+  G L + L +      P       A  
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAE 112

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQ 251
               L +LH   K +IYRD K  NILLD +   K++DFG AK  P+   T       GT 
Sbjct: 113 VCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165

Query: 252 GYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARK 311
            Y APE V T       D +SFG+++ E+L+G        P  + + ++    +LN   +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELR 219

Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT 349
                +                 L  + ++    QR  
Sbjct: 220 FPPFFNE------------DVKDLLSRLITRDLSQRLG 245

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 46/288 (15%), Positives = 81/288 (28%), Gaps = 37/288 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH-PHLV 144
           +GEG FG + +G     L      Q VA+K           +   E      L     + 
Sbjct: 13  IGEGSFGVIFEGT---NLLNN---QQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP 64

Query: 145 KLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEK 204
            +  +  E  H +LV + +  G     L           T    A      +  +H  EK
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EK 120

Query: 205 PVIYRDFKASNILLDSDYT-----AKLSDFGLAKDGPEGDDT-----HVSTRVMGTQGYA 254
            ++YRD K  N L+    +       + DFG+ K   +              + GT  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 255 APEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA--RPMLNDARKL 312
           +    +    +   D+ + G V +  L G       +    +   E    +      R+L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL 360
                                   +   +      P    +      +
Sbjct: 241 CAGFPEEF------------YKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 52/283 (18%), Positives = 108/283 (38%), Gaps = 25/283 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +GEG +G V+K   +         +  A+K + LE          + E+  L +L+H ++
Sbjct: 10  IGEGTYGVVYKAQNNYG-------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           VKL      ++  +LV+E++ +   +          L   T     L    G+A+ H  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH--D 118

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           + V++RD K  N+L++ +   K++DFGLA+        +    ++     A    + +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKK 177

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQ 323
            ++  D++S G +  E+++G           +   +       N          P+ +  
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 324 YSETGARK-----------AAALAYQCLSHRPKQRPTMSTVVK 355
           ++                    L  + L   P QR T    ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 66/343 (19%), Positives = 119/343 (34%), Gaps = 37/343 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEV-IFLGQLRHPHLV 144
           LG G  G V +   + + +     +  A+K L     Q   +   EV +     + PH+V
Sbjct: 20  LGLGINGKVLQI-FNKRTQ-----EKFALKML-----QDCPKARREVELHWRASQCPHIV 68

Query: 145 KLIGYC----CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLH 200
           +++          +  L+V E +  G L +++  R   +       +I     + + +LH
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 201 DAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
                + +RD K  N+L  S   +   KL+DFG AK+    +          T  Y APE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPE 183

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD 317
            +         D++S GV++  LL G        P      +  +  M    R       
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP-LKDFDDDIAIGTFVFTV 376
                + SE    +   L    L   P QR T++  +    P +               V
Sbjct: 238 NPEWSEVSE----EVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVPQTPLHTSRV 291

Query: 377 PTESSNNDKNNNEDLKECEAKKETKKEKGNHRQNHKLHNDIVN 419
             E     ++  E++    A      E+   ++     N ++ 
Sbjct: 292 LKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLL 334

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-39
 Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 30/289 (10%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQL---RH 140
           +GEG +G V K    D    G   + VA+K + ++  +       + EV  L  L    H
Sbjct: 15  IGEGAYGKVFKAR--DLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 141 PHLVKLIGYCCEEEHRLLVYEYMP----RGSLENQLFRRYSVSLPWSTRMKIALGAAKGL 196
           P++V+L   C            +        L   L +     +P  T   +     +GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 197 AFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
            FLH     V++RD K  NIL+ S    KL+DFGLA+           T V+ T  Y AP
Sbjct: 130 DFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 184

Query: 257 EYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV----------EWARPML 306
           E ++     +  D++S G +  E+   +     S    +   +          +W R + 
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
              +         +E ++          L  +CL+  P +R +  + + 
Sbjct: 245 LPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 4e-38
 Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 47/280 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHRE------WLTEVIFLGQLR 139
           LG GGFG+V+ G    ++       PVA+K+++ + +    E         EV+ L ++ 
Sbjct: 12  LGSGGFGSVYSGI---RVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 140 HPH--LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
                +++L+ +    +  +L+ E                 +L             + + 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124

Query: 198 FLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAP 256
             H     V++RD K  NIL+D +    KL DFG            V T   GT+ Y+ P
Sbjct: 125 HCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPP 178

Query: 257 EYVMTGHLTSMS-DVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI 315
           E++        S  V+S G++L +++ G        P      +   +            
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQ------- 225

Query: 316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                  + S     +   L   CL+ RP  RPT   +  
Sbjct: 226 -------RVSS----ECQHLIRWCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 75/280 (26%), Positives = 101/280 (36%), Gaps = 33/280 (11%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LT 130
           KVT   F     LG+G FG V     +         +  A+K L  E +    E    +T
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILV-REKATG-----RYYAMKILRKEVIIAKDEVAHTVT 54

Query: 131 EVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIAL 190
           E   L   RHP L  L       +    V EY   G L   L R                
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA 112

Query: 191 GAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
                L +LH   + V+YRD K  N++LD D   K++DFGL K+G     T       GT
Sbjct: 113 EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDAR 310
             Y APE +         D +  GVV+ E++ GR       P   Q        +L +  
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEI 222

Query: 311 KLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTM 350
           +  R + P            +A +L    L   PKQR   
Sbjct: 223 RFPRTLSP------------EAKSLLAGLLKKDPKQRLGG 250

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-37
 Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 33/292 (11%)

Query: 79  SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQL 138
           S++ +  +G G FG V++  + D        + VA+K +  +    +RE    +  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKVLQDKRFKNRE----LQIMRKL 70

Query: 139 RHPHLVKLIGYCCE------EEHRLLVYEYMPRGSLENQL-FRRYSVSLPWSTRMKIALG 191
            H ++V+L  +         E +  LV +Y+P         + R   +LP          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK    G+     + +   
Sbjct: 131 LFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSR 186

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV---------EW 301
              A          TS  DV+S G VL ELL G+          +   +         E 
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 302 ARPMLNDA--RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
            R M  +    K  +I        +      +A AL  + L + P  R T  
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-35
 Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 37/297 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG--HREWLTEVIFLGQLRHPHL 143
           +G+G FG V K       + G   Q VA+K + +E  +       L E+  L  L+H ++
Sbjct: 18  IGQGTFGEVFKAR---HRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 144 VKLIGYCCEEEHR--------LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
           V LI  C  +            LV+++         L     V    S   ++      G
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVS--TRVMGTQGY 253
           L ++H     +++RD KA+N+L+  D   KL+DFGLA+      ++  +  T  + T  Y
Sbjct: 130 LYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 254 AAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA---------- 302
             PE ++         D++  G ++ E+ +    +  +  Q + +L+             
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 303 ----RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                 +      +        +   +      A  L  + L   P QR      + 
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 53/284 (18%), Positives = 100/284 (35%), Gaps = 25/284 (8%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +GEG +G V K   + +       + VA+K + L+          L E+  L +L+H ++
Sbjct: 10  IGEGTYGTVFKA-KNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 144 VKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE 203
           V+L      ++   LV+E+  +   +        +               KGL F H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCHS-- 119

Query: 204 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH 263
           + V++RD K  N+L++ +   KL++FGLA+          S  V+               
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 264 LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ-----------SLVEWAR-PMLNDARK 311
            ++  D++S G +  EL +  + +       +Q           +  +W     L D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
                                  L    L   P QR +    ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 76/363 (20%), Positives = 136/363 (37%), Gaps = 53/363 (14%)

Query: 68  FTLAELKVTTQSFSSS----NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL- 122
           F   E+  T     +       +G G +GAV    +D +         VA+K L      
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA-VDGRTG-----AKVAIKKLYRPFQS 57

Query: 123 -QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR------LLVYEYMPRGSLENQLFRR 175
               +    E+  L  +RH +++ L+     +E         LV  +M  G+   +L + 
Sbjct: 58  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH 115

Query: 176 YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 235
               L       +     KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+  
Sbjct: 116 E--KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171

Query: 236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE 295
               D+ ++  V+     A    +     T   D++S G ++ E+++G+     S    +
Sbjct: 172 ----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227

Query: 296 QSLV---------EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAY----QCLSH 342
              +         E+ + + +D  K      P LE +   +    A+ LA     + L  
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287

Query: 343 RPKQRPTMSTVVKT--LEPLKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKECEAKKET 400
             +QR T    +     E L D +D+          P     +D  ++ D    E K+ T
Sbjct: 288 DAEQRVTAGEALAHPYFESLHDTEDE----------PQVQKYDDSFDDVDRTLDEWKRVT 337

Query: 401 KKE 403
            KE
Sbjct: 338 YKE 340

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (301), Expect = 5e-31
 Identities = 66/332 (19%), Positives = 114/332 (34%), Gaps = 46/332 (13%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREW---LTEVIFLGQLRHPH 142
           LG G FG V       +          A+K LD + +   ++    L E   L  +  P 
Sbjct: 49  LGTGSFGRVMLV-KHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 143 LVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
           LVKL     +  +  +V EY+  G + + L R              A        +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH-- 158

Query: 203 EKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG 262
              +IYRD K  N+L+D     +++DFG AK       T     + GT    APE +++ 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSK 213

Query: 263 HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEG 322
                 D ++ GV++ E+ +G        P      ++    +++           R   
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVS--------GKVRFPS 259

Query: 323 QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK--------DFDDDIAIGTFVF 374
            +S         L    L     +R     +   +  +K        D+           
Sbjct: 260 HFSS----DLKDLLRNLLQVDLTKRF--GNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

Query: 375 TVPTESSNNDKNNNEDLKECEAKKETKKEKGN 406
            +P      D +N +D +E E +    ++ G 
Sbjct: 314 FIPKFKGPGDTSNFDDYEEEEIRVSINEKCGK 345

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-30
 Identities = 72/285 (25%), Positives = 103/285 (36%), Gaps = 29/285 (10%)

Query: 74  KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL----QGHREWL 129
           KV  ++F     LG G +G V       K+      +  A+K L    +    +      
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVR---KISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 130 TEVIFLGQLRH-PHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKI 188
           TE   L  +R  P LV L      E    L+ +Y+  G L   L +R             
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIY 134

Query: 189 ALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVM 248
                  L  LH  +  +IYRD K  NILLDS+    L+DFGL+K+    +    +    
Sbjct: 135 VGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFC 191

Query: 249 GTQGYAAPEYVMTGH--LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML 306
           GT  Y AP+ V  G        D +S GV++ ELL+G        P            + 
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------SPFTVDGEKNSQAEIS 245

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS 351
               K     +P    + S      A  L  + L   PK+R    
Sbjct: 246 RRILK----SEPPYPQEMSA----LAKDLIQRLLMKDPKKRLGCG 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 48/295 (16%), Positives = 104/295 (35%), Gaps = 44/295 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLV 144
           LG G +  V +      +      + V VK L     +   +   E+  L  LR  P+++
Sbjct: 43  LGRGKYSEVFEAI---NITNN---EKVVVKILKPVKKK---KIKREIKILENLRGGPNII 93

Query: 145 KLIGYCCEEEHRL--LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA 202
            L     +   R   LV+E++     + QL++     L             K L + H  
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFK-QLYQT----LTDYDIRFYMYEILKALDYCH-- 146

Query: 203 EKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT 261
              +++RD K  N+++D +    +L D+GLA+    G +       + ++ +  PE ++ 
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVD 203

Query: 262 -GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ--------------------SLVE 300
                   D++S G +L  ++  ++         +Q                    ++  
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 301 WARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVK 355
             R      R   +  +  +  +     + +A     + L +  + R T    ++
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 64/341 (18%), Positives = 128/341 (37%), Gaps = 51/341 (14%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHL 143
           +G G  G V     D  L      + VA+K L          +    E++ +  + H ++
Sbjct: 25  IGSGAQGIVCAA-YDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 144 VKLIGYCC------EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLA 197
           + L+          E +   LV E M     +                  +      G+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIK 133

Query: 198 FLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPE 257
            LH     +I+RD K SNI++ SD T K+ DFGLA+       + + T  + T+ Y APE
Sbjct: 134 HLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188

Query: 258 YVMTGHLTSMSDVYSFGVVLLELLSGR----------------KSVDKSRPQREQSLVEW 301
            ++        D++S G ++ E++  +                + +    P+  + L   
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 302 ARPMLNDARKLGRIMDPRL--------EGQYSETGARKAAALAYQCLSHRPKQRPTMSTV 353
            R  + +  K   +  P+L        + ++++  A +A  L  + L   P +R ++   
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 354 VKTLEP-LKDFDDDIAIGTFVFTVPTESSNNDKNNNEDLKE 393
           ++   P +  + D   +      +  +  +  ++  E+ KE
Sbjct: 309 LQ--HPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 6e-26
 Identities = 57/286 (19%), Positives = 107/286 (37%), Gaps = 35/286 (12%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVK--NLDLEGLQGHREWLTEVIFLGQLRHPHL 143
           +G G +G+V   F     + G     VAVK  +   + +   +    E+  L  ++H ++
Sbjct: 26  VGSGAYGSVCAAF---DTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 144 VKLIGYC-----CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAF 198
           + L+         EE + + +  ++    L N +  +    L       +     +GL +
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKY 136

Query: 199 LHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEY 258
           +H     +I+RD K SN+ ++ D   K+ DFGLA+      D  ++  V      A    
Sbjct: 137 IH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIM 190

Query: 259 VMTGHLTSMSDVYSFGVVLLELLSGR------------KSVDKSRPQREQSLVEWARPML 306
           +   H     D++S G ++ ELL+GR            K + +        L++      
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 307 NDARKLGRIMDPRLEGQYSETGARKAAA-LAYQCLSHRPKQRPTMS 351
                      P++       GA   A  L  + L     +R T +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 96.3 bits (238), Expect = 2e-22
 Identities = 48/315 (15%), Positives = 99/315 (31%), Gaps = 53/315 (16%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVK 145
           LG G F  V        +        VA+K +  + +        E+  L ++      K
Sbjct: 21  LGWGHFSTVWLAK---DMVNN---THVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73

Query: 146 LIGYCCEEEHRLLVYEYMPRGSLEN--------------QLFRRYSVSLPWSTRMKIALG 191
                     +LL +      +  +               + +     +P     +I+  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 192 AAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGDDTHVSTRVMGT 250
              GL ++H     +I+ D K  N+L++  D    L    +A  G         T  + T
Sbjct: 134 LLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 251 QGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR---------------------KSVDK 289
           + Y +PE ++       +D++S   ++ EL++G                        +  
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 290 SRPQREQSLVEWARPMLNDARKLGRIMDPRL---------EGQYSETGARKAAALAYQCL 340
             P       ++ R   N    L  I   +          + ++S+  A++ +      L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 341 SHRPKQRPTMSTVVK 355
              P++R     +V 
Sbjct: 313 QLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.0 bits (168), Expect = 3e-14
 Identities = 21/159 (13%), Positives = 47/159 (29%), Gaps = 25/159 (15%)

Query: 86  LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL----------QGHREWLTEVIFL 135
           +GEG   AV   + +             VK   +              G   +    I  
Sbjct: 8   MGEGKESAVFNCYSEKF-------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 136 GQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKG 195
            +     L KL G    +      Y +     L   +  +    +      ++     + 
Sbjct: 61  ARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 196 LAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 234
           +A  +   + +++ D    N+L+  +    + DF  + +
Sbjct: 116 VAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	455
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.8
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.88
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.73

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=423.70  Aligned_cols=253  Identities=22%  Similarity=0.360  Sum_probs=213.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ++|++.+.||+|+||.||+|..      ..+++.||||++........+.+.+|+.+|+.++|||||++++++..++..|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~------~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMD------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEB------TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEE------CCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            4799999999999999999953      4468899999997766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      ||||||+||+|.+++...   .+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+|+....
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999999877653   6999999999999999999999976  99999999999999999999999999987654


Q ss_pred             CCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCC
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMD  317 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (455)
                      ....  ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........      ....         
T Consensus       169 ~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------~~~~---------  231 (293)
T d1yhwa1         169 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATN---------  231 (293)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHH---------
T ss_pred             cccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH------HHhC---------
Confidence            3322  3446799999999999999999999999999999999999999976543211111      0100         


Q ss_pred             CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          318 PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .......+..++.++.+|+.+||+.||++|||+.|+++|-+
T Consensus       232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (293)
T ss_dssp             CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            01111234556788999999999999999999999998843

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=418.66  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=210.0

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++...   .......+.+|+.+|+.++||||+++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREK------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEEC------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            57999999999999999999653      35789999998643   2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|||||||++|+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+|..
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeee
Confidence            999999999999999998765  47999999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .....    .....||+.|||||++.+..|+.++|||||||++|||++|+.||...........+      .        
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~--------  217 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------S--------  217 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H--------
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------H--------
Confidence            65432    23467999999999999999999999999999999999999999765432111110      0        


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        ..  ...++...+.++.+|+.+||+.||++|||+.|+++|-
T Consensus       218 --~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp  256 (263)
T d2j4za1         218 --RV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  256 (263)
T ss_dssp             --TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred             --cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence              00  1123445667899999999999999999999999884

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=424.13  Aligned_cols=258  Identities=25%  Similarity=0.357  Sum_probs=209.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|++.+.||+|+||.||+|...      .+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.+++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEEC------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            357999999999999999999643      3578999999865432 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .|||||||+||+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999999999988543  57999999999999999999999976  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ............+||+.|||||++.+..+ +.++|||||||++|||++|++||......... ...+.            
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~------------  220 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK------------  220 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHH------------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHh------------
Confidence            54443333455789999999999988776 67899999999999999999999765432111 11110            


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                        ............+.++.+|+.+||+.||++|||+.|+++|-+.
T Consensus       221 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         221 --EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             --TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             --cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence              0001111123456788999999999999999999999998543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=422.65  Aligned_cols=264  Identities=26%  Similarity=0.434  Sum_probs=207.6

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      ++..++|.+.+.||+|+||.||+|...         ..||||+++..  .....+.|.+|+.+|++++|||||++++++.
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~   74 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST   74 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS---------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC---------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence            345678999999999999999999532         25999998644  3345678899999999999999999999875


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                       .+..+||||||++|+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+
T Consensus        75 -~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          75 -APQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             -SSSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             -ccEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccc
Confidence             45689999999999999988654 357999999999999999999999966  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |+...............||+.|||||++.+   ..|+.++|||||||++|||++|+.||............      ...
T Consensus       151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~~~  224 (276)
T d1uwha_         151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGR  224 (276)
T ss_dssp             SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHH
T ss_pred             eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------Hhc
Confidence            987655444334455789999999999864   35899999999999999999999999865432211111      000


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                           ....+. ....+..++.++.+|+.+||+.+|++|||+.+|+++|+.+..
T Consensus       225 -----~~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         225 -----GYLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             -----TSCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 011111 123345567889999999999999999999999999987753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-56  Score=424.29  Aligned_cols=263  Identities=23%  Similarity=0.362  Sum_probs=217.8

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      +++..++|++.+.||+|+||.||+|.+..      +++.||||+++.+. ...+++.+|+.+|+.++|||||+++++|.+
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGG------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECC------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            34556789999999999999999996543      57889999987543 345679999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+..+||||||++|+|.+++.......+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999999998777778999999999999999999999966  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      +....... .......||+.|+|||++.+..|+.++|||||||++|||++|..||.......  .+...           
T Consensus       163 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~~~-----------  228 (287)
T d1opja_         163 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL-----------  228 (287)
T ss_dssp             TTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH-----------
T ss_pred             eecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHHHH-----------
Confidence            87654332 22333568999999999999999999999999999999999766654322211  11110           


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         +........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       229 ---i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         229 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               0111223345566788999999999999999999999999987764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=417.33  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=198.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  152 (455)
                      .++|++.+.||+|+||.||+|...      .+++.||||++....  ....+.+.+|+.+|+.++|||||++++++.+  
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             chhCEEeEEEecCCCeEEEEEEEC------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            367999999999999999999543      457899999986543  2344668899999999999999999999865  


Q ss_pred             CCeEEEEEEecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCC---CCeEEeccCCCCEEEcCCCceEEc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRR--YSVSLPWSTRMKIALGAAKGLAFLHDAE---KPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~---~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      ...+|||||||++|+|.+++.+.  ....+++..++.++.||+.||+|||+.+   .+||||||||+||||+.++.+||+
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            45689999999999999988653  3467999999999999999999999843   349999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||++|++||.......   +..   .+..
T Consensus       157 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~---~i~~  228 (269)
T d2java1         157 DFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG---KIRE  228 (269)
T ss_dssp             CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH
T ss_pred             eccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHH---HHHc
Confidence            9999987644322  2334789999999999999999999999999999999999999997654321   111   1110


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                                .. ....+..++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       229 ----------~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp  267 (269)
T d2java1         229 ----------GK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  267 (269)
T ss_dssp             ----------TC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ----------CC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence                      00 1123345567899999999999999999999999873

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=419.60  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      +.|++.+.||+|+||.||+|...      .++..||||+++.......+.+.+|+.+|+.++|||||++++++.+++..+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            46899999999999999999643      357899999997666666677899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  237 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~  237 (455)
                      ||||||++|+|.+++.+. ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999999999987654 357999999999999999999999977  99999999999999999999999999975432


Q ss_pred             CCCccceeccccCCCCcCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          238 GDDTHVSTRVMGTQGYAAPEYVM-----TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ..  ......+||+.|+|||++.     +..|+.++|||||||++|||++|+.||....+......+      ...    
T Consensus       163 ~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~~~----  230 (288)
T d2jfla1         163 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------AKS----  230 (288)
T ss_dssp             HH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HHS----
T ss_pred             Cc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcC----
Confidence            11  1123467999999999984     456899999999999999999999999876443221111      000    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         ..+  ....+..++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       231 ---~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp  270 (288)
T d2jfla1         231 ---EPP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP  270 (288)
T ss_dssp             ---CCC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             ---CCC--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence               001  1122345678899999999999999999999999884

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=419.76  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=206.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|++.+.||+|+||.||+|...      .+++.||||++....   ......+.+|+.+|+.++||||+++++++.++
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLAREL------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            367999999999999999999643      357899999986432   23446788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..|||||||+||+|.+++...  ..+++..+..++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||+|+
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccce
Confidence            9999999999999999988765  57999999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ..............+||+.|+|||++.+..|+.++|||||||++|||++|..||...+.....      ..+..      
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~~------  224 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF------QKIIK------  224 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHT------
T ss_pred             ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH------HHHHc------
Confidence            765444333344568999999999999999999999999999999999999999865432111      11110      


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHh
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKT  356 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~  356 (455)
                          .  ...++...+.++.+||.+||+.||++|||++|++.+
T Consensus       225 ----~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         225 ----L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ----T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ----C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                0  112344556789999999999999999999987543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=413.01  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=200.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|++.+.||+|+||.||+|.+.+       +..||||+++... ...+++.+|+.+++.++|||||+++|+|..++..
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT-------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC-------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence            4678899999999999999997543       4579999997543 3457799999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+++...
T Consensus        76 ~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheecc
Confidence            9999999999999987654 457899999999999999999999966  9999999999999999999999999998765


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG-RKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..... ......||+.|+|||++.+..|+.++|||||||++|||+|| .+||.......   .....   .    .    
T Consensus       153 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i---~----~----  217 (263)
T d1sm2a_         153 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI---S----T----  217 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHH---H----H----
T ss_pred             CCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHH---H----h----
Confidence            43322 22335799999999999999999999999999999999994 66665433211   11111   0    0    


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         ......+..++.++.+|+.+||+.||++|||+++|+++|+.+.
T Consensus       218 ---~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         218 ---GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence               0111223455678999999999999999999999999998764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=408.95  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=200.4

Q ss_pred             CCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe----CC
Q 012832           81 SSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE----EE  154 (455)
Q Consensus        81 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~  154 (455)
                      .+.+.||+|+||+||+|...      .++..||+|++....  ....+.+.+|+++|+.++|||||++++++..    ..
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             EeeeEEecCcCcEEEEEEEC------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            56678999999999999654      357889999986542  3345678899999999999999999999865    34


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc-CCCceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD-SDYTAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~-~~~~~kL~DfGla~  233 (455)
                      .+|||||||++|+|.+++.+.  ..+++..+..++.||+.||+|||+.+.+||||||||+||||+ .++.+||+|||+|+
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            689999999999999999765  578999999999999999999999777799999999999997 47899999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||........  +..   .+        
T Consensus       164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~---~i--------  225 (270)
T d1t4ha_         164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR---RV--------  225 (270)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH---HH--------
T ss_pred             eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH---HH--------
Confidence            64332    1334689999999998865 599999999999999999999999975432211  111   00        


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                        .....+..++...+.++.+|+.+||+.||++|||+.|+++|-
T Consensus       226 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         226 --TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  267 (270)
T ss_dssp             --TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence              011111122333456789999999999999999999999884

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=428.44  Aligned_cols=269  Identities=23%  Similarity=0.315  Sum_probs=208.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|++.+.||+|+||+||+|..      ..+++.||+|+++... ......+.+|+.+|+.++|||||+++++|.++
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   76 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSH------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD   76 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEE------TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEE------CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3467899999999999999999954      3467899999986543 33456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      +..|||||||+||+|.+++.+.  ..+++..+..++.|++.||.|||+ ++  |+||||||+||||+.++.+||+|||+|
T Consensus        77 ~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          77 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             SEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCc
Confidence            9999999999999999999765  469999999999999999999997 46  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh-hhhhh-----
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW-ARPML-----  306 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~-~~~~~-----  306 (455)
                      +.....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+............ .....     
T Consensus       153 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         153 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             HHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             cccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            864321    12346899999999999999999999999999999999999999976543211110000 00000     


Q ss_pred             --------------------HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 --------------------NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                                          ........+.............+.++.+|+.+||..||++|||++|+++|-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence                                000000000000000011122356899999999999999999999999983

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=424.57  Aligned_cols=265  Identities=24%  Similarity=0.357  Sum_probs=213.9

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEEEe
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYCCE  152 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  152 (455)
                      +..++|.+.+.||+|+||+||+|.+.... .......||+|.+.... ......+.+|+.+|.++ +|||||++++++..
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGIS-KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCS-SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCC-cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            44578999999999999999999875421 22345679999885432 33346688999999998 89999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEecc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYS---------------------VSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDF  211 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDl  211 (455)
                      .+..+||||||++|+|.++|..+..                     ..+++..++.++.||+.||+|||+.+  ||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDl  190 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL  190 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccC
Confidence            9999999999999999999976431                     35889999999999999999999966  999999


Q ss_pred             CCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCC
Q 012832          212 KASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKS  290 (455)
Q Consensus       212 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~  290 (455)
                      ||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |.+||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987655544434445679999999999999999999999999999999997 89999865


Q ss_pred             CccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          291 RPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .....  +...    ..          .......+..++.++.+||.+||+.+|++|||+++|+++|.
T Consensus       271 ~~~~~--~~~~----~~----------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDAN--FYKL----IQ----------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHH--HHHH----HH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHH--HHHH----Hh----------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            43221  1111    11          11122344556788999999999999999999999999984

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-54  Score=416.29  Aligned_cols=262  Identities=25%  Similarity=0.408  Sum_probs=202.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .++|.+.+.||+|+||.||+|.+...   ......||||.+... .....+.|.+|+.+|++++|||||+++|++...+.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLP---GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCC---CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            45688889999999999999976432   123346899988654 33445679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++|||||++|+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999999977654 457999999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccc---eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          236 PEGDDTHV---STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       236 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      ........   .....||+.|||||++.++.++.++|||||||++|||+| |.+||.......   +....         
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i---------  246 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAI---------  246 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHH---------
Confidence            54322211   122468999999999999999999999999999999998 899997654321   11111         


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                       ..    ......+..++.++.+|+.+||+.+|++|||+.+|++.|+.+.
T Consensus       247 -~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         247 -EQ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             -HT----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -Hc----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence             00    1112234556788999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=412.58  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=209.1

Q ss_pred             HHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           74 KVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      ++..++|++.+.||+|+||.||+|.+.+       +..||||+++... ...+.|.+|+.+|++++|||||+++|++. +
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~   79 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q   79 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECC-------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence            3455789999999999999999997543       4679999997543 34567999999999999999999999875 4


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..+|||||+++|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+|+
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceE
Confidence            56799999999999999887665557999999999999999999999966  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCC-CCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRK-SVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ....... .......||+.|+|||++.++.++.++|||||||++|||+||.. ||......   .....          +
T Consensus       158 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~----------i  223 (272)
T d1qpca_         158 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----------L  223 (272)
T ss_dssp             ECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----------H
T ss_pred             EccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHH----------H
Confidence            7654322 22334679999999999999999999999999999999999654 45433221   11111          0


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ...    .....+..++.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       224 ~~~----~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         224 ERG----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Hhc----CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            111    11223445667899999999999999999999999988764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-54  Score=415.71  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=195.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .+.|.+.+.||+|+||.||+|...      .+++.||||++..... .....+.+|+.+|+.++|||||++++++.+++.
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDK------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEET------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEeeccCeEEEEEEEC------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            456999999999999999999643      3578999999865433 233557789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc---CCCceEEccCCCc
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD---SDYTAKLSDFGLA  232 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~---~~~~~kL~DfGla  232 (455)
                      .|||||||+||+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+|||+.   .++.+||+|||+|
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             EEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEecccee
Confidence            99999999999999999754  57999999999999999999999976  99999999999995   4789999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      +.......   ....+||+.|||||++.+..|+.++|||||||++|||++|.+||.........   .   .+..     
T Consensus       158 ~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~---~i~~-----  223 (307)
T d1a06a_         158 KMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---E---QILK-----  223 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H---HHHT-----
T ss_pred             EEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---H---HHhc-----
Confidence            86543322   23467999999999999999999999999999999999999999765332111   1   0110     


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                         ....+........+.++.+|+.+||+.||++|||+.|+++|-+
T Consensus       224 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  266 (307)
T d1a06a_         224 ---AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW  266 (307)
T ss_dssp             ---TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             ---cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence               0111222334456778999999999999999999999999843

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.5e-54  Score=420.20  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=213.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++........+.+.+|+.+|+.++|||||++++++.+++..
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTER------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEEC------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            358999999999999999999543      46789999999877666677889999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC--CCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS--DYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~--~~~~kL~DfGla~~  234 (455)
                      |||||||+||+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+|||++.  ++.+||+|||+|+.
T Consensus        99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            9999999999999988644 346999999999999999999999977  999999999999964  67899999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ......   .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........      +...      
T Consensus       176 ~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~------  240 (350)
T d1koaa2         176 LDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN------VKSC------  240 (350)
T ss_dssp             CCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHT------
T ss_pred             cccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------HHhC------
Confidence            654332   3346899999999999999999999999999999999999999986543211111      1100      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ...+.......++.++.+||.+||..||++|||+.|+++|-+
T Consensus       241 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  282 (350)
T d1koaa2         241 --DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  282 (350)
T ss_dssp             --CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred             --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence              111111222345678999999999999999999999999843

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-54  Score=409.70  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=208.8

Q ss_pred             cCCCCCccc-ccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNF-LGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~-LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+. ||+|+||.||+|.+...    ..+..||||+++... ....+.|.+|+.+|++++|||||+++|++.. +
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecC----CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            456777775 99999999999976432    245689999986543 3445779999999999999999999999864 5


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..|||||||++|+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+.
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhc
Confidence            689999999999999987543 357999999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          235 GPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       235 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ....... .......||+.|+|||++.++.++.++|||||||++|||+| |..||...........+.            
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~------------  226 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------------  226 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH------------
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH------------
Confidence            6544322 12233568999999999999999999999999999999998 999998654321111110            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                       .    ......+..++.++.+||.+||+.+|++|||+.+|++.|+..
T Consensus       227 -~----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         227 -Q----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -T----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -c----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             0    111233456678899999999999999999999999887643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=405.59  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEEEEEE
Q 012832           84 NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYE  161 (455)
Q Consensus        84 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  161 (455)
                      +.||+|+||.||+|.+.+    ..+++.||||+++...  ....+.+.+|+.+|++++|||||+++++|.. +..+||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEEC----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEcc----CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            569999999999997654    2356789999986432  2335679999999999999999999999864 56789999


Q ss_pred             ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCCc
Q 012832          162 YMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDT  241 (455)
Q Consensus       162 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~  241 (455)
                      ||++|+|.+++...  ..+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999988764  57999999999999999999999966  999999999999999999999999999876544332


Q ss_pred             c-ceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCCc
Q 012832          242 H-VSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDPR  319 (455)
Q Consensus       242 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (455)
                      . ......||+.|||||++.+..++.++|||||||++|||++ |++||...........+.             .    .
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------------~----~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------------K----G  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------------T----T
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------------c----C
Confidence            2 2233579999999999999999999999999999999998 899998654321111110             0    1


Q ss_pred             ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          320 LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      .....+..++.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1123345567889999999999999999999999887754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=400.44  Aligned_cols=254  Identities=23%  Similarity=0.405  Sum_probs=212.2

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|++.+.||+|+||+||+|.+.+       +..||||+++.... ..+++++|+.+++.++||||++++|+|.++...
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~   74 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   74 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETT-------TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECC-------CCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence            4689999999999999999997532       56899999875443 456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++...
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheecc
Confidence            9999999999999887654 357889999999999999999999966  9999999999999999999999999998665


Q ss_pred             CCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...........+             .. 
T Consensus       152 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------------~~-  216 (258)
T d1k2pa_         152 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------AQ-  216 (258)
T ss_dssp             SSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------------HT-
T ss_pred             CCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------------Hh-
Confidence            43322 2334679999999999999999999999999999999998 89999876432211111             00 


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                         ......+..++.++.+|+.+||+.+|++|||+++|+++|..
T Consensus       217 ---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 ---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence               11122345566789999999999999999999999999854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=415.15  Aligned_cols=253  Identities=29%  Similarity=0.353  Sum_probs=212.9

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEe
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCE  152 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  152 (455)
                      ..++|.+.+.||+|+||.||+|..      ..+++.||||+++...   ......+.+|+.+|+.++||||+++++++.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~------~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVRE------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             chHhcEEEEEEecCcCeEEEEEEE------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            456899999999999999999954      4468899999986432   2345678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCc
Q 012832          153 EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLA  232 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla  232 (455)
                      .+.+|+|||||+||+|.+++...  ..+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a  152 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccc
Confidence            99999999999999999988775  57899999999999999999999977  999999999999999999999999999


Q ss_pred             cCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          233 KDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      +........  ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+....   ..   .+...    
T Consensus       153 ~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~---~i~~~----  220 (337)
T d1o6la_         153 KEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FE---LILME----  220 (337)
T ss_dssp             BCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHC----
T ss_pred             cccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HH---HHhcC----
Confidence            876543322  3447899999999999999999999999999999999999999987543211   11   11110    


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                              ...++...+.++.+||.+||+.||++||+     ++++++|-+
T Consensus       221 --------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         221 --------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             --------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence                    11234456678999999999999999994     899999854

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.8e-54  Score=419.94  Aligned_cols=255  Identities=21%  Similarity=0.287  Sum_probs=213.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRL  157 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  157 (455)
                      ++|++.+.||+|+||.||+|..      ..+++.||||+++.........+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVE------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999954      3467899999997766666677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEc--CCCceEEccCCCccCC
Q 012832          158 LVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLD--SDYTAKLSDFGLAKDG  235 (455)
Q Consensus       158 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~--~~~~~kL~DfGla~~~  235 (455)
                      ||||||+||+|.+++... ...+++..+..++.||+.||+|||+.+  ||||||||+||||+  .++.+||+|||+|...
T Consensus       103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceec
Confidence            999999999999877543 457999999999999999999999976  99999999999997  5789999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhccc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRI  315 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (455)
                      .....   .....||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.........+      ..        
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~--------  242 (352)
T d1koba_         180 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KR--------  242 (352)
T ss_dssp             CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HH--------
T ss_pred             CCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh--------
Confidence            54322   34467999999999999999999999999999999999999999865432211111      10        


Q ss_pred             CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          316 MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ....+........+.++.+||.+||+.||++|||+.|+++|-+
T Consensus       243 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            1112233334456788999999999999999999999999843

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-54  Score=407.92  Aligned_cols=266  Identities=24%  Similarity=0.397  Sum_probs=205.2

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch-hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .+..|++.++||+|+||.||+|.+...  .......||||++..... ....+|.+|+.+|+.++|||||+++|++.+.+
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCC--CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            346788999999999999999987652  123346799999865432 33456899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++|||||.+|+|.+++... ...+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++.
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999877654 467999999999999999999999966  99999999999999999999999999987


Q ss_pred             CCCCCCc-cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          235 GPEGDDT-HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       235 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ....... .......||+.|||||++.++.++.++|||||||++|||++|..||......  ..+....           
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i-----------  226 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI-----------  226 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH-----------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH-----------
Confidence            6443221 2223356899999999999999999999999999999999965554332211  1111110           


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                         ........+..++.++.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus       227 ---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 ---NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence               1111223445567889999999999999999999999999987654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-54  Score=412.95  Aligned_cols=248  Identities=28%  Similarity=0.384  Sum_probs=203.6

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      .|+..+.||+|+||.||+|...      .+++.||||++.....   ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDV------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hcEeeEEEecCCCeEEEEEEEC------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence            4899999999999999999543      3578999999865432   334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .|||||||.+|+|..++...  ..+++..+..++.||+.||.|||+.+  ||||||||+||||+.++.+||+|||+|...
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeeccccccc
Confidence            99999999999987665543  57999999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMT---GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ...      ....||+.|||||++.+   +.|+.++|||||||++|||++|..||..........      ....     
T Consensus       166 ~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~-----  228 (309)
T d1u5ra_         166 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-----  228 (309)
T ss_dssp             SSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH-----
T ss_pred             CCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHh-----
Confidence            432      23579999999999864   458999999999999999999999997643321110      0000     


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ...+.   ..+..++.++.+|+.+||+.||++|||+.++++|-+
T Consensus       229 --~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~  269 (309)
T d1u5ra_         229 --NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (309)
T ss_dssp             --SCCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             --CCCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence              00111   113345678999999999999999999999998843

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=406.54  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=209.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch------hhHHHHHHHHHHHhcCCCCCcccEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL------QGHREWLTEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||+++....      ...+.+.+|+.+|+.++|||||++++++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREK------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEEC------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            467999999999999999999653      3678999999854321      2356789999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC----ceEE
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY----TAKL  226 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~----~~kL  226 (455)
                      .+.+..|||||||+||+|.+++...  ..+++..+..++.|++.||+|||+.+  ||||||||+|||++.++    .+||
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEe
Confidence            9999999999999999999998765  47999999999999999999999977  99999999999998766    5999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML  306 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~  306 (455)
                      +|||+|........   .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.      
T Consensus       159 ~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------  229 (293)
T d1jksa_         159 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------  229 (293)
T ss_dssp             CCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------
T ss_pred             cchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH------
Confidence            99999987654332   234679999999999999999999999999999999999999998654322111110      


Q ss_pred             HhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          307 NDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      .        ....+....+...+.++.+||.+||+.||++|||+.++++|-+
T Consensus       230 ~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         230 A--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             T--------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             h--------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            0        0111111112334578899999999999999999999999843

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-53  Score=406.66  Aligned_cols=272  Identities=25%  Similarity=0.362  Sum_probs=219.6

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh-hHHHHHHHHHHHhcCCCCCcccEEE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ-GHREWLTEVIFLGQLRHPHLVKLIG  148 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~  148 (455)
                      +.++++..++|++.+.||+|+||.||+|.+... .+..++..||||+++..... ...++.+|+.+|+.++||||+++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCC-ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            345566778899999999999999999986532 23446678999998755433 3567899999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCe
Q 012832          149 YCCEEEHRLLVYEYMPRGSLENQLFRRY----------------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPV  206 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~i  206 (455)
                      +|......++||||+++|+|.+++....                      ...+++..++.++.|++.||+|||+.+  |
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--i  161 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F  161 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--e
Confidence            9999999999999999999999986532                      234889999999999999999999966  9


Q ss_pred             EEeccCCCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCC-C
Q 012832          207 IYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR-K  285 (455)
Q Consensus       207 iHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~-~  285 (455)
                      |||||||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998654444333344567999999999999999999999999999999999985 6


Q ss_pred             CCCCCCccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          286 SVDKSRPQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       286 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ||...........+.                +.. ....+..++.++.+|+.+||+.+|++|||+.+|++.|+.+.
T Consensus       242 p~~~~~~~e~~~~v~----------------~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAHEEVIYYVR----------------DGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCHHHHHHHHH----------------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCHHHHHHHHH----------------cCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            776654322111110                111 11234556678999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-52  Score=404.89  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=209.1

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|++.+.||+|+||.||+|..      ..+++.||||+++...   ....+.+.+|+.+|+.++|||||++++++.++
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   76 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRS------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEE------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence            35799999999999999999954      3467899999986432   23456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..|+|||||+||+|..++...  ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             CeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccce
Confidence            9999999999999999888665  57888999999999999999999966  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      .....     ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..........      .+...     
T Consensus       153 ~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~-----  216 (316)
T d1fota_         153 YVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNA-----  216 (316)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHC-----
T ss_pred             Eeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------HHHcC-----
Confidence            76543     233689999999999999999999999999999999999999998654321111      11110     


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                             ...++...+.++.+++.+||..||.+||     |++++++|-+
T Consensus       217 -------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         217 -------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence                   1123445567899999999999999996     9999999843

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=400.18  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=202.3

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      +..++|.+.+.||+|+||.||+|.+...   ...+..||||.++... ......+.+|+.+|+.++||||+++++++. +
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   79 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecC---CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3457899999999999999999976532   2345679999886443 334567899999999999999999999985 5


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+|+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence            6789999999999999877654 457899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+.            
T Consensus       157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------------  223 (273)
T d1mp8a_         157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------------  223 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------------
T ss_pred             eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------------
Confidence            7544322 22334678999999999999999999999999999999998 899998765432111110            


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                       .    ......+..++.++.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       224 -~----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         224 -N----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -c----CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             0    0111235566788999999999999999999999999987653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=406.52  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=208.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ..+|++.+.||+|+||.||+|.+...  ....+.+||+|.++.. .....+.+.+|+.+|++++|||||+++|+|.++ .
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCC--CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            35799999999999999999976542  1223457999988643 334567899999999999999999999999765 5


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .+++|||+.+|+|.+.+... ...+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+..
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceec
Confidence            67889999999999887654 467999999999999999999999966  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .............||+.|+|||++.++.|+.++|||||||++|||+| |.+||+..........+.       .      
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~------  228 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------K------  228 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------H------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------c------
Confidence            65444433444679999999999999999999999999999999998 899998764432211111       0      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                          ......+..++.++.+|+.+||+.+|++|||+.+|+++|+.+.
T Consensus       229 ----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                0111234556788999999999999999999999999987663

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-53  Score=405.46  Aligned_cols=273  Identities=26%  Similarity=0.350  Sum_probs=208.9

Q ss_pred             hHHHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEE
Q 012832           70 LAELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLI  147 (455)
Q Consensus        70 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~  147 (455)
                      ...+.+..++|.+.+.||+|+||.||+|.+... ....+++.||||+++... ....+.+.+|..++.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEEST-TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCC-CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            345556678899999999999999999986542 234567889999986543 33456677888888777 589999999


Q ss_pred             EEEEeC-CeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccC
Q 012832          148 GYCCEE-EHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFK  212 (455)
Q Consensus       148 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlk  212 (455)
                      +++... ...++|||||++|+|.+++....              ...+++..+..++.||+.||+|||+.+  |||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlK  161 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  161 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCC
Confidence            998765 46899999999999999997542              235889999999999999999999966  9999999


Q ss_pred             CCCEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCCC
Q 012832          213 ASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG-RKSVDKSR  291 (455)
Q Consensus       213 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~p~~~~~  291 (455)
                      |+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876554444334456799999999999999999999999999999999986 56786543


Q ss_pred             ccchhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          292 PQREQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ....  +..    .+..      .    .....+..++.++.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       242 ~~~~--~~~----~~~~------~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         242 IDEE--FCR----RLKE------G----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CSHH--HHH----HHHH------T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH--HHH----HHhc------C----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            3211  111    0110      0    111234455678999999999999999999999999998663

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=401.92  Aligned_cols=260  Identities=27%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      +..++|++.+.||+|+||.||+|.+.+       +..||||+++... ...+.|.+|+.+|++++|||||++++++. ++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~-------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~   84 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE   84 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECC-------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence            345689999999999999999997643       3469999997543 34577999999999999999999999985 55


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+++|+|..++.......+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhh
Confidence            6899999999999999887665567999999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ...... .......||+.|+|||++..+.++.++|||||||++|||++|..||......  ........          .
T Consensus       163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----------~  229 (285)
T d1fmka3         163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----------R  229 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----------T
T ss_pred             ccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----------h
Confidence            644322 2233467999999999999999999999999999999999965554332221  11111110          0


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                          ......+..++.++.+|+.+||+.||++|||+++|++.|+....
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         230 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                11223445567889999999999999999999999998877643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-52  Score=406.24  Aligned_cols=248  Identities=23%  Similarity=0.290  Sum_probs=209.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      ++|.+++.||+|+||.||+|..      ..+++.||||+++...   ....+.+.+|+.+|+.++|||||++++++....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKH------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEE------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            5799999999999999999954      3467899999986432   234467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                      ..++||||+.||+|.+++...  ..+++..+..++.||+.||.|||+++  ||||||||+||||+.++.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            999999999999999998765  47999999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      ....     .....||+.|||||++.+..|+.++|||||||++|||++|.+||.+........      .+...      
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~------  253 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIVSG------  253 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC------
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH------HHhcC------
Confidence            6432     223679999999999999999999999999999999999999997654321111      11110      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCC-----CCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQR-----PTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R-----Pt~~ell~~L~  358 (455)
                            ...++...+.++.+|+.+||..||.+|     ||++++++|-+
T Consensus       254 ------~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         254 ------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ------CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence                  112234456789999999999999999     49999999854

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-53  Score=396.55  Aligned_cols=253  Identities=27%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEe-C
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCE-E  153 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~  153 (455)
                      +..++|.+.+.||+|+||.||+|.+.        +..||||+++.+  ...+.+.+|+.+|++++||||++++|+|.+ .
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            34567888999999999999999653        467999999654  344678999999999999999999999865 4


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..+|||||+++|+|.+++..+....+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccce
Confidence            56899999999999999997765456899999999999999999999966  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhhh
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARKL  312 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (455)
                      ......     ....+|..|+|||++.++.++.++|||||||++|||++ |++||.......   ...+.          
T Consensus       152 ~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----------  213 (262)
T d1byga_         152 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----------  213 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----------
T ss_pred             ecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----------
Confidence            654322     22568999999999999999999999999999999998 788887654322   11111          


Q ss_pred             cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          313 GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      .    ......++..++.++.+|+.+||+.||++|||+.+|+++|+.++
T Consensus       214 ~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         214 E----KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             T----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            0    11122345556678999999999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.9e-52  Score=394.98  Aligned_cols=261  Identities=24%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||+++...   ......+.+|+.+|+.++||||+++++++...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDL------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEEC------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            467999999999999999999543      467899999986543   23345688999999999999999999998765


Q ss_pred             C----eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          154 E----HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       154 ~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                      +    ..|||||||+||+|.+++...  ..+++.++..++.||+.||+|||+.+  ||||||||+||||+.++.++|+||
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCC
T ss_pred             cCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehh
Confidence            4    379999999999999988765  57999999999999999999999977  999999999999999999999999


Q ss_pred             CCccCCCCCCC-ccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHh
Q 012832          230 GLAKDGPEGDD-THVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLND  308 (455)
Q Consensus       230 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  308 (455)
                      |.+........ .......+||+.|+|||++.+..++.++|||||||++|||++|++||....+....      ...+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~  229 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRE  229 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHC
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhc
Confidence            99875543322 12233467999999999999999999999999999999999999999865432111      111110


Q ss_pred             hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHhccccc
Q 012832          309 ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-TMSTVVKTLEPLK  361 (455)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-t~~ell~~L~~~~  361 (455)
                              .+..........+.++.+|+.+||+.||++|| |+++++..|..+.
T Consensus       230 --------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         230 --------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                    11112222344567899999999999999999 8999988876653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-51  Score=406.36  Aligned_cols=253  Identities=24%  Similarity=0.319  Sum_probs=205.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---hhHHHHH---HHHHHHhcCCCCCcccEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---QGHREWL---TEVIFLGQLRHPHLVKLIGYC  150 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~~~~~~  150 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....   .....+.   .++.+++.++|||||++++++
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~   76 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKA------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF   76 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEEC------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence            468999999999999999999643      4678999999854321   2222233   457788888999999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFG  230 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfG  230 (455)
                      ...+.+|||||||+||+|.++|...  ..+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeec
Confidence            9999999999999999999999765  57889999999999999999999976  9999999999999999999999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      +|+......    ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..........+...        
T Consensus       153 la~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--------  220 (364)
T d1omwa3         153 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------  220 (364)
T ss_dssp             TCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--------
T ss_pred             eeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence            998765432    233679999999999975 5689999999999999999999999986543322211110        


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPT-----MSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt-----~~ell~~L~  358 (455)
                           ..  .....++..++.++.+||.+||+.||++|||     ++++++|-+
T Consensus       221 -----~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         221 -----TL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             -----SS--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred             -----cc--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence                 00  1112234456678999999999999999999     799999843

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-52  Score=401.42  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=206.9

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc---hhhHHHHHHHHHHHh-cCCCCCcccEEEEEEeC
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG---LQGHREWLTEVIFLG-QLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~  153 (455)
                      ++|.+.+.||+|+||+||+|...      .+++.||||+++...   ....+.+..|..++. .++|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFK------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEEC------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            57999999999999999999643      468899999986432   233455667777665 68999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      +..|||||||++|+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhh
Confidence            9999999999999999998765  56899999999999999999999976  9999999999999999999999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhc
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLG  313 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (455)
                      ........  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+      ..      
T Consensus       152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~------  217 (320)
T d1xjda_         152 ENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RM------  217 (320)
T ss_dssp             CCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH------
T ss_pred             hccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------Hc------
Confidence            65443322  34468999999999999999999999999999999999999999865432211111      00      


Q ss_pred             ccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHHhc
Q 012832          314 RIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMS-TVVKTL  357 (455)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~-ell~~L  357 (455)
                        ..    ..++..++.++.+|+.+||+.||++|||+. ++++|-
T Consensus       218 --~~----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp  256 (320)
T d1xjda_         218 --DN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  256 (320)
T ss_dssp             --CC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             --CC----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence              01    123445567899999999999999999995 788773

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=393.83  Aligned_cols=261  Identities=27%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc---chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE---GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  153 (455)
                      .++|++.+.||+|+||.||+|.+...   ......||||+++..   .....++|.+|+.+|+.++||||++++|++.+ 
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT---TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECC---CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            46799999999999999999976542   224457999998643   23345678999999999999999999999965 


Q ss_pred             CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          154 EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       154 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      ...++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhh
Confidence            5678999999999999887765 346999999999999999999999966  9999999999999999999999999999


Q ss_pred             CCCCCCCccc-eeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchhhHHHhhhhhhHhhhh
Q 012832          234 DGPEGDDTHV-STRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQSLVEWARPMLNDARK  311 (455)
Q Consensus       234 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  311 (455)
                      .......... .....||..|+|||++.+..++.++|||||||++|||++ |.+||.+......   ...          
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~----------  226 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHK----------  226 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----------
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHH----------
Confidence            7655433222 233568889999999999999999999999999999998 8999976543211   111          


Q ss_pred             hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          312 LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                         +.........+..++.++.+|+.+||..||++|||+.+|++.|...
T Consensus       227 ---i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         227 ---IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               1111122233455667899999999999999999999999887643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-51  Score=389.42  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=207.8

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch---------hhHHHHHHHHHHHhcCC-CCCcccEE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL---------QGHREWLTEVIFLGQLR-HPHLVKLI  147 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~~~  147 (455)
                      ++|++.+.||+|+||+||+|...      .+++.||||+++....         .....+.+|+.+|++++ ||||++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHK------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             ccCEEceEEecCcCeEEEEEEEC------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            68999999999999999999543      3578999999864321         12245789999999997 99999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEc
Q 012832          148 GYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLS  227 (455)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~  227 (455)
                      +++.+++..|||||||+||+|.++|..+  ..+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEEC
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEc
Confidence            9999999999999999999999999765  47999999999999999999999976  9999999999999999999999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCcccccc------CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHh
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT------GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEW  301 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~  301 (455)
                      |||+++.......   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||...........   
T Consensus       153 DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~---  226 (277)
T d1phka_         153 DFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM---  226 (277)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred             cchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH---
Confidence            9999987654322   234679999999999863      3478899999999999999999999987543221111   


Q ss_pred             hhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          302 ARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                         +...        ...+........+.++.+|+.+||+.+|++|||+.|+++|-
T Consensus       227 ---i~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         227 ---IMSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             ---HHHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             ---HHhC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence               1110        11112223345678899999999999999999999999884

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=399.96  Aligned_cols=255  Identities=20%  Similarity=0.265  Sum_probs=208.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||+++.... ....+.+|+.+|+.++|||||++++++.+++.+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~------~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVET------SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC------CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            467999999999999999999643      3578999999976543 345578999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC--CCceEEccCCCccC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS--DYTAKLSDFGLAKD  234 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~--~~~~kL~DfGla~~  234 (455)
                      |||||||+||+|.+++... ...+++.++..++.||+.||+|||+.+  |+||||||+|||++.  .+.+||+|||+++.
T Consensus        77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhc
Confidence            9999999999999988654 347899999999999999999999976  999999999999985  45899999999987


Q ss_pred             CCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcc
Q 012832          235 GPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGR  314 (455)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (455)
                      .....   ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||..........      .+...      
T Consensus       154 ~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~------~i~~~------  218 (321)
T d1tkia_         154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------NIMNA------  218 (321)
T ss_dssp             CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHT------
T ss_pred             cccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC------
Confidence            64432   2334679999999999999999999999999999999999999998754321111      11110      


Q ss_pred             cCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          315 IMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                        ...+........+.++.+|+.+||..||++|||+.|+++|-+
T Consensus       219 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  260 (321)
T d1tkia_         219 --EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             --CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             --CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence              000111111234567899999999999999999999999843

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=395.40  Aligned_cols=267  Identities=25%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             HhcCCCCCcccccccCCeeEEEEEEcCCCCC-CcccccEEEEeccccch-hhHHHHHHHHHHHhcC-CCCCcccEEEEEE
Q 012832           75 VTTQSFSSSNFLGEGGFGAVHKGFIDDKLRP-GLQAQPVAVKNLDLEGL-QGHREWLTEVIFLGQL-RHPHLVKLIGYCC  151 (455)
Q Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~  151 (455)
                      +..++|.+.+.||+|+||.||+|......+. ...+..||||+++.+.. ....++.+|+..+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            4457899999999999999999976542211 23456799999976543 3456788899999888 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEE
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY--------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNIL  217 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nil  217 (455)
                      ++...++|||||++|+|.++|..+.              ...+++..++.++.||+.||+|||+.+  ||||||||+|||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiL  167 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL  167 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccccee
Confidence            9999999999999999999997553              245899999999999999999999977  999999999999


Q ss_pred             EcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCccchh
Q 012832          218 LDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQREQ  296 (455)
Q Consensus       218 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~~~~  296 (455)
                      ++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||........ 
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~-  246 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  246 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence            99999999999999987655444444455679999999999999999999999999999999998 7889876543211 


Q ss_pred             hHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          297 SLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                        ...    +.      .    ......+..++.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       247 --~~~----i~------~----~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         247 --FKL----LK------E----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             --HHH----HH------T----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHH----HH------c----CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              111    10      1    111223445567899999999999999999999999999765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=400.64  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=201.9

Q ss_pred             cCCCCCc-ccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhc-CCCCCcccEEEEEEe--
Q 012832           77 TQSFSSS-NFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQ-LRHPHLVKLIGYCCE--  152 (455)
Q Consensus        77 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~--  152 (455)
                      .++|.+. ++||+|+||.||+|...      .+++.||||+++..     ..+.+|+.++.+ ++|||||++++++.+  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~------~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNK------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEEC------CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            4678876 46999999999999643      36789999998532     345689988654 589999999999875  


Q ss_pred             --CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEc
Q 012832          153 --EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLS  227 (455)
Q Consensus       153 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~  227 (455)
                        ...+|||||||+||+|.++|..+....+++..+..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccc
Confidence              457899999999999999998765668999999999999999999999977  999999999999975   5679999


Q ss_pred             cCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhH
Q 012832          228 DFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLN  307 (455)
Q Consensus       228 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  307 (455)
                      |||+|+.......   ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.........+.       
T Consensus       157 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-------  226 (335)
T d2ozaa1         157 DFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------  226 (335)
T ss_dssp             CCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred             ccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-------
Confidence            9999987654332   234679999999999999999999999999999999999999997643321111000       


Q ss_pred             hhhhhcccCCC--cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          308 DARKLGRIMDP--RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       308 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                           ..+...  .++......++.++.+|+.+||+.||++|||+.++++|-+
T Consensus       227 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  274 (335)
T d2ozaa1         227 -----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  274 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred             -----HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence                 001111  1111122345778999999999999999999999999844

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=397.47  Aligned_cols=269  Identities=28%  Similarity=0.387  Sum_probs=218.7

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcC-CCCCcccEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQL-RHPHLVKLIGYC  150 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  150 (455)
                      +.+..++|.+.+.||+|+||.||+|.+... .+...+..||||+++... ......+.+|+.+++.+ +|||||+++++|
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEecc-ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344567899999999999999999987542 223567899999997543 34456788999999999 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCC
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRY----------------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKAS  214 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~  214 (455)
                      ......+||||||++|+|.+++....                ...+++..+..++.||+.||+|||+++  ||||||||+
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~  174 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR  174 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence            99999999999999999999987643                235889999999999999999999976  999999999


Q ss_pred             CEEEcCCCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCCCcc
Q 012832          215 NILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLS-GRKSVDKSRPQ  293 (455)
Q Consensus       215 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~p~~~~~~~  293 (455)
                      |||++.++.++|+|||+++...............||+.|+|||++.++.++.++|||||||++|||++ |.+||......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999998766554444455789999999999999999999999999999999998 56666554332


Q ss_pred             chhhHHHhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          294 REQSLVEWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      ...  ..    ++.          .......+...+.++.+||.+||+.||++|||+.+|++.|+..
T Consensus       255 ~~~--~~----~i~----------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 SKF--YK----MIK----------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHH--HH----HHH----------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH--HH----HHh----------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            111  11    111          1112223445567899999999999999999999999998754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=394.29  Aligned_cols=265  Identities=25%  Similarity=0.280  Sum_probs=197.6

Q ss_pred             CcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhh-----HHHHHHHHHHHhcCCCCCcccEEEEEEeCCeE
Q 012832           82 SSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQG-----HREWLTEVIFLGQLRHPHLVKLIGYCCEEEHR  156 (455)
Q Consensus        82 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  156 (455)
                      .+++||+|+||+||+|..      ..+++.||||+++......     ...+.+|+.+|+.++|||||++++++..++..
T Consensus         2 ~l~~lG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARD------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEEC------SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cceEeccCcCeEEEEEEE------CCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            357899999999999953      4468899999986543222     24578999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCC
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  236 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~  236 (455)
                      ||||||+.++++..++.  ....+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+|+...
T Consensus        76 ~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             eehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccC
Confidence            99999998877665443  3467899999999999999999999976  9999999999999999999999999998765


Q ss_pred             CCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh----hhHhhh
Q 012832          237 EGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP----MLNDAR  310 (455)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~----~~~~~~  310 (455)
                      .....  ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.........+.-. ..    .+....
T Consensus       152 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         152 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             CCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence            43322  2336799999999998654 5899999999999999999999999876543222111100 00    000000


Q ss_pred             hhcccC-CCcccC----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          311 KLGRIM-DPRLEG----QYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       311 ~~~~~~-~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...... ......    ......+.++.+|+.+||+.||++|||++|+++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence            000000 000000    011234568999999999999999999999999843

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=389.94  Aligned_cols=269  Identities=23%  Similarity=0.315  Sum_probs=203.8

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||.||+|...      .+++.||||+++....  .....+.+|+.+|++++|||||++++++.+...
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNK------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEEC------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            58999999999999999999643      4678999999865432  234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .|+||||+. |++.+++.......+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceec
Confidence            999999995 45666666666678999999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hh----hhHhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RP----MLNDA  309 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~----~~~~~  309 (455)
                      ......  .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+.-. ..    .....
T Consensus       153 ~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            443322  23357999999999887665 578999999999999999999999865432211111000 00    00000


Q ss_pred             hhhcccCC---CcccCC---CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          310 RKLGRIMD---PRLEGQ---YSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ........   ......   .....+.++.+|+.+||..||++|||++|+++|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~  284 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP  284 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence            00000000   000000   1123356889999999999999999999999983

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=393.76  Aligned_cols=260  Identities=26%  Similarity=0.382  Sum_probs=207.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcC-CCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQL-RHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  154 (455)
                      -++|++.+.||+|+||.||+|.+.+.    .....||||.+... .....+.+.+|+.+|..+ +|||||++++++...+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEET----TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCC----CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            36788999999999999999976542    12235788887533 333456789999999998 6999999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC
Q 012832          155 HRLLVYEYMPRGSLENQLFRR--------------YSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS  220 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~  220 (455)
                      .+++||||+++|+|.++|...              ....+++..++.++.||+.||.|||+.+  ||||||||+|||++.
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence            999999999999999998654              2367899999999999999999999966  999999999999999


Q ss_pred             CCceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCC-CCCCCCCccchhhHH
Q 012832          221 DYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGR-KSVDKSRPQREQSLV  299 (455)
Q Consensus       221 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~-~p~~~~~~~~~~~~~  299 (455)
                      ++.+||+|||+++.......   .....||..|+|||.+.++.++.++|||||||++|||++|. +||.......   +.
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~  236 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY  236 (309)
T ss_dssp             GGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH
T ss_pred             CCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH
Confidence            99999999999986543322   22356999999999999999999999999999999999965 5676543221   11


Q ss_pred             HhhhhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          300 EWARPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                      ...          ..    ......+..++.++.+||.+||+.||++|||+.+|+++|+.+..
T Consensus       237 ~~i----------~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         237 EKL----------PQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHG----------GG----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH----------Hh----cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            111          00    11223345567889999999999999999999999999987754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=393.19  Aligned_cols=270  Identities=25%  Similarity=0.392  Sum_probs=217.1

Q ss_pred             HHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc-chhhHHHHHHHHHHHhcCCCCCcccEEEEEE
Q 012832           73 LKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE-GLQGHREWLTEVIFLGQLRHPHLVKLIGYCC  151 (455)
Q Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  151 (455)
                      +++..++|.+.+.||+|+||.||+|.+... .....+..||||+++.. .......+.+|+.++++++||||+++++++.
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCc-ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            445568899999999999999999976431 11234578999999754 3344456899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCc
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRY--------SVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYT  223 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~  223 (455)
                      .++..++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.+  |+||||||+||||+.++.
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCce
Confidence            9999999999999999999886431        245788999999999999999999966  999999999999999999


Q ss_pred             eEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCCCccchhhHHHhh
Q 012832          224 AKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSG-RKSVDKSRPQREQSLVEWA  302 (455)
Q Consensus       224 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~p~~~~~~~~~~~~~~~~  302 (455)
                      +||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++| .+||...........+   
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i---  248 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---  248 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH---
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence            999999999876544433334446799999999999999999999999999999999998 4777654332111111   


Q ss_pred             hhhhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          303 RPMLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                                   .+.. ....+..++..+.+||.+||+.+|++|||+.+|+++|+...+
T Consensus       249 -------------~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 -------------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------------HhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                         0111 112244556789999999999999999999999999977643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=387.64  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEeccc-cchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-CeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDL-EGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-EHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~  160 (455)
                      .++||+|+||+||+|.+.+.   ..+...||||.++. .......+|.+|+++|++++||||++++|++... ...++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECC---CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            57899999999999987542   22345799999864 3445557899999999999999999999998764 5889999


Q ss_pred             EecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCCCCCCC
Q 012832          161 EYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDD  240 (455)
Q Consensus       161 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~~~~~~  240 (455)
                      |||++|+|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+||||++++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999977644 456788899999999999999999966  99999999999999999999999999987654432


Q ss_pred             c--cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhhhhhcccCCC
Q 012832          241 T--HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDARKLGRIMDP  318 (455)
Q Consensus       241 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (455)
                      .  .......||+.|+|||.+.++.++.++||||||+++|||++|..||......  .....   .+...       .  
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~---~i~~g-------~--  251 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV---YLLQG-------R--  251 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTT-------C--
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHcC-------C--
Confidence            2  1223356999999999999999999999999999999999987777543211  11111   11100       0  


Q ss_pred             cccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccccC
Q 012832          319 RLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLKD  362 (455)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~~  362 (455)
                        ....+..++.++.+|+.+||+.||++||++.||+++|+.+..
T Consensus       252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              112234556789999999999999999999999999988754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-51  Score=385.41  Aligned_cols=244  Identities=22%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch------hhHHHHHHHHHHHhcCC--CCCcccEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL------QGHREWLTEVIFLGQLR--HPHLVKLIG  148 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~~~~  148 (455)
                      .++|.+.+.||+|+||.||+|...      .+++.||||++.....      .....+.+|+.+|+.++  |||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRV------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEEC------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            467999999999999999999643      3578999999864321      11233568999999987  899999999


Q ss_pred             EEEeCCeEEEEEEecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-CCceEE
Q 012832          149 YCCEEEHRLLVYEYMPR-GSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-DYTAKL  226 (455)
Q Consensus       149 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-~~~~kL  226 (455)
                      ++..++..++||||+.+ +++.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+|||++. ++.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEE
Confidence            99999999999999976 5777777654  57999999999999999999999976  999999999999985 579999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHL-TSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~  305 (455)
                      +|||+|+......    .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     ..       
T Consensus       153 ~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------  216 (273)
T d1xwsa_         153 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------  216 (273)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------
T ss_pred             Cccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------
Confidence            9999998654322    334679999999999987765 677899999999999999999997421     00       


Q ss_pred             hHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          306 LNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ...            ...++...+.++.+|+.+||+.||++|||++|+++|-+
T Consensus       217 ~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         217 IRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             HHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             hhc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            000            01123344578999999999999999999999999843

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=386.15  Aligned_cols=269  Identities=26%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHH--HHHHHhcCCCCCcccEEEEEEeCC-
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLT--EVIFLGQLRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~nIv~~~~~~~~~~-  154 (455)
                      .+|.+.+.||+|+||.||+|.+        .++.||||+++....   ..+..  |+..+..++||||+++++++..++ 
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--------~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--------TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--------CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            4677888999999999999964        357899999865432   33334  555556789999999999998654 


Q ss_pred             ---eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCeEEeccCCCCEEEcCCCceE
Q 012832          155 ---HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDA------EKPVIYRDFKASNILLDSDYTAK  225 (455)
Q Consensus       155 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~iiHrDlkp~Nill~~~~~~k  225 (455)
                         ..|||||||++|+|.++|.+.   .+++..++.++.|++.||+|||+.      .++||||||||+||||+.++.+|
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             cceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence               589999999999999999764   689999999999999999999974      34699999999999999999999


Q ss_pred             EccCCCccCCCCCCCc--cceeccccCCCCcCccccccCC------CCccCchhhHHHHHHHHHhCCCCCCCCCccchhh
Q 012832          226 LSDFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEYVMTGH------LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQS  297 (455)
Q Consensus       226 L~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~  297 (455)
                      |+|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||++|.+||..........
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            9999999876443322  1233467999999999987643      5678999999999999999998875433211110


Q ss_pred             HH----HhhhhhhHhhhhhcccCCCcccCCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          298 LV----EWARPMLNDARKLGRIMDPRLEGQY-SETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       298 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                      ..    ......... ......+++.+...+ +...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       229 ~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         229 YDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             TTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHH-HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            00    000000000 111122233332222 3345677999999999999999999999999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=379.03  Aligned_cols=270  Identities=24%  Similarity=0.302  Sum_probs=201.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchh--hHHHHHHHHHHHhcC---CCCCcccEEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQ--GHREWLTEVIFLGQL---RHPHLVKLIGYCC  151 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~~  151 (455)
                      .++|++.+.||+|+||+||+|....     ..++.||||++......  ....+.+|+.+|+.|   +||||+++++++.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK-----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT-----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC-----CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            4789999999999999999996432     23567999998644221  223455677776655   7999999999985


Q ss_pred             e-----CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          152 E-----EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       152 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                      .     ....+++|||+.++.+.. ........+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeee
Confidence            3     246899999998776653 44444578999999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhh-
Q 012832          227 SDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPM-  305 (455)
Q Consensus       227 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~-  305 (455)
                      +|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.........+...... 
T Consensus       158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999999865432   2234478999999999999999999999999999999999999999876543222211110000 


Q ss_pred             ----hHh----hhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          306 ----LND----ARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       306 ----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                          +..    ...............+....+..+.+|+.+||+.||++|||+.|+++|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence                000    0000000001111123344567889999999999999999999999984

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.8e-49  Score=376.04  Aligned_cols=267  Identities=22%  Similarity=0.284  Sum_probs=201.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|.+.+.||+|+||+||+|...       +++.||||++.....  .....+.+|+.+|+.++||||+++++++..++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            58999999999999999999643       367899999865432  234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .+++|||+.++.+..+...  ...+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceec
Confidence            9999999977666554432  468999999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh-----hhhHhh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR-----PMLNDA  309 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~-----~~~~~~  309 (455)
                      ......  .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+....     ......
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            433221  2335699999999998764 56899999999999999999999998654322211111000     000000


Q ss_pred             hhhccc------CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          310 RKLGRI------MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       310 ~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      ......      ..+.....+....+.++.+|+.+||+.||++|||++|+++|-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            000000      001111122334567899999999999999999999999884

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-48  Score=372.46  Aligned_cols=264  Identities=17%  Similarity=0.161  Sum_probs=207.5

Q ss_pred             hcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC-CCcccEEEEEEeCC
Q 012832           76 TTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH-PHLVKLIGYCCEEE  154 (455)
Q Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~  154 (455)
                      ..++|.+.+.||+|+||.||+|...      .+++.||||++....  ....+.+|+++++.|.| +||+.+++++....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~------~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNL------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEET------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCCceEEEEEEecCCCeEEEEEEEC------CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            3578999999999999999999643      357899999875432  22346778999999975 89999999999999


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC-----CCceEEccC
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS-----DYTAKLSDF  229 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~-----~~~~kL~Df  229 (455)
                      ..++||||+ +++|.+++... ...++..++..++.|++.||+|||+.+  ||||||||+||||+.     ++.+||+||
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEccc
Confidence            999999999 78999877654 457999999999999999999999976  999999999999964     578999999


Q ss_pred             CCccCCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh
Q 012832          230 GLAKDGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP  304 (455)
Q Consensus       230 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~  304 (455)
                      |+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||.+...............
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            999865433221     122346799999999999999999999999999999999999999986654333222211110


Q ss_pred             hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccccc
Q 012832          305 MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPLK  361 (455)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~~  361 (455)
                         ....    .   ........+|.++.+++..|+..+|++||+++.+.+.|+.+.
T Consensus       231 ---~~~~----~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         231 ---KKQS----T---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             ---HHHH----S---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ---ccCC----C---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence               0000    0   000112234577999999999999999999999988876654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=378.57  Aligned_cols=263  Identities=22%  Similarity=0.285  Sum_probs=198.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  154 (455)
                      .++|.+.+.||+|+||+||+|...      .+++.||||+++...  ....+.+.+|+.+|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDG------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEET------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEEC------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            578999999999999999999643      357899999986432  234467889999999999999999999997654


Q ss_pred             ------eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          155 ------HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       155 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                            .+||||||+ +++|..++..   ..+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             cccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccc
Confidence                  479999999 6778776543   47999999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhh---
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARP---  304 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~---  304 (455)
                      ||+|+.....     .+...||+.|+|||++.+. .++.++|||||||++|+|++|++||.+...............   
T Consensus       165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            9999876443     2336799999999998764 578999999999999999999999987643322211111000   


Q ss_pred             -----------hhHhhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          305 -----------MLNDARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       305 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                                 ...............+ .......+.++.+||.+||..||++|||+.|+++|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp  302 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  302 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence                       0000011111111111 122334457789999999999999999999999993

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-48  Score=377.24  Aligned_cols=270  Identities=21%  Similarity=0.284  Sum_probs=199.0

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc-hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG-LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEE-  154 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-  154 (455)
                      +.+|.+++.||+|+||+||+|..      ..+++.||||++.... ....+.+++|+.+|+.++||||+++++++.... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYD------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEE------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCCeEEEEEEeeccCeEEEEEEE------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            45799999999999999999954      3467899999986443 344567889999999999999999999987653 


Q ss_pred             ---eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          155 ---HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       155 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                         ..+++|+|+.+|+|.+++...   .+++..+..++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCc
Confidence               234445556699999998653   6999999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCc-cceeccccCCCCcCccccc-cCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh---
Q 012832          232 AKDGPEGDDT-HVSTRVMGTQGYAAPEYVM-TGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML---  306 (455)
Q Consensus       232 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~---  306 (455)
                      +......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...................   
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            9865443221 1223467999999999985 4567899999999999999999999998765432222211110000   


Q ss_pred             --------HhhhhhcccCCCc--ccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          307 --------NDARKLGRIMDPR--LEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       307 --------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                              .............  .........+.++.+|+.+||+.||++|||+.++++|-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp  296 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  296 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                    0000000000000  00001122346789999999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.6e-48  Score=369.68  Aligned_cols=260  Identities=19%  Similarity=0.198  Sum_probs=198.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc-ccEEEEEEeCCeE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL-VKLIGYCCEEEHR  156 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~  156 (455)
                      ++|++.+.||+|+||.||+|...      .+++.||||++.....  ...+..|+++++.++|+|+ +.+.+++...+..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDI------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEEC------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            57999999999999999999653      3578999998765432  2357789999999987665 5555666788889


Q ss_pred             EEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcC---CCceEEccCCCcc
Q 012832          157 LLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDS---DYTAKLSDFGLAK  233 (455)
Q Consensus       157 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~---~~~~kL~DfGla~  233 (455)
                      ++||||+ +++|.+.+... ...+++..+..++.|++.||+|||+.+  ||||||||+|||++.   +..++|+|||+|+
T Consensus        79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9999999 66777665443 467999999999999999999999976  999999999999853   5679999999998


Q ss_pred             CCCCCCCc-----cceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh-hhhhH
Q 012832          234 DGPEGDDT-----HVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA-RPMLN  307 (455)
Q Consensus       234 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~-~~~~~  307 (455)
                      ........     .......||+.|||||++.+..++.++|||||||++|||++|..||............... .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            76443221     1233467999999999999999999999999999999999999999875443322222111 00000


Q ss_pred             hhhhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcccc
Q 012832          308 DARKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEPL  360 (455)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~~  360 (455)
                      .       .    .......+|.++.+|+.+||+.+|++||++.++.+.|+.+
T Consensus       235 ~-------~----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         235 T-------P----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             S-------C----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             C-------C----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0       0    0011233457899999999999999999999888777654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=375.81  Aligned_cols=264  Identities=24%  Similarity=0.293  Sum_probs=196.5

Q ss_pred             CCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-----
Q 012832           79 SFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-----  153 (455)
Q Consensus        79 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----  153 (455)
                      +|...++||+|+||+||+|...      .+++.||||++..+...    +.+|+.+|+.++||||+++++++...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~------~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC------CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            5888899999999999999654      35789999998654322    24699999999999999999998543     


Q ss_pred             -CeEEEEEEecCCCChHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCC
Q 012832          154 -EHRLLVYEYMPRGSLENQLF-RRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFG  230 (455)
Q Consensus       154 -~~~~lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfG  230 (455)
                       .+++||||||+++.+..+.. ......+++..+..++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEeccc
Confidence             35799999997654333322 233567999999999999999999999976  99999999999999765 89999999


Q ss_pred             CccCCCCCCCccceeccccCCCCcCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhh--h---h
Q 012832          231 LAKDGPEGDDTHVSTRVMGTQGYAAPEYVMT-GHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWA--R---P  304 (455)
Q Consensus       231 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~--~---~  304 (455)
                      +++.......   .....||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...........+...  .   .
T Consensus       169 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         169 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            9987644332   233679999999998875 46899999999999999999999999876533222111100  0   0


Q ss_pred             hhHhh-hhh-----cccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          305 MLNDA-RKL-----GRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       305 ~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .+... ...     .......+........+.++.+|+.+||..||++|||+.|+++|-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            00000 000     000001111122334567899999999999999999999999983

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=370.14  Aligned_cols=272  Identities=21%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch--hhHHHHHHHHHHHhcCCCCCcccEEEEEEe--
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL--QGHREWLTEVIFLGQLRHPHLVKLIGYCCE--  152 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--  152 (455)
                      .++|.+.+.||+|+||+||+|...      .+++.||||++.....  .....+.+|+.+|+.++||||+++++++..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            368999999999999999999653      3578999999854422  334668899999999999999999998855  


Q ss_pred             ------CCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEE
Q 012832          153 ------EEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKL  226 (455)
Q Consensus       153 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL  226 (455)
                            ....++||||+.++.+....  .....+++..+..++.||+.||.|||+.+  |+||||||+||||+.++.+||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEE
T ss_pred             ccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEe
Confidence                  34689999999776665332  33467899999999999999999999976  999999999999999999999


Q ss_pred             ccCCCccCCCCCCCc--cceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhh
Q 012832          227 SDFGLAKDGPEGDDT--HVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWAR  303 (455)
Q Consensus       227 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~  303 (455)
                      +|||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.........+....
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~  238 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  238 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999765433221  112235799999999998765 68999999999999999999999998754433222221110


Q ss_pred             hhhHhhhhhcccC--------CCcc--cCCCCH-----HHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          304 PMLNDARKLGRIM--------DPRL--EGQYSE-----TGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       304 ~~~~~~~~~~~~~--------~~~~--~~~~~~-----~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                      ..... .......        ....  ......     ....++.+|+.+||+.||++|||++|+++|-+.
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         239 GSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             CCCCT-TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCCCh-hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            00000 0000000        0000  000000     113467899999999999999999999999543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-48  Score=372.49  Aligned_cols=260  Identities=27%  Similarity=0.323  Sum_probs=208.4

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc----hhhHHHHHHHHHHHhcCCC-CCcccEEEEEE
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG----LQGHREWLTEVIFLGQLRH-PHLVKLIGYCC  151 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~  151 (455)
                      .++|.+.+.||+|+||+||+|....   ++.+++.||||+++...    ....+.+.+|+.+|++++| |||+++++++.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKIS---GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECS---STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             hhceEEEEEEecCCCeEEEEEEECc---cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            3679999999999999999996532   24568899999986432    2234557789999999976 89999999999


Q ss_pred             eCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCC
Q 012832          152 EEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGL  231 (455)
Q Consensus       152 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGl  231 (455)
                      +....++||||+.+|+|.+++...  ..+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             cCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999999998765  46788999999999999999999976  99999999999999999999999999


Q ss_pred             ccCCCCCCCccceeccccCCCCcCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhhHhh
Q 012832          232 AKDGPEGDDTHVSTRVMGTQGYAAPEYVMTG--HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPMLNDA  309 (455)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  309 (455)
                      ++........ ......||+.|+|||.+.+.  .++.++|||||||+||+|++|..||...........+.-.  ..   
T Consensus       176 a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~---  249 (322)
T d1vzoa_         176 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--IL---  249 (322)
T ss_dssp             EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HH---
T ss_pred             hhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cc---
Confidence            9866443322 23346799999999999765  4688999999999999999999999876543322221100  00   


Q ss_pred             hhhcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHhcc
Q 012832          310 RKLGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRP-----TMSTVVKTLE  358 (455)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----t~~ell~~L~  358 (455)
                               .....++..++.++.+|+.+||+.||++||     |++|+++|-+
T Consensus       250 ---------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         250 ---------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             ---------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ---------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence                     001123445678899999999999999999     5899998844

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.8e-47  Score=367.74  Aligned_cols=262  Identities=18%  Similarity=0.234  Sum_probs=200.1

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeC--C
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEE--E  154 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~  154 (455)
                      ++|++.+.||+|+||+||+|..      ..+++.||||+++...   ...+.+|+.+|+.++ ||||+++++++...  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~------~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAIN------ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEEE------CCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            5799999999999999999954      3468899999986533   456789999999996 99999999999754  5


Q ss_pred             eEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCC-ceEEccCCCcc
Q 012832          155 HRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDY-TAKLSDFGLAK  233 (455)
Q Consensus       155 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~-~~kL~DfGla~  233 (455)
                      ..++|||||.+++|..+.     ..+++..+..++.||+.||+|||+++  ||||||||+||||+.++ .+||+|||+|.
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccce
Confidence            689999999999987642     46899999999999999999999977  99999999999998654 69999999998


Q ss_pred             CCCCCCCccceeccccCCCCcCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHH--Hhhh-hhhHh-
Q 012832          234 DGPEGDDTHVSTRVMGTQGYAAPEYVMTG-HLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLV--EWAR-PMLND-  308 (455)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~--~~~~-~~~~~-  308 (455)
                      .......   .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||............  .... +.... 
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            7654332   2336799999999998765 4799999999999999999999999765432221111  0000 00000 


Q ss_pred             hh--------hhcccCC--------CcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          309 AR--------KLGRIMD--------PRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       309 ~~--------~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                      ..        .......        ...........+.++.+||.+||..||++|||++|+++|-+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            00        0000000        00111122334678999999999999999999999999854

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=358.81  Aligned_cols=268  Identities=20%  Similarity=0.223  Sum_probs=205.7

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeCCe
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEH  155 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  155 (455)
                      ++|++.+.||+|+||+||+|...      .+++.||||+++...  ......+.+|+.+|+.++||||+++++++.....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            57999999999999999999643      357889999986443  3345778899999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccCCCccCC
Q 012832          156 RLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  235 (455)
Q Consensus       156 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~DfGla~~~  235 (455)
                      .++||+++.+++|..++..  ...+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+||+|||.++..
T Consensus        76 ~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcc
Confidence            9999999999888876644  467899999999999999999999976  999999999999999999999999999876


Q ss_pred             CCCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccch-hhHHHhhh-h----hhHh
Q 012832          236 PEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQRE-QSLVEWAR-P----MLND  308 (455)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~-~~~~~~~~-~----~~~~  308 (455)
                      ......  .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...+.... .    ....
T Consensus       152 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         152 GIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             cCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence            544322  22346788999999987665 68999999999999999999998754332211 11111000 0    0000


Q ss_pred             hhhhccc------CCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhc
Q 012832          309 ARKLGRI------MDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTL  357 (455)
Q Consensus       309 ~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L  357 (455)
                      .......      .............+..+.+|+.+||+.||++|||++|+++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp  284 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence            0000000      000011122334457889999999999999999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=369.09  Aligned_cols=265  Identities=22%  Similarity=0.291  Sum_probs=198.5

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccc--hhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEG--LQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      +++|++.+.||+|+||+||+|..      ..+++.||||+++...  ......+.+|+.+|+.++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFD------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEE------TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            57899999999999999999954      3468899999986543  33446688999999999999999999998643 


Q ss_pred             ----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEccC
Q 012832          154 ----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSDF  229 (455)
Q Consensus       154 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~Df  229 (455)
                          ...+++|+|+.||+|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccccccccccc
Confidence                344667777889999998854   36999999999999999999999976  999999999999999999999999


Q ss_pred             CCccCCCCCCCccceeccccCCCCcCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHHhhhhhh--
Q 012832          230 GLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGH-LTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVEWARPML--  306 (455)
Q Consensus       230 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~~~~~~~--  306 (455)
                      |++......     .....||+.|+|||.+.+.. ++.++|||||||++|+|++|++||.+.+.......+.......  
T Consensus       166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            999765332     23367999999999877654 6889999999999999999999998765432222221110000  


Q ss_pred             --------Hhhhh----hcccCCCcccCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhcc
Q 012832          307 --------NDARK----LGRIMDPRLEGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLE  358 (455)
Q Consensus       307 --------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~  358 (455)
                              .....    ........+. ......+.++.+||.+||..||++|||+.|+++|-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~  303 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  303 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence                    00000    0000000000 001234567899999999999999999999999844

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=365.52  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=193.6

Q ss_pred             cCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc--chhhHHHHHHHHHHHhcCCCCCcccEEEEEEeC-
Q 012832           77 TQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE--GLQGHREWLTEVIFLGQLRHPHLVKLIGYCCEE-  153 (455)
Q Consensus        77 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-  153 (455)
                      .++|.+.+.||+|+||+||+|..      ..+++.||||++...  .......+.+|+.+|+.++||||+++++++... 
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d------~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYD------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEE------TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEE------CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            47899999999999999999954      346889999998643  233445688999999999999999999998643 


Q ss_pred             -----CeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCCCceEEcc
Q 012832          154 -----EHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSDYTAKLSD  228 (455)
Q Consensus       154 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~~~~kL~D  228 (455)
                           ..+|+|||||.++ |.+.+.    ..+++..+..++.||+.||+|||+.|  |+||||||+|||++.++.++++|
T Consensus        90 ~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeec
Confidence                 6789999999655 444443    46899999999999999999999977  99999999999999999999999


Q ss_pred             CCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchhhHHH--------
Q 012832          229 FGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQSLVE--------  300 (455)
Q Consensus       229 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~~~~~--------  300 (455)
                      ||+++......   .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+.        
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            99988655432   2334679999999999999999999999999999999999999997654322211110        


Q ss_pred             -hhhhhhHhhh----hh--------cccCCCcc---cCCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHhccc
Q 012832          301 -WARPMLNDAR----KL--------GRIMDPRL---EGQYSETGARKAAALAYQCLSHRPKQRPTMSTVVKTLEP  359 (455)
Q Consensus       301 -~~~~~~~~~~----~~--------~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~RPt~~ell~~L~~  359 (455)
                       +.........    ..        ........   ........+.++.+|+.+||..||++|||++|+++|-+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~  314 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  314 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence             0000000000    00        00000000   001123457789999999999999999999999999543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-41  Score=334.65  Aligned_cols=266  Identities=19%  Similarity=0.225  Sum_probs=193.4

Q ss_pred             CCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-----------CCCcccE
Q 012832           78 QSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-----------HPHLVKL  146 (455)
Q Consensus        78 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~  146 (455)
                      ++|.+++.||+|+||+||+|..      ..+++.||||+++.+.. ..+.+.+|+.+|+.++           |+||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~------~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKD------MVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEE------CCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            4699999999999999999954      44688999999975543 2356678888888775           5789999


Q ss_pred             EEEEEe--CCeEEEEEEecCCCC-hHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCeEEeccCCCCEEEcCCC
Q 012832          147 IGYCCE--EEHRLLVYEYMPRGS-LENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHD-AEKPVIYRDFKASNILLDSDY  222 (455)
Q Consensus       147 ~~~~~~--~~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~iiHrDlkp~Nill~~~~  222 (455)
                      ++++..  ....+++|+++..+. ............+++..+..++.||+.||+|||+ .+  |+||||||+||||+.++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccC
Confidence            988754  356677777765553 3333444455788999999999999999999997 55  99999999999997654


Q ss_pred             ------ceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCCCccchh
Q 012832          223 ------TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLLELLSGRKSVDKSRPQREQ  296 (455)
Q Consensus       223 ------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~p~~~~~~~~~~  296 (455)
                            .++|+|||.+.......     ...+||+.|+|||++.+..++.++||||+||++++|++|+.||.........
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence                  39999999998654322     2367999999999999999999999999999999999999999765332111


Q ss_pred             hHHHhhhhh-----------hHhhhh---------hcccCCC----------cccCCCCHHHHHHHHHHHHHHhccCCCC
Q 012832          297 SLVEWARPM-----------LNDARK---------LGRIMDP----------RLEGQYSETGARKAAALAYQCLSHRPKQ  346 (455)
Q Consensus       297 ~~~~~~~~~-----------~~~~~~---------~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~P~~  346 (455)
                      .........           ......         ....+..          .....+....+.++.+|+.+||..||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            111100000           000000         0000000          0112345677889999999999999999


Q ss_pred             CCCHHHHHHhc
Q 012832          347 RPTMSTVVKTL  357 (455)
Q Consensus       347 RPt~~ell~~L  357 (455)
                      |||+.|+++|-
T Consensus       319 Rpta~e~L~Hp  329 (362)
T d1q8ya_         319 RADAGGLVNHP  329 (362)
T ss_dssp             CBCHHHHHTCG
T ss_pred             CcCHHHHhcCc
Confidence            99999999984

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.7e-25  Score=199.09  Aligned_cols=171  Identities=15%  Similarity=0.116  Sum_probs=119.4

Q ss_pred             CCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccch------------------hhHHHHHHHHHHHhcCCCC
Q 012832           80 FSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGL------------------QGHREWLTEVIFLGQLRHP  141 (455)
Q Consensus        80 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  141 (455)
                      +.+.+.||+|+||.||+|...       +++.||||+++....                  ........|+..+..+.|.
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   74 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL   74 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred             chhCCEeeeCcceEEEEEECC-------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence            346789999999999999643       367899998643211                  0112345688899999999


Q ss_pred             CcccEEEEEEeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCeEEeccCCCCEEEcCC
Q 012832          142 HLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAEKPVIYRDFKASNILLDSD  221 (455)
Q Consensus       142 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~iiHrDlkp~Nill~~~  221 (455)
                      +++..+++.  .  .++||||++++.+.+         ++......++.|++.+|+|||+.+  |+||||||+|||++++
T Consensus        75 ~v~~~~~~~--~--~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~  139 (191)
T d1zara2          75 AVPKVYAWE--G--NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             SSCCEEEEE--T--TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT
T ss_pred             CcceEEEec--C--CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC
Confidence            999988653  2  379999998765432         344566789999999999999977  9999999999999865


Q ss_pred             CceEEccCCCccCCCCCCCccceeccccCCCCcCccccccCCCCccCchhhHHHHHH
Q 012832          222 YTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYVMTGHLTSMSDVYSFGVVLL  278 (455)
Q Consensus       222 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  278 (455)
                       .++|+|||+|.............+-+.   . -.+. ....|+.++|+||+.--+.
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHHHh
Confidence             589999999976543221110000000   0 0011 1356788999999875543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.80  E-value=1.3e-08  Score=92.67  Aligned_cols=148  Identities=14%  Similarity=0.026  Sum_probs=101.8

Q ss_pred             HHHHhcCCCCCcccccccCCeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEE
Q 012832           72 ELKVTTQSFSSSNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYC  150 (455)
Q Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~  150 (455)
                      +++.....|+..+..+.++.+.||+..        ..+..+++|+...........+.+|...+..+. +--+++++.++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~--------~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLV--------GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEE--------CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEE--------eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            445555677777776666678999863        234568889876544333445667888877765 43467888888


Q ss_pred             EeCCeEEEEEEecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------
Q 012832          151 CEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWSTRMKIALGAAKGLAFLHDAE---------------------------  203 (455)
Q Consensus       151 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------  203 (455)
                      ..++..++||++++|.++.+....       ......++.+++..|..||+..                           
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            888999999999998887654321       1122334555555566666311                           


Q ss_pred             ------------------------------CCeEEeccCCCCEEEcCCCceEEccCCCccC
Q 012832          204 ------------------------------KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  234 (455)
Q Consensus       204 ------------------------------~~iiHrDlkp~Nill~~~~~~kL~DfGla~~  234 (455)
                                                    ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                          1278999999999999877677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=5.5e-06  Score=74.31  Aligned_cols=74  Identities=19%  Similarity=0.055  Sum_probs=49.5

Q ss_pred             ccccC-CeeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCC--CCcccEEEEEEeCCeEEEEEEe
Q 012832           86 LGEGG-FGAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRH--PHLVKLIGYCCEEEHRLLVYEY  162 (455)
Q Consensus        86 LG~G~-fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~  162 (455)
                      +..|. -+.||+....       .+..+++|........   .+..|+..|+.+..  -.+++++.++.+++..++||++
T Consensus        18 ~~~G~s~~~v~r~~~~-------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECT-------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeC-------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            44444 3678987422       2456888976544322   35567777776653  3367788888888889999999


Q ss_pred             cCCCChH
Q 012832          163 MPRGSLE  169 (455)
Q Consensus       163 ~~~g~L~  169 (455)
                      ++|.++.
T Consensus        88 i~G~~~~   94 (255)
T d1nd4a_          88 VPGQDLL   94 (255)
T ss_dssp             CSSEETT
T ss_pred             eeccccc
Confidence            9886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.88  E-value=2.1e-05  Score=75.43  Aligned_cols=78  Identities=14%  Similarity=0.112  Sum_probs=47.0

Q ss_pred             cccccccCCeeEEEEEEcCCCCCCcccccEEEEecccc----c---hhhHHHHHHHHHHHhcCC-C--CCcccEEEEEEe
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRPGLQAQPVAVKNLDLE----G---LQGHREWLTEVIFLGQLR-H--PHLVKLIGYCCE  152 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~  152 (455)
                      .+.||.|....||+....+      .++.|+||.-...    .   .....+...|.+.|+.+. +  ..+++++.+  +
T Consensus        31 ~~eig~G~~N~vfrV~~~~------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEeCCCceEeEEEEEeCC------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            3468999999999984322      3567899864211    1   111233456777777653 2  345666654  4


Q ss_pred             CCeEEEEEEecCCCCh
Q 012832          153 EEHRLLVYEYMPRGSL  168 (455)
Q Consensus       153 ~~~~~lv~e~~~~g~L  168 (455)
                      ++..++|||++++..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            5566899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.03  E-value=0.00087  Score=63.79  Aligned_cols=80  Identities=15%  Similarity=0.132  Sum_probs=50.5

Q ss_pred             cccccccCCeeEEEEEEcCCCCC-CcccccEEEEeccccchhhHHHHHHHHHHHhcCC-CCCcccEEEEEEeCCeEEEEE
Q 012832           83 SNFLGEGGFGAVHKGFIDDKLRP-GLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLR-HPHLVKLIGYCCEEEHRLLVY  160 (455)
Q Consensus        83 ~~~LG~G~fG~Vy~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  160 (455)
                      ++.|+.|-.=.+|++...+.... +.....|++++.. . ........+|..+++.+. +.-.+++++++.+    ++||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            35688888899999876543211 1234557777654 2 222234457888888886 4334577776632    6899


Q ss_pred             EecCCCCh
Q 012832          161 EYMPRGSL  168 (455)
Q Consensus       161 e~~~~g~L  168 (455)
                      ||++|.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.77  E-value=0.0022  Score=59.19  Aligned_cols=68  Identities=15%  Similarity=0.027  Sum_probs=41.8

Q ss_pred             eeEEEEEEcCCCCCCcccccEEEEeccccchhhHHHHHHHHHHHhcCCCCCc--ccEE-----EEEEeCCeEEEEEEecC
Q 012832           92 GAVHKGFIDDKLRPGLQAQPVAVKNLDLEGLQGHREWLTEVIFLGQLRHPHL--VKLI-----GYCCEEEHRLLVYEYMP  164 (455)
Q Consensus        92 G~Vy~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~-----~~~~~~~~~~lv~e~~~  164 (455)
                      =.||++...       .|..|++|+.... .-....+..|...+..|...+|  +..+     ..+......+.++++++
T Consensus        36 N~vy~v~~~-------dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          36 NRVYQFQDE-------DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SEEEEECCT-------TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             ceeEEEEcC-------CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            479987433       3678999987543 2234556678877777652222  1111     12345677889999997


Q ss_pred             CCC
Q 012832          165 RGS  167 (455)
Q Consensus       165 ~g~  167 (455)
                      |..
T Consensus       108 G~~  110 (325)
T d1zyla1         108 GRQ  110 (325)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.73  E-value=0.046  Score=49.38  Aligned_cols=30  Identities=30%  Similarity=0.288  Sum_probs=26.8

Q ss_pred             CCeEEeccCCCCEEEcCCCceEEccCCCcc
Q 012832          204 KPVIYRDFKASNILLDSDYTAKLSDFGLAK  233 (455)
Q Consensus       204 ~~iiHrDlkp~Nill~~~~~~kL~DfGla~  233 (455)
                      .++||+|+.+.||+++++...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            359999999999999998878899999875